Citrus Sinensis ID: 015005
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | 2.2.26 [Sep-21-2011] | |||||||
| Q8W1D5 | 488 | CBL-interacting serine/th | yes | no | 0.990 | 0.840 | 0.680 | 1e-177 | |
| Q9LEU7 | 445 | CBL-interacting serine/th | no | no | 0.980 | 0.912 | 0.675 | 1e-173 | |
| Q6ERS4 | 456 | CBL-interacting protein k | yes | no | 0.990 | 0.899 | 0.588 | 1e-153 | |
| Q9SEZ7 | 469 | CBL-interacting serine/th | no | no | 0.975 | 0.861 | 0.602 | 1e-150 | |
| Q9LWM4 | 461 | CBL-interacting protein k | yes | no | 0.978 | 0.878 | 0.563 | 1e-143 | |
| Q9FJ54 | 439 | CBL-interacting serine/th | no | no | 0.954 | 0.899 | 0.593 | 1e-141 | |
| Q7X996 | 443 | CBL-interacting protein k | no | no | 0.971 | 0.907 | 0.576 | 1e-141 | |
| Q5W736 | 457 | CBL-interacting protein k | no | no | 0.983 | 0.890 | 0.579 | 1e-141 | |
| Q10LQ2 | 451 | CBL-interacting protein k | no | no | 0.975 | 0.895 | 0.564 | 1e-135 | |
| O65554 | 441 | CBL-interacting serine/th | no | no | 0.951 | 0.893 | 0.568 | 1e-131 |
| >sp|Q8W1D5|CIPKP_ARATH CBL-interacting serine/threonine-protein kinase 25 OS=Arabidopsis thaliana GN=CIPK25 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 620 bits (1599), Expect = e-177, Method: Compositional matrix adjust.
Identities = 301/442 (68%), Positives = 362/442 (81%), Gaps = 32/442 (7%)
Query: 5 TMDERVRN--ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQ 62
TM+E + +LF KYEMGR+LG+GTF KVYYGK + T ESVAIK+INKDQVK++G+MEQ
Sbjct: 28 TMEEEQQQLRVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQ 87
Query: 63 IKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQ 122
IKREIS+MRLV+HPNIVELKEVMATKTK+FF++EYVKGGELF+K++KGKLKE+SARKYFQ
Sbjct: 88 IKREISIMRLVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIVKGKLKEDSARKYFQ 147
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
QLISAVDFCHSRGV HRDLKPENLL+DENG+LKVSDFGLSALPEQ+ DGLLHTQCGTPA
Sbjct: 148 QLISAVDFCHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPA 207
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWIS 242
YVAPEVLRKKGYDGAK DIWSCG++L+VLL+GFLPFQ+EN+MKMYRKIFK+E+E+PPW S
Sbjct: 208 YVAPEVLRKKGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFS 267
Query: 243 CDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRD----------- 291
+++RLIS++LV DP KRIS+ IM PWF K + P+ ID+ + ++
Sbjct: 268 PESKRLISKLLVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVEDETPTTTAT 327
Query: 292 ------------------FISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLA 333
FISSMSSGFDLSSLFES+RK SMFTS+ S+S IMGKLE +
Sbjct: 328 TATTTTTPVSPKFFNAFEFISSMSSGFDLSSLFESKRKLRSMFTSRWSASEIMGKLEGIG 387
Query: 334 KKLNLGV-CVKEFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFC 392
K++N+ V K+FKVK+ GK EGRKG++AVTAEV+EVAPEVAVVE KSAGDTLEY +
Sbjct: 388 KEMNMKVKRTKDFKVKLFGKTEGRKGQIAVTAEVFEVAPEVAVVELCKSAGDTLEYNRLY 447
Query: 393 EEDVRPALKDIVWSWQGENNSQ 414
EE VRPAL++IVWSW G+N++
Sbjct: 448 EEHVRPALEEIVWSWHGDNHNN 469
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LEU7|CIPK5_ARATH CBL-interacting serine/threonine-protein kinase 5 OS=Arabidopsis thaliana GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 609 bits (1570), Expect = e-173, Method: Compositional matrix adjust.
Identities = 296/438 (67%), Positives = 358/438 (81%), Gaps = 32/438 (7%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV-KKQGLMEQIKRE 66
E R +LFGKYEMGR+LG+GTFAKVYYGK ++ E VAIKVINKDQV K+ G+MEQIKRE
Sbjct: 2 EEERRVLFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKRE 61
Query: 67 ISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLIS 126
IS+M+LV+HPNIVELKEVMATKTK+FFV+E+VKGGELF K+ KGKL E++AR+YFQQLIS
Sbjct: 62 ISIMKLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKISKGKLHEDAARRYFQQLIS 121
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
AVD+CHSRGV HRDLKPENLLLDENG+LK+SDFGLSALPEQ+ DGLLHTQCGTPAYVAP
Sbjct: 122 AVDYCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVAP 181
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDAR 246
EVL+KKGYDGAK+DIWSCGVVL+VLL+G LPFQ+EN+M MYRKIF+A++EFPPW S +AR
Sbjct: 182 EVLKKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEAR 241
Query: 247 RLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCID----------------DGDNR 290
RLIS++LV DP +RIS+ IM PW K F+ P+A ID DGD
Sbjct: 242 RLISKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDEPICSQSSKNNEEEEEDGDCE 301
Query: 291 D--------------FISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKL 336
+ FISSMSSGFDLSSLFES+RK S+FTS+ S++ +M K+E++ K++
Sbjct: 302 NQTEPISPKFFNAFEFISSMSSGFDLSSLFESKRKVQSVFTSRSSATEVMEKIETVTKEM 361
Query: 337 NLGV-CVKEFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEED 395
N+ V K+FKVKM+GK EGRKG+L++TAEV+EVAPE++VVEF KSAGDTLEY + EE+
Sbjct: 362 NMKVKRTKDFKVKMEGKTEGRKGRLSMTAEVFEVAPEISVVEFCKSAGDTLEYDRLYEEE 421
Query: 396 VRPALKDIVWSWQGENNS 413
VRPAL DIVWSW G+NN+
Sbjct: 422 VRPALNDIVWSWHGDNNN 439
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ERS4|CIPKG_ORYSJ CBL-interacting protein kinase 16 OS=Oryza sativa subsp. japonica GN=CIPK16 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 541 bits (1394), Expect = e-153, Method: Compositional matrix adjust.
Identities = 256/435 (58%), Positives = 333/435 (76%), Gaps = 25/435 (5%)
Query: 4 ETMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK-QGLMEQ 62
E D+ R ++ G+YE+GR+LGQGTFAKVYYG++L + ESVAIKVI+K ++++ +G++EQ
Sbjct: 8 EEADQVERKLVLGRYELGRLLGQGTFAKVYYGRDLRSGESVAIKVIDKARLRRTEGMVEQ 67
Query: 63 IKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQ 122
++REIS+MR+V+HPN+V ++EV+A++ +VF V+EY +GGELFAKV +G+L EE AR+YFQ
Sbjct: 68 LRREISIMRMVRHPNVVGIREVLASRARVFVVMEYARGGELFAKVARGRLTEEHARRYFQ 127
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
QL++AV FCH RGV HRDLKPENLLLDE G LKV+DFGL+ALPEQL DGLLHTQCGTPA
Sbjct: 128 QLVAAVGFCHGRGVAHRDLKPENLLLDEEGRLKVTDFGLAALPEQLRQDGLLHTQCGTPA 187
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWIS 242
YVAPEVLRK+GYDGA++D+WSCGVVL+VLL GFLPFQ+EN KMY+KIFKAEY+ PPW+S
Sbjct: 188 YVAPEVLRKRGYDGARADLWSCGVVLYVLLCGFLPFQHENYAKMYQKIFKAEYQVPPWVS 247
Query: 243 CDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVA-------------VCIDDGDN 289
DARRLI R+LV DP KRIS+ EIM PWF KGF PV V +D GD+
Sbjct: 248 GDARRLIVRLLVVDPAKRISIPEIMRTPWFKKGFVPPVPTSPVSPKKWEEDDVLLDGGDS 307
Query: 290 R----------DFISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNLG 339
ISSMSSGFDLS +FESE+K+ ++FTS+ ++ ++ KLE++ + L
Sbjct: 308 GAMSPRTCNAFQLISSMSSGFDLSGMFESEQKAATVFTSRAPAATVIQKLEAVGRSLGYS 367
Query: 340 VCV-KEFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRP 398
K +K++++ +G G+LAVT E EVA +VAVVEF+ AGD LE+ KFC DVRP
Sbjct: 368 ATRGKGWKLRLEATADGANGRLAVTVEALEVAADVAVVEFAHDAGDELEFNKFCAVDVRP 427
Query: 399 ALKDIVWSWQGENNS 413
L DIVW+WQG+ +
Sbjct: 428 GLADIVWAWQGDRPA 442
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SEZ7|CIPKG_ARATH CBL-interacting serine/threonine-protein kinase 16 OS=Arabidopsis thaliana GN=CIPK16 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 530 bits (1366), Expect = e-150, Method: Compositional matrix adjust.
Identities = 267/443 (60%), Positives = 338/443 (76%), Gaps = 39/443 (8%)
Query: 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV-KKQGLMEQIKREI 67
R +LF KY +GR+LG G FAKVY+G + T + VAIKVI KD V K++G+MEQI+REI
Sbjct: 6 RSSTVLFDKYNIGRLLGTGNFAKVYHGTEISTGDDVAIKVIKKDHVFKRRGMMEQIEREI 65
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLIS 126
+VMRL++HPN+VEL+EVMATK K+FFV+EYV GGELF + + GKL E+ ARKYFQQLIS
Sbjct: 66 AVMRLLRHPNVVELREVMATKKKIFFVMEYVNGGELFEMIDRDGKLPEDLARKYFQQLIS 125
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL--PEQLW-----NDGLLHTQCG 179
AVDFCHSRGV+HRD+KPENLLLD G+LKV+DFGLSAL PE L +D LLHT+CG
Sbjct: 126 AVDFCHSRGVFHRDIKPENLLLDGEGDLKVTDFGLSALMMPEGLGGRRGSSDDLLHTRCG 185
Query: 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP 239
TPAYVAPEVLR KGYDGA +DIWSCG+VL+ LL+GFLPF +EN+M +Y KIFKAE EFPP
Sbjct: 186 TPAYVAPEVLRNKGYDGAMADIWSCGIVLYALLAGFLPFIDENVMTLYTKIFKAECEFPP 245
Query: 240 WISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCID-------------- 285
W S +++ L+SR+LV DP++RIS+SEI + PWF K F+ VA ID
Sbjct: 246 WFSLESKELLSRLLVPDPEQRISMSEIKMIPWFRKNFTPSVAFSIDETIPSPPEPPTKKK 305
Query: 286 ---------DG------DNRDFISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLE 330
DG + FI+SMSSGFDLS+LFE +RK MFTSK + ++ +LE
Sbjct: 306 KKDLNEKEDDGASPRSFNAFQFITSMSSGFDLSNLFEIKRKPKRMFTSKFPAKSVKERLE 365
Query: 331 SLAKKLNLGV-CVKEFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYK 389
+ A+++++ V VK+ K+K+Q + EGRKG+L+VTAEV+EVAPEV+VVEF K++GDTLEY
Sbjct: 366 TAAREMDMRVKHVKDCKMKLQRRTEGRKGRLSVTAEVFEVAPEVSVVEFCKTSGDTLEYY 425
Query: 390 KFCEEDVRPALKDIVWSWQGENN 412
FCE+DVRPALKDIVWSWQG+++
Sbjct: 426 LFCEDDVRPALKDIVWSWQGDDD 448
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LWM4|CIPK5_ORYSJ CBL-interacting protein kinase 5 OS=Oryza sativa subsp. japonica GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 509 bits (1310), Expect = e-143, Method: Compositional matrix adjust.
Identities = 249/442 (56%), Positives = 327/442 (73%), Gaps = 37/442 (8%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREI 67
E+ +IL +YE+GRMLGQGTFAKVY+ +NL + +SVAIKVI+K++V + G+++QIKREI
Sbjct: 2 EKKASILMNRYELGRMLGQGTFAKVYHARNLASNQSVAIKVIDKEKVLRVGMIDQIKREI 61
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISA 127
S+MRLV+HPNIV+L EVMA+K+K++F +EYV+GGELF++V +G+LKE++ARKYFQQLI A
Sbjct: 62 SIMRLVRHPNIVQLHEVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIGA 121
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187
VDFCHSRGVYHRDLKPENLL+DENGNLKVSDFGLSA E DGLLHT CGTPAYVAPE
Sbjct: 122 VDFCHSRGVYHRDLKPENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAPE 181
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARR 247
++ K+GYDGAK+DIWSCGV+LFVLL+G+LPF + N+M+MYRKI K + +FP W + D RR
Sbjct: 182 IINKRGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVRR 241
Query: 248 LISRILVADPQKRISVSEIMINPWFIKGF------SKP----------VAVCIDDGDNR- 290
L+SR+L +P RI+V +++ +PWF KG+ S+P A D DN
Sbjct: 242 LLSRLLDPNPNIRITVEKLVEHPWFKKGYKPAVMLSQPNESNNLKDVHTAFSADHKDNEG 301
Query: 291 -----------------DFISSMSSGFDLSSLFES--ERKSGSMFTSKCSSSAIMGKLES 331
D I S+S GFDLS LFE+ E+K+ S F ++ +SAI+ KLE
Sbjct: 302 KAKEPASSLKPVSLNAFDII-SLSKGFDLSGLFENDKEQKADSRFMTQKPASAIVSKLEQ 360
Query: 332 LAKKLNLGVCVKEFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKF 391
+A+ + V ++ VK+QG EGRKG+LA+ AE++EV P VVE KSAGDTLEY+KF
Sbjct: 361 IAETESFKVKKQDGLVKLQGSKEGRKGQLAIDAEIFEVTPSFFVVEVKKSAGDTLEYEKF 420
Query: 392 CEEDVRPALKDIVWSWQGENNS 413
C + +RP+L+DI W Q E+ S
Sbjct: 421 CNKGLRPSLRDICWDGQSEHPS 442
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJ54|CIPKK_ARATH CBL-interacting serine/threonine-protein kinase 20 OS=Arabidopsis thaliana GN=CIPK20 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 503 bits (1294), Expect = e-141, Method: Compositional matrix adjust.
Identities = 250/421 (59%), Positives = 311/421 (73%), Gaps = 26/421 (6%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
+L KYE+GR+LGQGTFAKVY+ +N+ T ESVAIKVI+K +V K GL++QIKREISVMRL
Sbjct: 7 VLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRL 66
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
V+HP++V L EVMA+KTK++F +EYVKGGELF KV KGKLKE ARKYFQQLI A+D+CH
Sbjct: 67 VRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIGAIDYCH 126
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
SRGVYHRDLKPENLLLDENG+LK+SDFGLSAL E DGLLHT CGTPAYVAPEV+ KK
Sbjct: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKK 186
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRI 252
GYDGAK+D+WSCGVVL+VLL+GFLPF +N+++MYRKI K E++ P W + ++L+SRI
Sbjct: 187 GYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRI 246
Query: 253 LVADPQKRISVSEIMINPWFIKGFSK------PVAVCID---------------DGDNRD 291
L +P RI + +IM N WF KGF K P + ID + D
Sbjct: 247 LDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSVKPMSYNAFD 306
Query: 292 FISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLA---KKLNLGVCVKEFKVK 348
ISS+S GFDLS LFE E +S S FT+K + I+ K E +A ++ NL + VK
Sbjct: 307 LISSLSQGFDLSGLFEKEERSESKFTTKKDAKEIVSKFEEIATSSERFNL--TKSDVGVK 364
Query: 349 MQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVWSWQ 408
M+ K EGRKG LA+ E++EV +VEF KS GDT+EYK+FC+ ++RP+LKDIVW WQ
Sbjct: 365 MEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDRELRPSLKDIVWKWQ 424
Query: 409 G 409
G
Sbjct: 425 G 425
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner (By similarity). Required for the abscisic acid-mediated (ABA) signaling pathway involved in seed germination and growth elongation inhibition. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7X996|CIPK2_ORYSJ CBL-interacting protein kinase 2 OS=Oryza sativa subsp. japonica GN=CIPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 502 bits (1292), Expect = e-141, Method: Compositional matrix adjust.
Identities = 248/430 (57%), Positives = 316/430 (73%), Gaps = 28/430 (6%)
Query: 6 MDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR 65
M E+ N+L KYEMG++LGQGTFAKVY+ +N T ESVAIK+I+K++V K GLM+QIKR
Sbjct: 1 MAEQRGNMLMKKYEMGKLLGQGTFAKVYHARNTETSESVAIKMIDKEKVLKGGLMDQIKR 60
Query: 66 EISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLI 125
EISVM+LV+HPNIV+L EVMATKTK++FV+E+VKGGELF KV +G+LKE++ARKYFQQLI
Sbjct: 61 EISVMKLVRHPNIVQLYEVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLI 120
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVA 185
AVDFCHSRGVYHRDLKPENLLLDEN NLKVSDFGLSAL + DGLLHT CGTPAYVA
Sbjct: 121 CAVDFCHSRGVYHRDLKPENLLLDENSNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVA 180
Query: 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDA 245
PEV+ ++GYDGAK+DIWSCGV+LFVLL+G+LPF ++N+M MY+KI KAE++ P W + D
Sbjct: 181 PEVINRRGYDGAKADIWSCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPSWFNTDV 240
Query: 246 RRLISRILVADPQKRISVSEIMINPWFIKGFSKPV---------AVCIDDGDNRDF---- 292
RRL+ RIL +P RIS+ +IM NPWF KG + A+ +D + D
Sbjct: 241 RRLLLRILDPNPSTRISMDKIMENPWFRKGLDAKLLRYNLQPKDAIPVDMSTDFDSFNSA 300
Query: 293 --------------ISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNL 338
I S+S+G DLS +FE K S FTS ++S I+ K+E +AK L L
Sbjct: 301 PTLEKKPSNLNAFDIISLSTGLDLSGMFEESDKKESKFTSTSTASTIISKIEDIAKGLRL 360
Query: 339 GVCVKEFK-VKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVR 397
+ K+ +KM+G GRKG + + AE++EV P +VE K+ GDTLEY+K +++R
Sbjct: 361 KLTKKDGGLLKMEGSKPGRKGVMGIDAEIFEVTPNFHLVELKKTNGDTLEYRKVLNQEMR 420
Query: 398 PALKDIVWSW 407
PALKDIVW+W
Sbjct: 421 PALKDIVWAW 430
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5W736|CIPKI_ORYSJ CBL-interacting protein kinase 18 OS=Oryza sativa subsp. japonica GN=CIPK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 501 bits (1290), Expect = e-141, Method: Compositional matrix adjust.
Identities = 258/445 (57%), Positives = 325/445 (73%), Gaps = 38/445 (8%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREI 67
E+ NIL +YE+G++LGQGTFAKVY+G+N+VT +SVAIKVI+KD++ K GLM+QIKREI
Sbjct: 5 EKNGNILLRRYEIGKLLGQGTFAKVYHGRNIVTSQSVAIKVIDKDKIFKVGLMDQIKREI 64
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISA 127
SVM+LV+HPNIV+L EVMATK+K++FV+EYVKGGELF KV KG+LKE++ARKYFQQL+SA
Sbjct: 65 SVMKLVRHPNIVQLYEVMATKSKIYFVLEYVKGGELFNKVAKGRLKEDAARKYFQQLVSA 124
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187
VDFCHSRGVYHRDLKPENLL+DENGNLK++DFGLSAL E DGLLHT CGTPAYVAPE
Sbjct: 125 VDFCHSRGVYHRDLKPENLLVDENGNLKITDFGLSALAESRRQDGLLHTTCGTPAYVAPE 184
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARR 247
V+ +KGYDG K D WSCGV+LFVL++G+LPFQ+ N+M+MYRKI KAE++ P W S D R+
Sbjct: 185 VISRKGYDGVKVDTWSCGVILFVLMAGYLPFQDSNLMEMYRKIGKAEFKCPAWFSSDVRK 244
Query: 248 LISRILVADPQKRISVSEIMINPWFIKGF-----------SKPVAVCID----------- 285
L+SRIL +P+ R+ +++IM WF KG ++PV D
Sbjct: 245 LVSRILDPNPRSRMPITKIMETYWFKKGLDSKLILKNVETNEPVTALADVNVVFSSMGSS 304
Query: 286 --------------DGDNRDFISSMSSGFDLSSLF-ESERKSGSMFTSKCSSSAIMGKLE 330
N I S+S GFDLS LF E+++K + FTS S+SAI+ KLE
Sbjct: 305 SSKKTEEKQDAGKLTNLNAFDIISLSEGFDLSGLFEETDKKKEARFTSSQSASAIISKLE 364
Query: 331 SLAKKLNLGVCVKEFKV-KMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYK 389
+A L V KE V KM+G EGRKG LA+ AE++EV P +VE K+ GDTLEY+
Sbjct: 365 DVASCSKLTVKKKEGGVLKMEGASEGRKGVLAIDAEIFEVTPSFHLVEIKKNNGDTLEYQ 424
Query: 390 KFCEEDVRPALKDIVWSWQGENNSQ 414
+ED++PALKDIVW+WQGE Q
Sbjct: 425 HLWKEDMKPALKDIVWAWQGERQDQ 449
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10LQ2|CIPKA_ORYSJ CBL-interacting protein kinase 10 OS=Oryza sativa subsp. japonica GN=CIPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 481 bits (1238), Expect = e-135, Method: Compositional matrix adjust.
Identities = 249/441 (56%), Positives = 326/441 (73%), Gaps = 37/441 (8%)
Query: 6 MDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR 65
M E+ NIL +YE+G++LGQG+FAKVY+G+N+ +SVAIKVI+K+++ K LM+QI+R
Sbjct: 1 MVEQKGNILMKRYEIGKLLGQGSFAKVYHGRNIKNSQSVAIKVIDKEKILKCELMDQIRR 60
Query: 66 EISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLI 125
EISVM LV+HP IV+L EVMATKTK++F++EYVKGGELF KV +G+LKEE ARKYFQQLI
Sbjct: 61 EISVMNLVRHPCIVQLYEVMATKTKIYFILEYVKGGELFNKVRRGRLKEEVARKYFQQLI 120
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVA 185
SA+DFCHSRGVYHRDLKPENLLLDEN NLK+SDFGLSAL E DGLLHT CGTPAYVA
Sbjct: 121 SAIDFCHSRGVYHRDLKPENLLLDENRNLKISDFGLSALAECKRQDGLLHTTCGTPAYVA 180
Query: 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDA 245
PEV+ +KGYDGAK+D+W+CGV+L+VLL+G+LPFQ++N++ MY+KI KAE+++P W S D
Sbjct: 181 PEVINRKGYDGAKADVWACGVILYVLLAGYLPFQDKNVINMYKKICKAEFKWPSWFSSDI 240
Query: 246 RRLISRILVADPQKRISVSEIMINPWFIKGFS--------------KPVAVCIDD--GDN 289
R+L+ RIL +P RISVSEIM +PWF G + K V V +D G+
Sbjct: 241 RKLLRRILDPNPATRISVSEIMEDPWFRVGLNSDLLNKTIPTDKVDKVVHVDMDSTFGNL 300
Query: 290 RDFIS------------------SMSSGFDLSSLFESER-KSGSMFTSKCSSSAIMGKLE 330
+ I+ S+SSGFDLS++FE E K S FTS +++ I KLE
Sbjct: 301 SNNINEGKQEAENLTSLNAFDIISLSSGFDLSAMFEDENSKEESKFTSTNTATTITKKLE 360
Query: 331 SLAKKLNLGVCVKEFK-VKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYK 389
+AK L L K +KM+G GRKG +++ AE++++ P+ +VEF+K GDTLEY+
Sbjct: 361 DVAKNLRLKFLKKNGGLLKMEGSKPGRKGVMSINAEIFQITPDFHLVEFTKINGDTLEYQ 420
Query: 390 KFCEEDVRPALKDIVWSWQGE 410
K ++++RPALKDIVW+WQGE
Sbjct: 421 K-VKQEMRPALKDIVWAWQGE 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65554|CIPK6_ARATH CBL-interacting serine/threonine-protein kinase 6 OS=Arabidopsis thaliana GN=CIPK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 469 bits (1206), Expect = e-131, Method: Compositional matrix adjust.
Identities = 238/419 (56%), Positives = 311/419 (74%), Gaps = 25/419 (5%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
+L G+YE+GR+LG GTFAKVY+ +N+ T +SVA+KV+ K++V K G+++QIKREISVMR+
Sbjct: 19 LLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRM 78
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
VKHPNIVEL EVMA+K+K++F +E V+GGELFAKV KG+L+E+ AR YFQQLISAVDFCH
Sbjct: 79 VKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFCH 138
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
SRGVYHRDLKPENLLLDE GNLKV+DFGLSA E L DGLLHT CGTPAYVAPEV+ KK
Sbjct: 139 SRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKK 198
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRI 252
GYDGAK+D+WSCGV+LFVLL+G+LPFQ++N++ MYRKI++ +++ P W+S DARRL++++
Sbjct: 199 GYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKL 258
Query: 253 LVADPQKRISVSEIMINPWFIKGFSK----PVAVCI----DDGD-------------NRD 291
L +P RI++ ++M +PWF K ++ PVA I +D D N
Sbjct: 259 LDPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFLVHKSKEETETLNAF 318
Query: 292 FISSMSSGFDLSSLFESERKSGS---MFTSKCSSSAIMGKLESLAKKLN-LGVCVKEFKV 347
I ++S GFDLS LFE ++K F + +S+++ LE A+ N V E +V
Sbjct: 319 HIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAARVGNKFDVRKSESRV 378
Query: 348 KMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVWS 406
+++GK GRKGKLAV AE++ VAP VVE K GDTLEY FC +RPALKDI W+
Sbjct: 379 RIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTALRPALKDIFWT 437
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | ||||||
| 224089358 | 451 | predicted protein [Populus trichocarpa] | 0.968 | 0.889 | 0.745 | 0.0 | |
| 225430342 | 447 | PREDICTED: CBL-interacting serine/threon | 0.980 | 0.908 | 0.730 | 0.0 | |
| 255572733 | 454 | CBL-interacting serine/threonine-protein | 0.975 | 0.889 | 0.75 | 0.0 | |
| 229609831 | 447 | CBL-interacting protein kinase 15 [Vitis | 0.980 | 0.908 | 0.748 | 0.0 | |
| 225430344 | 450 | PREDICTED: CBL-interacting serine/threon | 0.971 | 0.893 | 0.732 | 0.0 | |
| 345104049 | 448 | calcineurin B-like protein-interacting p | 0.968 | 0.895 | 0.739 | 0.0 | |
| 345104083 | 448 | calcineurin B-like protein-interacting p | 0.968 | 0.895 | 0.739 | 0.0 | |
| 225465522 | 458 | PREDICTED: CBL-interacting serine/threon | 0.987 | 0.893 | 0.733 | 0.0 | |
| 345104079 | 448 | calcineurin B-like protein-interacting p | 0.968 | 0.895 | 0.736 | 0.0 | |
| 345104047 | 448 | calcineurin B-like protein-interacting p | 0.968 | 0.895 | 0.736 | 0.0 |
| >gi|224089358|ref|XP_002308703.1| predicted protein [Populus trichocarpa] gi|116265972|gb|ABJ91234.1| CBL-interacting protein kinase 6 [Populus trichocarpa] gi|222854679|gb|EEE92226.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 665 bits (1717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/429 (74%), Positives = 373/429 (86%), Gaps = 28/429 (6%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
R+++FGKYEMGR+LG+GTFAKVYYGK+LVT ESVAIKVI+KDQVKK+G+MEQI+REISVM
Sbjct: 4 RHVIFGKYEMGRLLGKGTFAKVYYGKHLVTGESVAIKVISKDQVKKEGMMEQIQREISVM 63
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
RLV+HPNIVELKEVMATKTK+FF++EYV+GGELFAKV KG+LKEE+ARKYFQQLISA+D+
Sbjct: 64 RLVRHPNIVELKEVMATKTKIFFIMEYVRGGELFAKVAKGRLKEEAARKYFQQLISAIDY 123
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
CHSRGVYHRDLKPEN+LLDE+ NLK+SDFGLSALPEQ DGLLHTQCGTPAYVAPEVLR
Sbjct: 124 CHSRGVYHRDLKPENMLLDEDENLKISDFGLSALPEQFRQDGLLHTQCGTPAYVAPEVLR 183
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250
KKGYDG+K+DIWSCGV+L+VLL+GFLPFQ+EN+MKMYRK+FKAEY+FPPW S D++RLIS
Sbjct: 184 KKGYDGSKADIWSCGVILYVLLAGFLPFQDENVMKMYRKVFKAEYQFPPWFSTDSKRLIS 243
Query: 251 RILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDD------GDNRD------------- 291
R+LVADP+KRI++ IM N WF+KGFS+PVA I + G +D
Sbjct: 244 RLLVADPEKRITIPAIMRNHWFLKGFSRPVAFSIQESSMDQTGQEQDLDSCSVVNTKVSS 303
Query: 292 --------FISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNLGVC-V 342
FISSMSSGFDLSSLFE++RKSGSMFTSK S+SAIM K+E +AK L+ V V
Sbjct: 304 PEFFNAFEFISSMSSGFDLSSLFETKRKSGSMFTSKFSASAIMEKIEGVAKGLSYKVAKV 363
Query: 343 KEFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKD 402
K+FKV +QG EGRKGKLAVTAEV+EVAPEVAVVEFSKS+GDTLEY KFCEEDVRPALKD
Sbjct: 364 KDFKVTLQGPCEGRKGKLAVTAEVFEVAPEVAVVEFSKSSGDTLEYTKFCEEDVRPALKD 423
Query: 403 IVWSWQGEN 411
IVW+WQG+N
Sbjct: 424 IVWTWQGDN 432
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225430342|ref|XP_002285264.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 25-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/434 (73%), Positives = 372/434 (85%), Gaps = 28/434 (6%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREI 67
E VR++LFGKYE GR+LG+GTFAKVYY K++V+ ESVAIKVINKD VKK+G+MEQIKREI
Sbjct: 2 EEVRSMLFGKYETGRLLGKGTFAKVYYAKHMVSGESVAIKVINKDYVKKEGMMEQIKREI 61
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISA 127
SVMRLV+HPNIVELKEVMATKTK+FFV+EYV+GGELFAKV KGKLKE+ +RKYFQQLISA
Sbjct: 62 SVMRLVRHPNIVELKEVMATKTKIFFVMEYVRGGELFAKVAKGKLKEDQSRKYFQQLISA 121
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187
+DFCHSRGV HRDLKPENLLLDEN +LKVSDFGLSALPEQL NDGLLHTQCGTPAYVAPE
Sbjct: 122 IDFCHSRGVSHRDLKPENLLLDENEDLKVSDFGLSALPEQLRNDGLLHTQCGTPAYVAPE 181
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARR 247
VLRKKGYDGAK+D+WSCGV+LFVLL+GFLPFQ EN+MKMYRK+FKAEY+FPPW S +A+R
Sbjct: 182 VLRKKGYDGAKADMWSCGVILFVLLAGFLPFQEENLMKMYRKVFKAEYQFPPWFSSEAKR 241
Query: 248 LISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCI--------DDGDNR--------- 290
LIS++LVADPQ+RI++ IM PWF KGFS+PVA I +D D
Sbjct: 242 LISKLLVADPQRRITIPAIMRVPWFRKGFSRPVAFSIEEPFPDKPEDSDTLKLEAAKSTN 301
Query: 291 ----------DFISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNLGV 340
+FISSMSSGFDLSSLFE+++K+GSMFTSKCS++AIM K+E +AK L V
Sbjct: 302 SPSPAFFNAFEFISSMSSGFDLSSLFENQKKAGSMFTSKCSAAAIMAKIELVAKGLKFRV 361
Query: 341 C-VKEFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPA 399
VK+FK+K+QG+ EGRKG+L++TAEV+EVAPEVA+VE KSAGDTLEY KFCEEDVRPA
Sbjct: 362 AKVKDFKLKLQGQSEGRKGRLSLTAEVFEVAPEVAIVELLKSAGDTLEYAKFCEEDVRPA 421
Query: 400 LKDIVWSWQGENNS 413
LKDIVW+WQG+N++
Sbjct: 422 LKDIVWTWQGDNHN 435
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572733|ref|XP_002527299.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223533299|gb|EEF35051.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/428 (75%), Positives = 361/428 (84%), Gaps = 24/428 (5%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
R+ILFGKYEMGR+LGQGTFAKVY GKN+ TQESVAIKV++KDQVKKQGLMEQ+KREIS M
Sbjct: 18 RHILFGKYEMGRLLGQGTFAKVYKGKNMATQESVAIKVVHKDQVKKQGLMEQLKREISAM 77
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
LVKHPN+VELKEVMATK KV+FV+EYV+GGELFAKV KGKLKE+ ARKYFQQLISAVD+
Sbjct: 78 NLVKHPNVVELKEVMATKLKVYFVMEYVRGGELFAKVKKGKLKEDLARKYFQQLISAVDY 137
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
CHSRGV HRDLKPENLLLDENG+LKVSDFGLSALPEQ WNDGLLHTQCGTPAYVAPEVLR
Sbjct: 138 CHSRGVSHRDLKPENLLLDENGDLKVSDFGLSALPEQHWNDGLLHTQCGTPAYVAPEVLR 197
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250
KKGYDG K+DIWSCGV+LFVLL+G+LPFQNEN+MKMY KIFKAEY PPWIS DA+RLIS
Sbjct: 198 KKGYDGGKADIWSCGVILFVLLAGYLPFQNENLMKMYMKIFKAEYAIPPWISPDAKRLIS 257
Query: 251 RILVADPQKRISVSEIMINPWFIKGFSKPVAVC--IDDGDNR------------------ 290
++LV DP+KRIS+ + M NPWF KG +KP+A +++ +
Sbjct: 258 KLLVVDPEKRISIPDTMKNPWFRKGLTKPIAFSNELEEKGQKAIEEEKLGLQASHSPPFY 317
Query: 291 ---DFISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNLGVCV-KEFK 346
+FIS+MSSGFDLSSLFES+RKSGSMFTSKCS+ I+ KLES AK+LN V EFK
Sbjct: 318 NAFEFISAMSSGFDLSSLFESKRKSGSMFTSKCSAPVILTKLESAAKELNFRVASDSEFK 377
Query: 347 VKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVWS 406
VK QG +GRKGKL VTAEVYEVAPEVAVVEFSKS+GDTLEY KFC EDVRPAL DIVWS
Sbjct: 378 VKFQGNVDGRKGKLEVTAEVYEVAPEVAVVEFSKSSGDTLEYTKFCVEDVRPALSDIVWS 437
Query: 407 WQGENNSQ 414
WQGE ++
Sbjct: 438 WQGETSTH 445
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|229609831|gb|ACQ83531.1| CBL-interacting protein kinase 15 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 655 bits (1690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/418 (74%), Positives = 368/418 (88%), Gaps = 12/418 (2%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREI 67
E VR++LFGKYE GR+LG+GTFAKVYY K++V+ ESVAIKVINKD VKK+G+MEQIKREI
Sbjct: 2 EEVRSMLFGKYETGRLLGKGTFAKVYYAKHMVSGESVAIKVINKDYVKKEGMMEQIKREI 61
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISA 127
SVMRLV+HPNIVELKEVMATKTK+FFV+EYV+GGELFAKV KGKLKE+ +RKYFQQLISA
Sbjct: 62 SVMRLVRHPNIVELKEVMATKTKIFFVMEYVRGGELFAKVAKGKLKEDQSRKYFQQLISA 121
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187
+DFCHSRGV HRDLKPENLLLDEN +LKVSDFGLSALPEQL NDGLLHTQCGTPAYVAPE
Sbjct: 122 IDFCHSRGVSHRDLKPENLLLDENEDLKVSDFGLSALPEQLRNDGLLHTQCGTPAYVAPE 181
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARR 247
VLRKKGYDGAK+D+WSCGV+LFVLL+GFLPFQ EN+MKMYRK+FKAEY+FPPW S +A+R
Sbjct: 182 VLRKKGYDGAKADMWSCGVILFVLLAGFLPFQEENLMKMYRKVFKAEYQFPPWFSSEAKR 241
Query: 248 LISRILVADPQKRISVSEIMINPWFIKGFSKP--VAVCIDDGDNR---------DFISSM 296
LIS++LVADPQ+RI++ IM PWF KGFS+P + N +FISSM
Sbjct: 242 LISKLLVADPQRRITIPAIMRVPWFRKGFSRPNHSRTSLRTSTNSPSPAFFNAFEFISSM 301
Query: 297 SSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNLGVC-VKEFKVKMQGKDEG 355
SSGFDLSSLFE+++K+GSMFTSKCS++AIM K+E +AK L V VK+FK+K+QG+ EG
Sbjct: 302 SSGFDLSSLFENQKKAGSMFTSKCSAAAIMAKIELVAKGLKFRVAKVKDFKLKLQGQSEG 361
Query: 356 RKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVWSWQGENNS 413
RKG+L++TAEV+EVAPEVA+VE KSAGDTLEY KFCEEDVRPALKDIVW+WQG+N++
Sbjct: 362 RKGRLSLTAEVFEVAPEVAIVELLKSAGDTLEYAKFCEEDVRPALKDIVWTWQGDNHN 419
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225430344|ref|XP_002285269.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 25-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/430 (73%), Positives = 369/430 (85%), Gaps = 28/430 (6%)
Query: 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
N+LFGKYE GR+LG+GTFAKVYY K++V+ ESVAIKVINKD VKK+G+MEQIKREISVMR
Sbjct: 9 NMLFGKYETGRLLGKGTFAKVYYAKHMVSGESVAIKVINKDYVKKEGMMEQIKREISVMR 68
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFC 131
LV+HPNIVELKEVMATKTK+FFV+EYV+GGELFAKV KGKLKE+ +RKYFQQLISA+DFC
Sbjct: 69 LVRHPNIVELKEVMATKTKIFFVMEYVRGGELFAKVAKGKLKEDQSRKYFQQLISAIDFC 128
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRK 191
HSRGV HRDLKPENLLLDEN +LKVSDFGLSALPEQL NDGLLHTQCGTPAYVAPEVLRK
Sbjct: 129 HSRGVSHRDLKPENLLLDENEDLKVSDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRK 188
Query: 192 KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251
KGYDGAK+D+WSCGV+LFVLL+GFLPFQ EN+MKMYRK+FKAEY+FPPW S +A+RLIS+
Sbjct: 189 KGYDGAKADMWSCGVILFVLLAGFLPFQEENLMKMYRKVFKAEYQFPPWFSSEAKRLISK 248
Query: 252 ILVADPQKRISVSEIMINPWFIKGFSKPVAVCI--------DDGDNR------------- 290
+LVADPQ+RI++ IM PWF KGFS+PVA I +D D
Sbjct: 249 LLVADPQRRITIPAIMRVPWFRKGFSRPVAFSIEEPFPDKPEDSDTLKLEAAKSTNSPSP 308
Query: 291 ------DFISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNLGVC-VK 343
+FISSMSSGFDLSSLFE+++K+GSMFTSKCS++AIM K+E +AK L V VK
Sbjct: 309 AFFNAFEFISSMSSGFDLSSLFENQKKAGSMFTSKCSAAAIMAKIELVAKGLKFRVAKVK 368
Query: 344 EFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDI 403
+FK+K+QG+ EGRKG+L++TAEV+EVAPEVA+VE KSAGDTLEY KFCEEDVRPALKDI
Sbjct: 369 DFKLKLQGQSEGRKGRLSLTAEVFEVAPEVAIVELLKSAGDTLEYAKFCEEDVRPALKDI 428
Query: 404 VWSWQGENNS 413
VW+WQG+N++
Sbjct: 429 VWTWQGDNHN 438
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104049|gb|AEN70846.1| calcineurin B-like protein-interacting protein kinase [Gossypium turneri] gi|345104077|gb|AEN70860.1| calcineurin B-like protein-interacting protein kinase [Gossypium harknessii] | Back alignment and taxonomy information |
|---|
Score = 653 bits (1684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 312/422 (73%), Positives = 367/422 (86%), Gaps = 21/422 (4%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
RN+LFGKYEMGR+LG+GTFAKVYYGK L T ESVA+KVI+KDQVKK+G+MEQIKREISVM
Sbjct: 4 RNVLFGKYEMGRLLGKGTFAKVYYGKELATGESVAVKVISKDQVKKKGMMEQIKREISVM 63
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
RLV+HPNIVELKEVMATK K+FFV+E+V+GGELFAKV KGKLKE ARKYFQQLISAVDF
Sbjct: 64 RLVRHPNIVELKEVMATKKKIFFVMEHVRGGELFAKVYKGKLKEHVARKYFQQLISAVDF 123
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
CHSRGV HRDLKPENLLLDEN +LK+SDFGLSALPEQL NDGLLHTQCGTPAYVAPEVLR
Sbjct: 124 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEVLR 183
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250
KKGYDG+++DIWSCGVVL+VLL+GFLPFQ+EN+MKMYRK+FKAE+EFP W S +++RLIS
Sbjct: 184 KKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRLIS 243
Query: 251 RILVADPQKRISVSEIMINPWFIKGFSKPVAVC----IDDGDNR---------------- 290
++LVADP+KRI++ IM +PWF K F++P+A IDD ++
Sbjct: 244 KLLVADPEKRITIPAIMRDPWFRKEFTRPLAFSIQEPIDDDESAPSKSTKLSSPKFFNAF 303
Query: 291 DFISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNLGVC-VKEFKVKM 349
+FISSMSSGFDLS +FE +RKSG+MFTS+CS+SAIM K+E++AK LN V K+FK+++
Sbjct: 304 EFISSMSSGFDLSGMFEDKRKSGTMFTSRCSASAIMSKVEAVAKGLNFRVGKAKDFKMRL 363
Query: 350 QGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVWSWQG 409
QG EGRKG+L VTAEV+EVAPEVAVVEFSKSAGDTLEY KFCEEDVRPALKDIVW+WQG
Sbjct: 364 QGSSEGRKGRLLVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEEDVRPALKDIVWTWQG 423
Query: 410 EN 411
++
Sbjct: 424 DS 425
|
Source: Gossypium turneri Species: Gossypium turneri Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104083|gb|AEN70863.1| calcineurin B-like protein-interacting protein kinase [Gossypium aridum] gi|345104087|gb|AEN70865.1| calcineurin B-like protein-interacting protein kinase [Gossypium lobatum] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1683), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 312/422 (73%), Positives = 367/422 (86%), Gaps = 21/422 (4%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
R++LFGKYEMGR+LG+GTFAKVYYGK L T ESVA+KVI+KDQVKK+G+MEQIKREISVM
Sbjct: 4 RHVLFGKYEMGRLLGKGTFAKVYYGKELATGESVAVKVISKDQVKKKGMMEQIKREISVM 63
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
RLV+HPNIVELKEVMATK K+FFV+EYV+GGELFAKV KGKLKE ARKYFQQLISAVDF
Sbjct: 64 RLVRHPNIVELKEVMATKKKIFFVMEYVRGGELFAKVYKGKLKEHVARKYFQQLISAVDF 123
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
CHSRGV HRDLKPENLLLDEN +LK+SDFGLSALPEQL NDGLLHTQCGTPAYVAPEVLR
Sbjct: 124 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEVLR 183
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250
KKGYDG+++DIWSCGVVL+VLL+GFLPFQ+EN+MKMYRK+FKAE+EFP W S +++RLIS
Sbjct: 184 KKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRLIS 243
Query: 251 RILVADPQKRISVSEIMINPWFIKGFSKPVAVC----IDDGDNR---------------- 290
++LVADP+KRI++ IM +PWF K F++P+A IDD ++
Sbjct: 244 KLLVADPEKRITIPAIMRDPWFRKEFTRPLAFSIQEPIDDDESAPSKSTKPSSPKFFNAF 303
Query: 291 DFISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNLGVC-VKEFKVKM 349
+FISSMSSGFDLS +FE +RKSG+MFTS+CS+SAIM K+E++AK LN V K+FK+++
Sbjct: 304 EFISSMSSGFDLSGMFEKKRKSGTMFTSRCSASAIMSKVEAVAKGLNFRVGKAKDFKMRL 363
Query: 350 QGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVWSWQG 409
QG EGRKG+L VTAEV+EVAPEVAVVEFSKSAGDTLEY KFCEEDVRPALKDIVW+WQG
Sbjct: 364 QGSSEGRKGRLLVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEEDVRPALKDIVWTWQG 423
Query: 410 EN 411
++
Sbjct: 424 DS 425
|
Source: Gossypium aridum Species: Gossypium aridum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465522|ref|XP_002273178.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 25-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/436 (73%), Positives = 368/436 (84%), Gaps = 27/436 (6%)
Query: 2 KFETMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLME 61
K + +DE R+ILF KYEMGR+LGQGTFAKVY+ K L + +SVAIKVINKD VKKQG+ME
Sbjct: 5 KNQVVDE-ARSILFKKYEMGRLLGQGTFAKVYHAKRLGSGDSVAIKVINKDHVKKQGMME 63
Query: 62 QIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYF 121
QI+REISVMRLV+HPN+VELKEVMATKTK+FF +E+VKGGELFAKV KG+LKE+SARKYF
Sbjct: 64 QIQREISVMRLVRHPNVVELKEVMATKTKIFFAMEFVKGGELFAKVTKGRLKEDSARKYF 123
Query: 122 QQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP 181
QQL+SA+DFCHSRGV HRDLKPENLLLDEN NLKVSDFGLS+LPEQL NDGLLHTQCGTP
Sbjct: 124 QQLVSAIDFCHSRGVSHRDLKPENLLLDENENLKVSDFGLSSLPEQLRNDGLLHTQCGTP 183
Query: 182 AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWI 241
AYVAPEVLRK+GYDGAK+D WSCGV+L+VLL GFLPF+ EN+MKMY K+FKAE+EFPPW+
Sbjct: 184 AYVAPEVLRKRGYDGAKADTWSCGVILYVLLCGFLPFRAENVMKMYTKVFKAEFEFPPWV 243
Query: 242 SCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDG-------------- 287
S A+RLIS++LVADP+KRI++S IM +PWF KGF KP+A I++
Sbjct: 244 STQAKRLISKLLVADPEKRITISAIMEDPWFQKGFRKPIAFSIEEQENNEEWQGCRGEVE 303
Query: 288 -----------DNRDFISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKL 336
+ +FISSMSSGFDLSSLF S+RKSGSMFTSKCS+S IM KLESLAK L
Sbjct: 304 MVRTKSSPPFYNAFEFISSMSSGFDLSSLFLSKRKSGSMFTSKCSASTIMAKLESLAKTL 363
Query: 337 NLGVC-VKEFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEED 395
N V VKEFKVKMQG +GRKGKL+VTAEV+EVAP VA+V+FSKSAGDTLEY KFCEE+
Sbjct: 364 NFRVVNVKEFKVKMQGLVDGRKGKLSVTAEVFEVAPAVALVQFSKSAGDTLEYTKFCEEE 423
Query: 396 VRPALKDIVWSWQGEN 411
RPALKDIVWSWQGEN
Sbjct: 424 ARPALKDIVWSWQGEN 439
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104079|gb|AEN70861.1| calcineurin B-like protein-interacting protein kinase [Gossypium davidsonii] gi|345104081|gb|AEN70862.1| calcineurin B-like protein-interacting protein kinase [Gossypium klotzschianum] | Back alignment and taxonomy information |
|---|
Score = 651 bits (1680), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 311/422 (73%), Positives = 367/422 (86%), Gaps = 21/422 (4%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
R++LFGKYEMGR+LG+GTFAKVYYGK L T ESVA+KVI+KDQVKK+G+MEQIKREISVM
Sbjct: 4 RHVLFGKYEMGRLLGKGTFAKVYYGKELATGESVAVKVISKDQVKKKGMMEQIKREISVM 63
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
RLV+HPNIVELKEVMATK K+FFV+E+V+GGELFAKV KGKLKE ARKYFQQLISAVDF
Sbjct: 64 RLVRHPNIVELKEVMATKKKIFFVMEHVRGGELFAKVYKGKLKEHVARKYFQQLISAVDF 123
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
CHSRGV HRDLKPENLLLDEN +LK+SDFGLSALPEQL NDGLLHTQCGTPAYVAPEVLR
Sbjct: 124 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEVLR 183
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250
KKGYDG+++DIWSCGVVL+VLL+GFLPFQ+EN+MKMYRK+FKAE+EFP W S +++RLIS
Sbjct: 184 KKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRLIS 243
Query: 251 RILVADPQKRISVSEIMINPWFIKGFSKPVAVC----IDDGDNR---------------- 290
++LVADP+KRI++ IM +PWF K F++P+A IDD ++
Sbjct: 244 KLLVADPEKRITIPAIMRDPWFRKEFTRPLAFTIQEQIDDDESAPSKSTKLSSPKFFNAF 303
Query: 291 DFISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNLGVC-VKEFKVKM 349
+FISSMSSGFDLS +FE +RKSG+MFTS+CS+SAIM K+E++AK LN V K+FK+++
Sbjct: 304 EFISSMSSGFDLSGMFEDKRKSGTMFTSRCSASAIMSKVEAVAKGLNFRVGKAKDFKMRL 363
Query: 350 QGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVWSWQG 409
QG EGRKG+L VTAEV+EVAPEVAVVEFSKSAGDTLEY KFCEEDVRPALKDIVW+WQG
Sbjct: 364 QGSSEGRKGRLLVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEEDVRPALKDIVWTWQG 423
Query: 410 EN 411
++
Sbjct: 424 DS 425
|
Source: Gossypium davidsonii Species: Gossypium davidsonii Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104047|gb|AEN70845.1| calcineurin B-like protein-interacting protein kinase [Gossypium schwendimanii] | Back alignment and taxonomy information |
|---|
Score = 651 bits (1680), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 311/422 (73%), Positives = 367/422 (86%), Gaps = 21/422 (4%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
R++LFGKYEMGR+LG+GTFAKVYYGK + T ESVA+KVI+KDQVKK+G+MEQIKREISVM
Sbjct: 4 RHVLFGKYEMGRLLGKGTFAKVYYGKEIATGESVAVKVISKDQVKKKGMMEQIKREISVM 63
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
RLV+HPNIVELKEVMATK K+FFV+EYV+GGELFAKV KGKLKE ARKYFQQLISAVDF
Sbjct: 64 RLVRHPNIVELKEVMATKKKIFFVMEYVRGGELFAKVYKGKLKEHVARKYFQQLISAVDF 123
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
CHSRGV HRDLKPENLLLDEN +LK+SDFGLSALPEQL NDGLLHTQCGTPAYVAPEVLR
Sbjct: 124 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEVLR 183
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250
KKGYDG+++DIWSCGVVL+VLL+GFLPFQ+EN+MKMYRK+FKAE+EFP W S +++RLIS
Sbjct: 184 KKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRLIS 243
Query: 251 RILVADPQKRISVSEIMINPWFIKGFSKPVAVC----IDDGDNR---------------- 290
++LVADP+KRI++ IM +PWF K F++P+A IDD ++
Sbjct: 244 KLLVADPEKRITIPAIMRDPWFRKEFTRPLAFSIQEPIDDDESAPSKSTKPSSPKFFNAF 303
Query: 291 DFISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNLGVC-VKEFKVKM 349
+FISSMSSGFDLS +FE +RKSG+MFTS+CS+SAIM K+E++AK LN V K+FK+++
Sbjct: 304 EFISSMSSGFDLSGMFEKKRKSGTMFTSRCSASAIMSKVEAVAKGLNFRVGKAKDFKMRL 363
Query: 350 QGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVWSWQG 409
QG EGRKG+L VTAEV+EVAPEVAVVEFSKSAGDTLEY KFCEEDVRPALKDIVW+WQG
Sbjct: 364 QGSSEGRKGRLLVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEEDVRPALKDIVWTWQG 423
Query: 410 EN 411
++
Sbjct: 424 DS 425
|
Source: Gossypium schwendimanii Species: Gossypium schwendimanii Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | ||||||
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.681 | 0.577 | 0.728 | 3.1e-140 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.673 | 0.626 | 0.721 | 8.2e-138 | |
| TAIR|locus:2040219 | 469 | CIPK16 "CBL-interacting protei | 0.678 | 0.599 | 0.626 | 5.3e-117 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.642 | 0.605 | 0.654 | 2.6e-115 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.678 | 0.637 | 0.604 | 5e-108 | |
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.647 | 0.559 | 0.611 | 1.7e-107 | |
| TAIR|locus:2124072 | 489 | CIPK12 "CBL-interacting protei | 0.659 | 0.558 | 0.627 | 8.3e-104 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.659 | 0.566 | 0.593 | 7.4e-103 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.647 | 0.587 | 0.615 | 9.5e-103 | |
| TAIR|locus:2029974 | 520 | CIPK18 "CBL-interacting protei | 0.661 | 0.526 | 0.614 | 6.6e-102 |
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1119 (399.0 bits), Expect = 3.1e-140, Sum P(2) = 3.1e-140
Identities = 207/284 (72%), Positives = 243/284 (85%)
Query: 5 TMDERVRN--ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQ 62
TM+E + +LF KYEMGR+LG+GTF KVYYGK + T ESVAIK+INKDQVK++G+MEQ
Sbjct: 28 TMEEEQQQLRVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQ 87
Query: 63 IKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQ 122
IKREIS+MRLV+HPNIVELKEVMATKTK+FF++EYVKGGELF+K++KGKLKE+SARKYFQ
Sbjct: 88 IKREISIMRLVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIVKGKLKEDSARKYFQ 147
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
QLISAVDFCHSRGV HRDLKPENLL+DENG+LKVSDFGLSALPEQ+ DGLLHTQCGTPA
Sbjct: 148 QLISAVDFCHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPA 207
Query: 183 YVAPEVLRKKGYDGAKSDIWSCXXXXXXXXXXXXPFQNENIMKMYRKIFKAEYEFPPWIS 242
YVAPEVLRKKGYDGAK DIWSC PFQ+EN+MKMYRKIFK+E+E+PPW S
Sbjct: 208 YVAPEVLRKKGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFS 267
Query: 243 CDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDD 286
+++RLIS++LV DP KRIS+ IM PWF K + P+ ID+
Sbjct: 268 PESKRLISKLLVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDE 311
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1086 (387.4 bits), Expect = 8.2e-138, Sum P(2) = 8.2e-138
Identities = 202/280 (72%), Positives = 238/280 (85%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV-KKQGLMEQIKRE 66
E R +LFGKYEMGR+LG+GTFAKVYYGK ++ E VAIKVINKDQV K+ G+MEQIKRE
Sbjct: 2 EEERRVLFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKRE 61
Query: 67 ISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLIS 126
IS+M+LV+HPNIVELKEVMATKTK+FFV+E+VKGGELF K+ KGKL E++AR+YFQQLIS
Sbjct: 62 ISIMKLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKISKGKLHEDAARRYFQQLIS 121
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
AVD+CHSRGV HRDLKPENLLLDENG+LK+SDFGLSALPEQ+ DGLLHTQCGTPAYVAP
Sbjct: 122 AVDYCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVAP 181
Query: 187 EVLRKKGYDGAKSDIWSCXXXXXXXXXXXXPFQNENIMKMYRKIFKAEYEFPPWISCDAR 246
EVL+KKGYDGAK+DIWSC PFQ+EN+M MYRKIF+A++EFPPW S +AR
Sbjct: 182 EVLKKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEAR 241
Query: 247 RLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDD 286
RLIS++LV DP +RIS+ IM PW K F+ P+A ID+
Sbjct: 242 RLISKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDE 281
|
|
| TAIR|locus:2040219 CIPK16 "CBL-interacting protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 925 (330.7 bits), Expect = 5.3e-117, Sum P(2) = 5.3e-117
Identities = 183/292 (62%), Positives = 226/292 (77%)
Query: 6 MDERVRN--ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV-KKQGLMEQ 62
M+E R+ +LF KY +GR+LG G FAKVY+G + T + VAIKVI KD V K++G+MEQ
Sbjct: 1 MEESNRSSTVLFDKYNIGRLLGTGNFAKVYHGTEISTGDDVAIKVIKKDHVFKRRGMMEQ 60
Query: 63 IKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYF 121
I+REI+VMRL++HPN+VEL+EVMATK K+FFV+EYV GGELF + + GKL E+ ARKYF
Sbjct: 61 IEREIAVMRLLRHPNVVELREVMATKKKIFFVMEYVNGGELFEMIDRDGKLPEDLARKYF 120
Query: 122 QQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL--PEQLW-----NDGLL 174
QQLISAVDFCHSRGV+HRD+KPENLLLD G+LKV+DFGLSAL PE L +D LL
Sbjct: 121 QQLISAVDFCHSRGVFHRDIKPENLLLDGEGDLKVTDFGLSALMMPEGLGGRRGSSDDLL 180
Query: 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCXXXXXXXXXXXXPFQNENIMKMYRKIFKAE 234
HT+CGTPAYVAPEVLR KGYDGA +DIWSC PF +EN+M +Y KIFKAE
Sbjct: 181 HTRCGTPAYVAPEVLRNKGYDGAMADIWSCGIVLYALLAGFLPFIDENVMTLYTKIFKAE 240
Query: 235 YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDD 286
EFPPW S +++ L+SR+LV DP++RIS+SEI + PWF K F+ VA ID+
Sbjct: 241 CEFPPWFSLESKELLSRLLVPDPEQRISMSEIKMIPWFRKNFTPSVAFSIDE 292
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 931 (332.8 bits), Expect = 2.6e-115, Sum P(2) = 2.6e-115
Identities = 174/266 (65%), Positives = 211/266 (79%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
+L KYE+GR+LGQGTFAKVY+ +N+ T ESVAIKVI+K +V K GL++QIKREISVMRL
Sbjct: 7 VLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRL 66
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
V+HP++V L EVMA+KTK++F +EYVKGGELF KV KGKLKE ARKYFQQLI A+D+CH
Sbjct: 67 VRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIGAIDYCH 126
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
SRGVYHRDLKPENLLLDENG+LK+SDFGLSAL E DGLLHT CGTPAYVAPEV+ KK
Sbjct: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKK 186
Query: 193 GYDGAKSDIWSCXXXXXXXXXXXXPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRI 252
GYDGAK+D+WSC PF +N+++MYRKI K E++ P W + ++L+SRI
Sbjct: 187 GYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRI 246
Query: 253 LVADPQKRISVSEIMINPWFIKGFSK 278
L +P RI + +IM N WF KGF K
Sbjct: 247 LDPNPNSRIKIEKIMENSWFQKGFKK 272
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 5.0e-108, Sum P(2) = 5.0e-108
Identities = 173/286 (60%), Positives = 226/286 (79%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
+L G+YE+GR+LG GTFAKVY+ +N+ T +SVA+KV+ K++V K G+++QIKREISVMR+
Sbjct: 19 LLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRM 78
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
VKHPNIVEL EVMA+K+K++F +E V+GGELFAKV KG+L+E+ AR YFQQLISAVDFCH
Sbjct: 79 VKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFCH 138
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
SRGVYHRDLKPENLLLDE GNLKV+DFGLSA E L DGLLHT CGTPAYVAPEV+ KK
Sbjct: 139 SRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKK 198
Query: 193 GYDGAKSDIWSCXXXXXXXXXXXXPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRI 252
GYDGAK+D+WSC PFQ++N++ MYRKI++ +++ P W+S DARRL++++
Sbjct: 199 GYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKL 258
Query: 253 LVADPQKRISVSEIMINPWFIKGFSK----PVAVCIDDGDNR-DFI 293
L +P RI++ ++M +PWF K ++ PVA I + DF+
Sbjct: 259 LDPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFL 304
|
|
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 888 (317.7 bits), Expect = 1.7e-107, Sum P(2) = 1.7e-107
Identities = 164/268 (61%), Positives = 213/268 (79%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREI 67
E ++L KY++GR+LGQGTFAKVYYG++++T +SVAIK+I+K++V K GL+EQIKREI
Sbjct: 2 ENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREI 61
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISA 127
SVMR+ +HPN+VEL EVMATKT+++FV+EY KGGELF KV KGKL+++ A KYF QLI+A
Sbjct: 62 SVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINA 121
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187
VDFCHSR VYHRD+KPENLLLD+N NLKVSDFGLSAL + DGLLHT CGTPAYVAPE
Sbjct: 122 VDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPE 181
Query: 188 VLRKKGYDGAKSDIWSCXXXXXXXXXXXXPFQNENIMKMYRKIFKAEYEFPPWISCDARR 247
V+ +KGYDG K+DIWSC PF + N+M+MYRKI KA+++ P W + + RR
Sbjct: 182 VINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRR 241
Query: 248 LISRILVADPQKRISVSEIMINPWFIKG 275
L+ ++L +P+ RI+++ I + WF KG
Sbjct: 242 LLCKMLDPNPETRITIARIRESSWFRKG 269
|
|
| TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 919 (328.6 bits), Expect = 8.3e-104, Sum P(2) = 8.3e-104
Identities = 172/274 (62%), Positives = 213/274 (77%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
++ G+YEMG++LG GTFAKVY +N+ T ESVAIKVI+K++V K GL+ IKREIS++R
Sbjct: 21 LILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILRR 80
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
V+HPNIV+L EVMATK K++FV+EYV+GGELF KV KG+LKEE ARKYFQQLISAV FCH
Sbjct: 81 VRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAVTFCH 140
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+RGVYHRDLKPENLLLDENGNLKVSDFGLSA+ +Q+ DGL HT CGTPAYVAPEVL +K
Sbjct: 141 ARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARK 200
Query: 193 GYDGAKSDIWSCXXXXXXXXXXXXPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRI 252
GYD AK DIWSC PF + N+M MY+KI++ E+ P W S + RL+S++
Sbjct: 201 GYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSKL 260
Query: 253 LVADPQKRISVSEIMINPWFIKGFSKPVAVCIDD 286
L +P+KR + EIM N WF KGF K + ++D
Sbjct: 261 LETNPEKRFTFPEIMENSWFKKGF-KHIKFYVED 293
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 887 (317.3 bits), Expect = 7.4e-103, Sum P(2) = 7.4e-103
Identities = 165/278 (59%), Positives = 212/278 (76%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
GKYE+GR LG+GTFAKV + +N+ ++VAIKVI+K++V K ++ QIKREIS M+L+KH
Sbjct: 29 GKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIKH 88
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSR 134
PN++ + EVMA+KTK++FV+E+V GGELF K+ G+LKE+ ARKYFQQLI+AVD+CHSR
Sbjct: 89 PNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHSR 148
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
GVYHRDLKPENLLLD NG LKVSDFGLSALP+Q+ DGLLHT CGTP YVAPEV+ KGY
Sbjct: 149 GVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKGY 208
Query: 195 DGAKSDIWSCXXXXXXXXXXXXPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILV 254
DGAK+D+WSC PF++ N+ +Y+KIFKAE+ PPW S A++LI RIL
Sbjct: 209 DGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRILD 268
Query: 255 ADPQKRISVSEIMINPWFIKGFSKP----VAVCIDDGD 288
+P RI+ +E++ N WF KG+ P V +DD D
Sbjct: 269 PNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVD 306
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 877 (313.8 bits), Expect = 9.5e-103, Sum P(2) = 9.5e-103
Identities = 165/268 (61%), Positives = 211/268 (78%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREI 67
E ++L +YE+GR+LGQGTFAKVY+G++ T ESVAIK+I+KD+V + GL +QIKREI
Sbjct: 2 ENKPSVLTERYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKREI 61
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISA 127
SVMR+ KHPN+VEL EVMATK++++FVIEY KGGELF KV KGKLKE+ A KYF QLISA
Sbjct: 62 SVMRIAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLISA 121
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187
VDFCHSRGVYHRD+KPENLLLD+N NLKVSDFGLSAL + DGLLHT CGTPAYVAPE
Sbjct: 122 VDFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPE 181
Query: 188 VLRKKGYDGAKSDIWSCXXXXXXXXXXXXPFQNENIMKMYRKIFKAEYEFPPWISCDARR 247
V+ +KGY+G K+DIWSC PF + N+M+MYRKI KA+++ P W + + +R
Sbjct: 182 VINRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVKR 241
Query: 248 LISRILVADPQKRISVSEIMINPWFIKG 275
L+ ++L + + RI++++I + WF KG
Sbjct: 242 LLCKMLDPNHETRITIAKIKESSWFRKG 269
|
|
| TAIR|locus:2029974 CIPK18 "CBL-interacting protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 889 (318.0 bits), Expect = 6.6e-102, Sum P(2) = 6.6e-102
Identities = 169/275 (61%), Positives = 209/275 (76%)
Query: 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
NIL GKYE+G++LG GTFAKVY +N+ + + VAIKVI+K+++ K GL+ IKREIS++R
Sbjct: 68 NILMGKYELGKLLGHGTFAKVYLAQNIKSGDKVAIKVIDKEKIMKSGLVAHIKREISILR 127
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFC 131
V+HP IV L EVMATK+K++FV+EYV GGELF V KG+L EE+AR+YFQQLIS+V FC
Sbjct: 128 RVRHPYIVHLFEVMATKSKIYFVMEYVGGGELFNTVAKGRLPEETARRYFQQLISSVSFC 187
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRK 191
H RGVYHRDLKPENLLLD GNLKVSDFGLSA+ EQL DGL HT CGTPAY+APEVL +
Sbjct: 188 HGRGVYHRDLKPENLLLDNKGNLKVSDFGLSAVAEQLRQDGLCHTFCGTPAYIAPEVLTR 247
Query: 192 KGYDGAKSDIWSCXXXXXXXXXXXXPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251
KGYD AK+D+WSC PF ++NIM MY+KI+K E+ P W S D RL++R
Sbjct: 248 KGYDAAKADVWSCGVILFVLMAGHIPFYDKNIMVMYKKIYKGEFRCPRWFSSDLVRLLTR 307
Query: 252 ILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDD 286
+L +P RI++ EIM N WF KGF K V I+D
Sbjct: 308 LLDTNPDTRITIPEIMKNRWFKKGF-KHVKFYIED 341
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8W1D5 | CIPKP_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6809 | 0.9903 | 0.8401 | yes | no |
| Q6ERS4 | CIPKG_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5885 | 0.9903 | 0.8991 | yes | no |
| Q9LWM4 | CIPK5_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5633 | 0.9782 | 0.8785 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 414 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-105 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-94 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-80 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-73 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-71 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-67 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-67 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-66 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-64 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-62 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-58 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-54 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-54 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-54 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-52 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-51 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-51 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-51 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-51 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-50 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-50 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-49 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-49 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-48 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-48 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-47 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-47 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-47 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-47 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-46 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-46 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-46 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-46 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-46 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-45 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-45 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-44 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-44 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-44 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-43 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-43 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-43 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-43 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-43 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-43 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-42 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-42 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-42 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-42 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-42 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-41 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-41 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 1e-40 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-40 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-40 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-40 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-40 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-40 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-39 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-39 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-39 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-39 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-39 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-39 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-39 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-39 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-39 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-39 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-38 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-38 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-38 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-38 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-38 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-38 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-38 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-38 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-37 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-37 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-37 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-37 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-37 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-36 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-36 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-36 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-36 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-36 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-35 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-35 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-35 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-35 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-35 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-35 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-35 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-34 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-34 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-34 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-33 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-33 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-33 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-32 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-32 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-32 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-32 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-31 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-31 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-31 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-31 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-31 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-30 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-30 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-30 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-30 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-30 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-30 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-30 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-30 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-29 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-29 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-29 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-29 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-29 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-29 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-29 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-29 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-29 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-28 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-28 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-28 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-28 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-28 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-28 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-27 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-27 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-27 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-27 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-27 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-26 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-26 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-26 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-26 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-25 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-25 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-25 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-25 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-25 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-24 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-24 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-24 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-24 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-24 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-23 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-22 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-22 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-22 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-21 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-20 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-20 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-19 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-18 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-17 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-16 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-14 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 1e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-04 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 7e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 311 bits (798), Expect = e-105
Identities = 119/260 (45%), Positives = 179/260 (68%), Gaps = 11/260 (4%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
YE+ LG+G+F KVY ++ T + VAIKVI K ++KK E+I REI +++ +KHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
IV L +V + K++ V+EY +GG+LF + K G+L E+ AR Y +Q++SA+++ HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
HRDLKPEN+LLDE+G++K++DFGL+ QL L T GTP Y+APEVL KGY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIFKAEYEFPPW---ISCDARRLISRI 252
DIWS GV+L+ LL+G PF + ++++++KI K + FPP IS +A+ LI ++
Sbjct: 176 -AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 253 LVADPQKRISVSEIMINPWF 272
LV DP+KR++ E + +P+F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 283 bits (726), Expect = 3e-94
Identities = 107/263 (40%), Positives = 155/263 (58%), Gaps = 11/263 (4%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
YE+ R LG G+F VY K+ T + VA+K++ K K + REI ++R + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
IV L + K ++ V+EY +GG+LF + + G L E+ A+K Q++ +++ HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
HRDLKPEN+LLDENG +K++DFGL+ L + L T GTP Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNENI---MKMYRKIFKAEYEFPPWISC----DARRLI 249
K D+WS GV+L+ LL+G PF ENI +++ R+I EF +A+ LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 250 SRILVADPQKRISVSEIMINPWF 272
+ L DP KR + EI+ +PWF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 245 bits (629), Expect = 9e-80
Identities = 103/254 (40%), Positives = 154/254 (60%), Gaps = 9/254 (3%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG+G+F KV + T + A+KV+ K ++ K+ +E E +++ + HP IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDL 141
T+ K++ V+EY GGELF L G+ EE AR Y +++ A+++ HS G+ +RDL
Sbjct: 61 AFQTEEKLYLVLEYAPGGELF-SHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 142 KPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDI 201
KPEN+LLD +G++K++DFGL+ +T CGTP Y+APEVL KGY A D
Sbjct: 120 KPENILLDADGHIKLTDFGLAKELSS--EGSRTNTFCGTPEYLAPEVLLGKGYGKA-VDW 176
Query: 202 WSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRI 261
WS GV+L+ +L+G PF E+ ++Y KI K FP ++S +AR LIS +L DP KR+
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRL 236
Query: 262 ---SVSEIMINPWF 272
EI +P+F
Sbjct: 237 GSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 230 bits (590), Expect = 2e-73
Identities = 91/262 (34%), Positives = 160/262 (61%), Gaps = 14/262 (5%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E + LG G+F +V ++ + + A+K+++K ++ K +E + E +++ ++HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
+V L + ++ V+EYV GGELF+ + K G+ E AR Y Q++ A+++ HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
+RDLKPENLLLD +G +K++DFG + + + + T CGTP Y+APE++ KGY
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY------TLCGTPEYLAPEIILSKGYG 176
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255
A D W+ G++++ +L+G+ PF ++N +++Y KI + + FP + S DA+ LI +L
Sbjct: 177 KA-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQV 235
Query: 256 DPQKRI-----SVSEIMINPWF 272
D KR+ V++I +PWF
Sbjct: 236 DLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 4e-71
Identities = 98/250 (39%), Positives = 140/250 (56%), Gaps = 38/250 (15%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG+G F VY ++ T + VAIK+I K+ L+E++ REI +++ + HPNIV+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 84 VMATKTKVFFVIEYVKGGELFA--KVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDL 141
V + ++ V+EY +GG L K +GKL E+ + Q++ +++ HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 142 KPENLLLDE-NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSD 200
KPEN+LLD NG +K++DFGLS L + LL T GTPAY+APEVL KGY KSD
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 201 IWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260
IWS GV+L YE P + + LI ++L DP+KR
Sbjct: 177 IWSLGVIL--------------------------YELP-----ELKDLIRKMLQKDPEKR 205
Query: 261 ISVSEIMINP 270
S EI+ +
Sbjct: 206 PSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 2e-67
Identities = 97/279 (34%), Positives = 161/279 (57%), Gaps = 25/279 (8%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHP 76
++ G+++G+G+F+ V K T + AIK+++K Q+ K+ ++ +K E V+ RL HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRG 135
I++L + ++FV+EY GEL + K G L E+ R Y +++ A+++ HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLS------ALPEQLWNDGLLHTQ------------ 177
+ HRDLKPEN+LLD++ ++K++DFG + + PE D
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 178 CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF 237
GT YV+PE+L +K G SD+W+ G +++ +L+G PF+ N ++KI K EY F
Sbjct: 183 VGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 238 PPWISCDARRLISRILVADPQKRISVS----EIMINPWF 272
PP DA+ LI ++LV DPQ R+ V+ E+ +P+F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 7e-67
Identities = 92/262 (35%), Positives = 154/262 (58%), Gaps = 15/262 (5%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
+ +G + +V+ K T + AIKVI K + ++ ++Q+ E ++ + P +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDL 141
K ++ V+EY+ GG+L A +L+ G L E+ AR Y +++ A+++ HS G+ HRDL
Sbjct: 61 SFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 142 KPENLLLDENGNLKVSDFGLSAL----PEQLWNDGLLHTQ--CGTPAYVAPEVLRKKGYD 195
KP+N+L+D NG+LK++DFGLS + + ND + GTP Y+APEV+ +G+
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH- 178
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP--PWISCDARRLISRIL 253
D WS G +L+ L G PF E ++++ I + E+P +S +A LIS++L
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLL 238
Query: 254 VADPQKRI---SVSEIMINPWF 272
V DP+KR+ S+ EI +P+F
Sbjct: 239 VPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 1e-66
Identities = 93/262 (35%), Positives = 149/262 (56%), Gaps = 14/262 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVIN--KDQVKKQGLMEQIKREISVMRLVK 74
KYE+ + +G+G+F KVY + + +K I+ K++ E E+ +++ +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER---EDALNEVKILKKLN 57
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK-----LKEESARKYFQQLISAVD 129
HPNI++ E K K+ V+EY GG+L K+ K K EE +F QL A+
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
+ HSR + HRD+KP+N+ L NG +K+ DFG+S + L T GTP Y++PE+
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLSPELC 175
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FPPWISCDARRL 248
+ K Y+ KSDIWS G VL+ L + PF+ EN++++ KI K +Y P S + R L
Sbjct: 176 QNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL 234
Query: 249 ISRILVADPQKRISVSEIMINP 270
+S +L DP++R S+++I+ +P
Sbjct: 235 VSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 5e-64
Identities = 85/263 (32%), Positives = 143/263 (54%), Gaps = 10/263 (3%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
++ G +LG+G+F VY + T E +A+K + ++ +E ++REI ++ ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHP 59
Query: 77 NIVELKEVMATKTKVFFVI--EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCH 132
NIV + K I EYV GG L + +LK GKL E RKY +Q++ + + H
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
S G+ HRD+K N+L+D +G +K++DFG + + + GTP ++APEV+R +
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIFKAEY--EFPPWISCDARRLI 249
Y G +DIWS G + + +G P+ N M KI + E P +S +A+ +
Sbjct: 179 EY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237
Query: 250 SRILVADPQKRISVSEIMINPWF 272
+ L DP+KR + E++ +P+
Sbjct: 238 RKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 7e-62
Identities = 93/259 (35%), Positives = 144/259 (55%), Gaps = 14/259 (5%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG G F +V K + A+K + K + + G E I E ++ HP IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLK 142
K ++ ++EY GGEL+ + G E +AR Y ++ A ++ H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 143 PENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIW 202
PENLLLD NG +K+ DFG + ++L + T CGTP YVAPE++ KGYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFA---KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176
Query: 203 SCGVVLFVLLSGFLPFQNENI--MKMYRKIFKAEY--EFPPWISCDARRLISRILVADPQ 258
S G++L+ LL+G PF ++ M++Y I K EFP +I A+ LI ++L +P+
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 259 KRI-----SVSEIMINPWF 272
+R+ + +I + WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 1e-58
Identities = 99/292 (33%), Positives = 167/292 (57%), Gaps = 24/292 (8%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+EMG LG G+F +V K+ T E AIK + K ++ K ++ + +E S++ + HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
IV + + +V+F++E+V GGELF + K G+ + A+ Y +L+ A ++ HS+ +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
+RDLKPENLLLD G++KV+DFG + +P++ + T CGTP Y+APEV++ KG+
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF------TLCGTPEYLAPEVIQSKGHG 193
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255
A D W+ GV+L+ ++G+ PF ++ ++Y KI +FP W AR L+ +L
Sbjct: 194 KA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQT 252
Query: 256 DPQKRI-----SVSEIMINPWF---------IKGFSKPVAVCID-DGDNRDF 292
D KR+ V+++ +P+F + + P+ V + GD +F
Sbjct: 253 DHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNF 304
|
Length = 329 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 1e-54
Identities = 92/300 (30%), Positives = 144/300 (48%), Gaps = 63/300 (21%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
YE LG+GT+ VY ++ T E VA+K I D +++G+ REIS+++ +KHPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPN 59
Query: 78 IVELKEVMATKTKVFFVIEYV----KGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS 133
IV+L +V+ T+ K++ V EY K + G L + QL+ + +CHS
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDMDLKK---YLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSA---LPEQ--------LWNDGLLHTQCGTPA 182
+ HRDLKP+N+L++ +G LK++DFGL+ +P + LW
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW------------- 163
Query: 183 YVAPEVL-RKKGYDGAKSDIWSCGVVLFVLLSG-------------FLPFQ-----NENI 223
Y APE+L K Y A DIWS G + +++G F FQ E
Sbjct: 164 YRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 224 ------MKMYRKIF-----KAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272
+ Y+ F K + P + + L+S++L +P KRIS E + +P+F
Sbjct: 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 2e-54
Identities = 97/289 (33%), Positives = 147/289 (50%), Gaps = 28/289 (9%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y + R LG+G+F +VY ++ ++ VA+KV+ K K +E+ REI ++ + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 77 -NIVELKEVMATKTKVFFVIEYVKGGELFA----KVLKGKLKEESARKYFQQLISAVDFC 131
NIV+L + + ++ V+EYV GG L KG L E A Q++SA+++
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 132 HSRGVYHRDLKPENLLLDENGN-LKVSDFGLSAL----PEQLWNDGLLHTQCGTPAYVAP 186
HS+G+ HRD+KPEN+LLD +G +K+ DFGL+ L L T GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 187 EVLR--KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN----IMKMYRKIFKAEYE---- 236
EVL Y + SDIWS G+ L+ LL+G PF+ E + + I +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 237 -----FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPV 280
P IS A L+ ++L DP+ R+S S + + K
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286
|
Length = 384 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-54
Identities = 91/257 (35%), Positives = 149/257 (57%), Gaps = 9/257 (3%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
++LG+GTF KV + T + A+K++ K+ + + + E V++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
K T ++ FV+EY GGELF + + E+ AR Y +++SA+ + HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSD 200
LK ENL+LD++G++K++DFGL E + + + T CGTP Y+APEVL Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 201 IWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260
W GVV++ ++ G LPF N++ K++ I E FP +S +A+ L++ +L DP++R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 261 I-----SVSEIMINPWF 272
+ EIM + +F
Sbjct: 238 LGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 3e-52
Identities = 86/263 (32%), Positives = 140/263 (53%), Gaps = 18/263 (6%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+E+ +G+G F +VY ++ T + VAIKVI + +K+ E+I EI +++ KHP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSR 134
NIV+ K +++ V+E+ GG L K L E ++L+ +++ HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
G+ HRD+K N+LL +G +K+ DFGLSA QL + +T GTP ++APEV+ K Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 195 DGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP------WISCDARRL 248
D K+DIWS G+ L G P+ MK +FK PP S + +
Sbjct: 175 DY-KADIWSLGITAIELAEGKPPYSELPPMKA---LFKIATNGPPGLRNPEKWSDEFKDF 230
Query: 249 ISRILVADPQKRISVSEIMINPW 271
+ + L +P+KR + +++ +P+
Sbjct: 231 LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 2e-51
Identities = 93/255 (36%), Positives = 144/255 (56%), Gaps = 7/255 (2%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
+G+G+F KV + TQ A+K I K + + + E +V+ V P IV LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLK 142
+ K++ V+ ++ GGELF + + G+ AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 143 PENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIW 202
PEN+LLD G++ + DFGL L + +D +T CGTP Y+APE+L GY A D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTKA-VDWW 177
Query: 203 SCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRIS 262
+ GV+L+ +L+G PF +EN+ +MYRKI + FP DA+ L+ +L DP +R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 263 VS---EIMINPWFIK 274
+ EI +P+F +
Sbjct: 238 YNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-51
Identities = 89/258 (34%), Positives = 151/258 (58%), Gaps = 10/258 (3%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
++LG+G+F KV + T E A+KV+ KD + + +E E V+ L KHP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L TK ++FFV+EYV GG+L + + G+ E AR Y +++ + F H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD G++K++DFG+ E + T CGTP Y+APE+L + Y G
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W+ GV+L+ +L+G PF+ ++ ++++ I + E +P W+S +A+ ++ L +P+K
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 260 RISVS-----EIMINPWF 272
R+ +I +P+F
Sbjct: 238 RLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 4e-51
Identities = 83/262 (31%), Positives = 153/262 (58%), Gaps = 14/262 (5%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
E + +G GTF +V+ ++ +++ A+KV+ +V + + + E V++ V HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRGV 136
I+ L + ++ ++EYV GGELF+ + G+ + Y +++ A+++ HS+ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
+RDLKPEN+LLD+ G++K++DFG + L ++ W T CGTP Y+APEV++ KG++
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW------TLCGTPEYLAPEVIQSKGHN 176
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255
A D W+ G++++ +L G+ PF ++N +Y KI + EFP + A+ LI ++LV
Sbjct: 177 KA-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVV 235
Query: 256 DPQKRI-----SVSEIMINPWF 272
D +R+ ++ + WF
Sbjct: 236 DRTRRLGNMKNGADDVKNHRWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 6e-51
Identities = 92/242 (38%), Positives = 138/242 (57%), Gaps = 5/242 (2%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHPNIVE 80
+++G+G+F KV K+ + A+KV+ K + K+ + I E +V+ + VKHP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHR 139
L T K++FV++YV GGELF + + + E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLKPEN+LLD G++ ++DFGL E + + T CGTP Y+APEVLRK+ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT-V 177
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W G VL+ +L G PF + + +MY I P IS AR L+ +L D K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 260 RI 261
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 5e-50
Identities = 89/266 (33%), Positives = 141/266 (53%), Gaps = 14/266 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+++ G +G GTF KVY NL T E +A+K I Q +++I E+ V+ L+KHP
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRI-QDNDPKTIKEIADEMKVLELLKHP 59
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRG 135
N+V+ V + KV+ +EY GG L + G+ L E R Y QL+ + + HS G
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYVAPEVLRK- 191
+ HRD+KP N+ LD NG +K+ DFG + + + GTPAY+APEV+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTPAYMAPEVITGG 178
Query: 192 --KGYDGAKSDIWSCGVVLFVLLSGFLPF--QNENIMKMYRKIFKAEYEFPP--WISCDA 245
KG+ A +DIWS G V+ + +G P+ + M+ + P +S +
Sbjct: 179 KGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237
Query: 246 RRLISRILVADPQKRISVSEIMINPW 271
+ + R L +DP+KR + SE++ +P+
Sbjct: 238 KDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 171 bits (433), Expect = 7e-50
Identities = 93/257 (36%), Positives = 154/257 (59%), Gaps = 9/257 (3%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
++LG+GTF KV + + + A+K++ K+ + + + E V++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLKGKL-KEESARKYFQQLISAVDFCHSRGVYHRD 140
K TK ++ FV+EYV GGELF + + ++ E+ R Y +++SA+D+ HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSD 200
LK ENL+LD++G++K++DFGL E + + + T CGTP Y+APEVL Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 201 IWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260
W GVV++ ++ G LPF N++ K++ I + +FP +S DA+ L+S +L+ DP KR
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 261 I-----SVSEIMINPWF 272
+ EIM + +F
Sbjct: 238 LGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 1e-49
Identities = 86/270 (31%), Positives = 139/270 (51%), Gaps = 23/270 (8%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVI---NKDQVKKQGLMEQIKREISVMRLV 73
YE+ +G+G+F V + + + K I N + +KQ Q+ E++++R +
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ----QLVSEVNILREL 56
Query: 74 KHPNIVEL--KEVMATKTKVFFVIEYVKGGELF-----AKVLKGKLKEESARKYFQQLIS 126
KHPNIV + + + ++ V+EY +GG+L K + ++EE + QL+
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 127 AVDFCHSRG-----VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP 181
A+ CH+R V HRDLKP N+ LD N N+K+ DFGL+ + + T GTP
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTP 174
Query: 182 AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPW 240
Y++PE L YD KSDIWS G +++ L + PF N +++ KI + ++ P
Sbjct: 175 YYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYR 233
Query: 241 ISCDARRLISRILVADPQKRISVSEIMINP 270
S + +I +L DP KR S E++ P
Sbjct: 234 YSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 2e-49
Identities = 90/258 (34%), Positives = 153/258 (59%), Gaps = 9/258 (3%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
++LG+GTF KV + T A+K++ K+ + + + E V++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLKGKL-KEESARKYFQQLISAVDFCHSRGVYHRD 140
K T ++ FV+EY GGELF + + ++ EE AR Y +++SA+++ HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSD 200
+K ENL+LD++G++K++DFGL E + + + T CGTP Y+APEVL Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 201 IWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260
W GVV++ ++ G LPF N++ +++ I E FP +S +A+ L++ +L DP++R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 261 I-----SVSEIMINPWFI 273
+ E+M + +F+
Sbjct: 238 LGGGPSDAKEVMEHRFFL 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 4e-49
Identities = 90/261 (34%), Positives = 152/261 (58%), Gaps = 13/261 (4%)
Query: 22 RMLGQGTFAKVYYGKNLVTQES---VAIKVINKDQ-VKKQGLMEQIKREISVMRLVKHPN 77
++LG+G + KV+ + + ++ A+KV+ K V+ Q K E +++ VKHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
IV+L T K++ ++EY+ GGELF + + G E++A Y ++ A++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
+RDLKPEN+LLD G++K++DFGL E + + HT CGT Y+APE+L + G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVAD 256
D WS G +++ +L+G PF EN K KI K + PP+++ +AR L+ ++L +
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 257 PQKRI-----SVSEIMINPWF 272
P R+ +E+ +P+F
Sbjct: 239 PSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 5e-48
Identities = 81/260 (31%), Positives = 143/260 (55%), Gaps = 10/260 (3%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y++G ++G+G F VY G NL T + VAIK I+ +++K++ L I +EI +++ +KHP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSR 134
NIV+ + T ++ ++EY + G L +++K G E Y Q++ + + H +
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSL-RQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCGTPAYVAPEVLRKKG 193
GV HRD+K N+L ++G +K++DFG++ L + + GTP ++APEV+ G
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLND---VSKDDASVVGTPYWMAPEVIEMSG 175
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK-MYRKIFKAEYEFPPWISCDARRLISRI 252
SDIWS G + LL+G P+ + N M ++R + P IS + + + +
Sbjct: 176 AS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC 234
Query: 253 LVADPQKRISVSEIMINPWF 272
DP R + +++ +PW
Sbjct: 235 FQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 9e-48
Identities = 98/317 (30%), Positives = 160/317 (50%), Gaps = 45/317 (14%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E+ +++G+G F +V+ ++ T + A+KV+ K + K+ + ++ E ++ P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELF-AKVLKGKLKEESARKYFQQLISAVDFCHSRGV 136
IV+L + ++ V+EY+ GG+L + K EE+AR Y +L+ A+D H G
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSA------------------------LPEQLWNDG 172
HRD+KP+N+L+D +G++K++DFGL L + +
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 173 LLHTQC---GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRK 229
GTP Y+APEVLR Y + D WS GV+L+ +L GF PF ++ + + Y K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241
Query: 230 I--FKAEYEFPP--WISCDARRLISRILVADPQKRI-SVSEIMINPWFIKGF-------S 277
I +K FPP +S +A LI R L+ DP+ R+ S EI +P+F KG +
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFF-KGIDWENLRET 299
Query: 278 KP--VAVCIDDGDNRDF 292
KP V D +F
Sbjct: 300 KPPFVPELSSPLDTSNF 316
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 94/258 (36%), Positives = 152/258 (58%), Gaps = 10/258 (3%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
++LG+GTF KV K T A+K++ K+ + + + E V++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLKGKL-KEESARKYFQQLISAVDFCHS-RGVYHR 139
K T ++ FV+EY GGELF + + ++ E+ AR Y +++SA+D+ HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK ENL+LD++G++K++DFGL E + + + T CGTP Y+APEVL Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W GVV++ ++ G LPF N++ K++ I E FP +S +A+ L+S +L DP++
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 260 RI-----SVSEIMINPWF 272
R+ EIM + +F
Sbjct: 238 RLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 3e-47
Identities = 96/273 (35%), Positives = 151/273 (55%), Gaps = 23/273 (8%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQES---VAIKVINKDQ-VKKQGLMEQIKREISVMRLV 73
+E+ R+LG G + KV+ + + ++ A+KV+ K V+K E + E V+ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 74 KH-PNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFC 131
+ P +V L T TK+ +++YV GGELF + + E R Y +++ A+D
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSA--LPEQLWNDGLLHTQCGTPAYVAPEVL 189
H G+ +RD+K EN+LLD G++ ++DFGLS L E+ ++ CGT Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER---AYSFCGTIEYMAPEVI 178
Query: 190 RKK--GYDGAKSDIWSCGVVLFVLLSGFLPF-----QNENIMKMYRKIFKAEYEFPPWIS 242
R G+D A D WS GV+ F LL+G PF QN ++ R+I K++ FP +S
Sbjct: 179 RGGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQ-SEISRRILKSKPPFPKTMS 236
Query: 243 CDARRLISRILVADPQKRI---SVSEIMINPWF 272
+AR I ++L DP+KR+ EI +P+F
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 3e-47
Identities = 78/261 (29%), Positives = 148/261 (56%), Gaps = 10/261 (3%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E+ R++G+G F KV + T++ A+K +NK + ++G + + E +++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 78 IVELKEVMATKTKVFFVIEYVKGGEL-FAKVLKGKLKEESARKYFQQLISAVDFCHSRGV 136
+V L + ++ V++ + GG+L + K K EE + + +++ A+++ HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
HRD+KP+N+LLDE G++ ++DF ++ ++ D L + GTP Y+APEVL ++GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQ---NENIMKMYRKIFKAEYEFPPWISCDARRLISRIL 253
D WS GV + L G P++ ++ K A+ +P S +A I+++L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 254 VADPQKRIS--VSEIMINPWF 272
DPQKR+ + ++ +P+F
Sbjct: 238 ERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 9e-47
Identities = 90/246 (36%), Positives = 142/246 (57%), Gaps = 5/246 (2%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHPNIVE 80
+++G+G+F KV ++ ++ A+KV+ K + K+ + I E +V+ + VKHP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHR 139
L T K++FV++Y+ GGELF + + + E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLKPEN+LLD G++ ++DFGL E + ++G T CGTP Y+APEVL K+ YD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W G VL+ +L G PF + N +MY I + P I+ AR L+ +L D K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 260 RISVSE 265
R+ +
Sbjct: 238 RLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 87/259 (33%), Positives = 144/259 (55%), Gaps = 11/259 (4%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVE 80
R+LG+G+F KV + + A+KV+ KD + + +E E ++ L + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHR 139
L T ++FFV+E+V GG+L + K + E AR Y ++ SA+ F H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD G+ K++DFG+ E ++N T CGTP Y+APE+L++ Y G
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W+ GV+L+ +L G PF+ EN ++ I E +P W+S DA ++ + +P
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 260 RISV------SEIMINPWF 272
R+ I+ +P+F
Sbjct: 238 RLGSLTLGGEEAILRHPFF 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-46
Identities = 90/258 (34%), Positives = 140/258 (54%), Gaps = 20/258 (7%)
Query: 26 QGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH-PNIVELKEV 84
+G F VY K T + AIKV+ K + + + +K E ++M + P + +L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 85 MATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLK 142
+K ++ V+EY+ GG+ A ++K G L E+ A++Y +++ V+ H RG+ HRD+K
Sbjct: 66 FQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124
Query: 143 PENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ-CGTPAYVAPEVLRKKGYDGAKSDI 201
PENLL+D+ G+LK++DFGLS GL + + GTP Y+APE + G D SD
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRN-------GLENKKFVGTPDYLAPETILGVGDDKM-SDW 176
Query: 202 WSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISCDARRLISRILVADP 257
WS G V+F L G+ PF E ++ I +P + S +A LI+R+L DP
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 258 QKRIS---VSEIMINPWF 272
KR+ EI +P+F
Sbjct: 237 AKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 89/287 (31%), Positives = 150/287 (52%), Gaps = 37/287 (12%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
++LG+G +V+ + T + A+KV++K ++ K+ ++++ E ++ + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 82 KEVMATKTKVFFVIEYVKGGELFA--KVLKGK-LKEESARKYFQQLISAVDFCHSRGVYH 138
T+T + V++Y GGELF + GK L EE AR Y +++ A+++ H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 139 RDLKPENLLLDENGNLKVSDFGLS-------ALPEQ----LWNDGLLHTQ---------- 177
RDLKPEN+LL E+G++ +SDF LS + +++
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 178 ------CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF 231
GT Y+APEV+ G+ A D W+ G++L+ +L G PF+ N + + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 232 KAEYEFP--PWISCDARRLISRILVADPQKRI----SVSEIMINPWF 272
K E FP P +S AR LI ++LV DP KR+ +EI +P+F
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 5e-46
Identities = 86/305 (28%), Positives = 136/305 (44%), Gaps = 68/305 (22%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
YE +G+GT+ +VY +N T E VA+K I + +K+G REI +++ ++HPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPN 59
Query: 78 IVELKEVMATKTK--VFFVIEYV----KGGELFAKVLKGKLKEESARKYFQQLISAVDFC 131
IV LKE++ +K K ++ V EY+ G + K E + Y +QL+ + +
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG---LLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ------------LWNDGLLHTQCG 179
HS G+ HRD+K N+L++ +G LK++DFGL+ + LW
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW---------- 166
Query: 180 TPAYVAPEVLR-KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA----- 233
Y PE+L Y D+WS G +L L G FQ ++ KIF+
Sbjct: 167 ---YRPPELLLGATRYGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT 222
Query: 234 -----EYEFPPW---------------------ISCDARRLISRILVADPQKRISVSEIM 267
PW I A L+ ++L DP+KRIS + +
Sbjct: 223 DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282
Query: 268 INPWF 272
+ +F
Sbjct: 283 QHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 8e-46
Identities = 90/289 (31%), Positives = 142/289 (49%), Gaps = 40/289 (13%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
Y+ +G+GT+ VY ++ +T E VAIK I + +G+ + REI +++ + HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF-ESEGIPKTALREIKLLKELNHPN 59
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK---LKEESARKYFQQLISAVDFCHSR 134
I++L +V K ++ V E++ K++K + L E + Y QL+ + FCHS
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT-QCGTPAYVAPEVLRKKG 193
G+ HRDLKPENLL++ G LK++DFGL+ + +T T Y APE+L
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARS---FGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 194 YDGAKSDIWSCGVVLFVLLSG--FLPFQNE--NIMKMYRKI------------------- 230
DIWS G + LLS P ++E + K++R +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234
Query: 231 ----FKAEYEFP---PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
KA P P S A L+S++L DP KRI+ + + +P+F
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 90/260 (34%), Positives = 160/260 (61%), Gaps = 13/260 (5%)
Query: 22 RMLGQGTFAKVYYGKNLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
++LGQG+F KV+ + + ++ A+KV+ K +K + + + K E ++ V HP I
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPFI 60
Query: 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLKGKL-KEESARKYFQQLISAVDFCHSRGVY 137
V+L T+ K++ ++++++GG+LF ++ K + EE + Y +L A+D HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 138 HRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGA 197
+RDLKPEN+LLDE G++K++DFGLS E + ++ ++ CGT Y+APEV+ ++G+ +
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 198 KSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADP 257
+D WS GV++F +L+G LPFQ ++ + I KA+ P ++S +A+ L+ + +P
Sbjct: 179 -ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237
Query: 258 QKRI-----SVSEIMINPWF 272
R+ V EI +P+F
Sbjct: 238 ANRLGAGPDGVEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-45
Identities = 87/242 (35%), Positives = 136/242 (56%), Gaps = 5/242 (2%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHPNIVE 80
+++G+G+F KV K A+KV+ K + K+ I E +V+ + +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHR 139
L T K++FV++YV GGELF + + + E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLKPEN+LLD G++ ++DFGL E + + T CGTP Y+APEVLRK+ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT-V 177
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W G VL+ +L G PF + ++ +MY I + P + A L+ +L D ++
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 260 RI 261
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 1e-44
Identities = 93/254 (36%), Positives = 148/254 (58%), Gaps = 6/254 (2%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
++LG+G+F KV + T E AIK + KD V + +E E V+ L +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L TK +FFV+EY+ GG+L + G+ E AR Y ++I + F H +G+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD++G++K++DFG+ E + +G T CGTP Y+APE+L+ + Y+
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYN-ESV 177
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D WS GV+L+ +L G PF E+ +++ I FP WIS +A+ +S++ DP K
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237
Query: 260 RISVS-EIMINPWF 272
R+ V +I +P+F
Sbjct: 238 RLGVDGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 86/260 (33%), Positives = 144/260 (55%), Gaps = 12/260 (4%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
++LG+G+F KV + T E AIKV+ KD + + ++ E ++ L KHP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLKG-KLKEESARKYFQQLISAVDFCHSRGVYHR 139
L TK ++FFV+EYV GG+L ++ + K E +R Y ++ A+ F H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD G+ K++DFG+ E + N T CGTP Y+APE+L++ Y G
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W+ GV+++ +++G PF+ +N ++ I + +P W+S +A ++ + +P K
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 260 RISV-------SEIMINPWF 272
R+ I +P+F
Sbjct: 238 RLGCVASQGGEDAIKQHPFF 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-44
Identities = 81/264 (30%), Positives = 136/264 (51%), Gaps = 22/264 (8%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR-----EISVMRL 72
+++ + LG+G++ VY K L + A+K ++ G M Q +R EI ++
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD------LGSMSQKEREDAVNEIRILAS 55
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK-----LKEESARKYFQQLISA 127
V HPNI+ KE K+ V+EY G+L + K K + E+ + F QL+
Sbjct: 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187
+ H + + HRDLK N+LL N +K+ D G+S + ++ + TQ GTP Y+APE
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPE 171
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FPPWISCDAR 246
V + + Y KSDIWS G +L+ + + PF+ ++ + K+ + +Y PP S D +
Sbjct: 172 VWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230
Query: 247 RLISRILVADPQKRISVSEIMINP 270
I +L P+ R + +I+ +P
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 89/263 (33%), Positives = 140/263 (53%), Gaps = 25/263 (9%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
+GQG + +V+ K T E VA+K + K + K + + E ++ K +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 84 VMATKTKVFFVIEYVKGGELFAKVL--KGKLKEESARKYFQQLISAVDFCHSRGVYHRDL 141
++ +EYV GG+ F +L G L E+ AR Y ++ AVD H G HRDL
Sbjct: 69 AFQDDEYLYLAMEYVPGGD-FRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127
Query: 142 KPENLLLDENGNLKVSDFGLSALPEQLWNDGLL---HTQCGTPAYVAPEVLRKKGYDGAK 198
KPEN L+D +G++K++DFGLS G++ ++ G+P Y+APEVLR KGYD
Sbjct: 128 KPENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FT 178
Query: 199 SDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI--FKAEYEFPPW------ISCDARRLIS 250
D WS G +L+ L GF PF + + + +K + P + +S +A LI+
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238
Query: 251 RILVADPQKRI-SVSEIMINPWF 272
+ L+ DP +R S+ +I +P+F
Sbjct: 239 K-LINDPSRRFGSLEDIKNHPFF 260
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 91/261 (34%), Positives = 139/261 (53%), Gaps = 14/261 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KYE R++G+G F V+ + Q+ V IK I +Q+ K + E V++L+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLSHP 59
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK---LKEESARKYFQQLISAVDFCHS 133
NI+E E + V+EY GG L + K L E++ +F Q++ A+ H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 134 RGVYHRDLKPENLLLDENGN-LKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ + HRDLK +N+LLD++ +K+ DFG+S + L + +T GTP Y++PE+ K
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGIS---KILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW---ISCDARRLI 249
Y+ KSDIW+ G VL+ L S F+ N+ + KI F P S D R+LI
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG--TFAPISDRYSPDLRQLI 233
Query: 250 SRILVADPQKRISVSEIMINP 270
+L DP KR +S+IM P
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 82/261 (31%), Positives = 146/261 (55%), Gaps = 12/261 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVIN--KDQVKKQGLMEQIKREISVMRLVK 74
++ G +LG G+F VY G NL + A+K ++ D Q ++Q+++EI+++ ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCH 132
HPNIV+ + ++ +E V GG L AK+LK G E R Y +Q++ +++ H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
R HRD+K N+L+D NG +K++DFG++ +Q+ + G+P ++APEV+ ++
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPF-QNENIMKMYRKI--FKAEYEFPPWISCDARRLI 249
G G +DIWS G + + +G P+ Q E + ++ KI K P +S +A+ I
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF-KIGRSKELPPIPDHLSDEAKDFI 235
Query: 250 SRILVADPQKRISVSEIMINP 270
+ L DP R + +E++ +P
Sbjct: 236 LKCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 4e-43
Identities = 92/286 (32%), Positives = 142/286 (49%), Gaps = 46/286 (16%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG+GT+A VY G+N T E VA+K I+ D ++G REIS+M+ +KH NIV L +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 84 VMATKTKVFFVIEYVKGGELFAKVL-----KGKLKEESARKYFQQLISAVDFCHSRGVYH 138
V+ T+ K+ V EY+ K + +G L + + + QL+ + FCH V H
Sbjct: 66 VIHTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 139 RDLKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
RDLKP+NLL+++ G LK++DFGL+ +P +++ ++ T Y AP+VL
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-----TLWYRAPDVLLGSRTY 178
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK----------------AEYE--F 237
DIWS G ++ +++G F N KIF+ EY+ F
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238
Query: 238 P-----------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
P P L+ R+L +P+ RIS + + +PWF
Sbjct: 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 4e-43
Identities = 94/259 (36%), Positives = 148/259 (57%), Gaps = 13/259 (5%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQ-VKKQGLMEQI-KREISVMRLVKH-PNIVE 80
+G+GTF +VY + T+ A+KV++K + V K+ + I +R I V L+ P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHR 139
LK T + ++ V +Y+ GGELF + K G+ E+ A+ Y +L+ A++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV-LRKKGYDGAK 198
DLKPEN+LLD G++ + DFGLS L ++ +T CGT Y+APEV L +KGY
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 199 SDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP-WISCDARRLISRILVADP 257
D WS GV++F + G+ PF E+ +MYR I + FP +S + R+ + +L +P
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 258 QKRI----SVSEIMINPWF 272
Q R+ E+ +P+F
Sbjct: 238 QHRLGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 95/306 (31%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK--KQGLMEQIKREISVMRLVK 74
+YE G+ LG+GT+A VY ++ T VAIK I + K K G+ REI +++ +K
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK---LKEESARKYFQQLISAVDFC 131
HPNI+ L +V K+ + V E++ +L KV+K K L + Y + +++
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFM-ETDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYVAPEV 188
HS + HRDLKP NLL+ +G LK++DFGL+ P + + Q T Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP-----NRKMTHQVVTRWYRAPEL 173
Query: 189 LRKKGYDGAKS-----DIWSCGVVLFVLLSG--FLPFQNENIMKMYRKIFKA-------- 233
L GA+ D+WS G + LL FLP ++ + KIF+A
Sbjct: 174 LF-----GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEEN 226
Query: 234 -----------EYEF---PPW------ISCDARRLISRILVADPQKRISVSEIMINPWFI 273
E++ P S DA L+ R+L +P KRI+ + + +P+F
Sbjct: 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF- 285
Query: 274 KGFSKP 279
+ P
Sbjct: 286 --SNDP 289
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 1e-42
Identities = 81/268 (30%), Positives = 147/268 (54%), Gaps = 23/268 (8%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y+ +G+G +VY + T + VAIK + ++KQ E I EI +M+ KHP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQN-KELIINEILIMKDCKHP 75
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL---KGKLKEESARKYFQQLISAVDFCHS 133
NIV+ + +++ V+EY+ GG L ++ ++ E ++++ +++ HS
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL-HTQCGTPAYVAPEVLRKK 192
+ V HRD+K +N+LL ++G++K++DFG +A QL + ++ GTP ++APEV+++K
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAA---QLTKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWI------SCDAR 246
Y K DIWS G++ + G P+ E + R +F + P + S + +
Sbjct: 192 DYG-PKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLITTKGIPPLKNPEKWSPEFK 247
Query: 247 RLISRILVADPQKRISVSEIMINPWFIK 274
+++ LV DP+KR S E++ +P F+K
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHP-FLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 1e-42
Identities = 90/272 (33%), Positives = 154/272 (56%), Gaps = 20/272 (7%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQES---VAIKVINKDQ-VKKQGLMEQIKREISVMRLV 73
+E+ ++LG G + KV+ + + ++ A+KV+ K V+K +E + E +V+ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 74 KH-PNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFC 131
+ P +V L T+ K+ +++YV GGE+F + + E+ R Y ++I A++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSA--LPEQLWNDGLLHTQCGTPAYVAPEVL 189
H G+ +RD+K EN+LLD G++ ++DFGLS L E+ ++ CGT Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE---KERTYSFCGTIEYMAPEII 178
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE----NIMKMYRKIFKAEYEFPPWISCDA 245
R KG G D WS G+++F LL+G PF E ++ R+I K + FP +I +A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 246 RRLISRILVADPQKRI-----SVSEIMINPWF 272
+ L+ ++L DP+KR+ SEI +P+F
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 88/246 (35%), Positives = 136/246 (55%), Gaps = 5/246 (2%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHPNIVE 80
+++G+G+F KV K + + A+KV+ K V + + I E +V+ + VKHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHR 139
L T K++FV+++V GGELF + + + E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLKPEN+LLD G++ ++DFGL E + T CGTP Y+APEV+RK+ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT-V 177
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W G VL+ +L G PF ++ +MY I P S A ++ +L D Q+
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 260 RISVSE 265
R+ E
Sbjct: 238 RLGAKE 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 3e-42
Identities = 87/294 (29%), Positives = 143/294 (48%), Gaps = 47/294 (15%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y++ +G+G V+ K+ T E+VA+K + +++ G+ Q REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHP 59
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK---LKEESARKYFQQLISAVDFCHS 133
+V+L +V + V+EY+ ++VL+ + L E + Y + L+ V + H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD--LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG--LLHTQCGTPAYVAPEVL-- 189
G+ HRDLKP NLL+ +G LK++DFGL+ L + L Q T Y APE+L
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARL---FSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 190 -RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA----------EYE-- 236
RK YD D+W+ G + LL+G F EN ++ +F+
Sbjct: 175 ARK--YDPG-VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 237 -------FP-----------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
FP P S +A L+ +LV DP KR+S +E + +P+F
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-42
Identities = 79/269 (29%), Positives = 134/269 (49%), Gaps = 17/269 (6%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVIN-KDQVKKQGLMEQIKREISVMRLVKHPN 77
E ++LGQG+ VY ++ T + A+K I+ + +Q+ RE+ +R + P
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF---RKQLLRELKTLRSCESPY 60
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHS-R 134
+V+ + ++ V+EY+ GG L A +LK GK+ E +Q++ +D+ H+ R
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
+ HRD+KP NLL++ G +K++DFG+S + E +T GT Y++PE ++ +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN--TLDQCNTFVGTVTYMSPERIQGE-S 176
Query: 195 DGAKSDIWSCGVVLFVLLSGFLPFQNENIMK---MYRKIFKAEYEFPP--WISCDARRLI 249
+DIWS G+ L G PF + + I P S + R I
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236
Query: 250 SRILVADPQKRISVSEIMINPWFIKGFSK 278
S L DP+KR S +E++ +P+ IK
Sbjct: 237 SACLQKDPKKRPSAAELLQHPF-IKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 5e-42
Identities = 86/254 (33%), Positives = 144/254 (56%), Gaps = 6/254 (2%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
+MLG+G+F KV+ + T + AIK + KD V +E E V+ L +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L TK +FFV+EY+ GG+L + K A Y ++I + F HS+G+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD +G++K++DFG+ E + D T CGTP Y+APE+L + Y
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D WS GV+L+ +L G PF + ++++ I +P W++ +A+ ++ ++ V +P++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237
Query: 260 RISV-SEIMINPWF 272
R+ V +I +P+F
Sbjct: 238 RLGVKGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 80/257 (31%), Positives = 129/257 (50%), Gaps = 11/257 (4%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQI---KREISVMRLVKHPNIVE 80
LG+G F KV + T E AIK + K + + +E + KR +HP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
L T+ V FV+EY GG+L + E A Y ++ + + H + +RD
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRD 126
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSD 200
LK +NLLLD G +K++DFGL E + T CGTP ++APEVL + Y A D
Sbjct: 127 LKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA-VD 183
Query: 201 IWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260
W GV+++ +L G PF ++ +++ I E +P ++S +A ++ R+L +P++R
Sbjct: 184 WWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERR 243
Query: 261 ISVSE-----IMINPWF 272
+ E + P+F
Sbjct: 244 LGSGEKDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 9e-41
Identities = 82/269 (30%), Positives = 141/269 (52%), Gaps = 16/269 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+ + +G+G+F +VY + T + VAIKVI+ ++ + + +E I++EI + + P
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSP 59
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGV 136
I + +K++ ++EY GG + GKL E ++++ +++ H G
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL-LHTQCGTPAYVAPEVLRKKGYD 195
HRD+K N+LL E G++K++DFG+S QL + +T GTP ++APEV+++ GYD
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP-----WISCDARRLIS 250
K+DIWS G+ L G P + + M++ I K PP S + +S
Sbjct: 177 E-KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---NNPPSLEGNKFSKPFKDFVS 232
Query: 251 RILVADPQKRISVSEIMINPWFIKGFSKP 279
L DP++R S E++ + FIK K
Sbjct: 233 LCLNKDPKERPSAKELLKHK-FIKKAKKT 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-40
Identities = 61/114 (53%), Positives = 76/114 (66%), Gaps = 4/114 (3%)
Query: 291 DFISSMSSGFDLSSLFESE--RKSGSMFTSKCSSSAIMGKLESLAKKLNLGVCVK-EFKV 347
D IS +SSG DLS LFE E K + FTS+ + I+ KLE AKKL V K E V
Sbjct: 4 DLIS-LSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEGGV 62
Query: 348 KMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALK 401
K++G+ GRKG+LAV+ EV+EV P + VVE KSAGDTLEY KF ++ +RP LK
Sbjct: 63 KLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 17/271 (6%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVIN-KDQVKKQGLMEQIKREISVMRLVKH 75
KY +GQG VY ++ T + VAIK +N + Q KK E I EI VMR KH
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK----ELIINEILVMRENKH 75
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRG 135
PNIV + +++ V+EY+ GG L V + + E ++ + A++F HS
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 135
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSA--LPEQLWNDGLLHTQCGTPAYVAPEVLRKKG 193
V HRD+K +N+LL +G++K++DFG A PEQ T GTP ++APEV+ +K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRSTMVGTPYWMAPEVVTRKA 191
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF---KAEYEFPPWISCDARRLIS 250
Y G K DIWS G++ ++ G P+ NEN ++ I E + P +S R ++
Sbjct: 192 Y-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250
Query: 251 RILVADPQKRISVSEIMINPWFIKGFSKPVA 281
R L D +KR S E++ +P F+K +KP++
Sbjct: 251 RCLEMDVEKRGSAKELLQHP-FLK-IAKPLS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-40
Identities = 77/261 (29%), Positives = 137/261 (52%), Gaps = 7/261 (2%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLME--QIKREISVMRLVKH 75
+ G++LGQG F +VY ++ T +A+K + D + E ++ EI +++ ++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKV-LKGKLKEESARKYFQQLISAVDFCHSR 134
IV+ + + +EY+ GG + ++ G L E RKY +Q++ V++ HS
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG-LLHTQCGTPAYVAPEVLRKKG 193
+ HRD+K N+L D GN+K+ DFG S + + + G + + GTP +++PEV+ +G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--AEYEFPPWISCDARRLISR 251
Y G K+D+WS G + +L+ P+ M KI + P +S DAR + R
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 252 ILVADPQKRISVSEIMINPWF 272
V + +KR S E++ + +
Sbjct: 243 TFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 90/301 (29%), Positives = 142/301 (47%), Gaps = 64/301 (21%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
Y+ +G+GT+ VY ++ +T E VA+K I + + +G+ REIS+++ + HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 78 IVELKEVMATKTKVFFVIEYV----KGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS 133
IV L +V+ ++ K++ V E++ K + L + Y QL+ + +CHS
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLK--KYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ--------LWNDGLLHTQCGTPA 182
V HRDLKP+NLL+D G LK++DFGL+ +P + LW
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW------------- 164
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVL--FVLLSGFLPFQNENIMKMYRKIFKA------- 233
Y APE+L DIWS G + V P +E I +++R IF+
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFR-IFRTLGTPDED 222
Query: 234 ---------EYE--FPPW-----------ISCDARRLISRILVADPQKRISVSEIMINPW 271
+Y+ FP W + D L+S++LV DP KRIS + +P+
Sbjct: 223 VWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
Query: 272 F 272
F
Sbjct: 283 F 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 88/303 (29%), Positives = 151/303 (49%), Gaps = 47/303 (15%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E +++G+G F +V + T A+K + K ++ ++ + ++ E ++ +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
+V+L + ++ ++EY+ GG++ ++K EE R Y + I A+D H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSA-------------LPEQLWNDGLLHTQ------ 177
HRD+KP+NLLLD G++K+SDFGL L L ++ L
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 178 -----------------CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN 220
GTP Y+APEV + GY + D WS GV+++ +L G+ PF +
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 221 ENIMKMYRKI--FKAEYEFPP--WISCDARRLISRILVADPQKRI---SVSEIMINPWFI 273
+N + YRKI +K +FP +S +A+ LI R L + ++R+ V+EI +P+F
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKR-LCCEAERRLGNNGVNEIKSHPFF- 299
Query: 274 KGF 276
KG
Sbjct: 300 KGV 302
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 89/298 (29%), Positives = 134/298 (44%), Gaps = 58/298 (19%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK-REI-SVMRLVKH 75
Y++ + LG GTF VY +N T E VAIK + K K E + RE+ S+ +L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK---KFYSWEECMNLREVKSLRKLNEH 57
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGG--ELFAKVLKGKLKEESARKYFQQLISAVDFCHS 133
PNIV+LKEV +++FV EY++G +L E R Q++ + H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP--AYV------A 185
G +HRDLKPENLL+ +K++DFGL+ + P YV A
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAR-----------EIRSRPPYTDYVSTRWYRA 166
Query: 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLP-FQNENIMKMYRKIF------------- 231
PE+L + + DIW+ G ++ L + P F + + KI
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225
Query: 232 ------KAEYEFP-----------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
K + FP P S +A LI +L DP+KR + S+ + +P+F
Sbjct: 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 85/251 (33%), Positives = 143/251 (56%), Gaps = 14/251 (5%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
R++G+G++AKV + T+ A+KVI K+ V ++ ++ E V HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 81 LKEVMATKTKVFFVIEYVKGGEL-FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L T++++FFVIE+V GG+L F + KL EE AR Y ++ A++F H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD G++K++D+G+ E + T CGTP Y+APE+LR + Y G
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 200 DIWSCGVVLFVLLSGFLPFQ--------NENIMK-MYRKIFKAEYEFPPWISCDARRLIS 250
D W+ GV++F +++G PF ++N +++ I + + P +S A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 251 RILVADPQKRI 261
L DP++R+
Sbjct: 238 GFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 84/279 (30%), Positives = 154/279 (55%), Gaps = 22/279 (7%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
L+ + E+ +G+G + VY GK++ T VA+K+IN D + I+RE++++ +
Sbjct: 2 LYQRLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD--VSDIQREVALLSQL 56
Query: 74 KH---PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
+ PNI + +++ ++EY +GG + + G + E+ ++++ A+ +
Sbjct: 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
H GV HRD+K N+L+ GN+K+ DFG++AL Q N T GTP ++APEV+
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMAPEVIT 174
Query: 191 K-KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWI-----SCD 244
+ K YD K+DIWS G+ ++ + +G P+ + + + I K++ PP + S
Sbjct: 175 EGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYSKL 230
Query: 245 ARRLISRILVADPQKRISVSEIMINPWFIKGFSK-PVAV 282
R ++ L +P++R+S E++ + W IK SK PV++
Sbjct: 231 LREFVAACLDEEPKERLSAEELLKSKW-IKAHSKTPVSI 268
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 80/267 (29%), Positives = 132/267 (49%), Gaps = 19/267 (7%)
Query: 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK---QGLMEQIKREISVMRLVKHPN 77
G+ LG G F+ Y +++ T +A+K + + + ++E +++EI +M + HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 78 IVELKEVMATKTKVFF--VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHS 133
I+ + + AT F +E++ GG + + +L G KE Y +QL+ + + H
Sbjct: 65 IIRM--LGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 134 RGVYHRDLKPENLLLDENGN-LKVSDFGLSA-LPEQLWNDGLLHTQ-CGTPAYVAPEVLR 190
+ HRD+K NLL+D G L+++DFG +A L + G Q GT A++APEVLR
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK-AEYEFPPWI----SCDA 245
+ Y G D+WS G V+ + + P+ E IFK A P I S
Sbjct: 182 GEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240
Query: 246 RRLISRILVADPQKRISVSEIMINPWF 272
R + R L P+ R E++ +P F
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 85/274 (31%), Positives = 142/274 (51%), Gaps = 28/274 (10%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
YE+ ++G G A VY L E VAIK I+ + K Q ++++++E+ M HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLE--KCQTSVDELRKEVQAMSQCNHPN 60
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELF----AKVLKGKLKEESARKYFQQLISAVDFCHS 133
+V+ +++ V+ Y+ GG L + +G L E ++++ +++ HS
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG-----LLHTQCGTPAYVAPEV 188
G HRD+K N+LL E+G++K++DFG+SA L + G + T GTP ++APEV
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSAS---LADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 189 L-RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDA-- 245
+ + GYD K+DIWS G+ L +G P+ MK+ + + PP + A
Sbjct: 178 MEQVHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---PPSLETGADY 233
Query: 246 -------RRLISRILVADPQKRISVSEIMINPWF 272
R++IS L DP KR + E++ + +F
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 2e-39
Identities = 87/277 (31%), Positives = 157/277 (56%), Gaps = 23/277 (8%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E +++ G + VY ++ T++ A+K INK + + ++Q+ E ++ ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRG 135
+V + TK + V+EYV+GG+ A +LK G L + AR YF + + A+++ H+ G
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDC-ATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLS-----ALPEQLWNDGL-------LHTQ-CGTPA 182
+ HRDLKP+NLL+ G++K++DFGLS +L L+ + L Q CGTP
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW-- 240
Y+APEV+ ++GY G D W+ G++L+ L G +PF + +++ ++ + E+P
Sbjct: 182 YIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240
Query: 241 -ISCDARRLISRILVADPQKRISVS---EIMINPWFI 273
+ DA+ LISR+L +P +R+ E+ + +F+
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 2e-39
Identities = 81/254 (31%), Positives = 143/254 (56%), Gaps = 6/254 (2%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
++LG+G+F KV + E A+K + KD V +E E V+ L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L TK +FFV+E++ GG+L + KG+ A Y +++ + F HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N++LD +G++K++DFG+ E ++ D T CGTP Y+APE+L+ Y +
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFS-V 177
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D WS GV+L+ +L G PF ++ +++ I +P WI+ +++ ++ ++ DP +
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 260 RISVS-EIMINPWF 272
R+ V I +P+F
Sbjct: 238 RLGVVGNIRGHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 3e-39
Identities = 90/315 (28%), Positives = 160/315 (50%), Gaps = 30/315 (9%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+++ ++G+G F +V + T + A+KV+ K + Q + + E ++ + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRG 135
I +L+ K ++ V+EY GG+L + + + + E+ A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ--CGTPAYVAPEVLR--- 190
HRD+KPEN+L+D G++K++DFG +A +L + +++++ GTP Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 191 --KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI--FKAEYEFP--PWISCD 244
KG G + D WS GV+ + ++ G PF K Y I F+ +FP P +S D
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 245 ARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRD----FISSMSSGF 300
LI L+ ++R+ + +P+F K ID + R+ F+ ++ S
Sbjct: 240 FLDLIQS-LLCGQKERLGYEGLCCHPFFSK---------IDWNNIRNSLPPFVPTLKSDD 289
Query: 301 DLSSLFESERKSGSM 315
D S+ E E+ S
Sbjct: 290 DTSNFDEPEKNSTRR 304
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 81/241 (33%), Positives = 140/241 (58%), Gaps = 5/241 (2%)
Query: 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVEL 81
+LG+G+F KV + T E AIK++ KD V + +E E V+ L K P + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
T +++FV+EYV GG+L ++ + G+ KE A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSD 200
LK +N++LD G++K++DFG+ E +W+ T CGTP Y+APE++ + Y G D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 201 IWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260
W+ GV+L+ +L+G PF+ E+ ++++ I + +P +S +A + ++ P KR
Sbjct: 184 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 243
Query: 261 I 261
+
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 84/266 (31%), Positives = 146/266 (54%), Gaps = 14/266 (5%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+++ +++G+G F +V ++ +++ A+K+++K ++ K+ E +M
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVY 137
IV+L ++ V+EY+ GG+L + + E+ AR Y +++ A+D HS G
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 138 HRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH--TQCGTPAYVAPEVLRKKGYD 195
HRD+KP+N+LLD++G+LK++DFG ++ +G++ T GTP Y++PEVL+ +G D
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 196 ---GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF--KAEYEFP--PWISCDARRL 248
G + D WS GV L+ +L G PF ++++ Y KI K FP IS A+ L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDL 281
Query: 249 ISRILVADPQK--RISVSEIMINPWF 272
I L + R V EI +P+F
Sbjct: 282 ICAFLTDREVRLGRNGVDEIKSHPFF 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-39
Identities = 78/267 (29%), Positives = 143/267 (53%), Gaps = 13/267 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV------KKQGLMEQIKREISVM 70
K+ G ++G G+F VY G N + E +A+K + V +K+ +++ + REI+++
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKV-LKGKLKEESARKYFQQLISAVD 129
+ ++H NIV+ + +EYV GG + A + G +E R + +Q++ ++
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ----CGTPAYVA 185
+ H+RG+ HRD+K N+L+D G +K+SDFG+S E + G+ ++A
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI-FKAEYEFPPWISCD 244
PEV+++ Y K+DIWS G ++ +L+G PF + ++ KI A E P IS +
Sbjct: 181 PEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239
Query: 245 ARRLISRILVADPQKRISVSEIMINPW 271
A + + D KR + +E++ +P+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-39
Identities = 80/241 (33%), Positives = 136/241 (56%), Gaps = 5/241 (2%)
Query: 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN-IVEL 81
+LG+G+F KV + T E AIK++ KD + + +E E V+ L P + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
T +++FV+EYV GG+L + + GK KE A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSD 200
LK +N++LD G++K++DFG+ E ++ T CGTP Y+APE++ + Y G D
Sbjct: 127 LKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 201 IWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260
W+ GV+L+ +L+G PF E+ ++++ I + +P +S +A + +L P KR
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243
Query: 261 I 261
+
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 73/268 (27%), Positives = 142/268 (52%), Gaps = 19/268 (7%)
Query: 21 GRMLGQGTFAKVYYGKNLVTQESVAIK-------VINKDQVKKQGLMEQIKREISVMRLV 73
G ++G+GT+ +VY N+ T E +A+K + + +++ +++ ++ EI ++ +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFC 131
H NIV+ T+ + +EYV GG + L+ G+ +E+ R + +Q++ + +
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV--L 189
HS+G+ HRDLK +NLL+D +G K+SDFG+S + ++++ + G+ ++APEV
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP------PWISC 243
+GY AK DIWS G V+ + +G P+ +E + K+ P +S
Sbjct: 185 YSQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSP 243
Query: 244 DARRLISRILVADPQKRISVSEIMINPW 271
A ++ +P R + E++ +P+
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 85/265 (32%), Positives = 145/265 (54%), Gaps = 17/265 (6%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVIN--KDQVKKQGLMEQIKREISVMRLVK 74
+YE+ + +G+G+F K+Y K E IK I+ K VK++ E K+E+ ++ +K
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK---EASKKEVILLAKMK 57
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK---LKEESARKYFQQLISAVDFC 131
HPNIV ++F V+EY GG+L ++ + + E+ +F Q+ +
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 132 HSRGVYHRDLKPENLLLDENGNL-KVSDFGLSALPEQLWNDG--LLHTQCGTPAYVAPEV 188
H R + HRD+K +N+ L +NG + K+ DFG++ + ND L +T GTP Y++PE+
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA----RQLNDSMELAYTCVGTPYYLSPEI 173
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FPPWISCDARR 247
+ + Y+ K+DIWS G VL+ L + PF+ N+ ++ KI + + P S D R
Sbjct: 174 CQNRPYNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRS 232
Query: 248 LISRILVADPQKRISVSEIMINPWF 272
LIS++ P+ R S++ I+ P+
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 3e-38
Identities = 90/263 (34%), Positives = 137/263 (52%), Gaps = 24/263 (9%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG G F KVY ++ T A K+I Q++ + +E EI ++ KHPNIV L E
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLKGK--LKEESARKYFQQLISAVDFCHSRGVYHRDL 141
+ K++ +IE+ GG L + +L+ + L E R +Q++ A++F HS V HRDL
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 142 KPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL-----RKKGYDG 196
K N+LL +G++K++DFG+SA + T GTP ++APEV+ + YD
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNPYD- 186
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP-------WISCDARRLI 249
K+DIWS G+ L L P N M++ KI K+E PP W S +
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PPTLDQPSKW-SSSFNDFL 242
Query: 250 SRILVADPQKRISVSEIMINPWF 272
LV DP R + +E++ +P+
Sbjct: 243 KSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 30/265 (11%)
Query: 19 EMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+G+ LG+G F +VY GK + VA+K + +D ++Q +E+ RE +MR +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLD 59
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCH 132
HPN+V+L V + ++ V+EY++GG+L + + + KL + Q+ +++
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV---APEVL 189
S+ HRDL N L+ EN +K+SDFGLS + D + + G + APE L
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLS----RDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYRKIFKAEYEFPPWI 241
++ + +KSD+WS GV+L+ + + G P+ E + YR PP
Sbjct: 176 KEGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL------PQPPNC 228
Query: 242 SCDARRLISRILVADPQKRISVSEI 266
+ L+ + DP+ R + SE+
Sbjct: 229 PPELYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 89/287 (31%), Positives = 147/287 (51%), Gaps = 48/287 (16%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
+G+GT+ VY +N +T E VA+K I D + +G+ REIS+++ + HPNIV+L +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLD-TETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 84 VMATKTKVFFVIEYVKGGELFAKVL----KGKLKEESARKYFQQLISAVDFCHSRGVYHR 139
V+ T+ K++ V E++ + K + + + Y QL+ + FCHS V HR
Sbjct: 67 VIHTENKLYLVFEFLH--QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 140 DLKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
DLKP+NLL++ G +K++DFGL+ +P + + ++ T Y APE+L Y
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEILLGCKYYS 179
Query: 197 AKSDIWSCGVVLFVLLS--GFLPFQNENIMKMYRKIFKA----------------EYE-- 236
DIWS G + +++ P +E I +++R IF+ +Y+
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFR-IFRTLGTPDEVVWPGVTSLPDYKPS 237
Query: 237 FPPW-----------ISCDARRLISRILVADPQKRISVSEIMINPWF 272
FP W + D R L+S++L DP KRIS + +P+F
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 5e-38
Identities = 99/288 (34%), Positives = 154/288 (53%), Gaps = 20/288 (6%)
Query: 4 ETMDERVRNILF-----GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQG 58
E + E++R+I+ KY +GQG VY ++ T + VAIK +N Q K+
Sbjct: 2 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK- 60
Query: 59 LMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESAR 118
E I EI VMR K+PNIV + +++ V+EY+ GG L V + + E
Sbjct: 61 --ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA 118
Query: 119 KYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA--LPEQLWNDGLLHT 176
++ + A+DF HS V HRD+K +N+LL +G++K++DFG A PEQ T
Sbjct: 119 AVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRST 174
Query: 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF---KA 233
GTP ++APEV+ +K Y G K DIWS G++ ++ G P+ NEN ++ I
Sbjct: 175 MVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
Query: 234 EYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVA 281
E + P +S R ++R L D +R S E++ +P F+K +KP++
Sbjct: 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP-FLK-LAKPLS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-38
Identities = 89/294 (30%), Positives = 140/294 (47%), Gaps = 63/294 (21%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK--REISVMR-LVKHPNIVE 80
+G+GTF++V ++ T + AIK + K +EQ+ REI +R L HPNI+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS----LEQVNNLREIQALRRLSPHPNILR 62
Query: 81 LKEVMATKT--KVFFVIEYVKGG--ELFAKVLKGK---LKEESARKYFQQLISAVDFCHS 133
L EV+ + ++ V E + EL +KG+ L E+ + Y QL+ ++D H
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYEL----IKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFG-----LSALPEQLWNDGLLHTQ-CGTPAYVAPE 187
G++HRD+KPEN+L+ ++ LK++DFG S P +T+ T Y APE
Sbjct: 119 NGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP---------YTEYISTRWYRAPE 168
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN------------------IMKMYRK 229
L GY G K DIW+ G V F +LS F F N ++K +RK
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228
Query: 230 IFKAEYEFPP----WISC-------DARRLISRILVADPQKRISVSEIMINPWF 272
Y FP + + L+ ++L DP +RI+ + + +P+F
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 6e-38
Identities = 85/285 (29%), Positives = 153/285 (53%), Gaps = 43/285 (15%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
+G+GT+ VY G+N T + VA+K I + + +++G+ REIS+++ ++HPNIV L++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 84 VMATKTKVFFVIEYVKGG--ELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHRD 140
V+ +++++ + E++ + + KG+ + E + Y Q++ + FCHSR V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 141 LKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGA 197
LKP+NLL+D G +K++DFGL+ +P +++ ++ T Y APEVL
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWYRAPEVLLGSPRYST 181
Query: 198 KSDIWSCGVVLFVLLSGFLPFQNEN-IMKMYRKIFKA----------------EYE--FP 238
DIWS G + + + F ++ I +++R IF+ +Y+ FP
Sbjct: 182 PVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-IFRILGTPTEDVWPGVTSLPDYKNTFP 240
Query: 239 PW-----------ISCDARRLISRILVADPQKRISVSEIMINPWF 272
W + D L+ ++L+ DP KRIS + + +P+F
Sbjct: 241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 8e-38
Identities = 73/203 (35%), Positives = 112/203 (55%), Gaps = 9/203 (4%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
KYE+ ++G+G + V +N T E VAIK K+ + + + RE+ V+R ++H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRH 59
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCH 132
NIV LKE K +++ V EYV+ L ++L+ G L ++ R Y QL+ A+ +CH
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGTPAYVAPEVLRK 191
S + HRD+KPEN+L+ E+G LK+ DFG + AL + L T Y APE+L
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR--PASPLTDYVATRWYRAPELLVG 175
Query: 192 KGYDGAKSDIWSCGVVLFVLLSG 214
G D+W+ G ++ LL G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 80/269 (29%), Positives = 138/269 (51%), Gaps = 30/269 (11%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
G +++ + +G+G F+ VY L+ VA+K + ++ + +EI +++ + H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGEL------FAKVLKGKLKEE-SARKYFQQLISAV 128
PN+++ ++ V+E G+L F K + +L E + KYF QL SA+
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSAL 119
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL-----SALPEQLWNDGLLHTQCGTPAY 183
+ HS+ + HRD+KP N+ + G +K+ D GL S H+ GTP Y
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-------HSLVGTPYY 172
Query: 184 VAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE--NIMKMYRKIFKAEYEFPP-- 239
++PE + + GY+ KSDIWS G +L+ + + PF + N+ + +KI K +Y PP
Sbjct: 173 MSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--PPLP 229
Query: 240 --WISCDARRLISRILVADPQKRISVSEI 266
S + R L+SR + DP+KR +S +
Sbjct: 230 ADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 4e-37
Identities = 88/268 (32%), Positives = 151/268 (56%), Gaps = 20/268 (7%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHPNIVE 80
R++G+G++AKV + T+ A+KV+ K+ V ++ ++ E V + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 81 LKEVMATKTKVFFVIEYVKGGEL-FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L T++++FFVIEYV GG+L F + KL EE AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD G++K++D+G+ E L T CGTP Y+APE+LR + Y G
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 200 DIWSCGVVLFVLLSGFLPFQ--------NENIMK-MYRKIFKAEYEFPPWISCDARRLIS 250
D W+ GV++F +++G PF ++N +++ I + + P +S A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 251 RILVADPQKRISV------SEIMINPWF 272
L DP++R+ ++I +P+F
Sbjct: 238 SFLNKDPKERLGCHPQTGFADIQGHPFF 265
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 136 bits (342), Expect = 5e-37
Identities = 98/288 (34%), Positives = 156/288 (54%), Gaps = 20/288 (6%)
Query: 4 ETMDERVRNILF-----GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQG 58
E + E++R I+ KY +GQG V+ ++ T + VAIK IN ++KQ
Sbjct: 2 EEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQP 58
Query: 59 LMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESAR 118
E I EI VM+ +K+PNIV + ++F V+EY+ GG L V + + E
Sbjct: 59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA 118
Query: 119 KYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA--LPEQLWNDGLLHT 176
++ + A++F H+ V HRD+K +N+LL +G++K++DFG A PEQ T
Sbjct: 119 AVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ----SKRST 174
Query: 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF---KA 233
GTP ++APEV+ +K Y G K DIWS G++ ++ G P+ NEN ++ I
Sbjct: 175 MVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
Query: 234 EYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVA 281
E + P +S R ++R L D +KR S E++ +P F+K +KP++
Sbjct: 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP-FLK-LAKPLS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 6e-37
Identities = 88/274 (32%), Positives = 157/274 (57%), Gaps = 19/274 (6%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQES---VAIKVINKDQ-VKKQGLMEQIKREISVMRLV 73
+E+ ++LG G + KV+ + + +S A+KV+ K V+K E + E V+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 74 KH-PNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFC 131
+ P +V L T TK+ +++Y+ GGELF + + + KE+ + Y +++ A++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR- 190
H G+ +RD+K EN+LLD NG++ ++DFGLS + + ++ CGT Y+AP+++R
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRG 180
Query: 191 -KKGYDGAKSDIWSCGVVLFVLLSGFLPF----QNENIMKMYRKIFKAEYEFPPWISCDA 245
G+D A D WS GV+++ LL+G PF + + ++ R+I K+E +P +S A
Sbjct: 181 GDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 246 RRLISRILVADPQKRI-----SVSEIMINPWFIK 274
+ +I R+L+ DP+KR+ EI +P+F K
Sbjct: 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 81/260 (31%), Positives = 135/260 (51%), Gaps = 24/260 (9%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG+G++ VY + T + VAIKV+ + +++I +EIS+++ P IV+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPYIVKYYG 65
Query: 84 VMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDL 141
T ++ V+EY G + K+ L EE Q + +++ HS HRD+
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 142 KPENLLLDENGNLKVSDFGLSALPEQLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSD 200
K N+LL+E G K++DFG+S QL + +T GTP ++APEV+++ GY+ K+D
Sbjct: 126 KAGNILLNEEGQAKLADFGVSG---QLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-NKAD 181
Query: 201 IWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP-------WISCDARRLISRIL 253
IWS G+ + G P+ + + M R IF + PP W S + + + L
Sbjct: 182 IWSLGITAIEMAEGKPPYSDIHPM---RAIFMIPNKPPPTLSDPEKW-SPEFNDFVKKCL 237
Query: 254 VADPQKRISVSEIMINPWFI 273
V DP++R S +++ +P FI
Sbjct: 238 VKDPEERPSAIQLLQHP-FI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 76/258 (29%), Positives = 138/258 (53%), Gaps = 8/258 (3%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KY + +G+G+F K K+ + IK IN ++ + E+ ++E++V+ +KHP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE-REESRKEVAVLSNMKHP 59
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK---LKEESARKYFQQLISAVDFCHS 133
NIV+ +E ++ V++Y +GG+L+ K+ + E+ +F Q+ A+ H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKG 193
R + HRD+K +N+ L ++G +K+ DFG++ + L T GTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISRI 252
Y+ KSDIW+ G VL+ + + F+ N+ + KI + Y S D R L+S++
Sbjct: 178 YNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236
Query: 253 LVADPQKRISVSEIMINP 270
+P+ R SV+ I+
Sbjct: 237 FKRNPRDRPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 78/259 (30%), Positives = 139/259 (53%), Gaps = 19/259 (7%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
+G+G+ V + T VA+K ++ ++KQ E + E+ +MR +HPNIVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKP 143
+++ V+E+++GG L V ++ EE ++ A+ F H++GV HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143
Query: 144 ENLLLDENGNLKVSDFGLSA-----LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAK 198
+++LL +G +K+SDFG A +P + + GTP ++APEV+ + Y G +
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKEVPRR-------KSLVGTPYWMAPEVISRLPY-GTE 195
Query: 199 SDIWSCGVVLFVLLSGFLPFQNE---NIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255
DIWS G+++ ++ G P+ NE MK R + + +S R + R+LV
Sbjct: 196 VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255
Query: 256 DPQKRISVSEIMINPWFIK 274
DP +R + +E++ +P+ K
Sbjct: 256 DPAQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 81/241 (33%), Positives = 136/241 (56%), Gaps = 5/241 (2%)
Query: 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVEL 81
+LG+G+F KV + T E AIK++ KD V + +E E V+ L K P + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
T +++FV+EYV GG+L + + GK KE A Y ++ + F H RG+ +RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSD 200
LK +N++LD G++K++DFG+ E + + T CGTP Y+APE++ + Y G D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 201 IWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260
W+ GV+L+ +L+G PF E+ ++++ I + +P +S +A + ++ P KR
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243
Query: 261 I 261
+
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 89/267 (33%), Positives = 140/267 (52%), Gaps = 22/267 (8%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
YE+ + +G GT+ VY +++ T E VAIKVI + E I++EIS+++ +HP
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHP 60
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSR 134
NIV + K++ V+EY GG L +V +G L E ++ + + + H
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND-GLLHTQCGTPAYVAPEVL---R 190
G HRD+K N+LL E+G++K++DFG+SA QL + GTP ++APEV R
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSA---QLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP-------WISC 243
K GYDG K DIW+ G+ L P + + M+ I K+ + PP W S
Sbjct: 178 KGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-PPKLKDKEKW-SP 234
Query: 244 DARRLISRILVADPQKRISVSEIMINP 270
I + L DP+KR + ++++ +P
Sbjct: 235 VFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 3e-36
Identities = 83/249 (33%), Positives = 142/249 (57%), Gaps = 12/249 (4%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHPNIVE 80
R++G+G++AKV + + A+KV+ K+ V ++ ++ E V + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 81 LKEVMATKTKVFFVIEYVKGGEL-FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L T +++F VIEYV GG+L F + KL EE AR Y ++ A++F H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD +G++K++D+G+ E L T CGTP Y+APE+LR + Y G
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 200 DIWSCGVVLFVLLSGFLPF----QNENIMK---MYRKIFKAEYEFPPWISCDARRLISRI 252
D W+ GV++F +++G PF N ++ +++ I + P ++S A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 253 LVADPQKRI 261
L DP++R+
Sbjct: 238 LNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 7e-36
Identities = 75/259 (28%), Positives = 127/259 (49%), Gaps = 12/259 (4%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
Y R+LG+G F + + V K +N ++ ++ EI ++ L++HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE-RRDALNEIVILSLLQHPN 60
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK---LKEESARKYFQQLISAVDFCHSR 134
I+ + +EY GG L+ K+++ K +EE Y Q++SAV + H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQC--GTPAYVAPEVLRKK 192
G+ HRD+K N+ L + G +K+ DFG+S ++ + GTP Y++PE+ +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGIS----KILGSEYSMAETVVGTPYYMSPELCQGV 176
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FPPWISCDARRLISR 251
Y+ KSDIW+ G VL+ LL+ F N + + KI + Y S + L+
Sbjct: 177 KYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS 235
Query: 252 ILVADPQKRISVSEIMINP 270
+L DP+KR + E++ P
Sbjct: 236 LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 8e-36
Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 31/266 (11%)
Query: 19 EMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+G+ LG+G F +VY G + VA+K + +D ++Q +E+ RE +MR +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLD 59
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYF-QQLISAVDFC 131
HPNIV+L V + + V+EY+ GG+L + + + K S F Q+ +++
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV---APEV 188
S+ HRDL N L+ EN +K+SDFGLS + D + G + APE
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLS----RDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYRKIFKAEYEFPPW 240
L++ + +KSD+WS GV+L+ + + G P+ E + K YR PP
Sbjct: 176 LKEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL------PKPPN 228
Query: 241 ISCDARRLISRILVADPQKRISVSEI 266
+ +L+ + DP+ R + SE+
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 84/292 (28%), Positives = 137/292 (46%), Gaps = 42/292 (14%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK--- 74
YE +G+G + VY ++L T VA+K + + + ++G+ REI++++ ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 75 HPNIVELKEVMATK-----TKVFFVIEYVKG--GELFAKVLKGKLKEESARKYFQQLISA 127
HPNIV L +V K+ V E+V +K K L E+ + +QL+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187
VDF HS + HRDLKP+N+L+ +G +K++DFGL+ + + L + T Y APE
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPE 176
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK-----AEYEFP---- 238
VL + Y D+WS G + L F+ + KIF +E E+P
Sbjct: 177 VLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235
Query: 239 -PWISCDARR-----------------LISRILVADPQKRISVSEIMINPWF 272
P S + L+ ++L +P KRIS E + +P+F
Sbjct: 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 96/288 (33%), Positives = 155/288 (53%), Gaps = 20/288 (6%)
Query: 4 ETMDERVRNILF-----GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQG 58
E + E++R+I+ KY +GQG VY ++ T + VAI+ +N Q K+
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK- 61
Query: 59 LMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESAR 118
E I EI VMR K+PNIV + +++ V+EY+ GG L V + + E
Sbjct: 62 --ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA 119
Query: 119 KYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA--LPEQLWNDGLLHT 176
++ + A++F HS V HRD+K +N+LL +G++K++DFG A PEQ ++
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-- 177
Query: 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF---KA 233
GTP ++APEV+ +K Y G K DIWS G++ ++ G P+ NEN ++ I
Sbjct: 178 --GTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
Query: 234 EYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVA 281
E + P +S R ++R L D +KR S E++ + F+K +KP++
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ-FLK-IAKPLS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 89/285 (31%), Positives = 157/285 (55%), Gaps = 18/285 (6%)
Query: 2 KFETMDERVRNILFG--KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGL 59
++E + ++R + Y++ +++G+G F +V ++ +Q+ A+K+++K ++ K+
Sbjct: 27 RYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD 86
Query: 60 MEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARK 119
E +M P +V+L ++ V+EY+ GG+L + + E+ A+
Sbjct: 87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF 146
Query: 120 YFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH--TQ 177
Y +++ A+D HS G+ HRD+KP+N+LLD++G+LK++DFG ++ G++ T
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE---TGMVRCDTA 203
Query: 178 CGTPAYVAPEVLRKK---GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF--K 232
GTP Y++PEVL+ + GY G + D WS GV LF +L G PF ++++ Y KI K
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 233 AEYEFPP--WISCDARRLISRILVADPQKRI---SVSEIMINPWF 272
FP IS A+ LI L D + R+ V EI +P+F
Sbjct: 264 NSLNFPEDVEISKHAKNLICAFL-TDREVRLGRNGVEEIKQHPFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 75/260 (28%), Positives = 130/260 (50%), Gaps = 19/260 (7%)
Query: 19 EMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
E+G+ LG+G F +VY G T+ VA+K + + +++ E+ E S+M+ +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE--REEFLEEASIMKKLS 59
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCH 132
HPNIV L V ++ V EY+ GG+L F + KL + + Q+ +++
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP---AYVAPEVL 189
S+ HRDL N L+ EN +K+SDFGLS ++ D + G ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLS---RDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPWISCDAR-- 246
+ + +KSD+WS GV+L+ + + G P+ + ++ + + Y P +C
Sbjct: 177 KDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELY 234
Query: 247 RLISRILVADPQKRISVSEI 266
L+ + DP+ R + SE+
Sbjct: 235 ELMLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 82/256 (32%), Positives = 138/256 (53%), Gaps = 11/256 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y + R++G+G+F + +++ + + A+K I K +E ++E ++ +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP--KSSSAVEDSRKEAVLLAKMKHP 58
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKV--LKGKL-KEESARKYFQQLISAVDFCHS 133
NIV KE ++ V+EY GG+L K+ +GKL E++ ++F Q+ V H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH-TQCGTPAYVAPEVLRKK 192
+ V HRD+K +N+ L +NG +K+ DFG + L L + G T GTP YV PE+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL---LTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FPPWISCDARRLISR 251
Y+ KSDIWS G +L+ L + PFQ + + K+ + Y+ P S + R LI +
Sbjct: 176 PYNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234
Query: 252 ILVADPQKRISVSEIM 267
+ +P+ R S + I+
Sbjct: 235 MFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 89/299 (29%), Positives = 137/299 (45%), Gaps = 58/299 (19%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KYE +G+GT+ V+ KN T E VA+K + D +G+ REI +++ +KH
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 59
Query: 77 NIVELKEVMATKTKVFFVIEYVKGG-ELFAKVLKGKLKEESARKYFQQLISAVDFCHSRG 135
NIV L +V+ + K+ V EY + + G + E + + QL+ + FCHS
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGL-----------SALPEQLWNDGLLHTQCGTPAYV 184
V HRDLKP+NLL+++NG LK++DFGL SA LW Y
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLW-------------YR 166
Query: 185 APEVL-RKKGYDGAKSDIWSCGVVLFVLLSGFLP-FQNENIMKMYRKIFK-----AEYEF 237
P+VL K Y D+WS G + L + P F ++ ++IF+ E +
Sbjct: 167 PPDVLFGAKLYS-TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW 225
Query: 238 P------------------------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
P P ++ R L+ +LV +P +RIS E + +P+F
Sbjct: 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 6e-35
Identities = 78/261 (29%), Positives = 136/261 (52%), Gaps = 19/261 (7%)
Query: 22 RMLGQGTFAKV----YYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
R LG G+F +V Y ++ VAIK K ++ KQ ++ + E ++ + HP
Sbjct: 36 RTLGTGSFGRVILATYKNEDF---PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGV 136
V L ++ ++ V+E+V GGE F + + K + Y Q++ ++ S +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI 152
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
+RDLKPENLLLD++G +K++DFG + + + +T CGTP Y+APE+L G+ G
Sbjct: 153 VYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGH-G 206
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVAD 256
+D W+ G+ ++ +L G PF + +Y+KI + FP ++ + + L+ ++L D
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHD 266
Query: 257 PQKRI-----SVSEIMINPWF 272
KR + +PWF
Sbjct: 267 LTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 8e-35
Identities = 79/300 (26%), Positives = 135/300 (45%), Gaps = 51/300 (17%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
+ +G G F +V + + T A+K + K V + +K E ++ + +V+L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
K ++FV++Y+ GG++ + +++ G +E+ AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 141 LKPENLLLDENGNLKVSDFGLSA-----------------------LPEQLWNDG----- 172
+KP+N+L+D +G++K++DFGL E+
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 173 -------------LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQ 219
L H+ GTP Y+APEVL + GY D WS GV+L+ +L G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFL 245
Query: 220 NENIMKMYRKI--FKAEYEFPPWI--SCDARRLISRILVADPQKRI---SVSEIMINPWF 272
+ + K+ ++ P S +A LI R L + R+ EI +P+F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 90/305 (29%), Positives = 145/305 (47%), Gaps = 54/305 (17%)
Query: 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREIS 68
R R++ ++E +G+GT+ VY ++ + E VA+K + D ++ G+ REI+
Sbjct: 2 RCRSV--TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREIT 58
Query: 69 VMRLVKHPNIVELKEVMATK--TKVFFVIEYVKGGELFAKVL---KGKLKEESARKYFQQ 123
++ ++HPNIVELKEV+ K +F V+EY + + A +L E + Q
Sbjct: 59 LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE--QDLASLLDNMPTPFSESQVKCLMLQ 116
Query: 124 LISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA- 182
L+ + + H + HRDLK NLLL + G LK++DFGL+ L + TP
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG-------LPAKPMTPKV 169
Query: 183 ----YVAPEVL-RKKGYDGAKSDIWSCGVVLFVLLSG--FLPFQ---------------- 219
Y APE+L Y A D+W+ G +L LL+ LP +
Sbjct: 170 VTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228
Query: 220 NENI------MKMYRKIF--KAEYEFP----PWISCDARRLISRILVADPQKRISVSEIM 267
NE+I + + K K Y PW+S RL++ +L+ DP+KR + E +
Sbjct: 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288
Query: 268 INPWF 272
+ +F
Sbjct: 289 ESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 87/267 (32%), Positives = 149/267 (55%), Gaps = 16/267 (5%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
YE+ +++G+G F +V ++ T++ A+K+++K ++ K+ E +M P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVY 137
+V+L ++ V+EY+ GG+L + + E+ AR Y +++ A+D HS G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 138 HRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH--TQCGTPAYVAPEVLRKK--- 192
HRD+KP+N+LLD++G+LK++DFG ++ +G++ T GTP Y++PEVL+ +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF--KAEYEFP--PWISCDARRL 248
GY G + D WS GV L+ +L G PF ++++ Y KI K FP IS +A+ L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281
Query: 249 ISRILVADPQKRI---SVSEIMINPWF 272
I L D + R+ V EI + +F
Sbjct: 282 ICAFL-TDREVRLGRNGVEEIKRHLFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 85/281 (30%), Positives = 145/281 (51%), Gaps = 37/281 (13%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVK 74
G +E+ ++G+GT+ KVY ++ T + VAIK+++ + ++ E+IK E +++R
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSN 61
Query: 75 HPNIVE-----LKEVMATK-TKVFFVIEYVKGG---ELFAKVLK--GKLKEESARKYFQQ 123
HPNI +K+ +++ V+E GG +L + K +LKEE ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 124 LISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND-GLLHTQCGTPA 182
+ + + H V HRD+K +N+LL +N +K+ DFG+SA QL + G +T GTP
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRRNTFIGTPY 178
Query: 183 YVAPEVL-----RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF 237
++APEV+ YD A+SD+WS G+ L G P + + M R +FK
Sbjct: 179 WMAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPM---RALFKIPRNP 234
Query: 238 PP-------WISCDARRLISRILVADPQKRISVSEIMINPW 271
PP W S IS L+ + ++R + E++ +P+
Sbjct: 235 PPTLKSPENW-SKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-33
Identities = 77/246 (31%), Positives = 128/246 (52%), Gaps = 13/246 (5%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG+G F +V + T + A K ++K ++KK+ + E ++ V IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 84 VMATKTKVFFVIEYVKGGEL---FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
TK + V+ + GG+L V + E A Y Q+I ++ H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 141 LKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
LKPEN+LLD++GN+++SD GL+ L + + GTP Y+APEVL+ + YD
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGG----KKIKGRAGTPGYMAPEVLQGEVYD-FSV 175
Query: 200 DIWSCGVVLFVLLSGFLPFQN--ENIMK--MYRKIFKAEYEFPPWISCDARRLISRILVA 255
D ++ G L+ +++G PF+ E + K + R+ + E+P S +A+ L +L
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235
Query: 256 DPQKRI 261
DP+KR+
Sbjct: 236 DPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 8/257 (3%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E+ +G+G+F V+ + A+K I+ ++ ++ E I E V+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSY 60
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKV---LKGKLKEESARKYFQQLISAVDFCHSR 134
I+ E K K+ V+EY + G+L + L E+ ++F Q++ + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
+ HRD+K NL LD N+K+ D G++ L N +T GTP Y++PE+ K Y
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPY 178
Query: 195 DGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FPPWISCDARRLISRIL 253
+ KSD+W+ GVVL+ +G PF N + KI + + S +LI + L
Sbjct: 179 N-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237
Query: 254 VADPQKRISVSEIMINP 270
D ++R +++ NP
Sbjct: 238 TKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 90/342 (26%), Positives = 144/342 (42%), Gaps = 67/342 (19%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINK---DQVKKQGLMEQIKREISVMRLV 73
+YE+ + +G G + V + T VAIK I+ D + ++I REI ++R +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI----DAKRILREIKLLRHL 56
Query: 74 KHPNIVELKEVMATKTK-----VFFVIEYVKGGELFAKVLKGKLK-EESARKYFQ-QLIS 126
+H NI+ L +++ + V+ V E +L KV+K + +YF Q++
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTEL-METDL-HKVIKSPQPLTDDHIQYFLYQILR 114
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS--ALPEQLWNDGLLHTQCGTPAYV 184
+ + HS V HRDLKP N+L++ N +LK+ DFGL+ P++ L T+ YV
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL--TE-----YV 167
Query: 185 ------APEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF------ 231
APE+ L Y A DIWS G + LL+ F + + I
Sbjct: 168 VTRWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226
Query: 232 -----------KA--------EYEFPPW------ISCDARRLISRILVADPQKRISVSEI 266
KA + P S +A L+ ++LV DP+KRI+ E
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286
Query: 267 MINPWFIKGFSKPVA--VCIDDGDNRDFISSMSSGFDLSSLF 306
+ +P+ P V D F + +L L
Sbjct: 287 LAHPYL-AQLHDPEDEPVAKPPFDFDFFDDDELTEEELKELI 327
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 59/304 (19%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
K+++ +G+GT+ +VY ++ T E VA+K + D +K+G REI ++R + H
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLNHR 66
Query: 77 NIVELKEVMATKTKV----------FFVIEYVKGGELFAKVLKGKL---KEESARKYFQQ 123
NIV LKE++ K + V EY+ +L +L+ L E+ + + +Q
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMG-LLESGLVHFSEDHIKSFMKQ 124
Query: 124 LISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN--DGLLHT-QCGT 180
L+ +++CH + HRD+K N+LL+ G +K++DFGL+ +L+N + +T + T
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA----RLYNSEESRPYTNKVIT 180
Query: 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM---------------- 224
Y PE+L + G D+WSCG +L L + FQ +
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240
Query: 225 -----------------KMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIM 267
K YR+ + E+ F P + D L+ +L DP KR + E +
Sbjct: 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALD---LLDHMLTLDPSKRCTAEEAL 297
Query: 268 INPW 271
+PW
Sbjct: 298 NSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 89/273 (32%), Positives = 153/273 (56%), Gaps = 24/273 (8%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E+ +++G+G F +V K T + A+K++NK ++ K+ + E V LV
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV--LVNGDR 60
Query: 78 --IVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHS 133
I L + ++ V++Y GG+L + K +L E+ AR Y +++ A+D H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ--CGTPAYVAPEVLRK 191
G HRD+KP+N+LLD+NG+++++DFG S L +L DG + + GTP Y++PE+L+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 192 ----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI--FKAEYEFPPW---IS 242
KG G + D WS GV ++ +L G PF E++++ Y KI K ++FPP +S
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVS 237
Query: 243 CDARRLISRILVADPQKRI---SVSEIMINPWF 272
+A+ LI R L+ P+ R+ + + +P+F
Sbjct: 238 EEAKDLIRR-LICSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 83/299 (27%), Positives = 130/299 (43%), Gaps = 72/299 (24%)
Query: 26 QGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVM 85
+GT+ VY ++ T E VA+K + ++ +K+G REI+++ ++HPNIV +KEV+
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLKLQHPNIVTVKEVV 73
Query: 86 ATKT--KVFFVIEYVKGGELFAKVLKGKLKE------ESARKYF-QQLISAVDFCHSRGV 136
K++ V+EYV+ LK ++ +S K QL+S V H +
Sbjct: 74 VGSNLDKIYMVMEYVEHD------LKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI 127
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA-----------YVA 185
HRDLK NLLL+ G LK+ DFGL+ + G+P Y A
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLA-------------REYGSPLKPYTQLVVTLWYRA 174
Query: 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA----------EY 235
PE+L D+WS G + LL+ F ++ + KIFK +
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234
Query: 236 -EFPPWISCDARR---------------------LISRILVADPQKRISVSEIMINPWF 272
E P + L++R+L DP KRIS + + +P+F
Sbjct: 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 75/265 (28%), Positives = 131/265 (49%), Gaps = 28/265 (10%)
Query: 22 RMLGQGTFAKVYYGK---NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
+ LG+G F +VY GK VA+K + +D +++ + +E VM+ + HPN+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNV 58
Query: 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKY---FQQLIS-AVDFC--- 131
V L V + ++ V+EY++GG+L + K + S K + L+S A+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 132 ---HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV---A 185
S+ HRDL N L+ E+ +K+SDFGLS +++D + G + A
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS---RDVYDDDYYRKKTGGKLPIRWMA 175
Query: 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPF---QNENIMKMYRKIFKAEYEFPPWI 241
PE L+ + +KSD+WS GV+L+ + + G P+ NE +++ RK ++ P +
Sbjct: 176 PESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR--LPKPEYC 232
Query: 242 SCDARRLISRILVADPQKRISVSEI 266
+ L+ DP+ R + SE+
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 84/297 (28%), Positives = 146/297 (49%), Gaps = 53/297 (17%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+YE +G+GT+ VY ++ VT E++A+K I +Q + +G+ REIS+++ ++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHG 61
Query: 77 NIVELKEVMATKTKVFFVIEYVK--------GGELFAKVLKGKLKEESARKYFQQLISAV 128
NIV L++V+ ++ +++ V EY+ FAK + + Y Q++ +
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR------LIKTYLYQILRGI 115
Query: 129 DFCHSRGVYHRDLKPENLLLDENGN-LKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYV 184
+CHS V HRDLKP+NLL+D N LK++DFGL+ +P + + ++ T Y
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-----TLWYR 170
Query: 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK------------ 232
APE+L + DIWS G + +++ F ++ + KIF+
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230
Query: 233 ----AEYE--FPPWISCDARR-----------LISRILVADPQKRISVSEIMINPWF 272
+Y+ FP W D L+S++L DP KRI+ + + +F
Sbjct: 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-32
Identities = 79/251 (31%), Positives = 140/251 (55%), Gaps = 16/251 (6%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E+ +++G+G F +V K + A+K++NK ++ K+ + E V+ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRG 135
I L + ++ V++Y GG+L + K +L E+ AR Y +++ A+D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ--CGTPAYVAPEVLRK-- 191
HRD+KP+N+L+D NG+++++DFG S L +L DG + + GTP Y++PE+L+
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 192 --KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF--KAEYEFPPW---ISCD 244
KG G + D WS GV ++ +L G PF E++++ Y KI K ++FP +S D
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 245 ARRLISRILVA 255
A+ LI R++ +
Sbjct: 240 AKDLIRRLICS 250
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-32
Identities = 79/269 (29%), Positives = 130/269 (48%), Gaps = 23/269 (8%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
E LG G V + T + +A+K I + + + +QI RE+ ++ P I
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYI 61
Query: 79 VELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHS-RG 135
V + +EY+ GG L K ++G++ E K ++ + + H
Sbjct: 62 VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
+ HRD+KP N+L++ G +K+ DFG+S QL N L T GT +Y+APE ++ Y
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNS-LAKTFVGTSSYMAPERIQGNDY- 176
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNEN-----IMKMYRKIFKAEYEFPPWI-----SCDA 245
KSDIWS G+ L L +G P+ EN I ++ + I E PP + S D
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPPRLPSGKFSPDF 233
Query: 246 RRLISRILVADPQKRISVSEIMINPWFIK 274
+ ++ L+ DP++R S E++ +P+ K
Sbjct: 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-32
Identities = 87/304 (28%), Positives = 144/304 (47%), Gaps = 59/304 (19%)
Query: 15 FGK---YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
FGK Y+ LG+G++A VY G++ +T + VA+K I + ++G RE S+++
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLK 58
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-------GKLKEESARKYFQQL 124
+KH NIV L +++ TK + V EY+ LK G L + R + QL
Sbjct: 59 DLKHANIVTLHDIIHTKKTLTLVFEYLD------TDLKQYMDDCGGGLSMHNVRLFLFQL 112
Query: 125 ISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTP 181
+ + +CH R V HRDLKP+NLL+ E G LK++DFGL+ ++P + +++ ++ T
Sbjct: 113 LRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-----TL 167
Query: 182 AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQ-NENIMKMYRKIFK-------- 232
Y P+VL D+W G + + + +G F + ++ KIF+
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227
Query: 233 ------AEYEFPPWISC------------------DARRLISRILVADPQKRISVSEIMI 268
+ EF P+ L + L +P+KRIS +E M
Sbjct: 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287
Query: 269 NPWF 272
+P+F
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 122/417 (29%), Positives = 198/417 (47%), Gaps = 40/417 (9%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KY + R+LG G V K + E A+KV++ + + + + + E+ +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKN-RAQAEVCCLLNCDFF 91
Query: 77 NIVELKEVMATKTK--------VFFVIEYVKGGELFAKVLKGKLK------EESARKYFQ 122
+IV+ E A K + V++Y G+L ++ K + K E A F
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI-KSRAKTNRTFREHEAGLLFI 150
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
Q++ AV HS+ + HRD+K N+LL NG +K+ DFG S + +D + T CGTP
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FPPWI 241
YVAPE+ R+K Y K+D++S GV+L+ LL+ PF EN+ ++ K Y+ PP I
Sbjct: 211 YVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSI 269
Query: 242 SCDARRLISRILVADPQKRISVSEIMINP---WFIKGFSKPVAVCID-DGDNRDFISSMS 297
S + + +++ +L +DP++R S S+++ P FI G + V G RD IS
Sbjct: 270 SPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQI 329
Query: 298 SGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNL--GVCVKEFKVKMQGKDEG 355
L + ER+ + S+A + A L G+ + E VK Q D
Sbjct: 330 Q--QTKQLLQVERRRIVRQMEESLSTAASTTILEGATPLTTLGGLTLYEGIVKKQSSDLS 387
Query: 356 RKGK-LAVTAEVYE-------VAPEVAVVEFSKS-AGDTLEYK----KFCE-EDVRP 398
K + L + E+ + VAP+ ++ + + DTLE + F + EDV P
Sbjct: 388 WKRRYLCIRGELEKGETLTVDVAPKFKSLDLVLAVSKDTLEQQCISTPFSDLEDVFP 444
|
Length = 496 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 2e-31
Identities = 81/271 (29%), Positives = 147/271 (54%), Gaps = 20/271 (7%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E+ +++G+G F +V K T+ A+K++NK ++ K+ + E +V+
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRG 135
I L + ++ V++Y GG+L + K +L E+ AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ--CGTPAYVAPEVLRK-- 191
HRD+KP+N+LLD NG+++++DFG S L ++ DG + + GTP Y++PE+L+
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCL--KMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 192 --KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFPPWI---SCD 244
G G + D WS GV ++ +L G PF E++++ Y KI E ++FP I S +
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 245 ARRLISRILVADPQKRI---SVSEIMINPWF 272
A+ LI R L+ ++R+ + + + +F
Sbjct: 240 AKDLIQR-LICSRERRLGQNGIEDFKKHAFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 86/296 (29%), Positives = 145/296 (48%), Gaps = 43/296 (14%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E +++G+G F +V + T A+K++ K + ++ + I+ E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
+V++ K ++ ++E++ GG++ ++K L EE+ + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 137 YHRDLKPENLLLDENGNLKVSDFGL------------------------------SALPE 166
HRD+KP+NLLLD G++K+SDFGL S
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 167 QLWNDG---LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI 223
+ W L ++ GTP Y+APEV + GY+ D WS GV+++ +L G+ PF +E
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 224 MKMYRKI--FKAEYEFPPW--ISCDARRLISRILVADPQKRI---SVSEIMINPWF 272
+ YRK+ +K FPP IS A+ LI R D + RI V EI +P+F
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-31
Identities = 76/261 (29%), Positives = 135/261 (51%), Gaps = 16/261 (6%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+++ + +G+G F++VY L+ ++ VA+K + ++ + +EI +++ + HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 78 IVELKEVMATKTKVFFVIEYVKGGEL-----FAKVLKGKLKEESARKYFQQLISAVDFCH 132
+++ + ++ V+E G+L + K K + E + KYF QL SAV+ H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
SR V HRD+KP N+ + G +K+ D GL H+ GTP Y++PE + +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHEN 181
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNE--NIMKMYRKIFKAEYEFPPW----ISCDAR 246
GY+ KSDIWS G +L+ + + PF + N+ + +KI + +Y PP S R
Sbjct: 182 GYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--PPLPTEHYSEKLR 238
Query: 247 RLISRILVADPQKRISVSEIM 267
L+S + DP +R + +
Sbjct: 239 ELVSMCIYPDPDQRPDIGYVH 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 82/299 (27%), Positives = 137/299 (45%), Gaps = 49/299 (16%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH- 75
YE +G+GT+ KVY ++ T + VA+K + ++ ++G+ REIS+++++
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSES 60
Query: 76 PNIVELKEVMATKTK-----VFFVIEYV-----KGGELFAKVLKGKLKEESARKYFQQLI 125
IV L +V + K ++ V EY+ K + + L ++ + + QL+
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGN-LKVSDFGLS---ALPEQLWNDGLLHTQCGTP 181
V CH GV HRDLKP+NLL+D+ LK++D GL ++P + + ++ T
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-----TL 175
Query: 182 AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-------- 233
Y APEVL + DIWS G + + F ++ ++ IFK
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235
Query: 234 ---------EYEFPPWISCDARR-----------LISRILVADPQKRISVSEIMINPWF 272
+EFP W D R L+ ++L DP KRIS + +P+F
Sbjct: 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 81/273 (29%), Positives = 133/273 (48%), Gaps = 23/273 (8%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVI---NKDQVKKQGLMEQIKREISVM 70
+ E +G G VY + T A+KVI ++D V++Q I REI ++
Sbjct: 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ-----ICREIEIL 126
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL-FAKVLKGKLKEESARKYFQQLISAVD 129
R V HPN+V+ ++ ++ ++E++ GG L + + + AR Q++S +
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIA 182
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV- 188
+ H R + HRD+KP NLL++ N+K++DFG+S + Q + ++ GT AY++PE
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERI 240
Query: 189 ---LRKKGYDGAKSDIWSCGVVLFVLLSGFLPF----QNENIMKMYRKIFKAEYEFPPWI 241
L YDG DIWS GV + G PF Q + M E P
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300
Query: 242 SCDARRLISRILVADPQKRISVSEIMINPWFIK 274
S + R IS L +P KR S +++ +P+ ++
Sbjct: 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333
|
Length = 353 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 81/266 (30%), Positives = 142/266 (53%), Gaps = 17/266 (6%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
LF K E +G+G+F +VY G + T+E VAIK+I+ ++ + + +E I++EI+V+
Sbjct: 5 LFTKLER---IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQC 59
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS 133
P I TK++ ++EY+ GG + G L+E ++++ +D+ HS
Sbjct: 60 DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHS 119
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL-LHTQCGTPAYVAPEVLRKK 192
HRD+K N+LL E G++K++DFG++ QL + + +T GTP ++APEV+++
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWI----SCDARRL 248
YD K+DIWS G+ L G P + + M R +F PP + S +
Sbjct: 177 AYD-FKADIWSLGITAIELAKGEPPNSDLHPM---RVLFLIPKNSPPTLEGQYSKPFKEF 232
Query: 249 ISRILVADPQKRISVSEIMINPWFIK 274
+ L DP+ R + E++ + + +
Sbjct: 233 VEACLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 85/301 (28%), Positives = 147/301 (48%), Gaps = 56/301 (18%)
Query: 15 FGKYEMG---RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
FGK E LG+GT+A VY G++ +T VA+K I + ++G RE+S+++
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLK 59
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKE-------ESARKYFQQL 124
+KH NIV L +++ T+ + V EY+ K LK L + + + + QL
Sbjct: 60 DLKHANIVTLHDIIHTEKSLTLVFEYLD------KDLKQYLDDCGNSINMHNVKLFLFQL 113
Query: 125 ISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTP 181
+ +++CH R V HRDLKP+NLL++E G LK++DFGL+ ++P + +++ ++ T
Sbjct: 114 LRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TL 168
Query: 182 AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------- 232
Y P++L + D+W G + + + +G F + + IF+
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228
Query: 233 ----------AEYEFP-----------PWISCDARRLISRILVADPQKRISVSEIMINPW 271
Y +P P + D L+S++L + +KRIS E M +P+
Sbjct: 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
Query: 272 F 272
F
Sbjct: 289 F 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 83/303 (27%), Positives = 143/303 (47%), Gaps = 53/303 (17%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
+++G+G F +V + T + A+K + K ++ K+ + +K E V+ P +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLKGKL-KEESARKYFQQLISAVDFCHSRGVYHRD 140
++ ++E++ GG+L ++K E+ R Y + + A++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 141 LKPENLLLDENGNLKVSDFGLS---------ALPEQL----------------------- 168
+KP+N+L+D G++K+SDFGLS A ++L
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 169 ----------WNDG---LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGF 215
W + ++ GTP Y+APE+ ++GY G + D WS G ++F L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 216 LPFQNENIMKMYRKI--FKAEYEFPPWI--SCDARRLISRILVADPQK--RISVSEIMIN 269
PF +EN + YRKI ++ FP I S +A LI R++ + R EI +
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSH 305
Query: 270 PWF 272
P+F
Sbjct: 306 PFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 86/261 (32%), Positives = 137/261 (52%), Gaps = 20/261 (7%)
Query: 23 MLGQGTFAKVYYGKNLVTQESVAIKVI-NKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
+LG+GT+ VY ++L TQ +AIK I +D Q L E EI++ +KH NIV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE----EIALHSYLKHRNIVQY 70
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLKGK-----LKEESARKYFQQLISAVDFCHSRGV 136
+ +E V GG L A +L+ K E++ Y +Q++ + + H +
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 137 YHRDLKPENLLLDE-NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRK--KG 193
HRD+K +N+L++ +G +K+SDFG S + + T GT Y+APEV+ K +G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQN--ENIMKMYR-KIFKAEYEFPPWISCDARRLIS 250
Y GA +DIWS G + + +G PF E M++ +FK E P +S +A+ I
Sbjct: 188 Y-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246
Query: 251 RILVADPQKRISVSEIMINPW 271
R DP KR S +++ +P+
Sbjct: 247 RCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 80/288 (27%), Positives = 139/288 (48%), Gaps = 41/288 (14%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y + +G G F V ++ +T ++VAIK I K L ++ RE+ +++ ++H
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYRELKLLKHLRHE 69
Query: 77 NIVELKEV-MATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQ-QLISAVDFCHSR 134
NI+ L ++ ++ ++FV E + G ++L + E+ +YF Q++ + + HS
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
GV HRDLKP N+L++EN +LK+ DFGL+ + D + T Y APE++
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 195 DGAKSDIWSCGVVLFVLLSG--FLPFQN-------------------------ENIMKMY 227
+ DIWS G + +L G P ++ EN ++
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242
Query: 228 RKIFKAE----YEFPPWISCDARRLISRILVADPQKRISVSEIMINPW 271
+ + K E E A L+ ++LV DPQKRIS +E + +P+
Sbjct: 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 84/303 (27%), Positives = 139/303 (45%), Gaps = 53/303 (17%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
+ LG G F +V + T A+K + K V + + +K E ++ + +V+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
K ++FV++Y+ GG++ + +++ E AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 141 LKPENLLLDENGNLKVSDFGL----------------------SALPEQLWND------- 171
+KP+N+L+D +G++K++DFGL S P LW+D
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 172 ----------------GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGF 215
L H+ GTP Y+APEVL +KGY D WS GV+LF +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 216 LPFQNENIMKMYRKIFKAE--YEFPPWI--SCDARRLISRILVADPQK--RISVSEIMIN 269
PF + K+ E PP + S +A LI+++ + ++ R +I +
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305
Query: 270 PWF 272
P+F
Sbjct: 306 PFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 74/263 (28%), Positives = 133/263 (50%), Gaps = 16/263 (6%)
Query: 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+ + + +G+G F++VY L+ VA+K + + +EI +++ +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK-----LKEESARKYFQQLISAVD 129
HPN+++ ++ V+E G+L + K + E++ KYF QL SA++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
HSR V HRD+KP N+ + G +K+ D GL H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE--NIMKMYRKIFKAEYEFPPW----ISC 243
+ GY+ KSDIWS G +L+ + + PF + N+ + +KI + +Y PP S
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSE 235
Query: 244 DARRLISRILVADPQKRISVSEI 266
+ R+L++ + DP+KR ++ +
Sbjct: 236 ELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 85/264 (32%), Positives = 133/264 (50%), Gaps = 28/264 (10%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG G F KVY KN T A KVI + K + +E EI ++ HP IV+L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDL 141
K++ +IE+ GG + A +L+ L E + +Q++ A+ + HS + HRDL
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 142 KPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ---CGTPAYVAPEV-----LRKKG 193
K N+LL +G++K++DFG+SA N L + GTP ++APEV ++
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAK-----NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISC------DARR 247
YD K+DIWS G+ L + P N M++ KI K+E PP +S + R
Sbjct: 192 YD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTLSQPSKWSMEFRD 247
Query: 248 LISRILVADPQKRISVSEIMINPW 271
+ L P+ R S ++++ +P+
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 81/270 (30%), Positives = 145/270 (53%), Gaps = 17/270 (6%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
LF K E +G+G+F +V+ G + TQ+ VAIK+I+ ++ + + +E I++EI+V+
Sbjct: 5 LFTKLER---IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQC 59
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS 133
P + + TK++ ++EY+ GG + G E ++++ +D+ HS
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL-LHTQCGTPAYVAPEVLRKK 192
HRD+K N+LL E G++K++DFG++ QL + + +T GTP ++APEV+++
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARR----L 248
YD +K+DIWS G+ L G P N ++ M R +F PP ++ + +
Sbjct: 177 AYD-SKADIWSLGITAIELAKGEPP--NSDMHPM-RVLFLIPKNNPPTLTGEFSKPFKEF 232
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSK 278
I L DP R + E++ + + +K K
Sbjct: 233 IDACLNKDPSFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 72/258 (27%), Positives = 145/258 (56%), Gaps = 17/258 (6%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
+G+G+ V + + VA+K+++ ++KQ E + E+ +MR +H N+VE+ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKP 143
+++ ++E+++GG L V + +L EE + ++ A+ + HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 144 ENLLLDENGNLKVSDFGLSALPEQLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIW 202
+++LL +G +K+SDFG A Q+ D + GTP ++APEV+ + Y G + DIW
Sbjct: 146 DSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIW 201
Query: 203 SCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW------ISCDARRLISRILVAD 256
S G+++ ++ G P+ +++ ++ +++ PP IS R + R+L +
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRL---RDSPPPKLKNAHKISPVLRDFLERMLTRE 258
Query: 257 PQKRISVSEIMINPWFIK 274
PQ+R + E++ +P+ ++
Sbjct: 259 PQERATAQELLDHPFLLQ 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 78/270 (28%), Positives = 142/270 (52%), Gaps = 17/270 (6%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
LF K E +G+G+F +V+ G + TQ+ VAIK+I+ ++ + + +E I++EI+V+
Sbjct: 5 LFTKLEK---IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQC 59
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS 133
P + + TK++ ++EY+ GG + G L E ++++ +D+ HS
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ-CGTPAYVAPEVLRKK 192
HRD+K N+LL E+G +K++DFG++ QL + + GTP ++APEV+++
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWI----SCDARRL 248
YD +K+DIWS G+ L G P + MK+ +F PP + S +
Sbjct: 177 AYD-SKADIWSLGITAIELAKGEPPHSELHPMKV---LFLIPKNNPPTLEGNYSKPLKEF 232
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSK 278
+ L +P R + E++ + + ++ K
Sbjct: 233 VEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 76/270 (28%), Positives = 140/270 (51%), Gaps = 26/270 (9%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
+G+G+ V T + VA+K K ++KQ E + E+ +MR H N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKP 143
+++ V+E+++GG L V ++ EE ++ A+ + H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 144 ENLLLDENGNLKVSDFGLSA-----LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAK 198
+++LL +G +K+SDFG A +P++ + GTP ++APEV+ + Y G +
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKR-------KSLVGTPYWMAPEVISRLPY-GTE 198
Query: 199 SDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW------ISCDARRLISRI 252
DIWS G+++ ++ G P+ NE ++ R+I PP +S R + +
Sbjct: 199 VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDNLPPRVKDSHKVSSVLRGFLDLM 255
Query: 253 LVADPQKRISVSEIMINPWFIKGFSKPVAV 282
LV +P +R + E++ +P F+K P +
Sbjct: 256 LVREPSQRATAQELLQHP-FLKLAGPPSCI 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 77/260 (29%), Positives = 135/260 (51%), Gaps = 14/260 (5%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVI--NKDQVKKQGLMEQIKREISVMRLVKH 75
+ +G++LGQG F +VY + T +A+K + + + + + ++ EI +++ + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 76 PNIVE----LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDF 130
IV+ L++ M +F +E++ GG + ++ G L E RKY +Q++ V +
Sbjct: 64 ERIVQYYGCLRDPMERTLSIF--MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL-LHTQCGTPAYVAPEVL 189
HS + HRD+K N+L D GN+K+ DFG S + + G + + GTP +++PEV+
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--AEYEFPPWISCDARR 247
+GY G K+DIWS G + +L+ P+ M KI PP +S R
Sbjct: 182 SGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240
Query: 248 LISRILVADPQKRISVSEIM 267
+ RI V + + R S E++
Sbjct: 241 FLKRIFV-EAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 74/260 (28%), Positives = 137/260 (52%), Gaps = 19/260 (7%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
+G+G+ V + + VA+K K ++KQ E + E+ +MR +H N+VE+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKP 143
+++ V+E+++GG L V ++ EE ++ A+ H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 144 ENLLLDENGNLKVSDFGLSA-----LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAK 198
+++LL +G +K+SDFG A +P + + GTP ++APE++ + Y G +
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRR-------KSLVGTPYWMAPELISRLPY-GPE 196
Query: 199 SDIWSCGVVLFVLLSGFLPFQNE---NIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255
DIWS G+++ ++ G P+ NE MKM R + + +S + + R+LV
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256
Query: 256 DPQKRISVSEIMINPWFIKG 275
DP +R + +E++ +P+ K
Sbjct: 257 DPAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 74/267 (27%), Positives = 131/267 (49%), Gaps = 17/267 (6%)
Query: 18 YEMGRMLGQGTFAKVYYG----KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
+ G +LG+G + VY G L+ + V + N +K+ E+++ E+ +++ +
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE--YEKLQEEVDLLKSL 59
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFC 131
KH NIV+ + +E+V GG + + +L G L E KY +Q++ V +
Sbjct: 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFG----LSALPEQLWNDGLLHTQCGTPAYVAPE 187
H+ V HRD+K N++L NG +K+ DFG L+ + + +L + GTP ++APE
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW---ISCD 244
V+ + GY G KSDIWS G +F + +G P + + + I P S
Sbjct: 179 VINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237
Query: 245 ARRLISRILVADPQKRISVSEIMINPW 271
A ++ L D +R S +++ + +
Sbjct: 238 AIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 81/263 (30%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLME--QIKREISVMRLVK 74
+Y + + LG+G+F VY K+ +KV+ + V + E Q +E ++ +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK-----LKEESARKYFQQLISAVD 129
HP IV+ + + EY +G +L K+ + K L E ++F QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
+ H R + HRDLK +N+ L N LK+ DFG+S L + + L T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRL 248
+ +GYD +KSDIWS G +L+ + F+ +N + + +I + P S +
Sbjct: 178 KHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236
Query: 249 ISRILVADPQKRISVSEIMINPW 271
+ +L DP R S +EI+ NP+
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 94/326 (28%), Positives = 156/326 (47%), Gaps = 55/326 (16%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E +++G+G F +V + T A+K++ K + ++ + I+ E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
+V++ K ++ ++E++ GG++ ++K L EE + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLS-----------------ALPE------------- 166
HRD+KP+NLLLD G++K+SDFGL +LP
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 167 QLWNDG---LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI 223
+ W L + GTP Y+APEV + GY+ D WS GV+++ +L G+ PF +E
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 224 MKMYRKI--FKAEYEFPPW--ISCDARRLISRILVADPQKRI---SVSEIMINPWFIKGF 276
+ Y+K+ +K FPP IS A+ LI R + + RI V EI NP+F +G
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNPFF-EGV 299
Query: 277 ------SKPVAV-----CIDDGDNRD 291
+P A+ IDD N D
Sbjct: 300 DWEHIRERPAAIPIEIKSIDDTSNFD 325
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 86/297 (28%), Positives = 141/297 (47%), Gaps = 53/297 (17%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVI----NKDQVKKQGLMEQIKREISVMRL 72
KYE ++G+G++ V K+ T + VAIK + VKK + REI +++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-----REIRMLKQ 56
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDF 130
++H N+V L EV K +++ V E+V L K G L E RKY Q++ ++F
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEF 115
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYVAPE 187
CHS + HRD+KPEN+L+ ++G +K+ DFG + A P +++ D T Y APE
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD-----YVATRWYRAPE 170
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSG--FLPFQNE------------NIMKMYRKIFK- 232
+L G DIW+ G ++ +L+G P ++ N++ +++IF+
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230
Query: 233 -----------------AEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272
E FP S L + L DP R S S+++ + +F
Sbjct: 231 NPLFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 80/263 (30%), Positives = 136/263 (51%), Gaps = 12/263 (4%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLME--QIKREISVMRLVKH 75
+ G++LGQG F +VY ++ T +A K + D + E ++ EI +++ ++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 76 PNIVELKEVM---ATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFC 131
IV+ + A KT F +EY+ GG + ++ G L E RKY +Q++ + +
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIF-MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL-LHTQCGTPAYVAPEVLR 190
HS + HRD+K N+L D GN+K+ DFG S + + G + + GTP +++PEV+
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--AEYEFPPWISCDARRL 248
+GY G K+D+WS G + +L+ P+ M KI + P IS AR
Sbjct: 183 GEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241
Query: 249 ISRILVADPQKRISVSEIMINPW 271
+ I V + + R S E++ +P+
Sbjct: 242 LGCIFV-EARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 79/288 (27%), Positives = 138/288 (47%), Gaps = 48/288 (16%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG+G++A VY G + + + VA+KVI+ ++G+ RE S+++ +KH NIV L +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 84 VMATKTKVFFVIEYVKGGELFAKVL---KGKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
++ TK + FV EY+ A+ + G L + R + QL+ + + H + + HRD
Sbjct: 71 IIHTKETLTFVFEYMHTD--LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRD 128
Query: 141 LKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGA 197
LKP+NLL+ G LK++DFGL+ ++P Q ++ ++ T Y P+VL +
Sbjct: 129 LKPQNLLISYLGELKLADFGLARAKSIPSQTYS-----SEVVTLWYRPPDVLLGATDYSS 183
Query: 198 KSDIWSCGVVLFVLLSGFLPFQN-----ENIMKMYR--------------KIFKAEYEFP 238
DIW G + +L G F E + K++ K+ + E+
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243
Query: 239 PWISC--------------DARRLISRILVADPQKRISVSEIMINPWF 272
A L S++L+ P+ RIS + +++P+F
Sbjct: 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 86/312 (27%), Positives = 137/312 (43%), Gaps = 67/312 (21%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIK-VINKDQVKKQGLMEQIKREISVMRLVKHP 76
YE+ LG+GTF +VY + + T VA+K ++ ++ K G REI +++ +KHP
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHP 67
Query: 77 NIVELKEVMA---------TKTKVFFVIEYVKGGELFAKVLKG-------KLKEESARKY 120
N+V L + MA + V+ V Y+ L G KL E + Y
Sbjct: 68 NVVPLID-MAVERPDKSKRKRGSVYMVTPYM------DHDLSGLLENPSVKLTESQIKCY 120
Query: 121 FQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL----PEQLWNDGLLHT 176
QL+ +++ H + HRD+K N+L+D G LK++DFGL+ P G T
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 177 QCGTPA-----YVAPE-VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI 230
+ T Y PE +L ++ Y A DIW G V + + Q ++ + I
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239
Query: 231 FKA-----EYEFPPWIS---CDARR----------------------LISRILVADPQKR 260
FK E +P W S C+ L+S++L DP KR
Sbjct: 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299
Query: 261 ISVSEIMINPWF 272
++ S+ + +P+F
Sbjct: 300 LTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 84/304 (27%), Positives = 138/304 (45%), Gaps = 55/304 (18%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
+ LG G F +V + + T+ A+K + K V + + +K E ++ + +V L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
K ++FV++Y+ GG++ + +++ G E+ AR Y +L AV+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 141 LKPENLLLDENGNLKVSDFGLSA---------------LPEQ-------LWNDG------ 172
+KP+N+L+D +G++K++DFGL Q W D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 173 -----------------LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGF 215
L H+ GTP Y+APEVL + GY D WS GV+L+ +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 245
Query: 216 LPFQNENIMKMYRKIFK--AEYEFPPW--ISCDARRLISRILVADPQKRI---SVSEIMI 268
PF + ++ K+ PP +S +A LI + L P+ R+ EI
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADEIKA 304
Query: 269 NPWF 272
+P+F
Sbjct: 305 HPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 4e-28
Identities = 78/226 (34%), Positives = 116/226 (51%), Gaps = 8/226 (3%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
K+E+ ++G+G + V ++ T+E VAIK KD + + + E RE+ ++R +K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 77 NIVELKEVMATKTKVFFVIEYVKGG--ELFAKVLKGKLKEESARKYFQQLISAVDFCHSR 134
NIVELKE + K++ V EYV+ EL ++ G E+ R Y QLI A+ +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK-VRSYIYQLIKAIHWCHKN 119
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCGTPAYVAPEVLRKKG 193
+ HRD+KPENLL+ N LK+ DFG + L E ++ T Y +PE+L
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG--SNANYTEYVATRWYRSPELLLGAP 177
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP 239
Y G D+WS G +L L G F E+ + I K P
Sbjct: 178 Y-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 81/295 (27%), Positives = 142/295 (48%), Gaps = 44/295 (14%)
Query: 15 FGKYEMG---RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
FGK E LG+GT+A V+ G++ +T+ VA+K I + ++G RE+S+++
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLK 59
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYV-KGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
+KH NIV L +++ T + V EY+ K + + + + + + Q++ + +
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYVAPE 187
CH R V HRDLKP+NLL++E G LK++DFGL+ ++P + +++ ++ T Y P+
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPD 174
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------------- 232
VL + D+W G + F + SG F + IF+
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234
Query: 233 ----AEYEFP-----------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
Y FP P + + L+++ L + +KRIS E M + +F
Sbjct: 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 25/275 (9%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
R +G G+F VY+ +++ T E VAIK ++ + + I +E+ ++ ++HPN +E
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 82 KEVMATKTKVFFVIEYVKGGEL-FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
K + + V+EY G +V K L+E + + + HS HRD
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140
Query: 141 LKPENLLLDENGNLKVSDFGLSAL--PEQLWNDGLLHTQCGTPAYVAPEV---LRKKGYD 195
+K N+LL E G +K++DFG ++L P + GTP ++APEV + + YD
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPAN--------SFVGTPYWMAPEVILAMDEGQYD 192
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDA-----RRLIS 250
G K D+WS G+ L P N N M I + + P +S + R +
Sbjct: 193 G-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLSSNDWSDYFRNFVD 248
Query: 251 RILVADPQKRISVSEIMINPWFIKGFSKPVAVCID 285
L PQ R S E++ + + ++ +P V ID
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVLR--ERPPTVIID 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 76/266 (28%), Positives = 137/266 (51%), Gaps = 21/266 (7%)
Query: 18 YEMGRMLGQGTFAKVY-YGKNLVTQESVAIKVIN-------KDQVKKQGLMEQIKREISV 69
Y + LG G F VY K Q +A+K IN KD+ ++ + I E+++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 70 MR-LVKHPNIVELKEVMATKTKVFFVIEYVKG---GELFA--KVLKGKLKEESARKYFQQ 123
++ ++HPNIV + +++ V++ ++G GE F K K + EE F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 124 LISAVDFCH-SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
++ A+ + H + + HRDL P N++L E+ + ++DFGL+ +Q + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA---KQKQPESKLTSVVGTIL 178
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP--W 240
Y PE+++ + Y G K+D+W+ G +L+ + + PF + N++ + KI +A YE P
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 241 ISCDARRLISRILVADPQKRISVSEI 266
S D +I+ L D + R + ++
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 81/278 (29%), Positives = 142/278 (51%), Gaps = 26/278 (9%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E+ LG G F KVY +N T A KVI+ K + +E EI ++ HPN
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVID---TKSEEELEDYMVEIDILASCDHPN 63
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK--LKEESARKYFQQLISAVDFCHSRG 135
IV+L + + ++ +IE+ GG + A +L+ + L E R +Q + A+++ H
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN--DGLLHTQCGTPAYVAPEVL---- 189
+ HRDLK N+L +G++K++DFG+SA + D + GTP ++APEV+
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCET 179
Query: 190 -RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWI------S 242
+ + YD K+D+WS G+ L + P N M++ KI K+E PP + S
Sbjct: 180 SKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTLAQPSRWS 235
Query: 243 CDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPV 280
+ + + + L + R + ++++ +P+ +KP+
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 80/249 (32%), Positives = 135/249 (54%), Gaps = 17/249 (6%)
Query: 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-KQG----LMEQIKREISVMRLVKHPN 77
++G+G F +VY + T + A+K ++K ++K KQG L E+I +S++ P
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--LSLVSTGDCPF 58
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
IV + T K+ F+++ + GG+L + + G E R Y ++I ++ H+R V
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK-GYD 195
+RDLKP N+LLDE+G++++SD GL+ ++ H GT Y+APEVL+K YD
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGVAYD 174
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQ---NENIMKMYRKIFKAEYEFPPWISCDARRLISRI 252
+ +D +S G +LF LL G PF+ ++ ++ R E P S + R L+ +
Sbjct: 175 -SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 233
Query: 253 LVADPQKRI 261
L D +R+
Sbjct: 234 LQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 72/236 (30%), Positives = 119/236 (50%), Gaps = 19/236 (8%)
Query: 40 TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL-KEVMATKTKVFFVIEYV 98
T VAIK++ D +++ + +RE ++ + HPNIV L A +F V EYV
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 99 KGGELFAKVL--KGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG---N 153
G L +VL G L + Q++ A+ H++G+ HRDLKP+N+++ + G +
Sbjct: 62 PGRTL-REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 154 LKVSDFGLSAL-PEQLWNDGLLHTQ----CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVL 208
KV DFG+ L P D T+ GTP Y APE LR + SD+++ G++
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179
Query: 209 FVLLSGFLPFQNENIMK-MYRKIFKAEYEFPPWISCDARRL---ISRILVADPQKR 260
L+G Q ++ + +Y+++ + PPWI+ L + + L DP++R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIA--GHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 78/248 (31%), Positives = 131/248 (52%), Gaps = 15/248 (6%)
Query: 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-KQG----LMEQIKREISVMRLVKHPN 77
++G+G F +VY + T + A+K ++K ++K KQG L E+I +S++ P
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--LSLVSTGDCPF 58
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
IV + T K+ F+++ + GG+L + + G E+ R Y ++I ++ H+R V
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
+RDLKP N+LLDE+G++++SD GL+ ++ H GT Y+APEVL+K
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGTAYD 174
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNENIMKMY---RKIFKAEYEFPPWISCDARRLISRIL 253
+ +D +S G +LF LL G PF+ + R E P S + + L+ +L
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL 234
Query: 254 VADPQKRI 261
D KR+
Sbjct: 235 QRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 83/298 (27%), Positives = 144/298 (48%), Gaps = 50/298 (16%)
Query: 15 FGKYE----MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
FGK E + + LG+GT+A V+ G++ +T+ VA+K I + ++G RE+S++
Sbjct: 1 FGKLETYVKLDK-LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLL 57
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQ-QLISA 127
+ +KH NIV L +++ T+ + V EY+ + L G L K F QL+
Sbjct: 58 KNLKHANIVTLHDIIHTERCLTLVFEYLDSD--LKQYLDNCGNLMSMHNVKIFMFQLLRG 115
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYV 184
+ +CH R + HRDLKP+NLL++E G LK++DFGL+ ++P + +++ ++ T Y
Sbjct: 116 LSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-----TLWYR 170
Query: 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK------------ 232
P+VL D+W G +L+ + +G F + + IF+
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230
Query: 233 -------AEYEFP-----------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
Y FP P + D L+S +L+ + + RIS + + +F
Sbjct: 231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 90/294 (30%), Positives = 140/294 (47%), Gaps = 47/294 (15%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIK--VINKD--QVKKQGLMEQIKREISVMRL 72
KYE +G+G++ V+ +N T + VAIK V ++D +KK L REI +++
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL-----REIRMLKQ 56
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDF 130
+KHPN+V L EV K K+ V EY L K +G + E +K Q + AV+F
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNF 115
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQC-GTPAYVAPEVL 189
CH HRD+KPEN+L+ + G +K+ DFG + + L G +T T Y APE+L
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARI---LTGPGDDYTDYVATRWYRAPELL 172
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSG--FLPFQNE------------NIMKMYRKIFKAEY 235
G D+W+ G V LL+G P +++ +++ +++IF
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232
Query: 236 EFP-----------------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
F P IS A + L DP +R+S E++ +P+F
Sbjct: 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 83/282 (29%), Positives = 128/282 (45%), Gaps = 27/282 (9%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
K LG+G V + T A+K I D L +QI RE+ + + K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKS 58
Query: 76 PNIVELKEVMATK--TKVFFVIEYVKGGEL---FAKVLK--GKLKEESARKYFQQLISAV 128
P IV+ + + + +EY +GG L + KV K G++ E+ K + ++ +
Sbjct: 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
+ HSR + HRD+KP N+LL G +K+ DFG+S +L N L T GT Y+APE
Sbjct: 119 SYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNS-LAGTFTGTSFYMAPER 174
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN------------IMKMYRKIFKAEYE 236
++ K Y SD+WS G+ L + PF E I+ M K E
Sbjct: 175 IQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233
Query: 237 FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSK 278
S + + I + L DP +R + +++ +PW IK K
Sbjct: 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW-IKAQMK 274
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-26
Identities = 75/266 (28%), Positives = 137/266 (51%), Gaps = 15/266 (5%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLME--QIKREISVMRLVKH 75
+ +G++LG+G F +VY + T +A+K + D ++ E ++ EI +++ ++H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 76 PNIVE----LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDF 130
IV+ L++ K +F +EY+ GG + ++ G L E R+Y +Q++ V +
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIF--VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL-LHTQCGTPAYVAPEVL 189
HS + HRD+K N+L D GN+K+ DFG S + + G + + GTP +++PEV+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--AEYEFPPWISCDARR 247
+GY G K+D+WS + +L+ P+ M KI + P +S R
Sbjct: 182 SGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240
Query: 248 LISRILVADPQKRISVSEIMINPWFI 273
+ +I V +KR +E ++ F+
Sbjct: 241 FLKQIFVE--EKRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 80/266 (30%), Positives = 134/266 (50%), Gaps = 23/266 (8%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG+G F +V + T + A K +NK ++KK+ E E ++ V IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYH 138
TKT + V+ + GG+L + E A Y Q+IS ++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 139 RDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ--CGTPAYVAPEVLRKKGYDG 196
RDLKPEN+LLD +GN+++SD GL+ +L DG T+ GTP ++APE+L+ + YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV---EL-KDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQN-----ENIMKMYRKIFKAEYEFPPWISCDARRLISR 251
+ D ++ GV L+ +++ PF+ EN ++ ++I +P S ++
Sbjct: 177 S-VDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRILNDSVTYPDKFSPASKSFCEA 234
Query: 252 ILVADPQKRI-----SVSEIMINPWF 272
+L DP+KR+ + + +P F
Sbjct: 235 LLAKDPEKRLGFRDGNCDGLRTHPLF 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 74/226 (32%), Positives = 121/226 (53%), Gaps = 17/226 (7%)
Query: 15 FGK---YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
FGK YE LG+G++A VY GK+ V + VA+KVI + ++G RE S+++
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLK 58
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVD 129
+KH NIV L +++ TK + V EYV +L + K G L E+ + + QL+ +
Sbjct: 59 GLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYVAP 186
+ H R + HRDLKP+NLL+ + G LK++DFGL+ ++P +++ ++ T Y P
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-----TLWYRPP 172
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIF 231
+VL D+W G + ++ G F ++I +IF
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 14/216 (6%)
Query: 22 RMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+ LG+G F KV + T E VA+K +N ++ +REI ++R + H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH--RSDFEREIEILRTLDHEN 67
Query: 78 IVELKEVM--ATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHS 133
IV+ K V + ++EY+ G L + + + ++ + + Q+ +D+ S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA-YVAPEVLRKK 192
+ HRDL N+L++ +K+SDFGL+ + + + + +P + APE LR
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQN--ENIMKM 226
+ + SD+WS GV L+ L + P Q+ ++M
Sbjct: 188 KFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 82/294 (27%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-- 74
+YE +G G + VY ++ + VA+K + + Q + GL RE+++++ ++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 75 -HPNIVELKEVMAT-----KTKVFFVIEYVKGG--ELFAKVLKGKLKEESARKYFQQLIS 126
HPNIV L +V AT +TKV V E+V KV L E+ + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE-QLWNDGLLHTQCGTPAYVA 185
+DF H+ + HRDLKPEN+L+ G +K++DFGL+ + Q+ ++ T Y A
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YRA 175
Query: 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK-----AEYEFP-- 238
PEVL + Y D+WS G + + F + KIF E ++P
Sbjct: 176 PEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234
Query: 239 --------------------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
P I +L+ +L +P KRIS + +P+F
Sbjct: 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 88/294 (29%), Positives = 137/294 (46%), Gaps = 46/294 (15%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
Y+ +G+G + V + T VAIK I+ + Q ++ REI ++R KH N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--FEHQTFCQRTLREIKILRRFKHEN 64
Query: 78 IVELKEVMATKT-----KVFFVIEYVKGGELFAKVLKGKLKEESARKYF-QQLISAVDFC 131
I+ + +++ + V+ V E ++ +L+ K++K + +YF Q++ + +
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGL--SALPEQLWNDGLLHTQCGTPAYVAPEV- 188
HS V HRDLKP NLLL+ N +LK+ DFGL A PE + G L T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD-HTGFLTEYVATRWYRAPEIM 181
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF----------------- 231
L KGY A DIWS G +L +LS F ++ + I
Sbjct: 182 LNSKGYTKA-IDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 232 KA-EY--EFP-----PWISC------DARRLISRILVADPQKRISVSEIMINPW 271
+A Y P PW A L+ ++L +P KRI+V E + +P+
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 77/255 (30%), Positives = 118/255 (46%), Gaps = 20/255 (7%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
+G+G F VY G L VA+K L + +E +++ HPNIV+L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISA---VDFCHSRGVYH 138
V K ++ V+E V GG L L+ K + +K Q + A +++ S+ H
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLT-FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 139 RDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP----AYVAPEVLRKKGY 194
RDL N L+ EN LK+SDFG+S E G+ G + APE L Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEE----GGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 195 DGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPWISC--DARRLISR 251
++SD+WS G++L+ S G P+ + + R+ ++ Y P C + RL+ +
Sbjct: 173 T-SESDVWSYGILLWETFSLGDTPYPGMSNQQT-RERIESGYRMPAPQLCPEEIYRLMLQ 230
Query: 252 ILVADPQKRISVSEI 266
DP+ R S SEI
Sbjct: 231 CWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 87/308 (28%), Positives = 143/308 (46%), Gaps = 56/308 (18%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y++ ++G+G++ V + T E VAIK IN D + +I REI ++RL++HP
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 59
Query: 77 NIVELKEVMATKTK-----VFFVIEYVKGGELFAKVLKGK--LKEESARKYFQQLISAVD 129
+IVE+K +M ++ ++ V E ++ +V+K L E + + QL+ A+
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS------ALPEQLWNDGLLHTQCGTPAY 183
+ H+ V+HRDLKP+N+L + + LK+ DFGL+ W D T Y
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD-----YVATRWY 172
Query: 184 VAPEVLRK--KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM----------------- 224
APE+ Y A DIWS G + +L+G F +N++
Sbjct: 173 RAPELCGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231
Query: 225 -------KMYRKIFKAEYEFP-------PWISCDARRLISRILVADPQKRISVSEIMINP 270
K R + + P P A RL+ R+L DP+ R + E + +P
Sbjct: 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291
Query: 271 WFIKGFSK 278
+F KG +K
Sbjct: 292 YF-KGLAK 298
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 83/302 (27%), Positives = 131/302 (43%), Gaps = 59/302 (19%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINK--DQVK--KQGLMEQIKREISVMRL 72
KY + +G+G + V KN T E VAIK I D K+ L REI ++R
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-----REIKLLRH 60
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGEL----FAKVLKGK--LKEESARKYFQQLIS 126
+ H N++ +K++M + F Y+ EL ++++ L ++ + + QL+
Sbjct: 61 LDHENVIAIKDIMPPPHREAFNDVYIV-YELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
+ + HS V HRDLKP NLLL+ N +LK+ DFGL+ + + T Y AP
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVTRWYRAP 177
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLS-----------------------------GFLP 217
E+L D+WS G + LL GF+
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI- 236
Query: 218 FQNENIMKMYRKI-------FKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINP 270
+NE + R + F + P + A L+ ++LV DP KRI+V E + +P
Sbjct: 237 -RNEKARRYIRSLPYTPRQSFARLF---PHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292
Query: 271 WF 272
+
Sbjct: 293 YL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
KYE +GQGTF +V+ ++ T++ VA+K + + +K+G REI +++L+K
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLK 69
Query: 75 HPNIVELKEVMATKTK-----------VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQ 123
H N+V L E+ TK VF E+ G L K +K L E +K +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE--IKKVMKM 127
Query: 124 LISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG--LLHTQCGTP 181
L++ + + H + HRD+K N+L+ ++G LK++DFGL+ N + T
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 182 AYVAPEVLRKKGYDGAKSDIWSCGVVL 208
Y PE+L + G D+W G ++
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 94/308 (30%), Positives = 146/308 (47%), Gaps = 56/308 (18%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVKH 75
KYE+ + LG+G + V+ + T+E VA+K I D + ++ REI ++ L H
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQRTFREIMFLQELGDH 66
Query: 76 PNIVELKEVM--ATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKY-FQQLISAVDFCH 132
PNIV+L V+ ++ V EY++ +L A V++ + E+ ++Y QL+ A+ + H
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMET-DLHA-VIRANILEDVHKRYIMYQLLKALKYIH 124
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGL----SALPEQLWNDGLLHTQ-CGTPAYVAPE 187
S V HRDLKP N+LL+ + +K++DFGL S L E N L T T Y APE
Sbjct: 125 SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL--TDYVATRWYRAPE 182
Query: 188 VLRK-----KGYDGAKSDIWSCGVVLFVLLSGFLPF-------QNENIM----------- 224
+L KG D+WS G +L +L G F Q E I+
Sbjct: 183 ILLGSTRYTKGV-----DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237
Query: 225 -------------KMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPW 271
+ + K E P S DA L+ ++LV +P KR++ E + +P
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP- 296
Query: 272 FIKGFSKP 279
++ F P
Sbjct: 297 YVAQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 77/265 (29%), Positives = 134/265 (50%), Gaps = 19/265 (7%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E+ + +G GT+ VY +N+ T E AIKVI + + +++Q EI +M+ KH N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSN 67
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKV-LKGKLKEESARKYFQQLISAVDFCHSRGV 136
IV + K++ +E+ GG L + G L E ++ + + + HS+G
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL---RKKG 193
HRD+K N+LL +NG++K++DFG+SA + + GTP ++APEV RK G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP-------WISCDAR 246
Y+ DIW+ G+ L P + + M+ + K+ ++ PP W S
Sbjct: 186 YNQL-CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PPKLKDKMKW-SNSFH 242
Query: 247 RLISRILVADPQKRISVSEIMINPW 271
+ L +P+KR + +++ +P+
Sbjct: 243 HFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 76/307 (24%), Positives = 131/307 (42%), Gaps = 53/307 (17%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKD----QVKKQGLMEQIKREISVMRL 72
+Y+ +G G + V + + + VAIK I + K+ L RE+ ++R
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-----RELKILRH 60
Query: 73 VKHPNIVELKEVMATKTKVF---FVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAV 128
KH NI+ +++++ F +V+ + +L + L EE R + QL+ +
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL--SALPEQLWNDGLLHTQCGTPAYVAP 186
+ HS V HRDLKP NLL++E+ L++ DFG+ + + T Y AP
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-------IMKMY------------ 227
E+L D+WS G + +L F +N I+ +
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240
Query: 228 ----RKIFKAEYEFP-----PW------ISCDARRLISRILVADPQKRISVSEIMINPWF 272
RK + P PW S +A L+S++L DP++RI+V + + +P F
Sbjct: 241 SDRVRKYIQN---LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP-F 296
Query: 273 IKGFSKP 279
+ + P
Sbjct: 297 LAQYHDP 303
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 78/289 (26%), Positives = 142/289 (49%), Gaps = 45/289 (15%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+Y++ R++G+G +VY + V VA+K I +D + L ++ RE + + H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARK-------------YFQ 122
P IV + + + V++ + Y++G L +LK ++ES K F
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND---------GL 173
++ + +++ HS+GV HRDLKP+N+LL G + + D+G + + D +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 174 LHTQ-------CGTPAYVAPEVLRKKGYDGAKS-DIWSCGVVLFVLLSGFLPFQNENIMK 225
++ GTP Y+APE R G ++S DI++ GV+L+ +L+ P++ + K
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPE--RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238
Query: 226 MYRK------IFKAEY-EFPPWISCDARRLISRILVADPQKRI-SVSEI 266
+ + I A Y E PP++S ++ + L DP +R SV E+
Sbjct: 239 ISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 64/211 (30%), Positives = 112/211 (53%), Gaps = 9/211 (4%)
Query: 64 KREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEE------SA 117
+ E+ + H IV+ + + K+ ++EY GG+L K +K +LKE
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL-NKQIKQRLKEHLPFQEYEV 171
Query: 118 RKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ 177
F Q++ A+D HSR + HRDLK N+ L G +K+ DFG S + + +
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 178 CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE- 236
CGTP Y+APE+ +K Y K+D+WS GV+L+ LL+ PF+ + ++ +++ +Y+
Sbjct: 232 CGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290
Query: 237 FPPWISCDARRLISRILVADPQKRISVSEIM 267
FP +S + L+ +L +P R + +++
Sbjct: 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-24
Identities = 78/272 (28%), Positives = 130/272 (47%), Gaps = 19/272 (6%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
R +G G+F VY+ +++ T E VAIK ++ + + I +E+ ++ +KHPN +E
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 82 KEVMATKTKVFFVIEYVKG-GELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
K + + V+EY G +V K L+E + + + HS + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV---LRKKGYDGA 197
+K N+LL E G +K++DFG +++ ++ GTP ++APEV + + YDG
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDG- 203
Query: 198 KSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCD----ARRLISRIL 253
K D+WS G+ L P N N M I A+ E P S + R + L
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNESPTLQSNEWSDYFRNFVDSCL 261
Query: 254 VADPQKRISVSEIMINPWFIKGFSKPVAVCID 285
PQ R + E++ + + ++ +P V ID
Sbjct: 262 QKIPQDRPTSEELLKHMFVLR--ERPETVLID 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 69/252 (27%), Positives = 125/252 (49%), Gaps = 13/252 (5%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
R+LG+G F +V + T + A K + K ++KK+ E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYH 138
TK + V+ + GG+L + +EE A Y +++ ++ H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 139 RDLKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGA 197
RDLKPEN+LLD+ G++++SD GL+ +PE + + GT Y+APEVL + Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPE----GESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 198 KSDIWSCGVVLFVLLSGFLPF--QNENIMK--MYRKIFKAEYEFPPWISCDARRLISRIL 253
D W G +++ ++ G PF + E + + + R++ + E + S +A+ + +L
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 254 VADPQKRISVSE 265
DP++R+ E
Sbjct: 241 TKDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 76/239 (31%), Positives = 123/239 (51%), Gaps = 38/239 (15%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+YE+ + +G G F +V+ K+ TQE K I+ +K++ Q+ E++VMR +KH
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE-KSQLVIEVNVMRELKHK 72
Query: 77 NIVELKEVMATKT--KVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVD 129
NIV + K K++ ++E+ G+L + K GK++E + +QL+ A+
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 130 FCHS-------RGVYHRDLKPENLLLD-----------ENGNL------KVSDFGLSALP 165
+CH+ V HRDLKP+N+ L + NL K+ DFGLS
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS--- 189
Query: 166 EQLWNDGLLHTQCGTPAYVAPEVL--RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN 222
+ + + + H+ GTP Y +PE+L K YD KSD+W+ G +++ L SG PF N
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 19/270 (7%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
+G G+F VY+ N T E VA+K ++ + + I +E+ ++ +KHPN +E K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 84 VMATKTKVFFVIEYVKG-GELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLK 142
+ + V+EY G +V K L+E + + + HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 143 PENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV---LRKKGYDGAKS 199
N+LL E G +K++DFG ++ ++ GTP ++APEV + + YDG K
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDG-KV 201
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCD----ARRLISRILVA 255
D+WS G+ L P N N M I A+ + P S + R + L
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNDSPTLQSNEWTDSFRGFVDYCLQK 259
Query: 256 DPQKRISVSEIMINPWFIKGFSKPVAVCID 285
PQ+R + +E++ + + + +P V ID
Sbjct: 260 IPQERPASAELLRHDFVRR--DRPARVLID 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 18/264 (6%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
R+LG+G F +V + T + A K + K ++KK+ E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVL---KGKLKEESARKYFQQLISAVDFCHSRGVYH 138
TK + V+ + GG+L + + +E A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 139 RDLKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGA 197
RDLKPEN+LLD++G++++SD GL+ +PE + + GT Y+APEV++ + Y +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPE----GQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 198 KSDIWSCGVVLFVLLSGFLPFQNENIM----KMYRKIFKAEYEFPPWISCDARRLISRIL 253
D W+ G +L+ +++G PFQ ++ R + + + E+ S DAR L +L
Sbjct: 182 -PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240
Query: 254 VADPQKRI-----SVSEIMINPWF 272
DP++R+ E+ +P F
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 84/329 (25%), Positives = 136/329 (41%), Gaps = 86/329 (26%)
Query: 17 KYEMGRMLGQGTFAKVY--YGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
KYE+ +G+GT+ +VY KN + AIK D+ + G+ + REI+++R +K
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 75 HPNIVELKEVMATKT--KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQ---------Q 123
H N+V L EV V+ + +Y + +L+ + K ++ R Q
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII---KFHRQAKRVSIPPSMVKSLLWQ 116
Query: 124 LISAVDFCHSRGVYHRDLKPENLLL----DENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179
+++ V + HS V HRDLKP N+L+ E G +K+ D GL+ +L+N L
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA----RLFNAPLKPLADL 172
Query: 180 TPA-----YVAPEVLRKKGYDGAKS-----DIWSCGVVLFVLLSG---F----------L 216
P Y APE+L GA+ DIW+ G + LL+ F
Sbjct: 173 DPVVVTIWYRAPELLL-----GARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227
Query: 217 PFQNE---------------------------NIMKMYRKIFKAEYEFPPWI------SC 243
PFQ + +MK ++ W+
Sbjct: 228 PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDS 287
Query: 244 DARRLISRILVADPQKRISVSEIMINPWF 272
L+ ++L DP KRI+ E + +P+F
Sbjct: 288 QGFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 69/263 (26%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
R+LG+G F +V + T + A K + K ++KK+ E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 82 KEVMATKTKVFFVIEYVKGGEL---FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYH 138
TK + V+ + GG+L + EE A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 139 RDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAK 198
RDLKPEN+LLD+ G++++SD GL+ ++ + + GT Y+APEV++ + Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 199 SDIWSCGVVLFVLLSGFLPFQ--NENIMK--MYRKIFKAEYEFPPWISCDARRLISRILV 254
D W G +++ ++ G PF+ E + + + R++ + + E+ S AR + ++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 255 ADPQKRI-----SVSEIMINPWF 272
DP R+ E+ +P+F
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 49/138 (35%), Positives = 83/138 (60%), Gaps = 1/138 (0%)
Query: 26 QGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVM 85
+G F KVY G+ + A+KV+ K + + ++ Q++ E + L K P IV L +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 86 ATKTKVFFVIEYVKGGELFAKV-LKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPE 144
+ V+ V+EY+ GG++ + + + G EE A KY ++ A+D+ H G+ HRDLKP+
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPD 133
Query: 145 NLLLDENGNLKVSDFGLS 162
N+L+ G++K++DFGLS
Sbjct: 134 NMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-23
Identities = 70/259 (27%), Positives = 135/259 (52%), Gaps = 9/259 (3%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
Y R++G+G++ +V ++ + IK +N ++ + ++E ++ +KHPN
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE-RKAAEQEAQLLSQLKHPN 60
Query: 78 IVELKEVM-ATKTKVFFVIEYVKGGELFAKV--LKGKL-KEESARKYFQQLISAVDFCHS 133
IV +E ++ V+ + +GG+L+ K+ KGKL E ++F Q+ A+ + H
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKG 193
+ + HRDLK +N+ L +KV D G++ + E + + T GTP Y++PE+ K
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKP 178
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISRI 252
Y+ KSD+W+ G ++ + + F +++ + +I + + P S + LI+ +
Sbjct: 179 YN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM 237
Query: 253 LVADPQKRISVSEIMINPW 271
L P+KR SV I+ P+
Sbjct: 238 LSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 8e-23
Identities = 72/239 (30%), Positives = 124/239 (51%), Gaps = 25/239 (10%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVK 74
G +E+ ++G GT+ +VY G+++ T + AIKV++ + ++ E+IK EI++++
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSH 71
Query: 75 HPNIVELKEVMATKT------KVFFVIEYVKGGEL--FAKVLKGK-LKEESARKYFQQLI 125
H NI K+ +++ V+E+ G + K KG LKE+ ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVA 185
+ H+ V HRD+K +N+LL EN +K+ DFG+SA ++ G +T GTP ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMA 189
Query: 186 PEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP 239
PEV+ YD +SDIWS G+ + G P + + M R +F PP
Sbjct: 190 PEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPM---RALFLIPRNPPP 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 80/274 (29%), Positives = 135/274 (49%), Gaps = 36/274 (13%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVKHP 76
+E+ +G+GT+ KV+ N A+K++ D + + E+I+ E ++++ L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPI--HDIDEEIEAEYNILKALSDHP 75
Query: 77 NIVEL-----KEVMATKTKVFFVIEYVKGGELFAKVLKGKLK-----EESARKY-FQQLI 125
N+V+ K+ + +++ V+E GG + ++KG LK EE Y + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL-LHTQCGTPAYV 184
+ H HRD+K N+LL G +K+ DFG+SA QL + L +T GTP ++
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTRLRRNTSVGTPFWM 191
Query: 185 APEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP 239
APEV+ YD A+ D+WS G+ L G P + + M R +FK PP
Sbjct: 192 APEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPM---RALFKIPRNPPP 247
Query: 240 WI------SCDARRLISRILVADPQKRISVSEIM 267
+ S + I + L D +KR +VS+++
Sbjct: 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-22
Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 17/260 (6%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
YE+ + +G GT+ VY +NL T E A+K+I + L++Q EI +++ KH N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCN 67
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKV-LKGKLKEESARKYFQQLISAVDFCHSRGV 136
IV ++ K++ +EY GG L + G L E ++ + + + HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV--LRKKGY 194
HRD+K N+LL +NG++K++DFG++A + + GTP ++APEV + K G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 195 DGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP-------WISCDARR 247
DIW+ G+ L P + + M+ + K+ ++ PP W S
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-PPKLKDKTKW-SSTFHN 243
Query: 248 LISRILVADPQKRISVSEIM 267
+ L +P+KR + ++
Sbjct: 244 FVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-22
Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 21/273 (7%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
R +G G+F VY+ +++ E VAIK ++ + + I +E+ ++ ++HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 82 KEVMATKTKVFFVIEYVKG-GELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
+ + + V+EY G +V K L+E + + + HS + HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV---LRKKGYDGA 197
+K N+LL E G +K+ DFG +++ + GTP ++APEV + + YDG
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDG- 193
Query: 198 KSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP-----PWISCDARRLISRI 252
K D+WS G+ L P N N M I A+ E P W S R +
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNESPALQSGHW-SEYFRNFVDSC 250
Query: 253 LVADPQKRISVSEIMINPWFIKGFSKPVAVCID 285
L PQ R SE+++ F+ +P V +D
Sbjct: 251 LQKIPQDR-PTSEVLLKHRFVLR-ERPPTVIMD 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 74/298 (24%), Positives = 131/298 (43%), Gaps = 54/298 (18%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLM--EQIKREISVMRLVK 74
+Y+ +G G + +V + T VAIK +++ Q + ++ RE+ +++ +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR---PFQSAIHAKRTYRELRLLKHMD 72
Query: 75 HPNIVELKEVMATKT------KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAV 128
H N++ L +V + V+ V + G +L V KL ++ + Q++ +
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGL 131
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
+ HS G+ HRDLKP N+ ++E+ LK+ DFGL+ D + T Y APE+
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEI 186
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-------IM----------------- 224
+ + DIWS G ++ LL+G F + IM
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246
Query: 225 ----------KMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272
+M +K FK E + A L+ ++LV DP KRI+ +E + +P+
Sbjct: 247 SARNYIQSLPQMPKKDFK---EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 6e-22
Identities = 85/283 (30%), Positives = 141/283 (49%), Gaps = 37/283 (13%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVK 74
+E+ +G+GT+ KVY N A+K++ D + + E+I+ E ++++ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISD--VDEEIEAEYNILQSLPN 77
Query: 75 HPNIVEL-----KEVMATKTKVFFVIEYVKGG---ELFAKVLK-GKLKEESARKYFQQLI 125
HPN+V+ K +++ V+E GG EL +L G+ +E+ Y L
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI--LY 135
Query: 126 SAV---DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL-LHTQCGTP 181
A+ H+ + HRD+K N+LL G +K+ DFG+SA QL + L +T GTP
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTRLRRNTSVGTP 192
Query: 182 AYVAPEVLR-KKGYD---GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF 237
++APEV+ ++ YD A+ D+WS G+ L G P + M + +FK
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD---MHPVKTLFKIPRNP 249
Query: 238 PPWIS-----CDA-RRLISRILVADPQKRISVSEIMINPWFIK 274
PP + C + IS+ L+ D + R SV+ ++ +P FIK
Sbjct: 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP-FIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 7e-22
Identities = 69/255 (27%), Positives = 129/255 (50%), Gaps = 12/255 (4%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG+G F +V + T + A K ++K ++KK+ + E ++ V P IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 84 VMATKTKVFFVIEYVKGGEL---FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
+KT + V+ + GG+L V + L+ E Y Q+ + HS + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSD 200
+KPEN+LLD+ GN ++SD GL+ +L + + + GT Y+APE+L+++ Y D
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYS-YPVD 176
Query: 201 IWSCGVVLFVLLSGFLPFQN--ENIMK--MYRKIFKAEYEFPPW-ISCDARRLISRILVA 255
++ G ++ +++G PF++ E + K + R+ + E +F + +++ + L
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236
Query: 256 DPQKRISVSEIMINP 270
P+ R+ E +P
Sbjct: 237 KPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-22
Identities = 78/303 (25%), Positives = 134/303 (44%), Gaps = 55/303 (18%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y+ + +G G V + V +VA+K +++ + Q ++ RE+ +++ V H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVNHK 80
Query: 77 NIVELKEVMATKTK------VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
NI+ L V + V+ V+E + +V+ +L E Q++ +
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKH 138
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
HS G+ HRDLKP N+++ + LK+ DFGL+ + ++ T Y APEV+
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTRYYRAPEVIL 195
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF------------------- 231
GY DIWS G ++ L+ G + FQ + + + K+
Sbjct: 196 GMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254
Query: 232 -----KAEYE-------FPPWI-----------SCDARRLISRILVADPQKRISVSEIMI 268
+ +Y FP WI + AR L+S++LV DP KRISV E +
Sbjct: 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314
Query: 269 NPW 271
+P+
Sbjct: 315 HPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 77/305 (25%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 21 GRMLGQGTFAKVYYGKNLVTQESVAIK-----VINKDQVKKQGLMEQIK------REISV 69
G LG+GT+ KV + +T + VAIK I+ D K + L+ RE+ +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 70 MRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK--LKEESARKYFQQLISA 127
M +KH NI+ L +V + V++ + KV+ K L E + Q+++
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILNG 131
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS------------ALPEQLWNDGLLH 175
++ H HRDL P N+ ++ G K++DFGL+ + E + +
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--- 232
++ T Y APE+L D+WS G + LL+G F EN + +IF+
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 233 ----------------AEYEFP---------PWISCDARRLISRILVADPQKRISVSEIM 267
E+ P S DA L+ +L +P +RIS E +
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 268 INPWF 272
+ +F
Sbjct: 312 KHEYF 316
|
Length = 335 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 2e-21
Identities = 79/276 (28%), Positives = 136/276 (49%), Gaps = 30/276 (10%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVK 74
G +E+ ++G GT+ +VY G+++ T + AIKV++ ++ E+IK+EI++++
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSH 61
Query: 75 HPNIVELKEVMATKT------KVFFVIEYVKGGEL--FAKVLKGK-LKEESARKYFQQLI 125
H NI K +++ V+E+ G + K KG LKEE ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVA 185
+ H V HRD+K +N+LL EN +K+ DFG+SA ++ G +T GTP ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMA 179
Query: 186 PEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW 240
PEV+ YD KSD+WS G+ + G P + M R +F P
Sbjct: 180 PEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCD---MHPMRALFLIPRNPAPR 235
Query: 241 I-----SCDARRLISRILVADPQKRISVSEIMINPW 271
+ S + I LV + +R + ++M +P+
Sbjct: 236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-21
Identities = 71/271 (26%), Positives = 122/271 (45%), Gaps = 30/271 (11%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
LG G V K++ T +A KV++ K + +QI RE+ +M + P IV
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSR-GVYHR 139
+ + +E++ G L K G + E K ++ + + ++ + HR
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
D+KP N+L++ G +K+ DFG+S +L N + T GT Y++PE ++ Y KS
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSG---ELINS-IADTFVGTSTYMSPERIQGGKYT-VKS 183
Query: 200 DIWSCGVVLFVLLSGFLPFQNEN-----------IMKMYRKIFK------AEYEFPPWIS 242
D+WS G+ + L G PF N I+ + ++I + +FP
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE--- 240
Query: 243 CDARRLISRILVADPQKRISVSEIMINPWFI 273
D R + L+ DP +R + ++ P FI
Sbjct: 241 -DLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 85/301 (28%), Positives = 135/301 (44%), Gaps = 55/301 (18%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVT--QESVAIK----VINKDQVKKQGLMEQIKREISVMR 71
YE+ + LGQG + V +N T +E+VAIK V +K + K+ L RE+ ++R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLLR 56
Query: 72 LVK-HPNIVELKE---VMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYF-QQLIS 126
+ H NI L + V ++ E + +L + G+ ++ + F Q++
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC 116
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL----SALPEQLWNDGLLHTQCGTPA 182
+ + HS V HRDLKP NLL++ + LK+ DFGL S P + N G + T
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE--NAGFMTEYVATRW 174
Query: 183 YVAPEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-------- 233
Y APE+ L + Y A D+WS G +L LL F+ ++ + +I +
Sbjct: 175 YRAPEIMLSFQSYTKA-IDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233
Query: 234 ----------EY--EFP-------PWI----SCDARRLISRILVADPQKRISVSEIMINP 270
Y P I + A L+ ++L DP KRISV E + +P
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293
Query: 271 W 271
+
Sbjct: 294 Y 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 7e-21
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVE 80
+ LG G F V+ GK + VAIK+I + + + +E+ K VM + HPN+V+
Sbjct: 9 LKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAK----VMMKLSHPNLVQ 63
Query: 81 LKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYH 138
L V + +F V EY+ G L + + KGKL E + A+++ S G H
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123
Query: 139 RDLKPENLLLDENGNLKVSDFGLS--ALPEQLWNDGLLHTQCGTP---AYVAPEVLRKKG 193
RDL N L+ E+ +KVSDFGL+ L +Q + GT + PEV
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ------GTKFPVKWAPPEVFDYSR 177
Query: 194 YDGAKSDIWSCGVVLFVLLS-GFLPFQN 220
+ +KSD+WS GV+++ + S G +P++
Sbjct: 178 FS-SKSDVWSFGVLMWEVFSEGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 7e-21
Identities = 72/258 (27%), Positives = 120/258 (46%), Gaps = 25/258 (9%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
++G +G+G F V G + VA+K + D Q + E SVM ++HPN+
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLA----EASVMTTLRHPNL 62
Query: 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFC------H 132
V+L V+ ++ V EY+ G L + + + + QQL A+D C
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ HRDL N+L+ E+ KVSDFGL+ Q + G L + + APE LR+K
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK-----WTAPEALREK 174
Query: 193 GYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPWISC--DARRLI 249
+ KSD+WS G++L+ + S G +P+ + + + K Y C + +++
Sbjct: 175 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVM 232
Query: 250 SRILVADPQKRISVSEIM 267
DP KR + ++
Sbjct: 233 KDCWELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 65/251 (25%), Positives = 123/251 (49%), Gaps = 11/251 (4%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
R+LG+G F +V + T + A K + K ++KK+ E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYH 138
TK + V+ + GG+L + E+ A Y +L ++ + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 139 RDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAK 198
RDLKPEN+LLD+ G++++SD GL+ Q+ + + GT Y+APEV+ + Y +
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKYTFS- 181
Query: 199 SDIWSCGVVLFVLLSGFLPFQ--NENIMK--MYRKIFKAEYEFPPWISCDARRLISRILV 254
D W G +++ ++ G PF+ E + + + R++ + + E+ S DA+ + +L
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 255 ADPQKRISVSE 265
+P++R+
Sbjct: 242 KNPKERLGCRG 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 25/274 (9%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH--PNIVEL 81
+G GT +VY + T +A+K + + K++ ++I ++ V+ L H P IV+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE--NKRILMDLDVV-LKSHDCPYIVKC 79
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSR-GVY 137
T + VF +E + K+LK G + E+ K ++ A+ + + GV
Sbjct: 80 YGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVI 137
Query: 138 HRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT-QCGTPAYVAPEVL----RKK 192
HRD+KP N+LLD +GN+K+ DFG+S D T G AY+APE +
Sbjct: 138 HRDVKPSNILLDASGNVKLCDFGISG----RLVDSKAKTRSAGCAAYMAPERIDPPDPNP 193
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENI-MKMYRKIFKAEYEFPPW---ISCDARRL 248
YD ++D+WS G+ L L +G P++N ++ KI + E P S D
Sbjct: 194 KYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSF 252
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSKPVAV 282
+ L D +KR E++ +P+ + + V V
Sbjct: 253 VDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 69/264 (26%), Positives = 124/264 (46%), Gaps = 48/264 (18%)
Query: 27 GTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA 86
G KV + TQ++ +K ++K + + I + V PN+V L + +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILK-----GLRKSSEYSRERLTI-IPHCV--PNMVCLHKYIV 55
Query: 87 TKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPEN 145
++ VF V+++ +GG+L++ + K + EE +++ +++ A+D H G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 146 LLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA----YVAPEVLRKKGYDGAKS-- 199
+LLD+ G+++++ F W++ + C A Y APEV G S
Sbjct: 116 ILLDDRGHIQLTYFS-------RWSE--VEDSCDGEAVENMYCAPEV-------GGISEE 159
Query: 200 ----DIWSCGVVLFVLLSG--FLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRIL 253
D WS G +LF LL+G + I P W+S +AR L+ ++L
Sbjct: 160 TEACDWWSLGAILFELLTGKTLVECHPSGINT------HTTLNIPEWVSEEARSLLQQLL 213
Query: 254 VADPQKRI-----SVSEIMINPWF 272
+P +R+ V +I +P+F
Sbjct: 214 QFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQ-ESVAIKVINKDQVKKQGLMEQIKREISVMRLVK- 74
+YE +G+G + KV+ ++L VA+K + + Q ++G+ RE++V+R ++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 75 --HPNIVELKEVMAT-----KTKVFFVIEYVKGG--ELFAKVLKGKLKEESARKYFQQLI 125
HPN+V L +V +TK+ V E+V KV + + E+ + QL+
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVA 185
+DF HS V HRDLKP+N+L+ +G +K++DFGL+ + L + T Y A
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRA 177
Query: 186 PEVLRKKGYDGAKSDIWSCGVVL 208
PEVL + Y D+WS G +
Sbjct: 178 PEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 76/307 (24%), Positives = 135/307 (43%), Gaps = 54/307 (17%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
L +Y R LG G+ V+ + + VA+K I + ++ REI ++R +
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS---VKHALREIKIIRRL 59
Query: 74 KHPNIVELKEVMATKTK--------------VFFVIEYVKGGELFAKVL-KGKLKEESAR 118
H NIV++ EV+ V+ V EY++ A VL +G L EE AR
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHAR 117
Query: 119 KYFQQLISAVDFCHSRGVYHRDLKPENLLLD-ENGNLKVSDFGLSALPEQLW-NDGLLHT 176
+ QL+ + + HS V HRDLKP N+ ++ E+ LK+ DFGL+ + + + + G L
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 177 QCGTPAYVAPE-VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-- 233
T Y +P +L Y A D+W+ G + +L+G F + ++ + I ++
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236
Query: 234 -------------------EY---------EFPPWISCDARRLISRILVADPQKRISVSE 265
+ P ++ +A + +IL +P R++ E
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296
Query: 266 IMINPWF 272
+++P+
Sbjct: 297 ALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 72/251 (28%), Positives = 122/251 (48%), Gaps = 15/251 (5%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
+G+G F +V+ G+ VA+K ++ + L + +E +++ HPNIV L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPD-LKAKFLQEARILKQYSHPNIVRLIG 60
Query: 84 VMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDL 141
V K ++ V+E V+GG+ F + +LK + + + + +++ S+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 142 KPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP----AYVAPEVLRKKGYDGA 197
N L+ E LK+SDFG+S E DG+ + G + APE L Y +
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEE----DGVYASTGGMKQIPVKWTAPEALNYGRYS-S 175
Query: 198 KSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPWISCDA-RRLISRILVA 255
+SD+WS G++L+ S G +P+ N + + I + P + DA RL+ R
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 256 DPQKRISVSEI 266
DP +R S S +
Sbjct: 236 DPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 69/267 (25%), Positives = 122/267 (45%), Gaps = 24/267 (8%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVI--NKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
LG+G + VY + T ++A+K I D+ K QI E+ ++ P IV+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK----FNQIIMELDILHKAVSPYIVDF 64
Query: 82 KEVMATKTKVFFVIEYVKGGEL----FAKVLKGKLKEESARKYFQQLISAVDFCHSR-GV 136
+ V+ +EY+ G L V + E+ R+ ++ + F +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
HRD+KP N+L++ NG +K+ DFG+S L T G +Y+APE ++ G +
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA----SLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 197 A-----KSDIWSCGVVLFVLLSGFLPFQNE---NIMKMYRKIFKAE-YEFPPWISCDARR 247
+SD+WS G+ + + G P+ E NI I + P S DA+
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQD 240
Query: 248 LISRILVADPQKRISVSEIMINPWFIK 274
+++ L P +R + ++++ +PW +K
Sbjct: 241 FVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 82/312 (26%), Positives = 133/312 (42%), Gaps = 66/312 (21%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK--REISVMRLVK 74
+Y+ + +G G V + VT ++VAIK K Q + + RE+ +M+LV
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAYRELVLMKLVN 73
Query: 75 HPNIVELKEVMATKTK------VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAV 128
H NI+ L V + V+ V+E + +V++ L E Q++ +
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMSYLLYQMLCGI 131
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT-QCGTPAYVAPE 187
HS G+ HRDLKP N+++ + LK+ DFGL+ + + T T Y APE
Sbjct: 132 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPE 187
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-------------- 233
V+ GY DIWS G ++ ++ G + F + + + KI +
Sbjct: 188 VILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246
Query: 234 -----------------EYEFPPWI------------SCDARRLISRILVADPQKRISVS 264
E FP + + AR L+S++LV DP+KRISV
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 265 EIM----INPWF 272
+ + IN W+
Sbjct: 307 DALQHPYINVWY 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 74/296 (25%), Positives = 134/296 (45%), Gaps = 46/296 (15%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK--REISVMRLVK 74
+Y+ +G G + V + ++ VA+K +++ Q L+ + RE+ +++ +K
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR---PFQSLIHARRTYRELRLLKHMK 72
Query: 75 HPNIVELKEVMATKTKV-----FFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVD 129
H N++ L +V T + +++ + G +L V KL +E + QL+ +
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLK 132
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
+ HS G+ HRDLKP N+ ++E+ L++ DFGL+ D + T Y APE++
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIM 187
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA----EYEFPPWISCD- 244
+ DIWS G ++ LL G F + + ++I + E IS +
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 245 ARR--------------------------LISRILVADPQKRISVSEIMINPWFIK 274
AR+ L+ ++LV D KRIS SE + +P+F +
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-20
Identities = 74/258 (28%), Positives = 119/258 (46%), Gaps = 29/258 (11%)
Query: 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELK 82
+LG+G F +V+ G L + VA+K +D Q L + E +++ HPNIV+L
Sbjct: 2 LLGKGNFGEVFKG-TLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 83 EVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
V + ++ V+E V GG+ F + K +LK + K+ + + + S+ HRD
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP----AYVAPEVLRKKGYDG 196
L N L+ EN LK+SDFG+S D +++ G + APE L Y
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYS- 172
Query: 197 AKSDIWSCGVVLFVLLS-GFLPF-------QNENIMKMYRKIFKAEYEFPPWISCDARRL 248
++SD+WS G++L+ S G P+ E + K YR P D ++
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR------MSCPQKCPDDVYKV 226
Query: 249 ISRILVADPQKRISVSEI 266
+ R P+ R SE+
Sbjct: 227 MQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 7e-20
Identities = 75/303 (24%), Positives = 130/303 (42%), Gaps = 55/303 (18%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y+ + +G G V + V +VAIK +++ + Q ++ RE+ +M+ V H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 76
Query: 77 NIVELKEVMATKTK------VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
NI+ L V + V+ V+E + +V++ +L E Q++ +
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH 134
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
HS G+ HRDLKP N+++ + LK+ DFGL+ + ++ T Y APEV+
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVIL 191
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI-------------------- 230
GY DIWS G ++ ++ + F + + + K+
Sbjct: 192 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 231 ----------------------FKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268
F A+ E + AR L+S++LV DP KRISV E +
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310
Query: 269 NPW 271
+P+
Sbjct: 311 HPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 8e-20
Identities = 67/252 (26%), Positives = 125/252 (49%), Gaps = 20/252 (7%)
Query: 18 YEMGRMLGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+ + R LG G F +V+ G KN V VAIK++ D + KQ + ++E+ ++ ++H
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRV---RVAIKILKSDDLLKQ---QDFQKEVQALKRLRH 61
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQ-QLISAVDFCH 132
+++ L V + V+ + E ++ G L F + +G++ ++ Q+ + +
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP-AYVAPEVLRK 191
+ HRDL N+L+ E+ KV+DFGL+ L + D L + P + APE
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASH 178
Query: 192 KGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPWISCDAR--RL 248
+ KSD+WS G++L+ + + G +P+ N ++Y +I A Y P C ++
Sbjct: 179 GTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI-TAGYRMPCPAKCPQEIYKI 236
Query: 249 ISRILVADPQKR 260
+ A+P+ R
Sbjct: 237 MLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 9e-20
Identities = 75/276 (27%), Positives = 136/276 (49%), Gaps = 27/276 (9%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVIN---KDQVKKQGLMEQIKREISVMRLVKHPNIVE 80
LG+G + V +++ T +A+K I Q +K+ LM+ +IS MR V P V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDL---DIS-MRSVDCPYTVT 64
Query: 81 LKEVMATKTKVFFVIEYVKGG--ELFAKVLKGKL--KEESARKYFQQLISAVDFCHSR-G 135
+ + V+ +E + + + KV L E+ K ++ A+++ HS+
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE----VLRK 191
V HRD+KP N+L++ NG +K+ DFG+S L + G Y+APE L +
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPELNQ 181
Query: 192 KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWI-----SCDAR 246
KGYD KSD+WS G+ + L +G P+ ++ ++++ + E P + S + +
Sbjct: 182 KGYD-VKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ 238
Query: 247 RLISRILVADPQKRISVSEIMINPWFIKGFSKPVAV 282
+++ L + ++R + E++ +P+F SK V
Sbjct: 239 DFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDV 274
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 63/228 (27%), Positives = 111/228 (48%), Gaps = 16/228 (7%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
+ LG G F V+ GK Q VAIK IN+ + ++ +E+ K VM + HP +V+L
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQL 64
Query: 82 KEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHR 139
V + ++ V E+++ G L + + +GKL ++ Q + +++ HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP---AYVAPEVLRKKGYDG 196
DL N L+ G +KVSDFG++ + D + G + PEV Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMT----RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 197 AKSDIWSCGVVLF-VLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISC 243
+KSD+WS GV+++ V G +PF+ ++ ++ I + + P ++
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 67/235 (28%), Positives = 115/235 (48%), Gaps = 35/235 (14%)
Query: 17 KYEMGRMLGQGTFAKVY--YGKNLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMR 71
K + R LGQG+F VY K +V E VAIK +N++ ++ + + E SVM+
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEE---------SARKYFQ 122
++V L V++T V+E + G+L L+ + E + +K+ Q
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDL-KSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 123 ---QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLW----NDGLL 174
++ + + ++ HRDL N ++ E+ +K+ DFG++ + E + GLL
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMK 225
+ ++APE L K G KSD+WS GVVL+ + + P+Q NE ++K
Sbjct: 184 PVR-----WMAPESL-KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK 232
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 74/303 (24%), Positives = 131/303 (43%), Gaps = 55/303 (18%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y+ + +G G V + + + +VAIK +++ + Q ++ RE+ +M+ V H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 83
Query: 77 NIVELKEVMATKTK------VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
NI+ L V + V+ V+E + +V++ +L E Q++ +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
HS G+ HRDLKP N+++ + LK+ DFGL+ + ++ T Y APEV+
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVIL 198
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI-------------------- 230
GY DIWS G ++ ++ G + F + + + K+
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 231 ----------------------FKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268
F A+ E + AR L+S++LV D KRISV E +
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 269 NPW 271
+P+
Sbjct: 318 HPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELK 82
+LG G VY +L+T+ +A+KVI D + L +QI E+ ++ P I+
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFY 65
Query: 83 EVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLK 142
+ ++ E++ GG L + K+ E + ++ + + S + HRD+K
Sbjct: 66 GAFFVENRISICTEFMDGGSL---DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122
Query: 143 PENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIW 202
P N+L++ G +K+ DFG+S QL N + T GT AY+APE + + Y G SD+W
Sbjct: 123 PSNMLVNTRGQVKLCDFGVST---QLVNS-IAKTYVGTNAYMAPERISGEQY-GIHSDVW 177
Query: 203 SCGVVLFVLLSGFLPF 218
S G+ L G P+
Sbjct: 178 SLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 7e-19
Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 36/229 (15%)
Query: 20 MGRMLGQGTFAKVYYGK-NLVTQESVAIKVINKDQVKKQGLM--EQIKREISVMRLVKHP 76
+ R LG G F +V+ G N T+ VA+K + K G M E +E +M+ ++H
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK--VAVKTL------KPGTMSPEAFLQEAQIMKKLRHD 61
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARK-YFQQLI-------SAV 128
+V+L V + + ++ V EY+ G L LK +K QL+ +
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDF-----LKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP-AYVAPE 187
+ SR HRDL N+L+ EN K++DFGL+ L E ++ P + APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED--DEYTAREGAKFPIKWTAPE 174
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
G KSD+WS G++L +++ G +P+ E + + YR
Sbjct: 175 AAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR 222
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 70/255 (27%), Positives = 121/255 (47%), Gaps = 17/255 (6%)
Query: 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIV 79
M LG G + +VY G +VA+K + +D ++ +E+ +E +VM+ +KHPN+V
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLV 65
Query: 80 ELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQ---QLISAVDFCHSRGV 136
+L V + + + E++ G L + + +E +A Q+ SA+++ +
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP---AYVAPEVLRKKG 193
HRDL N L+ EN +KV+DFGLS +L G + APE L
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 194 YDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLISR 251
+ KSD+W+ GV+L+ + + G P+ ++ ++Y + K E P L+
Sbjct: 182 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240
Query: 252 ILVADPQKRISVSEI 266
+P R S +EI
Sbjct: 241 CWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 65/250 (26%), Positives = 109/250 (43%), Gaps = 42/250 (16%)
Query: 65 REISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAK------VLKGKLKEESAR 118
RE+ ++ KH N++ +++ F YV EL V L + +
Sbjct: 48 RELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT-ELMQSDLHKIIVSPQPLSSDHVK 106
Query: 119 KYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ- 177
+ Q++ + + HS G+ HRD+KP NLL++ N LK+ DFGL+ + E ++ TQ
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP--DESKHMTQE 164
Query: 178 CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK------------ 225
T Y APE+L + + DIWS G + LL + FQ ++ ++
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224
Query: 226 ---------------MYRKIFKAE-----YEFPPWISCDARRLISRILVADPQKRISVSE 265
+ R K Y + +A L+ R+LV DP KRIS ++
Sbjct: 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284
Query: 266 IMINPWFIKG 275
+ +P+ +G
Sbjct: 285 ALAHPYLDEG 294
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 22/215 (10%)
Query: 19 EMGRMLGQGTFAKV----YYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+ R+LG+G F KV Y N T E VA+K + ++ Q K+EI++++ +
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY 64
Query: 75 HPNIVELKEVMATKTK--VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
H NIV+ K + + + ++EYV G L + K KL + QQ+ + + H
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPE-----QLWNDGLLHTQCGTPAY-VA 185
S+ HRDL N+LLD + +K+ DFGL+ A+PE ++ DG +P + A
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYA 178
Query: 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN 220
E L++ + A SD+WS GV L+ LL+ Q+
Sbjct: 179 VECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQS 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 70/293 (23%), Positives = 135/293 (46%), Gaps = 45/293 (15%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y + +G G + V + T E VAIK +++ + + ++ RE+++++ ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHE 74
Query: 77 NIVELKEVMATKT------KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
N++ L +V + + V+ Y++ K++ L E+ + Q++ + +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
HS G+ HRDLKP NL ++E+ LK+ DFGL+ D + T Y APEV+
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTGYVVTRWYRAPEVIL 187
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------EY--------- 235
+ DIWS G ++ +L+G F+ ++ + +I K E+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247
Query: 236 --------EFP--------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
++P P S A L+ ++L D KR++ +E + +P+F
Sbjct: 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 78/299 (26%), Positives = 136/299 (45%), Gaps = 56/299 (18%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
Y++G ++G G+F VY + T E VAIK + +D K RE+ +M+ + H N
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-------RELLIMKNLNHIN 120
Query: 78 IVELKEVMATKT------KVFF--VIEYVKGGELFAKVLKGKLKEESA------RKYFQQ 123
I+ LK+ T+ +F V+E++ + K +K + A + Y Q
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFLVKLYSYQ 178
Query: 124 LISAVDFCHSRGVYHRDLKPENLLLDENGN-LKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
L A+ + HS+ + HRDLKP+NLL+D N + LK+ DFG + L + C +
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLAGQRSVSYIC-SRF 235
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK---------- 232
Y APE++ D+WS G ++ ++ G+ F ++ + +I +
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 233 -------AEYEFPPWISCDARR------------LISRILVADPQKRISVSEIMINPWF 272
A+ +FP D ++ IS+ L +P KR++ E + +P+F
Sbjct: 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 66/249 (26%), Positives = 111/249 (44%), Gaps = 37/249 (14%)
Query: 24 LGQGTFAKVYYGK-----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
LG+G F KVY G+ ++ SVAIK + ++ K + ++ ++E +M ++HPNI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNI 70
Query: 79 VELKEVMATKTKVFFVIEYVKGGELF---------AKVLKGKLKEESARKYFQ------- 122
V L V + + EY+ G+L + V E
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 123 -QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP 181
Q+ + +++ S HRDL N L+ E +K+SDFGLS +++ Q +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD---IYSADYYRVQSKSL 187
Query: 182 ---AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLP---FQNENIMKMYRK--IFK 232
++ PE + G +SDIWS GVVL+ + S G P F N+ +++M R +
Sbjct: 188 LPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
Query: 233 AEYEFPPWI 241
+ P +
Sbjct: 247 CPEDCPARV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLM--EQIKREISVMRLVKHPNIVEL 81
+G G F V+ G L ++ VAIK I ++G M E E VM + HP +V+L
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTI------REGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 82 KEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHR 139
V ++ + V E+++ G L + + +GK +E+ + + + S V HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP---AYVAPEVLRKKGYDG 196
DL N L+ EN +KVSDFG++ + D + GT + +PEV Y
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMT----RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS- 179
Query: 197 AKSDIWSCGVVLFVLLS-GFLPFQN 220
+KSD+WS GV+++ + S G P++N
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 71/293 (24%), Positives = 134/293 (45%), Gaps = 44/293 (15%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y + +G G + V + T VAIK + + + + ++ RE+ +++ +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHE 74
Query: 77 NIVELKEVMATKTKV-----FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDF 130
N++ L +V + F+++ G +L K++K KL E+ + Q++ + +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDL-GKLMKHEKLSEDRIQFLVYQMLKGLKY 133
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
H+ G+ HRDLKP NL ++E+ LK+ DFGL+ D + T Y APEV+
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVIL 188
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK------AEY--------- 235
+ DIWS G ++ +L+G F+ + + +I K E+
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248
Query: 236 -----EFP-----------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
+ P P + A ++ ++LV D + RI+ +E + +P+F
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 8e-18
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE 83
LG G F V YGK Q VAIK+I + + + +E+ K VM + H +V+L
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMKLSHEKLVQLYG 66
Query: 84 VMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLIS-------AVDFCHSRGV 136
V + ++ V EY+ G L L+E R QL+ + + S+
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLL-----NYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV---APEVLRKKG 193
HRDL N L+D+ G +KVSDFGLS + D + G+ V PEVL
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLS----RYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 194 YDGAKSDIWSCGVVLFVLLS-GFLPFQNEN 222
+ +KSD+W+ GV+++ + S G +P++ N
Sbjct: 178 FS-SKSDVWAFGVLMWEVYSLGKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 69/294 (23%), Positives = 132/294 (44%), Gaps = 46/294 (15%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLM--EQIKREISVMRLVK 74
+Y+ +G G + V + T VA+K +++ Q ++ ++ RE+ +++ +K
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLLKHMK 74
Query: 75 HPNIVELKEVM--ATKTKVF---FVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVD 129
H N++ L +V A + F +++ ++ G +L V KL ++ + Q++ +
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 134
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
+ HS + HRDLKP NL ++E+ LK+ DFGL+ D + T Y APE++
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIM 189
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK----AEYEFPPWISCDA 245
+ DIWS G ++ LL+G F + + + I + E IS ++
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 246 RR---------------------------LISRILVADPQKRISVSEIMINPWF 272
R L+ ++LV D KRI+ ++ + + +F
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 68/238 (28%), Positives = 111/238 (46%), Gaps = 25/238 (10%)
Query: 22 RMLGQGTFAKVYYGKNLVTQE---SVAIKVINKDQVKKQGLMEQIKR----EISVMRLVK 74
+++G G F +V G+ + + VAIK + K G E+ +R E S+M
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL------KAGYTEKQRRDFLSEASIMGQFD 63
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCH 132
HPNI+ L+ V+ V V EY++ G L F + G+ + + S + +
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA-YVAPEVLRK 191
G HRDL N+L++ N KVSDFGLS + E P + APE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 192 KGYDGAKSDIWSCGVVLFVLLS-GFLPF---QNENIMKMYRKIFKAEYEFPPWISCDA 245
+ + A SD+WS G+V++ ++S G P+ N++++K + Y P + C A
Sbjct: 184 RKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA----IEEGYRLPAPMDCPA 236
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 68/233 (29%), Positives = 107/233 (45%), Gaps = 20/233 (8%)
Query: 22 RMLGQGTFAKVYYG---KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
+++G G F +V G + VAIK + KQ L E S+M HPNI
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNI 67
Query: 79 VELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRGV 136
+ L+ V+ V + EY++ G L F + GK + + S + +
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG-TPA-YVAPEVLRKKGY 194
HRDL N+L++ N KVSDFGLS E + T+ G P + APE + + +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 195 DGAKSDIWSCGVVLFVLLS-GFLPF---QNENIMKMYRKIFKAEYEFPPWISC 243
A SD+WS G+V++ ++S G P+ N++++K Y PP + C
Sbjct: 186 TSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED----GYRLPPPMDC 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 73/253 (28%), Positives = 127/253 (50%), Gaps = 23/253 (9%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
K +G ++G+G F V G+ T + VA+K I D V Q +E E +VM + H
Sbjct: 7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-VTAQAFLE----ETAVMTKLHHK 59
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESAR--KYFQQLISAVDFCH 132
N+V L V+ ++ V+E + G L F + +G+ + ++ + +++
Sbjct: 60 NLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRT-RGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
S+ + HRDL N+L+ E+G KVSDFGL+ + ++ L + + APE L+ K
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-----WTAPEALKHK 172
Query: 193 GYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPWISC--DARRLI 249
+ +KSD+WS GV+L+ + S G P+ ++ ++ + K Y P C D L+
Sbjct: 173 KFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCPADVYVLM 230
Query: 250 SRILVADPQKRIS 262
+ +P+KR S
Sbjct: 231 TSCWETEPKKRPS 243
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 75/257 (29%), Positives = 122/257 (47%), Gaps = 16/257 (6%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQE-SVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+GR +G+G F VY G + ++ +VA+K + E+ +E +MR H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDH 66
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHS 133
P+IV+L V+ T+ V+ V+E GEL + +V K L S Y QL +A+ + S
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT-P-AYVAPEVLRK 191
+ HRD+ N+L+ +K+ DFGLS E ++ G P ++APE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE---DESYYKASKGKLPIKWMAPESINF 182
Query: 192 KGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLI 249
+ + A SD+W GV ++ +L G PFQ + +I E PP L+
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 241
Query: 250 SRILVADPQKRISVSEI 266
++ DP KR +E+
Sbjct: 242 TKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 37/263 (14%)
Query: 27 GTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR------EISVMRLVK-HPNIV 79
G F KV K+ TQ K V+K IK E V +L+K +PN +
Sbjct: 27 GKFGKVSVLKHKPTQ---------KLFVQKI-----IKAKNFNAIEPMVHQLMKDNPNFI 72
Query: 80 ELKEVMATKTKVFFVIEYVKGGELFAKV-LKGKLKEESARKYFQQLISAVDFCHSRGVYH 138
+L + T +++Y+K G+LF + +GKL E +K +QL+ A++ H + H
Sbjct: 73 KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIH 132
Query: 139 RDLKPENLLLDEN-GNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGA 197
D+K EN+L D + + D+GL G GT Y +PE ++ YD
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYFSPEKIKGHNYD-V 185
Query: 198 KSDIWSCGVVLFVLLSGFLPFQNE-----NIMKMYRKIFKAEYEFPPWISCDARRLISRI 252
D W+ GV+ + LL+G PF+ + ++ + ++ K + F +S +A + +
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-KLPFIKNVSKNANDFVQSM 244
Query: 253 LVADPQKR-ISVSEIMINPWFIK 274
L + R + +EI+ +P+
Sbjct: 245 LKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 57/234 (24%), Positives = 105/234 (44%), Gaps = 42/234 (17%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+G+ V+ K+ T VA+K IN D K+ L + +++EI R ++HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDL-KLLQQEIITSRQLQHPN 60
Query: 78 IVELKEVMATKTKVFFVIEYVKGG---ELFAKVLKGKLKEESARKYFQQLISAVDFCHSR 134
I+ ++++ V + G +L L E + + +++A+D+ HS+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 135 GVYHRDLKPENLLLDENGNLKVS-------------------DFGLSALPEQLWNDGLLH 175
G HR +K ++LL +G + +S DF S++ W
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW------ 174
Query: 176 TQCGTPAYVAPEVLRK--KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMY 227
++PEVL++ +GY+ KSDI+S G+ L +G +PF++ +M
Sbjct: 175 --------LSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 54/300 (18%)
Query: 17 KYEMGRMLGQGTFAKVY----YGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
+Y + L G+ +V+ +G ++ V +K + + REI +++
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDE--QRKKVIVKAVTGGK--------TPGREIDILKT 142
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKV-LKGKLKEESARKYFQQLISAVDFC 131
+ H I+ L K+ V V+ K +LF V G L E A ++L+ A+ +
Sbjct: 143 ISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYL 201
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRK 191
H RG+ HRD+K EN+ LDE N + DFG + + + + GT +PE+L
Sbjct: 202 HGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL 261
Query: 192 KGYDGAKSDIWSCGVVLFVLLSGFLPF---------------------------QNE--N 222
Y AK+DIWS G+VLF + + QN N
Sbjct: 262 DPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320
Query: 223 IMKMYRK---IFKAEYEFPPWI-----SCDARRLISRILVADPQKRISVSEIMINPWFIK 274
+ K +++ + + Y PP I D LI+++L D + R S +I+ P F K
Sbjct: 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380
|
Length = 392 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 67/256 (26%), Positives = 117/256 (45%), Gaps = 20/256 (7%)
Query: 24 LGQGTFAKVYYGK---NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVE 80
LG G+F V G+ + VA+K + D++ +M+ +E ++M + H N++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENLIR 60
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESAR---KYFQQLISAVDFCHSRGVY 137
L V+ T + V E G L ++ K L Y Q+ + + + S+
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 138 HRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCG--TP-AYVAPEVLRKKG 193
HRDL N+LL + +K+ DFGL ALP+ N+ + P A+ APE LR +
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQ---NEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 194 YDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA--EYEFPPWISCDARRLIS 250
+ A SD+W GV L+ + + G P+ + ++ +KI K E P D ++
Sbjct: 177 FSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235
Query: 251 RILVADPQKRISVSEI 266
+ +P R + + +
Sbjct: 236 QCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 66/262 (25%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQES----VAIKVINKDQVKKQGLMEQIKREISVMR 71
+ E ++LG G F VY G + E VAIKV+ ++ K ++I E VM
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVMA 64
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL--KGKLKEESARKYFQQLISAVD 129
V HP++V L + + V + + + G L V K + + + Q+ +
Sbjct: 65 SVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG-TP-AYVAPE 187
+ + + HRDL N+L+ ++K++DFGL+ L + ++ H + G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV--DEKEYHAEGGKVPIKWMALE 181
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDA 245
+ + Y KSD+WS GV ++ L++ G P++ +++ + K E PP + D
Sbjct: 182 SILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240
Query: 246 RRLISRILVADPQKRISVSEIM 267
++ + + D + R + E++
Sbjct: 241 YMVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 26/195 (13%)
Query: 62 QIKREISVMRLVKHPNIVELKEV--------MATKTKVFFVIEYVKGGELFAK---VLKG 110
Q++ EI + + H NI++++E+ M T+ F + ++ K +LK
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK- 267
Query: 111 KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170
R +QL+ AV++ H + + HRD+K EN+ L+ +G + + DFG +A+P +
Sbjct: 268 -----QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKER 321
Query: 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN------ENI 223
+ + GT A +PE+L GY +DIWSCG++L +LS F P + + +
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380
Query: 224 MKMYRKIFKAEYEFP 238
+K+ + + EFP
Sbjct: 381 LKIIDSLSVCDEEFP 395
|
Length = 501 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 68/268 (25%), Positives = 128/268 (47%), Gaps = 30/268 (11%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQES-----VAIKVINKDQVKKQGLMEQIKREISVMRL 72
+ +GRMLG+G F V + + E VA+K++ D + +E+ RE + M+
Sbjct: 1 FTLGRMLGKGEFGSVR--EAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKE 57
Query: 73 VKHPNIVELKEV-MATKTK-----VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLI- 125
HPN+++L V + ++ K ++ ++K G+L +L ++ EE Q L+
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 126 ------SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179
S +++ S+ HRDL N +L+EN + V+DFGLS +++++ C
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCA 174
Query: 180 TP---AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE- 234
+ ++A E L Y SD+W+ GV ++ +++ G P+ ++Y + K
Sbjct: 175 SKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233
Query: 235 YEFPPWISCDARRLISRILVADPQKRIS 262
+ PP D L+ + +P+ R S
Sbjct: 234 LKQPPDCLEDVYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 64/237 (27%), Positives = 111/237 (46%), Gaps = 27/237 (11%)
Query: 23 MLGQGTFAKVYYGKNLVT---QESVAIKVINKDQVKKQGLMEQIKR----EISVMRLVKH 75
++G G F +V G+ + + VAIK + K G E+ +R E S+M H
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL------KSGYTEKQRRDFLSEASIMGQFDH 64
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHS 133
PNI+ L+ V+ V + E+++ G L F + G+ + + + + +
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA---YVAPEVLR 190
HRDL N+L++ N KVSDFGLS E +D + G + APE +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 191 KKGYDGAKSDIWSCGVVLFVLLS-GFLPF---QNENIMKMYRKIFKAEYEFPPWISC 243
+ + A SD+WS G+V++ ++S G P+ N++++ + +Y PP + C
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ----DYRLPPPMDC 236
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 8e-16
Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 34/280 (12%)
Query: 22 RMLGQGTFAKV----YYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
R LG+G F KV Y + T E VA+K + + + +K+EI ++R + H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 67
Query: 78 IVELKEVMATK--TKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHS 133
IV+ K + + ++E++ G L + K K+ + KY Q+ +D+ S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAY-VAPEVLRKK 192
R HRDL N+L++ +K+ DFGL+ E + +P + APE L +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 193 GYDGAKSDIWSCGVVLFVLL----------SGFL----PFQNENIMKMYRKIFKAEYEFP 238
+ A SD+WS GV L+ LL + FL P + + ++ + P
Sbjct: 188 KFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP 246
Query: 239 PWISCDAR--RLISRILVADPQKRISVSEIMINPWFIKGF 276
+C +L+ + P KR + + I+GF
Sbjct: 247 RPPNCPEEVYQLMRKCWEFQPSKRTTFQNL------IEGF 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 47/199 (23%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
Y + + L G+ +V+ + V +K+ K + ++ ++ V HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAML---------LQNVNHPS 118
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRG 135
++ +K+ + + V+ + +L+ + K L + A +Q++ + + H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND-GLLHTQCGTPAYVAPEVLRKKGY 194
+ HRD+K EN+ +++ + + D G + P GL GT APEVL + Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233
Query: 195 DGAKSDIWSCGVVLFVLLS 213
+ +K+DIWS G+VLF +L+
Sbjct: 234 N-SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 78/325 (24%), Positives = 143/325 (44%), Gaps = 79/325 (24%)
Query: 17 KYEMGRMLGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+YE G +G+GT+ VY K+ ++ A+K Q++ G+ REI+++R +K
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALK-----QIEGTGISMSACREIALLRELK 56
Query: 75 HPNIVELKEVMATKT--KVFFVIEYVKGGEL----FAKVLKG-----KLKEESARKYFQQ 123
HPN++ L++V + + KV+ + +Y + F + K +L + Q
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 124 LISAVDFCHSRGVYHRDLKPENLLL----DENGNLKVSDFGLSALPEQLWNDGL-----L 174
++ + + H+ V HRDLKP N+L+ E G +K++D G + +L+N L L
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA----RLFNSPLKPLADL 172
Query: 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG-------------FLPFQNE 221
T Y APE+L + DIW+ G + LL+ PF ++
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
Query: 222 NIMKMYRKI-FKAEYEFP--------PWISCDARR------------------------- 247
+ +++ + F A+ ++ P + D RR
Sbjct: 233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL 292
Query: 248 LISRILVADPQKRISVSEIMINPWF 272
L+ ++L DP KRI+ + + +P+F
Sbjct: 293 LLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 19 EMGRMLGQGTFAKVYYGK-NLVTQESVAIKVINKDQVKKQGLM--EQIKREISVMRLVKH 75
++ R LG G F +V+ G N T VA+K + K G M + E +M+ ++H
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTT--PVAVKTL------KPGTMDPKDFLAEAQIMKKLRH 60
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK---LKEESARKYFQQLISAVDFCH 132
P +++L V + ++ V E +K G L + G LK Q+ S + +
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGTP-AYVAPEVLR 190
++ HRDL N+L+ EN KV+DFGL+ + E ++ P + APE
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA---REGAKFPIKWTAPEAAL 177
Query: 191 KKGYDGAKSDIWSCGVVLFVLLS-GFLPF 218
+ KSD+WS G++L +++ G +P+
Sbjct: 178 YNRFS-IKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
+ +G+G F V G + VA+K I D + L E SVM ++H N+V+L
Sbjct: 12 QTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEA-----SVMTQLRHSNLVQL 64
Query: 82 KEVMAT-KTKVFFVIEYVKGGELFAKVLKGK----LKEESARKYFQQLISAVDFCHSRGV 136
V+ K ++ V EY+ G L L+ + L + K+ + A+++ +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSL-VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
HRDL N+L+ E+ KVSDFGL+ + G L + + APE LR+K +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAPEALREKKFS- 177
Query: 197 AKSDIWSCGVVLFVLLS-GFLPF 218
KSD+WS G++L+ + S G +P+
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 67/262 (25%), Positives = 117/262 (44%), Gaps = 24/262 (9%)
Query: 24 LGQGTFAKVYYGKNLVTQES-----VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
LG+G F +V+ K +E V +K + K K + L + +RE+ + R + H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK--TKDENLQSEFRRELDMFRKLSHKNV 70
Query: 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH--SRGV 136
V L + + ++EY G+L + K K+E + V C + G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 137 --------YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA-YVAPE 187
HRDL N L+ +KVS LS ++ P ++APE
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN--SEYYKLRNALIPLRWLAPE 188
Query: 188 VLRKKGYDGAKSDIWSCGVVLF-VLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDAR 246
+++ + KSD+WS GV+++ V G LPF + ++ ++ + E P C +R
Sbjct: 189 AVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR 247
Query: 247 --RLISRILVADPQKRISVSEI 266
+L++R +P+ R S SE+
Sbjct: 248 LYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 53/171 (30%), Positives = 86/171 (50%), Gaps = 21/171 (12%)
Query: 56 KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEE 115
K + QI RE+ V+ P IV + ++ +E++ GG L +VLK
Sbjct: 43 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLK------ 95
Query: 116 SARKYFQQLISAVDFCHSRG---------VYHRDLKPENLLLDENGNLKVSDFGLSALPE 166
A++ ++++ V RG + HRD+KP N+L++ G +K+ DFG+S
Sbjct: 96 EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG--- 152
Query: 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLP 217
QL D + ++ GT +Y++PE L+ Y +SDIWS G+ L L G P
Sbjct: 153 QLI-DSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 52/165 (31%), Positives = 87/165 (52%), Gaps = 9/165 (5%)
Query: 56 KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLK 113
K + QI RE+ V+ P IV + ++ +E++ GG L +VLK G++
Sbjct: 43 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP 101
Query: 114 EESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172
E+ K +I + + + + HRD+KP N+L++ G +K+ DFG+S QL D
Sbjct: 102 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLI-DS 157
Query: 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLP 217
+ ++ GT +Y++PE L+ Y +SDIWS G+ L + G P
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 69/251 (27%), Positives = 116/251 (46%), Gaps = 41/251 (16%)
Query: 24 LGQGTFAKVYYGKNLVT-----QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
LG+ F KVY G T ++VAIK + KD+ + L E+ K E + ++HPNI
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAE-GPLREEFKHEAMMRSRLQHPNI 70
Query: 79 VELKEVMATKTKVFFVIEYVKGGELFA-----------------KVLKGKLKEESARKYF 121
V L V+ + + + Y +L K +K L+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 122 QQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL-----SALPEQLWNDGLLHT 176
Q+ + ++F S V H+DL N+L+ + N+K+SD GL +A +L + LL
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLP---FQNENIMKMY--RKI 230
+ +++PE + G SDIWS GVVL+ + S G P + N+++++M R++
Sbjct: 191 R-----WMSPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV 244
Query: 231 FKAEYEFPPWI 241
+ P W+
Sbjct: 245 LPCPDDCPAWV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 61/268 (22%), Positives = 123/268 (45%), Gaps = 26/268 (9%)
Query: 20 MGRMLGQGTFAKVYYG---KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+G++LG+G F V G ++ +Q VA+K + D + E+ E + M+ HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI-EEFLSEAACMKDFDHP 61
Query: 77 NIVELKEVMATKT------KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLI----- 125
N+++L V + K ++ ++K G+L + +L +L + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 126 --SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP-- 181
+++ +R HRDL N +L E+ + V+DFGLS +++++
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS---KKIYSGDYYRQGRIAKMP 178
Query: 182 -AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFP 238
++A E L + Y +KSD+W+ GV ++ + + G P+ ++Y + + P
Sbjct: 179 VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237
Query: 239 PWISCDARRLISRILVADPQKRISVSEI 266
+ L+ ADP+ R + +++
Sbjct: 238 EDCLDELYDLMYSCWRADPKDRPTFTKL 265
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 29/226 (12%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQGLM--EQIKREISVMRLVK 74
++ + LG G F +V+ G VAIK + KQG M E E ++M+ ++
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNG---HTKVAIKSL------KQGSMSPEAFLAEANLMKQLQ 59
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKG-KLKEESARKYFQQLISAVDFC 131
HP +V L V+ T+ ++ + EY++ G L F K +G KL Q+ + F
Sbjct: 60 HPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP-AYVAPEVLR 190
+ HRDL+ N+L+ E K++DFGL+ L E N+ P + APE +
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI- 175
Query: 191 KKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
G KSD+WS G++L +++ G +P+ +N+ + YR
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQ---VKKQGLMEQIKREISVMRLVKHP 76
+G+ LG+G F V G + Q+ +KV K + + ME E M+ HP
Sbjct: 3 LGKTLGEGEFGSVMEG--QLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 77 NIVELKEVMATKTKV------FFVIEYVKGGELFAKVLKGKLKE-------ESARKYFQQ 123
N++ L V + ++ ++K G+L + +L +L + + K+
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 124 LISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ---CGT 180
+ S +++ S+ HRDL N +L+EN N+ V+DFGLS ++++N G + Q
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS---KKIYN-GDYYRQGRIAKM 176
Query: 181 PA-YVAPEVLRKKGYDGAKSDIWSCGVVLF 209
P ++A E L + Y KSD+WS GV ++
Sbjct: 177 PVKWIAIESLADRVYT-TKSDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 35/235 (14%)
Query: 24 LGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIV 79
LG+ F K+Y G + + VAIK + KD Q E ++E S+M + HPNIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGE-FQQEASLMAELHHPNIV 70
Query: 80 ELKEVMATKTKVFFVIEYVKGGELFAKVL--------------KGKLKEESARKYFQ--- 122
L V+ + V + EY+ G+L ++ G +K F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 123 -QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT- 180
Q+ + +++ S H+DL N+L+ E ++K+SD GLS ++++ Q +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS---REIYSADYYRVQPKSL 187
Query: 181 -PA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLP---FQNENIMKMYRK 229
P ++ PE + + + SDIWS GVVL+ + S G P F N+ +++M RK
Sbjct: 188 LPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 77/326 (23%), Positives = 138/326 (42%), Gaps = 81/326 (24%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+YE G +G+GT+ VY K ++ + Q++ G+ REI+++R +KHP
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDD---RDYALKQIEGTGISMSACREIALLRELKHP 58
Query: 77 NIVELKEVMATKT--KVFFVIEYVKGGEL----FAKVLKG-----KLKEESARKYFQQLI 125
N++ L++V + KV+ + +Y + F + K +L + Q++
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 126 SAVDFCHSRGVYHRDLKPENLLL----DENGNLKVSDFGLSALPEQLWNDGL-----LHT 176
+ + H+ V HRDLKP N+L+ E G +K++D G + +L+N L L
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA----RLFNSPLKPLADLDP 174
Query: 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS----------------------- 213
T Y APE+L + DIW+ G + LL+
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234
Query: 214 -------GF-----------LPFQNENIMKMYRK---------IFKAEYEFPPWISCDAR 246
GF +P ++ +MK +R+ + +++ P A
Sbjct: 235 DRIFNVMGFPADKDWEDIKKMP-EHSTLMKDFRRNTYTNCSLIKYMEKHKVKP--DSKAF 291
Query: 247 RLISRILVADPQKRISVSEIMINPWF 272
L+ ++L DP KRI+ + M +P+F
Sbjct: 292 HLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 78/290 (26%), Positives = 125/290 (43%), Gaps = 52/290 (17%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIK-----VINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
+G+G F V + + +A+K V K+Q K+ LM+ VMR P I
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ--KRLLMDLD----VVMRSSDCPYI 65
Query: 79 VEL-------------KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLI 125
V+ E+M F+ Y +VLK + EE K +
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYVY--------EVLKSVIPEEILGKIAVATV 117
Query: 126 SAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV 184
A+++ + HRD+KP N+LLD NGN+K+ DFG+S QL + G Y+
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYM 174
Query: 185 APEVL---RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-IMKMYRKIFKAEYEFPPW 240
APE + + GYD +SD+WS G+ L+ + +G P+ N + ++ K + PP
Sbjct: 175 APERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD---PPI 230
Query: 241 ISCDAR--------RLISRILVADPQKRISVSEIMINPWFIKGFSKPVAV 282
+S I+ L+ D KR E++ +P+ + V V
Sbjct: 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDV 280
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 67/281 (23%), Positives = 132/281 (46%), Gaps = 40/281 (14%)
Query: 17 KYEMGRMLGQGTFAKV----YYGKNLVTQES-VAIKVINKDQVKKQGLMEQIKREISVMR 71
+ +G+ LG+G F +V G + + S VA+K++ KD ++ L + + E+ +M+
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS-EMEMMK 70
Query: 72 LV-KHPNIVELKEVMATKTKVFFVIEYVKGGEL-----------------FAKVLKGKLK 113
++ KH NI+ L V + ++ V+EY G L + + L
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 114 EESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL----- 168
++ + Q+ ++F S+ HRDL N+L+ E+ +K++DFGL+ +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMY 227
+G L + ++APE L + Y +SD+WS GV+L+ + + G P+ + +++
Sbjct: 191 TTNGRLPVK-----WMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244
Query: 228 RKIFKAEY--EFPPWISCDARRLISRILVADPQKRISVSEI 266
K+ K Y E P + + L+ P +R + ++
Sbjct: 245 -KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 8e-14
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 24 LGQGTFAKVYYGK-NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELK 82
LGQG F +V+ G N T+ VAIK + + + ++ E VM+ ++H +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQLY 67
Query: 83 EVMATKTKVFFVIEYVKGGELFAKVLKGK----LKEESARKYFQQLISAVDFCHSRGVYH 138
V+ ++ ++ V EY+ G L LKG+ L+ Q+ S + + H
Sbjct: 68 AVV-SEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 139 RDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP-AYVAPEVLRKKGYDGA 197
RDL+ N+L+ EN KV+DFGL+ L E N+ P + APE G
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTI 182
Query: 198 KSDIWSCGVVLFVLLS-GFLPF 218
KSD+WS G++L L + G +P+
Sbjct: 183 KSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-13
Identities = 27/53 (50%), Positives = 35/53 (66%), Gaps = 4/53 (7%)
Query: 291 DFISSMSSGFDLSSLFESERKSG---SMFTSKCSSSAIMGKLESLAKKLNLGV 340
D IS +SSG DLS LFE E+KS + FTS+ +S I+ KLE +AK+L V
Sbjct: 5 DLIS-LSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKV 56
|
Length = 58 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 22 RMLGQGTFAKVYYGKNLV---TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
+++G G F +V+ G + + +VAIK + +KQ + E S+M H NI
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ--RQDFLSEASIMGQFSHHNI 68
Query: 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQL--ISA-VDFCHSRG 135
+ L+ V+ + EY++ G L K L+ E S+ + L I+A + +
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA--YVAPEVLRKKG 193
HRDL N+L++ N KVSDFGLS + E +G T G + APE + +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLED-DPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 194 YDGAKSDIWSCGVVLFVLLS-GFLPF---QNENIMKMYRKIFK 232
+ A SD+WS G+V++ ++S G P+ N +MK F+
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 21/171 (12%)
Query: 56 KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEE 115
K + QI RE+ V+ P IV + ++ +E++ GG L +VLK
Sbjct: 39 KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLK------ 91
Query: 116 SARKYFQQLISAVDFCHSRG---------VYHRDLKPENLLLDENGNLKVSDFGLSALPE 166
A + + ++ + RG + HRD+KP N+L++ G +K+ DFG+S
Sbjct: 92 KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--- 148
Query: 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLP 217
QL D + ++ GT +Y++PE L+ Y +SDIWS G+ L + G P
Sbjct: 149 QL-IDSMANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 23 MLGQGTFAKV----Y--YGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
LG+G F V Y N T E VA+K K Q + +REI +++ ++H
Sbjct: 11 QLGKGNFGSVELCRYDPLQDN--TGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 77 NIVELKEVM--ATKTKVFFVIEYVKGGELFAKVLKGKLKEESAR--KYFQQLISAVDFCH 132
NIV+ K V A + + V+EY+ G L + K + + + + Y Q+ +++
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCG-TPAY-VAPEVL 189
S+ HRDL N+L++ +K+ DFGL+ LP+ + + G +P + APE L
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD--KEYYKVREPGESPIFWYAPESL 183
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLS 213
+ + A SD+WS GVVL+ L +
Sbjct: 184 TESKFSVA-SDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 28/220 (12%)
Query: 19 EMGRMLGQGTFAKVYYG-KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
++ + LG G F +V+ G N T+ VA+K + + Q +E E ++M+ ++H
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLE----EANLMKTLQHDK 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELF--------AKVLKGKLKEESARKYFQQLISAVD 129
+V L V+ + ++ + EY+ G L KVL KL + SA Q+ +
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEGMA 117
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP-AYVAPEV 188
+ + HRDL+ N+L+ E+ K++DFGL+ + E N+ P + APE
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEA 175
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLS-GFLPF---QNENIM 224
+ + KSD+WS G++L+ +++ G +P+ N ++M
Sbjct: 176 INFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM 214
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 24 LGQGTFAKVYYGKNLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVE 80
LG G F V G L+ VA+K + ++ + ++ RE SVM + HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG--KKEFLREASVMAQLDHPCIVR 60
Query: 81 LKEVMATKTKVF-FVIEYVKGGELFAKVLKGK--LKEESARKYFQQLISAVDFCHSRGVY 137
L V K + V+E G L K LK + + ++ Q+ + + S+
Sbjct: 61 LIGV--CKGEPLMLVMELAPLGPLL-KYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 138 HRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGT-P-AYVAPEVLRKKGY 194
HRDL N+LL K+SDFG+S AL +D T G P + APE + +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 195 DGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM 226
+KSD+WS GV L+ S G P+ ++ M
Sbjct: 176 S-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM 210
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 67/265 (25%), Positives = 125/265 (47%), Gaps = 41/265 (15%)
Query: 22 RMLGQGTFAKVYYGKNLVTQES----VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
R++G+G F VY+G L+ + A+K +N+ + +EQ +E +M+ HPN
Sbjct: 1 RVIGKGHFGCVYHGT-LIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPN 57
Query: 78 IVELKEVMATKTKV-FFVIEYVKGGELFAKVLKGKLKEESARKYFQQLIS-------AVD 129
++ L + V+ Y+K G+L + ++ E+ + LI ++
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDL-----RNFIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCGTPA-YVAPE 187
+ S+ HRDL N +LDE+ +KV+DFGL+ + ++ + HT P ++A E
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPWISCDAR 246
L+ + + KSD+WS GV+L+ L++ G P+ + + + + R
Sbjct: 173 SLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL------------QGR 219
Query: 247 RLISRILVADPQKRISVSEIMINPW 271
RL+ DP + E+M++ W
Sbjct: 220 RLLQPEYCPDP-----LYEVMLSCW 239
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 23/235 (9%)
Query: 26 QGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR---EISVMRLVKHPNIVELK 82
+GTF +++YG + + +V K VK Q+ E ++ + H NI+ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVK-TVKDHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 83 EVMATKTKVFFVIE-YVKGGELFAKVLKGKLKEE------SARKYFQ---QLISAVDFCH 132
V + FV+ Y+ G L + + +L E S ++ Q+ + + H
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL--LHTQCGTP-AYVAPEVL 189
RGV H+D+ N ++DE +K++D +AL L+ L P ++A E L
Sbjct: 135 KRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDYHCLGDNENRPVKWMALESL 191
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPWISC 243
K Y A SD+WS GV+L+ L++ G P+ + +M + K Y I+C
Sbjct: 192 VNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL-KDGYRLAQPINC 244
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 79/339 (23%), Positives = 147/339 (43%), Gaps = 59/339 (17%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQE-------SVAIKVINKDQVKKQGLMEQIKREISV 69
+ +G+ LG+G F +V + + + +VA+K++ D K + + E+ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD--LSDLVSEMEM 70
Query: 70 MRLV-KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKG-------------KLKEE 115
M+++ KH NI+ L ++ ++EY G L + L+ KL EE
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL-REYLRARRPPGMDYSFDTCKLPEE 129
Query: 116 SARKYFQQLIS-------AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168
F+ L+S +++ S+ HRDL N+L+ E+ +K++DFGL+ +
Sbjct: 130 QLT--FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187
Query: 169 WNDGLLHTQCGT-PA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMK 225
D T G P ++APE L + Y +SD+WS GV+L+ + + G P+ + +
Sbjct: 188 --DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
Query: 226 MYRKIFKAEYEFPPWISC--DARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVC 283
++ K+ K + +C + ++ A P +R + ++
Sbjct: 245 LF-KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL----------------- 286
Query: 284 IDDGDNRDFISSMSSGFDLSSLFESERKSGSMFTSKCSS 322
++D D ++S DLS FE S CSS
Sbjct: 287 VEDLDRVLTVTSTDEYLDLSVPFEQYSPGCPDSPSSCSS 325
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 33/88 (37%), Positives = 50/88 (56%), Gaps = 1/88 (1%)
Query: 122 QQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP 181
+QL+SA+D+ H G+ HRD+K EN+L++ ++ + DFG + W+ + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 182 AYVAPEVLRKKGYDGAKSDIWSCGVVLF 209
APEVL Y DIWS G+V+F
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 2/161 (1%)
Query: 54 VKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLK 113
V K G E ++R + HP+I++LK ++ K K +
Sbjct: 121 VIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIA 180
Query: 114 EESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173
+ ++ A+ + H + HRD+K EN+ ++ G++ + DFG + P + N
Sbjct: 181 ICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANK 239
Query: 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG 214
+ GT A APE+L + Y G DIWS G+VLF + +
Sbjct: 240 YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 55/224 (24%)
Query: 22 RMLGQGTFAKVYYGK--NLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
R LG+G F KV+ G+ +L + VA+K + K+ + +RE ++ +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KE-TASNDARKDFEREAELLTNFQHE 68
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK----------------GKLKEESARKY 120
NIV+ V V EY++ G+L K L+ G+L +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 121 FQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---------------ALP 165
Q+ S + + S+ HRDL N L+ + +K+ DFG+S LP
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 166 EQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLF 209
+ ++ PE + + + +SD+WS GVVL+
Sbjct: 188 IR---------------WMPPESIMYRKFT-TESDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 32/217 (14%)
Query: 20 MGRMLGQGTFAKVY----YGKNLVTQE---SVAIKVINKDQVKKQGLMEQIKREISVMRL 72
+G+ LG+G F +V YG + + +VA+K++ KD + L + I E+ +M+L
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EMELMKL 73
Query: 73 V-KHPNIVELKEVMATKTKVFFVIEYVKGGEL-----------------FAKVLKGKLKE 114
+ KH NI+ L V + ++ ++EY G L KV + +L
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 115 ESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174
+ Q+ +++ SR HRDL N+L+ E+ +K++DFGL+ + D
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI--DYYK 191
Query: 175 HTQCG-TPA-YVAPEVLRKKGYDGAKSDIWSCGVVLF 209
T G P ++APE L + Y +SD+WS G++++
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 65/289 (22%), Positives = 125/289 (43%), Gaps = 49/289 (16%)
Query: 17 KYEMGRMLGQGTFAKVYYG-----KNLVTQESVAIKVI--NKDQVKKQGLMEQIKREISV 69
+G+ LG+G F KV K +VA+K++ N + + L+ E ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLS----EFNL 56
Query: 70 MRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFA------KVLKGKLKEESARK---- 119
++ V HP++++L + + ++EY K G L + KV L + R
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 120 ---------------YFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164
+ Q+ + + + HRDL N+L+ E +K+SDFGLS
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS-- 174
Query: 165 PEQLWNDG--LLHTQCGTPA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN 220
++ + + ++ P ++A E L Y +SD+WS GV+L+ +++ G P+
Sbjct: 175 -RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPG 232
Query: 221 ---ENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEI 266
E + + + ++ E P S + L+ +P KR + ++I
Sbjct: 233 IAPERLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 5e-12
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 24 LGQGTFAKVYYGK-NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELK 82
LGQG F +V+ G N T+ VAIK + + + ++ E +M+ ++H +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPLY 67
Query: 83 EVMATKTKVFFVIEYVKGGEL--FAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHR 139
V+ ++ ++ V E++ G L F K GK LK Q+ + + HR
Sbjct: 68 AVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP-AYVAPEVLRKKGYDGAK 198
DL+ N+L+ +N K++DFGL+ L E N+ P + APE G K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTIK 183
Query: 199 SDIWSCGVVLFVLLS-GFLPF 218
SD+WS G++L L++ G +P+
Sbjct: 184 SDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 67/254 (26%), Positives = 118/254 (46%), Gaps = 33/254 (12%)
Query: 24 LGQGTFAKVYYGK-NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELK 82
LG G F +V+ G N T+ VA+K + + + +E E +M+ ++H +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLE----EAQIMKKLRHDKLVQLY 67
Query: 83 EVMATKTKVFFVIEYVKGGEL--FAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHR 139
V+ ++ ++ V EY+ G L F K +G+ LK + Q+ + + + HR
Sbjct: 68 AVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 126
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP-AYVAPEVLRKKGYDGAK 198
DL+ N+L+ + K++DFGL+ L E N+ P + APE G K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTIK 183
Query: 199 SDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADP 257
SD+WS G++L L++ G +P+ N ++ ++ + Y P C
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCP------------- 229
Query: 258 QKRISVSEIMINPW 271
IS+ E+M+ W
Sbjct: 230 ---ISLHELMLQCW 240
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 69/268 (25%), Positives = 114/268 (42%), Gaps = 31/268 (11%)
Query: 19 EMGRMLGQGTFAKVY----YGKNLVTQESVAIKVINK------DQVKKQGLMEQIKREIS 68
G+ LG G F KV YG +++ +KV K +++ LM ++K
Sbjct: 38 SFGKTLGAGAFGKVVEATAYG---LSKSDAVMKVAVKMLKPTAHSSEREALMSELK---- 90
Query: 69 VM-RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK---LKEESARKYFQQL 124
+M L H NIV L + + EY G+L + + + L E + Q+
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150
Query: 125 ISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT--PA 182
+ F S+ HRDL N+LL +K+ DFGL+ + ND + P
Sbjct: 151 AKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA---RDIMNDSNYVVKGNARLPV 207
Query: 183 -YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEF--P 238
++APE + Y +SD+WS G++L+ + S G P+ + + K+ K Y P
Sbjct: 208 KWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266
Query: 239 PWISCDARRLISRILVADPQKRISVSEI 266
+ ++ ADP KR + +I
Sbjct: 267 EHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 34/225 (15%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQE-------SVAIKVINKDQVKKQGLMEQIKREISV 69
K +G+ LG+G F +V + L + +VA+K++ D +K + + E+ +
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 73
Query: 70 MRLV-KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKY-------- 120
M+++ KH NI+ L ++ ++EY G L + L+ + Y
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL-REYLRARRPPGMEYSYDIARVPDE 132
Query: 121 ---FQQLIS-------AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170
F+ L+S +++ S+ HRDL N+L+ EN +K++DFGL+ +
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI-- 190
Query: 171 DGLLHTQCGT-PA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS 213
D T G P ++APE L + Y +SD+WS GV+++ + +
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 16/193 (8%)
Query: 40 TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVK 99
T E V ++ IN + + ++ ++ E+ V +L HPNIV + +++ V ++
Sbjct: 24 TGEYVTVRRINLEACTNE-MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 100 GG---ELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV 156
G +L + E + Q ++ A+D+ H G HR +K ++L+ +G + +
Sbjct: 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL 142
Query: 157 SDFGLSALPEQLWNDGLLHTQCGTPAY-------VAPEVLRK--KGYDGAKSDIWSCGVV 207
S GL + + + L P Y ++PEVL++ +GYD AKSDI+S G+
Sbjct: 143 S--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGIT 199
Query: 208 LFVLLSGFLPFQN 220
L +G +PF++
Sbjct: 200 ACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 74/299 (24%), Positives = 135/299 (45%), Gaps = 19/299 (6%)
Query: 22 RMLGQGTFAKVYYGKNLVTQES----VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
++LG G F VY G + E VAIK + + K ++I E VM V +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 70
Query: 78 IVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRG 135
+ L + T T V + + + G L + + K + + + Q+ +++ R
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG-TP-AYVAPEVLRKKG 193
+ HRDL N+L+ ++K++DFGL+ L ++ H + G P ++A E + +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESILHRI 187
Query: 194 YDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLISR 251
Y +SD+WS GV ++ L++ G P+ ++ + K E PP + D ++ +
Sbjct: 188 YT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 246
Query: 252 ILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRDFISSMS-SGFDLSSLFESE 309
+ D R E++I F K P + GD R + S + S F + + E +
Sbjct: 247 CWMIDADSRPKFRELIIE--FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEED 303
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 37/310 (11%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
E+GR G VY ++ T V +++ + + ++ L + ++ E+ + +HPNI
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 79 VELKEVMATKTKVFFV---IEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRG 135
+ V T + ++ + + Y L + E + +++ H G
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT------QCGTPA--YVAPE 187
HR++K ++L+ +G + +S GLS L L +G Q T +++PE
Sbjct: 122 YIHRNIKASHILISGDGLVSLS--GLSHL-YSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 188 VLRKK--GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWIS--- 242
+LR+ GY+ KSDI+S G+ L +G +PFQ+ +M + K P I+
Sbjct: 179 LLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237
Query: 243 CDARRL----------ISRILVADPQKRISVSEIMINP---WFIKGFSKPVAVCI-DDGD 288
C+ R+ I +VA + SE + P F F V +C+ D +
Sbjct: 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPE 297
Query: 289 NRDFISSMSS 298
R SS+ S
Sbjct: 298 KRPSASSLLS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 64/249 (25%), Positives = 101/249 (40%), Gaps = 65/249 (26%)
Query: 19 EMGRMLGQGTFAKVYYG-----KNLVTQESVAIKVINKD---QVKKQGLMEQIKREISVM 70
+ R LG G F +VY G + VA+K + + Q + LME + +M
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL-----IM 63
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAV 128
H NIV L V + F ++E + GG+L F + + + + S+ L A
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 129 DF---CH---SRGVYHRDLKPENLLLDENGN---LKVSDFGLS---------------AL 164
D C HRD+ N LL G K++DFG++ L
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG---AKSDIWSCGVVLFVLLS-GFLPF-- 218
P + W P PE DG +K+D+WS GV+L+ + S G++P+
Sbjct: 184 PIK-W----------MP----PEAF----LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224
Query: 219 -QNENIMKM 226
N+ +M+
Sbjct: 225 RTNQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 59/233 (25%), Positives = 112/233 (48%), Gaps = 21/233 (9%)
Query: 19 EMGRMLGQGTFAKVY---YGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
++ + LG G F +V+ Y K+ VA+K + + + + E +VM+ ++H
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKH----TKVAVKTMKPGSMSVEAFLA----EANVMKTLQH 60
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKG-KLKEESARKYFQQLISAVDFCH 132
+V+L V+ TK ++ + E++ G L F K +G K + Q+ + F
Sbjct: 61 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP-AYVAPEVLRK 191
R HRDL+ N+L+ + K++DFGL+ + E N+ P + APE +
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINF 177
Query: 192 KGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPWISC 243
+ KSD+WS G++L +++ G +P+ + ++ R + + Y P +C
Sbjct: 178 GSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENC 228
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 63/234 (26%), Positives = 113/234 (48%), Gaps = 33/234 (14%)
Query: 17 KYEMGRMLGQGTFAKVYYG--KNLVTQE---SVAIKVINKDQVKKQGLMEQIKREISVMR 71
K M R LGQG+F VY G K +V E VAIK +N+ ++ + + E SVM+
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESA--------RKYFQ- 122
++V L V++ ++E + G+L + + + + E+ +K Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 123 --QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLW----NDGLLH 175
++ + + ++ HRDL N ++ E+ +K+ DFG++ + E + GLL
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMK 225
+ +++PE L K G SD+WS GVVL+ + + P+Q NE +++
Sbjct: 185 VR-----WMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 179 GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP 238
GTP Y+APE+L K + A D W+ GV LF L+G PF +E ++++ I + +P
Sbjct: 542 GTPDYLAPELLLGKPHGPA-VDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 239 PW---ISCDARRLISRILVADPQKRISVSEIMINPWF 272
+S +A+ I +L DP KR + E+ +P F
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 42/226 (18%)
Query: 20 MGRMLGQGTFAKVYYGK---------NLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
+G+ LG+G F +V + N VT+ VA+K++ D +K + + E+ +M
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTK--VAVKMLKSDATEKD--LSDLISEMEMM 77
Query: 71 RLV-KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKY--------- 120
+++ KH NI+ L ++ ++EY G L + + + +Y
Sbjct: 78 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGMEYCYNPTQVPE 134
Query: 121 ----FQQLIS-------AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169
F+ L+S +++ S+ HRDL N+L+ E+ +K++DFGL+ +
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI- 193
Query: 170 NDGLLHTQCGT-PA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS 213
D T G P ++APE L + Y +SD+WS GV+L+ + +
Sbjct: 194 -DYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 65/260 (25%), Positives = 108/260 (41%), Gaps = 65/260 (25%)
Query: 16 GKYEMGRMLGQGTFAKVYYGK--NLVTQES---VAIKVINKDQVKKQGLMEQIKREISVM 70
E R +GQG F +V+ + L+ E VA+K++ K++ + +RE ++M
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQAD-FQREAALM 62
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESA------RKYFQ 122
HPNIV+L V A + + EY+ G+L F + + + + RK
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 123 ---QLISAVDFCHSRGV------------YHRDLKPENLLLDENGNLKVSDFGLS----- 162
L C ++ V HRDL N L+ EN +K++DFGLS
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 163 ----------ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLL 212
A+P + ++ PE + Y +SD+W+ GVVL+ +
Sbjct: 183 ADYYKASENDAIPIR---------------WMPPESIFYNRYT-TESDVWAYGVVLWEIF 226
Query: 213 S-GFLPF---QNENIMKMYR 228
S G P+ +E ++ R
Sbjct: 227 SYGMQPYYGMAHEEVIYYVR 246
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 37/236 (15%)
Query: 17 KYEMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIK--REISV 69
K + R LGQG+F VY G ++++ E+ VA+K +N+ L E+I+ E SV
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASV 62
Query: 70 MRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESAR--KYFQQLI 125
M+ ++V L V++ V+E + G+L + + L+ + + R Q++I
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 126 S-------AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLW----NDGL 173
+ + +++ HRDL N ++ + +K+ DFG++ + E + GL
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMK 225
L + ++APE L K G SD+WS GVVL+ + S P+Q NE ++K
Sbjct: 183 LPVR-----WMAPESL-KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 7/190 (3%)
Query: 24 LGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
LG G F V G K ++++VA+K++ K+ L +++ RE +VM+ + +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHRD 140
+ ++ V+E + G L + K K + E++ + Q+ + + HRD
Sbjct: 62 IGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA-YVAPEVLRKKGYDGAKS 199
L N+LL K+SDFGLS N T P + APE + + +KS
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS-SKS 179
Query: 200 DIWSCGVVLF 209
D+WS GV+++
Sbjct: 180 DVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 56/249 (22%), Positives = 108/249 (43%), Gaps = 38/249 (15%)
Query: 42 ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELK----EVMATKTKVFFVIEY 97
+ V I+ K + L++ + EI +R + NI+++ +++ ++ ++EY
Sbjct: 44 KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103
Query: 98 VKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVY---------HRDLKPENLLL 148
G L+ L +E + +L A+D C +G+Y +++L + L+
Sbjct: 104 CTRG-----YLREVLDKEKDLSFKTKLDMAIDCC--KGLYNLYKYTNKPYKNLTSVSFLV 156
Query: 149 DENGNLKVSDFGL----SALPEQLWNDGLLHTQCGTPAYVAPEVLRK--KGYDGAKSDIW 202
EN LK+ GL S+ P + N Y + ++L Y K DI+
Sbjct: 157 TENYKLKIICHGLEKILSSPPFKNVNF---------MVYFSYKMLNDIFSEYT-IKDDIY 206
Query: 203 SCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISC--DARRLISRILVADPQKR 260
S GVVL+ + +G +PF+N ++Y I + C + + ++ D KR
Sbjct: 207 SLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKR 266
Query: 261 ISVSEIMIN 269
++ EI+ N
Sbjct: 267 PNIKEILYN 275
|
Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 20 MGRMLGQGTFAKVYYGK--NLVTQES---VAIKVIN--KDQVKKQGLMEQIKREISVMRL 72
+ R LG+G F KV+ + NL ++ VA+K + D +K RE ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD-----FHREAELLTN 63
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKG---------------KLKEESA 117
++H +IV+ V + V EY+K G+L K L+ +L +
Sbjct: 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 118 RKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS--ALPEQLWNDGLLH 175
QQ+ + + + S+ HRDL N L+ EN +K+ DFG+S + G H
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG-GH 181
Query: 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS 213
T ++ PE + + + +SD+WS GVVL+ + +
Sbjct: 182 TMLPI-RWMPPESIMYRKFT-TESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 22 RMLGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQGLMEQIK--REISVMRLVKHPN 77
LG G F +VY G +++ S I+V K K E+ + +E +M HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKL-KEESARKYFQQLIS-AVDFCHSRG 135
IV+L V + ++E ++GG+L + + ++ + ++L+ +D
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG-C 119
Query: 136 VY-------HRDLKPENLLLDENGN-----LKVSDFGL-----SALPEQLWNDGLLHTQC 178
VY HRDL N L+ E G +K+ DFGL + + +GLL +
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 179 GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPF---QNENIMKMYRKIFKAE 234
++APE L G +SD+WS GV+++ +L+ G P+ N+ +++
Sbjct: 179 ----WMAPESL-LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA--GGR 231
Query: 235 YEFPPWISCDARRLISRILVADPQKRISVSEI 266
+ P +L++ DP +R + I
Sbjct: 232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRI 263
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 68/281 (24%), Positives = 122/281 (43%), Gaps = 52/281 (18%)
Query: 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR------------EISVM 70
++G+G F +V + I KD ++ ++++K E+ V+
Sbjct: 14 VIGEGNFGQVLKAR------------IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 61
Query: 71 -RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEE----------SARK 119
+L HPNI+ L + ++ IEY G L + K ++ E ++
Sbjct: 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 120 YFQQLIS-------AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172
QQL+ +D+ + HRDL N+L+ EN K++DFGLS E
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---- 177
Query: 173 LLHTQCGTPA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKI 230
+ T P ++A E L Y SD+WS GV+L+ ++S G P+ ++Y K+
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
Query: 231 FKAEYEFPPWISCDAR--RLISRILVADPQKRISVSEIMIN 269
+ Y ++CD L+ + P +R S ++I+++
Sbjct: 237 PQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISV 69
+ +IL E ++ +G Y GK++ +K IN V E I+
Sbjct: 685 INDILSSLKEEN-VISRGKKGASYKGKSIKNGMQFVVKEIND--VNSIPSSE-----IAD 736
Query: 70 MRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVD 129
M ++HPNIV+L + ++ + + EY++G L ++VL+ L E RK + A+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-SEVLRN-LSWERRRKIAIGIAKALR 794
Query: 130 FCH---SRGVYHRDLKPENLLLD--ENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV 184
F H S V +L PE +++D + +L++S LP L D + AYV
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLS------LPGLLCTD---TKCFISSAYV 845
Query: 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLSG 214
APE K KSDI+ G++L LL+G
Sbjct: 846 APETRETKDIT-EKSDIYGFGLILIELLTG 874
|
Length = 968 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 71/299 (23%), Positives = 132/299 (44%), Gaps = 20/299 (6%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESV----AIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
++LG G F VY G + E+V AIK++N+ K + + E +M + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK--LKEESARKYFQQLISAVDFCHSRG 135
+V L V + T + V + + G L V + K + + + Q+ + + R
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP---AYVAPEVLRKK 192
+ HRDL N+L+ ++K++DFGL+ L E D + G ++A E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLE---GDEKEYNADGGKMPIKWMALECIHYR 186
Query: 193 GYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLIS 250
+ +SD+WS GV ++ L++ G P+ ++ + K E PP + D ++
Sbjct: 187 KFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMV 245
Query: 251 RILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRDFISSMSSGFDLSSLFESE 309
+ + D R E+ F + P + GD+R + S + +L + E
Sbjct: 246 KCWMIDADSRPKFKELAAE--FSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLDEE 302
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 23/258 (8%)
Query: 22 RMLGQGTFAKVYYG--KNLVTQE-SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
R+LG G F ++ G K +E VAI + KQ E + H NI
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRR--GFLAEALTLGQFDHSNI 68
Query: 79 VELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRGV 136
V L+ V+ + V EY+ G L F + +G+L L S + + G
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY 128
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG-TPA-YVAPEVLRKKGY 194
H+ L +L++ + K+S F L E ++ + T G +P + APE ++ +
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RLQEDK-SEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 195 DGAKSDIWSCGVVLFVLLS-GFLPF---QNENIMKMYRKIFKAEYEFPPWISCDA--RRL 248
A SD+WS G+V++ ++S G P+ ++++K F+ P +C +L
Sbjct: 186 SSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR----LPAPRNCPNLLHQL 240
Query: 249 ISRILVADPQKRISVSEI 266
+ + +R S+I
Sbjct: 241 MLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 69/287 (24%), Positives = 117/287 (40%), Gaps = 53/287 (18%)
Query: 24 LGQGTFAKVYYGKNLVTQES----------------VAIKVINKDQVKKQGLMEQIKREI 67
LG+G F +V+ + Q+ VA+KV+ D E +E+
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEV 70
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQ----- 122
++ + PNI L V + ++EY++ G+L + L+ + E S
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLACNSKSLSF 129
Query: 123 --------QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174
Q+ S + + S HRDL N L+ +N +K++DFG+S L++
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS---RNLYSSDYY 186
Query: 175 HTQCGTPA---YVAPE-VLRKKGYDGAKSDIWSCGVVLFVLLSGFL---PFQN------- 220
Q P ++A E VL K + KSD+W+ GV L+ +L+ P+++
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGK-FT-TKSDVWAFGVTLWEILT-LCREQPYEHLTDQQVI 243
Query: 221 ENIMKMYRKIFKAEY-EFPPWISCDARRLISRILVADPQKRISVSEI 266
EN +R + Y PP D L+ D + R + EI
Sbjct: 244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 33/232 (14%)
Query: 23 MLGQGTFAKVYYGKNLVTQE----SVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHPN 77
++G+G F +V + ++ ++ + AIK++ + + E+ V+ +L HPN
Sbjct: 9 VIGEGNFGQVI--RAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPN 64
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEES---ARKY-------FQQLIS- 126
I+ L + ++ IEY G L + K ++ E A+++ QQL+
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 127 AVD------FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180
A D + + HRDL N+L+ EN K++DFGLS E+++ + T
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-GEEVY---VKKTMGRL 180
Query: 181 PA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKI 230
P ++A E L Y KSD+WS GV+L+ ++S G P+ ++Y K+
Sbjct: 181 PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 60/240 (25%), Positives = 104/240 (43%), Gaps = 49/240 (20%)
Query: 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR------------EISVM 70
++G+G F +V I KD ++ ++++K E+ V+
Sbjct: 2 VIGEGNFGQVLKA------------RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 49
Query: 71 -RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEES---ARKY------ 120
+L HPNI+ L + ++ IEY G L + K ++ E A
Sbjct: 50 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 109
Query: 121 -FQQLI-------SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172
QQL+ +D+ + HRDL N+L+ EN K++DFGLS ++++
Sbjct: 110 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVY--- 165
Query: 173 LLHTQCGTPA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKI 230
+ T P ++A E L Y SD+WS GV+L+ ++S G P+ ++Y K+
Sbjct: 166 VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 24 LGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
LG G F V G K Q VAIKV+ + K + +++ RE +M + +P IV +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKS--VRDEMMREAEIMHQLDNPYIVRM 60
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKE---ESARKYFQQLISAVDFCHSRGVYH 138
V + + V+E GG L K L GK E + + Q+ + + + H
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 139 RDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGTP---AYVAPEVLRKKGY 194
RDL N+LL K+SDFGLS AL +D + + APE + + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 195 DGAKSDIWSCGVVLFVLLS 213
++SD+WS G+ ++ S
Sbjct: 176 S-SRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 28/163 (17%)
Query: 120 YFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179
Y Q+ ++F SR HRDL N+LL EN +K+ DFGL+ ++ D
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---RDIYKD-------- 227
Query: 180 TPAYV------------APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKM 226
P YV APE + K Y +SD+WS GV+L+ + S G P+ I +
Sbjct: 228 -PDYVRKGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
Query: 227 YRKIFK--AEYEFPPWISCDARRLISRILVADPQKRISVSEIM 267
+ + K P + + R++ DP++R + S ++
Sbjct: 286 FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-09
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 24 LGQGTFAKVYYGK--NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
+G G F KV G+ +++ V +K + + L +E+ R + HPN+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL--LFLQEVQPYRELNHPNVLQC 60
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKE-ESARKYFQQ-----LISAVDFCHSRG 135
V+E+ G+L + + + A+K Q + S + + H
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQC-GTP-AYVAPEVLRKKG 193
H DL N L + ++K+ D+GL+ EQ D + C P ++APE++ +G
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLAL--EQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 194 YD------GAKSDIWSCGVVLFVL 211
D KS+IWS GV ++ L
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 24 LGQGTFAKVYYGK-------NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
LGQGTF K++ G + + V +KV++K + E S+M + H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLSHK 59
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSR 134
++V V + V EYVK G L + K K + + +QL A+ F +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 135 GVYHRDLKPENLLL-----DENGN---LKVSDFGLS--ALPEQLWNDGLLHTQCGTPAYV 184
G+ H ++ +N+LL + GN +K+SD G+S LP+++ + + +V
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI--------PWV 171
Query: 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLSG 214
PE + +D WS G L+ + SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 69/267 (25%), Positives = 115/267 (43%), Gaps = 32/267 (11%)
Query: 22 RMLGQGTFAKVYYGKNLVTQES----VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
++LG G F VY G + E+ VAIKV+ ++ K ++I E VM V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPY 70
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVL--KGKLKEESARKYFQQLISAVDFCHSRG 135
+ L + T T V V + + G L V K ++ + + Q+ + +
Sbjct: 71 VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG-TP-AYVAPEVLRKKG 193
+ HRDL N+L+ ++K++DFGL+ L + ++ H G P ++A E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESILHRR 187
Query: 194 YDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRI 252
+ +SD+WS GV ++ L++ G P+ A E P + R
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYDG----------IPAR-EIPDLLEKGER------ 229
Query: 253 LVADPQKRISVSEIMINPWFIKGFSKP 279
L P I V IM+ W I +P
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRP 256
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 65/269 (24%), Positives = 119/269 (44%), Gaps = 33/269 (12%)
Query: 24 LGQGTFAKVYYGK--NLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
LG+G F KV+ + NL+ ++ VA+K + + + + +RE ++ +++H +I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQHQHI 69
Query: 79 VELKEVMATKTKVFFVIEYVKGGELF---------AKVLKGKLKEESARKYFQQLISAVD 129
V V + V EY++ G+L AK+L G + Q+++
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 130 FCHSRGVY-------HRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT-- 180
S VY HRDL N L+ + +K+ DFG+S +++ T
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS---RDIYSTDYYRVGGRTML 186
Query: 181 PA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLP-FQNENIMKMYRKIFKAEYEF 237
P ++ PE + + + +SDIWS GVVL+ + + G P +Q N + E E
Sbjct: 187 PIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELER 245
Query: 238 PPWISCDARRLISRILVADPQKRISVSEI 266
P + ++ +PQ+R+ + +I
Sbjct: 246 PRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 20 MGRMLGQGTFAKVYYGK--NLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+ R LG+G F KV+ + NL + VA+K + + + + +RE ++ ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAELLTNLQ 65
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELF---------AKVL--------KGKLKEESA 117
H +IV+ V + V EY+K G+L A +L KG+L
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 118 RKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS--ALPEQLWNDGLLH 175
Q+ S + + S+ HRDL N L+ N +K+ DFG+S + G H
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG-GH 184
Query: 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS 213
T ++ PE + + + +SD+WS GV+L+ + +
Sbjct: 185 TMLPI-RWMPPESIMYRKFT-TESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 21 GRMLGQGTFAKVYYGKNLVTQES----VAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
++LG G F V+ G + +S VAIK I +D+ +Q E I + M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTFQE-ITDHMLAMGSLDHA 69
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL--KGKLKEESARKYFQQLISAVDFCHSR 134
IV L + + V + G L V + L + + Q+ + +
Sbjct: 70 YIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG--LLHTQCGTP-AYVAPEVLRK 191
+ HR+L N+LL + ++++DFG++ L L+ D +++ TP ++A E +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADL---LYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 192 KGYDGAKSDIWSCGVVLFVLLS 213
Y +SD+WS GV ++ ++S
Sbjct: 186 GRYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 14/131 (10%)
Query: 44 VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL 103
VA+K++ +D K +EI +M +K PNI+ L V T + + EY++ G+L
Sbjct: 49 VAVKMLREDANKNA--RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 104 FAKVLKGKLKEESA------------RKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN 151
+ + + +E + Q+ S + + S HRDL N L+ +N
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN 166
Query: 152 GNLKVSDFGLS 162
+K++DFG+S
Sbjct: 167 YTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 25/106 (23%)
Query: 120 YFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179
Y Q+ ++F SR HRDL N+LL EN +K+ DFGL+ ++ D
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---RDIYKD-------- 226
Query: 180 TPAYV------------APEVLRKKGYDGAKSDIWSCGVVLFVLLS 213
P YV APE + K Y +SD+WS GV+L+ + S
Sbjct: 227 -PDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 32/132 (24%), Positives = 60/132 (45%), Gaps = 15/132 (11%)
Query: 44 VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL 103
VA+K++ D K +EI +M +K+PNI+ L V + + + EY++ G+L
Sbjct: 47 VAVKMLRADVTKTA--RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 104 FAKVLKGKLKEESARK-------------YFQQLISAVDFCHSRGVYHRDLKPENLLLDE 150
+ + +++ Q+ S + + S HRDL N L+
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 151 NGNLKVSDFGLS 162
+ +K++DFG+S
Sbjct: 165 HYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 28/163 (17%)
Query: 120 YFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179
Y Q+ ++F SR HRDL N+LL EN +K+ DFGL+ ++ D
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---RDIYKD-------- 232
Query: 180 TPAYV------------APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKM 226
P YV APE + + Y +SD+WS GV+L+ + S G P+ I +
Sbjct: 233 -PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290
Query: 227 YRKIFK--AEYEFPPWISCDARRLISRILVADPQKRISVSEIM 267
+ + K P + + + + + +P +R + SE++
Sbjct: 291 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 8e-07
Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 46/273 (16%)
Query: 24 LGQGTFAKVYYGK--------NLVTQESVAIKVINKDQVKKQGLMEQIKREISV------ 69
LG+GT ++Y G + IKVI K +++ R+IS+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILK-------VLDPSHRDISLAFFETA 55
Query: 70 --MRLVKHPNIVELKEVMATKTKVFFVIEYVKGG--ELFAKVLKGKLKEESARKYFQQLI 125
MR V H +IV L V + V E+V+ G +LF L K +QL
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLA 115
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENG-------NLKVSDFG--LSALPEQLWNDGLLHT 176
SA+ + + + H ++ +N+LL G +K+SD G ++ L Q + +
Sbjct: 116 SALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--- 172
Query: 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLF-VLLSGFLPFQNENIMKMYRKIFKAEY 235
++APE + +D WS G L+ + +G +P +++ + + R F
Sbjct: 173 -----PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER--FYEGQ 225
Query: 236 EFPPWISCDA-RRLISRILVADPQKRISVSEIM 267
SC L++ + DP +R IM
Sbjct: 226 CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 33/195 (16%)
Query: 44 VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL 103
VA+K++ D K +E+ ++ +K PNI+ L V + + + EY++ G+L
Sbjct: 49 VAVKILRPDANKNA--RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 104 ----FAKVLKGKLKEESARKYFQ-----------------QLISAVDFCHSRGVYHRDLK 142
+ L K +E Q+ S + + S HRDL
Sbjct: 107 NQFLSSHHLDDK-EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 143 PENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA----YVAPEVLRKKGYDGAK 198
N L+ EN +K++DFG+S L+ Q G ++A E + + A
Sbjct: 166 TRNCLVGENLTIKIADFGMS---RNLYAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTA- 220
Query: 199 SDIWSCGVVLFVLLS 213
SD+W+ GV L+ +L
Sbjct: 221 SDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 63/268 (23%), Positives = 105/268 (39%), Gaps = 39/268 (14%)
Query: 24 LGQGTFAKVYYGKNLV------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
LGQGTF +Y G V + V+ K S+M + H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 78 IVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRG 135
+V+L V + + V EYVK G L F K + +QL SA+ + +
Sbjct: 63 LVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 136 VYHRDLKPENLLL----DENGN---LKVSDFG--LSALPEQLWNDGLLHTQCGTPA-YVA 185
+ H ++ +N+L+ G +K+SD G ++ L + + ++A
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE---------ERVERIPWIA 172
Query: 186 PEVLRKKGYDGAKS-----DIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPP 239
PE +R +G S D WS G L + S G P + + R ++ ++ P
Sbjct: 173 PECIR----NGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQDQHRLPM 227
Query: 240 WISCDARRLISRILVADPQKRISVSEIM 267
+ LI++ DP KR S I+
Sbjct: 228 PDCAELANLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 38/214 (17%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK--REISVMRLVKHPNIVEL 81
+G G F KV G+ V +V+ K+ + EQ+K E R ++H N+++
Sbjct: 3 IGNGWFGKVILGE--VNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESAR---KYFQQL----ISAVDFCHSR 134
T V+E+ G+L L+ K E Q++ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDL-KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSAL---------PEQLWNDGLLHTQCGTP-AYV 184
H DL N LL + +K+ D+GLS P+QLW P ++
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW----------VPLRWI 169
Query: 185 APEVLRKKG-----YDGAK-SDIWSCGVVLFVLL 212
APE++ + D K S++WS GV ++ L
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 18/47 (38%), Positives = 32/47 (68%), Gaps = 1/47 (2%)
Query: 118 RKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-NGNLKVSDFGLSA 163
+ +Q++ A+D HS G+ HRD+KP+N++ E +G+ K+ D G +A
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 28/151 (18%), Positives = 60/151 (39%), Gaps = 24/151 (15%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH-----P 76
++L G +VY E +K+ + +RE+++++L+ P
Sbjct: 4 KLLKGGLTNRVYLLGT--KDEDYVLKINPSREKG-----ADREREVAILQLLARKGLPVP 56
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGV 136
++ E + ++E+++G L ++ EE +QL + H +
Sbjct: 57 KVLASGES---DGWSYLLMEWIEGETL------DEVSEEEKEDIAEQLAELLAKLHQLPL 107
Query: 137 Y---HRDLKPENLLLDENGNLKVSDFGLSAL 164
H DL P N+L+D+ L + D+ +
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 5e-05
Identities = 17/39 (43%), Positives = 28/39 (71%)
Query: 122 QQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFG 160
+Q+++ + H G+ HRD+KPENLL+ +G +K+ DFG
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 38/146 (26%), Positives = 71/146 (48%), Gaps = 10/146 (6%)
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT-- 180
Q+ ++F S+ HRDL N+LL + +K+ DFGL+ + +D ++ T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA---RDIMHDSNYVSKGSTFL 301
Query: 181 PA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEF- 237
P ++APE + Y SD+WS G++L+ + S G P+ + + K+ Y
Sbjct: 302 PVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
Query: 238 -PPWISCDARRLISRILVADPQKRIS 262
P + + ++ + ++P+KR S
Sbjct: 361 KPDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
++++ +LG+GTF KV + +E A+K++ V K K EI M V+
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR--NVPK--YTRDAKIEIQFMEKVRQ 184
Query: 76 PNIVELKEVMATKTKVFF-------VIEYVKGGE-LFAKVLK-GKLKEESARKYFQQLIS 126
+ + +M K + +F I K G L ++K G + Q
Sbjct: 185 ADPADRFPLM--KIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGV 242
Query: 127 AVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALP----------------EQLW 169
A+D+ H+ + H DLKPEN+L+ E + V ALP E+
Sbjct: 243 ALDYFHTELHLMHTDLKPENILM-ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS 301
Query: 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFL 216
++ T+ Y +PEV+ G+ +D+WS G +++ L +G L
Sbjct: 302 RTAIVSTR----HYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKL 343
|
Length = 467 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG--LLHTQCGT 180
Q+ + F S+ HRDL N+LL K+ DFGL+ + ND ++
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIRNDSNYVVKGNARL 278
Query: 181 PA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEF- 237
P ++APE + Y +SD+WS G++L+ + S G P+ + + K+ K Y
Sbjct: 279 PVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337
Query: 238 -PPWISCDARRLISRILVADPQKRISVSEIM 267
P + ++ ADP KR + +I+
Sbjct: 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQ--IKREISVMRLVKHPNIVEL 81
+G G F KV + + T VA +V+ K+ EQ ++ R+++HPNI++
Sbjct: 3 IGNGWFGKVLLSE-IYTDTGVA-RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQ-----LISAVDFCHSRGV 136
V EY + G+L + + + + +++ Q + + V H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL--HTQCGTPAYVAPEVL--RKK 192
H DL N L + +KV D+G+ P + D + +C ++APE++
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 193 GYDGAK----SDIWSCGVVLFVLL 212
G A+ S++W+ GV L+ L
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYF--QQLI 125
S+M V H ++ + V ++ V E+V+ G L + K K + A K QQL
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENG-------NLKVSDFGLS--ALPEQLWNDGLLHT 176
SA+ + + + H ++ +N+LL G +K+SD G+S AL + + +
Sbjct: 128 SALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI--- 184
Query: 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLF-VLLSGFLPFQNENIMKMYRKIFKAEY 235
++APE + +D WS G L + G +P + + R ++ ++
Sbjct: 185 -----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYEKKH 238
Query: 236 EFP-PWISC-DARRLISRILVADPQKRISVSEIM 267
P P SC + LIS+ L +P +R S I+
Sbjct: 239 RLPEP--SCKELATLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 33/127 (25%), Positives = 50/127 (39%), Gaps = 30/127 (23%)
Query: 106 KVLKGKLKEESARKYFQQLISAV--DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163
+V L EE I AV + HR K N+LL +G
Sbjct: 8 EVRGRPLNEEE--------IWAVCLQCLGALRELHRQAKSGNILLTWDG----------- 48
Query: 164 LPEQLWNDGLLHTQC-----GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPF 218
L DG + + P ++APEV++ + Y K+DI+S G+ L+ L LP+
Sbjct: 49 ---LLKLDGSVAFKTPEQSRPDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPY 104
Query: 219 QNENIMK 225
E +
Sbjct: 105 NEERELS 111
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 10/150 (6%)
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG--LLHTQCGT 180
Q+ +DF S+ HRD+ N+LL + K+ DFGL+ + ND ++
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA---RDIMNDSNYVVKGNARL 276
Query: 181 PA-YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEF- 237
P ++APE + Y +SD+WS G++L+ + S G P+ + + K+ K Y+
Sbjct: 277 PVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS 335
Query: 238 -PPWISCDARRLISRILVADPQKRISVSEI 266
P + + ++ +P +R + S+I
Sbjct: 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 7e-04
Identities = 18/83 (21%), Positives = 32/83 (38%), Gaps = 4/83 (4%)
Query: 316 FTSKCSSSAIMGKLESLAK--KLNLGVCVKEFKVKMQGKDEGRK--GKLAVTAEVYEVAP 371
S+ S I + + + NL + F + + ++ EVYEV P
Sbjct: 8 IHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIEVYEVGP 67
Query: 372 EVAVVEFSKSAGDTLEYKKFCEE 394
+ +V+F K G T + K +
Sbjct: 68 GLFMVDFKKKTGSTKTFTKLATK 90
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 30/100 (30%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT-- 180
Q+ + ++F S+ HRDL N+L+ E +K+ DFGL+ + D ++ T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA---RDIMRDSNYISKGSTFL 303
Query: 181 P-AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPF 218
P ++APE + Y SD+WS G++L+ + + G P+
Sbjct: 304 PLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.9 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.64 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.63 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.38 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.32 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.25 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.98 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.94 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.92 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.74 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.69 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.67 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 98.65 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.6 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.48 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.45 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.37 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.28 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.26 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.22 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.0 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.0 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.95 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.94 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.93 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.91 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.88 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.82 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.62 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.57 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.46 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.3 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.3 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.25 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.21 | |
| PLN02236 | 344 | choline kinase | 97.13 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.89 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.76 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.73 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.46 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.46 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.34 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.33 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.3 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.12 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.07 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.92 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.6 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-66 Score=479.33 Aligned_cols=262 Identities=42% Similarity=0.743 Sum_probs=236.7
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh----hHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ----GLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
...+.+.|.+.++||+|+||.|.+|..+.||+.||||++++...... .-...+.+|+++|++|+|||||+++++++
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 45688899999999999999999999999999999999998766542 12345789999999999999999999999
Q ss_pred eCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC---CCeEEeecCCC
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN---GNLKVSDFGLS 162 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~---~~~kl~DFGla 162 (414)
.++..||||||+.||+|++++.. +.+.+...+.+++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999999987 789999999999999999999999999999999999999866 57999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCC--CCCccchhhhhhhhhhhhcCCCCCCCchHHH-HHHHHHhcccCCCC
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY--DGAKSDIWSCGVVLFVLLSGFLPFQNENIMK-MYRKIFKAEYEFPP 239 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~~~~ 239 (414)
+..+ +...+.+.||||.|.|||++.+.++ ++.++||||+||+||.+|+|.+||.+..... +.++|.++.+.+-+
T Consensus 327 K~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 327 KVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred hccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 9754 5678899999999999999987653 3457899999999999999999999876655 88899999988743
Q ss_pred --C--CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 240 --W--ISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 240 --~--~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
| +|.++++||.+||..||++|||++|+|+||||+..
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 3 89999999999999999999999999999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-64 Score=488.99 Aligned_cols=260 Identities=39% Similarity=0.703 Sum_probs=247.8
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.+|+.++.||+|||+.||.+++..+|+.||+|++.+.........+.+.+||+|++.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999988888888899999999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
|+|+.++|..+.++ ..++|.+|+.+++||+.||.|||++||+|||||..|+||+++-++||+|||||+.... .....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 99999999988886 7899999999999999999999999999999999999999999999999999997664 34567
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 254 (414)
.+.||||.|+|||++.+.++. ..+||||+||+||.||+|++||+..+..+.+++|...++.+|..+|.++++||++||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 889999999999999998885 8999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCChHHHhcCCccccCCCC
Q 015005 255 ADPQKRISVSEIMINPWFIKGFSK 278 (414)
Q Consensus 255 ~dp~~R~s~~eil~hp~f~~~~~~ 278 (414)
+||.+|||+++||.|+||.+++.+
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcC
Confidence 999999999999999999777643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-63 Score=487.98 Aligned_cols=262 Identities=41% Similarity=0.773 Sum_probs=248.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..-+|-|+++++||.|+.|.|.+|+|..||+.+|||++.+...........+.+||-||+.+.|||++++|++|++..++
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 45688999999999999999999999999999999999987544444567799999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+|+||++||+||+++.. |+++|.++.++|+||+.||.|||..+||||||||+|+|||..+++||+|||+|.+-. +
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~ 164 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV---P 164 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc---C
Confidence 999999999999999886 999999999999999999999999999999999999999999999999999998633 5
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 250 (414)
+..+.+.||+|.|.|||++.|.+|+|.++||||||||||.||+|.+||++.+...++.++..|.+.+|..+|+++++||+
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLR 244 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHH
Confidence 77899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhcccCcCCCCChHHHhcCCccccCC
Q 015005 251 RILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
+||+.||.+|+|.+||++|||+....
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCC
Confidence 99999999999999999999997653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-62 Score=478.58 Aligned_cols=261 Identities=57% Similarity=1.005 Sum_probs=246.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh--hHHHHHHHHHHHHHhCC-CCCccceEEEEEeC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ--GLMEQIKREISVMRLVK-HPNIVELKEVMATK 88 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 88 (414)
....++|++++.||+|+||+|++|.+..+++.||+|++++...... ...+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 3678899999999999999999999999999999998887633311 34567889999999998 99999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC-CCeEEeecCCCcccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN-GNLKVSDFGLSALPE 166 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~-~~~kl~DFGla~~~~ 166 (414)
..+|+|||||.||+|++++.. ++++|.+++.+|+||++||+|||++||+||||||||||+|.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999998 999999999999999999999999999999999999999999 999999999999764
Q ss_pred cccCCCccccccCCCcccCchhhcccC-CCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCC-CHH
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKG-YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWI-SCD 244 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~ 244 (414)
..+....+.||||.|+|||++.+.. |++.++|||||||+||.|++|..||+..+...++.++..+.+.+|.++ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3567889999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 245 ARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+++||++||.+||.+|+|+.+|+.||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-62 Score=449.59 Aligned_cols=259 Identities=37% Similarity=0.718 Sum_probs=241.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.-.+.|++.++||+|+||+|++++.+.|++.||+|+++|.........+.+..|..||..++||.||+++..|+++..+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44678999999999999999999999999999999999998887777889999999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+|+||+.||+|+..+++ +.++|..++.|+.+|+.||.|||++||+||||||||||||.+|+++|+|||+|+..-. .+
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CC
Confidence 99999999999999996 8999999999999999999999999999999999999999999999999999985332 34
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC-CCCCHHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP-PWISCDARRLIS 250 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~s~~~~~li~ 250 (414)
....+.|||+.|||||++.+.+|+ ..+|+||||+++|+|++|.+||.+.+...++++|..+....+ ..++.++++||+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 466778999999999999999997 889999999999999999999999999999999999995554 459999999999
Q ss_pred hhcccCcCCCC----ChHHHhcCCcccc
Q 015005 251 RILVADPQKRI----SVSEIMINPWFIK 274 (414)
Q Consensus 251 ~~L~~dp~~R~----s~~eil~hp~f~~ 274 (414)
++|..||++|. ++.+|.+||||..
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999996 6899999999964
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-61 Score=430.07 Aligned_cols=256 Identities=37% Similarity=0.724 Sum_probs=243.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.-..+|+..++||.|+||.|.+++++.+|..+|+|++++..+-+...++...+|..+|+.+.||+++++++.+.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45678999999999999999999999999999999999998887777889999999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+||||++||+|+.++++ +++++..++.|+.|++.||+|||+++|++|||||||||+|.+|.+||+|||+|+.. .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-----~ 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-----S 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe-----c
Confidence 99999999999999998 99999999999999999999999999999999999999999999999999999853 3
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 251 (414)
+...+.||||.|+|||++..++|. .++|+|||||++|||++|.+||...+...+|++|..++..+|+.+++++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 347899999999999999999996 8899999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCC-----ChHHHhcCCcccc
Q 015005 252 ILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 252 ~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
+|+.|-.+|. ...+|.+||||..
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999995 5789999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-59 Score=451.48 Aligned_cols=262 Identities=34% Similarity=0.648 Sum_probs=243.2
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 90 (414)
.--..+|..++.||+|+|++|++|+++.+++.||||++.|..+..+.-++.+.+|-.+|.+| .||+|++|+..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 33456899999999999999999999999999999999999888777788899999999999 89999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+|+||+++|+|.++|.+ |.|++..++.|+.||+.||+|||++||+||||||||||||.++++||+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999999999998 999999999999999999999999999999999999999999999999999998765322
Q ss_pred CC-------C----ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC
Q 015005 170 ND-------G----LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP 238 (414)
Q Consensus 170 ~~-------~----~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 238 (414)
.. . ...+.+||..|++||++..... +..+|||+||||||+|++|.+||.+.+....+++|+.-.+.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 11 1 1245789999999999987655 5899999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+.+++.+++||+++|..||.+|+|+.||.+||||..
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 999999999999999999999999999999999954
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-58 Score=424.58 Aligned_cols=255 Identities=30% Similarity=0.506 Sum_probs=231.8
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-EEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT-KVF 92 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~ 92 (414)
.....+.++.||+|+.|+||+++|+.|++.+|+|++.... ++...+++.+|+++++.++||+||.+|+.|..+. .++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 3457888999999999999999999999999999994332 3445789999999999999999999999999999 599
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+||||.||+|.+.+.. ++++|.....++.+++.||.|||+ ++|+||||||+|||++..|.+||||||.|.....
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--- 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--- 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---
Confidence 99999999999999887 899999999999999999999995 9999999999999999999999999999986543
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc-----hHHHHHHHHHhccc-CCCCC-CCH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE-----NIMKMYRKIFKAEY-EFPPW-ISC 243 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~~-~~~~~-~s~ 243 (414)
....+..||..|||||.+.+..|. .++||||||+.++|+++|+.||... +..+++..|..+.+ ..|.. +|+
T Consensus 232 -S~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 232 -SIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred -hhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 267889999999999999999886 8899999999999999999999875 66788888888654 56765 999
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++++||..||++||.+|||+.|+++|||+++.
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 99999999999999999999999999999764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-57 Score=438.21 Aligned_cols=261 Identities=34% Similarity=0.643 Sum_probs=236.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
.+-.++|++++.||+||||.||+|+.+.||+.+|+|+++|......+.++.++.|-.+|....+|+||++|..|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34578999999999999999999999999999999999999888777889999999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc---
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ--- 167 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~--- 167 (414)
||||||++||++..++.+ +.++|..++.|+.+++.|++.||+.|++||||||+|+|||..|++||+|||||+-...
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999999999999987 8999999999999999999999999999999999999999999999999999863211
Q ss_pred -----------------ccCCC-------------------------ccccccCCCcccCchhhcccCCCCCccchhhhh
Q 015005 168 -----------------LWNDG-------------------------LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCG 205 (414)
Q Consensus 168 -----------------~~~~~-------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlG 205 (414)
...+. .....+|||.|||||++.+.+|. ..+|+||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHH
Confidence 00000 11245799999999999999985 899999999
Q ss_pred hhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCCCCC--CCHHHHHHHHhhcccCcCCCCC---hHHHhcCCcccc
Q 015005 206 VVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFPPW--ISCDARRLISRILVADPQKRIS---VSEIMINPWFIK 274 (414)
Q Consensus 206 vil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~--~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~f~~ 274 (414)
||+||||.|.+||.++++.+.+++|..-. ..+|.. +++++++||.+||. ||.+|.. ++||.+||||..
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 99999999999999999999999998765 566654 78999999999999 9999984 899999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-57 Score=423.79 Aligned_cols=259 Identities=37% Similarity=0.676 Sum_probs=237.0
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
-..++|.+.+.||+|+||+||+|+++.++..||||.+.+.... ....+.+..|+.+|+.++|||||.+++++++++.+|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 3578899999999999999999999999999999999988653 345678899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC------CCeEEeecCCCccc
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN------GNLKVSDFGLSALP 165 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~------~~~kl~DFGla~~~ 165 (414)
+|||||.||+|.+++.+ +.++|..++.++.||+.||++||+++|+||||||+||||+.+ -.+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999999998 799999999999999999999999999999999999999865 45999999999976
Q ss_pred ccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC---CCCCCC
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE---FPPWIS 242 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s 242 (414)
. ......+.||||.|||||++....|+ .|+|+||+|+|||+|++|+.||+..+..+++..+.+++.. .|.+++
T Consensus 166 ~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 166 Q---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred C---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 5 46778899999999999999988997 8999999999999999999999999999999888776643 345688
Q ss_pred HHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 243 CDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
....+|+...|..||..|.+..+-+.|++.....
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8889999999999999999999999999986543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-58 Score=428.39 Aligned_cols=264 Identities=39% Similarity=0.743 Sum_probs=248.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.+..+|++.++||+|.||+|.+|.....|+.||||.+.++.+.++..+-.+++||+||..|+||||+++|++|++.+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 45568999999999999999999999999999999999999998888889999999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
|||||..||+|++++.. +.++|.+++.+|+||++|+.|||.++++|||||.+|||+|.|+++||+|||++-++. ..
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---cc
Confidence 99999999999999997 899999999999999999999999999999999999999999999999999998765 46
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 251 (414)
..+.+.||+|.|.+||++.+.+|.++.+|-|||||+||.|+.|..||++.+...+.++|..+.|.-|. -+.++.-||+.
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRw 285 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRW 285 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHH
Confidence 67899999999999999999999999999999999999999999999999999999999999988776 56678999999
Q ss_pred hcccCcCCCCChHHHhcCCccccCCCCCc
Q 015005 252 ILVADPQKRISVSEIMINPWFIKGFSKPV 280 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f~~~~~~~~ 280 (414)
||..||++|.|+.+|-.|=|+.=++..+.
T Consensus 286 mLmVNP~RRATieDiAsHWWvNwgy~~~V 314 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWVNWGYNMPV 314 (668)
T ss_pred HHhcCcccchhHHHHhhhheeeccccccc
Confidence 99999999999999999988866655543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-56 Score=440.64 Aligned_cols=261 Identities=33% Similarity=0.620 Sum_probs=245.7
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 89 (414)
+..-.++|++.++||+|+||+|++|..+.+++.||||+++|..+-....++..+.|.+|+... +||.+++++..|++++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 355678999999999999999999999999999999999999988777899999999999988 5999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
++|+||||+.||++..++..+.+++..++.|+..++.||+|||++||+|||||.+|||||.+|++||+|||+++. ..+
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe--~m~ 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE--GMG 520 (694)
T ss_pred eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc--cCC
Confidence 999999999999977666679999999999999999999999999999999999999999999999999999984 233
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
.+....+.||||.|||||++.+..|+ .++|+|||||+||+||.|+.||.+++.++++..|...++.+|.|+|.++.+++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence 56688999999999999999999996 89999999999999999999999999999999999999999999999999999
Q ss_pred HhhcccCcCCCCC-----hHHHhcCCcccc
Q 015005 250 SRILVADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 250 ~~~L~~dp~~R~s-----~~eil~hp~f~~ 274 (414)
+++|.+||++|.. +.+|.+||||+.
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999995 588999999975
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-58 Score=399.42 Aligned_cols=259 Identities=36% Similarity=0.707 Sum_probs=236.7
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..+-+.|++.+.||+|+|+.||++.+..||+.+|+|+++....... ..+.+.+|++|-+.|+||||+++++.+.+....
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 3566789999999999999999999999999999999987776544 467899999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC---CCCeEEeecCCCccccc
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---NGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 167 (414)
|+|+|++.|++|+.-|.+ --++|..+-.+++||+.||.|||.+||+|||+||+|+|+.. ..-+||+|||+|...+
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999999999877665 67899999999999999999999999999999999999963 3479999999998544
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC----CCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP----WISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~ 243 (414)
.........|||.|||||++...+|. .++|||++|||||.||.|.+||.+++...+|+.|..+.+.+|+ .+++
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence 45567788899999999999999885 8899999999999999999999999999999999999988765 3899
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++++||++||..||.+|+|+.|.|+|||+.+.
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 99999999999999999999999999999754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-56 Score=419.15 Aligned_cols=269 Identities=36% Similarity=0.662 Sum_probs=237.6
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh-----------hHHHHHHHHHHHHHhCCCCCcc
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ-----------GLMEQIKREISVMRLVKHPNIV 79 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~Ei~il~~l~hpnIv 79 (414)
+...++.|++.+.||+|.||+|.+|++..+++.||||++++...... .-.+++++||.+|++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 44677899999999999999999999999999999999987654321 1146899999999999999999
Q ss_pred ceEEEEEeC--CEEEEEEEccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEE
Q 015005 80 ELKEVMATK--TKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV 156 (414)
Q Consensus 80 ~l~~~~~~~--~~~~lv~E~~~gg~L~~~i~~~~-~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl 156 (414)
+|+++..++ +.+|||+|||..|.+...-.... +++.+|++|++.++.||+|||.+||+||||||.|+||+.+|++||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 999999765 68999999999999865554555 999999999999999999999999999999999999999999999
Q ss_pred eecCCCcccccc---cCCCccccccCCCcccCchhhcc---cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHH
Q 015005 157 SDFGLSALPEQL---WNDGLLHTQCGTPAYVAPEVLRK---KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI 230 (414)
Q Consensus 157 ~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i 230 (414)
+|||.+...... ..+..+....|||.|+|||.+.+ ..|.+.+.||||+||+||.|+.|++||.++...+++.+|
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 999998755221 22334556889999999999877 457788999999999999999999999999999999999
Q ss_pred HhcccCCCCC--CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCCCCC
Q 015005 231 FKAEYEFPPW--ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279 (414)
Q Consensus 231 ~~~~~~~~~~--~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~~~ 279 (414)
.+....+|.. +..++++||.+||++||++|+++.+|..|||..+....+
T Consensus 332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 9999888865 799999999999999999999999999999998775543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=385.03 Aligned_cols=260 Identities=36% Similarity=0.701 Sum_probs=246.1
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
....-.++|++++.||+|-||.||+|+.+.++-.||+|++.++.+...+...++.+|++|...|+||||+++|++|.+..
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 35567889999999999999999999999999999999999999888778899999999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
.+|+++||+++|+|+..+.. .++++..+..|+.|++.||.|||.++|+||||||+|+|++..|.+||+|||-+...
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~- 174 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA- 174 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec-
Confidence 99999999999999999983 56999999999999999999999999999999999999999999999999998743
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHH
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDAR 246 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 246 (414)
+.+.-.+.|||..|.|||...+.+++ ..+|+|++|++.|+++.|..||...+..+.|++|.+.++.+|+.++.++.
T Consensus 175 ---p~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~ 250 (281)
T KOG0580|consen 175 ---PSNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAA 250 (281)
T ss_pred ---CCCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHH
Confidence 24556788999999999999999997 78999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 247 RLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+||.+||..+|.+|.+..|++.|||...
T Consensus 251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 251 DLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-56 Score=397.61 Aligned_cols=249 Identities=32% Similarity=0.583 Sum_probs=223.6
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEE-EE-EeC
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE-VM-ATK 88 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~-~~~ 88 (414)
+..-...|++.+.||+|+||+||++++..+|+.+|.|.+.-.... ....+++..|+.+|++|+|||||++++ .+ ++.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 344556799999999999999999999999999999999855544 345678899999999999999999998 34 444
Q ss_pred CEEEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--CC--cEEecCCCCcEEEcCCCCeEEeec
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHS--RG--VYHRDLKPENLLLDENGNLKVSDF 159 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~--~g--i~HrDlkp~NILl~~~~~~kl~DF 159 (414)
..++||||||.+|+|...|.. ..++|..++++|.|++.||.+||+ .. |.||||||.||+|+.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 559999999999999988864 469999999999999999999999 44 999999999999999999999999
Q ss_pred CCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-CC
Q 015005 160 GLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FP 238 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~ 238 (414)
|+++.+.. .....++.+|||.||+||++.+.+|+ .++||||+||++|||+.-+.||.+.+..++.++|..++++ .|
T Consensus 173 GL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 173 GLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 99998765 34566788999999999999999997 8999999999999999999999999999999999999886 67
Q ss_pred -CCCCHHHHHHHHhhcccCcCCCCCh
Q 015005 239 -PWISCDARRLISRILVADPQKRISV 263 (414)
Q Consensus 239 -~~~s~~~~~li~~~L~~dp~~R~s~ 263 (414)
..+|.++..||..|+.+||+.||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 5689999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-54 Score=402.83 Aligned_cols=259 Identities=31% Similarity=0.553 Sum_probs=220.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC--EEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT--KVF 92 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 92 (414)
.-+|..++.||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 345889999999999999999999999999999997763222 577899999999999999999999854444 799
Q ss_pred EEEEccCCCchHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC-CCCeEEeecCCCccccc-c
Q 015005 93 FVIEYVKGGELFAKVLK-G-KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-NGNLKVSDFGLSALPEQ-L 168 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~-~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-~~~~kl~DFGla~~~~~-~ 168 (414)
+.|||++||+|.+.+.+ + +++|..++.+.+|++.||.|||++||+||||||+|||++. ++.+||+|||++..... .
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999999998 4 7999999999999999999999999999999999999999 79999999999986553 1
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC-chHHHHHHHHH-hc-ccCCCCCCCHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIF-KA-EYEFPPWISCDA 245 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~-~~-~~~~~~~~s~~~ 245 (414)
..........|||.|||||++......+.++||||+||++.+|+||..||.. .......-.+. .. .+.+|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1222344677999999999998633333589999999999999999999987 33333333333 33 357889999999
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 246 RRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
++||.+|+..||++|||+.++|+|||.....
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999999999999999987654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-53 Score=411.62 Aligned_cols=261 Identities=40% Similarity=0.758 Sum_probs=239.9
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCC
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKT 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 89 (414)
...+...|++.+.||+|.||.||+++++.||+.+|+|++.+.........+.+.+|+++|+++. |||||.+++++++.+
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 4556778999999999999999999999999999999999988765545678999999999998 999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC----CCeEEeecCCCccc
Q 015005 90 KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN----GNLKVSDFGLSALP 165 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~----~~~kl~DFGla~~~ 165 (414)
.+|+|||+|.||+|++.+.+..++|..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|||++...
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999987559999999999999999999999999999999999999743 47999999999865
Q ss_pred ccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC--CC--C
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP--PW--I 241 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~--~ 241 (414)
.. .......||||.|+|||++...+|. ..+||||+||++|.|++|..||.+.+....+.++..+++.++ .| +
T Consensus 190 ~~---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 190 KP---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred cC---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence 43 5678899999999999999988885 899999999999999999999999999999999999988664 33 7
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+..++++|++||..||.+|+|+.++|+|||+...
T Consensus 266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999999999999999998754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=416.25 Aligned_cols=257 Identities=35% Similarity=0.655 Sum_probs=240.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.|....+ ...+.+.+|++|++.++|||||.++++|++..++++|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 468999999999999999999999999999999998865443 3467899999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
.|||.| +|+.++.. +.++|+.++.+..|+++||.|||+++|.|||+||.|||++.+|.+|+||||+|+.+.. +...
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999987 99999997 8999999999999999999999999999999999999999999999999999997664 4556
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRIL 253 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 253 (414)
.....|||.|||||++.+.+|+ ..+|+||||||+||+++|++||...+..++.+.|.......|+..|..+.+|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6777899999999999999997 889999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCChHHHhcCCccccCC
Q 015005 254 VADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 254 ~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.+||.+|.|..+++.|||.....
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999986553
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-53 Score=408.84 Aligned_cols=259 Identities=36% Similarity=0.697 Sum_probs=236.2
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
......++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 34556789999999999999999999999999999999998765444444677899999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.+|+||||++||+|.+.+.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 170 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD- 170 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence 99999999999999999887 7899999999999999999999999999999999999999999999999999975432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRL 248 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 248 (414)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+..+...+|.+++..+++|
T Consensus 171 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 245 (329)
T PTZ00263 171 ----RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDL 245 (329)
T ss_pred ----CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHH
Confidence 22356899999999999888775 8999999999999999999999998888888999989999999999999999
Q ss_pred HHhhcccCcCCCCC-----hHHHhcCCcccc
Q 015005 249 ISRILVADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 249 i~~~L~~dp~~R~s-----~~eil~hp~f~~ 274 (414)
|++||+.||.+|++ ++++++||||..
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999999997 799999999975
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=387.84 Aligned_cols=255 Identities=31% Similarity=0.481 Sum_probs=219.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|+.+..+|+|+||+||+++++.||+.||||.+..+. +++...+-..|||++|++++|||+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 468999999999999999999999999999999995443 3344456678999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
+|||+..-|..+-.. .++++..++.|+.|++.|+.|||+++++||||||||||++.+|.+||||||+|+.... +...
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~ 157 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN 157 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence 999987666544443 7899999999999999999999999999999999999999999999999999997654 3334
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh--------------ccc----
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------------AEY---- 235 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------~~~---- 235 (414)
-...+.|.+|.|||.+.+...+|.++||||+||++.||++|.+.|.+.+.-++...|.. .+.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 45677899999999999865557999999999999999999999999877655544332 111
Q ss_pred -CCC------------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 236 -EFP------------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 236 -~~~------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.+| +.++.-+.+|+++||+.||.+|++.+|++.||||
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 111 2367788999999999999999999999999999
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-54 Score=408.61 Aligned_cols=261 Identities=40% Similarity=0.718 Sum_probs=244.4
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
-+.|-|.+.++||+|-|+.|.+|++..||+.||||++++.+...- ...++..|++.|+.++|||||++|++..+...+|
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 356789999999999999999999999999999999999887643 3467889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc-CCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD-ENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+|+-.||+|+++|.+ .++.|+.+++||.||+.|+.|||+..++||||||+|+.+- .-|-+||+|||++-.+.
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--- 170 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--- 170 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC---
Confidence 99999999999999997 6899999999999999999999999999999999998775 56899999999998655
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
++..+.+.||+..|-|||++.+..|+.+++||||||||||-|++|++||...+..+....|+...|..|..+|.++++||
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHH
Confidence 35678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 250 SRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
.+||..||++|.+.+||..++|++..-.
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHhcCchhhccHHHHhccccccCCCC
Confidence 9999999999999999999999976543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-53 Score=394.96 Aligned_cols=263 Identities=31% Similarity=0.523 Sum_probs=236.6
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
+.+-...|++++.||.|.-|+||+|+...++..+|+|++++..........++..|-+||..++||.++.+|..+++...
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 34456689999999999999999999999999999999999888776677889999999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
.|++||||+||+|....++ ..+++..++.|+.+++.||+|||-.||++||||||||||.++|++-|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999988876 4699999999999999999999999999999999999999999999999999743110
Q ss_pred ---------------------------------ccC---------------------CCccccccCCCcccCchhhcccC
Q 015005 168 ---------------------------------LWN---------------------DGLLHTQCGTPAYVAPEVLRKKG 193 (414)
Q Consensus 168 ---------------------------------~~~---------------------~~~~~~~~gt~~y~APE~~~~~~ 193 (414)
... +......+||-.|+|||++.|.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 01123446999999999999999
Q ss_pred CCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC--CCCHHHHHHHHhhcccCcCCCCC----hHHHh
Q 015005 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP--WISCDARRLISRILVADPQKRIS----VSEIM 267 (414)
Q Consensus 194 ~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~li~~~L~~dp~~R~s----~~eil 267 (414)
+. .++|+|+|||+|||||.|.+||.+.+..+.+.+++.....+|. .++..+++||+++|.+||++|.. +.||.
T Consensus 312 Hg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 312 HG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 85 8999999999999999999999999999999999999988885 47899999999999999999998 99999
Q ss_pred cCCcccc
Q 015005 268 INPWFIK 274 (414)
Q Consensus 268 ~hp~f~~ 274 (414)
+||||..
T Consensus 391 ~HpFF~g 397 (459)
T KOG0610|consen 391 RHPFFEG 397 (459)
T ss_pred cCccccC
Confidence 9999965
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-54 Score=382.15 Aligned_cols=260 Identities=39% Similarity=0.728 Sum_probs=234.7
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc-----hhhHHHHHHHHHHHHHhC-CCCCccceEEE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-----KQGLMEQIKREISVMRLV-KHPNIVELKEV 84 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 84 (414)
.+-+..+|+..+.||.|..++|.++.++.+|+.+|+|++...... .....+.-.+|+.||+++ .||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 345677899999999999999999999999999999999753322 223456678999999998 69999999999
Q ss_pred EEeCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 85 MATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
|+++..+++|.|.|+.|+|+|++.. -.++|.+++.+++|++.|+.|||.++|+||||||+|||+|++-++||+|||+|+
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 9999999999999999999999998 789999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCcccCchhhcc------cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCC
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRK------KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF 237 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (414)
..+ .+..+...||||+|.|||.+.. .+| +..+|+||||||+|.||.|.+||......-+.+.|..+++.+
T Consensus 172 ~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF 247 (411)
T KOG0599|consen 172 QLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF 247 (411)
T ss_pred ccC---CchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence 655 4567788999999999999863 345 478999999999999999999999988888999999999876
Q ss_pred --CCC--CCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 238 --PPW--ISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 238 --~~~--~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
|.| +|.++++||++||+.||.+|+|+.|+|+||||..
T Consensus 248 ~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 248 RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 455 7999999999999999999999999999999953
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=398.90 Aligned_cols=253 Identities=32% Similarity=0.635 Sum_probs=230.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997655433334567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 99999999999876 7899999999999999999999999999999999999999999999999999875432 22
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 254 (414)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+..+...+|..+++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 345799999999999888775 8899999999999999999999999888889999989889999999999999999999
Q ss_pred cCcCCCCC-----hHHHhcCCcccc
Q 015005 255 ADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 255 ~dp~~R~s-----~~eil~hp~f~~ 274 (414)
.||.+||+ ++++++||||..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=402.18 Aligned_cols=250 Identities=36% Similarity=0.643 Sum_probs=226.6
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (414)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444567789999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCC
Q 015005 102 ELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180 (414)
Q Consensus 102 ~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 180 (414)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 99998876 7899999999999999999999999999999999999999999999999999874221 22334556899
Q ss_pred CcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCC
Q 015005 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260 (414)
Q Consensus 181 ~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 260 (414)
+.|+|||++.+..+. .++||||+||++|+|++|..||...+....+..+......+|..+++++.+||++||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999888775 8999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----ChHHHhcCCcccc
Q 015005 261 I-----SVSEIMINPWFIK 274 (414)
Q Consensus 261 ~-----s~~eil~hp~f~~ 274 (414)
| ++.++++||||..
T Consensus 238 ~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=403.35 Aligned_cols=259 Identities=34% Similarity=0.554 Sum_probs=226.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCC-
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKT- 89 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~- 89 (414)
..++++|.+.+.||.|+||.||+|+...+|+.||||.+.++...-++. .-.||+..|++++ |||||++.+++.+.+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 467889999999999999999999999999999999997665442211 2358999999998 999999999998888
Q ss_pred EEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
.+|+|||||+ ..|++++.. ..|++..++.|+.||++||+|+|++|+.|||+||||||+..+..+||+|||+|+...
T Consensus 84 ~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~- 161 (538)
T KOG0661|consen 84 ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR- 161 (538)
T ss_pred eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc-
Confidence 9999999996 589898886 579999999999999999999999999999999999999999999999999999544
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh---------------
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------------- 232 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------- 232 (414)
...+....+.|.+|.|||++...++++.+.|+||+|||++|+.+-++.|.+.+..+...+|+.
T Consensus 162 --SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 --SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred --cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 345566778999999999999999888999999999999999999999999888777666543
Q ss_pred ----cccCCC-----------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 233 ----AEYEFP-----------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 233 ----~~~~~~-----------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
-++.+| +..+.++.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 122232 23688999999999999999999999999999997654
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=401.79 Aligned_cols=258 Identities=29% Similarity=0.591 Sum_probs=233.5
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCC-eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQ-ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
...-.++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4556778999999999999999999876654 789999998765544445677889999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.+|+||||++||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 99999999999999999986 6899999999999999999999999999999999999999999999999999975432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRL 248 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 248 (414)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+..+...+|..+++++.++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 23456799999999999887775 8999999999999999999999999888889999988888999999999999
Q ss_pred HHhhcccCcCCCC-----ChHHHhcCCcccc
Q 015005 249 ISRILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 249 i~~~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
|++||+.||.+|+ +++++++||||..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999996 8999999999975
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=409.66 Aligned_cols=262 Identities=41% Similarity=0.798 Sum_probs=247.6
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
....+.|.+.++||+|.|++|.+|++..++..||||++++....... .+.+.+|+++|+.++|||||+++.+.+....+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 45688999999999999999999999999999999999998876543 34589999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+||||+.||++++++.+ +++.+..++.+|.|+++|++|||+++|+|||||++||||+.+-++||+|||++..+. .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 999999999999999998 899999999999999999999999999999999999999999999999999999766 4
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 250 (414)
.....+.||+|.|.|||++.+..|+++++|+||+|++||.|++|.+||++.+..++..+.+.+.+.+|-.++.+..+||+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 66789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhcccCcCCCCChHHHhcCCccccCCC
Q 015005 251 RILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
++|.++|.+|+++++++.|.|......
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhh
Confidence 999999999999999999999865543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=395.06 Aligned_cols=249 Identities=37% Similarity=0.653 Sum_probs=225.2
Q ss_pred eeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCch
Q 015005 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL 103 (414)
Q Consensus 24 LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 103 (414)
||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++.+.+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999865544444456788999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCc
Q 015005 104 FAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182 (414)
Q Consensus 104 ~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 182 (414)
.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 999876 7899999999999999999999999999999999999999999999999999875322 1223445679999
Q ss_pred ccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCCC-
Q 015005 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRI- 261 (414)
Q Consensus 183 y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~- 261 (414)
|+|||++.+..++ .++||||+||++|+|++|..||.+.+..+.+..+......+|..+++++.+||.+||+.||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999888775 78999999999999999999999998888899998888889999999999999999999999997
Q ss_pred --ChHHHhcCCccccC
Q 015005 262 --SVSEIMINPWFIKG 275 (414)
Q Consensus 262 --s~~eil~hp~f~~~ 275 (414)
++.|+++||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999763
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-52 Score=394.87 Aligned_cols=259 Identities=32% Similarity=0.553 Sum_probs=226.4
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK--TKV 91 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 91 (414)
..+.|+.++.||+|+||.||+|++..+|+.||+|.+..+... ++...-..|||.||++|+||||+++.+...+. +.+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 356789999999999999999999999999999999877644 34566788999999999999999999998876 789
Q ss_pred EEEEEccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLKG--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+|+|||+. +|.-++... .|++.+++.|++||+.||+|||++||+|||||..|||||.+|++||+|||||+++...
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~- 271 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS- 271 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC-
Confidence 999999975 776777763 7999999999999999999999999999999999999999999999999999977653
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--c--------cCCC-
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--E--------YEFP- 238 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~--------~~~~- 238 (414)
........+-|.+|.|||++.|..-++.++|+||+||||.||++|++.|.+.+..++..+|++- . ..+|
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3334667778999999999998876679999999999999999999999999988888777641 0 0111
Q ss_pred ------------------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 239 ------------------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 239 ------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..++..+.+|+..||..||.+|.|+.++|.++||...
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 1367889999999999999999999999999999544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-52 Score=365.69 Aligned_cols=256 Identities=33% Similarity=0.550 Sum_probs=224.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.+|...+.||+|.||.||+|++..||+.||||.+......+ +......|||+.|+.++||||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 57999999999999999999999999999999998775543 34456789999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||++ .+|...++. -.++..+++.|+.+++.||+|||++.|.||||||+|+|++++|.+||+|||+|+.+.... ..
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~--~~ 157 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN--RI 157 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC--cc
Confidence 9997 689888886 469999999999999999999999999999999999999999999999999999876532 22
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--------------------
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-------------------- 233 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------- 233 (414)
....+-|..|.|||.+.|...++..+|+||.|||+.||+-|.+-|.+.+.-++...|+..
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 333478999999999998876779999999999999999999999998887777666541
Q ss_pred --ccCCC------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 --EYEFP------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 --~~~~~------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.++.| +..+.++.+|+.+||..||.+|+|+.|+|+|+||...
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 01111 2257789999999999999999999999999999874
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=395.26 Aligned_cols=250 Identities=36% Similarity=0.671 Sum_probs=225.6
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (414)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445667889999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCC
Q 015005 102 ELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180 (414)
Q Consensus 102 ~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 180 (414)
+|.+.+.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 99988876 6799999999999999999999999999999999999999999999999999874321 12233456899
Q ss_pred CcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCC
Q 015005 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260 (414)
Q Consensus 181 ~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 260 (414)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||++||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 999999999887775 8999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----ChHHHhcCCcccc
Q 015005 261 I-----SVSEIMINPWFIK 274 (414)
Q Consensus 261 ~-----s~~eil~hp~f~~ 274 (414)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-51 Score=399.53 Aligned_cols=257 Identities=31% Similarity=0.566 Sum_probs=223.3
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544445677889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC----
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN---- 170 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 170 (414)
||++||+|.+++.+ +.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999976 7899999999999999999999999999999999999999999999999999875321100
Q ss_pred -----------------------------CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc
Q 015005 171 -----------------------------DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE 221 (414)
Q Consensus 171 -----------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 221 (414)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012345899999999999888886 7999999999999999999999998
Q ss_pred hHHHHHHHHHhc--ccCCCCC--CCHHHHHHHHhhcccCcC---CCCChHHHhcCCcccc
Q 015005 222 NIMKMYRKIFKA--EYEFPPW--ISCDARRLISRILVADPQ---KRISVSEIMINPWFIK 274 (414)
Q Consensus 222 ~~~~~~~~i~~~--~~~~~~~--~s~~~~~li~~~L~~dp~---~R~s~~eil~hp~f~~ 274 (414)
+..+.+.++... ...+|+. +++++++||.+|+. +|. .||+++||++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 888888887753 3445543 78999999999775 444 4689999999999965
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-51 Score=384.20 Aligned_cols=263 Identities=32% Similarity=0.545 Sum_probs=231.6
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
..+-.+.|++...||.|..++||+|+...+++.||||+++.++..+. .+.+.+|++.|+.++||||++++..|..+..
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 34556789999999999999999999999999999999998887654 7899999999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
+|+||.||.+|++.+.+.. ..++|..+..++++++.||.|||.+|-+|||||+.||||+.+|.+||+|||.+..+-.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999999986 5799999999999999999999999999999999999999999999999999875433
Q ss_pred ccCCC--ccccccCCCcccCchhhc--ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC----
Q 015005 168 LWNDG--LLHTQCGTPAYVAPEVLR--KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP---- 239 (414)
Q Consensus 168 ~~~~~--~~~~~~gt~~y~APE~~~--~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~---- 239 (414)
.+... ...+..|||+|||||++. ..+|+ .|+||||||++..||.+|..||..-.+.++.-.-+.+.++.+.
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL 257 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC
Confidence 22211 115668999999999954 34676 8999999999999999999999988877766666666665332
Q ss_pred ------CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 240 ------WISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 240 ------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.++..++.+|..||+.||.+|||++++|+|+||++..
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 2677899999999999999999999999999998754
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-51 Score=393.17 Aligned_cols=254 Identities=30% Similarity=0.551 Sum_probs=227.5
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHH---HhCCCCCccceEEEEEeCCEEEEE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM---RLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999876544334456677777765 456799999999999999999999
Q ss_pred EEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 95 IEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
|||++||+|...+..+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcc
Confidence 9999999999988888999999999999999999999999999999999999999999999999999874322 22234
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 254 (414)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+....+......+|..++.++.++|++||+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999887775 8899999999999999999999999888888888888888999999999999999999
Q ss_pred cCcCCCC-----ChHHHhcCCcccc
Q 015005 255 ADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 255 ~dp~~R~-----s~~eil~hp~f~~ 274 (414)
.||.+|| ++.++++||||.+
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999 6999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-51 Score=392.97 Aligned_cols=250 Identities=35% Similarity=0.658 Sum_probs=225.4
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (414)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444567788999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCC
Q 015005 102 ELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180 (414)
Q Consensus 102 ~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 180 (414)
+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 99988876 6799999999999999999999999999999999999999999999999999874221 12233456799
Q ss_pred CcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCC
Q 015005 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260 (414)
Q Consensus 181 ~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 260 (414)
+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+......+|..+++++.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999887775 8899999999999999999999998888888888888888899999999999999999999999
Q ss_pred C-----ChHHHhcCCcccc
Q 015005 261 I-----SVSEIMINPWFIK 274 (414)
Q Consensus 261 ~-----s~~eil~hp~f~~ 274 (414)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=379.61 Aligned_cols=261 Identities=35% Similarity=0.639 Sum_probs=244.0
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
..+-+++|..+++||+|.||+|.+++.+.+++.||+|+++++.+-....+..-..|-++|+..+||.+..+...|+..++
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 34568899999999999999999999999999999999999887766667778889999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+||||+.||+|+-.+.+ ..++|..++.|-..|++||.|||+++|++||||.+|+|+|.+|++||+|||+++. ...
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~ 320 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIK 320 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--ccc
Confidence 9999999999999988887 7899999999999999999999999999999999999999999999999999984 223
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
......+.||||.|.|||++....|. .++|+|.+||++|+|++|++||...+...++.-|...+..+|..++++++.|+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred ccceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHH
Confidence 45578899999999999999998885 89999999999999999999999999999999999999999999999999999
Q ss_pred HhhcccCcCCCC-----ChHHHhcCCcccc
Q 015005 250 SRILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 250 ~~~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
..+|.+||.+|. .+.||.+|+||..
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 999999999998 4789999999954
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-51 Score=392.00 Aligned_cols=250 Identities=34% Similarity=0.640 Sum_probs=224.9
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444456777888888876 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 999998876 7899999999999999999999999999999999999999999999999999874321 2233445679
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.......|.+++.++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887775 789999999999999999999999999899999998888999999999999999999999999
Q ss_pred CCCh------HHHhcCCcccc
Q 015005 260 RISV------SEIMINPWFIK 274 (414)
Q Consensus 260 R~s~------~eil~hp~f~~ 274 (414)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 89999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=391.60 Aligned_cols=250 Identities=37% Similarity=0.656 Sum_probs=224.9
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (414)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+++++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765544444567788999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 102 ELFAKVLK-GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 102 ~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
+|...+.. +.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 99988876 679999999999999999999997 7999999999999999999999999999874221 2223345679
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999887775 899999999999999999999999888888888888888889999999999999999999999
Q ss_pred CC-----ChHHHhcCCcccc
Q 015005 260 RI-----SVSEIMINPWFIK 274 (414)
Q Consensus 260 R~-----s~~eil~hp~f~~ 274 (414)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=398.72 Aligned_cols=254 Identities=32% Similarity=0.555 Sum_probs=229.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
..+|.....||+|+.|.||.|....+++.||||.++...... .+-+.+|+.+|+..+|+|||++++.|.-.+.+++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 347999999999999999999999999999999998876554 36788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 95 IEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
|||++||+|.|.+....++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|...... ...-
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~~KR 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--QSKR 426 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc--cCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876542 2245
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHH-hccc--CCCCCCCHHHHHHHHh
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF-KAEY--EFPPWISCDARRLISR 251 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~-~~~~--~~~~~~s~~~~~li~~ 251 (414)
.+.+|||+|||||++....|. .++||||||++++||+-|++||-.+++....+.|. ++.+ ..|..+|+.+++|+.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 677899999999999999985 99999999999999999999999777665555554 3433 4577899999999999
Q ss_pred hcccCcCCCCChHHHhcCCcccc
Q 015005 252 ILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
||+.||.+|+++.|+|+||||..
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999954
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=391.65 Aligned_cols=253 Identities=32% Similarity=0.545 Sum_probs=225.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765544444677889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999976 7899999999999999999999999999999999999999999999999999975432 33
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCCCC------CCCHHHH
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFPP------WISCDAR 246 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~------~~s~~~~ 246 (414)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+.... ...|. .++.++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 456799999999999888775 89999999999999999999999988877776665422 22222 3589999
Q ss_pred HHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 247 RLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+||.+||..+|.+||++.++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=390.68 Aligned_cols=250 Identities=34% Similarity=0.632 Sum_probs=225.2
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444456677899998876 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|...+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 999988876 7899999999999999999999999999999999999999999999999999874322 2233445679
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+......+|.+++.++.+||++||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999887775 789999999999999999999999999999999999998999999999999999999999999
Q ss_pred CC-------ChHHHhcCCcccc
Q 015005 260 RI-------SVSEIMINPWFIK 274 (414)
Q Consensus 260 R~-------s~~eil~hp~f~~ 274 (414)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 8999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=389.72 Aligned_cols=255 Identities=31% Similarity=0.583 Sum_probs=228.5
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC-CccceEEEEEeCCEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP-NIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~ 95 (414)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..+.|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 489999999999999999999999999999999876544444456788899999999764 5888999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
||++||+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 99999999998876 7899999999999999999999999999999999999999999999999999864221 22334
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 254 (414)
...+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..+.+..+......+|..++.++.++|++||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 556799999999999888775 7899999999999999999999999888889999888888899999999999999999
Q ss_pred cCcCCCCCh-----HHHhcCCcccc
Q 015005 255 ADPQKRISV-----SEIMINPWFIK 274 (414)
Q Consensus 255 ~dp~~R~s~-----~eil~hp~f~~ 274 (414)
+||.+|+++ +++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999987 89999999965
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=396.21 Aligned_cols=257 Identities=32% Similarity=0.617 Sum_probs=224.0
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC---
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND--- 171 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 171 (414)
||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999876 78999999999999999999999999999999999999999999999999998643211000
Q ss_pred ---------------------------------CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCC
Q 015005 172 ---------------------------------GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPF 218 (414)
Q Consensus 172 ---------------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf 218 (414)
......+||+.|+|||++.+.+++ .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011245799999999999888875 8999999999999999999999
Q ss_pred CCchHHHHHHHHHhcc--cCCCC--CCCHHHHHHHHhhcccCcCCCCC---hHHHhcCCcccc
Q 015005 219 QNENIMKMYRKIFKAE--YEFPP--WISCDARRLISRILVADPQKRIS---VSEIMINPWFIK 274 (414)
Q Consensus 219 ~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~f~~ 274 (414)
...+..+.+..+.... ..+|. .+++++.+||++||. +|.+|++ +.++++||||..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9988877777776543 33444 368999999999997 9999998 999999999965
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=396.55 Aligned_cols=257 Identities=31% Similarity=0.549 Sum_probs=221.0
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987665555556788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC-----
Q 015005 97 YVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN----- 170 (414)
Q Consensus 97 ~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~----- 170 (414)
|++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999877 7799999999999999999999999999999999999999999999999999753211000
Q ss_pred ----------------------------------------CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhh
Q 015005 171 ----------------------------------------DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFV 210 (414)
Q Consensus 171 ----------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ 210 (414)
.....+.+||+.|+|||++.+..++ .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 0012345799999999999888775 88999999999999
Q ss_pred hhcCCCCCCCchHHHHHHHHHh--cccCCCC--CCCHHHHHHHHhhc--ccCcCCCCChHHHhcCCcccc
Q 015005 211 LLSGFLPFQNENIMKMYRKIFK--AEYEFPP--WISCDARRLISRIL--VADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 211 ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~~~~li~~~L--~~dp~~R~s~~eil~hp~f~~ 274 (414)
|++|..||...+......++.. .....|. .+++++.+||.+|| ..+|..|+++.++++||||..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 9999999998877666666553 2344444 47999999999965 455556999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=381.92 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=220.4
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.|++.+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987655443334567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 97 ~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|++||+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 9999999877753 3689999999999999999999999999999999999999999999999999975422 222
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH----HHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM----KMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
.....||+.|+|||++.+..++ .++||||+||++|+|++|..||...... .....+......++..++.++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 3456799999999999888775 7899999999999999999999875432 2333344455567778999999999
Q ss_pred HhhcccCcCCCCC-----hHHHhcCCccccC
Q 015005 250 SRILVADPQKRIS-----VSEIMINPWFIKG 275 (414)
Q Consensus 250 ~~~L~~dp~~R~s-----~~eil~hp~f~~~ 275 (414)
++||+.||.+||+ ++++++||||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999999997 8999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=396.35 Aligned_cols=257 Identities=30% Similarity=0.576 Sum_probs=221.4
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+++++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997765444445677899999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC----
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN---- 170 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 170 (414)
||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999876 7899999999999999999999999999999999999999999999999999863211000
Q ss_pred ---------C--------------------------------CccccccCCCcccCchhhcccCCCCCccchhhhhhhhh
Q 015005 171 ---------D--------------------------------GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLF 209 (414)
Q Consensus 171 ---------~--------------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~ 209 (414)
. ......+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 0 001135799999999999888775 8899999999999
Q ss_pred hhhcCCCCCCCchHHHHHHHHHhc--ccCCCC--CCCHHHHHHHHhhcccCcCCC---CChHHHhcCCcccc
Q 015005 210 VLLSGFLPFQNENIMKMYRKIFKA--EYEFPP--WISCDARRLISRILVADPQKR---ISVSEIMINPWFIK 274 (414)
Q Consensus 210 ~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dp~~R---~s~~eil~hp~f~~ 274 (414)
+|++|..||...+..+.+..+... ...+|. .++.++.+||++||. +|.+| +|+.|++.||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877777777642 344554 378999999999998 77765 59999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=387.06 Aligned_cols=251 Identities=31% Similarity=0.602 Sum_probs=222.6
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||.||+|.+..+|+.||+|++.+..............|..++... +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999876543333345677788888765 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|...+.. +.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 999988876 6899999999999999999999999999999999999999999999999999874221 2233456789
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+......+|.+++.++++||++||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999888775 889999999999999999999999888888888888888889999999999999999999999
Q ss_pred CCCh-HHHhcCCccccC
Q 015005 260 RISV-SEIMINPWFIKG 275 (414)
Q Consensus 260 R~s~-~eil~hp~f~~~ 275 (414)
||++ +++++||||...
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9998 589999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=394.79 Aligned_cols=261 Identities=31% Similarity=0.536 Sum_probs=228.1
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.-.++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999999999999999997654433334556789999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 93 FVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
+||||++||+|.+++....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~-~~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC-Ccc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999998754321 111
Q ss_pred ccccccCCCcccCchhhcccC---CCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCCCC--CCCHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKG---YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFPP--WISCDA 245 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~ 245 (414)
.....+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+....+.++.... ..+|. .+|.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 234567999999999987543 23578999999999999999999999998888888887643 44554 479999
Q ss_pred HHHHHhhcccCcCC--CCChHHHhcCCcccc
Q 015005 246 RRLISRILVADPQK--RISVSEIMINPWFIK 274 (414)
Q Consensus 246 ~~li~~~L~~dp~~--R~s~~eil~hp~f~~ 274 (414)
.+||++||+.+|.+ |+|+.++++||||..
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 99999999999988 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=395.92 Aligned_cols=256 Identities=31% Similarity=0.579 Sum_probs=221.6
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999987655444456788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc------
Q 015005 97 YVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW------ 169 (414)
Q Consensus 97 ~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~------ 169 (414)
||+||+|.+.+.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999999876 779999999999999999999999999999999999999999999999999975321000
Q ss_pred ---------------------------------------CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhh
Q 015005 170 ---------------------------------------NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFV 210 (414)
Q Consensus 170 ---------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ 210 (414)
........+||+.|+|||++.+.+|+ .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHHH
Confidence 00011235799999999999988886 89999999999999
Q ss_pred hhcCCCCCCCchHHHHHHHHHhc--ccCCC--CCCCHHHHHHHHhhcccCcCCCCC---hHHHhcCCcccc
Q 015005 211 LLSGFLPFQNENIMKMYRKIFKA--EYEFP--PWISCDARRLISRILVADPQKRIS---VSEIMINPWFIK 274 (414)
Q Consensus 211 ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~f~~ 274 (414)
|++|..||...+..+...++... ....| ..+++++.+||.+|+ .||.+|++ +.++++||||..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 99999999988777666666543 23344 357999999999987 59999997 999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=392.28 Aligned_cols=257 Identities=34% Similarity=0.652 Sum_probs=227.6
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544445677889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc-----
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW----- 169 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----- 169 (414)
||++|++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999887 689999999999999999999999999999999999999999999999999997544321
Q ss_pred ----------------------CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHH
Q 015005 170 ----------------------NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMY 227 (414)
Q Consensus 170 ----------------------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~ 227 (414)
.........||+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 01123456799999999999988775 8999999999999999999999998887777
Q ss_pred HHHHh--cccCCCCC--CCHHHHHHHHhhcccCcCCCCC-hHHHhcCCcccc
Q 015005 228 RKIFK--AEYEFPPW--ISCDARRLISRILVADPQKRIS-VSEIMINPWFIK 274 (414)
Q Consensus 228 ~~i~~--~~~~~~~~--~s~~~~~li~~~L~~dp~~R~s-~~eil~hp~f~~ 274 (414)
.++.. ....+|.. +++++.+||.+||. ||.+||+ +.++++||||..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77766 44455544 59999999999997 9999999 999999999965
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-50 Score=393.95 Aligned_cols=262 Identities=32% Similarity=0.555 Sum_probs=226.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999999999999999997654443334566889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 93 FVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
+||||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 120 lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~-~~~ 198 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC-Cce
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999854321 111
Q ss_pred ccccccCCCcccCchhhcccC---CCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCCCC--CCCHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKG---YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFPP--WISCDA 245 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~ 245 (414)
...+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||...+....+.++.... ..+|. .++..+
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 278 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence 234667999999999997643 23578999999999999999999999988888888877643 44554 469999
Q ss_pred HHHHHhhcccCcCC--CCChHHHhcCCccccC
Q 015005 246 RRLISRILVADPQK--RISVSEIMINPWFIKG 275 (414)
Q Consensus 246 ~~li~~~L~~dp~~--R~s~~eil~hp~f~~~ 275 (414)
+++|.+||..++.+ |+|+.|+++||||...
T Consensus 279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999866654 8999999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-50 Score=386.32 Aligned_cols=255 Identities=31% Similarity=0.582 Sum_probs=228.5
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
+|++.+.||+|+||+||+|.+..+++.||+|++.+.........+....|..++..+ +||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 489999999999999999999999999999999876544443455677788888877 5899999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
||++||+|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 99999999998876 7899999999999999999999999999999999999999999999999999874321 22234
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 254 (414)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+......+|..++.++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 456799999999999988875 8999999999999999999999999988899999988888999999999999999999
Q ss_pred cCcCCCCCh-----HHHhcCCcccc
Q 015005 255 ADPQKRISV-----SEIMINPWFIK 274 (414)
Q Consensus 255 ~dp~~R~s~-----~eil~hp~f~~ 274 (414)
.||.+|++. .++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999984 89999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=380.92 Aligned_cols=253 Identities=29% Similarity=0.521 Sum_probs=212.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||+|+||+||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 567999999999999999999999999999999997543221 234677899999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||++| +|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PTK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CCc
Confidence 999985 88888765 3589999999999999999999999999999999999999999999999999875332 122
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-------------------
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------------------- 233 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------- 233 (414)
......||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 3345678999999999876443358999999999999999999999887765544433211
Q ss_pred ccCC-----------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 234 EYEF-----------PPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 234 ~~~~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
...+ .+.++.++.+||++||++||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0011 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-50 Score=387.46 Aligned_cols=250 Identities=34% Similarity=0.619 Sum_probs=219.8
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876655444567788999999998 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|.+.+.+ +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence 999988876 7899999999999999999999999999999999999999999999999999874211 2233456689
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc---------hHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE---------NIMKMYRKIFKAEYEFPPWISCDARRLIS 250 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 250 (414)
|+.|+|||++.+..++ .++|+|||||++|+|++|..||... .....++.+......+|..++.++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887775 7899999999999999999999631 22334566677778889999999999999
Q ss_pred hhcccCcCCCCC------hHHHhcCCcccc
Q 015005 251 RILVADPQKRIS------VSEIMINPWFIK 274 (414)
Q Consensus 251 ~~L~~dp~~R~s------~~eil~hp~f~~ 274 (414)
+||+.||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=385.53 Aligned_cols=250 Identities=37% Similarity=0.688 Sum_probs=221.4
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+..|..++..+ +||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876543333445566777777654 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 999998876 7899999999999999999999999999999999999999999999999999974322 2233455679
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+......+|.+++.++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 889999999999999999999999988888888888888889999999999999999999999
Q ss_pred CCChH-HHhcCCcccc
Q 015005 260 RISVS-EIMINPWFIK 274 (414)
Q Consensus 260 R~s~~-eil~hp~f~~ 274 (414)
||++. ++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99864 8889999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=394.06 Aligned_cols=257 Identities=30% Similarity=0.559 Sum_probs=220.8
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997655443344567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc-----
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW----- 169 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----- 169 (414)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999887 678999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc
Q 015005 170 ------------------------------------NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS 213 (414)
Q Consensus 170 ------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~ 213 (414)
........+||+.|+|||++.+..++ .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 00011235799999999999888875 89999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHhc--ccCCCC--CCCHHHHHHHHhhcccCcCCCC---ChHHHhcCCcccc
Q 015005 214 GFLPFQNENIMKMYRKIFKA--EYEFPP--WISCDARRLISRILVADPQKRI---SVSEIMINPWFIK 274 (414)
Q Consensus 214 g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~f~~ 274 (414)
|..||.+.+..+....+... ...+|. .+++++.+||.+|+ .+|.+|+ |+.++++||||..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999988877666655443 233333 57899999999977 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=385.38 Aligned_cols=250 Identities=37% Similarity=0.640 Sum_probs=221.1
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHH-HHHhCCCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREIS-VMRLVKHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++.+.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765443333445555655 56789999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 999998876 6899999999999999999999999999999999999999999999999999874221 2233445679
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+.......++.++.++.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999888775 789999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCh----HHHhcCCcccc
Q 015005 260 RISV----SEIMINPWFIK 274 (414)
Q Consensus 260 R~s~----~eil~hp~f~~ 274 (414)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9998 69999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=390.96 Aligned_cols=257 Identities=32% Similarity=0.596 Sum_probs=223.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
+.|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998655444445677889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC----
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN---- 170 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 170 (414)
||++||+|.+.+.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999876 7899999999999999999999999999999999999999999999999999864321100
Q ss_pred -----------------------------CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc
Q 015005 171 -----------------------------DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE 221 (414)
Q Consensus 171 -----------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 221 (414)
.......+||+.|+|||++.+.+++ .++|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0112245799999999999988886 7999999999999999999999998
Q ss_pred hHHHHHHHHHhc--ccCCCCC--CCHHHHHHHHhhcccCcCCCC---ChHHHhcCCcccc
Q 015005 222 NIMKMYRKIFKA--EYEFPPW--ISCDARRLISRILVADPQKRI---SVSEIMINPWFIK 274 (414)
Q Consensus 222 ~~~~~~~~i~~~--~~~~~~~--~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~f~~ 274 (414)
+....+.++... ...+|+. ++.++++||.+|+. ||.+|+ ++.++++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 888888777653 3445543 78999999999874 999998 4799999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-50 Score=385.33 Aligned_cols=251 Identities=35% Similarity=0.655 Sum_probs=223.2
Q ss_pred eeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccc-hhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 21 GRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVK-KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.+.||+|+||.||+|.+. .+++.||+|++.+.... .......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 47889999999765432 22234567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 97 YVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 97 ~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
|++||+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 9999999999876 7789999999999999999999999999999999999999999999999999874321 222344
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 255 (414)
..+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..+....|+.+++++.+||++||++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 56799999999999887775 88999999999999999999999998888888888888899999999999999999999
Q ss_pred CcCCCC-----ChHHHhcCCcccc
Q 015005 256 DPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 256 dp~~R~-----s~~eil~hp~f~~ 274 (414)
||++|| +++++++||||..
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCC
Confidence 999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=384.20 Aligned_cols=250 Identities=35% Similarity=0.684 Sum_probs=225.1
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444456778899999888 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 999998887 6899999999999999999999999999999999999999999999999999864221 2223345679
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+......+|..++.++.+||++||+.||.+
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999888775 789999999999999999999999888888888888888888899999999999999999999
Q ss_pred CCCh-----HHHhcCCcccc
Q 015005 260 RISV-----SEIMINPWFIK 274 (414)
Q Consensus 260 R~s~-----~eil~hp~f~~ 274 (414)
|||+ .++++||||..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCC
Confidence 9999 99999999966
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=377.56 Aligned_cols=254 Identities=31% Similarity=0.481 Sum_probs=213.3
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||+||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999999765332 223567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
||++++.+...... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc-ccccc
Confidence 99999877665544 67999999999999999999999999999999999999999999999999999864321 11222
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--------------c-----c
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--------------E-----Y 235 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------------~-----~ 235 (414)
....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+... . .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 345799999999999887775 7999999999999999999999876544332222110 0 0
Q ss_pred CCC-------------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 236 EFP-------------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 236 ~~~-------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
..| ..+|.++.+||++||++||++|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 011 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=380.56 Aligned_cols=256 Identities=30% Similarity=0.464 Sum_probs=209.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||+|+||+||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 468999999999999999999999999999999997544322 234567899999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||++ ++|.+.+.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence 99996 567666654 5799999999999999999999999999999999999999999999999999874332 122
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH-HHHHHHHHh--ccc---------C----
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI-MKMYRKIFK--AEY---------E---- 236 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~--~~~---------~---- 236 (414)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+.. +.. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 334567899999999987655445789999999999999999999987432 222222211 000 0
Q ss_pred --------CC---------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 237 --------FP---------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 237 --------~~---------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.| ...++++.+||++||+.||.+|||+.|+++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 0135678999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=382.65 Aligned_cols=250 Identities=34% Similarity=0.647 Sum_probs=221.5
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|++..+++.||+|++.+..............|..++... +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876443233345667788888764 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|.+.+.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 999999887 6899999999999999999999999999999999999999999999999999874221 1223345679
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+.|+|||++.+..++ .++||||+||++|+|++|..||...+..+.++.+......+|.+++.++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999887775 899999999999999999999999888888888877777888899999999999999999999
Q ss_pred CCChH-HHhcCCcccc
Q 015005 260 RISVS-EIMINPWFIK 274 (414)
Q Consensus 260 R~s~~-eil~hp~f~~ 274 (414)
||++. ++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 238 RLGVKGDIRQHPFFRE 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99996 8999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=384.16 Aligned_cols=250 Identities=33% Similarity=0.625 Sum_probs=218.8
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554444566788999998877 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|...+.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 999888876 7899999999999999999999999999999999999999999999999999874321 1223345689
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC---------chHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN---------ENIMKMYRKIFKAEYEFPPWISCDARRLIS 250 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 250 (414)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.. .........+......+|..++.++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999888775 789999999999999999999952 122344556677778889999999999999
Q ss_pred hhcccCcCCCCC------hHHHhcCCcccc
Q 015005 251 RILVADPQKRIS------VSEIMINPWFIK 274 (414)
Q Consensus 251 ~~L~~dp~~R~s------~~eil~hp~f~~ 274 (414)
+||+.||.+||+ +.++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 479999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=382.72 Aligned_cols=255 Identities=31% Similarity=0.584 Sum_probs=227.3
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~ 95 (414)
+|+..+.||+|+||+||+|.+..+|+.||+|++.+.........+.+..|..++..+. ||+|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998765444444567788999998885 577889999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
||++||+|.+.+.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 99999999999887 7899999999999999999999999999999999999999999999999999874321 12233
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 254 (414)
...+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+.......+......+|..++.++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999887775 7899999999999999999999999888888899888888999999999999999999
Q ss_pred cCcCCCCCh-----HHHhcCCcccc
Q 015005 255 ADPQKRISV-----SEIMINPWFIK 274 (414)
Q Consensus 255 ~dp~~R~s~-----~eil~hp~f~~ 274 (414)
.||.+|+++ .++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 999999974 78999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=383.04 Aligned_cols=257 Identities=34% Similarity=0.621 Sum_probs=221.1
Q ss_pred CEEEeeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccc-hhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVK-KQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKV 91 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 91 (414)
+|++.+.||+|+||+||+|++. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999864 47899999999765432 223356788999999999 599999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+||||++||+|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-E 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc-C
Confidence 999999999999998876 67999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc----hHHHHHHHHHhcccCCCCCCCHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE----NIMKMYRKIFKAEYEFPPWISCDAR 246 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~ 246 (414)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 222345679999999999987654457899999999999999999999643 3344555666677788888999999
Q ss_pred HHHHhhcccCcCCCC-----ChHHHhcCCcccc
Q 015005 247 RLISRILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 247 ~li~~~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
+||.+||+.||++|| +++++++||||..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999 7889999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=384.18 Aligned_cols=256 Identities=30% Similarity=0.565 Sum_probs=223.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46999999999999999999999999999999998765544445677889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN-KMVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC-Ccee
Confidence 99999999999876 57999999999999999999999999999999999999999999999999999754321 1112
Q ss_pred cccccCCCcccCchhhcc------cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCCC--CCCCH
Q 015005 174 LHTQCGTPAYVAPEVLRK------KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFP--PWISC 243 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~ 243 (414)
....+||+.|+|||++.. ..+ +.++|||||||++|+|++|..||...+....+.++.... ..+| +.++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTY-GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eecccCCccccCHHHhccccccccCCC-CCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 334579999999999863 334 478999999999999999999999888777777776532 2333 35799
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
++.+||++||. ||.+|||++++++||||..
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 99999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=382.64 Aligned_cols=250 Identities=36% Similarity=0.626 Sum_probs=220.7
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHH-HHHhCCCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREIS-VMRLVKHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765433333455566655 46778999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|...+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 999988876 7899999999999999999999999999999999999999999999999999874221 2223445679
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.++.+.......++..+..+.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999888775 789999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCh----HHHhcCCcccc
Q 015005 260 RISV----SEIMINPWFIK 274 (414)
Q Consensus 260 R~s~----~eil~hp~f~~ 274 (414)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9987 58999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=387.67 Aligned_cols=262 Identities=32% Similarity=0.537 Sum_probs=226.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.-.++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 44579999999999999999999999999999999997655444434566789999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 93 FVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 120 lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~-~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-Ccc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999754321 111
Q ss_pred ccccccCCCcccCchhhcccC---CCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCCCC--CCCHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKG---YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFPP--WISCDA 245 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~ 245 (414)
.....+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||...+....+.++.... ..+|. .++.++
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 278 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence 234567999999999997543 23579999999999999999999999998888888887643 34443 589999
Q ss_pred HHHHHhhcccCcCC--CCChHHHhcCCccccC
Q 015005 246 RRLISRILVADPQK--RISVSEIMINPWFIKG 275 (414)
Q Consensus 246 ~~li~~~L~~dp~~--R~s~~eil~hp~f~~~ 275 (414)
++||.+||..++.+ |++++++++||||...
T Consensus 279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=383.64 Aligned_cols=249 Identities=34% Similarity=0.605 Sum_probs=217.7
Q ss_pred eeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV---KHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 24 LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
||+|+||+||+|++..+++.||+|++.+..............|..++..+ .||||+++++++.+.+.+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999775544333344556677777655 699999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|.+.+.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 999988876 7899999999999999999999999999999999999999999999999999874322 2233456789
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCC-CCHHHHHHHHhhcccCcC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW-ISCDARRLISRILVADPQ 258 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~s~~~~~li~~~L~~dp~ 258 (414)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+..+.+..+..+...+|.. +++++.+||++||++||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 9999999999765433588999999999999999999999998888888888887777754 799999999999999999
Q ss_pred CCC----ChHHHhcCCcccc
Q 015005 259 KRI----SVSEIMINPWFIK 274 (414)
Q Consensus 259 ~R~----s~~eil~hp~f~~ 274 (414)
+|| ++.++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 6899999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-50 Score=368.83 Aligned_cols=259 Identities=30% Similarity=0.505 Sum_probs=220.1
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe-----C
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT-----K 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~ 88 (414)
+..+|...+.||+|+||.|..|.+..+|+.||||.+... ..+.-..++..||+.+|+.++|+||+.+.+++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 345677789999999999999999999999999999633 2333446788999999999999999999999865 3
Q ss_pred CEEEEEEEccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~-~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
..+|+|+|+| +.+|...+..++ +++..++.++.|++.||.|+|+.||+||||||.|+|++.+..+||+|||+|+....
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 5699999999 579999999876 99999999999999999999999999999999999999999999999999997654
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh---------------
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------------- 232 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------- 232 (414)
....+.+...+.|.+|.|||++....-++.+.||||+|||+.||++|++-|.+.+..++.+.|..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 33455667788999999999986554445899999999999999999999998766554443322
Q ss_pred --------cccCCC--------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 233 --------AEYEFP--------PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 233 --------~~~~~~--------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..+..| +..++.+.+|+.+||..||.+|+|++|+|+|||+..
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 112222 357899999999999999999999999999999965
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=379.92 Aligned_cols=250 Identities=35% Similarity=0.612 Sum_probs=220.5
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHH-HHHhCCCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREIS-VMRLVKHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765443333445556654 57889999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 999988876 6799999999999999999999999999999999999999999999999999874321 2233445679
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+......+|+..+.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999887775 789999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCh----HHHhcCCcccc
Q 015005 260 RISV----SEIMINPWFIK 274 (414)
Q Consensus 260 R~s~----~eil~hp~f~~ 274 (414)
|+++ .++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9976 49999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=380.47 Aligned_cols=250 Identities=36% Similarity=0.651 Sum_probs=222.3
Q ss_pred eeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 21 GRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
++.||+|+||.||++.+. .+|+.||+|++.+...... ....+.+|++++++++||||+++++++.+++.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999999763 5789999999986543322 234677899999999999999999999999999999999
Q ss_pred cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcccc
Q 015005 98 VKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT 176 (414)
Q Consensus 98 ~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 176 (414)
++||+|.+++.+ ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYS 157 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceec
Confidence 999999999876 6799999999999999999999999999999999999999999999999999875432 2223445
Q ss_pred ccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccC
Q 015005 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVAD 256 (414)
Q Consensus 177 ~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d 256 (414)
.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||+.|
T Consensus 158 ~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred ccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 6799999999999887775 789999999999999999999999888888888888888889999999999999999999
Q ss_pred cCCCCC-----hHHHhcCCcccc
Q 015005 257 PQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 257 p~~R~s-----~~eil~hp~f~~ 274 (414)
|.+||+ +.+++.||||..
T Consensus 237 P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 237 PANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HhHcCCCCCCCHHHHhCCCCcCC
Confidence 999999 777999999965
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=379.21 Aligned_cols=250 Identities=36% Similarity=0.645 Sum_probs=219.4
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHH-HHHhCCCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREIS-VMRLVKHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998755433323344445544 56788999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 999999886 6799999999999999999999999999999999999999999999999999874321 2233456679
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+.......++.++.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887775 789999999999999999999999888888888888877888889999999999999999999
Q ss_pred CCChH----HHhcCCcccc
Q 015005 260 RISVS----EIMINPWFIK 274 (414)
Q Consensus 260 R~s~~----eil~hp~f~~ 274 (414)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999954
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=362.68 Aligned_cols=253 Identities=37% Similarity=0.676 Sum_probs=223.9
Q ss_pred ccccCCEEEe-eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEe--
Q 015005 12 NILFGKYEMG-RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMAT-- 87 (414)
Q Consensus 12 ~~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-- 87 (414)
..+.++|.+. ++||-|-.|+|-.+.++.||+.+|+|++... ...++|++++-.. .|||||.++++|++
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 3466778876 6799999999999999999999999998543 3566899998777 69999999999864
Q ss_pred --CCEEEEEEEccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC---CCCeEEeec
Q 015005 88 --KTKVFFVIEYVKGGELFAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---NGNLKVSDF 159 (414)
Q Consensus 88 --~~~~~lv~E~~~gg~L~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---~~~~kl~DF 159 (414)
..++.+|||.++||+|++++.. | .|+|.+|..+++||..|+.|||+.+|+||||||||+|... |..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 4689999999999999999997 4 4999999999999999999999999999999999999974 457999999
Q ss_pred CCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch----HHHHHHHHHhccc
Q 015005 160 GLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN----IMKMYRKIFKAEY 235 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~ 235 (414)
|+|+... ..+.+.+.|-||.|+|||++....|+ ..+|+||+||++|.||+|.+||.... ...+.++|..+.+
T Consensus 209 GFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 209 GFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 9999644 35678899999999999999988887 78999999999999999999998754 3467788999999
Q ss_pred CCCC--C--CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 236 EFPP--W--ISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 236 ~~~~--~--~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.||. | +|.+++++|+.+|..+|.+|.|+.++++|||+....
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 8875 3 899999999999999999999999999999997643
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=378.60 Aligned_cols=250 Identities=32% Similarity=0.604 Sum_probs=219.6
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999877655555567788999999888 699999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
|+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 999988876 7899999999999999999999999999999999999999999999999999874221 2233456789
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc-------hHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE-------NIMKMYRKIFKAEYEFPPWISCDARRLISRI 252 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 252 (414)
|+.|+|||++.+..++ .++|||||||++|+|++|..||... .....++.+......+|..++..+.++|++|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999887775 8999999999999999999999532 2334556666667778888999999999999
Q ss_pred cccCcCCCCC------hHHHhcCCcccc
Q 015005 253 LVADPQKRIS------VSEIMINPWFIK 274 (414)
Q Consensus 253 L~~dp~~R~s------~~eil~hp~f~~ 274 (414)
|+.||.+|++ +.++++||||..
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 9999999998 469999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=384.82 Aligned_cols=256 Identities=29% Similarity=0.495 Sum_probs=229.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
-..|+..+.||+|+||.||+|.+..+++.||+|+++.+...++ ++.+++|+.++..+++|||.++|+.+..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 3468888999999999999999999999999999998876554 78899999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLKGKL-KEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~~~~-~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||||.||++.+.+..+.+ .|.++..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+...... ...
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~r 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKR 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech--hhc
Confidence 999999999999998665 99999999999999999999999999999999999999999999999999865542 233
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-CCCCCCHHHHHHHHhh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FPPWISCDARRLISRI 252 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~ 252 (414)
..+..|||.|||||++.+.+|+ .++||||||++.++|++|.+||...+++.....|-+..++ ....+|+.+++||..|
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 3788999999999999988997 8999999999999999999999988775544444444433 2335899999999999
Q ss_pred cccCcCCCCChHHHhcCCccccC
Q 015005 253 LVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
|++||+.||||.++|+|+|+++.
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhc
Confidence 99999999999999999999774
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=370.36 Aligned_cols=248 Identities=30% Similarity=0.484 Sum_probs=214.4
Q ss_pred eeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCch
Q 015005 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL 103 (414)
Q Consensus 24 LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 103 (414)
||+|+||+||++.+..+++.||+|.+.+.........+.+..|+.+++.++||||+++++++..+..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999876554433456778899999999999999999999999999999999999999
Q ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcccccc
Q 015005 104 FAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQC 178 (414)
Q Consensus 104 ~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 178 (414)
.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... .........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC--CCccccccC
Confidence 877632 4699999999999999999999999999999999999999999999999999875432 122234457
Q ss_pred CCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH----HHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 015005 179 GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI----MKMYRKIFKAEYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 179 gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 254 (414)
||+.|+|||++.+..++ .++|||||||++|+|++|+.||..... ......+......+|..++.++.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999988775 789999999999999999999976432 2334445555566777899999999999999
Q ss_pred cCcCCCC-----ChHHHhcCCcccc
Q 015005 255 ADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 255 ~dp~~R~-----s~~eil~hp~f~~ 274 (414)
.||++|| +++++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=368.86 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=219.6
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.|++.+.||+|+||+||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976554443334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 97 ~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|++||+|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 9999999887754 4699999999999999999999999999999999999999999999999999875432 222
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHH----HHHHHhcccCCCCCCCHHHHHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKM----YRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~li 249 (414)
....+|++.|+|||++.+..++ .++||||+||++|+|++|..||.+.+.... ...+......++..++..+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 3445799999999999877765 789999999999999999999987654332 23333444556677899999999
Q ss_pred HhhcccCcCCCC-----ChHHHhcCCcccc
Q 015005 250 SRILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 250 ~~~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
.+||+.||.+|| +++++++||||.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=382.64 Aligned_cols=256 Identities=30% Similarity=0.539 Sum_probs=236.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE-EEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK-VFF 93 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~l 93 (414)
++.|+.++.+|+|+||.+++++++..++.+++|.+......... .+...+|+.++++++|||||.+.+.|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57899999999999999999999999999999999887765442 3467899999999999999999999998888 999
Q ss_pred EEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 94 VIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
||+||+||+|.+.+.+ .-++|+.+..||.|++.||.|||++.|+|||||+.||+++.++.+||+|||+|+.+.. .
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~--~ 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP--E 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--c
Confidence 9999999999999986 2499999999999999999999999999999999999999999999999999998765 3
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLI 249 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 249 (414)
.....+..|||.||+||++.+.+|. .++|||||||++|+|++-+.+|.+.+...+..+|..+. .+.|...+.+++.||
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 3477889999999999999999996 99999999999999999999999999999999999887 577888999999999
Q ss_pred HhhcccCcCCCCChHHHhcCCcccc
Q 015005 250 SRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+.||..+|..||++.++|.+|....
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999998753
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=374.96 Aligned_cols=258 Identities=30% Similarity=0.552 Sum_probs=219.3
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444444567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||++||+|.+++.+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-GTVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-CCcc
Confidence 99999999999875 57999999999999999999999999999999999999999999999999998643321 1112
Q ss_pred cccccCCCcccCchhhcc----cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCCC---CCCCHH
Q 015005 174 LHTQCGTPAYVAPEVLRK----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFP---PWISCD 244 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~ 244 (414)
....+||+.|+|||++.. ....+.++||||+||++|+|++|..||...+..+.+..+.... ..+| ..++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 233569999999999863 2333578999999999999999999999888777777776433 2333 347999
Q ss_pred HHHHHHhhcccCcCC--CCChHHHhcCCcccc
Q 015005 245 ARRLISRILVADPQK--RISVSEIMINPWFIK 274 (414)
Q Consensus 245 ~~~li~~~L~~dp~~--R~s~~eil~hp~f~~ 274 (414)
+++||++||..++++ |+++.++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999999765444 789999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=377.46 Aligned_cols=248 Identities=32% Similarity=0.521 Sum_probs=214.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeE-EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-EEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQES-VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT-KVF 92 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~ 92 (414)
.....+.+.||+|+||+||+|.. .|.. ||+|++......... .+.+.+|+.+|.+++|||||++++++.++. .++
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 44556677799999999999985 4555 999999876655443 678999999999999999999999999887 799
Q ss_pred EEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-cEEecCCCCcEEEcCCC-CeEEeecCCCccccc
Q 015005 93 FVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRG-VYHRDLKPENLLLDENG-NLKVSDFGLSALPEQ 167 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~g-i~HrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 167 (414)
+||||+++|+|.+++.. +.++...+..++.||+.|+.|||+++ |+||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999965 68999999999999999999999999 99999999999999998 999999999986543
Q ss_pred ccCCCccccccCCCcccCchhhc--ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh--cccCCCCCCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLR--KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--AEYEFPPWISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~--~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~ 243 (414)
.. .......||+.|||||++. ...|+ .++||||+|++||||+||..||...........+.. ..+.+|..+++
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 21 2334468999999999999 55775 899999999999999999999999887655555542 34556777999
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhc
Q 015005 244 DARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+..|+.+||+.||.+||+..+|+.
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=360.21 Aligned_cols=257 Identities=30% Similarity=0.442 Sum_probs=221.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT--KTKVF 92 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 92 (414)
++.|+.+..|++|+||.||+|+++.|++.||+|.++-+.. ..+.--.-.|||.+|.+++|||||.+-++... -+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4579999999999999999999999999999999976653 33343445699999999999999999998754 46799
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+|||||+. +|...+.. .+|...+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.++.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-- 230 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-- 230 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC--
Confidence 99999974 88888876 58999999999999999999999999999999999999999999999999999976653
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-----------------
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA----------------- 233 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------------- 233 (414)
.......+-|..|.|||.+.+...++.++|+||+|||+.+|+++.+-|.+.+..++..+|+.-
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 334556678999999999998876678999999999999999999999999888877777541
Q ss_pred --ccCCCC-----------C--CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 --EYEFPP-----------W--ISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 --~~~~~~-----------~--~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
...++. + ++....+|++.+|..||.+|.|+.|.|+|+||...
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 011111 1 45788999999999999999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=373.42 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=218.1
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+..++|++.+.||+|+||.||+|++..++..+|+|++..... ....+.+.+|+++++.++||||+++++++.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 346789999999999999999999999999999999976432 223567899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+||||++||+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 99999999999999887 6799999999999999999999986 699999999999999999999999999875422
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHH--------------------
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI-------------------- 230 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i-------------------- 230 (414)
.......||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+..+....+
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -cccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 223455799999999999887775 7999999999999999999999776544332211
Q ss_pred --------------------------Hhcc-cCCC-CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 231 --------------------------FKAE-YEFP-PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 231 --------------------------~~~~-~~~~-~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.... ...+ ..+++++.+||++||+.||++|||+.++++||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 1111 1111 1368899999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=375.57 Aligned_cols=255 Identities=30% Similarity=0.499 Sum_probs=207.7
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----CEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK-----TKV 91 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 91 (414)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 699999999999999999999999999999998753322 12245688999999999999999999988543 358
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+||||+. ++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 688888876 6799999999999999999999999999999999999999999999999999975422111
Q ss_pred -CCccccccCCCcccCchhhcc--cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh---------------
Q 015005 171 -DGLLHTQCGTPAYVAPEVLRK--KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------------- 232 (414)
Q Consensus 171 -~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------- 232 (414)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 112244679999999999865 445 4789999999999999999999987654332211100
Q ss_pred -----------cccCC-----CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 233 -----------AEYEF-----PPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 233 -----------~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
...+. .+.+++++.++|.+||+.||++|||++|+++||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 00010 1236788999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-50 Score=409.76 Aligned_cols=260 Identities=31% Similarity=0.559 Sum_probs=233.0
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+-.++|+++++||+|+||.|.+++++.|++.||+|+++|-..........|..|-.+|...+.+-|++++..|+++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34568999999999999999999999999999999998855444445678999999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+||||++||+|..++.+ ++++|..|++|+..|+.||.-||+.|+|||||||+|||||.+|++||+|||.+-.+... ..
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d-G~ 230 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD-GT 230 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC-Cc
Confidence 99999999999999998 67999999999999999999999999999999999999999999999999998765531 22
Q ss_pred CccccccCCCcccCchhhcc----cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--ccCCC--CCCCH
Q 015005 172 GLLHTQCGTPAYVAPEVLRK----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EYEFP--PWISC 243 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~ 243 (414)
......+|||.|+|||++.. .+.+|..+|+||+||++|+|+.|.+||..++..+.|.+|.+. .+.|| ..+|.
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence 34567789999999999863 245579999999999999999999999999999999999876 67788 45899
Q ss_pred HHHHHHHhhcccCcCCCCC---hHHHhcCCcccc
Q 015005 244 DARRLISRILVADPQKRIS---VSEIMINPWFIK 274 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s---~~eil~hp~f~~ 274 (414)
++++||++++. +|..|.. ++++..||||..
T Consensus 311 eakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 311 EAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 99999999886 5788887 999999999965
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=363.13 Aligned_cols=249 Identities=33% Similarity=0.515 Sum_probs=212.9
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--C---
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK--T--- 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~--- 89 (414)
.=.|+-.+++|+|+||.||.|....+++.||||.+..+.-.. .+|+++|+.++|||||++..+|... +
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 336899999999999999999999999999999987655333 2899999999999999999888542 2
Q ss_pred EEEEEEEccCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC-CCeEEeecCCCc
Q 015005 90 KVFFVIEYVKGGELFAKVL-----KGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN-GNLKVSDFGLSA 163 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~-----~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~-~~~kl~DFGla~ 163 (414)
+..+||||+| .+|.+.++ +.+++...++-|..||+.||.|||+.|||||||||.|+|+|.+ |.+||||||.|+
T Consensus 96 ~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 4568999997 58888877 3689999999999999999999999999999999999999976 899999999999
Q ss_pred ccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh-----------
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK----------- 232 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~----------- 232 (414)
.... +....+...|..|.|||.+.+...++.+.||||+|||+.||+-|++-|.+++..++...|.+
T Consensus 175 ~L~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 175 VLVK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eecc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 7653 33446677899999999999877667999999999999999999999999887776665543
Q ss_pred -c-----ccCC------------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 233 -A-----EYEF------------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 233 -~-----~~~~------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
. +..+ ....++++.+|+.++|..+|.+|.++.|++.||||..
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 0 1111 2236899999999999999999999999999999965
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=387.89 Aligned_cols=252 Identities=29% Similarity=0.430 Sum_probs=206.6
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC---
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK--- 88 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--- 88 (414)
....++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 344568999999999999999999999999999999986532 2234799999999999999999887432
Q ss_pred -----CEEEEEEEccCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-CeEEe
Q 015005 89 -----TKVFFVIEYVKGGELFAKVL-----KGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-NLKVS 157 (414)
Q Consensus 89 -----~~~~lv~E~~~gg~L~~~i~-----~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-~~kl~ 157 (414)
..+++||||+++ +|.+.+. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 257899999986 5555543 25799999999999999999999999999999999999999765 69999
Q ss_pred ecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc----
Q 015005 158 DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA---- 233 (414)
Q Consensus 158 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---- 233 (414)
|||+|+.... .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+...++...
T Consensus 214 DFGla~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 214 DFGSAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred ccccchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999985432 223345678999999999876543358999999999999999999999987665544443220
Q ss_pred -------------cc------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 234 -------------EY------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 234 -------------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.. .+|...+.++.+||++||+.||.+|||+.|+++||||..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 01 123456789999999999999999999999999999965
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=370.84 Aligned_cols=258 Identities=29% Similarity=0.546 Sum_probs=220.0
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||+||++.+..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444444556888999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||++||+|.+++.+ +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999976 57999999999999999999999999999999999999999999999999998643221 1112
Q ss_pred cccccCCCcccCchhhcc----cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCCCC---CCCHH
Q 015005 174 LHTQCGTPAYVAPEVLRK----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFPP---WISCD 244 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 244 (414)
....+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...+..+.+.++.... ..+|. .++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234579999999999863 2223578999999999999999999999988888888876543 23333 47999
Q ss_pred HHHHHHhhcccCcCC--CCChHHHhcCCcccc
Q 015005 245 ARRLISRILVADPQK--RISVSEIMINPWFIK 274 (414)
Q Consensus 245 ~~~li~~~L~~dp~~--R~s~~eil~hp~f~~ 274 (414)
+++||++||..++.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765554 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=367.50 Aligned_cols=257 Identities=30% Similarity=0.522 Sum_probs=213.4
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
.+++|++.+.||+|+||+||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 3578999999999999999999999999999999997654322 23456789999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 94 VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
||||+++ +|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 158 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--PT 158 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC--Cc
Confidence 9999985 77777664 4589999999999999999999999999999999999999999999999999875332 12
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc------------------
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------------------ 233 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------ 233 (414)
.......+|+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22334568999999999876544458999999999999999999999887654433322210
Q ss_pred -ccCCC-----------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 -EYEFP-----------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 -~~~~~-----------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
...+| +.+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 01111 2368899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=355.92 Aligned_cols=257 Identities=33% Similarity=0.635 Sum_probs=223.4
Q ss_pred CEEEe-eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEE
Q 015005 17 KYEMG-RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 17 ~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv 94 (414)
-|.+. +.||+|+||.|--+.+..+|..||||++.|.... ...++.+|++++.++ .|+||++++++|++++..|+|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 34443 6799999999999999999999999999887432 357899999999999 599999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC---CeEEeecCCCccccc---
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG---NLKVSDFGLSALPEQ--- 167 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~---~~kl~DFGla~~~~~--- 167 (414)
||-+.||.|...|.+ ..|+|.+|..+.+.|+.||.+||.+||+||||||+|||..... -+|||||.+..-...
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 999999999999988 6799999999999999999999999999999999999997554 589999999763221
Q ss_pred --ccCCCccccccCCCcccCchhhc----ccCCCCCccchhhhhhhhhhhhcCCCCCCCc---------------hHHHH
Q 015005 168 --LWNDGLLHTQCGTPAYVAPEVLR----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE---------------NIMKM 226 (414)
Q Consensus 168 --~~~~~~~~~~~gt~~y~APE~~~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---------------~~~~~ 226 (414)
......+.+.||+..|||||+.. ...++..++|.||||||||.||+|++||.+. -.+.+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 12234566889999999999863 2334458999999999999999999999763 24578
Q ss_pred HHHHHhcccCCCC--C--CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 227 YRKIFKAEYEFPP--W--ISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 227 ~~~i~~~~~~~~~--~--~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
+..|..+.+.||. | +|.++++||+.+|..|+.+|.++.++++|||+....
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 9999999999996 3 899999999999999999999999999999997643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=359.13 Aligned_cols=257 Identities=32% Similarity=0.520 Sum_probs=219.9
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC-ccceEEEEEeCC----
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN-IVELKEVMATKT---- 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 89 (414)
...|+.++.||+|+||+||+|+++.+|+.||+|.+..+... ++.-....+|+.+++.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56688888999999999999999999999999999876543 334456779999999999999 999999998877
Q ss_pred --EEEEEEEccCCCchHHHHhc-C----CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 90 --KVFFVIEYVKGGELFAKVLK-G----KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 90 --~~~lv~E~~~gg~L~~~i~~-~----~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
.+|+|+||+. -+|..++.. . .++...++.++.||+.||+|||++||+||||||+|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999996 588888776 3 5888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc---------
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--------- 233 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------- 233 (414)
+.... .........+|..|.|||++.+...++...||||+|||+++|++++.-|.+.+..++...|..-
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 86543 2233556678999999999999866668999999999999999999999998887776666531
Q ss_pred ---------ccCCCCC------------CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 ---------EYEFPPW------------ISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 ---------~~~~~~~------------~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
...+|.| .+++..+++.+||+.+|.+|.|+..+|.||||...
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1122222 23578999999999999999999999999999764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=370.62 Aligned_cols=257 Identities=29% Similarity=0.530 Sum_probs=220.0
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||+||++.+..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654433334566888999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD-GTVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-Ccee
Confidence 99999999999976 57999999999999999999999999999999999999999999999999998754321 1112
Q ss_pred cccccCCCcccCchhhcc-----cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCCCC---CCCH
Q 015005 174 LHTQCGTPAYVAPEVLRK-----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFPP---WISC 243 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~ 243 (414)
....+||+.|+|||++.+ ..+ +.++||||+||++|+|++|..||...+..+.+.++.... .++|. .++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCC-CCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 234579999999999875 234 478999999999999999999999888877777776543 33443 3689
Q ss_pred HHHHHHHhhcccCcCC--CCChHHHhcCCcccc
Q 015005 244 DARRLISRILVADPQK--RISVSEIMINPWFIK 274 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~--R~s~~eil~hp~f~~ 274 (414)
++++||.+||..++++ |++++++++||||..
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 9999999999976655 568999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=390.54 Aligned_cols=262 Identities=32% Similarity=0.522 Sum_probs=227.9
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT- 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 89 (414)
.....++|++.+.||+|+||+||+|.+..+++.||||++....... .....+.+|+.++..++|+||+++++.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3455689999999999999999999999999999999997765432 23566889999999999999999988775432
Q ss_pred -------EEEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEe
Q 015005 90 -------KVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVS 157 (414)
Q Consensus 90 -------~~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~ 157 (414)
.+++||||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence 47899999999999998864 368999999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-C
Q 015005 158 DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-E 236 (414)
Q Consensus 158 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~ 236 (414)
|||+++..............+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+..+.. +
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 99999865433233344567899999999999887775 899999999999999999999999888888777776654 4
Q ss_pred CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 237 FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.|+.+++++.+|+.+||+.||.+||++.++++|||+..
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 67789999999999999999999999999999999864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=387.84 Aligned_cols=258 Identities=25% Similarity=0.445 Sum_probs=224.7
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCC-CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVT-QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
.....|.+.+.||+|++|.||+|.+..+ +..||+|.+..... .....+.+|+.+++.++||||+++++++..++.+
T Consensus 64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE---RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 3445699999999999999999998877 78899998754432 2345678899999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 92 FFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
|+||||++||+|.+.+.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999999887642 468999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHH
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDA 245 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~ 245 (414)
...........+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+....+..+.. +.|..++.++
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 299 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence 32222334566899999999999887775 889999999999999999999999888888877776655 4566789999
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 246 RRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.+||.+||.+||++||++.+++.|||+..
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999853
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=361.23 Aligned_cols=253 Identities=36% Similarity=0.708 Sum_probs=229.8
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++||||+++++++.+...+|++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765544445677899999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999876 78999999999999999999999999999999999999999999999999998754321 3
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 254 (414)
...+|++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+..+...+|..++..+.++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 455789999999999876654 7899999999999999999999988877778888888888888899999999999999
Q ss_pred cCcCCCC-----ChHHHhcCCcccc
Q 015005 255 ADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 255 ~dp~~R~-----s~~eil~hp~f~~ 274 (414)
.||.+|+ +++|+++||||..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 8999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=374.01 Aligned_cols=257 Identities=29% Similarity=0.504 Sum_probs=210.8
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC---
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT--- 89 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 89 (414)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 4678999999999999999999999999999999999765332 223466789999999999999999999986543
Q ss_pred ---EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 90 ---KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 90 ---~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
.+|+||||++++ |.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDAN-LCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCcC-HHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 579999999764 555543 468999999999999999999999999999999999999999999999999997432
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh--------------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK-------------- 232 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-------------- 232 (414)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..
T Consensus 175 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 T---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred c---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 2 2233456789999999999888875 789999999999999999999987654433222111
Q ss_pred --------cccC---------CCC-----------CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 233 --------AEYE---------FPP-----------WISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 233 --------~~~~---------~~~-----------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.... ++. ..+.++++||.+||+.||++|||+.|+++||||...+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 1111 111 1356789999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=375.13 Aligned_cols=256 Identities=30% Similarity=0.480 Sum_probs=213.7
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
..+.|+..+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+++++.++||||+++++++...+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 35679999999999999999999999999999999965432 2335678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 94 VIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||||+++|+|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 150 v~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDP 224 (353)
T ss_pred EEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--ccc
Confidence 9999999998643 34678888999999999999999999999999999999999999999999999864321 122
Q ss_pred cccccCCCcccCchhhcc----cCCCCCccchhhhhhhhhhhhcCCCCCCCchH---HHHHHHHH-hcccCCCCCCCHHH
Q 015005 174 LHTQCGTPAYVAPEVLRK----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI---MKMYRKIF-KAEYEFPPWISCDA 245 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~-~~~~~~~~~~s~~~ 245 (414)
.....||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||..... ......+. ......+..++.++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 345679999999999743 23445689999999999999999999974322 22222222 22334566789999
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 246 RRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.+||.+||+.||++|||+.|+++||||.+..
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999999999999999999999998754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=362.27 Aligned_cols=251 Identities=31% Similarity=0.485 Sum_probs=207.3
Q ss_pred CCEEEeeeeeecCCeEEEEEEECC-CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCccceEEEEE-----
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLV-TQESVAIKVINKDQVKKQGLMEQIKREISVMRLV---KHPNIVELKEVMA----- 86 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----- 86 (414)
.+|++.+.||+|+||+||+|.+.. ++..||+|.+....... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999865 56889999987654332 2234556788777766 6999999999985
Q ss_pred eCCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
....+++||||++ ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999997 578888764 458999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc--------
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-------- 235 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------- 235 (414)
.... ........||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 5432 2234456799999999999887775 789999999999999999999998777666555543110
Q ss_pred -------------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 236 -------------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 236 -------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
...+.++..+.+||.+||+.||++|||+.|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=355.73 Aligned_cols=251 Identities=40% Similarity=0.700 Sum_probs=215.4
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
|++++.||+|+||+||+|.+..+++.||+|++......... .....+|+.++++++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999887654432 23445699999999999999999999999999999999
Q ss_pred cCCCchHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcccc
Q 015005 98 VKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT 176 (414)
Q Consensus 98 ~~gg~L~~~i~-~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 176 (414)
+++++|.+++. .+.+++..+..++.|++.||.+||++|++||||||+||+++.++.++|+|||.+.... ........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccc
Confidence 99999999998 5899999999999999999999999999999999999999999999999999987431 12344556
Q ss_pred ccCCCcccCchhhc-ccCCCCCccchhhhhhhhhhhhcCCCCCCCc---hHHHHHHHHHhcccCCCC----CCCHHHHHH
Q 015005 177 QCGTPAYVAPEVLR-KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE---NIMKMYRKIFKAEYEFPP----WISCDARRL 248 (414)
Q Consensus 177 ~~gt~~y~APE~~~-~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~----~~s~~~~~l 248 (414)
..+++.|+|||++. +..+ +.++||||||+++|+|++|..||... +......+........+. ..+..+.++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 77999999999998 4444 58999999999999999999999987 333444444333222221 124799999
Q ss_pred HHhhcccCcCCCCChHHHhcCCcc
Q 015005 249 ISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~hp~f 272 (414)
|++||+.||++|||+.++++||||
T Consensus 237 i~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHccCChhHCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=376.52 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=206.7
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
...++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++++.++||||+++++++......+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 345689999999999999999999999999999997532 34568999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
++||++. ++|..++.. ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~ 237 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NA 237 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-cc
Confidence 9999995 678887765 78999999999999999999999999999999999999999999999999999753221 12
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch-------HHHHHHHHH-------------
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-------IMKMYRKIF------------- 231 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-------~~~~~~~i~------------- 231 (414)
......+||+.|+|||++.+..|. .++||||+||++|+|++|..||.... .......+.
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 233456899999999999887775 89999999999999999998864321 111111110
Q ss_pred -------------hccc----CCCC-----CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 232 -------------KAEY----EFPP-----WISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 232 -------------~~~~----~~~~-----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.... ..|. .++.++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0000 0111 246689999999999999999999999999999763
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=367.95 Aligned_cols=256 Identities=23% Similarity=0.423 Sum_probs=216.1
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+..++|++.+.||+|+||.||+|.+..++..+|+|++..... ......+.+|+++++.++||||+++++++.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 345789999999999999999999999999999999876532 223567889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+||||++||+|.+++.. +.+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--- 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence 99999999999999886 6799999999999999999999985 799999999999999999999999999875422
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHH---------------------
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRK--------------------- 229 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~--------------------- 229 (414)
......+||+.|+|||++.+..+. .++|+|||||++|+|++|..||...........
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred -hccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 122345799999999999887765 789999999999999999999986544322111
Q ss_pred -----------------------HHhcc-cCCC-CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 230 -----------------------IFKAE-YEFP-PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 230 -----------------------i~~~~-~~~~-~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+.... ...+ ..++.++.+||.+||+.||++|||+.|++.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 11111 1111 1367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=353.16 Aligned_cols=256 Identities=29% Similarity=0.536 Sum_probs=220.0
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch--hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK--QGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
+.|++.+.||+|++|.||.|.+..+++.||+|.+....... ....+.+.+|+.++++++||||+++++++.+....|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987553321 2234678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 94 VIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
++||++|++|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999998876 779999999999999999999999999999999999999999999999999987543211111
Q ss_pred -ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Q 015005 173 -LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EYEFPPWISCDARRLI 249 (414)
Q Consensus 173 -~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li 249 (414)
......|++.|+|||++.+..++ .++||||+|+++|+|++|+.||...+......+.... ....|..++.++.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 11345688999999999887764 8999999999999999999999876655544444332 3456777899999999
Q ss_pred HhhcccCcCCCCChHHHhcCCcc
Q 015005 250 SRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~hp~f 272 (414)
++||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=358.32 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=216.1
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.|++.+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999976654443334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 97 ~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|++|++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 9999999888754 3699999999999999999999999999999999999999999999999999875332 122
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH---HHHHHH-HhcccCCCCCCCHHHHHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM---KMYRKI-FKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---~~~~~i-~~~~~~~~~~~s~~~~~li 249 (414)
.....||+.|+|||++.+..++ .++||||+||++|+|++|..||...... ...... .......+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 2345799999999999887775 7899999999999999999999864321 112222 1222345667899999999
Q ss_pred HhhcccCcCCCCC-----hHHHhcCCcccc
Q 015005 250 SRILVADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 250 ~~~L~~dp~~R~s-----~~eil~hp~f~~ 274 (414)
++||+.||.+||| +.|+++||||..
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=374.20 Aligned_cols=256 Identities=26% Similarity=0.455 Sum_probs=212.9
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-----EE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT-----KV 91 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 91 (414)
.|++.+.||+|+||+||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 478899999999999999999999999999998654222 223467889999999999999999999998876 89
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+||||+. ++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 99999997 577777765 78999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh------------------
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK------------------ 232 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------------ 232 (414)
........+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 22233456899999999998765445889999999999999999999988765544433321
Q ss_pred -----ccc---------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 233 -----AEY---------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 233 -----~~~---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
... ......++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1223457889999999999999999999999999999774
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=370.68 Aligned_cols=258 Identities=27% Similarity=0.428 Sum_probs=214.0
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK-- 88 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 88 (414)
...+.++|++.+.||+|+||+||+|.+..+++.||+|.+.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 3345689999999999999999999999999999999997653321 2245677899999999999999999987543
Q ss_pred ----CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 89 ----TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 89 ----~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
...|++||++ |++|.+.+..+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 4579999998 78998888778999999999999999999999999999999999999999999999999999985
Q ss_pred cccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc----------
Q 015005 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE---------- 234 (414)
Q Consensus 165 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---------- 234 (414)
... ......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 168 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 168 ADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred cCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 432 23455799999999999775444589999999999999999999998766544433332110
Q ss_pred -------------cCCC--------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 235 -------------YEFP--------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 235 -------------~~~~--------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
...| ...++.+.+||.+||+.||.+|||+.|+++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0011 1246678999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=360.00 Aligned_cols=256 Identities=30% Similarity=0.544 Sum_probs=213.9
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
-.++|++.+.||+|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++..+...|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 4578999999999999999999999999999999987544322 23456789999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 94 VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
||||++ ++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ..
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~~ 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PT 158 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--CC
Confidence 999997 578777765 5689999999999999999999999999999999999999999999999999875332 12
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc------------------
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------------------ 233 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------ 233 (414)
.......+++.|+|||++.+....+.++|||||||++|+|++|..||...+..+....+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22334567899999999876554457899999999999999999999887665444332210
Q ss_pred -ccCCC-----------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 234 -EYEFP-----------PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 234 -~~~~~-----------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
....| +.+++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00111 246888999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=356.09 Aligned_cols=247 Identities=26% Similarity=0.448 Sum_probs=208.8
Q ss_pred eeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCch
Q 015005 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL 103 (414)
Q Consensus 24 LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 103 (414)
||+|+||+||++.+..+|+.||+|.+.+...........+..|+++++.++||||++++++++++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765543333344566799999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCC
Q 015005 104 FAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180 (414)
Q Consensus 104 ~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 180 (414)
.+.+.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..... ........||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 888754 3589999999999999999999999999999999999999999999999999875432 2223445799
Q ss_pred CcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH----HHHHHHHHhcccCCC-CCCCHHHHHHHHhhccc
Q 015005 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI----MKMYRKIFKAEYEFP-PWISCDARRLISRILVA 255 (414)
Q Consensus 181 ~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~-~~~s~~~~~li~~~L~~ 255 (414)
+.|+|||++.+..++ .++||||+||++|+|++|..||..... ..............+ ..++.++.+||++||++
T Consensus 158 ~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 999999999887765 899999999999999999999976432 233344444444333 35899999999999999
Q ss_pred CcCCCCCh----HHHhcCCcccc
Q 015005 256 DPQKRISV----SEIMINPWFIK 274 (414)
Q Consensus 256 dp~~R~s~----~eil~hp~f~~ 274 (414)
||++||++ .+++.||||..
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=364.45 Aligned_cols=260 Identities=30% Similarity=0.513 Sum_probs=233.6
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
..+-.+.|+..++||+|+||.||-++.+.||+.||+|.+.++.+....-.....+|-.||.+++.|.||.+-..|++++.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34556778999999999999999999999999999999999888766556677899999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
+++||..|.||+|...|-+ | .+++..++.|+.+|+.||++||+.+|++|||||+|||+|+.|+++|+|+|||..+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~- 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP- 338 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC-
Confidence 9999999999999877766 5 79999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch----HHHHHHHHHhcccCCCCCCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN----IMKMYRKIFKAEYEFPPWISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~ 243 (414)
...+....+||.+|||||++.+..|+ ..+|+|||||+||+|+.|+.||...- .++.-+.+......+|..+|+
T Consensus 339 --~g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 339 --EGKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred --CCCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence 34455666999999999999998886 88999999999999999999997643 335556677777788999999
Q ss_pred HHHHHHHhhcccCcCCCCC-----hHHHhcCCcccc
Q 015005 244 DARRLISRILVADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s-----~~eil~hp~f~~ 274 (414)
++++|.+.+|++||.+|.. ++++.+||||+.
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 9999999999999999984 679999999976
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=357.41 Aligned_cols=250 Identities=32% Similarity=0.492 Sum_probs=206.1
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCccceEEEEEe-----C
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV---KHPNIVELKEVMAT-----K 88 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 88 (414)
+|++.+.||+|+||+||+|.+..+++.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5999999999999999999999999999999987643222 2233456777777765 69999999998864 3
Q ss_pred CEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
..++++|||+++ +|.+++.. ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999985 78777765 35899999999999999999999999999999999999999999999999999864
Q ss_pred ccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc-----------
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE----------- 234 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----------- 234 (414)
.. ........||+.|+|||++.+..+. .++||||+||++|+|++|..||..........++....
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cC---cccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 32 2223345689999999999887775 89999999999999999999998876655544443210
Q ss_pred c----------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 235 Y----------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 235 ~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
. ...+.++..+.+||.+||++||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112467788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=368.55 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=210.7
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK---- 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 88 (414)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 4678999999999999999999999999999999999765332 22346778899999999999999999998643
Q ss_pred --CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 --TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 --~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
...|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 5555554 368899999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh--------------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK-------------- 232 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-------------- 232 (414)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 2233456799999999999888775 789999999999999999999988665443332211
Q ss_pred --------ccc-----C---------------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 233 --------AEY-----E---------------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 233 --------~~~-----~---------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
... . .+...+.++++||.+||+.||++|||+.|+++||||...+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 000 0 0112356789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=369.25 Aligned_cols=256 Identities=28% Similarity=0.475 Sum_probs=211.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK---- 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 88 (414)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 3578999999999999999999999999999999999764322 22346678999999999999999999987543
Q ss_pred --CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 --TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 --~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
..+|+||||+++ +|.+.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 468999999976 5655554 358899999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-------------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------------- 233 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 233 (414)
. ........||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+.++...
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 2233456799999999999888775 7899999999999999999999887665554444321
Q ss_pred ---------ccCC--------------------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 ---------EYEF--------------------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 ---------~~~~--------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
...+ +...+.++++||.+||+.||.+|||+.|+|+||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0000 01134678999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=361.05 Aligned_cols=260 Identities=32% Similarity=0.601 Sum_probs=240.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 90 (414)
.+...+|..+.+||+|+||+|-+|..+.+.+.||||++.++.+-....++--..|-++|... +-|.+++++.+|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 34566899999999999999999999999999999999998776555566667788888877 57899999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+||||+.||+|...+++ |++.|..|..|+.+|+-||-+||++||++||||.+|||+|.+|++||+|||+++. ...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--ccc
Confidence 9999999999999999998 9999999999999999999999999999999999999999999999999999984 344
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
.+....+.||||.|+|||++.-++|. ..+|+||+||+|||||.|+.||++++..++++.|...+..+|..+|.++.++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 56678899999999999999999885 88999999999999999999999999999999999999999999999999999
Q ss_pred HhhcccCcCCCCCh-----HHHhcCCcccc
Q 015005 250 SRILVADPQKRISV-----SEIMINPWFIK 274 (414)
Q Consensus 250 ~~~L~~dp~~R~s~-----~eil~hp~f~~ 274 (414)
+..|.+.|.+|... .+|..||||+.
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhh
Confidence 99999999999864 68999999975
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=354.51 Aligned_cols=255 Identities=27% Similarity=0.472 Sum_probs=219.8
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+++++.++|+||+.+++.+..++..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999977655444444567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 97 ~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|+++++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 9999999887754 3699999999999999999999999999999999999999999999999999865322 122
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH----HHHHHHhcccCCCCCCCHHHHHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK----MYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
.....|++.|+|||++.+..++ .++|+||+||++|+|++|..||....... ....+......++..++.++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 2345799999999999887775 78999999999999999999998765433 233334444556677899999999
Q ss_pred HhhcccCcCCCCC-----hHHHhcCCccccC
Q 015005 250 SRILVADPQKRIS-----VSEIMINPWFIKG 275 (414)
Q Consensus 250 ~~~L~~dp~~R~s-----~~eil~hp~f~~~ 275 (414)
.+||+.||.+||+ +.+++.||||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=367.25 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=204.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATK 88 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 88 (414)
.++|++.+.||+|+||.||+|.+. .++..||+|++...... .....+.+|+.++..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--SEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--HHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999752 35578999998754322 2346788999999999 899999999988764
Q ss_pred -CEEEEEEEccCCCchHHHHhcC---------------------------------------------------------
Q 015005 89 -TKVFFVIEYVKGGELFAKVLKG--------------------------------------------------------- 110 (414)
Q Consensus 89 -~~~~lv~E~~~gg~L~~~i~~~--------------------------------------------------------- 110 (414)
..+|++|||++||+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999888641
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCccc
Q 015005 111 ------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV 184 (414)
Q Consensus 111 ------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 184 (414)
.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...............+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 36778889999999999999999999999999999999999999999999997543211111222344678899
Q ss_pred CchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHH-HHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCC
Q 015005 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMY-RKIFKAE-YEFPPWISCDARRLISRILVADPQKRI 261 (414)
Q Consensus 185 APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~-~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~ 261 (414)
|||++.+..++ .++|||||||++|+|++ |..||.+....+.+ ..+..+. ...|..+++++.+|+.+||+.||.+||
T Consensus 244 aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999887775 89999999999999997 99999876543333 3333332 345667899999999999999999999
Q ss_pred ChHHHhc
Q 015005 262 SVSEIMI 268 (414)
Q Consensus 262 s~~eil~ 268 (414)
|+.|+++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=380.89 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=202.8
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC------CCccceEEEEEe
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH------PNIVELKEVMAT 87 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~ 87 (414)
..++|++.+.||+|+||+||+|.+..+++.||||++..... .......|+.+++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 35789999999999999999999999999999999964321 23345667777776654 458889998876
Q ss_pred C-CEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCC------------
Q 015005 88 K-TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENG------------ 152 (414)
Q Consensus 88 ~-~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~------------ 152 (414)
. .++|+|||++ |++|.+++.+ +.+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 5 5789999988 6788887766 789999999999999999999998 5999999999999998765
Q ss_pred ----CeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHH
Q 015005 153 ----NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYR 228 (414)
Q Consensus 153 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~ 228 (414)
.+||+|||++.... ......+||+.|+|||++.+..|. .++|||||||++|+|++|+.||.+.+..+...
T Consensus 282 ~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999886322 223456899999999999988885 88999999999999999999998866544332
Q ss_pred HHHhcccCCC-----------------------C-------------------CCCHHHHHHHHhhcccCcCCCCChHHH
Q 015005 229 KIFKAEYEFP-----------------------P-------------------WISCDARRLISRILVADPQKRISVSEI 266 (414)
Q Consensus 229 ~i~~~~~~~~-----------------------~-------------------~~s~~~~~li~~~L~~dp~~R~s~~ei 266 (414)
.+......+| + ..++.+.+||++||+.||.+|||+.|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 2211100000 0 013457799999999999999999999
Q ss_pred hcCCccccCCC
Q 015005 267 MINPWFIKGFS 277 (414)
Q Consensus 267 l~hp~f~~~~~ 277 (414)
|+||||.+.+.
T Consensus 436 L~Hp~~~~~~~ 446 (467)
T PTZ00284 436 TTHPYVLKYYP 446 (467)
T ss_pred hcCccccccCC
Confidence 99999987544
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=346.10 Aligned_cols=252 Identities=27% Similarity=0.511 Sum_probs=219.1
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe-CCEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT-KTKVFFVI 95 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv~ 95 (414)
+|++.+.||+|++|.||++.+..+++.||+|.+....... ...+.+.+|+.+++.++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5999999999999999999999999999999997654332 234568899999999999999999998864 45789999
Q ss_pred EccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 96 EYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 96 E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
||+++++|.+.+.. ..+++.++..++.|++.||.+||++|++||||||+||+++.++.++|+|||++..... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence 99999999998875 3589999999999999999999999999999999999999999999999999876533 122
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHHh
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISR 251 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 251 (414)
......|++.|+|||++.+..++ .++|+||+|+++|+|++|..||...+.......+..+.. ..+..+++++.++|.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 33456789999999999887775 789999999999999999999998777766666655544 4556789999999999
Q ss_pred hcccCcCCCCChHHHhcCCcc
Q 015005 252 ILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f 272 (414)
||++||++|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=353.96 Aligned_cols=256 Identities=33% Similarity=0.495 Sum_probs=221.0
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
...+|++.+.||+|+||.||+|.+..+++.||+|.+....... .+.+.+|+.+++.++||||+++++.+......|+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 4568999999999999999999999999999999997655432 3668899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 94 VIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||||++|++|.+++..+.+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ....
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~--~~~~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 172 (296)
T ss_pred eecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc--cccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999875432 1122
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-c--cCCCCCCCHHHHHHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-E--YEFPPWISCDARRLIS 250 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~--~~~~~~~s~~~~~li~ 250 (414)
.....|++.|+|||.+.+..+. .++||||+||++|+|++|..||...+.......+... . ...|..++..+.+||.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred cCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 2345789999999999877664 8999999999999999999999887654433333222 1 2335568889999999
Q ss_pred hhcccCcCCCCChHHHhcCCccccC
Q 015005 251 RILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+||.+||++|||+.++++||||...
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=346.92 Aligned_cols=255 Identities=30% Similarity=0.567 Sum_probs=218.8
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch------hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK------QGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
+|.+.+.||.|++|.||+|.+..+++.+|+|.+....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5888999999999999999998899999999987543321 2234678899999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
.+++|||+++++|.+++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999987 789999999999999999999999999999999999999999999999999987654211
Q ss_pred C----CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-ccCCCCCCCHH
Q 015005 170 N----DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-EYEFPPWISCD 244 (414)
Q Consensus 170 ~----~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 244 (414)
. ........|++.|+|||.+.+..++ .++|+|||||++|+|++|..||...+......++... ....|..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 1112234588999999999887765 7899999999999999999999887655544444333 34566678999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 245 ARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
+.++|++||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=350.61 Aligned_cols=252 Identities=31% Similarity=0.526 Sum_probs=208.4
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999998754332 2234677899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 97 YVKGGELFAKVLK----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 97 ~~~gg~L~~~i~~----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|++ ++|.+++.. +.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 997 577777654 46899999999999999999999999999999999999999999999999998754321 12
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc------------------c
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------------------E 234 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------~ 234 (414)
......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234467899999999876554457899999999999999999999876543222211100 0
Q ss_pred c-----------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 235 Y-----------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 235 ~-----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
. .....+++++.+||++||+.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 0122378899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=352.16 Aligned_cols=255 Identities=33% Similarity=0.501 Sum_probs=221.3
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
..+|++.+.||.|++|.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 35799999999999999999999999999999999764432 246788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 95 IEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
+||++|++|...+....+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~--~~~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKR 172 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc--cccC
Confidence 99999999999998888999999999999999999999999999999999999999999999999998754321 1222
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc---cCCCCCCCHHHHHHHHh
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE---YEFPPWISCDARRLISR 251 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~ 251 (414)
....|++.|+|||.+.+..+. .++|+|||||++|+|++|..||...+.......+.... ...|..+++.+.+||++
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 345689999999999877664 78999999999999999999998876654444443322 23455688999999999
Q ss_pred hcccCcCCCCChHHHhcCCccccC
Q 015005 252 ILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
||..||.+|||+.+++.||||...
T Consensus 252 ~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 252 CLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HhhcChhhCCCHHHHhhChHhhhc
Confidence 999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=353.84 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=214.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||.||+|.+..++..+|+|.+..... .....++.+|++++++++||||+++++.+.+++.+|++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 469999999999999999999999999999999875432 223567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||++|++|.+++.+ +.+++..+..++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 99999999999876 789999999999999999999997 5999999999999999999999999999874322 22
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh---------------------
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------------------- 232 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------------- 232 (414)
....+|++.|+|||.+.+..+. .++|+|||||++|+|++|..||...+.......+..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 3456789999999999877664 789999999999999999999976553332221110
Q ss_pred ---------------c-ccCCCC-CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 233 ---------------A-EYEFPP-WISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 233 ---------------~-~~~~~~-~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
. .+..|. .++.++.+||.+||..||++|||+.++++||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0 011111 267889999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=354.36 Aligned_cols=258 Identities=33% Similarity=0.562 Sum_probs=226.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.+|++.+.||+|++|.||+|.+..+++.||+|.+.+.........+.+.+|+++++.++||||+++++.+......|++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998776554345677899999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC-
Q 015005 96 EYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND- 171 (414)
Q Consensus 96 E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 171 (414)
||+.|++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999998875 46899999999999999999999999999999999999999999999999998643221100
Q ss_pred --------------------------CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH
Q 015005 172 --------------------------GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK 225 (414)
Q Consensus 172 --------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~ 225 (414)
.......||..|+|||++.+..++ .++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC-chHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 011234688999999999887764 78999999999999999999999888887
Q ss_pred HHHHHHhcccCCCCC--CCHHHHHHHHhhcccCcCCCCC----hHHHhcCCcccc
Q 015005 226 MYRKIFKAEYEFPPW--ISCDARRLISRILVADPQKRIS----VSEIMINPWFIK 274 (414)
Q Consensus 226 ~~~~i~~~~~~~~~~--~s~~~~~li~~~L~~dp~~R~s----~~eil~hp~f~~ 274 (414)
.+..+......++.. ++.++.++|.+||..||++||| ++|+++||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 777777666666554 6899999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=346.73 Aligned_cols=252 Identities=31% Similarity=0.586 Sum_probs=223.4
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++||||+++++.+.++...|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987665544456789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 97 YVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 97 ~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
|+.|++|.+.+.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---Ccccc
Confidence 9999999999987 5899999999999999999999999999999999999999999999999999875432 22334
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH---HHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI---MKMYRKIFKAEYEFPPWISCDARRLISRI 252 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 252 (414)
...|+..|+|||.+.+..+. .++|+||||+++|+|++|..||...+. ..............|..++.++.++|++|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCCC-CcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 56689999999999877764 889999999999999999999988763 33333333356677778899999999999
Q ss_pred cccCcCCCCCh--HHHhcCCcc
Q 015005 253 LVADPQKRISV--SEIMINPWF 272 (414)
Q Consensus 253 L~~dp~~R~s~--~eil~hp~f 272 (414)
|..||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=348.68 Aligned_cols=255 Identities=30% Similarity=0.486 Sum_probs=217.8
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
|++.+.||+|+||.||+|.+..++..+|+|.+..... ...+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH---HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 7888999999999999999999999999999965432 2356788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 98 VKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 98 ~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
+++++|...+.. +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..... ......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--cccccc
Confidence 999999887764 6799999999999999999999999999999999999999999999999999875322 112234
Q ss_pred cccCCCcccCchhhc-----ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc---cCCCCCCCHHHHH
Q 015005 176 TQCGTPAYVAPEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE---YEFPPWISCDARR 247 (414)
Q Consensus 176 ~~~gt~~y~APE~~~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~ 247 (414)
...|++.|+|||++. +..+ +.++||||+||++|+|++|..||...+.......+.... ...|..++.++.+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred cccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 456899999999984 2334 368999999999999999999998877666655554433 2345568899999
Q ss_pred HHHhhcccCcCCCCChHHHhcCCccccCCCC
Q 015005 248 LISRILVADPQKRISVSEIMINPWFIKGFSK 278 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp~f~~~~~~ 278 (414)
||.+||+.||.+||++.++++||||......
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 271 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence 9999999999999999999999999865443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=351.80 Aligned_cols=258 Identities=31% Similarity=0.618 Sum_probs=222.4
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||.||++.+..+++.||+|.+.+.........+.+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999998765443444567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc-----
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW----- 169 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----- 169 (414)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999976 779999999999999999999999999999999999999999999999999986311000
Q ss_pred --------CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC--
Q 015005 170 --------NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP-- 239 (414)
Q Consensus 170 --------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 239 (414)
.........|++.|+|||.+.+..+. .++|+|||||++|+|++|..||.+.+..+....+..+....|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 00011234678899999998877664 8899999999999999999999988877777777666544433
Q ss_pred -CCCHHHHHHHHhhcccCcCCCCC---hHHHhcCCcccc
Q 015005 240 -WISCDARRLISRILVADPQKRIS---VSEIMINPWFIK 274 (414)
Q Consensus 240 -~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~f~~ 274 (414)
.++.++.++|++||+.||++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 47889999999999999999997 789999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=340.97 Aligned_cols=252 Identities=28% Similarity=0.471 Sum_probs=221.5
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.|.+.+.||+|++|.||+|.+..+++.|++|.+....... .....+.+|+.+++.++||||+++++++...+..|++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 4889999999999999999999999999999997654332 235678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 97 ~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 9999999998876 46899999999999999999999999999999999999999999999999998754431 222
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-CCCCCCHHHHHHHHhh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FPPWISCDARRLISRI 252 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~ 252 (414)
....+|++.|+|||++.+..++ .++|+||||+++|+|++|..||...+.......+..+..+ .+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3445789999999999887765 7899999999999999999999988877777776665543 4446889999999999
Q ss_pred cccCcCCCCChHHHhcCCcc
Q 015005 253 LVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f 272 (414)
|+.+|++||++.+++.|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=352.74 Aligned_cols=252 Identities=33% Similarity=0.570 Sum_probs=208.0
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+...+|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 599999999999999999999999999999999765332 2234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 97 YVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 97 ~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
|+++ +|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence 9975 67666653 67999999999999999999999999999999999999999999999999998754321 1222
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCC-CCchHHHHHHHHHhc----------------cc--
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPF-QNENIMKMYRKIFKA----------------EY-- 235 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf-~~~~~~~~~~~i~~~----------------~~-- 235 (414)
....+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+..+.++.+... ..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877554458899999999999999998885 444444444333210 00
Q ss_pred -----------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 236 -----------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 236 -----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
...+.+++++.+||.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0112367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=353.16 Aligned_cols=257 Identities=33% Similarity=0.506 Sum_probs=220.5
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
...+|++.+.||+|+||.||+|.+..+++.||+|.+....... .+.+.+|+.+++.++||||+++++++......|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 4578999999999999999999999999999999997654332 3567899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 94 VIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||||++|++|.+++.+..+++.++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++..... ....
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~--~~~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 171 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC--CccC
Confidence 99999999999999888899999999999999999999999999999999999999999999999999875432 1122
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh-cc--cCCCCCCCHHHHHHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK-AE--YEFPPWISCDARRLIS 250 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-~~--~~~~~~~s~~~~~li~ 250 (414)
.....|++.|+|||.+.+..+. .++|+||+||++|+|++|..||...+.......+.. +. ...|..++..+.+||.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred cCcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 2345689999999999887764 789999999999999999999987655433222222 11 2244567889999999
Q ss_pred hhcccCcCCCCChHHHhcCCccccCC
Q 015005 251 RILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
+||..||++||++.++++||||....
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHccCChhhCcCHHHHhcCchhcccc
Confidence 99999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=350.54 Aligned_cols=255 Identities=34% Similarity=0.508 Sum_probs=220.1
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||.|+||.||+|.+..++..+|+|++.... ....+.+.+|+.+++.++||||+++++.+..+...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 356999999999999999999998899999999996543 22346788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~--~~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc--ccc
Confidence 999999999998876 4699999999999999999999999999999999999999999999999999875332 122
Q ss_pred ccccccCCCcccCchhhcc-----cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc---CCCCCCCHH
Q 015005 173 LLHTQCGTPAYVAPEVLRK-----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY---EFPPWISCD 244 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~ 244 (414)
......|++.|+|||++.. ..+ +.++|+||||+++|+|++|..||...+......++..+.. ..|..++.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~-~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPY-DYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCC-CccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence 2334568999999999853 223 3689999999999999999999998877666666665533 335568899
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 245 ARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+.++|.+||+.||.+||++.++++||||.+.
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=366.22 Aligned_cols=254 Identities=31% Similarity=0.463 Sum_probs=217.0
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-C-----CCccceEE
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-H-----PNIVELKE 83 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~ 83 (414)
+.+++..+|++.++||+|+||+|-+|.+..|++.||||+++.... ...+...|+.+|..|+ | -|+|++++
T Consensus 180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred ecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 456777799999999999999999999999999999999976543 3567778999999996 4 37999999
Q ss_pred EEEeCCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC--CeEEee
Q 015005 84 VMATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG--NLKVSD 158 (414)
Q Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~--~~kl~D 158 (414)
+|...+++|||.|.+. -+|+++++. .+++...++.++.||+.||..||+.||+|+|||||||||...+ .+||+|
T Consensus 256 ~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred ccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEe
Confidence 9999999999999994 699999986 5799999999999999999999999999999999999997543 799999
Q ss_pred cCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh------
Q 015005 159 FGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK------ 232 (414)
Q Consensus 159 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------ 232 (414)
||.|+... ....+.+-+..|.|||++.|.+|+ .+.||||||||++||++|.+.|.+++..+++..|..
T Consensus 335 FGSSc~~~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 335 FGSSCFES-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred cccccccC-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99998533 234477889999999999999997 899999999999999999999999887766554432
Q ss_pred ----------------------------------------------cccCCCCC-----------CCHHHHHHHHhhccc
Q 015005 233 ----------------------------------------------AEYEFPPW-----------ISCDARRLISRILVA 255 (414)
Q Consensus 233 ----------------------------------------------~~~~~~~~-----------~s~~~~~li~~~L~~ 255 (414)
.+...|+. -...+.++|++||++
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 00011200 123578999999999
Q ss_pred CcCCCCChHHHhcCCcccc
Q 015005 256 DPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 256 dp~~R~s~~eil~hp~f~~ 274 (414)
||.+|+|+.|+|+||||..
T Consensus 489 dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 489 DPAERITPAQALNHPFLTG 507 (586)
T ss_pred CchhcCCHHHHhcCccccc
Confidence 9999999999999999974
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=347.30 Aligned_cols=255 Identities=29% Similarity=0.510 Sum_probs=222.6
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||.|++|.||+|.+..+++.||+|.+...... .....+.+|+++++.++||||+++++++.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 4799999999999999999999999999999999765422 23466889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 96 EYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 96 E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
||+++++|.+++..+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 99999999999988899999999999999999999999999999999999999999999999999998654321 2233
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCC-CCHHHHHHHHhhc
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPW-ISCDARRLISRIL 253 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~~~~~li~~~L 253 (414)
...|++.|+|||.+.+..++ .++||||+|+++|+|++|..||...+.......+..... ..+.. ++.++.+++.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 45688999999999887765 899999999999999999999988766555555544433 33444 7889999999999
Q ss_pred ccCcCCCCChHHHhcCCccccC
Q 015005 254 VADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 254 ~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..||++|||++++++||||.+.
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCC
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=366.44 Aligned_cols=254 Identities=29% Similarity=0.445 Sum_probs=208.4
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEEC--CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNL--VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
.....+|++.+.||+|+||.||+|... .+++.||+|.+.... ...+|+.+++.++||||+++++++....
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 345668999999999999999999754 356789999986532 3458999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.+|++||++. ++|.+++.. +.+++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999996 578787765 78999999999999999999999999999999999999999999999999999754432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH---HHHHHHHHh-------------
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI---MKMYRKIFK------------- 232 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~------------- 232 (414)
..........||+.|+|||++.+..|. .++|||||||++|+|++|..||.+... ...+..+..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 222233456799999999999888775 789999999999999999999976431 111111111
Q ss_pred ----------------cccCCCC-----CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 233 ----------------AEYEFPP-----WISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 233 ----------------~~~~~~~-----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..+..|. .++.++.++|++||..||++|||+.|+|+||||.+.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0011111 246688999999999999999999999999999764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=373.00 Aligned_cols=257 Identities=32% Similarity=0.486 Sum_probs=228.7
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.+.|+|+..||.|+||+||+|.++.++-..|.|+|.... ...++++.-||+||..++||+||++++.|..++.++|+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 346899999999999999999999999999999996544 23467888999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
.|||.||-....+.. ..+++.++..+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.+..... ...
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q 185 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ 185 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence 999999999888776 6799999999999999999999999999999999999999999999999999874222 223
Q ss_pred ccccccCCCcccCchhhc-----ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC---CCCCCCHH
Q 015005 173 LLHTQCGTPAYVAPEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE---FPPWISCD 244 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~ 244 (414)
...+..|||+|||||++. ..+|+ .++||||||++|.+|.-+.+|...-++....-+|.+..++ -|+..+..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence 446778999999999863 45676 8999999999999999999999999999988888887765 46778899
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 245 ARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
+.+++.+||.+||..||+++++|+||||.....
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 999999999999999999999999999986543
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=348.73 Aligned_cols=256 Identities=32% Similarity=0.454 Sum_probs=218.5
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
..++|++.+.||.|+||.||+|.+..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.....+|+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 3577999999999999999999999999999999997543 2235678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 94 VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
||||++|++|...+.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ..
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~ 164 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TL 164 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc--cc
Confidence 9999999999887754 5789999999999999999999999999999999999999999999999999864322 11
Q ss_pred CccccccCCCcccCchhhcc-----cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc---CCCCCCCH
Q 015005 172 GLLHTQCGTPAYVAPEVLRK-----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY---EFPPWISC 243 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~ 243 (414)
.......+++.|+|||++.+ ..+ +.++|+|||||++|+|++|..||...+......++..... ..+..++.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred cccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence 22234568899999999853 233 3689999999999999999999988776665555544432 23456788
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++.++|++||..||++||+++++++||||..-
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 99999999999999999999999999999653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=347.11 Aligned_cols=251 Identities=29% Similarity=0.466 Sum_probs=211.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++.+...+.+|++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999998755322 235678899999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|||+++++|.+++.. +.+++.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--cccc
Confidence 999999999998876 7899999999999999999999999999999999999999999999999999875432 1222
Q ss_pred cccccCCCcccCchhhc---ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC-----CCCCHHH
Q 015005 174 LHTQCGTPAYVAPEVLR---KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP-----PWISCDA 245 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~~ 245 (414)
.....|++.|+|||++. ...+ +.++|+||+||++|+|++|..||...................+ ..++..+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred cccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 34457999999999974 3335 4789999999999999999999976544333322222222221 2367889
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCc
Q 015005 246 RRLISRILVADPQKRISVSEIMINPW 271 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~ 271 (414)
.++|.+||..||++|||++++++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=346.02 Aligned_cols=254 Identities=31% Similarity=0.484 Sum_probs=211.6
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|++|.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 5799999999999999999999999999999998654322 122356789999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
||++++.|...+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP--GDDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC--cccc
Confidence 99999988887765 67999999999999999999999999999999999999999999999999999865432 1122
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-------------------cc
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-------------------EY 235 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~ 235 (414)
....++..|+|||++.+....+.++||||+|+++|+|++|..||.+.+..+....+... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34457889999999876544457899999999999999999999876544332222110 00
Q ss_pred CCC------------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 236 EFP------------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 236 ~~~------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
..| +.++..+.+||.+||++||++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.58 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=212.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.....+|
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 3456899999999999999999999999999999999754322 2356789999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+||||+++++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~ 160 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--I 160 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--c
Confidence 99999999999998875 78999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CccccccCCCcccCchhhcc---cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC-----CCCCH
Q 015005 172 GLLHTQCGTPAYVAPEVLRK---KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP-----PWISC 243 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~ 243 (414)
.......|++.|+|||.+.. ..+ +.++|+||+||++|+|++|..||...........+.......+ ..++.
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred cccCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 12234568999999999853 234 4789999999999999999999976554433322222222221 23678
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCc
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPW 271 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~ 271 (414)
.+.+||++||+.||++|||++++++|+|
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=354.67 Aligned_cols=246 Identities=28% Similarity=0.468 Sum_probs=193.4
Q ss_pred eeeeeecCCeEEEEEEEC--CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEEEEEEE
Q 015005 21 GRMLGQGTFAKVYYGKNL--VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT--KTKVFFVIE 96 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E 96 (414)
++.||+|+||+||+|.+. .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 568999999999999865 4678999999865432 2356789999999999999999999854 467899999
Q ss_pred ccCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE----cCCCCeEEeecCCC
Q 015005 97 YVKGGELFAKVLK----------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL----DENGNLKVSDFGLS 162 (414)
Q Consensus 97 ~~~gg~L~~~i~~----------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl----~~~~~~kl~DFGla 162 (414)
|+. ++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 996 477776642 258999999999999999999999999999999999999 45678999999999
Q ss_pred ccccccc-CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH---------HHHHHHHHh
Q 015005 163 ALPEQLW-NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI---------MKMYRKIFK 232 (414)
Q Consensus 163 ~~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---------~~~~~~i~~ 232 (414)
....... ........+||+.|+|||++.+....+.++||||+||++|+|++|..||..... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 8654321 112234567899999999998765445889999999999999999999965321 111111111
Q ss_pred c----------------------------ccCC----------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 233 A----------------------------EYEF----------PPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 233 ~----------------------------~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
. .... ....+.++.+||++||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0000 01135578999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=386.85 Aligned_cols=264 Identities=30% Similarity=0.450 Sum_probs=218.7
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe-
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT- 87 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 87 (414)
..++.+.++|++.+.||+|+||+||+|.+..++..||+|++....... .....+.+|+.+++.++|||||++++++..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 347788999999999999999999999999999999999997654432 235678899999999999999999998854
Q ss_pred -CCEEEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-------CcEEecCCCCcEEEcC----
Q 015005 88 -KTKVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSR-------GVYHRDLKPENLLLDE---- 150 (414)
Q Consensus 88 -~~~~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~-------gi~HrDlkp~NILl~~---- 150 (414)
...+||||||+++|+|.+.+.. +.+++..++.++.||+.||.|||+. +|+||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4679999999999999998864 5799999999999999999999984 4999999999999964
Q ss_pred -------------CCCeEEeecCCCcccccccCCCccccccCCCcccCchhhccc-CCCCCccchhhhhhhhhhhhcCCC
Q 015005 151 -------------NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK-GYDGAKSDIWSCGVVLFVLLSGFL 216 (414)
Q Consensus 151 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DiwSlGvil~~ll~g~~ 216 (414)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 23589999999985432 2233456799999999998643 223478999999999999999999
Q ss_pred CCCCchHHHHHHHHHhcccCCC-CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 217 PFQNENIMKMYRKIFKAEYEFP-PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 217 Pf~~~~~~~~~~~i~~~~~~~~-~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
||...+............+..| ...+.++.+||.+||..+|.+||++.|+|.|||+....
T Consensus 242 PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 9986554433333333333333 34789999999999999999999999999999997543
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=342.14 Aligned_cols=255 Identities=30% Similarity=0.517 Sum_probs=219.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||.|+||+||+|.+..++..+|+|++....... ..+.+.+|+.+++.++||||+++++.+......|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999997654433 3578899999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 96 EYVKGGELFAKVLK----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 96 E~~~gg~L~~~i~~----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
|+++|++|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999875 35899999999999999999999999999999999999999999999999998755432221
Q ss_pred --CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-CC-----CCCCH
Q 015005 172 --GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FP-----PWISC 243 (414)
Q Consensus 172 --~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~-----~~~s~ 243 (414)
.......|++.|+|||++......+.++|+|||||++|+|++|..||...+....+.++...... .+ ..++.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12244568999999999877633458899999999999999999999887766666655544322 11 24678
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.+.+++.+||..||++|||+.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=345.67 Aligned_cols=250 Identities=25% Similarity=0.444 Sum_probs=211.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.++++++||||+++++.+......+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 368899999999999999999999999999999976532 223467889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 96 EYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 96 E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
||+++++|... ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..... ....
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----cccc
Confidence 99999998544 4678999999999999999999999999999999999999999999999999975432 2234
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH-------HHHHHHHHhcccC-C-CCCCCHHHH
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI-------MKMYRKIFKAEYE-F-PPWISCDAR 246 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~-~-~~~~s~~~~ 246 (414)
..+||+.|+|||++.+..+. .++|+||+|+++|+|++|..||..... ......+...... . ....++++.
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 56799999999999887775 899999999999999999999965321 1222222222222 2 234788999
Q ss_pred HHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 247 RLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++|.+||+.||.+||++.++++||||...
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=339.70 Aligned_cols=252 Identities=30% Similarity=0.564 Sum_probs=221.3
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||+|+||.||++.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 6999999999999999999999999999999997654332 234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 97 ~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VEL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--hhh
Confidence 9999999998865 25899999999999999999999999999999999999999999999999999754331 112
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHHhh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISRI 252 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~ 252 (414)
.....|++.|+|||++.+..+. .++|+|||||++|+|++|..||...+..+....+..+.. ..|..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 2344588999999999877664 789999999999999999999998887777777766554 35666899999999999
Q ss_pred cccCcCCCCChHHHhcCCcc
Q 015005 253 LVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f 272 (414)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=342.65 Aligned_cols=256 Identities=28% Similarity=0.531 Sum_probs=214.7
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch-------hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK-------QGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6899999999999999999998899999999986432211 123457889999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
..++||||++|++|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999887 78999999999999999999999999999999999999999999999999999754432
Q ss_pred cCCCccccccCCCcccCchhhcccC-CCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--ccCCCC----CC
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKG-YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EYEFPP----WI 241 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~----~~ 241 (414)
..........|+..|+|||.+.... ..+.++|+||||+++|++++|..||...........+... ...++. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222234456899999999987654 2247899999999999999999999766554433333222 222332 35
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
+.++.++|.+||.+||.+|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=367.39 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=204.3
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
...+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|++++++++||||+++++++...+..|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 45689999999999999999999999999999996422 235689999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 94 VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+||++. ++|..++.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 678777765 56999999999999999999999999999999999999999999999999999865432222
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc--------hHHHHHHHHHhccc--------
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE--------NIMKMYRKIFKAEY-------- 235 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--------~~~~~~~~i~~~~~-------- 235 (414)
......+||+.|+|||++.+..++ .++|||||||+||+|++|..|+... ......+.+.....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 223345799999999999888775 8999999999999999987654221 11222222221111
Q ss_pred ---------------------CCCC-----CCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 236 ---------------------EFPP-----WISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 236 ---------------------~~~~-----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..+. .++.++.+||++||+.||.+|||+.|+|+||||..
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111 24568999999999999999999999999999964
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=357.84 Aligned_cols=246 Identities=37% Similarity=0.676 Sum_probs=218.1
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (414)
++||+|.||+||-|.++.+|+.||||+++|......+ ..++++|+.||..+.||+||.+.-.|++.+.+++|||-+.|.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 7899999999999999999999999999987765432 478999999999999999999999999999999999999765
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC---CCeEEeecCCCcccccccCCCcccc
Q 015005 102 ELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN---GNLKVSDFGLSALPEQLWNDGLLHT 176 (414)
Q Consensus 102 ~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~~~~~~~~ 176 (414)
-|.-.+.. |++++...+.++.||+.||.|||-+||+|+||||||||+... ..+||||||+|+.... .....+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksFRrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSFRRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---hhhhhh
Confidence 55444443 899999999999999999999999999999999999999754 3799999999997653 445567
Q ss_pred ccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC--C--CCHHHHHHHHhh
Q 015005 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP--W--ISCDARRLISRI 252 (414)
Q Consensus 177 ~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s~~~~~li~~~ 252 (414)
.+|||.|.|||++..++|+ ..-|+||.|||+|.-|+|..||... ++.-.+|.+..+.+|+ | +++++.+||..+
T Consensus 726 VVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~L 802 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNL 802 (888)
T ss_pred hcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence 8899999999999999997 7899999999999999999999764 3445566677776664 4 899999999999
Q ss_pred cccCcCCCCChHHHhcCCcccc
Q 015005 253 LVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f~~ 274 (414)
|+..-.+|+|+...+.|||++.
T Consensus 803 LqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHhcchHhhccchhhhc
Confidence 9999999999999999999864
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=344.17 Aligned_cols=251 Identities=29% Similarity=0.470 Sum_probs=210.7
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC-----
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATK----- 88 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~----- 88 (414)
.+.|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 46799999999999999999999999999999999754322 35678899999998 799999999998753
Q ss_pred -CEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 89 -TKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 89 -~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
..+|++|||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 468999999999999998875 3589999999999999999999999999999999999999999999999999875
Q ss_pred cccccCCCccccccCCCcccCchhhcc-----cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc--CC
Q 015005 165 PEQLWNDGLLHTQCGTPAYVAPEVLRK-----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY--EF 237 (414)
Q Consensus 165 ~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~ 237 (414)
... .........|++.|+|||++.+ ..+ +.++|+||+||++|+|++|..||...........+..... ..
T Consensus 161 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 161 LDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred ccc--ccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 432 1223345679999999999863 234 4789999999999999999999977655444433332221 12
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
+..++.++.+|+.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 23478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=341.97 Aligned_cols=254 Identities=28% Similarity=0.488 Sum_probs=215.6
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc---hhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK---KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
+|++.+.||.|+||+||+|.+ .+++.+|+|.+...... .......+.+|+++++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 488999999999999999986 57889999998754321 22234678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc---
Q 015005 94 VIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW--- 169 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 169 (414)
++||++|++|.+++.+ +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999887 789999999999999999999999999999999999999999999999999987532111
Q ss_pred -CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc---ccCCCCCCCHHH
Q 015005 170 -NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA---EYEFPPWISCDA 245 (414)
Q Consensus 170 -~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~ 245 (414)
.........|++.|+|||++.+..+. .++|+|||||++|+|++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11223345689999999999887775 7899999999999999999999876554443333322 234566689999
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 246 RRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.++|++||+++|.+||++.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=345.35 Aligned_cols=254 Identities=31% Similarity=0.530 Sum_probs=214.9
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||+|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 599999999999999999999999999999999765432 2335678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 97 YVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 97 ~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
|+ |++|.+.+.. ..+++.+++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-CCcc
Confidence 99 9999998865 579999999999999999999999999999999999999999999999999998654321 1223
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-------------------cc
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-------------------EY 235 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~ 235 (414)
....|++.|+|||.+.+....+.++||||+|+++|+|++|..||.+.+....+..+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 44578999999999876655468999999999999999999999876655544433221 00
Q ss_pred C-----------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 236 E-----------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 236 ~-----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
. ..+..+.++.+||.+||+.||++|||++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 1123578899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=347.06 Aligned_cols=239 Identities=20% Similarity=0.295 Sum_probs=208.8
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe----CCEEEEEEEc
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT----KTKVFFVIEY 97 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~ 97 (414)
..||+|++|.||+|.. +|+.||+|.+.+.........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999985 789999999987655444456788899999999999999999999877 4578999999
Q ss_pred cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 98 VKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 98 ~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
++||+|.+++.. +.+++.....++.|++.||.|||+. |++||||||+|||++.++.+||+|||++..... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----ccc
Confidence 999999999987 6799999999999999999999984 999999999999999999999999999875432 123
Q ss_pred cccCCCcccCchhhcc--cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--ccCCCCCCCHHHHHHHHh
Q 015005 176 TQCGTPAYVAPEVLRK--KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EYEFPPWISCDARRLISR 251 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~ 251 (414)
...||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..+.+..+... .++.|...++++.+|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999976 456 48999999999999999999999998888887777544 345555689999999999
Q ss_pred hcccCcCCCCChHHHhc
Q 015005 252 ILVADPQKRISVSEIMI 268 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~ 268 (414)
||+.||++|||+.|+++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999985
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=341.98 Aligned_cols=247 Identities=37% Similarity=0.677 Sum_probs=219.4
Q ss_pred eeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCch
Q 015005 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL 103 (414)
Q Consensus 24 LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 103 (414)
||.|++|.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++...|++|||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876655444567899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCc
Q 015005 104 FAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182 (414)
Q Consensus 104 ~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 182 (414)
.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... .......|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc---cccccccCCcC
Confidence 999987 57899999999999999999999999999999999999999999999999999854331 12334578999
Q ss_pred ccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch--HHHHHHHHH--hcccCCCCCCCHHHHHHHHhhcccCcC
Q 015005 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN--IMKMYRKIF--KAEYEFPPWISCDARRLISRILVADPQ 258 (414)
Q Consensus 183 y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~--~~~~~~~~~~s~~~~~li~~~L~~dp~ 258 (414)
|+|||.+.+..++ .++|+||+|+++|+|++|..||.... ....+..+. .....+|...+.++.++|.+||..||+
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998877775 78999999999999999999998776 666666666 445667777899999999999999999
Q ss_pred CCCC-----hHHHhcCCcccc
Q 015005 259 KRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 259 ~R~s-----~~eil~hp~f~~ 274 (414)
+||+ +.|+++||||..
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999964
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=355.23 Aligned_cols=253 Identities=22% Similarity=0.389 Sum_probs=205.9
Q ss_pred Eeeeeeec--CCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 20 MGRMLGQG--TFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 20 ~~~~LG~G--~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
++++||+| +|++||++.+..+|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 78999999999999999999997654332 2456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC----
Q 015005 98 VKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN---- 170 (414)
Q Consensus 98 ~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 170 (414)
+++|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999998864 4589999999999999999999999999999999999999999999999986543211100
Q ss_pred -CCccccccCCCcccCchhhccc--CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-----------
Q 015005 171 -DGLLHTQCGTPAYVAPEVLRKK--GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE----------- 236 (414)
Q Consensus 171 -~~~~~~~~gt~~y~APE~~~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~----------- 236 (414)
........++..|+|||++.+. .| +.++||||+||++|+|++|..||..............+..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0111234577889999999763 45 47899999999999999999999875443333222211110
Q ss_pred -----------------------------------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 237 -----------------------------------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 237 -----------------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
....+++++.+||++||+.||++|||++|+++||||.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 01124678999999999999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=337.72 Aligned_cols=248 Identities=31% Similarity=0.573 Sum_probs=217.1
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... ...+.+.+|+.+++.++||||+++++.+.+.+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 589999999999999999999999999999998754322 235678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 97 ~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|+++|+|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 9999999988864 45899999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHHhh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISRI 252 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~ 252 (414)
.....|++.|+|||++.+..++ .++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.+||++|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 2345689999999999887765 789999999999999999999998887777777666554 35666889999999999
Q ss_pred cccCcCCCCChHHHhcC
Q 015005 253 LVADPQKRISVSEIMIN 269 (414)
Q Consensus 253 L~~dp~~R~s~~eil~h 269 (414)
|+.||++|||+.+++.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=347.47 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=213.6
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ...+.+.+|+++++.++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999899999999986644332 33567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
||+++++|...... ..+++.++..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999999887765 57999999999999999999999999999999999999999999999999998754331 1223
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-------------------cc
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-------------------EY 235 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~ 235 (414)
....++..|+|||++.+....+.++||||+|+++|+|++|..||......+....+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34568899999999876554457899999999999999999999876544433332210 00
Q ss_pred C------------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 236 E------------FPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 236 ~------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
. .++.++..+.+|+.+||+.||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=347.30 Aligned_cols=254 Identities=26% Similarity=0.479 Sum_probs=215.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 468999999999999999999999999999999865422 223467889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 96 EYVKGGELFAKVLKG----KLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 96 E~~~gg~L~~~i~~~----~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
||++|++|..++..+ .+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999998888764 79999999999999999999997 5999999999999999999999999999874321
Q ss_pred CCccccccCCCcccCchhhcccCC-----CCCccchhhhhhhhhhhhcCCCCCCCchHHHHHH---HHHhcc-cCCCCCC
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGY-----DGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYR---KIFKAE-YEFPPWI 241 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~---~i~~~~-~~~~~~~ 241 (414)
.......|++.|+|||.+.+... .+.++|+|||||++|+|++|..||........+. .+..+. ...|+.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 22344568899999999865432 2478999999999999999999997765544333 233332 3456678
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+.++.+||.+||+.+|.+||++.+++.||||...
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=362.78 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=207.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCC-----CeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVT-----QESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATK 88 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 88 (414)
.++|++++.||+|+||.||+|.+..+ +..||+|++....... ....+.+|+.+++.+ +||||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--EREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH--HHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 45799999999999999999986544 3579999997654322 256788999999999 899999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc-----------------------------------------------------------
Q 015005 89 TKVFFVIEYVKGGELFAKVLK----------------------------------------------------------- 109 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~----------------------------------------------------------- 109 (414)
..+|+||||+++|+|.+++..
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999988753
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccc
Q 015005 110 ------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ 177 (414)
Q Consensus 110 ------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 177 (414)
.++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..............
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 13678889999999999999999999999999999999999999999999998754321111112223
Q ss_pred cCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc--ccCCCCCCCHHHHHHHHhhcc
Q 015005 178 CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA--EYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 178 ~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~ 254 (414)
.+++.|+|||++.+..++ .++|||||||++|+|++ |..||........+...... ....|..+++++.++|.+||+
T Consensus 275 ~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 275 RLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred CCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 356789999999877775 89999999999999997 99999876554444444333 334566789999999999999
Q ss_pred cCcCCCCChHHHhc
Q 015005 255 ADPQKRISVSEIMI 268 (414)
Q Consensus 255 ~dp~~R~s~~eil~ 268 (414)
.||.+|||+.++++
T Consensus 354 ~dp~~RPs~~~l~~ 367 (374)
T cd05106 354 LEPTERPTFSQISQ 367 (374)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=344.99 Aligned_cols=247 Identities=30% Similarity=0.502 Sum_probs=204.0
Q ss_pred eeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHH---hCCCCCccceEEEEEeCCEEEEEEEccC
Q 015005 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR---LVKHPNIVELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 23 ~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 99 (414)
.||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++ ...||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997765432222233344544443 4479999999999999999999999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcccccc
Q 015005 100 GGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQC 178 (414)
Q Consensus 100 gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 178 (414)
||+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..... .......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----cCccCcC
Confidence 9999988876 7899999999999999999999999999999999999999999999999999874332 1223457
Q ss_pred CCCcccCchhhcc-cCCCCCccchhhhhhhhhhhhcCCCCCCCch---HHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 015005 179 GTPAYVAPEVLRK-KGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN---IMKMYRKIFKAEYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 179 gt~~y~APE~~~~-~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 254 (414)
||+.|+|||.+.+ ..+ +.++||||+||++|+|++|..||.... ...............|+.+++++.++|++||.
T Consensus 157 ~~~~y~aPE~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCC-CchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 9999999999864 444 478999999999999999999997532 22222223334455677789999999999999
Q ss_pred cCcCCCC-----ChHHHhcCCcccc
Q 015005 255 ADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 255 ~dp~~R~-----s~~eil~hp~f~~ 274 (414)
.||.+|| |+.++++||||..
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCccccC
Confidence 9999999 6999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=344.93 Aligned_cols=256 Identities=36% Similarity=0.699 Sum_probs=228.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 94 (414)
++|.+.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++ ||||+++++++.+.+..|++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765544444577889999999998 99999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC--
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND-- 171 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 171 (414)
|||+++++|.+.+.+ +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999987 58999999999999999999999999999999999999999999999999998764432211
Q ss_pred ----------------CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc
Q 015005 172 ----------------GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY 235 (414)
Q Consensus 172 ----------------~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 235 (414)
.......|++.|+|||++.+..+ +.++|+||||++++++++|..||...+....++.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 12233457899999999887665 4789999999999999999999999887777777777788
Q ss_pred CCCCCCCHHHHHHHHhhcccCcCCCCCh----HHHhcCCcc
Q 015005 236 EFPPWISCDARRLISRILVADPQKRISV----SEIMINPWF 272 (414)
Q Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~s~----~eil~hp~f 272 (414)
.+|..+++.+.++|.+||+.||.+|||+ .++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=342.54 Aligned_cols=256 Identities=27% Similarity=0.485 Sum_probs=215.7
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc---hhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK---KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
+|+..+.||+|++|.||+|.+..+++.||+|++...... .....+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488899999999999999999999999999999754422 12245788999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-CeEEeecCCCcccccccC-
Q 015005 94 VIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-NLKVSDFGLSALPEQLWN- 170 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~- 170 (414)
||||++|++|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999998876 7899999999999999999999999999999999999998776 599999999875443211
Q ss_pred -CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHH---H--hcccCCCCCCCHH
Q 015005 171 -DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI---F--KAEYEFPPWISCD 244 (414)
Q Consensus 171 -~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i---~--~~~~~~~~~~s~~ 244 (414)
........|+..|+|||.+.+..++ .++|+||+|+++|+|++|..||...........+ . ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1112234688999999999877765 7899999999999999999999765432222222 1 2234556678999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 245 ARRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
+.+++.+||..||.+|||+.++++||||.
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=337.97 Aligned_cols=250 Identities=32% Similarity=0.503 Sum_probs=216.2
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||.|+||.||+|.+..+++.+|+|++...... ..+.+.+|+.+++.++||||+++++++.+...+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999999765433 3577889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||+++++|.+++.. ..+++.++..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--hhc
Confidence 99999999998875 58999999999999999999999999999999999999999999999999998754331 112
Q ss_pred cccccCCCcccCchhhccc---CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-----CCCCCCHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKK---GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-----FPPWISCDA 245 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~~ 245 (414)
.....++..|+|||.+.+. .++ .++|+||||+++|+|++|..||...+.......+....+. .+..++.++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 3345689999999998766 564 7899999999999999999999887655544444443222 223467889
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCc
Q 015005 246 RRLISRILVADPQKRISVSEIMINPW 271 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~ 271 (414)
.++|++||..||..|||+.+++.|||
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=343.67 Aligned_cols=257 Identities=28% Similarity=0.528 Sum_probs=218.8
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC---CCCccceEEEEEeCCEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK---HPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 93 (414)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.+++.++ |||++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 588899999999999999999999999999998764322 23567889999999986 9999999999999999999
Q ss_pred EEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 94 VIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
+|||++|++|.+++..+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ...
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSK 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC--ccc
Confidence 999999999999998888999999999999999999999999999999999999999999999999998765432 222
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCC-CCHHHHHHHHh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPW-ISCDARRLISR 251 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~~~~~li~~ 251 (414)
.....|++.|+|||.+.+....+.++|+|||||++|+|++|..||...........+..... .++.. ++.++.+++++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 34456899999999987544445789999999999999999999988766554443333222 22332 78899999999
Q ss_pred hcccCcCCCCChHHHhcCCccccCCC
Q 015005 252 ILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
||+.||.+||++.+++.||||.+...
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhcccc
Confidence 99999999999999999999977543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.05 Aligned_cols=254 Identities=32% Similarity=0.549 Sum_probs=206.8
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
..++|++.+.||+|++|.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 3578999999999999999999999999999999987643221 12346689999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 94 VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
||||+++ +|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~ 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--S 157 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--C
Confidence 9999985 88888765 56899999999999999999999999999999999999999999999999998743221 1
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch-HHHHHHHHHhc-----------------
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-IMKMYRKIFKA----------------- 233 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~----------------- 233 (414)
.......+++.|+|||++.+....+.++||||+|+++|+|++|..||.... ..+....+...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 112234578899999998764433578999999999999999999997654 22222221110
Q ss_pred --ccCC-----------CCCCC--HHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 234 --EYEF-----------PPWIS--CDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 234 --~~~~-----------~~~~s--~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.... .+.++ .++.++|.+||++||++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=362.97 Aligned_cols=259 Identities=32% Similarity=0.567 Sum_probs=240.7
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.++-+.+.+++.+||-|+||.|=++........+|+|+++|..+-+....+.+..|-.||..++.|.||++|-.|.+..+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 45667788999999999999999998665555699999999888777778889999999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|++||-|-||+|+..+.. |.|.+..++.|...++.|++|||++||++|||||+|+++|.+|-+||.|||+|+...
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--- 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--- 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---
Confidence 9999999999999999987 899999999999999999999999999999999999999999999999999999654
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--ccCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EYEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ 247 (414)
......+.||||.|+|||++..++++ .++|.||||+++||||+|.+||.+.++...|..|+++ .+.+|..++..+.+
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD 650 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence 46678899999999999999999997 8899999999999999999999999999999999987 46789999999999
Q ss_pred HHHhhcccCcCCCCC-----hHHHhcCCccc
Q 015005 248 LISRILVADPQKRIS-----VSEIMINPWFI 273 (414)
Q Consensus 248 li~~~L~~dp~~R~s-----~~eil~hp~f~ 273 (414)
||++++..+|.+|.. +.+|.+|.||.
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 999999999999996 89999999994
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=339.15 Aligned_cols=255 Identities=28% Similarity=0.514 Sum_probs=214.3
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc--hhhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK--KQGLMEQIKREISVMRLVKHPNIVELKEVMAT--KTKVF 92 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 92 (414)
+|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.+ ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 689999999999999999999999999999998754322 22335678899999999999999999999875 46789
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc-C
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW-N 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 170 (414)
+++||+++++|.+.+.. +.+++.....++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 99999999999999876 679999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh--cccCCCCCCCHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--AEYEFPPWISCDARRL 248 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~l 248 (414)
........++..|+|||.+.+..++ .++|+||+||++|+|++|..||...........+.. ....+|..++..+.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 1122335588999999999887664 789999999999999999999987665544444332 2344566788999999
Q ss_pred HHhhcccCcCCCCChHHHhcCCccc
Q 015005 249 ISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
| +||..+|++||+++|+++||||.
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 57778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=347.80 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=204.9
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECC----------------CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLV----------------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn 77 (414)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCC
Confidence 35789999999999999999997532 345799999875432 223567889999999999999
Q ss_pred ccceEEEEEeCCEEEEEEEccCCCchHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCcE
Q 015005 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKG--------------------KLKEESARKYFQQLISAVDFCHSRGVY 137 (414)
Q Consensus 78 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--------------------~~~e~~~~~~~~ql~~al~~lH~~gi~ 137 (414)
|+++++++.+.+..|++|||+++|+|.+++... .++...+..++.|++.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999988642 356778899999999999999999999
Q ss_pred EecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc--CC
Q 015005 138 HRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS--GF 215 (414)
Q Consensus 138 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~--g~ 215 (414)
||||||+|||++.++.+||+|||++................+++.|+|||++.+..++ .++||||||+++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999754322111122334567899999999877765 89999999999999986 67
Q ss_pred CCCCCchHHHHHHHHHh---c-----ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 216 LPFQNENIMKMYRKIFK---A-----EYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 216 ~Pf~~~~~~~~~~~i~~---~-----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.||...+..+....+.. . ....|+.++..+.+|+.+||+.||.+|||+.+|.+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 88887665544433211 1 12345568899999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=344.05 Aligned_cols=255 Identities=28% Similarity=0.487 Sum_probs=220.0
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
+.|+..+.||.|+||.||+|.+..++..||+|++...... .....+.+|+.+++.+.||||+++++++.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588899999999999999999999999999998765432 23567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 96 EYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 96 E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
||++||+|.+++..+++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 82 e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 159 (277)
T cd06640 82 EYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRN 159 (277)
T ss_pred ecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--ccccc
Confidence 9999999999998889999999999999999999999999999999999999999999999999998754321 11223
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHHHhhcc
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLISRILV 254 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 254 (414)
...++..|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+.... ...+..++.++.++|.+||+
T Consensus 160 ~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred cccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 34688899999999877664 78999999999999999999998776655444443332 23344578899999999999
Q ss_pred cCcCCCCChHHHhcCCccccC
Q 015005 255 ADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 255 ~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+|++||++.++++||||.+.
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred cCcccCcCHHHHHhChHhhhc
Confidence 999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=342.66 Aligned_cols=249 Identities=31% Similarity=0.484 Sum_probs=207.6
Q ss_pred eeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHH---HHHHhCCCCCccceEEEEEeCCEEEEEEEccC
Q 015005 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREI---SVMRLVKHPNIVELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 23 ~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 99 (414)
.||+|+||.||+|.+..+++.||+|.+.+..............|. ..++...||||+.+++++.+.+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999876543222122233343 44555689999999999999999999999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcccccc
Q 015005 100 GGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQC 178 (414)
Q Consensus 100 gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 178 (414)
||+|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence 9999988876 6799999999999999999999999999999999999999999999999999875432 1223457
Q ss_pred CCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc---hHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 015005 179 GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE---NIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255 (414)
Q Consensus 179 gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 255 (414)
|++.|+|||++.+....+.++||||+||++|+|++|..||... ................|..++.++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875432347899999999999999999999876 3334444444455667777899999999999999
Q ss_pred CcCCCC-----ChHHHhcCCccccC
Q 015005 256 DPQKRI-----SVSEIMINPWFIKG 275 (414)
Q Consensus 256 dp~~R~-----s~~eil~hp~f~~~ 275 (414)
||.+|| ++.++++||||...
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=335.35 Aligned_cols=252 Identities=30% Similarity=0.523 Sum_probs=222.3
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|+..+.||.|+||.||.+.+..+++.+++|.+....... .....+.+|++++++++||||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987655433 234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 97 ~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|++|++|.+.+.. ..+++.++..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~--~~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc--ccc
Confidence 9999999999876 35899999999999999999999999999999999999999999999999998754332 113
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-CCCCCCHHHHHHHHhh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FPPWISCDARRLISRI 252 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~ 252 (414)
.....|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+..+....+..+.+. .+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3455689999999999877664 7899999999999999999999998888877777666544 3455789999999999
Q ss_pred cccCcCCCCChHHHhcCCcc
Q 015005 253 LVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f 272 (414)
|.+||.+||++.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=335.34 Aligned_cols=251 Identities=35% Similarity=0.555 Sum_probs=219.7
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999998764432 235678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-CeEEeecCCCcccccccCCC
Q 015005 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-NLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 97 ~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~ 172 (414)
|++|++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++ .+||+|||++..... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~---~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC---Cc
Confidence 9999999999976 2489999999999999999999999999999999999998654 589999999985432 22
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHHh
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISR 251 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 251 (414)
......|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+..... +.+..++.++.++|.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 23345689999999999877664 789999999999999999999998877776666655443 4566789999999999
Q ss_pred hcccCcCCCCChHHHhcCCcc
Q 015005 252 ILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f 272 (414)
||.+||.+|||+.|+++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=337.46 Aligned_cols=255 Identities=29% Similarity=0.508 Sum_probs=214.4
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc--hhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK--KQGLMEQIKREISVMRLVKHPNIVELKEVMATK--TKV 91 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 91 (414)
.+|++.+.||+|+||.||.|.+..++..||+|.+...... .....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4699999999999999999999999999999998643321 223356788999999999999999999998763 578
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|++|||++|++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999999876 6789999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--ccCCCCCCCHHHHH
Q 015005 171 -DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EYEFPPWISCDARR 247 (414)
Q Consensus 171 -~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ 247 (414)
........|+..|+|||++.+..++ .++|||||||++|+|++|..||...+......++... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 1122345689999999999877764 7899999999999999999999876555444444322 23355667888999
Q ss_pred HHHhhcccCcCCCCChHHHhcCCcc
Q 015005 248 LISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
+|++||. +|++||+++++++|||+
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCccc
Confidence 9999995 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=344.49 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=215.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCC-----eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQ-----ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 457999999999999999999876555 6899999865432 223567889999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC
Q 015005 90 KVFFVIEYVKGGELFAKVLK-----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-----------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~ 152 (414)
..|++|||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999998865 3478889999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHH
Q 015005 153 NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIF 231 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 231 (414)
.++|+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998754322222233445678899999998877775 88999999999999998 999999888877777776
Q ss_pred hccc-CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 232 KAEY-EFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 232 ~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.... ..|..+++++.+|+.+||+.||.+||++.||+++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5543 4566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=347.95 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=218.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
+.|.....||+|+||.||++.+..++..||||.+..... ...+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 446667889999999999999999999999999865432 23466889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 96 EYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 96 E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
||+++++|.+++..+.+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~--~~~~~~ 176 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRK 176 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc--ccccCc
Confidence 999999999988888899999999999999999999999999999999999999999999999999875432 122234
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc---cCCCCCCCHHHHHHHHhh
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE---YEFPPWISCDARRLISRI 252 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~~ 252 (414)
...|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+.... ...+..++..+.++|.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 45689999999999877775 78999999999999999999998877665555443322 122234788999999999
Q ss_pred cccCcCCCCChHHHhcCCccccCCC
Q 015005 253 LVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
|..||.+|||++++++||||.....
T Consensus 256 l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 256 LVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred ccCChhHCcCHHHHhhChhhhccCC
Confidence 9999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=361.90 Aligned_cols=251 Identities=30% Similarity=0.536 Sum_probs=220.6
Q ss_pred eeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCc
Q 015005 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGE 102 (414)
Q Consensus 23 ~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~ 102 (414)
+||+|.||+||-|++..|....|||.+...... ..+.+..||.++++|+|.|||++++.+..++++-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr---~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR---EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch---hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 699999999999999999999999999765433 36788999999999999999999999999999999999999999
Q ss_pred hHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc-CCCCeEEeecCCCcccccccCCCccccc
Q 015005 103 LFAKVLK--GKL--KEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD-ENGNLKVSDFGLSALPEQLWNDGLLHTQ 177 (414)
Q Consensus 103 L~~~i~~--~~~--~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~ 177 (414)
|.++++. |++ .|.....|.+||+.||.|||++.|+|||||-+|+|++ -.|.+||+|||-++.... -+....+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 9999986 888 8888999999999999999999999999999999997 578999999999986544 34456778
Q ss_pred cCCCcccCchhhcc--cCCCCCccchhhhhhhhhhhhcCCCCCCCc--hHHHHHHH-HHhcccCCCCCCCHHHHHHHHhh
Q 015005 178 CGTPAYVAPEVLRK--KGYDGAKSDIWSCGVVLFVLLSGFLPFQNE--NIMKMYRK-IFKAEYEFPPWISCDARRLISRI 252 (414)
Q Consensus 178 ~gt~~y~APE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--~~~~~~~~-i~~~~~~~~~~~s~~~~~li~~~ 252 (414)
.||..|||||++.. .+| +.++|||||||++.||.||++||..- ....+++- .++-.+++|..+|.+++.+|.+|
T Consensus 737 TGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred ccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 89999999999964 345 68999999999999999999999753 33344442 34567788989999999999999
Q ss_pred cccCcCCCCChHHHhcCCccccCCCCC
Q 015005 253 LVADPQKRISVSEIMINPWFIKGFSKP 279 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f~~~~~~~ 279 (414)
+.+||..||++.++|.+||++.+..++
T Consensus 816 Fepd~~~R~sA~~LL~DpFlq~~~kk~ 842 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPFLQHNNKKP 842 (1226)
T ss_pred cCCCcccCccHHHhccCcccccCCCCC
Confidence 999999999999999999998775443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=345.04 Aligned_cols=258 Identities=33% Similarity=0.498 Sum_probs=215.5
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc--hhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK--KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... .......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765543 122345677899999999999999999999999999999
Q ss_pred EEccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLKG--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||+ +|+|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence 9999 89999999873 6999999999999999999999999999999999999999999999999999765432 12
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc------------------
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE------------------ 234 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------ 234 (414)
......+++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+..+.+.++...-
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22334578899999998665444588999999999999999988888776555444433210
Q ss_pred -----cC-----CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 235 -----YE-----FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 235 -----~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
.. .....+.++.++|.+||.+||++|||+.|++.||||.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 00 01234678999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=343.46 Aligned_cols=247 Identities=32% Similarity=0.519 Sum_probs=212.2
Q ss_pred eeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCch
Q 015005 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL 103 (414)
Q Consensus 24 LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 103 (414)
||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++||||+++++++...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999875544333455667899999999999999999999999999999999999999
Q ss_pred HHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCC
Q 015005 104 FAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180 (414)
Q Consensus 104 ~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 180 (414)
.+++.. + .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 988876 4 699999999999999999999999999999999999999999999999999875432 2223345688
Q ss_pred CcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH----HHHHHHHHhcccCCCCCCCHHHHHHHHhhcccC
Q 015005 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI----MKMYRKIFKAEYEFPPWISCDARRLISRILVAD 256 (414)
Q Consensus 181 ~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d 256 (414)
..|+|||++.+..+. .++||||+|+++|+|++|..||..... ......+.......|..+++++.++|++||+.|
T Consensus 158 ~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 899999999877764 789999999999999999999977543 233333344455566778999999999999999
Q ss_pred cCCCC-----ChHHHhcCCcccc
Q 015005 257 PQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 257 p~~R~-----s~~eil~hp~f~~ 274 (414)
|.+|| ++.++++||||.+
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.61 Aligned_cols=259 Identities=30% Similarity=0.486 Sum_probs=213.8
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK--TKV 91 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 91 (414)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 4578999999999999999999999999999999987554322 2223456899999999999999999998765 578
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+||||+.+ +|.+.+.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~- 161 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP- 161 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc-
Confidence 999999975 77777765 67999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc----------------
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA---------------- 233 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------------- 233 (414)
........+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 -AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred -cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 122233346888999999876544458899999999999999999999988776665554331
Q ss_pred ---ccCCC-----------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 234 ---EYEFP-----------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 234 ---~~~~~-----------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
....+ .+.++++.+||++||++||++|||+.+++.||||.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 01111 23588899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=359.25 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=206.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEE-----CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKN-----LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATK 88 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 88 (414)
.++|++.+.||+|+||+||+|.+ ..++..||+|++...... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 44799999999999999999964 346778999998654322 2346788999999999 899999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhcC----------------------------------------------------------
Q 015005 89 TKVFFVIEYVKGGELFAKVLKG---------------------------------------------------------- 110 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~---------------------------------------------------------- 110 (414)
+..|+|||||+||+|.+++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 9999999999999999888541
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 111 ------------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 111 ------------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 36788899999999999999999999999999999999999999999999997543221111
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE--YEFPPWISCDARRLI 249 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~li 249 (414)
......++..|+|||++.+..++ .++|||||||++|+|++ |..||........+.+..... ...|...+.++.+||
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 12223456789999999887775 89999999999999998 899998765443333333332 234556788999999
Q ss_pred HhhcccCcCCCCChHHHhcC
Q 015005 250 SRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~h 269 (414)
.+||+.||++|||+.|+++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=338.45 Aligned_cols=250 Identities=20% Similarity=0.268 Sum_probs=210.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+...... .....+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 457999999999999999999764 45678999999765322 2346788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+||||+++|+|.+++.. +.+++..+..++.|++.||+|||++|++||||||+|||++.++.++++|||.+......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~- 160 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE- 160 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc-
Confidence 999999999999998875 57899999999999999999999999999999999999999999999999987643211
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 247 (414)
.........+++.|+|||.+.+..++ .++||||+||++|++++ |..||...+..+....+..+. .+.|..++..+.+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 01111223456789999999887775 79999999999999775 999999887777666665442 3456678899999
Q ss_pred HHHhhcccCcCCCCChHHHhc
Q 015005 248 LISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~ 268 (414)
++.+||+.+|.+||++.+|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=355.16 Aligned_cols=246 Identities=25% Similarity=0.420 Sum_probs=199.7
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
..+|++.+.||+|+||.||+|.+..+++.||+|+..+.. ...|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 457999999999999999999999999999999854332 24689999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
||++. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 99996 577777754 5799999999999999999999999999999999999999999999999999874321 22
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCC-CCCCchH---------HHHHHHHHhc----ccCCC
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFL-PFQNENI---------MKMYRKIFKA----EYEFP 238 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~-Pf~~~~~---------~~~~~~i~~~----~~~~~ 238 (414)
......||+.|+|||++.+..+. .++|||||||++|+|+++.. +|..... ......+... ...+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 23456799999999999888775 89999999999999998544 4443211 0111111110 00011
Q ss_pred ------------------------------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 239 ------------------------------PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 239 ------------------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..++.++.+||++||+.||.+|||+.|+|+||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667888999999999999999999999999974
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=336.56 Aligned_cols=249 Identities=29% Similarity=0.491 Sum_probs=215.8
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .+.+.+|+++++.++||||+++++.+.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 579999999999999999999998899999999865432 567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||+++++|.+.+.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ...
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~--~~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC--ccc
Confidence 99999999999874 57899999999999999999999999999999999999999999999999998865432 112
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc---ccCCCCCCCHHHHHHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA---EYEFPPWISCDARRLIS 250 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~ 250 (414)
.....|+..|+|||++.+..++ .++||||+|+++|+|++|..||...+.......+... ....+..++.++.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 2344588999999999887775 7899999999999999999999876655443333222 12234457889999999
Q ss_pred hhcccCcCCCCChHHHhcCCcc
Q 015005 251 RILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f 272 (414)
+||+.||++|||+.|++.||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=334.28 Aligned_cols=253 Identities=29% Similarity=0.530 Sum_probs=217.2
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc--hhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK--KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+|+..+.||+|++|+||+|.+..+++.|++|.+...... .....+.+.+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 588899999999999999999889999999998764422 123456789999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
+||++|++|.+++.+ +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~---~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc---cc
Confidence 999999999999887 56999999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh--cccCCCCCCCHHHHHHHHh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--AEYEFPPWISCDARRLISR 251 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li~~ 251 (414)
.....|++.|+|||.+......+.++|+||+|+++|+|++|..||...........+.. ....+|+.+++++.+++++
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34566899999999987665234789999999999999999999987664444333332 2334566789999999999
Q ss_pred hcccCcCCCCChHHHhcCCcc
Q 015005 252 ILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f 272 (414)
||+.+|.+||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=352.07 Aligned_cols=258 Identities=29% Similarity=0.503 Sum_probs=212.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK---- 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 88 (414)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 4578999999999999999999999999999999998654322 22345677899999999999999999988643
Q ss_pred --CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 --TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 --~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 777766554 9999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-------------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------------- 233 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 233 (414)
. ........|++.|+|||.+.+..+. .++|||||||++|+|++|..||...+....+.++...
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 2223445689999999999888875 8899999999999999999999876654443333210
Q ss_pred ---------ccC--------------C-------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 234 ---------EYE--------------F-------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 234 ---------~~~--------------~-------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
... + +...+..+++||.+||+.||++|||+.|+|.||||...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 000 0 1123557899999999999999999999999999976554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=349.12 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=211.3
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK----- 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 88 (414)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 45789999999999999999999999999999999864321 22346678899999999999999999987654
Q ss_pred CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
...|+++||+. ++|.+.+....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhcc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 35899999996 48888887789999999999999999999999999999999999999999999999999998754321
Q ss_pred c-CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh---------------
Q 015005 169 W-NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------------- 232 (414)
Q Consensus 169 ~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------- 232 (414)
. ........+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 1 111223457899999999876544335889999999999999999999987654332221110
Q ss_pred c-----------ccC-----CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 233 A-----------EYE-----FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 233 ~-----------~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
. ... ..+.++.++.++|.+||+.||++|||+.|+++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 000 1123678899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.55 Aligned_cols=252 Identities=33% Similarity=0.546 Sum_probs=209.4
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.|++.+.||.|++|.||+|.+..+++.||+|.+...... ......+.+|++++++++||||+++++++.+.+..|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 489999999999999999999999999999998754322 2234578899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 97 ~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|+. ++|..++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 578777754 56899999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc------------------cc
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------------------EY 235 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------~~ 235 (414)
.....+++.|+|||++.+....+.++||||||+++|+|++|..||...+......++... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 234457889999999877655457899999999999999999999876554333222210 00
Q ss_pred C-----------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 236 E-----------FPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 236 ~-----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
. ..+.++++++++|.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=339.33 Aligned_cols=253 Identities=28% Similarity=0.492 Sum_probs=219.4
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.+++.++||||+++++.+..+...|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 77889999999999999999889999999998654432 2356788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccc
Q 015005 98 VKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ 177 (414)
Q Consensus 98 ~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 177 (414)
+++++|.+++..+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... .......
T Consensus 84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hhhhccc
Confidence 99999999998888999999999999999999999999999999999999999999999999998754321 1122334
Q ss_pred cCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHHhhcccC
Q 015005 178 CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISRILVAD 256 (414)
Q Consensus 178 ~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~d 256 (414)
.|+..|+|||.+.+...+ .++|+||+||++|+|++|..||...+.......+..... ..+..++.++.++|.+||+.+
T Consensus 162 ~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 240 (277)
T ss_pred cCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence 688999999999876664 789999999999999999999987766555555543332 355568899999999999999
Q ss_pred cCCCCChHHHhcCCccccC
Q 015005 257 PQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 257 p~~R~s~~eil~hp~f~~~ 275 (414)
|.+||++.++++||||.+.
T Consensus 241 p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 241 PSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred hhhCcCHHHHHhCHHHhhh
Confidence 9999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=337.43 Aligned_cols=250 Identities=35% Similarity=0.651 Sum_probs=220.7
Q ss_pred eeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCch
Q 015005 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL 103 (414)
Q Consensus 24 LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 103 (414)
||.|+||.||+|.+..+|+.+|+|++...........+.+.+|++++++++||||+++++.+..+...|++|||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999776554444567889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC------CCcccc
Q 015005 104 FAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN------DGLLHT 176 (414)
Q Consensus 104 ~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~------~~~~~~ 176 (414)
.+++.+ +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999887 7899999999999999999999999999999999999999999999999999875332111 112234
Q ss_pred ccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCC--CHHHHHHHHhhcc
Q 015005 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWI--SCDARRLISRILV 254 (414)
Q Consensus 177 ~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--s~~~~~li~~~L~ 254 (414)
..+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||........+..+..+....|... +..+.+++++||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999987765 4789999999999999999999999888888888877777666655 8999999999999
Q ss_pred cCcCCCCCh---HHHhcCCcccc
Q 015005 255 ADPQKRISV---SEIMINPWFIK 274 (414)
Q Consensus 255 ~dp~~R~s~---~eil~hp~f~~ 274 (414)
.+|.+|||+ .++++||||.+
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=338.18 Aligned_cols=252 Identities=31% Similarity=0.476 Sum_probs=211.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC----
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT---- 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~---- 89 (414)
.++|++.+.||+|++|.||+|.+..+++.+++|++..... ..+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4789999999999999999999998999999999876543 235788999999999 7999999999997644
Q ss_pred --EEEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 90 --KVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 90 --~~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
.+|+||||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999888764 47999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccCchhhcccC----CCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc---
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKG----YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY--- 235 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--- 235 (414)
..... .........|++.|+|||++.... ..+.++|||||||++|+|++|..||...+.......+.....
T Consensus 161 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eeccc--chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 75432 122234456899999999985422 224689999999999999999999987655555444444322
Q ss_pred CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 236 EFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
..+..++.++.+||.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2223367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=339.31 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=212.1
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC----
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATK---- 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~---- 88 (414)
..++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++++ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 46889999999999999999999999999999999865432 235677899999998 899999999998653
Q ss_pred -CEEEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 89 -TKVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 89 -~~~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
...|+||||++|++|.+.+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 468999999999999987752 56899999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCC----CCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc---
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY----DGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY--- 235 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~----~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--- 235 (414)
...... ........|++.|+|||++..... .+.++|||||||++|+|++|+.||...+.......+.....
T Consensus 176 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 176 AQLTST--RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred hhcccc--cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 754321 112234568999999999864321 24789999999999999999999988765554444443322
Q ss_pred CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 236 EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
..+...+..+.+||.+||+.||++||++.|+++||||+
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23445778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=341.32 Aligned_cols=252 Identities=29% Similarity=0.449 Sum_probs=210.0
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEe-----
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMAT----- 87 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----- 87 (414)
-.+.|++.+.||.|+||.||+|.+..+++.+|+|++..... ....+..|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 45789999999999999999999999999999999866432 235678899999998 79999999999853
Q ss_pred -CCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 88 -KTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 88 -~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
...+|++|||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 4689999999999999998875 458899999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCccccccCCCcccCchhhcc-----cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-C-
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRK-----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-E- 236 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~- 236 (414)
.... .........|++.|+|||++.. ..++ .++|+|||||++|+|++|..||...........+..... .
T Consensus 170 ~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhc--cccCCCcccccccccCHhhcCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 5432 1122345678999999999863 3343 689999999999999999999977654443333332221 1
Q ss_pred CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 237 FPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.+..++.++.+||++||..||.+|||+.|+++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 123478899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=333.51 Aligned_cols=254 Identities=33% Similarity=0.568 Sum_probs=216.3
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++.+.+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999889999999999776543 3356789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC-c-
Q 015005 97 YVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG-L- 173 (414)
Q Consensus 97 ~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~- 173 (414)
|+++++|.+.+.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999999999987 568999999999999999999999999999999999999999999999999988654321111 1
Q ss_pred cccccCCCcccCchhhcccC---CCCCccchhhhhhhhhhhhcCCCCCCCchH-HHHHHHHH-hcccCCCCCC--CHHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKKG---YDGAKSDIWSCGVVLFVLLSGFLPFQNENI-MKMYRKIF-KAEYEFPPWI--SCDAR 246 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~-~~~~~~~~~~--s~~~~ 246 (414)
.....+++.|+|||++.+.. + +.++||||+|+++|++++|..||...+. ......+. .....+|.+. +..+.
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~-~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGH-GRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCC-CcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHH
Confidence 22456889999999987654 4 4789999999999999999999976532 22222222 2334455554 89999
Q ss_pred HHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 247 RLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
++|.+||+.||.+|||+.+++.|||+
T Consensus 239 ~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 239 DFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=352.45 Aligned_cols=243 Identities=26% Similarity=0.428 Sum_probs=210.6
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
+.+.+.||+|-||.||+|... ....||+|.+...... .+.+.+|+++|++|+|+|||++++++..+..+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 445689999999999999864 3347999999765443 25677999999999999999999999998899999999
Q ss_pred cCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 98 VKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 98 ~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
++.|+|.+++.. +.+...+...++.||++|++||+++++|||||...|||++++..+||+|||||+..... .....
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~ 361 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTAS 361 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeec
Confidence 999999999996 56999999999999999999999999999999999999999999999999999943321 11111
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhh
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLISRI 252 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~ 252 (414)
....-...|.|||.+....++ .++|||||||+||||+| |+.||.+.+..+..+.+-.| ..+.|+.+|+++.+++..|
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 222234569999999988886 89999999999999999 99999999999998888766 5678889999999999999
Q ss_pred cccCcCCCCChHHHh
Q 015005 253 LVADPQKRISVSEIM 267 (414)
Q Consensus 253 L~~dp~~R~s~~eil 267 (414)
|+.+|++|||++.+.
T Consensus 441 W~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLR 455 (468)
T ss_pred hhCCcccCCCHHHHH
Confidence 999999999998654
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=340.03 Aligned_cols=252 Identities=30% Similarity=0.477 Sum_probs=203.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++|+||+++++++.++...|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 67999999999999999999999999999999996553322 2345678999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||+. ++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ...
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQT 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CCC
Confidence 9996 566555543 56889999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHHHh--c------------cc---
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKIFK--A------------EY--- 235 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~--~------------~~--- 235 (414)
.....+++.|+|||.+.+....+.++|||||||++|+|++|..||...+.. +...++.. + ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 234567999999999876543347899999999999999999999765432 22111110 0 00
Q ss_pred ------CCCC---------CCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 236 ------EFPP---------WISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 236 ------~~~~---------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
..+. ..+.++.+++.+||..||.+|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=340.50 Aligned_cols=255 Identities=32% Similarity=0.534 Sum_probs=214.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+++++.++||||+++++++..++..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 5799999999999999999999999999999998754332 233567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
||++++.+.....+ ..+++.++..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99999888776665 6799999999999999999999999999999999999999999999999999886543211 133
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc---------------------
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--------------------- 233 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------------------- 233 (414)
....+++.|+|||++.+....+.++|+||+|+++|+|++|..||...+..+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 44568899999999987733358999999999999999999999876544332222110
Q ss_pred c-----------cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 234 E-----------YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 234 ~-----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
. ..++..++.++.+||++||..||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01233458899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=344.78 Aligned_cols=254 Identities=29% Similarity=0.487 Sum_probs=217.6
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
+.|+..+.||+|+||.||+|.+..+++.||+|.+....... ..+.+.+|+.+++.++||||+++++.+..+...|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH--HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 34777889999999999999999999999999987554322 3567899999999999999999999999999999999
Q ss_pred EccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 96 EYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 96 E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
||+++++|.+.+..+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRN 159 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhhh
Confidence 9999999999988888999999999999999999999999999999999999999999999999998754321 11223
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHHHhhcc
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLISRILV 254 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 254 (414)
...|+..|+|||.+.+..++ .++|+|||||++|+|++|..||...........+..+. ...+..++.++.++|.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 34688999999999887765 78999999999999999999998765544444333332 22344578899999999999
Q ss_pred cCcCCCCChHHHhcCCcccc
Q 015005 255 ADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 255 ~dp~~R~s~~eil~hp~f~~ 274 (414)
.+|.+|||+.++++||||.+
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred CCcccCcCHHHHHHhHHHHH
Confidence 99999999999999999965
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=343.17 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=206.6
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT---- 89 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 89 (414)
..++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 4568999999999999999999999999999999986543322 22345668999999999999999999987653
Q ss_pred ----EEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 90 ----KVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 90 ----~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
..|+||||+.+ +|.+.+.. ..+++.++..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 46999999975 77777765 379999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCC--CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh--cc-----
Q 015005 164 LPEQLWND--GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--AE----- 234 (414)
Q Consensus 164 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~----- 234 (414)
........ .......++..|+|||.+.+....+.++||||+|+++|+|++|..||.+.+.......+.. +.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 54332111 1223446788999999987654335789999999999999999999988765433322211 00
Q ss_pred ------------cCCC-------------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 235 ------------YEFP-------------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 235 ------------~~~~-------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
...| ...+..+.+||.+||..||.+|||++|+++||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=338.55 Aligned_cols=248 Identities=33% Similarity=0.563 Sum_probs=205.0
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeC--CEEEEE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATK--TKVFFV 94 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lv 94 (414)
|++.+.||+|+||.||+|.+..+++.||+|.+.+...... .....+|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999875432221 223457899998885 99999999999988 899999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||+++ +|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++. +.+||+|||++..... ..
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~---~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS---KP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc---CC
Confidence 999975 77777764 56899999999999999999999999999999999999999 9999999999975432 22
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh------------------cc
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK------------------AE 234 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------------~~ 234 (414)
......+++.|+|||.+...++.+.++||||+||++|+|++|..||.+.+..+....+.. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 223346889999999876655556899999999999999999999988766554433321 11
Q ss_pred cCCC-----------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 235 YEFP-----------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 235 ~~~~-----------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
..+| +.++.++.++|.+||++||++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=333.65 Aligned_cols=252 Identities=33% Similarity=0.561 Sum_probs=218.9
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT--KTKVFFV 94 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv 94 (414)
+|++.+.||.|+||.||+|.+..+++.||+|.+....... ...+.+.+|+++++.++||||+++++.+.. +...|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 5899999999999999999999999999999997654432 235678899999999999999999998754 4678999
Q ss_pred EEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-----hCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 95 IEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCH-----SRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH-----~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
|||+++++|.+.+.. +.+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999888864 47899999999999999999999 99999999999999999999999999999986
Q ss_pred cccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCH
Q 015005 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISC 243 (414)
Q Consensus 165 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~ 243 (414)
.... ........|++.|+|||++.+..++ .++|+||||+++|+|++|..||...+.....+.+..+.. ..|..++.
T Consensus 160 ~~~~--~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHD--SSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCC--cccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 5432 1113445789999999999877664 789999999999999999999998887777776666554 45667889
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
++.+++.+||+.+|.+|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=343.34 Aligned_cols=254 Identities=32% Similarity=0.488 Sum_probs=212.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK--TKVF 92 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 92 (414)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999999999999999765433 22345677899999999999999999999877 8999
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+||||+++ +|.+.+.. ..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-- 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC--
Confidence 99999975 88888765 45899999999999999999999999999999999999999999999999998854432
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-----------------
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA----------------- 233 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------------- 233 (414)
........+++.|+|||.+.+....+.++|+||+|+++|+|++|..||...+......++...
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 122334567899999999876554457899999999999999999999887665544443211
Q ss_pred --------------ccCCCCC-CCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 234 --------------EYEFPPW-ISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 234 --------------~~~~~~~-~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
...++.. +++.+.++|++||+.||++|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=339.28 Aligned_cols=251 Identities=35% Similarity=0.556 Sum_probs=210.6
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||.|++|+||+|.+..+|+.||+|.+...... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999999765432 124567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 97 YVKGGELFAKVLK----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 97 ~~~gg~L~~~i~~----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|+++ +|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence 9985 77777764 35899999999999999999999999999999999999999999999999999754321 11
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc------------------
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE------------------ 234 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------ 234 (414)
......+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345678999999998765544588999999999999999999998877655544433210
Q ss_pred cC-----------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 235 YE-----------FPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 235 ~~-----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.. ..+.++..+.++|.+||+.||.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=339.38 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=209.5
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEE-----e
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMA-----T 87 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-----~ 87 (414)
..++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 56789999999999999999999999999999999864322 135677899999999 6999999999873 4
Q ss_pred CCEEEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
....|++|||++|++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 5679999999999999887642 46899999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccCchhhcc-----cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc---
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRK-----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--- 234 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--- 234 (414)
..... .........|++.|+|||++.. ..+ +.++||||+||++|+|++|..||...........+....
T Consensus 172 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 172 AQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred eeccc--CCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 75432 1222344569999999999853 234 478999999999999999999998766544433332221
Q ss_pred cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 235 YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
...|..++.++.+||.+||+.||++|||+.|+++|+||
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 12344567889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=334.74 Aligned_cols=252 Identities=29% Similarity=0.545 Sum_probs=212.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998764444444456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 95 IEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+||+++|+|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~- 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence 999999999887752 45899999999999999999999999999999999999999999999999998764321
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH--HHHHHHHHhccc-CCC-CCCCHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI--MKMYRKIFKAEY-EFP-PWISCDA 245 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~--~~~~~~i~~~~~-~~~-~~~s~~~ 245 (414)
........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||..... ......+..... +.+ ..++..+
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred -hHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 1223345689999999999887775 789999999999999999999966432 334444333222 222 3477889
Q ss_pred HHHHHhhcccCcCCCCChHHHhcC
Q 015005 246 RRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.++|.+||+.+|++||++.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=360.01 Aligned_cols=245 Identities=34% Similarity=0.580 Sum_probs=216.4
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKV 91 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 91 (414)
.+...|++...+|.|+|+.|..+.+..+++.+++|++.+.... ..+|+.++... +||||+++++++.++...
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCcee
Confidence 4678899999999999999999999999999999999877322 33677676665 799999999999999999
Q ss_pred EEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE-cCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL-DENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl-~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+|||++.|+.|.+.+...+....++..|+.||+.|+.|||++||+||||||+|||+ +..|+++|+|||.++....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~--- 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER--- 468 (612)
T ss_pred eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch---
Confidence 999999999999999998666668899999999999999999999999999999999 5889999999999985433
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
...+.|-|..|.|||++...+|+ .++||||||++||+||+|+.||...... ++...+..+.+. .++|.++++||
T Consensus 469 --~~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 469 --SCDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred --hhcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 25567889999999999999997 8999999999999999999999875544 555555444333 78999999999
Q ss_pred HhhcccCcCCCCChHHHhcCCcc
Q 015005 250 SRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~hp~f 272 (414)
++||+.||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=334.68 Aligned_cols=246 Identities=35% Similarity=0.616 Sum_probs=210.0
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHH-HhCCCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+|||++++++++...+.+|++|||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765433322334445555544 455899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999999877 7899999999999999999999999999999999999999999999999999874322 234468
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCCCHHHHHHHHhhccc
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISCDARRLISRILVA 255 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~ 255 (414)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+.......+ ..++.++.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999988765 4899999999999999999999998888777777665544332 34789999999999999
Q ss_pred CcCCCCC---hHHHhcCCcccc
Q 015005 256 DPQKRIS---VSEIMINPWFIK 274 (414)
Q Consensus 256 dp~~R~s---~~eil~hp~f~~ 274 (414)
||++||+ ++|++.||||.+
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 9999995 579999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=343.82 Aligned_cols=255 Identities=26% Similarity=0.466 Sum_probs=218.7
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.-|+....||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+..++..|++|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 3456677899999999999999999999999999654332 2456889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 96 EYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 96 E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
||+++++|...+....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .....
T Consensus 98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~ 175 (297)
T cd06659 98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRK 175 (297)
T ss_pred ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--ccccc
Confidence 9999999999887788999999999999999999999999999999999999999999999999998744321 12234
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc---CCCCCCCHHHHHHHHhh
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY---EFPPWISCDARRLISRI 252 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~ 252 (414)
..+|++.|+|||++.+..+. .++|+||+||++|+|++|..||...+.......+..... ..+..++..+.++|++|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ceecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 46789999999999887764 789999999999999999999987766655555443322 22345788999999999
Q ss_pred cccCcCCCCChHHHhcCCccccCC
Q 015005 253 LVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
|+.+|.+||++.++++||||.+..
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccCC
Confidence 999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=337.28 Aligned_cols=254 Identities=28% Similarity=0.480 Sum_probs=219.5
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.|...+.||+|++|.||+|.+..+++.+|+|.+...... ..+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 566678999999999999999999999999998654322 24568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcccc
Q 015005 97 YVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT 176 (414)
Q Consensus 97 ~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 176 (414)
|++|++|.+.+..+++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ......
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~ 174 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKS 174 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccccc
Confidence 999999999998888999999999999999999999999999999999999999999999999988643321 112234
Q ss_pred ccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCC---CCCCCHHHHHHHHhhc
Q 015005 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF---PPWISCDARRLISRIL 253 (414)
Q Consensus 177 ~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~s~~~~~li~~~L 253 (414)
..|++.|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+.....+. +..++..+.++|++||
T Consensus 175 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 5689999999999877765 78999999999999999999998877766666665543222 2337889999999999
Q ss_pred ccCcCCCCChHHHhcCCccccCC
Q 015005 254 VADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 254 ~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
+.||++|||+.++++||||.+..
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ccChhhCcCHHHHccCcccccCC
Confidence 99999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=342.57 Aligned_cols=256 Identities=34% Similarity=0.498 Sum_probs=218.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||+|+||.||++.+..++..||+|.+...... ..+.+.+|+.+++.++||||+++++.+......|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 57899999999999999999999889999999998654322 246788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 95 IEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
+||+++++|.+++.+..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ....
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--~~~~ 172 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKR 172 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--cccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998754321 2223
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh-cccC--CCCCCCHHHHHHHHh
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK-AEYE--FPPWISCDARRLISR 251 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-~~~~--~~~~~s~~~~~li~~ 251 (414)
....|++.|+|||.+.+..++ .++|+||||+++|++++|..||...+.......+.. +... .+..++..++++|++
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 345689999999999877664 789999999999999999999987665443332222 2222 233467889999999
Q ss_pred hcccCcCCCCChHHHhcCCccccCC
Q 015005 252 ILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
||..+|++||++.+++.||||....
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=336.91 Aligned_cols=252 Identities=29% Similarity=0.482 Sum_probs=216.8
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|++|.||+|.+..+++.+|+|.+...... .....+.+|+++++.++||||+++++.+......|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 4688999999999999999999999999999999765432 23567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
||++|++|.+++.. ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 99999999999875 678999999999999999999999 99999999999999999999999999998754321
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc-----hHHHHHHHHHhcc-cCCCCC-CCHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE-----NIMKMYRKIFKAE-YEFPPW-ISCDA 245 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~s~~~ 245 (414)
......|++.|+|||.+.+..++ .++||||+|+++|+|++|..||... ......+.+.... ...+.. ++.++
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred HhhcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 11226789999999999887775 8899999999999999999999764 2333444444332 234444 78899
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 246 RRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.++|.+||..||.+|||+.+++.||||++
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=339.68 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=216.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
..+|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+++++.++||||+++++.+.....+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 4679999999999999999999999999999999875432 23457789999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||+++++|.+.+.. +.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----S 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----h
Confidence 999999999998877 679999999999999999999997 6999999999999999999999999999864322 1
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-----------HHHHHHHhcc-cCCCCC
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-----------KMYRKIFKAE-YEFPPW 240 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-----------~~~~~i~~~~-~~~~~~ 240 (414)
.....+|+..|+|||++.+..++ .++||||+||++|+|++|..||...... .....+.... ..++..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred ccCccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 22345799999999999877664 7899999999999999999999865431 2233333222 223333
Q ss_pred -CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 241 -ISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 241 -~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
++.++.+||.+||++||.+|||+.|+++||||.+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 778999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=345.36 Aligned_cols=246 Identities=28% Similarity=0.468 Sum_probs=192.0
Q ss_pred eeeeeecCCeEEEEEEECC--CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE--eCCEEEEEEE
Q 015005 21 GRMLGQGTFAKVYYGKNLV--TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA--TKTKVFFVIE 96 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv~E 96 (414)
+..||+|+||+||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. ....+|++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999998654 668899999865432 235678999999999999999999885 3568899999
Q ss_pred ccCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE----cCCCCeEEeecCCC
Q 015005 97 YVKGGELFAKVLK----------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL----DENGNLKVSDFGLS 162 (414)
Q Consensus 97 ~~~gg~L~~~i~~----------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl----~~~~~~kl~DFGla 162 (414)
|+.+ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9975 66666531 248899999999999999999999999999999999999 46679999999999
Q ss_pred cccccccC-CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH---------HHHHHHHh
Q 015005 163 ALPEQLWN-DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM---------KMYRKIFK 232 (414)
Q Consensus 163 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------~~~~~i~~ 232 (414)
........ ........||+.|+|||++.+....+.++||||+||++|+|++|..||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 86533211 112344578999999999977554458899999999999999999999753211 01111000
Q ss_pred ----------------------------ccc----------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 233 ----------------------------AEY----------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 233 ----------------------------~~~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
... ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=338.70 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=213.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECC-----CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLV-----TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+...... ...+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4578999999999999999998743 4678999998755332 23568899999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCe
Q 015005 90 KVFFVIEYVKGGELFAKVLK---------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNL 154 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~---------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~ 154 (414)
..|++|||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999998864 237889999999999999999999999999999999999999999
Q ss_pred EEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc
Q 015005 155 KVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA 233 (414)
Q Consensus 155 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~ 233 (414)
||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999998743221111122334467889999999887775 78999999999999998 99999888777777777666
Q ss_pred ccC-CCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 234 EYE-FPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 234 ~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
... .+..++..+.+++.+||+.||.+||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 554 34568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=350.80 Aligned_cols=257 Identities=27% Similarity=0.410 Sum_probs=212.0
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 92 (414)
-...|++.+.||+||.++||++... ....||+|.+..... +...+.-+.+|+..|.+| .|.+||++++|-..++.+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3456999999999999999999854 345566666544333 344578899999999999 5999999999999999999
Q ss_pred EEEEccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLKG--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+||||-+ .+|..++.++ .++...++.|..||+.|+.++|+.||||.||||.|+|+ -.|.+||+|||+|........
T Consensus 437 mvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 437 MVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccc
Confidence 9999853 5898888873 35556899999999999999999999999999999998 789999999999997776555
Q ss_pred CCccccccCCCcccCchhhcccCCC----------CCccchhhhhhhhhhhhcCCCCCCCch-HHHHHHHHHhcc--cCC
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYD----------GAKSDIWSCGVVLFVLLSGFLPFQNEN-IMKMYRKIFKAE--YEF 237 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~----------~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~--~~~ 237 (414)
.-...+.+||+.|||||.+....+. +.++||||||||||+|+.|++||..-. ...-+..|...+ ++|
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief 594 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF 594 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence 6677889999999999998644332 578999999999999999999997632 334445555543 356
Q ss_pred CCCCCHH-HHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 238 PPWISCD-ARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 238 ~~~~s~~-~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
|..-+.. +.++++.||..||.+|||+.++|+|||++-
T Consensus 595 p~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 595 PDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 6544444 999999999999999999999999999853
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=336.78 Aligned_cols=245 Identities=28% Similarity=0.455 Sum_probs=205.1
Q ss_pred ccCCEEEeeee--eecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 015005 14 LFGKYEMGRML--GQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTK 90 (414)
Q Consensus 14 ~~~~y~~~~~L--G~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 90 (414)
+.++|++.+.+ |+|+||.||++.+..++..+|+|.+....... .|+.....+ +||||+++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 35678888777 99999999999999999999999997654322 122222222 79999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-CeEEeecCCCcccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-NLKVSDFGLSALPEQL 168 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 168 (414)
+|+||||++|++|.+++.. +.+++.++..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 9999999999999999987 5899999999999999999999999999999999999999988 999999999875432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH----HHHHHHhcccCCCCCCCHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK----MYRKIFKAEYEFPPWISCD 244 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s~~ 244 (414)
.....|++.|+|||++.+..+. .++|+||+|+++|+|++|..||....... .+..........++.+++.
T Consensus 163 -----~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 163 -----PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred -----CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 1234689999999999887775 78999999999999999999998654322 1222223334555668999
Q ss_pred HHHHHHhhcccCcCCCCC-hHHHhcCCccc
Q 015005 245 ARRLISRILVADPQKRIS-VSEIMINPWFI 273 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s-~~eil~hp~f~ 273 (414)
+.+||.+||++||.+||+ ++++++||||.
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999999996 69999999995
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=338.20 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=211.9
Q ss_pred cCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
..+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 357999999999999999999752 355679999986543 223567889999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-C-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeE
Q 015005 90 KVFFVIEYVKGGELFAKVLK-G-------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLK 155 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~-------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~k 155 (414)
.+|++|||+++++|.+++.. + .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999998864 2 389999999999999999999999999999999999999999999
Q ss_pred EeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc
Q 015005 156 VSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE 234 (414)
Q Consensus 156 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 234 (414)
|+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999998754321111122234467889999999877665 78999999999999998 999999888777777777665
Q ss_pred c-CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 235 Y-EFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 235 ~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
. ..+..++.++.+|+.+||++||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3 445568899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=331.58 Aligned_cols=252 Identities=32% Similarity=0.593 Sum_probs=217.4
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||+|+||.||+|.+..+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+......|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5899999999999999999999999999999997654322 224577899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-CeEEeecCCCcccccccCCC
Q 015005 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-NLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 97 ~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~ 172 (414)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||.+..... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--Ccc
Confidence 9999999998875 2479999999999999999999999999999999999999886 469999999876532 112
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHHh
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISR 251 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 251 (414)
......|++.|+|||++.+..++ .++|+||||+++|+|++|..||...+.......+..+.. ..++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 22345689999999998877665 789999999999999999999998777666665554433 3455678899999999
Q ss_pred hcccCcCCCCChHHHhcCCcc
Q 015005 252 ILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f 272 (414)
||..+|++|||+.++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=346.43 Aligned_cols=256 Identities=26% Similarity=0.423 Sum_probs=214.8
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC---
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT--- 89 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 89 (414)
.+.++|++.+.||+|+||.||+|.+..++..||+|.+.+... .......+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 467899999999999999999999999999999999865432 2223456889999999999999999999987653
Q ss_pred ---EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 90 ---KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 90 ---~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
.+++||||+ |++|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 468999999 7799888888899999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-----------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY----------- 235 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 235 (414)
. ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+....+..+.....
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 2 223446789999999987644345889999999999999999999987765544443322111
Q ss_pred --------------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 236 --------------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 236 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
...+.+++++.++|.+||+.||.+|||+.+++.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0123578889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=336.62 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=210.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
+..++|++.+.||+|+||.||+|.+. .++..||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34568999999999999999999864 24578999998643321 224568899999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEE
Q 015005 88 KTKVFFVIEYVKGGELFAKVLKG-----------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV 156 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~-----------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl 156 (414)
....++||||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999988651 2467788999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc
Q 015005 157 SDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY 235 (414)
Q Consensus 157 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~ 235 (414)
+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999998743321111111233567889999999877765 88999999999999999 7999998887777766655543
Q ss_pred -CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 236 -EFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 236 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
..+..++..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4566688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=337.58 Aligned_cols=254 Identities=31% Similarity=0.464 Sum_probs=207.3
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCE----
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTK---- 90 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 90 (414)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 4799999999999999999999999999999998765322 223456788999999995 6999999999987665
Q ss_pred -EEEEEEccCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC-CCCeEEeecCCC
Q 015005 91 -VFFVIEYVKGGELFAKVLK------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-NGNLKVSDFGLS 162 (414)
Q Consensus 91 -~~lv~E~~~gg~L~~~i~~------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-~~~~kl~DFGla 162 (414)
.|++|||+++ +|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 78777653 24799999999999999999999999999999999999998 889999999998
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--------
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE-------- 234 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------- 234 (414)
...... ........+++.|+|||++.+....+.++||||+|+++|+|++|..||.+.+......++....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 754321 1222334578899999998764444589999999999999999999998876554443332210
Q ss_pred ------------cC--------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 235 ------------YE--------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 235 ------------~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
.. ..+.++.++.+||.+||.+||.+||++.|++.||||.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 0123788899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=367.70 Aligned_cols=246 Identities=30% Similarity=0.496 Sum_probs=207.6
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEE-EEe------C
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEV-MAT------K 88 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~~------~ 88 (414)
+++|.+.|.+|||+.||+|++...|..||+|.+-.. ++...+.+.+||++|+.|+ |||||.+++. ... .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 678899999999999999999888899999998655 3445788999999999996 9999999993 321 1
Q ss_pred CEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRG--VYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~g--i~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
-.++|+||||+||.|-|++.. .+|+|.++.+||.|++.||.+||... |+|||||-|||||+.+|++||||||.++
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 258899999999999999884 57999999999999999999999998 9999999999999999999999999997
Q ss_pred ccccccCC--C-----ccccccCCCcccCchhh---cccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc
Q 015005 164 LPEQLWND--G-----LLHTQCGTPAYVAPEVL---RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA 233 (414)
Q Consensus 164 ~~~~~~~~--~-----~~~~~~gt~~y~APE~~---~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 233 (414)
..-..... . .--...-|+.|.|||++ .+.+. +.|+|||+|||+||-|+...+||+.... -.|+++
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNG 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEec
Confidence 43221100 0 00123469999999986 34555 5899999999999999999999987633 357788
Q ss_pred ccCCCC--CCCHHHHHHHHhhcccCcCCCCChHHHhcCC
Q 015005 234 EYEFPP--WISCDARRLISRILVADPQKRISVSEIMINP 270 (414)
Q Consensus 234 ~~~~~~--~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 270 (414)
+|.+|+ .++..+.+||+.||++||.+||++.+++.+-
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 998886 5899999999999999999999999987553
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=332.31 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=212.5
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCC---CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVT---QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
++|++.+.||+|+||+||+|.+..+ ...||+|.+..... ......+.+|+.+++.++||||+++++.+......|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 5699999999999999999987654 45799999865432 223467889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
++|||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 99999999999999875 5799999999999999999999999999999999999999999999999999986542111
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRL 248 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 248 (414)
........+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...........+... ..+.+...+..+.+|
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1122233456789999999877775 78999999999999998 99999877766666666544 334556689999999
Q ss_pred HHhhcccCcCCCCChHHHhcC
Q 015005 249 ISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~h 269 (414)
+.+||+.+|++||++.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.28 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=215.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
....+|.+.+.||+|+||+||+|.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++++.+....|
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34567999999999999999999999999999999997554433344567889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+||||++| +|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~--- 167 (307)
T cd06607 92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP--- 167 (307)
T ss_pred EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC---
Confidence 99999975 55565543 6799999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccCCCcccCchhhcc---cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CC-CCCCCHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRK---KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EF-PPWISCDA 245 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~s~~~ 245 (414)
.....|++.|+|||++.+ ..+ +.++||||+|+++|+|++|..||...+.......+..... .. +..++.++
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~-~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 168 ---ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred ---CCCccCCccccCceeeeccCCCCC-CcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 224568899999998742 334 4789999999999999999999988776555444443322 22 23367889
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 246 RRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.++|.+||..||++||++.+++.||||.+..
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=346.79 Aligned_cols=257 Identities=28% Similarity=0.468 Sum_probs=210.2
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK----- 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 88 (414)
+.++|++.+.||.|+||.||+|.+..+++.||+|.+...... ..+.+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 458999999999999999999999999999999998765432 346788999999999999999999876543
Q ss_pred ---------CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC-CCCeEEee
Q 015005 89 ---------TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-NGNLKVSD 158 (414)
Q Consensus 89 ---------~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-~~~~kl~D 158 (414)
...|++|||++ ++|.+.+..+.+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 36899999997 58988888788999999999999999999999999999999999999984 55789999
Q ss_pred cCCCcccccccC-CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc---
Q 015005 159 FGLSALPEQLWN-DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--- 234 (414)
Q Consensus 159 FGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--- 234 (414)
||++........ ........|+..|+|||.+.+....+.++|||||||++|+|++|..||...+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999975432111 1122334688999999987654444578999999999999999999998765544433322110
Q ss_pred ----------------------c-----CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 235 ----------------------Y-----EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 235 ----------------------~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
. ...+.++.++.+||++||++||.+|||+.+++.||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0 012346788999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=332.31 Aligned_cols=248 Identities=32% Similarity=0.515 Sum_probs=207.3
Q ss_pred EeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccC
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 99 (414)
....||+|+||.||+|.+..++..||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..|+++||++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 345899999999999999999999999998765432 24678899999999999999999999999999999999999
Q ss_pred CCchHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC-CCCeEEeecCCCcccccccCCCcc
Q 015005 100 GGELFAKVLK--GKL--KEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-NGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 100 gg~L~~~i~~--~~~--~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
+++|.+.+.. +.+ ++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++..... .....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--~~~~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc--CCCcc
Confidence 9999999875 455 88889999999999999999999999999999999986 67999999999875432 11223
Q ss_pred ccccCCCcccCchhhcccC-CCCCccchhhhhhhhhhhhcCCCCCCCchHH--HHHHH-HHhcccCCCCCCCHHHHHHHH
Q 015005 175 HTQCGTPAYVAPEVLRKKG-YDGAKSDIWSCGVVLFVLLSGFLPFQNENIM--KMYRK-IFKAEYEFPPWISCDARRLIS 250 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~~-i~~~~~~~~~~~s~~~~~li~ 250 (414)
....|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||...... ..+.. .......+|..+++++.+|++
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence 3345899999999986543 2347899999999999999999999764322 22221 223344567778999999999
Q ss_pred hhcccCcCCCCChHHHhcCCcc
Q 015005 251 RILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f 272 (414)
+||+.+|.+|||+.|++.||||
T Consensus 247 ~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=342.55 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=209.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeE----EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQES----VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
..+|++.+.||+|+||+||+|.+..+++. ||+|.+..... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 45799999999999999999987666654 89999864322 22356788999999999999999999999765 5
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.++++||+++|+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 7899999999999999886 46899999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDAR 246 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 246 (414)
..........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+....+....+..+ ..+.|+.++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 121122233456789999999887775 89999999999999997 99999887666554433332 3345667889999
Q ss_pred HHHHhhcccCcCCCCChHHHhcC
Q 015005 247 RLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~h 269 (414)
+++.+||..||.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=336.28 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=213.0
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECC-----CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLV-----TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
..++|++.+.||+|+||.||+|.+.. .+..||+|.+....... ....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR--ERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 35689999999999999999997542 35589999986543221 234577899999999999999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc-C----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEe
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-G----------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVS 157 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~----------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~ 157 (414)
+..|++|||+++|+|.+++.. + .++...+..++.|++.||.|||++||+||||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999999864 1 24567788999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-c
Q 015005 158 DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-Y 235 (414)
Q Consensus 158 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~ 235 (414)
|||+++...............++..|+|||.+.+..++ .++|+|||||++|+|++ |..||.+.+..+....+..+. .
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99998754321111112233457789999999877765 79999999999999998 799999887777666665543 3
Q ss_pred CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc------CCcccc
Q 015005 236 EFPPWISCDARRLISRILVADPQKRISVSEIMI------NPWFIK 274 (414)
Q Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~------hp~f~~ 274 (414)
..+..+++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 456667899999999999999999999999986 888753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=334.50 Aligned_cols=254 Identities=24% Similarity=0.441 Sum_probs=205.8
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHH-HHhCCCCCccceEEEEEeCCEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISV-MRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
++|++.+.||+|+||.||+|.+..+|+.||+|.+........ ...+..|+.+ ++.++||||+++++++...+..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 469999999999999999999999999999999976543222 2345556665 6667999999999999999999999
Q ss_pred EEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 95 IEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
|||++ |+|.+.+.. ..+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99997 566665543 4689999999999999999999998 999999999999999999999999999875432
Q ss_pred cCCCccccccCCCcccCchhhcc----cCCCCCccchhhhhhhhhhhhcCCCCCCCch-HHHHHHHHHhc-ccCCC-CCC
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRK----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-IMKMYRKIFKA-EYEFP-PWI 241 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~-~~~~~-~~~ 241 (414)
........|+..|+|||.+.+ ..+ +.++|+||+||++|+|++|..||.... ..+....+..+ ....| ..+
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 157 --SVAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred --ccccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 112223568899999999865 234 478999999999999999999997532 22222233322 33343 347
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
|.++.++|.+||..+|.+||++.++++||||.+..
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 89999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.32 Aligned_cols=244 Identities=27% Similarity=0.430 Sum_probs=203.6
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (414)
+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 468999999999999999999999999864432 223567889999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 102 ELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 102 ~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999865 4689999999999999999999999999999999999999999999999999875332111111111123
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCc
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLISRILVADP 257 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dp 257 (414)
+..|+|||.+.+..+. .++||||||+++|+|++ |..||...+.......+... ....|..++..+.+|+.+||+.||
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 4579999999877765 78999999999999997 99999876665554444432 345566688999999999999999
Q ss_pred CCCCChHHHhc
Q 015005 258 QKRISVSEIMI 268 (414)
Q Consensus 258 ~~R~s~~eil~ 268 (414)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=341.58 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=205.9
Q ss_pred CEEEeeeeeecCCeEEEEEEECC--CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLV--TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK--TKVF 92 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 92 (414)
+|++.+.||+|+||.||+|.+.. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999999875433333456778999999999999999999999988 8899
Q ss_pred EEEEccCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC----CCCeEEeecCCC
Q 015005 93 FVIEYVKGGELFAKVLK------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE----NGNLKVSDFGLS 162 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~----~~~~kl~DFGla 162 (414)
+||||+++ +|.+.+.. ..+++..++.++.|++.||+|||++|++||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 56555532 26899999999999999999999999999999999999999 899999999999
Q ss_pred cccccccC-CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH---------HHHHHH-
Q 015005 163 ALPEQLWN-DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK---------MYRKIF- 231 (414)
Q Consensus 163 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~---------~~~~i~- 231 (414)
........ .......++++.|+|||++.+....+.++|||||||++|+|++|..||....... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86543211 1123345689999999998765444578999999999999999999997643221 011100
Q ss_pred -------------------------hcccCCC-----------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 232 -------------------------KAEYEFP-----------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 232 -------------------------~~~~~~~-----------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.....++ ...+.++.++|.+||++||++|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0001111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=335.48 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=211.1
Q ss_pred cCCEEEeeeeeecCCeEEEEEEEC----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNL----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
+..|++.+.||+|+||+||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 467999999999999999999853 4567899999975332 2234678899999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC
Q 015005 91 VFFVIEYVKGGELFAKVLK------------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~------------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~ 152 (414)
.|++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 9999999999999998852 2378888999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHH
Q 015005 153 NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIF 231 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 231 (414)
.+||+|||+++...............++..|+|||++.+..++ .++|+|||||++|+|++ |..||.+.+.......+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999754322112223344567789999999877664 89999999999999998 999998877666555554
Q ss_pred hcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 232 KAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 232 ~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
... .+.|..+++.+.+++.+||++||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 433 34566789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=330.64 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=213.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
...|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+++++.++||||+++++++...+.++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 4569999999999999999999999999999999865432 245688999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 95 IEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
|||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999999998865 35899999999999999999999999999999999999999999999999998754321111
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLI 249 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 249 (414)
......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+.+..+..+ ....|..++.++.++|
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 11122346679999999877775 78999999999999998 99999988877777776554 4456677899999999
Q ss_pred HhhcccCcCCCCChHHHhc
Q 015005 250 SRILVADPQKRISVSEIMI 268 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~ 268 (414)
.+||+.||++|||+.++++
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=353.48 Aligned_cols=257 Identities=29% Similarity=0.566 Sum_probs=221.3
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.-|..++.||-|+||+|.+++...|...||+|.+.|..+...+.+..++.|-.||..-..+-||+||..|++++++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 35888999999999999999999999999999999988887777888999999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc------
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL------ 168 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~------ 168 (414)
+|++||++..++.+ |-|+|..|++|+.+|.+|+++.|..|++||||||+|||||.+|++||+||||++-+...
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999999998877 99999999999999999999999999999999999999999999999999998632110
Q ss_pred ----------------c------------------CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcC
Q 015005 169 ----------------W------------------NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG 214 (414)
Q Consensus 169 ----------------~------------------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g 214 (414)
+ .....+..+||+.|+|||++...+|. ..+|+||.|||||+|+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhC
Confidence 0 00012344799999999999999996 889999999999999999
Q ss_pred CCCCCCchHHHHHHHHHh--cccCCC--CCCCHHHHHHHHhhcccCcCCCC---ChHHHhcCCcccc
Q 015005 215 FLPFQNENIMKMYRKIFK--AEYEFP--PWISCDARRLISRILVADPQKRI---SVSEIMINPWFIK 274 (414)
Q Consensus 215 ~~Pf~~~~~~~~~~~i~~--~~~~~~--~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~f~~ 274 (414)
+.||-..+.-+...++.+ ....+| ..+|.++.+||.+++. +++.|. .++++..||||+.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 999988776555444332 222333 4589999999998654 578887 4678999999965
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=334.33 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=211.5
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECC-----CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLV-----TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
-.++|.+.+.||+|++|.||+|.+.. ++..||+|.+...... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999877 7789999998654322 2245688899999999999999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC---CeEEe
Q 015005 89 TKVFFVIEYVKGGELFAKVLKG--------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG---NLKVS 157 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~--------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~---~~kl~ 157 (414)
...|++|||++|++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 9999999999999999988752 488999999999999999999999999999999999998765 59999
Q ss_pred ecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-cc
Q 015005 158 DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EY 235 (414)
Q Consensus 158 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~ 235 (414)
|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999854221111111222345689999999877775 89999999999999997 99999988777666655443 34
Q ss_pred CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 236 EFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
..|..++..+.+++.+||+.||++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5567789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=325.57 Aligned_cols=252 Identities=31% Similarity=0.587 Sum_probs=220.3
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|++++++++|||++++++++.+....|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999876543 2345789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 97 YVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 97 ~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
|+++++|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--~~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC--ccccc
Confidence 9999999999887 78999999999999999999999999999999999999999999999999999865432 12234
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHH-HhcccCCCCCCCHHHHHHHHhhcc
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI-FKAEYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i-~~~~~~~~~~~s~~~~~li~~~L~ 254 (414)
...|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+......+. .......|..++..+.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4568999999999887765 48899999999999999999999876544433333 344455677789999999999999
Q ss_pred cCcCCCCChHHHhcCCcc
Q 015005 255 ADPQKRISVSEIMINPWF 272 (414)
Q Consensus 255 ~dp~~R~s~~eil~hp~f 272 (414)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=326.00 Aligned_cols=252 Identities=36% Similarity=0.643 Sum_probs=222.1
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||.|+||.||++.+..++..||+|.+...... ......+.+|+++++.++|||++++.+.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999999999999999765442 2235678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 97 YVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 97 ~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
|++|++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999998875 569999999999999999999999999999999999999999999999999998654321
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLIS 250 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 250 (414)
.......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+............. ..|..++.++.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 233456789999999998877765 789999999999999999999998877777666655443 455568899999999
Q ss_pred hhcccCcCCCCChHHHhcCCcc
Q 015005 251 RILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f 272 (414)
+||..+|++|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=328.14 Aligned_cols=246 Identities=41% Similarity=0.725 Sum_probs=221.6
Q ss_pred eeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCch
Q 015005 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL 103 (414)
Q Consensus 24 LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 103 (414)
||.|+||.||++.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.++++...|++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999889999999999887665544567889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCc
Q 015005 104 FAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182 (414)
Q Consensus 104 ~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 182 (414)
.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ........++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--GSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC--CCcccCCcCCcc
Confidence 999987 57999999999999999999999999999999999999999999999999998754331 123345568999
Q ss_pred ccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCCCC
Q 015005 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRIS 262 (414)
Q Consensus 183 y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s 262 (414)
|+|||.+.+.... .++|+||||+++|+|++|..||...+.....+.+......+|..++..+.++|++||..||++||+
T Consensus 159 ~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGYG-KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 9999999876654 789999999999999999999988887777788777778888888999999999999999999999
Q ss_pred h---HHHhcCCcc
Q 015005 263 V---SEIMINPWF 272 (414)
Q Consensus 263 ~---~eil~hp~f 272 (414)
+ .++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=326.20 Aligned_cols=254 Identities=31% Similarity=0.551 Sum_probs=219.3
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK--TKVFFV 94 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv 94 (414)
+|.+.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999999999999999766543 23467889999999999999999999999988 899999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999887 5899999999999999999999999999999999999999999999999999886544221112
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch-HHHHHHHHH--hcccCCCCCCCHHHHHHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-IMKMYRKIF--KAEYEFPPWISCDARRLIS 250 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~--~~~~~~~~~~s~~~~~li~ 250 (414)
.....++..|+|||.+.+..+. .++|+||+|+++|+|++|..||.... .......+. ......|..++..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYG-RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 3456789999999999877654 88999999999999999999998765 222333333 2334566678999999999
Q ss_pred hhcccCcCCCCChHHHhcCCcc
Q 015005 251 RILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f 272 (414)
+||+.||++||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=339.43 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=208.5
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeE--EEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQES--VAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT 89 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 89 (414)
+-.++|++.+.||+|+||.||+|.+..++.. +|+|.+.... .......+.+|+.++.++ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3456899999999999999999998877764 5677664322 223356788999999999 8999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC
Q 015005 90 KVFFVIEYVKGGELFAKVLKG-----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~-----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~ 152 (414)
.+|++|||+++|+|.+++... .+++..++.++.|++.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 999999999999999988642 478999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHH
Q 015005 153 NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIF 231 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 231 (414)
.+||+|||++...... .......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...+..+.+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 162 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 9999999998632211 111122346679999999777664 78999999999999998 999998877776666654
Q ss_pred hc-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 232 KA-EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 232 ~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.. ....|..+++++.+||.+||+.+|++||++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 43 233455578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=328.97 Aligned_cols=254 Identities=31% Similarity=0.515 Sum_probs=220.5
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
+.|++.+.||+|++|.||+|.+..+++.||+|.+...... .....+.+|+..+..++||||+++++++......|++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999999765432 33577899999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||+++++|.+++.. +.+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT--LDQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC--CCc
Confidence 99999999999986 789999999999999999999999 99999999999999999999999999998865331 122
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc---hHHHHHHHHHhcc-cCCCCC-CCHHHHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE---NIMKMYRKIFKAE-YEFPPW-ISCDARRL 248 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~-~~~~~~-~s~~~~~l 248 (414)
.....++..|+|||.+.+..++ .++|+||||+++|+|++|..||... ...+....+.... ...+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYS-YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCCC-chhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 2345688999999999877654 7899999999999999999999876 4445555544332 334555 78899999
Q ss_pred HHhhcccCcCCCCChHHHhcCCcccc
Q 015005 249 ISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
|.+||.++|++|||+.++++|||+..
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=332.55 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=213.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCC-----CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVT-----QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
+..++|++.+.||+|+||.||+|.+... +..||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 3456899999999999999999987644 478999998654322 224567899999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEE
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK-----------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV 156 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-----------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl 156 (414)
....|++|||+++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 9999999999999999998864 23678889999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-c
Q 015005 157 SDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-E 234 (414)
Q Consensus 157 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~ 234 (414)
+|||+++...............++..|+|||.+.+..++ .++|||||||++|++++ |..||.+.+.....+.+..+ .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 999998754332111223344578899999999876664 78999999999999998 99999888777776666544 3
Q ss_pred cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 235 YEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
...|..++.++.++|.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4567778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=370.47 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=207.3
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++.+.||+|+||.||+|.+..+++.||+|++...........+++.+|+++++.++||||+++++++.+.+..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47999999999999999999999999999999999765544444567789999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 95 IEYVKGGELFAKVLK------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
|||++||+|.+.+.. ...+...+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999988753 13455678899999999999999999999999999999999999999999999
Q ss_pred cccccccC----------------CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHH
Q 015005 163 ALPEQLWN----------------DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKM 226 (414)
Q Consensus 163 ~~~~~~~~----------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~ 226 (414)
........ .......+||+.|+|||++.+..++ .++||||+||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 75421100 0011234699999999999887775 899999999999999999999987654433
Q ss_pred HHHH-HhcccCCC--CCCCHHHHHHHHhhcccCcCCCCChHHHh
Q 015005 227 YRKI-FKAEYEFP--PWISCDARRLISRILVADPQKRISVSEIM 267 (414)
Q Consensus 227 ~~~i-~~~~~~~~--~~~s~~~~~li~~~L~~dp~~R~s~~eil 267 (414)
.... ........ ..+++.+.+++.+||+.||++||+..+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 2221 11111111 24788999999999999999998765554
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=335.16 Aligned_cols=251 Identities=32% Similarity=0.540 Sum_probs=208.7
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
|++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.++|||++++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999999765432 22345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 98 VKGGELFAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 98 ~~gg~L~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
++ ++|.+++.. . .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 688888876 3 5899999999999999999999999999999999999999999999999998754321 1122
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc---------------------
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--------------------- 233 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------------------- 233 (414)
....+++.|+|||++.+....+.++|+||||+++|+|++|..||...+......++...
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 33457889999999876544357899999999999999999999876654333322210
Q ss_pred --c------cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 234 --E------YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 234 --~------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
. ....+.++.++.++|.+||++||.+|||+.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 01123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=327.63 Aligned_cols=255 Identities=27% Similarity=0.502 Sum_probs=215.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeecccc--chhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV--KKQGLMEQIKREISVMRLVKHPNIVELKEVMATK--TKV 91 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 91 (414)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.++++++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 369999999999999999999999999999999864321 1223456888999999999999999999998764 568
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
++++||++|++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999999876 6799999999999999999999999999999999999999999999999999975432211
Q ss_pred -CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--ccCCCCCCCHHHHH
Q 015005 171 -DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EYEFPPWISCDARR 247 (414)
Q Consensus 171 -~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ 247 (414)
........|+..|+|||.+.+..++ .++|+|||||++|+|++|..||..........++... ...+|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1122345689999999999887664 7899999999999999999999887655555544432 23467778999999
Q ss_pred HHHhhcccCcCCCCChHHHhcCCcc
Q 015005 248 LISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
+|.+||. +|.+||++.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=335.18 Aligned_cols=256 Identities=30% Similarity=0.501 Sum_probs=209.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++.+.||+|++|+||+|.+..+|+.||+|.+...... ....+.+.+|++++++++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998665432 22345678899999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC-CCCeEEeecCCCcccccccC
Q 015005 95 IEYVKGGELFAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-NGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~ 170 (414)
|||+++ +|.+.+.. . .+++..+..++.|++.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999964 77777654 2 3688889999999999999999999999999999999985 457999999999754321
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--c--------------
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--E-------------- 234 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~-------------- 234 (414)
........|++.|+|||.+.+....+.++||||+||++|+|++|..||...+..+...++... .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112234467899999999876544457899999999999999999999876655444433210 0
Q ss_pred -----cC--------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 235 -----YE--------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 235 -----~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.. ..+.+++++.++|.+||+.||++||++.+++.||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00 12346888999999999999999999999999999975
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.76 Aligned_cols=254 Identities=26% Similarity=0.454 Sum_probs=216.3
Q ss_pred EEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEcc
Q 015005 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYV 98 (414)
Q Consensus 19 ~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 98 (414)
.....||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++.+...+..|++|||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 334679999999999999999999999999854332 23467889999999999999999999999999999999999
Q ss_pred CCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcccccc
Q 015005 99 KGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQC 178 (414)
Q Consensus 99 ~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 178 (414)
++++|.+.+..+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++..... .........
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~--~~~~~~~~~ 177 (292)
T cd06657 100 EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLV 177 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc--ccccccccc
Confidence 999999988778899999999999999999999999999999999999999999999999999864432 111223456
Q ss_pred CCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc---cCCCCCCCHHHHHHHHhhccc
Q 015005 179 GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE---YEFPPWISCDARRLISRILVA 255 (414)
Q Consensus 179 gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~~L~~ 255 (414)
|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+.... ......+++.+.+++.+||+.
T Consensus 178 ~~~~y~~pE~~~~~~~~-~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 178 GTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred cCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 89999999998776664 78999999999999999999998876655544443222 223345788999999999999
Q ss_pred CcCCCCChHHHhcCCccccCCCC
Q 015005 256 DPQKRISVSEIMINPWFIKGFSK 278 (414)
Q Consensus 256 dp~~R~s~~eil~hp~f~~~~~~ 278 (414)
||.+||++.++++||||.+...+
T Consensus 257 ~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 257 DPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred CcccCcCHHHHhcChHHhccCCC
Confidence 99999999999999999887653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=328.02 Aligned_cols=245 Identities=27% Similarity=0.430 Sum_probs=214.2
Q ss_pred eeeeecCCeEEEEEEECCC---CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEcc
Q 015005 22 RMLGQGTFAKVYYGKNLVT---QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYV 98 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 98 (414)
+.||+|+||.||+|.+... +..||+|.+....... ..+.+.+|+.+++.++||||+++++++.+...++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999998866 8899999997655433 3578899999999999999999999999999999999999
Q ss_pred CCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 99 KGGELFAKVLK----------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 99 ~gg~L~~~i~~----------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999875 56899999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDAR 246 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 246 (414)
..........+++.|+|||.+....++ .++||||||+++|+|++ |..||...+.....+.+..+ ....|..++.++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 222233455678999999999877664 88999999999999999 69999998877777777654 3456777899999
Q ss_pred HHHHhhcccCcCCCCChHHHhcC
Q 015005 247 RLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~h 269 (414)
+++.+||..||.+|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=346.17 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=204.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEe-
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMAT- 87 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 87 (414)
.++|++.+.||+|+||.||+|.+. .+++.||+|++...... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 358999999999999999999743 34578999998754322 2246678899999999 89999999998864
Q ss_pred CCEEEEEEEccCCCchHHHHhc----------------------------------------------------------
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK---------------------------------------------------------- 109 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~---------------------------------------------------------- 109 (414)
...+|++|||+++++|.+.+..
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4678999999999999988753
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccC
Q 015005 110 ----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVA 185 (414)
Q Consensus 110 ----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 185 (414)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++................++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578899999999999999999999999999999999999999999999999986432111112223446778999
Q ss_pred chhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHH-hc-ccCCCCCCCHHHHHHHHhhcccCcCCCCC
Q 015005 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIF-KA-EYEFPPWISCDARRLISRILVADPQKRIS 262 (414)
Q Consensus 186 PE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~-~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s 262 (414)
||++.+..++ .++|||||||++|+|++ |..||.+....+.+.... .+ ....|...++++.+++.+||+.+|++||+
T Consensus 244 PE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 9999888876 78999999999999997 999998754433333322 22 22345567899999999999999999999
Q ss_pred hHHHhcC
Q 015005 263 VSEIMIN 269 (414)
Q Consensus 263 ~~eil~h 269 (414)
+.|+++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.82 Aligned_cols=257 Identities=30% Similarity=0.466 Sum_probs=210.9
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK----- 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 88 (414)
+..+|.+.+.||+|+||+||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 4568999999999999999999999999999999987543222 2245677899999999999999999988654
Q ss_pred CEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
...|+++||+. ++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 678888776 7899999999999999999999999999999999999999999999999999985432
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh---------------
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------------- 232 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------- 232 (414)
. ........++..|+|||.+......+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 161 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 K--GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred C--cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 1 12334456899999999987543345899999999999999999999987654332221110
Q ss_pred --------c-----cc---CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 233 --------A-----EY---EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 233 --------~-----~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
. .. ...+.+++++.+||++||++||++|||+.++++||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0 00 012357889999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.77 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=215.8
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE--
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK-- 90 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 90 (414)
.+.++|++.+.||+|++|.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4677899999999999999999999999999999998654322 2234667789999999999999999988866554
Q ss_pred ----EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 91 ----VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 91 ----~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
.|+|+||+ |++|.+.+....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999998 6799999988899999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-----------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY----------- 235 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 235 (414)
. ......+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred c-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 2 133456889999999987644445899999999999999999999987766555444332110
Q ss_pred --------------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 236 --------------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 236 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.....++.++.+||++||++||.+|||+.++++||||.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 00123588999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.11 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=213.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCC-----CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVT-----QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
..+|++.+.||+|+||+||+|.+..+ +..||+|++..... ....+.+.+|+.++..++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45688999999999999999987543 57899999975432 223567889999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC
Q 015005 90 KVFFVIEYVKGGELFAKVLK-----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-----------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~ 152 (414)
..++++||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 99999999999999988752 2478888999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHH
Q 015005 153 NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIF 231 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 231 (414)
.+||+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+....+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998754332222223344567899999999877664 78999999999999998 899999888777777776
Q ss_pred hccc-CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 232 KAEY-EFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 232 ~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.... +.|..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 6554 4567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=338.29 Aligned_cols=255 Identities=21% Similarity=0.393 Sum_probs=212.7
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECC-------CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLV-------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKE 83 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 83 (414)
++..++|.+.+.||+|+||.||+|.+.. +...+|+|.+...... .....+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh--HHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4556889999999999999999998643 2356999999764322 2246788899999999 7999999999
Q ss_pred EEEeCCEEEEEEEccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcE
Q 015005 84 VMATKTKVFFVIEYVKGGELFAKVLKG-----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENL 146 (414)
Q Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NI 146 (414)
++...+..|+||||+++|+|.+++... .++..++..++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 999999999999999999999998752 378899999999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHH
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMK 225 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 225 (414)
+++.++.+||+|||++................+++.|+|||++.+..+. .++|+|||||++|+|++ |..||.+.+..+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999998754321111112222345789999999877665 88999999999999998 899998887777
Q ss_pred HHHHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 226 MYRKIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 226 ~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
....+.... ...|..++.++.+||.+||..+|++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 776665544 35566789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=335.04 Aligned_cols=254 Identities=23% Similarity=0.410 Sum_probs=213.8
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCC-----CeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVT-----QESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMA 86 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 86 (414)
.-.++|++.+.||+|+||.||++.+... ...+|+|.+...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3456899999999999999999987643 378999998764332 2346688999999999 8999999999999
Q ss_pred eCCEEEEEEEccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK-----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD 149 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~-----------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~ 149 (414)
..+.+|++|||+++|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 99999999999999999998853 3588999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHH
Q 015005 150 ENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYR 228 (414)
Q Consensus 150 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~ 228 (414)
.++.+||+|||++................++..|+|||++.+..++ .++|||||||++|+|++ |..||......+.++
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999999864432111122233456789999998877775 78999999999999997 999999888777777
Q ss_pred HHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 229 KIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 229 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.+..+. ...|...+.++.+|+.+||..||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 665543 34566788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=327.79 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=209.4
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
..|++.+.||+|+||.||+|... .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++......|++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 46899999999999999999864 4567999998654332 356788999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||++||+|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~-~~~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-EYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC-ceec
Confidence 99999999998874 56899999999999999999999999999999999999999999999999998753221 0111
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHHh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISR 251 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 251 (414)
.....++..|+|||++.+..+. .++|+||||+++|+|++ |..||...+..+....+..+.. ..|...+.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1122356689999999877775 78999999999999999 9999998888777777766543 3455678899999999
Q ss_pred hcccCcCCCCChHHHhc
Q 015005 252 ILVADPQKRISVSEIMI 268 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~ 268 (414)
||+.||++|||+.++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=329.28 Aligned_cols=259 Identities=33% Similarity=0.613 Sum_probs=235.6
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKV 91 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 91 (414)
+-...|.++++||+|+|++|-+++++.|.+.||+|+++++...+...++.++.|-.+..+- +||.+|-++.+|++++.+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 3456899999999999999999999999999999999999888777788999999998877 799999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
++|.||++||+|.-.+.+ .+++|+.|+.|...|+.||.|||++||++||||.+|+|+|..|++||+|+|+++. ....
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~l~~ 404 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GLGP 404 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--CCCC
Confidence 999999999999766665 7899999999999999999999999999999999999999999999999999984 2335
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC--------chHHHHHHHHHhcccCCCCCCC
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN--------ENIMKMYRKIFKAEYEFPPWIS 242 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~--------~~~~~~~~~i~~~~~~~~~~~s 242 (414)
.....+.||||.|+|||++.+..| +..+|+|+|||++++|+.|+.||+- .+..-+++-|+..+..+|..+|
T Consensus 405 gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls 483 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS 483 (593)
T ss_pred CcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee
Confidence 567889999999999999999998 4899999999999999999999953 2344578888899999999999
Q ss_pred HHHHHHHHhhcccCcCCCCC------hHHHhcCCcccc
Q 015005 243 CDARRLISRILVADPQKRIS------VSEIMINPWFIK 274 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s------~~eil~hp~f~~ 274 (414)
-.+..+++..|++||.+|.. .+++..|+||+.
T Consensus 484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 99999999999999999974 689999999963
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=331.59 Aligned_cols=254 Identities=29% Similarity=0.449 Sum_probs=210.7
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT--KTKVFF 93 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 93 (414)
++|+..+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+++++.++||||+++++++.+ .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 4799999999999999999999999999999999765332 235678899999999999999999998864 457999
Q ss_pred EEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 94 VIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999877542 4689999999999999999999999999999999999999999999999999875332
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch-----HHHHHHHHHhccc-CCC----
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-----IMKMYRKIFKAEY-EFP---- 238 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-----~~~~~~~i~~~~~-~~~---- 238 (414)
.......++..|+|||.+.+..++ .++|||||||++|+|++|..||.... ..+....+..... ..+
T Consensus 158 ---~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 158 ---SLAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ---cccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 112244578899999999887775 78999999999999999999998752 2233333332111 111
Q ss_pred --CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 239 --PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 239 --~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
...++.+.++|.+||+.||.+|||+.|++.||||.+..
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 12457899999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=331.41 Aligned_cols=251 Identities=28% Similarity=0.535 Sum_probs=212.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++.+.||+|+||.||+|.+..+++.+|+|.+.............+.+|+.+++.++||||+++++++..++..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 36799999999999999999999999999999998765544444456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 95 IEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|||++|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~-- 158 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-- 158 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc--
Confidence 999999999988762 4589999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH--HHHHHHHHhcccC-C-CCCCCHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI--MKMYRKIFKAEYE-F-PPWISCDA 245 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~-~-~~~~s~~~ 245 (414)
........+|++.|+|||.+.+..++ .++|+||||+++|+|++|..||.+... ......+....++ . +..++..+
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 12223455789999999999887775 789999999999999999999976533 2333444333322 2 23578899
Q ss_pred HHHHHhhcccCcCCCCChHHHhc
Q 015005 246 RRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.++|.+||+.||++|||+.+|++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=350.68 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=205.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCC-----CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVT-----QESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATK 88 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 88 (414)
.++|++++.||+|+||.||+|.+... +..||+|++...... ...+.+.+|+++++++. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 56788999999999999999986433 357999999654322 23467889999999996 99999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc-----------------------------------------------------------
Q 015005 89 TKVFFVIEYVKGGELFAKVLK----------------------------------------------------------- 109 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~----------------------------------------------------------- 109 (414)
+.+|+|||||++|+|.+++..
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999887753
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC
Q 015005 110 --------------------------------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN 151 (414)
Q Consensus 110 --------------------------------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~ 151 (414)
..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 136778889999999999999999999999999999999999
Q ss_pred CCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHH-HHH
Q 015005 152 GNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKM-YRK 229 (414)
Q Consensus 152 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~-~~~ 229 (414)
+.+||+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||........ +..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 99999999999754322111222334577889999999887775 89999999999999997 9999987544333 333
Q ss_pred HHhc-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 230 IFKA-EYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 230 i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+..+ ....+..++.++.+++.+||+.||++|||+.++.+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3332 23455668899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=318.93 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=210.6
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK---- 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 88 (414)
+-..||++.+.||+|||+.||++++..+++.||+|.+.....++ .+...+|++..++++|||+++++++...+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~---~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED---IEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH---HHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 34568999999999999999999999999999999998776433 57788999999999999999998876433
Q ss_pred -CEEEEEEEccCCCchHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHhCC--cEEecCCCCcEEEcCCCCeEEeecC
Q 015005 89 -TKVFFVIEYVKGGELFAKVLK----G-KLKEESARKYFQQLISAVDFCHSRG--VYHRDLKPENLLLDENGNLKVSDFG 160 (414)
Q Consensus 89 -~~~~lv~E~~~gg~L~~~i~~----~-~~~e~~~~~~~~ql~~al~~lH~~g--i~HrDlkp~NILl~~~~~~kl~DFG 160 (414)
...|++++|...|+|.+.++. | -++|.++..||.+++.||.+||+.. .+||||||.|||+.+.+.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 359999999999999998874 3 5999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccCCC-------ccccccCCCcccCchhhcccCC--CCCccchhhhhhhhhhhhcCCCCCCCchHH--HHHHH
Q 015005 161 LSALPEQLWNDG-------LLHTQCGTPAYVAPEVLRKKGY--DGAKSDIWSCGVVLFVLLSGFLPFQNENIM--KMYRK 229 (414)
Q Consensus 161 la~~~~~~~~~~-------~~~~~~gt~~y~APE~~~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~~ 229 (414)
.++.....-... .......|..|.|||.+.-+.+ -+.++|||||||+||.|+.|..||+..-.. .+.-.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 998644321111 1123347999999999864432 258999999999999999999999753221 11223
Q ss_pred HHhcccCCCC--CCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 230 IFKAEYEFPP--WISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 230 i~~~~~~~~~--~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+.++++.+|. .+|..+.+||+.||+.||.+||++.+++.+
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 4456666664 489999999999999999999999999864
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=327.19 Aligned_cols=250 Identities=30% Similarity=0.564 Sum_probs=213.0
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|++++++++|+||+++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999997654444444677889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 96 EYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 96 E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
||++||+|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~--~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--K 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC--C
Confidence 99999999988753 4589999999999999999999999999999999999999999999999999875432 1
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch--HHHHHHHHHhccc-CCCC-CCCHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN--IMKMYRKIFKAEY-EFPP-WISCDAR 246 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~s~~~~ 246 (414)
........|++.|+|||.+.+..+. .++|+|||||++|+|++|..||.... .......+..+.. +.|. .++.++.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 2223445689999999999887775 78999999999999999999996543 2334444443332 3343 5788999
Q ss_pred HHHHhhcccCcCCCCChHHHhc
Q 015005 247 RLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~ 268 (414)
++|.+||.++|++|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=343.53 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=211.9
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE----eCCE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA----TKTK 90 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~ 90 (414)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 47899999999999999999999999999999999764322 223567788999999999999999998875 3457
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+||||+. ++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 899999996 588888865 679999999999999999999999999999999999999999999999999987543211
Q ss_pred --CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh---------------
Q 015005 170 --NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------------- 232 (414)
Q Consensus 170 --~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------- 232 (414)
.........|+..|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 111223457899999999987644345899999999999999999999987654333222111
Q ss_pred -----------cccCC-----CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 233 -----------AEYEF-----PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 233 -----------~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
..... .+.++.++.++|++||+.||.+|||+++++.||||.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00011 133688999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=336.81 Aligned_cols=252 Identities=24% Similarity=0.418 Sum_probs=219.1
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
-|.++..||+|+||.||+|.++.+|+.+|||.+..+. .++.+.+|+.||++++.|++|++|+.|-....++||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3678899999999999999999999999999987653 36788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 97 YVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 97 ~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
||..|+..+.++. ..++|.++..+++.-+.||+|||...-+|||||..|||++.+|+.||+|||.|..... .-...
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence 9999999998875 6799999999999999999999999999999999999999999999999999975432 12234
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc---cCCCCCCCHHHHHHHHh
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE---YEFPPWISCDARRLISR 251 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~ 251 (414)
.+..|||.|||||++..-+|+ .++||||||+...+|..|++||.+-.+....-.|-... +.-|...|.++.++|++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred CccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence 577899999999999999998 78999999999999999999998876553322221111 11234468899999999
Q ss_pred hcccCcCCCCChHHHhcCCccccCC
Q 015005 252 ILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
||.++|++|.|+-++++|||.+...
T Consensus 266 CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 9999999999999999999987653
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=382.93 Aligned_cols=259 Identities=31% Similarity=0.525 Sum_probs=223.9
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
+.-+|.-+..||.|.||.||-|.+..+|+..|+|-+.-.... ....+.+.+|..++..++|||+|++|++-...+.+||
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 334688899999999999999999999999999999766554 4456788999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc--C
Q 015005 94 VIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW--N 170 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~~~-~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--~ 170 (414)
.||||+||+|.+.++.|+ .+|...+.|..|++.|+.|||+.|||||||||+||+|+.+|.+|++|||.|....... -
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999999999999999854 6777788899999999999999999999999999999999999999999997544321 2
Q ss_pred CCccccccCCCcccCchhhcccC--CCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHH-HhcccCCCCCCCHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKG--YDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKI-FKAEYEFPPWISCDAR 246 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i-~~~~~~~~~~~s~~~~ 246 (414)
.+......|||.|||||++.+.. -.+.++||||||||+.||+||+.||..-+.+ ....++ ....+++|..+|++.+
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHH
Confidence 24456778999999999997643 2246899999999999999999999764433 334444 4456778999999999
Q ss_pred HHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 247 RLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
++|.+||..||++|+++.|++.|-|-.
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 999999999999999999999998754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=341.16 Aligned_cols=258 Identities=25% Similarity=0.403 Sum_probs=211.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK---- 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 88 (414)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 3558899999999999999999999999999999999764322 12245678899999999999999999988643
Q ss_pred --CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 --TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 --~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
...|++++++ |++|.+.+....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478888887 7899888887889999999999999999999999999999999999999999999999999987532
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc------------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE------------ 234 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 234 (414)
. ......|++.|+|||.+.+....+.++||||+||++|+|++|..||...+.......+....
T Consensus 172 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 172 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred c-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 2 22345689999999998764333578999999999999999999998765544333322110
Q ss_pred -----------cCCC--------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 235 -----------YEFP--------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 235 -----------~~~~--------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
...| ...++++.+||.+||+.||.+||++.+++.||||.+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0011 125778999999999999999999999999999987443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=330.51 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=206.4
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCe--EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC------C
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQE--SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK------T 89 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~ 89 (414)
|.+++.||+|+||.||+|.+..++. .+|+|.+...... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3578899999999999999877765 6999998765332 23356788999999999999999999987432 3
Q ss_pred EEEEEEEccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 90 KVFFVIEYVKGGELFAKVLK-------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
..+++|||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999887742 24789999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc-CCCCC
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPW 240 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 240 (414)
................+++.|+|||.+.+..++ .++||||||+++|+|++ |..||........+..+..+.. ..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 864322111112233467789999999887775 89999999999999999 8999988777777766665543 45667
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
++..+.++|.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=329.96 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=208.4
Q ss_pred EEEeeeeeecCCeEEEEEEECC---CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE----
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLV---TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK---- 90 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 90 (414)
|.+++.||+|+||.||+|.... ++..||+|.+...... ......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5788999999999999998754 3478999998764433 2235678899999999999999999998865543
Q ss_pred --EEEEEEccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCC
Q 015005 91 --VFFVIEYVKGGELFAKVLK-------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL 161 (414)
Q Consensus 91 --~~lv~E~~~gg~L~~~i~~-------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGl 161 (414)
.+++|||+++|+|...+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999888743 2589999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCC
Q 015005 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPP 239 (414)
Q Consensus 162 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~ 239 (414)
++...............++..|+|||.+.+..+. .++|||||||++|+|++ |..||.+....+.+..+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 9754332111122233456789999999777664 89999999999999999 99999888777777666654 345677
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.++.++.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=336.27 Aligned_cols=253 Identities=22% Similarity=0.391 Sum_probs=211.4
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECC-------CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLV-------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVM 85 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 85 (414)
-.++|.+.+.||+|+||.||+|.+.. ....+|+|.+...... .....+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD--KDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh--HHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 34689999999999999999997632 3457999998754322 2356788999999999 699999999999
Q ss_pred EeCCEEEEEEEccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE
Q 015005 86 ATKTKVFFVIEYVKGGELFAKVLK-----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL 148 (414)
Q Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~~-----------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl 148 (414)
.....+|++|||+++|+|.+++.. ..++...+..++.|++.||.|||++|++||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 999999999999999999998864 247888999999999999999999999999999999999
Q ss_pred cCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHH
Q 015005 149 DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMY 227 (414)
Q Consensus 149 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~ 227 (414)
+.++.+||+|||+++...............+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+.+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999854332111122223355689999999877665 78999999999999999 89999988877777
Q ss_pred HHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 228 RKIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 228 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
..+.... ...|..++.++.+||.+||..||++|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7665543 34566788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=331.77 Aligned_cols=258 Identities=32% Similarity=0.595 Sum_probs=217.3
Q ss_pred CEEEeeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccch-hhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVKK-QGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKV 91 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 91 (414)
.|++.+.||.|+||.||+|.+. .+|+.||+|++....... ....+.+.+|+.+++.+ +||||+++++.++.+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999874 478999999997644322 22346778999999999 699999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++...... .
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-E 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc-c
Confidence 999999999999999876 67999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCccccccCCCcccCchhhccc-CCCCCccchhhhhhhhhhhhcCCCCCCCch----HHHHHHHHHhcccCCCCCCCHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKK-GYDGAKSDIWSCGVVLFVLLSGFLPFQNEN----IMKMYRKIFKAEYEFPPWISCDA 245 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 245 (414)
........|+..|+|||.+.+. ...+.++||||+|+++|+|++|..||.... .......+.....++|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1223345689999999998653 223478999999999999999999997432 33444555556667777789999
Q ss_pred HHHHHhhcccCcCCCC-----ChHHHhcCCccccC
Q 015005 246 RRLISRILVADPQKRI-----SVSEIMINPWFIKG 275 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~-----s~~eil~hp~f~~~ 275 (414)
.+++++||+.||.+|| ++.+++.||||.+.
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 88999999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=349.46 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=218.8
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
|.=++.||.|+||-||.|++..+.+.||||.+.........--+++.+|+..|++++|||+|.+.++|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56678899999999999999999999999999765544333346789999999999999999999999999999999999
Q ss_pred cCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 98 VKGGELFAKVL--KGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 98 ~~gg~L~~~i~--~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
|- |+-.|++. +.++.|.++..+..+.+.||.|||+.+.+|||||..|||+++.|.|||+|||.|.+..+ ..
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An 180 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN 180 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence 96 56667665 36899999999999999999999999999999999999999999999999999986543 56
Q ss_pred cccCCCcccCchhhc---ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-CC-CCCCHHHHHHHH
Q 015005 176 TQCGTPAYVAPEVLR---KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FP-PWISCDARRLIS 250 (414)
Q Consensus 176 ~~~gt~~y~APE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~-~~~s~~~~~li~ 250 (414)
+.+|||.|||||++. ...|+ -++||||||++..+|.-.++|+-..+.......|..++.+ .+ +..|..++.|+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 789999999999985 34566 6899999999999999999998887777666666555443 33 236889999999
Q ss_pred hhcccCcCCCCChHHHhcCCccccCCC
Q 015005 251 RILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
.||++-|.+|||.+++|.|+|+.+.-+
T Consensus 260 ~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHhhCcccCCcHHHHhhcchhccCCC
Confidence 999999999999999999999876544
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=329.88 Aligned_cols=246 Identities=24% Similarity=0.417 Sum_probs=212.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.+|++.+.||.|+||.||+|.+.. +..+|+|++....... ...+.+|+.+++.++||||+++++++.+....|++|
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLK---QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhh---HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 468999999999999999999877 8899999997654322 456889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 96 EYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 96 E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~~ 159 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--VY 159 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--cc
Confidence 99999999999975 36899999999999999999999999999999999999999999999999999754321 11
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLIS 250 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 250 (414)
......+++.|+|||++.+..+. .++||||||+++|+|++ |..||...+..+.+..+..+ ..+.|..+++++.++|.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred cccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence 12233467789999999877665 78999999999999998 89999988777777766644 34556678999999999
Q ss_pred hhcccCcCCCCChHHHhc
Q 015005 251 RILVADPQKRISVSEIMI 268 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~ 268 (414)
+||+.||.+|||+.++++
T Consensus 239 ~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 239 ECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=332.78 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=211.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
.++|.+.+.||+|+||.||+|.+. .++..+++|.+...... ..+.+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH---HHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 467999999999999999999753 34567999998654432 2456889999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC
Q 015005 90 KVFFVIEYVKGGELFAKVLK-----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-----------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~ 152 (414)
..++||||+++++|.+++.. +.+++..+..++.||+.||+|||++|++||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999864 2378999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHH
Q 015005 153 NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIF 231 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 231 (414)
.++|+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||...+..+....+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999999754322111222344578899999999887765 78999999999999998 999998877777776666
Q ss_pred hcccC-CCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 232 KAEYE-FPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 232 ~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+... .+..++..+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 55443 44557889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=335.21 Aligned_cols=259 Identities=30% Similarity=0.523 Sum_probs=212.0
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT- 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 89 (414)
|....++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+++++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 4567789999999999999999999999999999999997654322 22356778999999999999999999987654
Q ss_pred ---------EEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEee
Q 015005 90 ---------KVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSD 158 (414)
Q Consensus 90 ---------~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~D 158 (414)
.+|+++||+++ ++...+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 89999999986 66666664 4799999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc---cc
Q 015005 159 FGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA---EY 235 (414)
Q Consensus 159 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~ 235 (414)
||++........ .......+++.|+|||.+.+....+.++|||||||++|+|++|+.||...+..+....+... ..
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999986543211 12223356888999999876544457899999999999999999999877655544433221 00
Q ss_pred ---------------------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 236 ---------------------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 236 ---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.....++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=361.35 Aligned_cols=261 Identities=25% Similarity=0.410 Sum_probs=197.3
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCC-CeEEEEEE--------------eeccccchhhHHHHHHHHHHHHHhCCCC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVT-QESVAIKV--------------INKDQVKKQGLMEQIKREISVMRLVKHP 76 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-~~~vaiK~--------------~~~~~~~~~~~~~~~~~Ei~il~~l~hp 76 (414)
..+.++|++++.||+|+||+||+|..+.. +...+.|. +.+...........+.+|+.++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 45678999999999999999999876432 22222221 1111111122346688999999999999
Q ss_pred CccceEEEEEeCCEEEEEEEccCCCchHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC
Q 015005 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKG------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE 150 (414)
Q Consensus 77 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~ 150 (414)
||+++++++...+..|+++|++. ++|..++..+ .....+++.++.||+.||.|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 99999999999999999999995 5666666432 2446778899999999999999999999999999999999
Q ss_pred CCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCC-CCCCc--hHHHHH
Q 015005 151 NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFL-PFQNE--NIMKMY 227 (414)
Q Consensus 151 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~-Pf~~~--~~~~~~ 227 (414)
++.+||+|||++...... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|.. ||... .....+
T Consensus 303 ~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999765421 11223346799999999999988875 88999999999999999875 44322 111111
Q ss_pred HHHHh----------------------ccc-----CCC-----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 228 RKIFK----------------------AEY-----EFP-----PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 228 ~~i~~----------------------~~~-----~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.++.. ..+ .++ ..++.++.++|.+||+.||.+|||+.|+|+||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 11111 000 001 1246678889999999999999999999999999764
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=333.49 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=208.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCe--EEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQE--SVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 92 (414)
++|++.+.||+|+||.||+|....++. .+++|.+.... .....+.+.+|+.++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877765 46888875322 122346788999999999 7999999999999999999
Q ss_pred EEEEccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeE
Q 015005 93 FVIEYVKGGELFAKVLKG-----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLK 155 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~~-----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~k 155 (414)
++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999998652 478899999999999999999999999999999999999999999
Q ss_pred EeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc
Q 015005 156 VSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE 234 (414)
Q Consensus 156 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 234 (414)
|+|||++...... ........+..|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+.
T Consensus 160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccce---eccCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999998642211 011112235579999999877775 78999999999999997 999999888877777765543
Q ss_pred -cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 235 -YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 235 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
...|..++.++.+||.+||+.||.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34556689999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=327.10 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=208.4
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.+|++.+.||+|+||.||+|.+. ++..+|+|++.+.... ...+.+|+.+++.++||||+++++++...+..|++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 35889999999999999999875 5678999998654332 245778999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~-~~~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc-cccc
Confidence 99999999999875 56899999999999999999999999999999999999999999999999998754221 0011
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHHHh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLISR 251 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~ 251 (414)
.....++..|+|||.+.+..+. .++||||||+++|+|++ |..||...+..+....+..+ ....|...+.++.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1112234579999999887775 78999999999999999 89999887776666666544 345566689999999999
Q ss_pred hcccCcCCCCChHHHhcC
Q 015005 252 ILVADPQKRISVSEIMIN 269 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~h 269 (414)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=333.17 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=212.9
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.+.|...+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|||++++++++.+....|++
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34477788999999999999999999999999999765544444456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||+.| +|.+.+.. ..+++.++..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++....
T Consensus 100 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------ 172 (313)
T cd06633 100 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------ 172 (313)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence 999975 66666654 578999999999999999999999999999999999999999999999999986422
Q ss_pred ccccccCCCcccCchhhcc---cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-C-CCCCCHHHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRK---KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-F-PPWISCDARR 247 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~s~~~~~ 247 (414)
......|+..|+|||++.. ..+ +.++|||||||++|+|++|..||...+.......+.....+ . ...++..+.+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~-~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred CCCCccccccccChhhccccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 2234578999999999842 334 47899999999999999999999887665554444433322 2 2346778999
Q ss_pred HHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 248 LISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
|+.+||+.+|.+||++.+++.||||...
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=342.25 Aligned_cols=262 Identities=31% Similarity=0.475 Sum_probs=214.0
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC--
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATK-- 88 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-- 88 (414)
..+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.+..... .....+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 356789999999999999999999999899999999986543221 2235677899999999 999999999998653
Q ss_pred CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
...|+||||++ ++|...+..+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 46899999997 58988888788899999999999999999999999999999999999999999999999999854332
Q ss_pred cCC---CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc-----------
Q 015005 169 WND---GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE----------- 234 (414)
Q Consensus 169 ~~~---~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----------- 234 (414)
... .......||+.|+|||++.+....+.++||||||+++|+|++|+.||.+........++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 111 223345689999999998765544588999999999999999999998765443332221110
Q ss_pred ----------------c----CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 235 ----------------Y----EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 235 ----------------~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
. ...+.++.++.++|.+||+.||++|||+.++++|||+.+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0112368899999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=333.79 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=210.9
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEE-----CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKN-----LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVM 85 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 85 (414)
....++|++.+.||+|+||.||+|.+ ..++..||+|.+...... ...+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 45566899999999999999999975 335568999998754322 2346788999999999 799999999999
Q ss_pred EeCCEEEEEEEccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 86 ATKTKVFFVIEYVKGGELFAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
...+..|++|||+++|+|.+++.. . .+++.++..++.|++.||.|||++|++|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999999999875 2 3899999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc--cCCCC
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE--YEFPP 239 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~ 239 (414)
................+++.|+|||.+.+..++ .++||||+||++|+|++ |..||........+.+..... ...+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence 754321111112233467889999999887765 78999999999999998 999998876655554444332 23455
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
..++++.+++.+||+++|++|||+.|+++
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 68899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=339.79 Aligned_cols=262 Identities=27% Similarity=0.393 Sum_probs=214.0
Q ss_pred cccCCEEE-eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh-----------hHHHHHHHHHHHHHhCCCCCccc
Q 015005 13 ILFGKYEM-GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ-----------GLMEQIKREISVMRLVKHPNIVE 80 (414)
Q Consensus 13 ~~~~~y~~-~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~Ei~il~~l~hpnIv~ 80 (414)
.+.++|.. .+.||+|+||+||+|.+..+++.||+|.+........ .....+.+|+++++.++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 35678865 5779999999999999999999999999865433221 01124678999999999999999
Q ss_pred eEEEEEeCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeec
Q 015005 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDF 159 (414)
Q Consensus 81 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DF 159 (414)
+++++..++..|++|||+. |+|.+.+.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999997 588888876 67999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccc------------cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHH
Q 015005 160 GLSALPEQL------------WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMY 227 (414)
Q Consensus 160 Gla~~~~~~------------~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~ 227 (414)
|++...... ..........+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998754310 01112233457889999999876554468999999999999999999999887766555
Q ss_pred HHHHhcc--c-------------------C-------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 228 RKIFKAE--Y-------------------E-------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 228 ~~i~~~~--~-------------------~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..+.... + . ..+..+.++.++|.+||+.||++|||++|++.||||...
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 4443210 0 0 012357789999999999999999999999999999764
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=332.65 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=209.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCC----------------eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQ----------------ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 78 (414)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+++++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876544 56899998765432 235678899999999999999
Q ss_pred cceEEEEEeCCEEEEEEEccCCCchHHHHhc-C-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcE
Q 015005 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLK-G-----------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENL 146 (414)
Q Consensus 79 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~-----------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NI 146 (414)
+++++++..++..+++|||+++++|.+++.. . .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 9999999999999999999999999998876 3 589999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc--CCCCCCCchHH
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS--GFLPFQNENIM 224 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~ 224 (414)
+++.++.++|+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999998754322112223344567899999998876664 89999999999999988 78899876666
Q ss_pred HHHHHHHhc--------ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 225 KMYRKIFKA--------EYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 225 ~~~~~i~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
..+...... ....++.++.++.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 555544322 12334557899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=333.24 Aligned_cols=255 Identities=22% Similarity=0.396 Sum_probs=214.2
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEEC-------CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNL-------VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKE 83 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 83 (414)
....++|++.+.||+|+||.||+|+.. ..+..||+|.+...... .....+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch--HHHHHHHHHHHHHHhhccCCCchheeE
Confidence 455778999999999999999999753 23457999998754322 2356788999999999 8999999999
Q ss_pred EEEeCCEEEEEEEccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcE
Q 015005 84 VMATKTKVFFVIEYVKGGELFAKVLKG-----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENL 146 (414)
Q Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NI 146 (414)
++......|++|||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999988752 367788899999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHH
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMK 225 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 225 (414)
+++.++.+||+|||++................+++.|+|||++.+..++ .++||||||+++|+|++ |..||.+.+..+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 9999999999999999865432222223344567889999999887775 78999999999999998 899999888877
Q ss_pred HHHHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 226 MYRKIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 226 ~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
....+..+. ...|..++.++.+||.+||.++|.+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 777765443 24456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=334.83 Aligned_cols=259 Identities=29% Similarity=0.460 Sum_probs=208.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC---
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK--- 88 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--- 88 (414)
....++|++.+.||+|+||.||+|.+..+++.+|+|.+........ ....+.+|+++++.++||||+++++++...
T Consensus 4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 3457899999999999999999999999999999999876543221 234567899999999999999999887443
Q ss_pred -----CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCC
Q 015005 89 -----TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL 161 (414)
Q Consensus 89 -----~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGl 161 (414)
..+|++|||+.+ +|...+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 83 SKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 357999999975 56666654 5799999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCC---------CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh
Q 015005 162 SALPEQLWND---------GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK 232 (414)
Q Consensus 162 a~~~~~~~~~---------~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~ 232 (414)
+......... .......|++.|+|||.+.+....+.++||||+||++|+|++|..||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9754322111 1112335788999999987654345789999999999999999999988776655544432
Q ss_pred ccc-----------------------CCC-------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 233 AEY-----------------------EFP-------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 233 ~~~-----------------------~~~-------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
... ..+ ..++.++.++|.+||+.||.+|||+.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 100 000 1244678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=328.45 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=208.9
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCe----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQE----SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
...+|++.+.||+|+||+||+|.+..+++ .||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 35679999999999999999999877776 489999865432 22356788999999999999999999998754
Q ss_pred EEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
..++++||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999875 5699999999999999999999999999999999999999999999999999986542
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDA 245 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 245 (414)
...........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+..+. .+.+...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 1111112223356789999999887775 78999999999999998 999998776665555554432 34556689999
Q ss_pred HHHHHhhcccCcCCCCChHHHhc
Q 015005 246 RRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+++.+||+.||++||++.+++.
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=329.76 Aligned_cols=252 Identities=33% Similarity=0.535 Sum_probs=210.7
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEEEEEE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK--TKVFFVI 95 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv~ 95 (414)
|++.+.||+|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998764 2223346788999999999999999999999988 8999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||+++ +|.+.+.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~-~~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN-SAD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC-ccc
Confidence 99975 88888776 479999999999999999999999999999999999999999999999999998654321 112
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc------------------
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY------------------ 235 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------------ 235 (414)
.....++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23446788999999877654345899999999999999999999988776655444432100
Q ss_pred -----CC-------CCC-CCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 236 -----EF-------PPW-ISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 236 -----~~-------~~~-~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.. ... .+..+.++|++||..||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=333.50 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=216.0
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
...|...+.||+|+||.||+|.+..++..+|+|.+.............+.+|+++++.++|||++++++++.+....|+|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 34588999999999999999999999999999999765444444456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||++| +|.+.+.. ..+++.++..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 999975 66666543 6789999999999999999999999999999999999999999999999999874332
Q ss_pred ccccccCCCcccCchhhcc---cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-C-CCCCCHHHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRK---KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-F-PPWISCDARR 247 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~s~~~~~ 247 (414)
.....|++.|+|||.+.. ..+ +.++|+||+||++|+|++|..||...+.......+...... . +..++..+.+
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 234568999999999742 334 47899999999999999999999887666655555554332 2 2347888999
Q ss_pred HHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 248 LISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
+|.+||+.+|.+||++.++++|+|+.....
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 999999999999999999999999976433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=318.98 Aligned_cols=248 Identities=32% Similarity=0.521 Sum_probs=213.7
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999988999999999976554 235678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 97 YVKGGELFAKVLKG--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 97 ~~~gg~L~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
|++|++|.+.+... .+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998764 799999999999999999999999999999999999999999999999999876543211 3
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-ccCCCC--CCCHHHHHHHHh
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-EYEFPP--WISCDARRLISR 251 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~~~--~~s~~~~~li~~ 251 (414)
....|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+........... ....+. .++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999987665 47899999999999999999999887544333333222 222222 248899999999
Q ss_pred hcccCcCCCCChHHHhcCCc
Q 015005 252 ILVADPQKRISVSEIMINPW 271 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~ 271 (414)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=330.99 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=208.1
Q ss_pred CEEEeeeeeecCCeEEEEEEECC-----CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLV-----TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
+|++.+.||+|+||.||+|.+.. ....+|+|.+...... .....+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998653 2357999998654332 2246788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcE
Q 015005 92 FFVIEYVKGGELFAKVLK-------------------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENL 146 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-------------------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NI 146 (414)
|++|||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999988753 2477888999999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHH
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMK 225 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 225 (414)
|++.++.+||+|||++................++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999998754322111122334567789999998777665 88999999999999998 999999887777
Q ss_pred HHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 226 MYRKIFKA-EYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 226 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+..+... ....|..++.++.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66655433 33446668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=324.29 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=208.5
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++.+.||+|+||+||+|... .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++......|++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 56999999999999999999764 3456999998654332 356889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...... ....
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~-~~~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC-ceee
Confidence 99999999999875 46899999999999999999999999999999999999999999999999998753221 1111
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcccC-CCCCCCHHHHHHHHh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYE-FPPWISCDARRLISR 251 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~ 251 (414)
.....++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+.......+..+... .+...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1122355679999999877765 78999999999999998 99999887777776766655433 355578899999999
Q ss_pred hcccCcCCCCChHHHhcC
Q 015005 252 ILVADPQKRISVSEIMIN 269 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~h 269 (414)
||+.||.+|||+.+++.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=323.64 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=209.2
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
..++|++.+.||+|++|.||+|.+. +++.||+|.+...... .+.+.+|+.++++++||||+++++++...+..|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 3467999999999999999999864 5578999998754432 3568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 94 VIEYVKGGELFAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+|||++|++|.+++.. . .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999999999876 2 589999999999999999999999999999999999999999999999999986542111
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRL 248 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 248 (414)
.......++..|+|||++.+..++ .++||||||+++|+|++ |+.||.+.+.......+... ..+.+...+..+.++
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05068 159 -EAREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDI 236 (261)
T ss_pred -cccCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 111112234579999999877665 78999999999999999 99999988777666666443 234556688999999
Q ss_pred HHhhcccCcCCCCChHHHhc
Q 015005 249 ISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~ 268 (414)
+.+||+.||.+||++.++++
T Consensus 237 i~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 237 MLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHhhcCcccCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=324.81 Aligned_cols=248 Identities=19% Similarity=0.344 Sum_probs=208.7
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
-.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+....|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 3568999999999999999999864 566799999865432 24678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 94 VIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+|||+++++|.+++.. ..++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 157 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE- 157 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc-
Confidence 9999999999998864 468899999999999999999999999999999999999999999999999998643211
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRL 248 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 248 (414)
........++..|+|||.+.+..++ .++|||||||++|+|++ |..||...........+... ..+.+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1111223356789999999877664 78999999999999998 99999887776666665543 223344578999999
Q ss_pred HHhhcccCcCCCCChHHHhc
Q 015005 249 ISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~ 268 (414)
+.+||..||++|||++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.34 Aligned_cols=149 Identities=33% Similarity=0.635 Sum_probs=139.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++.+.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876555555567889999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
|||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999876 778999999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=323.71 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=203.8
Q ss_pred eeeecCCeEEEEEEE--CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 23 MLGQGTFAKVYYGKN--LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 23 ~LG~G~~g~Vy~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
.||+|+||.||+|.. ..++..+|+|++..... .....+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 689999999999964 45788999999865433 23345778899999999999999999998864 567899999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC-Ccccccc
Q 015005 101 GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND-GLLHTQC 178 (414)
Q Consensus 101 g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~ 178 (414)
|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||.||+++.++.+||+|||++......... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999876 67999999999999999999999999999999999999999999999999999754322111 0112234
Q ss_pred CCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHHHhhcccC
Q 015005 179 GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLISRILVAD 256 (414)
Q Consensus 179 gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d 256 (414)
+++.|+|||.+....+. .++|+|||||++|+|++ |..||...+..+....+..+. ++.|..+++++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 56789999998776664 78999999999999998 999999877777766666543 4567779999999999999999
Q ss_pred cCCCCChHHHhc
Q 015005 257 PQKRISVSEIMI 268 (414)
Q Consensus 257 p~~R~s~~eil~ 268 (414)
|++||++++|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.62 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=207.4
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
..++|++.+.||+|+||.||+|.+..+ ..||+|.+...... .+.+.+|+++++.++||||+++++.+.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 357899999999999999999987655 45999999764432 2467899999999999999999998754 56899
Q ss_pred EEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 94 VIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+|||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~- 156 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 156 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-
Confidence 9999999999999875 358999999999999999999999999999999999999999999999999997543211
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRL 248 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 248 (414)
........++..|+|||++.+..++ .++||||||+++|+|++ |..||.+.........+..+. .+.+..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred cccccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 1112234467789999998877774 89999999999999999 899998877776666655432 34456688999999
Q ss_pred HHhhcccCcCCCCChHHHhc
Q 015005 249 ISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~ 268 (414)
|.+||++||.+||++.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=328.68 Aligned_cols=256 Identities=29% Similarity=0.509 Sum_probs=220.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
-..+.|++.+.||+|++|.||+|.+..++..||+|++..... ..+.+.+|+++++.++||||+++++.+......|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 355679999999999999999999988999999999976543 2467889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLKG--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+++||++|++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-- 169 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE-- 169 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc--
Confidence 999999999999999884 8999999999999999999999999999999999999999999999999998644321
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CC--CCCCCHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EF--PPWISCDARR 247 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~--~~~~s~~~~~ 247 (414)
........+++.|+|||.+.+..++ .++|+|||||++|+|++|..||...+.......+..... .. +..++.++.+
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 1122344588999999999877765 889999999999999999999988766555444433322 22 2237889999
Q ss_pred HHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 248 LISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+|++||+.+|.+|||+.+++.||||.+.
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 9999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=325.18 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=210.0
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCe---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQE---SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
.+.|++.+.||+|+||.||+|.+..+++ .||+|.+..... ......+.+|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4569999999999999999999877665 699999875432 22356789999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
++||||+++++|.+++.. +.+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999998875 568999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCcccccc---CCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHH
Q 015005 170 NDGLLHTQC---GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCD 244 (414)
Q Consensus 170 ~~~~~~~~~---gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 244 (414)
......... ++..|+|||.+.+..++ .++||||+||++|+|++ |..||...+.......+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111111 24579999999887775 78999999999999886 99999887776666665433 23445567889
Q ss_pred HHHHHHhhcccCcCCCCChHHHhc
Q 015005 245 ARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+.+++.+||..+|.+||++.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=340.45 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=204.0
Q ss_pred cCCEEEeeeeeecCCeEEEEEEE-----CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEe-
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKN-----LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMAT- 87 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 87 (414)
.++|++.+.||+|+||+||+|.+ ..+++.||||.+...... .....+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 46899999999999999999974 356789999999754332 2246788999999999 68999999998865
Q ss_pred CCEEEEEEEccCCCchHHHHhcC---------------------------------------------------------
Q 015005 88 KTKVFFVIEYVKGGELFAKVLKG--------------------------------------------------------- 110 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~--------------------------------------------------------- 110 (414)
+..++++|||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45789999999999999887641
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 111 -----------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 111 -----------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
.++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 257778889999999999999999999999999999999999999999999875422111111223345
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHH-HHHHhc-ccCCCCCCCHHHHHHHHhhcccC
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMY-RKIFKA-EYEFPPWISCDARRLISRILVAD 256 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~s~~~~~li~~~L~~d 256 (414)
++.|+|||.+.+..+. .++||||||+++|+|++ |..||......... ..+..+ ....|.+.++++.+++.+||+.|
T Consensus 244 ~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 6789999999887775 78999999999999996 99999875433222 223222 33456678899999999999999
Q ss_pred cCCCCChHHHhcC
Q 015005 257 PQKRISVSEIMIN 269 (414)
Q Consensus 257 p~~R~s~~eil~h 269 (414)
|.+|||+.+|++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=334.33 Aligned_cols=258 Identities=29% Similarity=0.495 Sum_probs=212.4
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe-CCEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT-KTKVF 92 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 92 (414)
+.++|++.+.||.|+||.||+|.+..+++.||+|.+.+.... ....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 567899999999999999999999999999999998754322 2234678899999999999999999999865 56789
Q ss_pred EEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 93 FVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
++|||+ +++|...+..+.+++..+..++.|++.||.|||++|++||||+|.||+++.++.++|+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred EEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 999998 56898888878899999999999999999999999999999999999999999999999999874322
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh--------------------
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK-------------------- 232 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-------------------- 232 (414)
......+++.|+|||.+.+....+.++||||+|+++|+|++|..||...+....+..+..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 223456788999999986633335899999999999999999999987654322211110
Q ss_pred ------cccCCC-----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCCCC
Q 015005 233 ------AEYEFP-----PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSK 278 (414)
Q Consensus 233 ------~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~~ 278 (414)
.....| +.++.++.++|++||+.+|++|||+++++.||||.....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 000111 3467899999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=328.37 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=209.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
..+|++.+.||+|+||.||+|... .++..+|+|.+.... ....+.+.+|+++++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 456889999999999999999642 356789999886543 223567899999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC
Q 015005 90 KVFFVIEYVKGGELFAKVLKG----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN 153 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~ 153 (414)
..+++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 999999999999999988752 3788999999999999999999999999999999999999999
Q ss_pred eEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHh
Q 015005 154 LKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFK 232 (414)
Q Consensus 154 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~ 232 (414)
+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999998744321111112233457889999999887775 78999999999999998 9999988776666666655
Q ss_pred cc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 233 AE-YEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 233 ~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+. ...|..+++.+.+||.+||+.||.+||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 43 3456678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=324.36 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=209.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCe---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQE---SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+...... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3579999999999999999998765543 7999998654322 2356788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|++|||++|++|.+++.. +.++..++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999876 468999999999999999999999999999999999999999999999999998654321
Q ss_pred CCC-ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHH
Q 015005 170 NDG-LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDAR 246 (414)
Q Consensus 170 ~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 246 (414)
... ......++..|+|||.+.+..++ .++|+||||+++|++++ |..||...+..+....+... ..+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 111 11112235689999999877764 89999999999999886 99999887766666655544 2334455788999
Q ss_pred HHHHhhcccCcCCCCChHHHhc
Q 015005 247 RLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~ 268 (414)
+++.+||+.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=338.30 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=216.3
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-----EE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT-----KV 91 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 91 (414)
+|++.+.||.|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 69999999999999999999998999999999976432 1233567889999999999999999999998775 79
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|++|||++ ++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 478888876 6899999999999999999999999999999999999999999999999999986543211
Q ss_pred -CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc--------------
Q 015005 171 -DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-------------- 235 (414)
Q Consensus 171 -~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------------- 235 (414)
........+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 11234456899999999998773335899999999999999999999988877665555433110
Q ss_pred -----------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 236 -----------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 236 -----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
...+.++.++.++|.+||++||.+|||+.+++.||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 01123678899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=326.82 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=206.3
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeE----EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQES----VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.++|++.+.||+|+||+||+|.+..++.. +++|.+..... ......+..|+.+++.++||||+++++++. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc--hHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 46799999999999999999998777764 67777643221 223466788888999999999999999875 456
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.++++||+++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999999999999975 57899999999999999999999999999999999999999999999999999754322
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCDAR 246 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~ 246 (414)
..........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.........+..+.. ..+...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 111222344577889999999877775 89999999999999998 9999988776655554444433 33455678899
Q ss_pred HHHHhhcccCcCCCCChHHHhcC
Q 015005 247 RLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~h 269 (414)
+++.+||..||.+|||+.|+++.
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=338.04 Aligned_cols=252 Identities=21% Similarity=0.358 Sum_probs=202.4
Q ss_pred eeeeec--CCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccC
Q 015005 22 RMLGQG--TFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 22 ~~LG~G--~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 99 (414)
..||+| +||+||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..|++|||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 345655 99999999999999999999997654332 235788999999999999999999999999999999999999
Q ss_pred CCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC----
Q 015005 100 GGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG---- 172 (414)
Q Consensus 100 gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~---- 172 (414)
+++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999998875 358999999999999999999999999999999999999999999999998654221110000
Q ss_pred -ccccccCCCcccCchhhccc--CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-------------
Q 015005 173 -LLHTQCGTPAYVAPEVLRKK--GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE------------- 236 (414)
Q Consensus 173 -~~~~~~gt~~y~APE~~~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------------- 236 (414)
......++..|+|||++.+. ++ +.++||||+||++|+|++|..||..................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGY-NVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred cccccccCccCccChhhhcCCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 01122356779999999764 34 47899999999999999999999876544433332221110
Q ss_pred ----------------------------------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 237 ----------------------------------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 237 ----------------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+..++..+.+||++||+.||++|||+.|+++||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 112256779999999999999999999999999999653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=321.32 Aligned_cols=250 Identities=31% Similarity=0.532 Sum_probs=219.6
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999997654332 234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 97 YVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 97 ~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999988765 56899999999999999999999999999999999999999999999999999765432
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLIS 250 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 250 (414)
......|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+..+.+ ..+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 33345689999999999887775 789999999999999999999998887776666655554 345568899999999
Q ss_pred hhcccCcCCCCChHHHhcCCcc
Q 015005 251 RILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f 272 (414)
+||..+|.+|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=345.06 Aligned_cols=237 Identities=26% Similarity=0.454 Sum_probs=207.1
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
..-++-||.|+.|-||+|+ ..++.||||.++.- -..+|+-|++|+|||||.|.++|....++||||||
T Consensus 126 IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGR--LHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred hhhhhhhccCcccceeeee--ccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 3345679999999999998 56788999987432 12578889999999999999999999999999999
Q ss_pred cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcccc
Q 015005 98 VKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT 176 (414)
Q Consensus 98 ~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 176 (414)
|+.|-|+..++. ..++......|.++|+.|++|||.+.|+|||||.-||||..+..+||+|||-++.... ....-.
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STkMS 270 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTKMS 270 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh---hhhhhh
Confidence 999999999998 6799999999999999999999999999999999999999999999999999985443 245567
Q ss_pred ccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--ccCCCCCCCHHHHHHHHhhcc
Q 015005 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 177 ~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~ 254 (414)
.+||..|||||++...+.. .++||||||||||+||||..||.+-+...++--+-.+ ..+.|..++..++-||++||+
T Consensus 271 FaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 8999999999999988875 8999999999999999999999887655443322222 346788899999999999999
Q ss_pred cCcCCCCChHHHhcCC
Q 015005 255 ADPQKRISVSEIMINP 270 (414)
Q Consensus 255 ~dp~~R~s~~eil~hp 270 (414)
..|..||++.+||.|-
T Consensus 350 sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLHL 365 (904)
T ss_pred cCCCCCccHHHHHHHH
Confidence 9999999999999984
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=337.49 Aligned_cols=254 Identities=27% Similarity=0.449 Sum_probs=208.5
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK----- 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 88 (414)
+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 467999999999999999999999999999999998764322 22345678999999999999999999998754
Q ss_pred -CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 89 -TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 89 -~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
..+|+||||+.+ +|.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred CceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 357999999964 665544 35789999999999999999999999999999999999999999999999999875322
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--------------
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-------------- 233 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------- 233 (414)
......|++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2234567899999999876443357899999999999999999999987655444333221
Q ss_pred ---------ccCC--------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 ---------EYEF--------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 ---------~~~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.... .+..+.++.+||.+||+.||.+||++++++.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0001 12367789999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=335.78 Aligned_cols=255 Identities=21% Similarity=0.389 Sum_probs=212.0
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCC-------CeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVT-------QESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEV 84 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 84 (414)
....+|++++.||+|+||.||+|++... +..||+|.+...... ...+.+.+|+.+++++ +||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--HHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3345799999999999999999986432 236999988754322 2356788999999999 89999999999
Q ss_pred EEeCCEEEEEEEccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEE
Q 015005 85 MATKTKVFFVIEYVKGGELFAKVLKG-----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLL 147 (414)
Q Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NIL 147 (414)
+...+..|++|||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 99999999999999999999988641 3677888999999999999999999999999999999
Q ss_pred EcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHH
Q 015005 148 LDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKM 226 (414)
Q Consensus 148 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 226 (414)
++.++.+||+|||+++...............++..|+|||++.+..++ .++||||||+++|+|++ |..||.+.+..+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999998754332111122233345789999999887775 78999999999999998 8999998887777
Q ss_pred HHHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCC
Q 015005 227 YRKIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMINP 270 (414)
Q Consensus 227 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 270 (414)
+..+.... ...|..++.++.+|+.+||+.+|.+|||+.|++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 246 FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 77665543 345666889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=324.63 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=212.4
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCe----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQE----SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
-.++|++.+.||+|+||+||+|.+..+|+ .+|+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 35789999999999999999999876665 589998866543 2235678899999999999999999999987 7
Q ss_pred EEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
..+++|||+++|+|.+.+.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 89999999999999999876 4699999999999999999999999999999999999999999999999999986542
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDA 245 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 245 (414)
...........++..|+|||.+....+. .++|+||||+++|++++ |..||......+....+..+. .+.|...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2111111222346789999998776665 78999999999999998 999999988777776666543 35566688999
Q ss_pred HHHHHhhcccCcCCCCChHHHhc
Q 015005 246 RRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+++.+||..||.+||++.++++
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=347.82 Aligned_cols=258 Identities=23% Similarity=0.481 Sum_probs=223.0
Q ss_pred hccccCCE-EEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc-hhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 11 RNILFGKY-EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-KQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 11 ~~~~~~~y-~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
...-.|+| +....||+|+|-+||+|.|..+|..||.--+...... .+...+++..|+.+|+.|+|||||++|++|.+.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 34445666 5567899999999999999999999997666544332 344568999999999999999999999999876
Q ss_pred CE--EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEEecCCCCcEEEcCC-CCeEEeecCCC
Q 015005 89 TK--VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEN-GNLKVSDFGLS 162 (414)
Q Consensus 89 ~~--~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~g--i~HrDlkp~NILl~~~-~~~kl~DFGla 162 (414)
.. +.+|+|++..|+|+.+..+ ++++...++.|++||+.||.|||++. |+|||||-+||+|+.+ |.+||+|+|||
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence 65 8899999999999999998 89999999999999999999999985 9999999999999854 89999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC-chHHHHHHHHHhcccCC--CC
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIFKAEYEF--PP 239 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~--~~ 239 (414)
++... .......|||.|||||+.. ..|+ ..+||||||+++.||+|+..||.. .+..+.|+++..|..+- ..
T Consensus 194 tl~r~----s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 194 TLLRK----SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred HHhhc----cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc
Confidence 97653 3344578999999999998 5686 899999999999999999999976 56778889988876542 22
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
--.+++++||.+||.. ...|+|+.|+|+||||...
T Consensus 268 V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 2478999999999999 9999999999999999765
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=330.68 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=205.2
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 94 (414)
++|+..+.||+|+||.||++.+..+++.||+|.+.+.... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 3567788999999999999999999999999998765433 23567889999999995 99999999999999999999
Q ss_pred EEccCCCchHH---HHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 95 IEYVKGGELFA---KVL---KGKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 95 ~E~~~gg~L~~---~i~---~~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
|||+.+ ++.+ .+. .+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 4433 322 25799999999999999999999975 999999999999999999999999999874322
Q ss_pred ccCCCccccccCCCcccCchhhccc---CCCCCccchhhhhhhhhhhhcCCCCCCCchH-HHHHHHHHhccc-CCC----
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKK---GYDGAKSDIWSCGVVLFVLLSGFLPFQNENI-MKMYRKIFKAEY-EFP---- 238 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~-~~~---- 238 (414)
........|++.|+|||++.+. .+ +.++||||+||++|+|++|..||..... .+...++..+.. ..+
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 161 ---SIAKTRDAGCRPYMAPERIDPSARDGY-DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred ---CCccccccCccCccCHHHhccccccCC-cchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 2222344689999999999766 34 4789999999999999999999976542 122233322222 221
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..++.++.+||.+||++||.+|||++++++||||.+
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 237889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=328.27 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=211.1
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECC-----CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLV-----TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4679999999999999999998743 678999999875432 223467889999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcE
Q 015005 90 KVFFVIEYVKGGELFAKVLKG-----------------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENL 146 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~-----------------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NI 146 (414)
..|++|||+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 999999999999999988641 367888999999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHH
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMK 225 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 225 (414)
+++.++.++|+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998743221111112233456789999999887775 78999999999999997 889998877777
Q ss_pred HHHHHHhccc-CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 226 MYRKIFKAEY-EFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 226 ~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
....+..+.. ..|..++.++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777665554 346678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=343.95 Aligned_cols=254 Identities=21% Similarity=0.326 Sum_probs=208.1
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMA 86 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 86 (414)
+-.++|.+++.||+|+||.||+|.+. .+++.||+|++....... ..+.+.+|+.++.++. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS--EKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh--HHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 44567899999999999999999853 456789999997653322 2456889999999997 999999999999
Q ss_pred eCCEEEEEEEccCCCchHHHHhcC--------------------------------------------------------
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLKG-------------------------------------------------------- 110 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~-------------------------------------------------------- 110 (414)
..+..|+||||+++|+|.+++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 999999999999999999988642
Q ss_pred -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEE
Q 015005 111 -------------------------------------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLL 147 (414)
Q Consensus 111 -------------------------------------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NIL 147 (414)
.++...+..++.|++.||.|||++|++||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 2566678889999999999999999999999999999
Q ss_pred EcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHH
Q 015005 148 LDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKM 226 (414)
Q Consensus 148 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 226 (414)
++.++.+||+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC-cHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999754321111122334578899999999877664 78999999999999998 8999987554444
Q ss_pred HHHH-Hhc-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 227 YRKI-FKA-EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 227 ~~~i-~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.... ..+ ....|..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 351 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 351 FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3333 333 234566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=323.16 Aligned_cols=248 Identities=23% Similarity=0.365 Sum_probs=207.8
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+..++|++.+.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.++++++|||++++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 34568999999999999999999865 5667999998765432 246889999999999999999999885 45689
Q ss_pred EEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
++|||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999998875 358999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 247 (414)
........++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+.+..+....+... ..+.+...+..+.+
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05070 157 -YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 234 (260)
T ss_pred -cccccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1111223356689999998776664 78999999999999999 99999887777766666543 34556678899999
Q ss_pred HHHhhcccCcCCCCChHHHhc
Q 015005 248 LISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~ 268 (414)
|+.+||.+||++|||++++.+
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.18 Aligned_cols=251 Identities=20% Similarity=0.269 Sum_probs=204.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCC--------------CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccc
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVT--------------QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVE 80 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 80 (414)
.++|++.+.||+|+||.||+|.+..+ ...||+|.+..... ......+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence 35899999999999999999987543 23599999975432 223567889999999999999999
Q ss_pred eEEEEEeCCEEEEEEEccCCCchHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEE
Q 015005 81 LKEVMATKTKVFFVIEYVKGGELFAKVLKG-------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLL 147 (414)
Q Consensus 81 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NIL 147 (414)
+++++...+..|+||||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 999999999999999999999999988542 3678889999999999999999999999999999999
Q ss_pred EcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc--CCCCCCCchHHH
Q 015005 148 LDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS--GFLPFQNENIMK 225 (414)
Q Consensus 148 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~~ 225 (414)
++.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999998754321111122233457789999998877764 89999999999999987 778998766555
Q ss_pred HHHHHHh-----c---ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 226 MYRKIFK-----A---EYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 226 ~~~~i~~-----~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
....+.. . ....++.+++.+.+|+++||+.||++|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4443321 1 12234557899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=326.43 Aligned_cols=258 Identities=34% Similarity=0.591 Sum_probs=215.6
Q ss_pred CEEEeeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccch-hhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVKK-QGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKV 91 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 91 (414)
.|++.+.||+|++|.||+|.+. .+++.||+|++.+..... ....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 467899999997654322 22346788999999999 699999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+||||++||+|.+.+.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... .
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-E 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc-c
Confidence 999999999999998876 67999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCccccccCCCcccCchhhcccC-CCCCccchhhhhhhhhhhhcCCCCCCCch----HHHHHHHHHhcccCCCCCCCHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKG-YDGAKSDIWSCGVVLFVLLSGFLPFQNEN----IMKMYRKIFKAEYEFPPWISCDA 245 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 245 (414)
.......+|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||.... ..+..+.+.....+.|..++.++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11223456899999999987643 23478999999999999999999996432 23444555566667777889999
Q ss_pred HHHHHhhcccCcCCCCC---hHHHhcCCccccC
Q 015005 246 RRLISRILVADPQKRIS---VSEIMINPWFIKG 275 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s---~~eil~hp~f~~~ 275 (414)
.++|.+||+.||++||| +.++++||||...
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999998 5677999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=324.36 Aligned_cols=252 Identities=31% Similarity=0.542 Sum_probs=212.9
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc--hhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK--KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+|.+.+.||+|+||+||++.+..++..+++|++...... ......++.+|+.+++.++||||+++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888887888777543321 112234577899999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 95 IEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|||+++++|.+.+.. ..+++.++..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999887753 46999999999999999999999999999999999999975 6799999999875432
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRL 248 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~l 248 (414)
.........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+..+.. ..+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 22233345689999999999877775 789999999999999999999988776666666655433 3455688999999
Q ss_pred HHhhcccCcCCCCChHHHhcCCcc
Q 015005 249 ISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~hp~f 272 (414)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=313.94 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=210.7
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
..+.+..||+|+.|+|++++.+.+|...|||.+.+..... ..+++...++++... .+|+||+.+++|..+..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke--e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH--HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 4556688999999999999999999999999998765443 367888888887766 4899999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|.|. ..+..++.. ++++|..+-++...++.||.||.++ ||+|||+||+|||+|..|++||||||++..+-. ..
T Consensus 171 elMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---Sk 246 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SK 246 (391)
T ss_pred HHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec---cc
Confidence 9984 334334433 7899999999999999999999965 899999999999999999999999999975432 22
Q ss_pred ccccccCCCcccCchhhcc---cCCCCCccchhhhhhhhhhhhcCCCCCCCch-HHHHHHHHHhcccCCCC---CCCHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRK---KGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-IMKMYRKIFKAEYEFPP---WISCDA 245 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~~~~---~~s~~~ 245 (414)
......|.+.|||||.+.. ..|+ ..+||||||+.|++|.||+.||.+.+ .-+...++.+.+++.-+ .+|+++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence 2344569999999999853 3565 78999999999999999999999854 34667777776654322 389999
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 246 RRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.+|+..||++|+.+||...++|+|||+..
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 99999999999999999999999999864
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=329.63 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=212.1
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
....|...+.||+|+||.||+|++..+++.+|+|.+............++.+|+++++.++|||++++++++......|+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34458888999999999999999999999999999875433333345678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 94 VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
||||+. |+|.+.+.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 999997 467666543 5689999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccCCCcccCchhhcc---cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-C-CCCCCHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRK---KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-F-PPWISCDAR 246 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~s~~~~ 246 (414)
.....|++.|+|||.+.+ ..+ +.++|||||||++|+|++|..||...+.......+..+..+ . +..++..+.
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCC-CcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHH
Confidence 234568899999999753 234 47899999999999999999999876554444444433322 2 235788899
Q ss_pred HHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 247 RLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+||++||..+|.+||++.++++|||+...
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=328.13 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=203.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECC----------------CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLV----------------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 78 (414)
.++|++.+.||+|+||.||++.+.. ++..+|+|++..... ......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence 4679999999999999999985432 345799999875432 2235678899999999999999
Q ss_pred cceEEEEEeCCEEEEEEEccCCCchHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcE
Q 015005 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLKG------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENL 146 (414)
Q Consensus 79 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NI 146 (414)
+++++++...+..|++|||+++|+|.+++... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999988752 266778999999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc--CCCCCCCchHH
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS--GFLPFQNENIM 224 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~ 224 (414)
|++.++.++|+|||++................+++.|+|||...+..+. .++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999998754321111112233456789999998776664 89999999999999998 78999876655
Q ss_pred HHHHHHH--------hcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 225 KMYRKIF--------KAEYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 225 ~~~~~i~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+...... ....+.|..+++.+.+|+.+||+.||.+||++.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4433221 1122345567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=325.78 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=202.3
Q ss_pred cCCE-EEeeeeeecCCeEEEEEE----ECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-
Q 015005 15 FGKY-EMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK- 88 (414)
Q Consensus 15 ~~~y-~~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 88 (414)
.++| ++.+.||+|+||+||++. ...++..||+|++...... .....+.+|+++++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4566 999999999999998864 3457889999999765321 2345678999999999999999999987653
Q ss_pred -CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 89 -TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 89 -~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
..+|++|||+++++|.+++....+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 4689999999999999999888899999999999999999999999999999999999999999999999999985432
Q ss_pred ccCCC-ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH--HHH------------HHHH-
Q 015005 168 LWNDG-LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM--KMY------------RKIF- 231 (414)
Q Consensus 168 ~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~------------~~i~- 231 (414)
..... ......++..|+|||.+.+..++ .++||||||+++|+|++|..||...... +.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 11111 11223456779999999877664 8999999999999999999998653311 110 0111
Q ss_pred -hcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 232 -KAEYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 232 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
....+.|..++.++.+++.+||++||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1122345567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=325.67 Aligned_cols=247 Identities=32% Similarity=0.499 Sum_probs=203.5
Q ss_pred EEeeeeeecCCeEEEEEEEC----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 19 EMGRMLGQGTFAKVYYGKNL----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 19 ~~~~~LG~G~~g~Vy~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.+.+.||.|+||.||+|... ..+..|+||.+..... ....+.+.+|++.+++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS--EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS--HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc--cccceeeeeccccccccccccccccccccccccccccc
Confidence 57889999999999999877 4567899999954322 22367889999999999999999999999988889999
Q ss_pred EEccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 95 IEYVKGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+||+++|+|.+++... .+++.....++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999998874 7999999999999999999999999999999999999999999999999999765221111
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLI 249 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li 249 (414)
.......+...|+|||.+....++ .++||||||+++|+|++ |..||...+..+....+..+.. ..|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 222344567789999999887764 89999999999999999 7899998887777777755544 45666899999999
Q ss_pred HhhcccCcCCCCChHHHhc
Q 015005 250 SRILVADPQKRISVSEIMI 268 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~ 268 (414)
.+||..||++|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=319.88 Aligned_cols=243 Identities=25% Similarity=0.351 Sum_probs=203.5
Q ss_pred eeeeecCCeEEEEEEECCCC---eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEcc
Q 015005 22 RMLGQGTFAKVYYGKNLVTQ---ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYV 98 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 98 (414)
+.||+|+||.||+|....++ ..+|+|.+...... ...+.+.+|+++++.+.||||+++++++. ....+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876554 78999999766543 23567889999999999999999999886 45689999999
Q ss_pred CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC-cccc
Q 015005 99 KGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG-LLHT 176 (414)
Q Consensus 99 ~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 176 (414)
++|+|.+++.. +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999987 569999999999999999999999999999999999999999999999999998653321111 0111
Q ss_pred ccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHHHhhcc
Q 015005 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLISRILV 254 (414)
Q Consensus 177 ~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 254 (414)
..++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+.... ...|..++..+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 2235679999999877765 79999999999999998 999998877766666655443 35566789999999999999
Q ss_pred cCcCCCCChHHHhc
Q 015005 255 ADPQKRISVSEIMI 268 (414)
Q Consensus 255 ~dp~~R~s~~eil~ 268 (414)
+||++||++.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=320.14 Aligned_cols=247 Identities=24% Similarity=0.351 Sum_probs=205.8
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
..++|++.+.||+|++|.||+|.+..+ ..+|+|.+...... .+.+.+|+.+++.++|||++++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 346799999999999999999987655 45999998654322 356788999999999999999999885 456899
Q ss_pred EEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 94 VIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~-~ 156 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN-E 156 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC-c
Confidence 9999999999999875 24789999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRL 248 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 248 (414)
........++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+....+....+... ..+.+..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 1111223466789999998876664 78999999999999999 99999987777666665543 234556688999999
Q ss_pred HHhhcccCcCCCCChHHHhc
Q 015005 249 ISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~ 268 (414)
+++||.+||++||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=320.49 Aligned_cols=248 Identities=23% Similarity=0.375 Sum_probs=208.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+..+.|++.+.||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.++++++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 4567899999999999999999985 46778999998765432 356889999999999999999999874 45789
Q ss_pred EEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
++|||+++++|.+.+.. ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~- 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN- 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC-
Confidence 99999999999998864 36899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 247 (414)
.........++..|+|||++.+..+. .++||||||+++|+|++ |..||.+.+..+....+... ..+.+...+.++.+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYE 234 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11111233456789999999877664 78999999999999998 99999887776666655443 23455667889999
Q ss_pred HHHhhcccCcCCCCChHHHhc
Q 015005 248 LISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~ 268 (414)
+|.+||+.||++|||++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.95 Aligned_cols=238 Identities=25% Similarity=0.335 Sum_probs=198.0
Q ss_pred eeeeecCCeEEEEEEECCCCe-------EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 22 RMLGQGTFAKVYYGKNLVTQE-------SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+.||+|+||+||+|.+..++. .+|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999998865544 48888886543 22356788899999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC--------eEEeecCCCcc
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN--------LKVSDFGLSAL 164 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~--------~kl~DFGla~~ 164 (414)
|||+++|+|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999999876 35899999999999999999999999999999999999987765 69999999864
Q ss_pred cccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcC-CCCCCCchHHHHHHHHHhcccCCCCCCCH
Q 015005 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG-FLPFQNENIMKMYRKIFKAEYEFPPWISC 243 (414)
Q Consensus 165 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 243 (414)
... .....+++.|+|||++.+....+.++|||||||++|+|++| ..||...+.... .........+|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCCCCcH
Confidence 321 23456889999999998754445789999999999999998 567666544433 2334455667777788
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 244 DARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
++.+||.+||+.||++|||++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=320.90 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=209.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCe---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQE---SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
...|+..+.||+|+||.||+|.+..++. .+|+|.+...... ...+.+.+|+++++.++||||+++.+++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4578999999999999999999876654 7999998654322 2246788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+||||+++++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999998865 578999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCc-cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHH
Q 015005 170 NDGL-LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDAR 246 (414)
Q Consensus 170 ~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 246 (414)
.... ......++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+.... .+.+...+.++.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1111 1112234579999999877775 88999999999999997 999998877777766665432 233445788999
Q ss_pred HHHHhhcccCcCCCCChHHHhc
Q 015005 247 RLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~ 268 (414)
+++.+||+.+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=323.97 Aligned_cols=249 Identities=33% Similarity=0.529 Sum_probs=207.1
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCccceEEEEEeCCE----
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV---KHPNIVELKEVMATKTK---- 90 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 90 (414)
|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++++ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 78899999999999999999889999999999755432 22334566788887766 59999999999988776
Q ss_pred -EEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 91 -VFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 91 -~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
+|++|||+++ +|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 78887765 358999999999999999999999999999999999999999999999999987643
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc-----cC-----
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE-----YE----- 236 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-----~~----- 236 (414)
. ........+++.|+|||++.+..+. .++|+||+||++|+|++|..||...+..+...++.... ..
T Consensus 159 ~---~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 F---EMALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred C---CcccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 2 2222344578999999999887765 78999999999999999999999887766665554310 00
Q ss_pred ------C-----------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 237 ------F-----------PPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 237 ------~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
+ .+.++..+.++|.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=326.40 Aligned_cols=251 Identities=34% Similarity=0.557 Sum_probs=210.4
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
|++.+.||+|++|.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++.+++..|+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998765433 23456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 98 VKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 98 ~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
+++ +|.+.+.. +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 975 77777765 489999999999999999999999999999999999999999999999999987554321 1223
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-------------------ccC
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-------------------EYE 236 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~~ 236 (414)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+.+..+... ...
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 3458889999999877633458999999999999999999999887665544433211 000
Q ss_pred -----------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 237 -----------FPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 237 -----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
..+.++.++.++|.+||++||.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=325.11 Aligned_cols=251 Identities=34% Similarity=0.560 Sum_probs=210.5
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 6788999999999999999999999999999987642 223346678899999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 98 VKGGELFAKVLKG--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 98 ~~gg~L~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
++ ++|.+.+... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~ 156 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT 156 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence 98 5899998874 7999999999999999999999999999999999999999999999999998754331 11233
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc------------------ccCC
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------------------EYEF 237 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------~~~~ 237 (414)
...++..|+|||.+.+....+.++|+|||||++|+|++|..||...+......++... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4456788999999876633458899999999999999999999887655544433210 0011
Q ss_pred C-----------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 238 P-----------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 238 ~-----------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
+ +.++.++.++|++||..||++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=318.35 Aligned_cols=242 Identities=26% Similarity=0.453 Sum_probs=209.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 45799999999999999999985 478999999976543 356788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 95 IEYVKGGELFAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
|||+++++|.+++.. . .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~--- 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG--- 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc---
Confidence 999999999999876 3 6999999999999999999999999999999999999999999999999999854221
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLI 249 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 249 (414)
.....++..|+|||.+....+. .++||||||+++|+|++ |..||...+.......+... ....|..+++++.++|
T Consensus 156 --~~~~~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 156 --QDSGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred --cccCCCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence 1123356679999998776664 78999999999999997 99999888777666655443 3345666889999999
Q ss_pred HhhcccCcCCCCChHHHhc
Q 015005 250 SRILVADPQKRISVSEIMI 268 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~ 268 (414)
++||..+|++|||+.++++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 233 KDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHhccChhhCcCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=318.61 Aligned_cols=242 Identities=22% Similarity=0.332 Sum_probs=201.2
Q ss_pred eeeecCCeEEEEEEEC--CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCC
Q 015005 23 MLGQGTFAKVYYGKNL--VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 23 ~LG~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
.||+|+||.||+|.+. ..+..||+|++..... ....+.+.+|+.++++++||||++++++++. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999765 4556799999865432 2335678999999999999999999999864 578999999999
Q ss_pred CchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC-ccccc
Q 015005 101 GELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG-LLHTQ 177 (414)
Q Consensus 101 g~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 177 (414)
++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999998864 579999999999999999999999999999999999999999999999999997543221111 11122
Q ss_pred cCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhccc
Q 015005 178 CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLISRILVA 255 (414)
Q Consensus 178 ~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~ 255 (414)
.+++.|+|||.+.+..++ .++|||||||++|++++ |..||......+....+..+ ....|+..++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 345789999999877664 78999999999999996 99999887777666665544 3456777899999999999999
Q ss_pred CcCCCCChHHHhc
Q 015005 256 DPQKRISVSEIMI 268 (414)
Q Consensus 256 dp~~R~s~~eil~ 268 (414)
||++||++.+|.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=321.53 Aligned_cols=241 Identities=25% Similarity=0.389 Sum_probs=200.9
Q ss_pred eeeeecCCeEEEEEEECCCCe--EEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEEcc
Q 015005 22 RMLGQGTFAKVYYGKNLVTQE--SVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVIEYV 98 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 98 (414)
+.||+|+||.||+|.+..++. .+|+|.+..... ....+.+.+|+.++.++ +||||+++++++...+..|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC--HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999888775 468888864322 22346788999999999 8999999999999999999999999
Q ss_pred CCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCC
Q 015005 99 KGGELFAKVLKG-----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL 161 (414)
Q Consensus 99 ~gg~L~~~i~~~-----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGl 161 (414)
++|+|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999998652 378899999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCC
Q 015005 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPP 239 (414)
Q Consensus 162 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~ 239 (414)
+...... ........++.|+|||++....++ .++|||||||++|+|++ |..||.+.+..+.+..+..+ ....+.
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchh---hhccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 8632211 111122346679999999777664 78999999999999997 99999887777766666544 234455
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.++.++.+|+.+||..||.+|||+.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 67889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=318.35 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=211.5
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.-.++|++.+.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 34578999999999999999999875 5577999998765432 356889999999999999999999999989999
Q ss_pred EEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
++|||+++++|.+.+.. ..++...+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD- 156 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch-
Confidence 99999999999999876 36899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 247 (414)
.........++..|+|||.+.+..+. .++|+||+|+++|+|++ |+.||.+.+.......+..+ ..+.|...+.++.+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11111222356789999999877664 78999999999999998 99999887777777766554 33456667899999
Q ss_pred HHHhhcccCcCCCCChHHHhc
Q 015005 248 LISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~ 268 (414)
++.+||..||++||++.++++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=331.30 Aligned_cols=257 Identities=29% Similarity=0.441 Sum_probs=205.9
Q ss_pred CEEEeeeeeecCCeEEEEEEECCC--CeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEe----CC
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVT--QESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMAT----KT 89 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 89 (414)
+|++.+.||+|+||.||+|.+..+ +..||+|.+...... ....+.+.+|+.+++++ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 899999998653222 22345678899999999 59999999987543 24
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.+|+++||+. ++|.+.+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999986 688888765 68999999999999999999999999999999999999999999999999999754321
Q ss_pred cC--CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-------------
Q 015005 169 WN--DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------------- 233 (414)
Q Consensus 169 ~~--~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 233 (414)
.. ........||+.|+|||++.+....+.++||||+||++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112234578999999998866433348899999999999999999999876544333222110
Q ss_pred ------------c---cCC---CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 ------------E---YEF---PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 ------------~---~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
. ..+ .+..+..+.+|+.+||+.||.+|||+.+++.|||+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 001 12357889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=295.51 Aligned_cols=255 Identities=32% Similarity=0.570 Sum_probs=216.3
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.+|.-.+.||+|.||+||+|++..+++.||+|.++.+... ++.-....+|+.+++.++|.|||+++++..++..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 4577778999999999999999999999999999876543 344567789999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|||. .+|..+... |.+..+.++.++.|++.||.+||++++.||||||.|+||+.||.+|++|||+++-++.+ -.-
T Consensus 81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--vrc 157 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRC 157 (292)
T ss_pred HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEe
Confidence 9996 477666665 88999999999999999999999999999999999999999999999999999865542 112
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-------cc----------
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-------EY---------- 235 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-------~~---------- 235 (414)
....+-|..|.+|.++.+...++...|+||.|||+.++.. |.+.|.+.+..++..+|+.. ++
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 2344578999999999998766788999999999999987 88889999888887777541 00
Q ss_pred ---CCC---------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 236 ---EFP---------PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 236 ---~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.+| +.++..-++|++++|.-+|.+|+++++.++||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 011 113345689999999999999999999999999965
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=318.00 Aligned_cols=241 Identities=27% Similarity=0.441 Sum_probs=205.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEE-EeCCEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVM-ATKTKVFF 93 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~l 93 (414)
..+|++.+.||+|+||.||++.. .|..+|+|.+.... ..+.+.+|+.++++++|||++++++++ ...+..|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 45799999999999999999975 47889999986432 235688999999999999999999975 45678999
Q ss_pred EEEccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 94 VIEYVKGGELFAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+|||+++++|.+++.. + .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~--- 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc---
Confidence 9999999999999875 2 488999999999999999999999999999999999999999999999999874322
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRL 248 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 248 (414)
......++..|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+ ....++.+++.+.++
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 155 --TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred --cCCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 11233456789999999887775 78999999999999997 99999988777766666544 234556789999999
Q ss_pred HHhhcccCcCCCCChHHHhc
Q 015005 249 ISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~ 268 (414)
|.+||+.||++|||+.++++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=323.76 Aligned_cols=249 Identities=33% Similarity=0.506 Sum_probs=206.2
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEEE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 96 (414)
|++.+.||+|++|+||+|....+++.||+|.+........ .....+|+..++.++ ||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6889999999999999999988999999999876543211 233457999999998 9999999999999999999999
Q ss_pred ccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 97 YVKGGELFAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 97 ~~~gg~L~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|+ +|+|.+.+.. . .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCC
Confidence 99 7788888775 3 689999999999999999999999999999999999999999999999999975432 222
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-------------------c
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-------------------E 234 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~ 234 (414)
.....|+..|+|||++.+....+.++|+||||+++++|++|..||...+..+.+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999999865443357899999999999999999999877655444332210 0
Q ss_pred cC-----------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 235 YE-----------FPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 235 ~~-----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.. ..+..+.++.++|++||+.||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 012246789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.43 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=208.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECC----CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe-CC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLV----TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT-KT 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 89 (414)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .....+.+.+|+.+++.++||||+++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4689999999999999999999865 36789999986432 22335778899999999999999999998765 57
Q ss_pred EEEEEEEccCCCchHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecC
Q 015005 90 KVFFVIEYVKGGELFAKVLK---------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFG 160 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~---------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFG 160 (414)
..++++||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 88999999999999998865 348899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCC
Q 015005 161 LSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFP 238 (414)
Q Consensus 161 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~ 238 (414)
+++...............++..|+|||++.+..++ .++|||||||++|++++ |..||...+..+....+..+. ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 99754321111111223456789999999877775 88999999999999999 999998877766655554432 2345
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
..+++++.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.94 Aligned_cols=243 Identities=27% Similarity=0.447 Sum_probs=203.5
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (414)
+.||+|+||.||+|... ++..+|+|.+...... .....+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQ--ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999854 6889999998754322 23456889999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 102 ELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 102 ~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
+|.+++.. +.+++..+..++.|++.||.|+|++|++||||||+||+++.++.+||+|||++....... ........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 99998875 468999999999999999999999999999999999999999999999999986432210 111112244
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCc
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLISRILVADP 257 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dp 257 (414)
++.|+|||++.+..+. .++||||+|+++|++++ |..||...........+..+ ....+..++.++.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 6789999999876664 78999999999999998 99999887766665555444 234566789999999999999999
Q ss_pred CCCCChHHHhcC
Q 015005 258 QKRISVSEIMIN 269 (414)
Q Consensus 258 ~~R~s~~eil~h 269 (414)
++||++.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 999999999753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.43 Aligned_cols=243 Identities=28% Similarity=0.411 Sum_probs=205.0
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (414)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|++++++++||||+++++++.+....|++|||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999877 999999998765443 23567889999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccC
Q 015005 102 ELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179 (414)
Q Consensus 102 ~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 179 (414)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999865 5689999999999999999999999999999999999999999999999999875432111111112234
Q ss_pred CCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCc
Q 015005 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLISRILVADP 257 (414)
Q Consensus 180 t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dp 257 (414)
+..|+|||.+.+..+. .++|+|||||++|+|++ |..||...........+... ....|...+.++.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 5679999999877664 89999999999999998 89999887766655555443 334566788999999999999999
Q ss_pred CCCCChHHHhc
Q 015005 258 QKRISVSEIMI 268 (414)
Q Consensus 258 ~~R~s~~eil~ 268 (414)
.+|||+.|+++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.00 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=209.0
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 90 (414)
..-.+.|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ....+.+|+.++... .||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 345678999999999999999999999899999999997654322 234566677766666 59999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
.|++|||++ +.|.+.+.. +.+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999999985 466666654 579999999999999999999997 5999999999999999999999999999875432
Q ss_pred ccCCCccccccCCCcccCchhhcccC---CCCCccchhhhhhhhhhhhcCCCCCCCchH-HHHHHHHHhccc-CCCC--C
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKG---YDGAKSDIWSCGVVLFVLLSGFLPFQNENI-MKMYRKIFKAEY-EFPP--W 240 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~-~~~~--~ 240 (414)
........+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... .+....+..... ..+. .
T Consensus 168 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 168 ---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred ---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 12223345788999999987543 124789999999999999999999976432 234444444332 2222 3
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++.++.+||.+||..||++||++.+++.||||...
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 68899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=316.17 Aligned_cols=247 Identities=27% Similarity=0.396 Sum_probs=209.5
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+...... ...+.+|+++++.++||||+++++++......|++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 47999999999999999999874 4678999998755432 246788999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~~~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-QYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC-cccc
Confidence 99999999998875 56899999999999999999999999999999999999999999999999998743221 1111
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHHh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISR 251 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 251 (414)
.....++..|+|||.+.+..+. .++||||||+++|+|++ |..||...........+..+.. ..|...+..+.+|+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 1223356789999999877765 78999999999999998 9999998877777776655433 3455578999999999
Q ss_pred hcccCcCCCCChHHHhcC
Q 015005 252 ILVADPQKRISVSEIMIN 269 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~h 269 (414)
||+.+|++|||+.+++++
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HcccChhhCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=316.93 Aligned_cols=243 Identities=25% Similarity=0.402 Sum_probs=205.5
Q ss_pred eeeeecCCeEEEEEEECC-CC--eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEcc
Q 015005 22 RMLGQGTFAKVYYGKNLV-TQ--ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYV 98 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 98 (414)
+.||+|++|.||+|.+.. .+ ..||+|.+...... ...+.+.+|+.++++++||||+++++.+.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999998755 33 36999999876653 346789999999999999999999999988 8999999999
Q ss_pred CCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC-Ccc
Q 015005 99 KGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND-GLL 174 (414)
Q Consensus 99 ~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~ 174 (414)
++++|.+.+... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 999999998762 5899999999999999999999999999999999999999999999999999865331111 111
Q ss_pred ccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc--ccCCCCCCCHHHHHHHHh
Q 015005 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA--EYEFPPWISCDARRLISR 251 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~ 251 (414)
....++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+..+....+... ....|..++..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234577899999999877775 78999999999999998 99999887777666665532 233455678999999999
Q ss_pred hcccCcCCCCChHHHhc
Q 015005 252 ILVADPQKRISVSEIMI 268 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~ 268 (414)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=315.36 Aligned_cols=246 Identities=29% Similarity=0.443 Sum_probs=210.3
Q ss_pred EEeeeeeecCCeEEEEEEECCCC----eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 19 EMGRMLGQGTFAKVYYGKNLVTQ----ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 19 ~~~~~LG~G~~g~Vy~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
++.+.||.|+||.||+|.+..++ ..||+|.+....... ..+.+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 57789999999999999988766 899999996554321 356888999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CC--CCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 95 IEYVKGGELFAKVLK-GK--LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~--~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
|||+++++|.+.+.. .. +++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999999876 22 999999999999999999999999999999999999999999999999999754432111
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLI 249 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li 249 (414)
......+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...+.....+.+..... ..+...+.++.+++
T Consensus 160 -~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (258)
T smart00219 160 -KKKGGKLPIRWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM 237 (258)
T ss_pred -ccccCCCcccccChHHhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 11123377899999999766664 89999999999999998 8999988877777777665443 45566899999999
Q ss_pred HhhcccCcCCCCChHHHhc
Q 015005 250 SRILVADPQKRISVSEIMI 268 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~ 268 (414)
.+||..||++|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHCcCChhhCcCHHHHHh
Confidence 9999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=341.76 Aligned_cols=251 Identities=24% Similarity=0.446 Sum_probs=212.8
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
++..+...++..||+|.||+||+|.+- | .||||+++......+ ..+.|++|+.++++-+|.||+-+.|++..+..
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 345566778899999999999999853 2 499999998877655 67899999999999999999999999988877
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
.||+.+|+|.+|+.++.- .+|.....+.|++|++.|+.|||.++|+|||||..||++.+++.|||+|||+++......
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 999999999999999875 578999999999999999999999999999999999999999999999999998765544
Q ss_pred CCCccccccCCCcccCchhhccc---CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-----CCCCCC
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKK---GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-----EFPPWI 241 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~ 241 (414)
.........|...|||||++... +| +..+||||+|+|+|||++|.+||...+.+...-.+-.|.. ......
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence 45556677799999999998643 45 4889999999999999999999996665544333323311 112346
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+.++++|+..||..++++||.+.+||.
T Consensus 622 pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 779999999999999999999999986
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=361.75 Aligned_cols=254 Identities=29% Similarity=0.509 Sum_probs=210.0
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK----- 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 88 (414)
....|+.++.||+||||.||+++++-+|+.||||.|.... .......+.+|+..+.+|+|||||++|..|...
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4567889999999999999999999999999999998765 233467899999999999999999997543100
Q ss_pred --------------------------------------------------------------------------------
Q 015005 89 -------------------------------------------------------------------------------- 88 (414)
Q Consensus 89 -------------------------------------------------------------------------------- 88 (414)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CEEEEEEEccCCCchHHHHhcCCCC--HHHHHHHHHHHHHHHHHHH
Q 015005 89 ----------------------------------TKVFFVIEYVKGGELFAKVLKGKLK--EESARKYFQQLISAVDFCH 132 (414)
Q Consensus 89 ----------------------------------~~~~lv~E~~~gg~L~~~i~~~~~~--e~~~~~~~~ql~~al~~lH 132 (414)
..+||-||||+..+|.+++..+.+. ...++++|+||+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1279999999999999999887764 8889999999999999999
Q ss_pred hCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc----------------cccCCCccccccCCCcccCchhhcccC---
Q 015005 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE----------------QLWNDGLLHTQCGTPAYVAPEVLRKKG--- 193 (414)
Q Consensus 133 ~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~APE~~~~~~--- 193 (414)
++|++||||||.||++|+++.|||+|||+|+... ...+.+.....+||..|+|||++.+..
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998611 011223456678999999999998765
Q ss_pred CCCCccchhhhhhhhhhhhcCCCCCCCc-hHHHHHHHHHhcccCCCCCC----CHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNE-NIMKMYRKIFKAEYEFPPWI----SCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 194 ~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
|+ .++|+|||||||+||+. ||... .......++.++..+.|+.+ -+....+|++||+.||.+||||.|+|+
T Consensus 795 Yn-~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 795 YN-SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cc-chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 65 89999999999999984 46543 23345566667777766322 234678999999999999999999999
Q ss_pred CCccc
Q 015005 269 NPWFI 273 (414)
Q Consensus 269 hp~f~ 273 (414)
+.||.
T Consensus 871 s~llp 875 (1351)
T KOG1035|consen 871 SELLP 875 (1351)
T ss_pred ccCCC
Confidence 99985
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.86 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=210.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECC-----CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLV-----TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.+|++.+.||+|+||+||+|+... +.+.+|+|.+..... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 579999999999999999998654 346799999865432 2235678899999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-C---------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecC
Q 015005 91 VFFVIEYVKGGELFAKVLK-G---------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFG 160 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~---------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFG 160 (414)
.|+||||+++|+|.+++.. . .+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 9999999999999999875 3 58999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcccC--C
Q 015005 161 LSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYE--F 237 (414)
Q Consensus 161 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~--~ 237 (414)
++...... .........+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...........+..+... .
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccCcc-cccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 98643211 11122334567889999998876664 78999999999999998 89999877666666666555433 3
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+..++..+.+++.+||..||.+|||+.+++++
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 55688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=317.79 Aligned_cols=228 Identities=28% Similarity=0.465 Sum_probs=193.8
Q ss_pred cCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCchHHH
Q 015005 27 GTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAK 106 (414)
Q Consensus 27 G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 106 (414)
|.+|+||+|++..+++.||+|.+.+... ..+|...+....||||+++++++.+....|++|||++||+|.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976532 22445555566799999999999999999999999999999998
Q ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccC
Q 015005 107 VLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVA 185 (414)
Q Consensus 107 i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 185 (414)
+.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+..... ......++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 876 6799999999999999999999999999999999999999999999999998764332 1234456788999
Q ss_pred chhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCCCCh--
Q 015005 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISV-- 263 (414)
Q Consensus 186 PE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~-- 263 (414)
||.+.+..++ .++|+||+|+++|+|++|..||....... ........|+++++.+.++|.+||+.||++||++
T Consensus 151 PE~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEET-EACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 9998777664 78999999999999999998876532210 0112345778899999999999999999999986
Q ss_pred ---HHHhcCCcc
Q 015005 264 ---SEIMINPWF 272 (414)
Q Consensus 264 ---~eil~hp~f 272 (414)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=328.14 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=199.6
Q ss_pred EeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccC
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 99 (414)
+++.+|. +|.||.+++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++......|++|||++
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 3444444 455666666679999999999875332 2346789999999999999999999999999999999999999
Q ss_pred CCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC-----C
Q 015005 100 GGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN-----D 171 (414)
Q Consensus 100 gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-----~ 171 (414)
+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+........ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999998875 4689999999999999999999999999999999999999999999999998864321111 1
Q ss_pred CccccccCCCcccCchhhccc--CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc--------------
Q 015005 172 GLLHTQCGTPAYVAPEVLRKK--GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-------------- 235 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------------- 235 (414)
.......++..|+|||++.+. ++ +.++|+||+||++|+|++|..||...+..........+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 112334578889999998763 45 4789999999999999999999987554332221111100
Q ss_pred --------------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 236 --------------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 236 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
..+..++.++.+|+.+||..||++|||+.++++||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 01112356788999999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=335.65 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=214.3
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCe---E-EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQE---S-VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~-vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
...+-.+.+.||+|+||.||+|.....+. . ||+|....+..........+.+|+++|++++|||||++||+.....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34455667999999999999998765422 3 8999987644334445788999999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-G-KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~-~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
.+|+|||+|+||+|.+++.+ + .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++....
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 99999999999999999998 3 499999999999999999999999999999999999999999999999999885321
Q ss_pred ccCCCccccc-cCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc--CCCCCCCH
Q 015005 168 LWNDGLLHTQ-CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY--EFPPWISC 243 (414)
Q Consensus 168 ~~~~~~~~~~-~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~ 243 (414)
....... .-...|+|||.+...-|+ .++||||+||++||+++ |..||.+....+...++....+ +.|...+.
T Consensus 315 ---~~~~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~ 390 (474)
T KOG0194|consen 315 ---YVMKKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPK 390 (474)
T ss_pred ---eeeccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHH
Confidence 1111112 245689999999888775 89999999999999999 8899999999999999866555 45566788
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhc
Q 015005 244 DARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
++..++.+||..||+.|||+.++.+
T Consensus 391 ~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 391 ELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHhccCChhhccCHHHHHH
Confidence 8999999999999999999998864
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=321.77 Aligned_cols=237 Identities=24% Similarity=0.349 Sum_probs=193.8
Q ss_pred eeeecCCeEEEEEEECCC------------------------CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc
Q 015005 23 MLGQGTFAKVYYGKNLVT------------------------QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78 (414)
Q Consensus 23 ~LG~G~~g~Vy~a~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 78 (414)
.||+|+||.||+|....+ ...||+|++..... .....+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999974321 23588999865432 234568889999999999999
Q ss_pred cceEEEEEeCCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC----
Q 015005 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG---- 152 (414)
Q Consensus 79 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~---- 152 (414)
+++++++...+..|+||||+++|+|..++.. +.+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999988864 6789999999999999999999999999999999999997654
Q ss_pred ---CeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhh-hcCCCCCCCchHHHHHH
Q 015005 153 ---NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVL-LSGFLPFQNENIMKMYR 228 (414)
Q Consensus 153 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~l-l~g~~Pf~~~~~~~~~~ 228 (414)
.+|++|||++..... .....+++.|+|||.+.+....+.++|||||||++|+| ++|..||......+..
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence 389999998763211 12345788999999987644345899999999999998 5799999876554432
Q ss_pred HHHhcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 229 KIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 229 ~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.........|...++++.++|.+||+.+|.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 232 RFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 23333445555567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.57 Aligned_cols=244 Identities=18% Similarity=0.271 Sum_probs=192.2
Q ss_pred eeeeecCCeEEEEEEECC--CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccC
Q 015005 22 RMLGQGTFAKVYYGKNLV--TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 99 (414)
+.||+|+||+||+|.... ....+|+|.+..... ......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 468999999999996432 456788998754432 2234567889999999999999999999999999999999999
Q ss_pred CCchHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 100 GGELFAKVLKG------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 100 gg~L~~~i~~~------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
+|+|.+++... ..++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999998752 246778899999999999999999999999999999999999999999999864322111111
Q ss_pred cccccCCCcccCchhhccc------CCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHh-cccC-----CCCC
Q 015005 174 LHTQCGTPAYVAPEVLRKK------GYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFK-AEYE-----FPPW 240 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~------~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~-~~~~-----~~~~ 240 (414)
.....+++.|+|||++... ...+.++|||||||++|+|++ |..||......+....... .... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 2333467789999997532 122578999999999999999 8899987765555444433 2222 2335
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
++....+++..|+ .||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888899999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.23 Aligned_cols=238 Identities=23% Similarity=0.329 Sum_probs=193.9
Q ss_pred eeeeecCCeEEEEEEECC------------CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 22 RMLGQGTFAKVYYGKNLV------------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
+.||+|+||+||+|.... ....+|+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999997432 22358899876543 223457888999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC-------eEEeecC
Q 015005 90 KVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN-------LKVSDFG 160 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~-------~kl~DFG 160 (414)
..+++|||+++|+|..++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888764 56999999999999999999999999999999999999987664 8999999
Q ss_pred CCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhh-cCCCCCCCchHHHHHHHHHhcccCCCC
Q 015005 161 LSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLL-SGFLPFQNENIMKMYRKIFKAEYEFPP 239 (414)
Q Consensus 161 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll-~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 239 (414)
++..... .....|+..|+|||.+......+.++|||||||++|+|+ +|..||......+.. ...........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 9864321 223457889999999874443458899999999999997 589999876554432 23334444444
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
..+.++.+||.+||+.||.+||++.+|+.+
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 467889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=324.30 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=206.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCe----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQE----SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.+.|+..+.||+|+||.||+|.+..++. .+|+|.+...... .....+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4578999999999999999999877776 4788888654322 2234688999999999999999999998764 4
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.++++||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 6799999999999999876 36899999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDAR 246 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 246 (414)
..........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.........+..+ ..+.++..+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 111122334467789999999877765 88999999999999997 99999876655544443333 2344556788999
Q ss_pred HHHHhhcccCcCCCCChHHHhcC
Q 015005 247 RLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~h 269 (414)
+++.+||..||++||++.++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=317.33 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=208.0
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCC---CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVT---QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..+|.+.+.||+|+||.||+|.+... ...||+|........ ...+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP--SVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 45699999999999999999987544 356999998654422 235678899999999999999999999876 457
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|++|||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 899999999999999976 358999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 247 (414)
........+++.|+|||.+....+. .++||||||+++|+|++ |..||...+..+....+..+. ...|..++.++.+
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 162 -YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred -ceecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 1111223345689999998877765 88999999999999886 999998887766666655543 4566778999999
Q ss_pred HHHhhcccCcCCCCChHHHhcC
Q 015005 248 LISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~h 269 (414)
+|.+||..+|.+|||+.+++..
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=314.03 Aligned_cols=248 Identities=22% Similarity=0.374 Sum_probs=207.1
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+..++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ..+.+.+|+.+++.++|+||+++++.+.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 56789999999999999999999854 556799998865432 24578899999999999999999999987 7889
Q ss_pred EEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
++|||+++++|.+++.+ ..++...+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~- 155 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN- 155 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC-
Confidence 99999999999999875 35788899999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 247 (414)
.........++..|+|||++....++ .++|+|||||++|++++ |..||...+.......+..+. .+.+...+.++.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcC-ccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence 11111223356779999999876664 78999999999999998 999999877766666554432 2345668899999
Q ss_pred HHHhhcccCcCCCCChHHHhc
Q 015005 248 LISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~ 268 (414)
++.+||++||++||++.++++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=319.55 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=201.1
Q ss_pred CEEEeeeeeecCCeEEEEEEE----CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKN----LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK--TK 90 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 90 (414)
.|++.+.||+|+||.||+|.. ..++..||+|.+..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 368999999999999999974 45788999999865432 22356789999999999999999999998775 67
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.++||||++|++|.+++.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 8999999999999999875 35899999999999999999999999999999999999999999999999999864322
Q ss_pred cCC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch---------------HHHHHHHHHh
Q 015005 169 WND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN---------------IMKMYRKIFK 232 (414)
Q Consensus 169 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---------------~~~~~~~i~~ 232 (414)
... .......|+..|+|||++.+..++ .++|||||||++|+|+++..|+.... .......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 111 112234567789999998877665 78999999999999999876653211 0111111111
Q ss_pred c-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 233 A-EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 233 ~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+ ..+.+..++..+.+|+.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1 223455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=318.43 Aligned_cols=244 Identities=24% Similarity=0.362 Sum_probs=202.5
Q ss_pred eeeeecCCeEEEEEEECCCC------eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 22 RMLGQGTFAKVYYGKNLVTQ------ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
+.||+|+||.||+|.+.... +.+|+|.+.+.... .....+.+|+.+++.++||||+++++++......|++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46899999999999876543 78999998654321 22457889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-----CeEEeecCCC
Q 015005 96 EYVKGGELFAKVLK--------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-----NLKVSDFGLS 162 (414)
Q Consensus 96 E~~~gg~L~~~i~~--------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-----~~kl~DFGla 162 (414)
||++|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999998864 2378899999999999999999999999999999999999887 8999999998
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCC
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPW 240 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 240 (414)
................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 75432111112223456788999999987766 489999999999999998 99999887766665555433 3455667
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
++..+.++|.+||.++|.+||++.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=315.82 Aligned_cols=244 Identities=19% Similarity=0.258 Sum_probs=192.9
Q ss_pred eeeeecCCeEEEEEEEC--CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccC
Q 015005 22 RMLGQGTFAKVYYGKNL--VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 99 (414)
+.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.++||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999754 35678999998655432 123568889999999999999999999999999999999999
Q ss_pred CCchHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 100 GGELFAKVLKG------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 100 gg~L~~~i~~~------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
+|+|.+++... ..++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999988641 356777889999999999999999999999999999999999999999999875322111112
Q ss_pred cccccCCCcccCchhhcccC------CCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHH-hcccCCC-----CC
Q 015005 174 LHTQCGTPAYVAPEVLRKKG------YDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIF-KAEYEFP-----PW 240 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~------~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~-~~~~~~~-----~~ 240 (414)
.....|++.|+|||++.+.. ..+.++||||+|+++|+|++ |..||......+...... ......+ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 23346788999999986432 12478999999999999996 999998766554433322 2222222 23
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+..+.+++.+|+ .+|++|||++||+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 5778999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=313.06 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=198.4
Q ss_pred eeeeecCCeEEEEEEECC---CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE-eCCEEEEEEEc
Q 015005 22 RMLGQGTFAKVYYGKNLV---TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA-TKTKVFFVIEY 97 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lv~E~ 97 (414)
+.||+|+||.||+|.+.. .+..+|+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 34679999985432 1223567889999999999999999999775 45678999999
Q ss_pred cCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC--CCc
Q 015005 98 VKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN--DGL 173 (414)
Q Consensus 98 ~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--~~~ 173 (414)
+++|+|.+++.. ...+...+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++........ ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999875 4567888899999999999999999999999999999999999999999999874322110 011
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHHh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISR 251 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 251 (414)
.....+++.|+|||.+.+..+. .++|||||||++|+|++ |.+||...+..+....+..+.. ..+..++..+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1233467789999999877775 79999999999999999 5777877766666665555433 3455678999999999
Q ss_pred hcccCcCCCCChHHHhcC
Q 015005 252 ILVADPQKRISVSEIMIN 269 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~h 269 (414)
||.++|++||++.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=315.19 Aligned_cols=264 Identities=28% Similarity=0.438 Sum_probs=211.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCe----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe-
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQE----SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT- 87 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 87 (414)
.-...|++.+.||+|.||.||+|....++. .+|||.+..+.. ..+......||+.+++.++|||++.+..++.+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 345679999999999999999997665543 689999965532 22344667799999999999999999999877
Q ss_pred CCEEEEEEEccCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC----CCeEEe
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN----GNLKVS 157 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~----~~~kl~ 157 (414)
+..+++++||++. +|+..|.- ..++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.+||+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 7899999999975 78777763 358999999999999999999999999999999999999877 899999
Q ss_pred ecCCCcccccccCC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH---------HHHH
Q 015005 158 DFGLSALPEQLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI---------MKMY 227 (414)
Q Consensus 158 DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---------~~~~ 227 (414)
|||+++.+...-.. ......+-|..|.|||.+.|...++.+.|+||.|||+.||++-.+-|.+... .+..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999986643222 2344556789999999999988777999999999999999998888865421 1222
Q ss_pred HHHHh--ccc---------CCC--------------------CC------CCHHHHHHHHhhcccCcCCCCChHHHhcCC
Q 015005 228 RKIFK--AEY---------EFP--------------------PW------ISCDARRLISRILVADPQKRISVSEIMINP 270 (414)
Q Consensus 228 ~~i~~--~~~---------~~~--------------------~~------~s~~~~~li~~~L~~dp~~R~s~~eil~hp 270 (414)
.+|++ +.+ .+| .| -++.+.+|+.+||+.||.+|+|+++.|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 23321 000 011 11 245688999999999999999999999999
Q ss_pred ccccCCCC
Q 015005 271 WFIKGFSK 278 (414)
Q Consensus 271 ~f~~~~~~ 278 (414)
||.....+
T Consensus 339 yF~~d~lp 346 (438)
T KOG0666|consen 339 YFTEDPLP 346 (438)
T ss_pred ccccCCCC
Confidence 99887544
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=316.94 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=199.2
Q ss_pred CCEEEeeeeeecCCeEEEEEE----ECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CC
Q 015005 16 GKYEMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT--KT 89 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 89 (414)
.+|++.+.||+|+||.||+|. +..++..||+|.+..... ...+.+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999997 445788999999865432 235678899999999999999999998754 35
Q ss_pred EEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
.+++||||+++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 78999999999999999875 4689999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCc-cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH---------------HHHHHH
Q 015005 168 LWNDGL-LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK---------------MYRKIF 231 (414)
Q Consensus 168 ~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~---------------~~~~i~ 231 (414)
...... .....++..|+|||++.+..+. .++|||||||++|+|++|..|+....... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 111111 1112244569999999877664 78999999999999999887765432110 011112
Q ss_pred hc--ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 232 KA--EYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 232 ~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.. ..+.+..++.++.+||.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22 22344568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=311.09 Aligned_cols=240 Identities=28% Similarity=0.454 Sum_probs=203.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||+|+||.||++. .+++.||+|.+..... .+.+.+|+.+++.++||||+++++++... ..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 4679999999999999999986 5788899999865421 35678999999999999999999998765 47999
Q ss_pred EEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 95 IEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~---- 152 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM---- 152 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc----
Confidence 999999999999875 2589999999999999999999999999999999999999999999999999874321
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLI 249 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 249 (414)
.......+..|+|||.+.+..+. .++|+|||||++|+|++ |..||...+..+....+..+. ...+..++..+.+++
T Consensus 153 -~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (254)
T cd05083 153 -GVDNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230 (254)
T ss_pred -cCCCCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence 11223346789999999877664 78999999999999997 999999887776666554442 233455789999999
Q ss_pred HhhcccCcCCCCChHHHhc
Q 015005 250 SRILVADPQKRISVSEIMI 268 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~ 268 (414)
++||+.+|++||++++++.
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 231 TSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=314.57 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=205.7
Q ss_pred EEEeeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-----
Q 015005 18 YEMGRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT----- 89 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 89 (414)
|++.++||+|+||.||+|... .++..||+|++..+.... ...+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999854 357899999997654332 23567889999999999999999999886532
Q ss_pred -EEEEEEEccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCC
Q 015005 90 -KVFFVIEYVKGGELFAKVLK-------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL 161 (414)
Q Consensus 90 -~~~lv~E~~~gg~L~~~i~~-------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGl 161 (414)
..++++||+++|+|.+++.. ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 35789999999999877642 2478999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCC
Q 015005 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPP 239 (414)
Q Consensus 162 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~ 239 (414)
+................+++.|++||.+....++ .++|||||||++|+|++ |..||.+.+..+.+..+.... ...++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8854321111122233456789999999877765 78999999999999999 899998887777766665543 34556
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
..+..+.+++.+||..+|++|||+.+++.+
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.27 Aligned_cols=235 Identities=26% Similarity=0.325 Sum_probs=192.8
Q ss_pred eeeeecCCeEEEEEEECCCC----------eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 22 RMLGQGTFAKVYYGKNLVTQ----------ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999988776 35788877544321 4678899999999999999999999988 778
Q ss_pred EEEEEccCCCchHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-------CeEEeecCCC
Q 015005 92 FFVIEYVKGGELFAKVLK-G-KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-------NLKVSDFGLS 162 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~-~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-------~~kl~DFGla 162 (414)
++||||+++|+|.+++.. + .++...+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999999886 3 689999999999999999999999999999999999999887 7999999998
Q ss_pred cccccccCCCccccccCCCcccCchhhccc-CCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcccCCCCC
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKK-GYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEFPPW 240 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 240 (414)
..... .....++..|+|||++.+. ...+.++||||||+++|+|++ |..||...+......... .....|..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 75322 2334577889999998776 233588999999999999999 688887765333322222 22223333
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
....+.++|.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3478999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=315.23 Aligned_cols=257 Identities=14% Similarity=0.183 Sum_probs=195.3
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCC---CeEEEEEEeeccccch--hhH------HHHHHHHHHHHHhCCCCC
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVT---QESVAIKVINKDQVKK--QGL------MEQIKREISVMRLVKHPN 77 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~--~~~------~~~~~~Ei~il~~l~hpn 77 (414)
.+.++..++|++.+.||+|+||+||+|.+..+ +..+|+|+........ +.. ......+...+..+.|+|
T Consensus 5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 34567778999999999999999999998777 6778888754332111 000 011223344456678999
Q ss_pred ccceEEEEEeCC----EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC
Q 015005 78 IVELKEVMATKT----KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 78 Iv~l~~~~~~~~----~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~ 152 (414)
|+++++++.... ..++++|++.. ++.+.+.. ...++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 999999876543 45788888753 55555555 4578999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccC-----CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH-HH-
Q 015005 153 NLKVSDFGLSALPEQLWN-----DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI-MK- 225 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~- 225 (414)
.++|+|||+|+....... ........||+.|+|||++.+..++ .++||||+||++|+|++|..||.+... ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 999999999975432111 1122334699999999999888775 899999999999999999999987632 11
Q ss_pred -------HHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 226 -------MYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 226 -------~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
....+..+.... +..+..+.+++..|+..+|++||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223333333333 346789999999999999999999999874
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=310.76 Aligned_cols=244 Identities=18% Similarity=0.275 Sum_probs=192.5
Q ss_pred eeeeecCCeEEEEEEECCC--CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccC
Q 015005 22 RMLGQGTFAKVYYGKNLVT--QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 99 (414)
+.||+|+||+||+|..... ...+++|.+...... ...+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS--KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh--HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975432 345667776544322 235678899999999999999999999999999999999999
Q ss_pred CCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 100 GGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 100 gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
+|+|.+++.+ ...++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999998875 23567778899999999999999999999999999999999999999999998632211111122
Q ss_pred ccccCCCcccCchhhcccC------CCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc------cCCCCCC
Q 015005 175 HTQCGTPAYVAPEVLRKKG------YDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE------YEFPPWI 241 (414)
Q Consensus 175 ~~~~gt~~y~APE~~~~~~------~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~------~~~~~~~ 241 (414)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+.... ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999985321 11468999999999999996 678998776666666554332 2233447
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
++.+.+++.+|| .+|.+||++.+|++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 888999999999 67999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=312.51 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=203.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEEC----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CC
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNL----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT--KT 89 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 89 (414)
..|++.+.||+|+||.||+|... .+++.+|+|++...... ...+.+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46888999999999999999864 35889999999765443 235688999999999999999999999887 56
Q ss_pred EEEEEEEccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLKG--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
..+++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 899999999999999999873 499999999999999999999999999999999999999999999999999986542
Q ss_pred ccCCC-ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH--------------HHHHHHh
Q 015005 168 LWNDG-LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK--------------MYRKIFK 232 (414)
Q Consensus 168 ~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~--------------~~~~i~~ 232 (414)
..... ......++..|+|||.+.+..+. .++||||||+++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 11111 11123355679999999877664 78999999999999999999987643221 1112222
Q ss_pred cc--cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 233 AE--YEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 233 ~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.. .+.+..++.++.+|+.+||++||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 2334567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=310.47 Aligned_cols=249 Identities=27% Similarity=0.524 Sum_probs=209.5
Q ss_pred CEEEeeeeeecCCeEEEEEEECC-CCeEEEEEEeecccc-------chhhHHHHHHHHHHHHHh-CCCCCccceEEEEEe
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLV-TQESVAIKVINKDQV-------KKQGLMEQIKREISVMRL-VKHPNIVELKEVMAT 87 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 87 (414)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999887 788999999864321 122234567788888865 699999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCC
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGL 161 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGl 161 (414)
.+..|++|||++|++|.+.+.. ..+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999887632 468999999999999999999996 7899999999999999999999999999
Q ss_pred CcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCC-CC-
Q 015005 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF-PP- 239 (414)
Q Consensus 162 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-~~- 239 (414)
+...... .......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+....... +.
T Consensus 161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 9864331 13445678999999999987666 489999999999999999999998877766666665554332 22
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.+++++.++|.+||+.||++||++.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=335.30 Aligned_cols=244 Identities=33% Similarity=0.498 Sum_probs=200.4
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC---
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT--- 89 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 89 (414)
.-.+.|...+.||+||||.||+++++.+|+.||||.+++..... ..+...+|+++|++++|||||+++++-++..
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGL 87 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCc
Confidence 34477899999999999999999999999999999998755333 2567889999999999999999999876654
Q ss_pred ---EEEEEEEccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc--CCC--CeEEee
Q 015005 90 ---KVFFVIEYVKGGELFAKVLK----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD--ENG--NLKVSD 158 (414)
Q Consensus 90 ---~~~lv~E~~~gg~L~~~i~~----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~--~~~--~~kl~D 158 (414)
...+|||||+||+|+..+++ .+++|.+...++..+..||.|||++||+||||||.||++- .+| ..||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 46799999999999999986 4799999999999999999999999999999999999995 223 589999
Q ss_pred cCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch-----HHHHHHHHHh-
Q 015005 159 FGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-----IMKMYRKIFK- 232 (414)
Q Consensus 159 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-----~~~~~~~i~~- 232 (414)
||.|+-.+ .+....+..||+.|.+||++..+++++..+|.||+||++|+..||.+||.... ..-++..+.+
T Consensus 168 fG~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 168 FGAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred ccccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 99999654 35578888999999999999975566789999999999999999999995422 1123332221
Q ss_pred -------------------cccCCCCCCCH----HHHHHHHhhcccCcCCCC
Q 015005 233 -------------------AEYEFPPWISC----DARRLISRILVADPQKRI 261 (414)
Q Consensus 233 -------------------~~~~~~~~~s~----~~~~li~~~L~~dp~~R~ 261 (414)
...++|...++ .+..++..+|..||++|.
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11233333333 345788889999999999
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=338.50 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=213.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECC-----CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLV-----TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
..-+..+.||+|+||+||+|+... ....||||.++.... ....++|+||++++..++|||||+|+|+|..++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--NQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 355677899999999999997542 335799999966543 2346889999999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-C--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeE
Q 015005 91 VFFVIEYVKGGELFAKVLK-G--------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLK 155 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~--------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~k 155 (414)
+|+|+|||..|+|..++.. + +++..+...++.||+.|+.||-++.++||||-..|.||.++-.||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 9999999999999998863 1 178889999999999999999999999999999999999999999
Q ss_pred EeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc
Q 015005 156 VSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE 234 (414)
Q Consensus 156 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 234 (414)
|+|||+++-.-............-..+|||||.+....|+ .++||||+||+|||+++ |..||.+-+.++..+.+..++
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 9999999843221111122223345689999999988886 78999999999999999 999999999999999988876
Q ss_pred c-CCCCCCCHHHHHHHHhhcccCcCCCCChHHH
Q 015005 235 Y-EFPPWISCDARRLISRILVADPQKRISVSEI 266 (414)
Q Consensus 235 ~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei 266 (414)
. +.|..+|.++.+|+..||+.+|.+||++.||
T Consensus 723 lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 723 LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 5 6788899999999999999999999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=320.24 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=195.2
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-EEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT-KVFFV 94 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lv 94 (414)
++|.-...||+|+||.||+|... +|..||||.+....... ..++.+|+.++.+++|||+|+++|+|.+.+ ..++|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 56777889999999999999854 45899999876554321 345999999999999999999999999988 59999
Q ss_pred EEccCCCchHHHHhc--C-CCCHHHHHHHHHHHHHHHHHHHhCC---cEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 95 IEYVKGGELFAKVLK--G-KLKEESARKYFQQLISAVDFCHSRG---VYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~-~~~e~~~~~~~~ql~~al~~lH~~g---i~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
+||++.|+|.+.+.. + .+++....+|+.+++.||+|||+.. |+||||||+|||||++.+.||+|||+|......
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999999999999886 3 7899999999999999999999864 999999999999999999999999999754321
Q ss_pred cCCCccccc-cCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch------HHHHHH-HHHhcc------
Q 015005 169 WNDGLLHTQ-CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN------IMKMYR-KIFKAE------ 234 (414)
Q Consensus 169 ~~~~~~~~~-~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~------~~~~~~-~i~~~~------ 234 (414)
.....+. .||.+|+|||.+..... +.++||||+||+|.||++|+.|.+... ..+... .+..+.
T Consensus 231 --~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 231 --DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred --ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 2222222 89999999999977545 589999999999999999998887532 111111 111111
Q ss_pred cCCC-CCCC--H---HHHHHHHhhcccCcCCCCChHHHhc
Q 015005 235 YEFP-PWIS--C---DARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 235 ~~~~-~~~s--~---~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
..+. ...+ . .+..+..+|++.+|.+||++.|+++
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1222 2 2567788999999999999999754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=311.08 Aligned_cols=255 Identities=31% Similarity=0.488 Sum_probs=209.1
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC--CCC----ccceEE
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK--HPN----IVELKE 83 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~--hpn----Iv~l~~ 83 (414)
+++.+.++|++.+++|+|.||+|-.+.+..++..||+|+++.-. .+.+..+-|++++.++. .|+ +|++.+
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 57888999999999999999999999999999999999985322 23456678999999993 343 788889
Q ss_pred EEEeCCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC----------
Q 015005 84 VMATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---------- 150 (414)
Q Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---------- 150 (414)
+|.-.++++||.|.+ |.++++++.. .+++-..++.+..||+.++++||+.+++|-||||||||+-+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999998 6799999987 36999999999999999999999999999999999999831
Q ss_pred ----------CCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC
Q 015005 151 ----------NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN 220 (414)
Q Consensus 151 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~ 220 (414)
+..++|+|||.|+.... .-.+.+.|..|.|||++.+-++. .++||||+||||+|+.+|...|..
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceeccc
Confidence 33589999999985432 22566789999999999999996 889999999999999999999976
Q ss_pred chHH---HHHHHHHhc------------------ccCCCC-------------------------CCCHHHHHHHHhhcc
Q 015005 221 ENIM---KMYRKIFKA------------------EYEFPP-------------------------WISCDARRLISRILV 254 (414)
Q Consensus 221 ~~~~---~~~~~i~~~------------------~~~~~~-------------------------~~s~~~~~li~~~L~ 254 (414)
.+.. .+.+.|... ....|. ..-.++-+||++||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 5422 244443321 111110 011247799999999
Q ss_pred cCcCCCCChHHHhcCCccccC
Q 015005 255 ADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 255 ~dp~~R~s~~eil~hp~f~~~ 275 (414)
.||.+|+|+.|+|.||||...
T Consensus 392 fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFARL 412 (415)
T ss_pred cCccccccHHHHhcCHHhhcC
Confidence 999999999999999999753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=343.69 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=213.5
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCC-C----eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVT-Q----ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-~----~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
+--..-++.+.||+|+||.||.|..... | ..||+|.+.+.. +.+...++.+|..+|+.++|||||++++++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 3345678899999999999999976543 2 238888886543 34457889999999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeec
Q 015005 88 KTKVFFVIEYVKGGELFAKVLKG--------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDF 159 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~--------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DF 159 (414)
....+|++|||.||+|..++++. .++..+...++.|++.|+.||++++++||||...|+||+....+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999864 3888999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCccccccC--CCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHH-Hhccc
Q 015005 160 GLSALPEQLWNDGLLHTQCG--TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKI-FKAEY 235 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i-~~~~~ 235 (414)
|+|+-.-. .+.......+ ...|||||.+....++ .++|||||||+|||++| |..||.+.+..+...-+ ..+..
T Consensus 847 GlArDiy~--~~yyr~~~~a~lPvkWm~PEsl~d~iFt-skSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 847 GLARDIYD--KDYYRKHGEAMLPVKWMPPESLKDGIFT-SKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred chhHhhhh--chheeccCccccceecCCHHHHhhcccc-cccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 99983211 1111111112 3479999999987775 89999999999999999 99999998887777744 45677
Q ss_pred CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 236 EFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+.|..++..+.+++..||+.+|++||++..|++
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 888999999999999999999999999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.74 Aligned_cols=255 Identities=19% Similarity=0.292 Sum_probs=179.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCC----CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEE----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVT----QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEV---- 84 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~---- 84 (414)
...++|++.+.||+|+||+||+|.+..+ +..||+|.+....... ....| .++...+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3467899999999999999999999888 8999999875432111 11111 1122222222222211
Q ss_pred --EEeCCEEEEEEEccCCCchHHHHhcCCC---------------------CHHHHHHHHHHHHHHHHHHHhCCcEEecC
Q 015005 85 --MATKTKVFFVIEYVKGGELFAKVLKGKL---------------------KEESARKYFQQLISAVDFCHSRGVYHRDL 141 (414)
Q Consensus 85 --~~~~~~~~lv~E~~~gg~L~~~i~~~~~---------------------~e~~~~~~~~ql~~al~~lH~~gi~HrDl 141 (414)
......+++|+||+++++|.+++....+ .+..+..++.|++.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456789999999999999988875322 23446789999999999999999999999
Q ss_pred CCCcEEEcC-CCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCC---------------------CCcc
Q 015005 142 KPENLLLDE-NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD---------------------GAKS 199 (414)
Q Consensus 142 kp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~---------------------~~~~ 199 (414)
||+|||++. ++.+||+|||+|+..... ........+||+.|+|||.+....+. +.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 579999999999754321 12234566899999999976432221 2356
Q ss_pred chhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC---------------------CCCCCCHHHHHHHHhhcccCcC
Q 015005 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE---------------------FPPWISCDARRLISRILVADPQ 258 (414)
Q Consensus 200 DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~~~s~~~~~li~~~L~~dp~ 258 (414)
||||+||+||+|+++..|+.... ......+...... .....+....+||.+||++||+
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999999887765421 1111111111110 0111223456899999999999
Q ss_pred CCCChHHHhcCCccccCC
Q 015005 259 KRISVSEIMINPWFIKGF 276 (414)
Q Consensus 259 ~R~s~~eil~hp~f~~~~ 276 (414)
+|||+.|+|+||||....
T Consensus 440 kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 440 QRISAKAALAHPYFDREG 457 (566)
T ss_pred cCCCHHHHhCCcCcCCCC
Confidence 999999999999997643
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=300.04 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=212.6
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe------
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT------ 87 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 87 (414)
..+.|+-...||+|.||.||+|++..+|+.||+|.+--+.. ..+.-....+|+.+|..++|+|++.+++.|.+
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 45678899999999999999999999999999998754432 23444566799999999999999999988743
Q ss_pred --CCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 88 --KTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 88 --~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
...+|+|+.+|+. +|+-.+.. .+++..++.+++++++.||.|+|++.|+|||+||+|+||+.+|.+||+|||+++
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 2459999999974 77777765 579999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCC--CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh--ccc----
Q 015005 164 LPEQLWND--GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--AEY---- 235 (414)
Q Consensus 164 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~---- 235 (414)
.+....+. ......+-|..|.+||.+.|..-++++.|||+.|||+.+|.+|.+-+.+.+.......|.. +..
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 65432211 1223445699999999999877667999999999999999999999998876655443321 100
Q ss_pred ----------------CCCC-------------CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 236 ----------------EFPP-------------WISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 236 ----------------~~~~-------------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
+.|. --++++.+|+.++|..||.+|+++.++++|.||.+..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 0110 1245789999999999999999999999999998753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=311.93 Aligned_cols=265 Identities=29% Similarity=0.500 Sum_probs=219.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc----hhhHHHHHHHHHHHHHhCCCCCccceEEEEE-
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK----KQGLMEQIKREISVMRLVKHPNIVELKEVMA- 86 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~- 86 (414)
.++.++|-++.+||+|+|+.||+|.+...++.||||+-...+.. .+++.+...+|.+|++.|.||.||++|+++.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 35778999999999999999999999999999999997544332 3345677889999999999999999999996
Q ss_pred eCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC--CcEEecCCCCcEEEc---CCCCeEEeecC
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSR--GVYHRDLKPENLLLD---ENGNLKVSDFG 160 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~--gi~HrDlkp~NILl~---~~~~~kl~DFG 160 (414)
+.+.+|-|+|||+|.+|.-++.. ..++|.+|+.++.||+.||.||.+. -|+|-||||.|||+- .-|.+||+|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 45678899999999999888887 6799999999999999999999986 599999999999995 34789999999
Q ss_pred CCcccccccCC-----CccccccCCCcccCchhhc-c--cCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHH--HH
Q 015005 161 LSALPEQLWND-----GLLHTQCGTPAYVAPEVLR-K--KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMY--RK 229 (414)
Q Consensus 161 la~~~~~~~~~-----~~~~~~~gt~~y~APE~~~-~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~--~~ 229 (414)
+++.++....+ .......||-+|.+||.+. + .+..+.++||||.|||+|..+.|+.||...... +.. ..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99987653222 2345567999999999864 2 233468999999999999999999999875433 222 22
Q ss_pred HHh-cccCCCC--CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 230 IFK-AEYEFPP--WISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 230 i~~-~~~~~~~--~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
|++ .+..||+ -++++++++|++||+..-+.|..+.++-.||||.-..
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 333 3445664 4899999999999999999999999999999996543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.50 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=208.4
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHh-CCCCCccceEEEEEeCCEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL-VKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lv 94 (414)
++.+-...||.|+||+|++-.++.+|+..|||.++...... ..+++..|.+...+ -+.||||++|+..-.++..+|.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k--eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK--EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH--HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 34455678999999999999999999999999998776633 36788888887544 4799999999999999999999
Q ss_pred EEccCCCchHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 95 IEYVKGGELFAKV------LKGKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 95 ~E~~~gg~L~~~i------~~~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
||+|. .+|..+. .+..++|+..-.+....+.||.||-+. .|+|||+||+|||+|..|.+||||||++.....
T Consensus 142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99996 4553322 236899999999999999999999865 899999999999999999999999999874432
Q ss_pred ccCCCccccccCCCcccCchhhcc--cCCCCCccchhhhhhhhhhhhcCCCCCCCc-hHHHHHHHHHhcccCC---CC--
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRK--KGYDGAKSDIWSCGVVLFVLLSGFLPFQNE-NIMKMYRKIFKAEYEF---PP-- 239 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~~~---~~-- 239 (414)
........|..+|||||.+.. .+|+ -++|+||||++|||+.||..|+.+- +..++...+..+.++. +.
T Consensus 221 ---SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~ 296 (361)
T KOG1006|consen 221 ---SIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKEC 296 (361)
T ss_pred ---HHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccc
Confidence 222334568999999999864 4576 8999999999999999999999763 3445566666676653 22
Q ss_pred -CCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 240 -WISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 240 -~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.++..+..+|.-||.+|-+.||...+++++||++.
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 27889999999999999999999999999999865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=289.20 Aligned_cols=239 Identities=48% Similarity=0.856 Sum_probs=208.3
Q ss_pred CCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCchHHHH
Q 015005 28 TFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKV 107 (414)
Q Consensus 28 ~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i 107 (414)
+||.||+|.+..+++.+|+|++........ .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999988999999999976554322 568889999999999999999999999999999999999999999998
Q ss_pred hc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCc
Q 015005 108 LK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186 (414)
Q Consensus 108 ~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 186 (414)
.. ..++...+..++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+...... .......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence 87 44899999999999999999999999999999999999999999999999999864432 234556789999999
Q ss_pred hhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC-chHHHHHHHHHhcccCCCCC---CCHHHHHHHHhhcccCcCCCCC
Q 015005 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIFKAEYEFPPW---ISCDARRLISRILVADPQKRIS 262 (414)
Q Consensus 187 E~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~s~~~~~li~~~L~~dp~~R~s 262 (414)
|.+.+..++ .++||||+|+++++|++|..||.. .+.....+.+.......+.. ++.++.+++.+||..||++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999877775 699999999999999999999988 55555566555555443332 8889999999999999999999
Q ss_pred hHHHhcCCcc
Q 015005 263 VSEIMINPWF 272 (414)
Q Consensus 263 ~~eil~hp~f 272 (414)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=319.43 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=219.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEe-----C
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMAT-----K 88 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-----~ 88 (414)
.+.|++.++||.|.+|+||++.++.+++..|+|+.+.....+ +.+..|.++++.+ .|||++.+++++.. +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 567999999999999999999999999999999987654332 5677899999888 69999999999853 5
Q ss_pred CEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
+.+++|||||.||+.-|+++. .++.|..+..+++.++.|+.+||.+.++|||||=.|||++.+|.+||+|||.+...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 789999999999999999886 57999999999999999999999999999999999999999999999999999865
Q ss_pred ccccCCCccccccCCCcccCchhhccc-----CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC---C
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKK-----GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE---F 237 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~ 237 (414)
.. ..+...+..|||.|||||++... .|+ ..+|+||||++..||.-|.+|+-+..+....-.|..+.++ -
T Consensus 174 ds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 174 DS--TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR 250 (953)
T ss_pred ec--ccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence 54 34556788899999999998643 354 7899999999999999999999887776554444333222 2
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
|...+.++.++|..||.+|..+||+..+++.|||...+
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 34468899999999999999999999999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=311.91 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=190.4
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEEC----------------CCCeEEEEEEeeccccchh-----------hHHHHHHH
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNL----------------VTQESVAIKVINKDQVKKQ-----------GLMEQIKR 65 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~----------------~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~ 65 (414)
.-.++|++.+.||+|+||+||+|... ..++.||||.+........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34678999999999999999999752 2446799999864321110 01122345
Q ss_pred HHHHHHhCCCCCc-----cceEEEEEe--------CCEEEEEEEccCCCchHHHHhc--C--------------------
Q 015005 66 EISVMRLVKHPNI-----VELKEVMAT--------KTKVFFVIEYVKGGELFAKVLK--G-------------------- 110 (414)
Q Consensus 66 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~i~~--~-------------------- 110 (414)
|+.++.+++|.++ +++++++.. .+..++|+||+++++|.+++.. +
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766554 667776643 3568999999999999887753 1
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCch
Q 015005 111 ---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187 (414)
Q Consensus 111 ---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 187 (414)
.++...++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ........+|+.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChh
Confidence 23456788999999999999999999999999999999999999999999997543211 11112233589999999
Q ss_pred hhcccC--------------------CC-CCccchhhhhhhhhhhhcCCC-CCCCchH-----------HHHHHHHHhcc
Q 015005 188 VLRKKG--------------------YD-GAKSDIWSCGVVLFVLLSGFL-PFQNENI-----------MKMYRKIFKAE 234 (414)
Q Consensus 188 ~~~~~~--------------------~~-~~~~DiwSlGvil~~ll~g~~-Pf~~~~~-----------~~~~~~i~~~~ 234 (414)
++.... |. ..+.||||+||++|+|++|.+ ||..... ...++.+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 975422 11 124799999999999999986 7754211 11222333344
Q ss_pred cCCC--CCCCHHHHHHHHhhcccCc---CCCCChHHHhcCCccccC
Q 015005 235 YEFP--PWISCDARRLISRILVADP---QKRISVSEIMINPWFIKG 275 (414)
Q Consensus 235 ~~~~--~~~s~~~~~li~~~L~~dp---~~R~s~~eil~hp~f~~~ 275 (414)
+.++ +..++..++|+.+||..+| .+|+|+.|+|+||||...
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 4444 3478999999999999876 689999999999999653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=302.81 Aligned_cols=256 Identities=28% Similarity=0.486 Sum_probs=213.5
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC------CCccceE
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH------PNIVELK 82 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~ 82 (414)
.+|+.+-++|.+....|+|-|++|..|.+..-|..||||+|....+- .+.=.+|++||++|+. -|+++++
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 46889999999999999999999999999999999999999765432 3445689999999952 4899999
Q ss_pred EEEEeCCEEEEEEEccCCCchHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-CeEEe
Q 015005 83 EVMATKTKVFFVIEYVKGGELFAKVLK-G---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-NLKVS 157 (414)
Q Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~i~~-~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-~~kl~ 157 (414)
-.|...+++|||+|-+. ..|.+.+.+ | ++....++.|..||+.||..|-..||+|.||||.|||+++.. .+|||
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeec
Confidence 99999999999999885 688888887 4 588999999999999999999999999999999999998764 69999
Q ss_pred ecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCC
Q 015005 158 DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF 237 (414)
Q Consensus 158 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (414)
|||.|.... ........-+..|.|||++.|.+|+ ...|+||.||+||+|.||+..|.+.+...+.+-...-.-++
T Consensus 580 DfGSA~~~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 580 DFGSASFAS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred cCccccccc----cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 999998543 2334445567789999999999997 88999999999999999999999877665544322111011
Q ss_pred ------------------------------------------C---------------C---CCCHHHHHHHHhhcccCc
Q 015005 238 ------------------------------------------P---------------P---WISCDARRLISRILVADP 257 (414)
Q Consensus 238 ------------------------------------------~---------------~---~~s~~~~~li~~~L~~dp 257 (414)
| . .+-..+++|+.+||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 0 0 011257899999999999
Q ss_pred CCCCChHHHhcCCcccc
Q 015005 258 QKRISVSEIMINPWFIK 274 (414)
Q Consensus 258 ~~R~s~~eil~hp~f~~ 274 (414)
++|.|+.++|+||||+.
T Consensus 735 ~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 735 EKRITVNQALKHPFITE 751 (752)
T ss_pred hhcCCHHHHhcCCcccC
Confidence 99999999999999964
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=277.36 Aligned_cols=250 Identities=27% Similarity=0.490 Sum_probs=201.2
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCC--E
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKT--K 90 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~--~ 90 (414)
..++|++.+.+|+|.|+.||.|.+..+++.++||++..-. .+.+.+|+.||..|. ||||++++++..++. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3568999999999999999999999999999999985322 367899999999996 999999999997753 5
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC-CCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-NGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 169 (414)
..+++||+...+...+. ..++.-.++.++.|++.||.|||++||.|||+||.|++||. ...++|+|+|+|.+..+.
T Consensus 110 paLiFE~v~n~Dfk~ly--~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~- 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY--PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
T ss_pred chhHhhhhccccHHHHh--hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC-
Confidence 67999999877654433 46888999999999999999999999999999999999995 468999999999876542
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC-chHHHHHHHHHh----------------
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIFK---------------- 232 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~---------------- 232 (414)
..-.-.+.+..|--||.+..-.+....-|+|||||+|..|+..+-||-. .+..++.-+|.+
T Consensus 187 --~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 187 --KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred --ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 2233456788899999987655555789999999999999999999743 222222111110
Q ss_pred ----------cccCC-----------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 233 ----------AEYEF-----------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 233 ----------~~~~~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+...- ...+++++.+|+.++|..|-++|+|+.|++.||||..
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 01110 0125799999999999999999999999999999964
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=305.78 Aligned_cols=202 Identities=30% Similarity=0.538 Sum_probs=184.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHH-----HHHHHHHHHHHhCC---CCCccceEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLM-----EQIKREISVMRLVK---HPNIVELKEVMA 86 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~-----~~~~~Ei~il~~l~---hpnIv~l~~~~~ 86 (414)
...|...+.+|+|+||+|++|.++.+...|+||.+.|+++....++ -.+-.||+||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4569999999999999999999999999999999999876543333 23568999999997 999999999999
Q ss_pred eCCEEEEEEEcc-CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 87 TKTKVFFVIEYV-KGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 87 ~~~~~~lv~E~~-~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
+.+++||+||-- +|-+||++|+. ..++|.++..+|+|++.|+++||+.||+|||||-+|+.++.+|-+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999976 56699999997 7899999999999999999999999999999999999999999999999999985
Q ss_pred cccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC
Q 015005 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN 220 (414)
Q Consensus 165 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~ 220 (414)
. ..++.....||..|.|||++.|.+|-+.+-|||++|++||.++....||..
T Consensus 720 ~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 T----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred h----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 3 457788899999999999999999999999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=312.01 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=221.1
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCe---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQE---SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
..++-...-.|.++||.|.||.|++|+.+..|+ .||||.++.....+ ...+|..|+.||-+++||||++|.++..
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek--qrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH--HHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 344445567899999999999999999887774 69999997665543 3678999999999999999999999999
Q ss_pred eCCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
....+.||.|||++|+|..+++. |+|+..+...+++.|+.|+.||-+.|.+||||...|||++.+-..|++|||+++.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 99999999999999999999986 8899999999999999999999999999999999999999999999999999997
Q ss_pred cccccCCCccccccC--CCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCC
Q 015005 165 PEQLWNDGLLHTQCG--TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPW 240 (414)
Q Consensus 165 ~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 240 (414)
.+... +....+.-| ..+|.|||.+.-..++ .++||||+||+|||.++ |..||.+.+..+..+.|-.+ ..+.|..
T Consensus 781 ledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD 858 (996)
T KOG0196|consen 781 LEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD 858 (996)
T ss_pred cccCC-CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC
Confidence 75432 112222222 3579999999988886 78999999999999877 99999998888888877554 3455667
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+|..+..|+..||++|-.+||.+.+|+++
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 89999999999999999999999999764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=286.54 Aligned_cols=253 Identities=31% Similarity=0.510 Sum_probs=210.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK---- 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 88 (414)
+.-.+|.-++.+|.|+- .|-.|.+..++++||+|....+.. +..-.++..+|..++..++|+||++++.++.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34568999999999999 888899999999999999877633 233356788999999999999999999998533
Q ss_pred --CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 --TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 --~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
...|+|||++. .+|.+.+. -.+.......++.|+++|++|||+.||+||||||+||++..++.+||.|||+|...+
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 45899999996 57766666 467788899999999999999999999999999999999999999999999998533
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-------------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------------- 233 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 233 (414)
. +-.....+.|..|.|||++.+.+|. +.+||||+||++.+|++|..-|.+.+.-+.+.++...
T Consensus 170 ~---~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 T---DFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred c---ccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 2 2355667789999999999998875 8899999999999999999999987765555443320
Q ss_pred ---------c-----c----CCCC-----------CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 234 ---------E-----Y----EFPP-----------WISCDARRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 234 ---------~-----~----~~~~-----------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
. . .+|+ .-+..+++|+.+||..||++|.|+.++|+|||+.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 0 1121 1234689999999999999999999999999997
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=305.35 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=204.2
Q ss_pred EEEeeeeeecCCeEEEEEEECCC--C--eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVT--Q--ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~--~--~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
.++.+.||+|-||.||.|..... | -.||||..+.+...+ ..+.|..|..+|+.++|||||+++|+|.. ...+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d--~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD--DTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh--hHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34457899999999999975432 3 358999986654332 36789999999999999999999999975 57899
Q ss_pred EEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 94 VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
|||+++-|+|..+++. ..++......|..||+.||.|||+..++||||-..|||+....-+||+|||+++..+....
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y- 546 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY- 546 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch-
Confidence 9999999999999986 5788899999999999999999999999999999999999999999999999997654211
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLI 249 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 249 (414)
.......-...|||||.+.-..++ .++|||-|||++||++. |..||.+-...+..-.+-+| ..+.|+.+|+.+..|+
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslm 625 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLM 625 (974)
T ss_pred hhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHH
Confidence 112222234569999999877775 78999999999999887 99999987665555555444 5789999999999999
Q ss_pred HhhcccCcCCCCChHHH
Q 015005 250 SRILVADPQKRISVSEI 266 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~ei 266 (414)
.+||+.+|.+||++.||
T Consensus 626 skcWayeP~kRPrftei 642 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTEI 642 (974)
T ss_pred HHHhccCcccCCcHHHH
Confidence 99999999999998765
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=308.22 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=217.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECC-CCe--EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLV-TQE--SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
++.++.+.||+|+||.|++|.+.. +|+ .||||++....... ...+|.+|+.+|.+|+|||+|++|++..+ ..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 456778999999999999998765 343 68999997766543 57899999999999999999999999987 7889
Q ss_pred EEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+|++++|+|.+.+.+ +.|.-.....|+.||+.|+.||.+++.|||||-..|+|+-....+||+||||++-.....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999986 568888999999999999999999999999999999999999999999999998665432
Q ss_pred CCCccc-cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHH
Q 015005 170 NDGLLH-TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDAR 246 (414)
Q Consensus 170 ~~~~~~-~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 246 (414)
....+. ...-...|+|||.+....+. .++|+|++||+||||++ |..||.+.....+.+++-.+ ..+-|..++.++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 222111 11234469999999988886 89999999999999999 89999999998888888654 4577888999999
Q ss_pred HHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 247 RLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+++.+||..+|.+|||+..|.+.-+...
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHHHh
Confidence 9999999999999999999976655433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=291.96 Aligned_cols=135 Identities=29% Similarity=0.520 Sum_probs=118.8
Q ss_pred hhhcccc-CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-----C---CCcc
Q 015005 9 RVRNILF-GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-----H---PNIV 79 (414)
Q Consensus 9 ~~~~~~~-~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv 79 (414)
.+|+.|. ++|.+.+.||-|-|++||+|.+..+.+.||+|+.+... .+.+....||.+|++++ | .+||
T Consensus 70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 4678888 99999999999999999999999999999999996543 34566778999999883 3 3699
Q ss_pred ceEEEEE----eCCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEE
Q 015005 80 ELKEVMA----TKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLL 148 (414)
Q Consensus 80 ~l~~~~~----~~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl 148 (414)
+|++.|. .+.++++|+|++ |..|..+|.. .+++...++.|++|++.||.|||++ ||+|-||||+|||+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 9999996 456899999999 6788888876 5799999999999999999999965 99999999999998
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=297.78 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=208.6
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
+.--.+..+.+.||+|-||.|.++.- ..+..||+|.++.....+ ....+.+|+++|.+|+|||||+++++|..++.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 34455778999999999999999984 456899999997665443 367899999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 92 FFVIEYVKGGELFAKVLKGKL---KEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~~~~---~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
+++|||++.|+|.+++.+... .......++.||++|++||.+.+++||||.|.|+|+|.++++||+|||+++..-..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 999999999999999987532 44556779999999999999999999999999999999999999999999843221
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc--CCCCCCCchHHHHHHHHHh---c-----ccCCC
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS--GFLPFQNENIMKMYRKIFK---A-----EYEFP 238 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~~~~~~i~~---~-----~~~~~ 238 (414)
.....-...+-...|||||.+.-..++ .++|+|++|+++||+++ ...||...+.++..++... . -...|
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 111112223345789999998877775 79999999999999754 8899988777766655432 1 12456
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+-++.++.+|+-+||..|..+|||++++-.
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 678999999999999999999999999853
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.31 Aligned_cols=245 Identities=28% Similarity=0.441 Sum_probs=198.3
Q ss_pred EEeeeeeecCCeE-EEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEE
Q 015005 19 EMGRMLGQGTFAK-VYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 19 ~~~~~LG~G~~g~-Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.--+.+|.|+-|+ ||+|. ..|+.||||.+-.+. .....+|++.|+.. +|||||++|+.-.+.+..||..|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred ccHHHcccCCCCcEEEEEe--eCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3346789999876 58887 578899999985432 34567999999998 69999999999999999999999
Q ss_pred ccCCCchHHHHhcC-C----CCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC---CC--CeEEeecCCCcccc
Q 015005 97 YVKGGELFAKVLKG-K----LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---NG--NLKVSDFGLSALPE 166 (414)
Q Consensus 97 ~~~gg~L~~~i~~~-~----~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---~~--~~kl~DFGla~~~~ 166 (414)
.|. .+|.++++.. . ......+..+.|+++||++||+.+|+||||||.||||+. ++ .++|+|||+++...
T Consensus 584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 996 5999999873 1 122456889999999999999999999999999999986 34 68999999998654
Q ss_pred ccc-CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcC-CCCCCCchHHHHHHHHHhcccCCCC---CC
Q 015005 167 QLW-NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG-FLPFQNENIMKMYRKIFKAEYEFPP---WI 241 (414)
Q Consensus 167 ~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~~~---~~ 241 (414)
... .-....+..||-+|+|||++...... .++||||+||++|+.++| ..||...-. ...+|..+++.... .-
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEPLP 739 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeeccCc
Confidence 321 22235566799999999999887664 689999999999998885 999987533 23466777665422 12
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..++.+||.+|++++|..||++.++|.||+|+..
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 2289999999999999999999999999999864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=297.01 Aligned_cols=243 Identities=28% Similarity=0.423 Sum_probs=211.1
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
..+...||-|.||.||.|.++.-.-.||||.++.+.. .++.|..|+.+|+.++|||+|+++++|..+..+|||+||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3455789999999999999999999999999965443 367899999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcc
Q 015005 98 VKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174 (414)
Q Consensus 98 ~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 174 (414)
|..|.|.++++. ..++......++.||.+|++||..++++||||-..|.|+.++..+|++||||++++... ....
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD--TYTA 422 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD--TYTA 422 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC--ceec
Confidence 999999999986 35788888899999999999999999999999999999999999999999999987542 1222
Q ss_pred cccc-CCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHHHh
Q 015005 175 HTQC-GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLISR 251 (414)
Q Consensus 175 ~~~~-gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~ 251 (414)
+... -...|.|||-+.-..+. .++|||+|||+||++.| |..||.+.+....|.-+-++ ...-|..+++.+.+|++.
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMra 501 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRA 501 (1157)
T ss_pred ccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHH
Confidence 2111 24569999999877775 89999999999999998 99999999988887766544 345688899999999999
Q ss_pred hcccCcCCCCChHHHh
Q 015005 252 ILVADPQKRISVSEIM 267 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil 267 (414)
||+++|..||+++||-
T Consensus 502 CW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 502 CWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HhcCCcccCccHHHHH
Confidence 9999999999999873
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.63 Aligned_cols=237 Identities=25% Similarity=0.355 Sum_probs=188.3
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
..|...+.||+|+||.||+|.+..++..||+|.+...... ...|++++++++|||||++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 4566778999999999999999899999999998643321 125688999999999999999999999999999
Q ss_pred EccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 96 EYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH---SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 96 E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH---~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
||++||+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred eCCCCCcHHHHHh--cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 9999999999986 4888999999999999999999 6799999999999999998888775 665542211
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch-----HHHHHHHHHh---------ccc---
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-----IMKMYRKIFK---------AEY--- 235 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-----~~~~~~~i~~---------~~~--- 235 (414)
.....||+.|+|||++.+..|+ .++||||+||++|||++|+.||+... ..+..+.... ...
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1233689999999999887775 89999999999999999999986431 1111111110 000
Q ss_pred -CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 236 -EFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 236 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
..+.....++.+++.+||+.||++|||+.|+++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0111112356789999999999999999999865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=277.79 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=207.7
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-----EEE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT-----KVF 92 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~ 92 (414)
.+..+.||-|+||.||.+.+..+|+.||+|.+..-. .+-...+.+.+|+.++..++|.|++..+++.+... .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 455688999999999999999999999999885322 12223578899999999999999999998886553 478
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+++|++. .+|...|.. ..++.+.++-++.||+.||.|||+.||.||||||.|+|++.|..+||||||+++..+.. ..
T Consensus 134 V~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d-~~ 211 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR-DR 211 (449)
T ss_pred HHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-hh
Confidence 8899885 577777776 78999999999999999999999999999999999999999999999999999975542 22
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHH--------------------
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF-------------------- 231 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~-------------------- 231 (414)
..+...+-|-.|.|||++.|...++.+.||||.|||+.|||..+..|...++-+..+.|.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 234445568899999999988766789999999999999999999998876654443332
Q ss_pred ---hcccCCCC-----------CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 232 ---KAEYEFPP-----------WISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 232 ---~~~~~~~~-----------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+....|+ .-..+...++.++|.+||.+|.+.++.+.|++.-++
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 12222221 123467899999999999999999999999998654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=299.96 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=223.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.-.++|++.+.+|.|+||.||+|+++.+++..|+|+++.+...+ ..-+..|+-+++.++|||||.+++.+...+.++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 55678999999999999999999999999999999998766543 466778999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+.||||.||+|.+...- +.++|.++....+..+.|++|||+.|-+|||||=.|||+++.|.+|++|||.+..+.. .-
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti 166 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI 166 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence 99999999999998876 9999999999999999999999999999999999999999999999999999875433 23
Q ss_pred CccccccCCCcccCchhh---cccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC-----CCCCH
Q 015005 172 GLLHTQCGTPAYVAPEVL---RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP-----PWISC 243 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~---~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~ 243 (414)
.......|||.|||||+- +..+|. ..+|||++|+...++---+.|.....+.....-..+..+..| ...++
T Consensus 167 ~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 345677899999999985 344565 899999999999999888888766665555444445555444 23678
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+-+|++.+|.++|++|||++.+|.|||....
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 89999999999999999999999999998655
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=283.33 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=199.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHh--CCCCCccceEEEEEeCC---
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL--VKHPNIVELKEVMATKT--- 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~--- 89 (414)
.....+.+.||+|.||.||+|+ -+++.||||+++... .+.+.+|-+|.+. ++|+||++++++-+..+
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 4467788999999999999998 467999999996543 3567788888775 48999999999887666
Q ss_pred -EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCcEEecCCCCcEEEcCCCCeEEeec
Q 015005 90 -KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS---------RGVYHRDLKPENLLLDENGNLKVSDF 159 (414)
Q Consensus 90 -~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~---------~gi~HrDlkp~NILl~~~~~~kl~DF 159 (414)
.++||+||.+.|+|.+++....++.....+++..++.||+|||+ .+|+|||||..|||+.+++...|+||
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 89999999999999999999999999999999999999999996 36999999999999999999999999
Q ss_pred CCCcccccccCCCccccccCCCcccCchhhcccCCC-----CCccchhhhhhhhhhhhcCC------------CCCCC--
Q 015005 160 GLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD-----GAKSDIWSCGVVLFVLLSGF------------LPFQN-- 220 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-----~~~~DiwSlGvil~~ll~g~------------~Pf~~-- 220 (414)
|+|..+......+.....+||.+|||||++.+.-.- -.+.||||+|.|||||++.- +||..
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988776667777789999999999999764321 13689999999999998852 34431
Q ss_pred ---chHHHHHHHHH--hcccCCCCC-----CCHHHHHHHHhhcccCcCCCCChHH
Q 015005 221 ---ENIMKMYRKIF--KAEYEFPPW-----ISCDARRLISRILVADPQKRISVSE 265 (414)
Q Consensus 221 ---~~~~~~~~~i~--~~~~~~~~~-----~s~~~~~li~~~L~~dp~~R~s~~e 265 (414)
++.+++..... +.++.+|.. -...+.+.+..||+.||+-|.|+.=
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 23344444333 345556542 2345889999999999999999853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=263.38 Aligned_cols=254 Identities=28% Similarity=0.437 Sum_probs=205.7
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEE-EEeCCE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEV-MATKTK 90 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~~ 90 (414)
.+.+.|.|.+.||+|.||++.+|.|+.++..+++|.++++... .+++.+|..---.| .|.||+.-|++ |++.+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 4677899999999999999999999999999999999887654 46788887765555 58999988764 688889
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC--CCCeEEeecCCCcccccc
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--NGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 168 (414)
+.++|||+|.|+|..-+...++.|...+.++.|+++|+.|+|+++++|||||.+||||-. ...+||||||+++..+
T Consensus 97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 999999999999999999999999999999999999999999999999999999999942 3489999999987432
Q ss_pred cCCCccccccCCCcccCchhhcccC---C-CCCccchhhhhhhhhhhhcCCCCCCCchHH----HHHHHHHhcc-cCCCC
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKG---Y-DGAKSDIWSCGVVLFVLLSGFLPFQNENIM----KMYRKIFKAE-YEFPP 239 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~---~-~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~-~~~~~ 239 (414)
...+..--+..|.|||+..... + ..+.+|+|.||+++|.+|+|.+||...... ..+.++..+. +..|.
T Consensus 175 ---~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 175 ---TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred ---ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 2233334567899999875321 1 136789999999999999999999864332 3344444433 33443
Q ss_pred ---CCCHHHHHHHHhhcccCcCCC---CChHHHhcCCccccC
Q 015005 240 ---WISCDARRLISRILVADPQKR---ISVSEIMINPWFIKG 275 (414)
Q Consensus 240 ---~~s~~~~~li~~~L~~dp~~R---~s~~eil~hp~f~~~ 275 (414)
.+|+.+..+.++-|.++|++| .++..-....|.-..
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 379999999999999999999 566666777786544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.47 Aligned_cols=248 Identities=25% Similarity=0.449 Sum_probs=207.7
Q ss_pred CEEEeeeeeecCCeEEEEEEEC----C---CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNL----V---TQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATK 88 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~----~---~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 88 (414)
+..+.+.||+|+||+|++|.-. . ....||||.+...... ...+.+..|+++|+.+ +||||+.+++++...
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3456679999999999999632 1 1457999999765544 3467899999999999 699999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC
Q 015005 89 TKVFFVIEYVKGGELFAKVLKGK-----------------LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN 151 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~-----------------~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~ 151 (414)
+.+++|+||+..|+|.+++...+ ++..+...+..||+.|++||+++.++||||-..|||+..+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN 454 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence 99999999999999999998766 8999999999999999999999999999999999999999
Q ss_pred CCeEEeecCCCcccccccCCCccccccCCC--cccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCch-HHHHH
Q 015005 152 GNLKVSDFGLSALPEQLWNDGLLHTQCGTP--AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNEN-IMKMY 227 (414)
Q Consensus 152 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~--~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~-~~~~~ 227 (414)
..+||+|||+|+..... .........|+. .|||||.+....|+ .++||||+||+|||+++ |..||.+-. ..+.+
T Consensus 455 ~~~kIaDFGlar~~~~~-~~y~~~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNK-DYYRTKSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CEEEEccccceeccCCC-CceEecCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 99999999999843221 111112223333 49999999987775 89999999999999999 999999854 55666
Q ss_pred HHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 228 RKIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 228 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+.+..|. ...|..++.++.++++.||+.+|++||++.++..
T Consensus 533 ~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 6566554 4678889999999999999999999999998864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=291.96 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=212.7
Q ss_pred EEeeeeeecCCeEEEEEEECCCCe----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 19 EMGRMLGQGTFAKVYYGKNLVTQE----SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 19 ~~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+-.++||+|+||+||+|.....|+ +||||++....... ....+..|+-+|.+++|||++++++++.... +.||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~--~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK--ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch--hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 445799999999999998766565 68888886655432 2567889999999999999999999998766 8899
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
++|+++|.|.++++. +.+.......|..||++|+.|||+++++||||-..|+|+....++||.|||+++.........
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999999885 789999999999999999999999999999999999999999999999999999877654444
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLIS 250 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 250 (414)
......-.+.|||=|.+....|. .++||||+||.+||++| |..|+.+....+.-..+..+ +.+.|+..+.++..++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 44444456779999999888885 89999999999999998 99999998877776666544 46788899999999999
Q ss_pred hhcccCcCCCCChHHHh
Q 015005 251 RILVADPQKRISVSEIM 267 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil 267 (414)
+||..|+..||++.++-
T Consensus 935 kCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELA 951 (1177)
T ss_pred HHhccCcccCccHHHHH
Confidence 99999999999998874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=271.37 Aligned_cols=251 Identities=25% Similarity=0.441 Sum_probs=199.1
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHh--CCCCCccceEEEEE
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL--VKHPNIVELKEVMA 86 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~ 86 (414)
-++.++.....+.+.||+|.||.||+|. .-|+.||||++.... .+...+|.+|.+. |+|+||+.+++.-.
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecc--ccCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 3456778889999999999999999998 468899999996543 2457788888875 59999999988754
Q ss_pred eC----CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEEecCCCCcEEEcCCCCe
Q 015005 87 TK----TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSR--------GVYHRDLKPENLLLDENGNL 154 (414)
Q Consensus 87 ~~----~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~--------gi~HrDlkp~NILl~~~~~~ 154 (414)
.. ++++||.+|-+.|+|+|++....++.+...+++..+++||++||.. .|+|||||..|||+..+|..
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 32 4799999999999999999999999999999999999999999953 59999999999999999999
Q ss_pred EEeecCCCccccccc--CCCccccccCCCcccCchhhcccC----CC-CCccchhhhhhhhhhhhcC----------CCC
Q 015005 155 KVSDFGLSALPEQLW--NDGLLHTQCGTPAYVAPEVLRKKG----YD-GAKSDIWSCGVVLFVLLSG----------FLP 217 (414)
Q Consensus 155 kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~----~~-~~~~DiwSlGvil~~ll~g----------~~P 217 (414)
.|+|+|||-...... -+......+||.+|||||++...- +. -..+||||||.|+||++.. ++|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999997654432 123456778999999999986421 11 1368999999999998763 588
Q ss_pred CCC-----chHHHHHHHHH--hcccCCCC-CCCHH----HHHHHHhhcccCcCCCCChHHHh
Q 015005 218 FQN-----ENIMKMYRKIF--KAEYEFPP-WISCD----ARRLISRILVADPQKRISVSEIM 267 (414)
Q Consensus 218 f~~-----~~~~~~~~~i~--~~~~~~~~-~~s~~----~~~li~~~L~~dp~~R~s~~eil 267 (414)
|.+ ++.+++.+-+. +-.+.+|. |-+.+ +..|++.||..||.-|.|+--|.
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 865 34445544333 23344554 44433 45789999999999999987664
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=272.35 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=202.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECC---CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLV---TQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATK 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 88 (414)
.+...|.++..||+|.|++||+|.+.. .++.||+|.+..... ..++.+|+++|..+ .+.||+++.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 456789999999999999999998877 788999999965443 35688999999999 699999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC-CCCeEEeecCCCccccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-NGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 167 (414)
+...+||||.+..+..++... ++-.+++.|++.++.||.++|.+||+||||||.|+|.+. -+.-.|+|||+|...+.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999998877777654 568889999999999999999999999999999999984 46889999999872110
Q ss_pred c-------c------------------------CCC-----------ccccccCCCcccCchhhcccCCCCCccchhhhh
Q 015005 168 L-------W------------------------NDG-----------LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCG 205 (414)
Q Consensus 168 ~-------~------------------------~~~-----------~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlG 205 (414)
. . ..+ ......|||+|.|||++.+.+-.++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 0 000 011235999999999999887777899999999
Q ss_pred hhhhhhhcCCCCCCCchH-----HHH--------HHH----------------------------H-----Hhccc---C
Q 015005 206 VVLFVLLSGFLPFQNENI-----MKM--------YRK----------------------------I-----FKAEY---E 236 (414)
Q Consensus 206 vil~~ll~g~~Pf~~~~~-----~~~--------~~~----------------------------i-----~~~~~---~ 236 (414)
||+..++++..||-.... .++ .++ + .+... .
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999999854211 000 000 0 00000 0
Q ss_pred ---CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 237 ---FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 237 ---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
....++..+.+|+.+||+.||.+|.|+++.|+||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00124568899999999999999999999999999974
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=246.43 Aligned_cols=210 Identities=24% Similarity=0.446 Sum_probs=173.2
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv 94 (414)
+...-+..||+|++|.|-+.++..+|...|+|.+...... ...+++.+|+.+..+. .+|.+|.+|+.+..+..++|.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 3445567899999999999999999999999999765442 3467788899886655 799999999999999999999
Q ss_pred EEccCCCchHHHHh----c-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 95 IEYVKGGELFAKVL----K-GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 95 ~E~~~gg~L~~~i~----~-~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
||.+. .+|..+.. + +.++|...-+++..++.||.|||++ .++|||+||+|||++.+|++|+||||++....
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~-- 200 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV-- 200 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh--
Confidence 99996 46654433 3 5799999999999999999999987 89999999999999999999999999997543
Q ss_pred cCCCcccc-ccCCCcccCchhhc----ccCCCCCccchhhhhhhhhhhhcCCCCCCC-chHHHHHHHHHhc
Q 015005 169 WNDGLLHT-QCGTPAYVAPEVLR----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIFKA 233 (414)
Q Consensus 169 ~~~~~~~~-~~gt~~y~APE~~~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~ 233 (414)
+....+ ..|.-.|||||.+. .++|+ -++||||||+.++||.+++.||+. .++-++.+++...
T Consensus 201 --dSiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 201 --DSIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred --hhhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 222333 66889999999974 34675 899999999999999999999865 3444555555544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=246.74 Aligned_cols=212 Identities=44% Similarity=0.762 Sum_probs=187.0
Q ss_pred eeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCch
Q 015005 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL 103 (414)
Q Consensus 24 LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 103 (414)
||+|++|.||++.+..+++.+++|++....... ..+.+.+|++.++.++|++|+++++++......++++|+++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997665432 246788999999999999999999999999999999999999999
Q ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC-CCCeEEeecCCCcccccccCCCccccccCC
Q 015005 104 FAKVLKG--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-NGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180 (414)
Q Consensus 104 ~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 180 (414)
.+++... .++...+..++.+++.++++||++|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9998874 7999999999999999999999999999999999999999 89999999999985433211 23445688
Q ss_pred CcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCC
Q 015005 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260 (414)
Q Consensus 181 ~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 260 (414)
..|++||.+......+.++|+|++|+++++| ..+.+++.+|++.||.+|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987762335889999999999999 678899999999999999
Q ss_pred CChHHHhcCC
Q 015005 261 ISVSEIMINP 270 (414)
Q Consensus 261 ~s~~eil~hp 270 (414)
|++.++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=299.15 Aligned_cols=261 Identities=31% Similarity=0.528 Sum_probs=215.1
Q ss_pred ccCCE-EEeeeeeecCCeEEEEEEECCCCeEEEEEEeecc---ccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 14 LFGKY-EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKD---QVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 14 ~~~~y-~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
+..+| .....+|.|++|.|+.+......+.++.|.+... ..........+..|+.+-..++|||++.....+....
T Consensus 315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 34556 5678899999999999888777777777765421 1112222333778888889999999988877777666
Q ss_pred EEEEEEEccCCCchHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLKG-KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~-~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
..+-.||||++ +|+.++... .++..++..+++||+.||+|+|+.||.||||||+|+++..+|.+||+|||.+..+...
T Consensus 395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 66666999999 999999984 9999999999999999999999999999999999999999999999999999988777
Q ss_pred cCC--CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHH--HHH-------HhcccCC
Q 015005 169 WND--GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMY--RKI-------FKAEYEF 237 (414)
Q Consensus 169 ~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~--~~i-------~~~~~~~ 237 (414)
++. ......+|+.+|+|||++.+..|++...||||+|++++.|.+|+.||..+...+.. ... ..+....
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 766 66778899999999999999999999999999999999999999999876544221 111 1111122
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
-..++...+.+|.+||++||.+|.|+++|++++||+..
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 23477889999999999999999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=246.99 Aligned_cols=218 Identities=43% Similarity=0.696 Sum_probs=186.5
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
|.+.+.||.|++|+||++.+..+++.+|+|.+...... ...+.+.+|++.++.++|+|++++++.+...+..++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999888999999999876543 1357888999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc-CC-CCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 98 VKGGELFAKVLK-GK-LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 98 ~~gg~L~~~i~~-~~-~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
+++++|.+.+.. .. +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 999999999987 44 8999999999999999999999999999999999999999999999999988654321 11334
Q ss_pred cccCCCcccCchhh-cccCCCCCccchhhhhhhhhhhhcCCCCCCC--chHHHHHHHHHhcccCCCC
Q 015005 176 TQCGTPAYVAPEVL-RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN--ENIMKMYRKIFKAEYEFPP 239 (414)
Q Consensus 176 ~~~gt~~y~APE~~-~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~--~~~~~~~~~i~~~~~~~~~ 239 (414)
...++..|++||.+ ....+. .++|+||||+++++|++|+.||.. .+...+.+.+..+.+...+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 55688899999998 555554 689999999999999999999987 4444677777776655444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=292.73 Aligned_cols=199 Identities=16% Similarity=0.170 Sum_probs=146.5
Q ss_pred hCCC-CCccceEEEE-------EeCCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecC
Q 015005 72 LVKH-PNIVELKEVM-------ATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDL 141 (414)
Q Consensus 72 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDl 141 (414)
.++| +||.++++++ .....++.++|++ +++|++++.. +.+++.+++.++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5777777776 2334677888987 5699999975 46999999999999999999999999999999
Q ss_pred CCCcEEEcCCC-------------------CeEEeecCCCcccccccC--------------CCccccccCCCcccCchh
Q 015005 142 KPENLLLDENG-------------------NLKVSDFGLSALPEQLWN--------------DGLLHTQCGTPAYVAPEV 188 (414)
Q Consensus 142 kp~NILl~~~~-------------------~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APE~ 188 (414)
||+||||+..| .+|++|||+++....... .......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996544 455666666543211000 000112468999999999
Q ss_pred hcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHHhhcccCcCCCCChHHHh
Q 015005 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISRILVADPQKRISVSEIM 267 (414)
Q Consensus 189 ~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 267 (414)
+.+..|. .++|||||||+||||++|..|+..... ....+..... +.+....+...+++.+||++||.+||++.|++
T Consensus 187 ~~~~~~~-~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSSN-CASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCCC-chhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 9888885 899999999999999999988764321 2222211111 11111345678899999999999999999999
Q ss_pred cCCcccc
Q 015005 268 INPWFIK 274 (414)
Q Consensus 268 ~hp~f~~ 274 (414)
+||||..
T Consensus 264 ~h~~~~~ 270 (793)
T PLN00181 264 QSEFINE 270 (793)
T ss_pred hchhhhh
Confidence 9999965
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=229.62 Aligned_cols=255 Identities=36% Similarity=0.614 Sum_probs=211.9
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC-CccceEEEEEeCCEEEEEEE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP-NIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~E 96 (414)
|++.+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999977 88999999876655433567899999999999988 79999999988888999999
Q ss_pred ccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-CeEEeecCCCcccccccCC
Q 015005 97 YVKGGELFAKVLKG----KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-NLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 97 ~~~gg~L~~~i~~~----~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 171 (414)
++.++++.+.+... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999777764 699999999999999999999999999999999999999988 7999999999754332211
Q ss_pred ----CccccccCCCcccCchhhccc--CCCCCccchhhhhhhhhhhhcCCCCCCCchH----HHHHHHHHhcccC-CCCC
Q 015005 172 ----GLLHTQCGTPAYVAPEVLRKK--GYDGAKSDIWSCGVVLFVLLSGFLPFQNENI----MKMYRKIFKAEYE-FPPW 240 (414)
Q Consensus 172 ----~~~~~~~gt~~y~APE~~~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~-~~~~ 240 (414)
......+||+.|+|||.+.+. .+.....|+||+|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 134677899999999999874 3445889999999999999999999887763 4444444444433 2222
Q ss_pred CC--------HHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 241 IS--------CDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 241 ~s--------~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 21 478999999999999999999999988766543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=240.79 Aligned_cols=171 Identities=22% Similarity=0.210 Sum_probs=135.5
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECC-CCeEEEEEEeecccc--chhhHHHHHHHHHHHHHhCCCCCccc-eEEEEE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLV-TQESVAIKVINKDQV--KKQGLMEQIKREISVMRLVKHPNIVE-LKEVMA 86 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~ 86 (414)
-..+.++|++.+.||+|+||+||+|++.. +++.+|||.+..... ......+.+.+|+++|+.++|+|++. +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 45788999999999999999999998876 678889998753311 12223567899999999999999985 4432
Q ss_pred eCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecC-CCCcEEEcCCCCeEEeecCCCccc
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDL-KPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDl-kp~NILl~~~~~~kl~DFGla~~~ 165 (414)
+..|+||||++|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 468999999999999632 11 11 2468899999999999999999999 999999999999999999999865
Q ss_pred ccccCCCc------cccccCCCcccCchhhcc
Q 015005 166 EQLWNDGL------LHTQCGTPAYVAPEVLRK 191 (414)
Q Consensus 166 ~~~~~~~~------~~~~~gt~~y~APE~~~~ 191 (414)
........ ....++++.|+|||.+..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 44322222 246678999999999853
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=232.26 Aligned_cols=251 Identities=21% Similarity=0.283 Sum_probs=205.1
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCC-----eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE-eC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQ-----ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA-TK 88 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~ 88 (414)
..++++.-.+-+|.||.||.|..+... +.|-+|.+..... +-.+..+..|...+..+.|||+.++.+++. +.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS--~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS--QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc--HHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 456888889999999999999765432 3455565533221 223566788888899999999999999874 55
Q ss_pred CEEEEEEEccCCCchHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeec
Q 015005 89 TKVFFVIEYVKGGELFAKVLK---------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDF 159 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~---------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DF 159 (414)
...+.++.+..-|.|..++.. ..++..+...+..|++.|++|||+.||+|.||-..|.+||+.-.+||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 678888999989999988872 24788889999999999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCC
Q 015005 160 GLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEF 237 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~ 237 (414)
.+++-.-+...............|||||.+....|. .++|+|||||+||||+| |+.|+..-++.++..-+..|. ...
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 999854332222223333456679999999999886 88999999999999998 999999999998887777663 456
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
|-.+|+++-.++..||..+|++||+.+|+..
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 7789999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=223.00 Aligned_cols=158 Identities=23% Similarity=0.273 Sum_probs=129.1
Q ss_pred CchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcccccc
Q 015005 101 GELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQC 178 (414)
Q Consensus 101 g~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 178 (414)
|+|.+.+.. ..+++.+++.++.|++.||.|||++| ||+|||++.++.+|+ ||++..... ....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence 688898885 46999999999999999999999999 999999999999999 999875432 1236
Q ss_pred CCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHHHhcccCC-------CCCCCH--HHHHH
Q 015005 179 GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKIFKAEYEF-------PPWISC--DARRL 248 (414)
Q Consensus 179 gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~-------~~~~s~--~~~~l 248 (414)
||+.|+|||++.+..|+ .++||||+||++|+|++|..||...... .....+....... +..++. ++.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999988885 8999999999999999999999765432 3333333222111 122333 69999
Q ss_pred HHhhcccCcCCCCChHHHhcCCcccc
Q 015005 249 ISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
|.+||..||.+||++.|+++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=256.36 Aligned_cols=238 Identities=34% Similarity=0.605 Sum_probs=208.4
Q ss_pred eeeecCCeEEEEEEE---CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEEEcc
Q 015005 23 MLGQGTFAKVYYGKN---LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKVFFVIEYV 98 (414)
Q Consensus 23 ~LG~G~~g~Vy~a~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 98 (414)
++|+|+||.|++++. ...|..+|+|+..+......... .-..|..++..++ ||.+|+++..++.++..|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998753 34677899999987665433222 4556888888886 999999999999999999999999
Q ss_pred CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccc
Q 015005 99 KGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ 177 (414)
Q Consensus 99 ~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 177 (414)
.||+|+....+ ..+.+...+.+...++-+++++|+.||+|||+|++||+++.+|++++.|||+++..-. ....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~------~~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK------EKIA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh------hhhc
Confidence 99999998887 6789999999999999999999999999999999999999999999999999985432 1222
Q ss_pred cCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 015005 178 CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADP 257 (414)
Q Consensus 178 ~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 257 (414)
|||..|||||++. ++. ..+|.||+|+++|+|++|..||.. +....|.+..+.+|..++..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999998 444 689999999999999999999988 777888999999999999999999999999999
Q ss_pred CCCCC-----hHHHhcCCcccc
Q 015005 258 QKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 258 ~~R~s-----~~eil~hp~f~~ 274 (414)
.+|.. +.|+++|++|..
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHhccCcchhHHHhccchhee
Confidence 99985 479999999964
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=223.68 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=194.5
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCC-eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC----CCccceEEEE-EeCCE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQ-ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH----PNIVELKEVM-ATKTK 90 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 90 (414)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+......... ..+..|+.++..+.. +++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987775 6899999876533221 257789999988863 6899999999 58889
Q ss_pred EEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC-----CCeEEeecCCC
Q 015005 91 VFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN-----GNLKVSDFGLS 162 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~-----~~~kl~DFGla 162 (414)
-|+||+.+ |.+|.++... +.++...+..++.|++.+|.++|+.|++||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 7899887753 579999999999999999999999999999999999999854 36999999999
Q ss_pred cccccccCCC-------c-cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH---HHHHHHH
Q 015005 163 ALPEQLWNDG-------L-LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM---KMYRKIF 231 (414)
Q Consensus 163 ~~~~~~~~~~-------~-~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---~~~~~i~ 231 (414)
+........+ . .....||..|+++.+..+... +.+.|+||++.++.+++.|.+||...... ..+.+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8332111111 1 223459999999999998877 48999999999999999999999775432 2222222
Q ss_pred hcccC--CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 232 KAEYE--FPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 232 ~~~~~--~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
..... .....+.++..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 21111 233355677888888777899999988777544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-27 Score=204.41 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=198.4
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-CCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH-PNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~ 90 (414)
-+..++|++++.||+|+||.+|+|.+..+|+.||||+-....- ..++..|..+.+.|++ ..|..+..+...+.+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 3568899999999999999999999999999999999754432 2367789999999964 778888888888889
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC---CCeEEeecCCCccc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN---GNLKVSDFGLSALP 165 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~---~~~kl~DFGla~~~ 165 (414)
-.+||+++ |.+|.++..- ..++...+.-++-|++.-++|+|.++++||||||+|+|..-+ ..+.++|||+|+.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999998 7888888774 689999999999999999999999999999999999999643 46999999999865
Q ss_pred ccccCC-----CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch---HHHHHHHHHhcccCC
Q 015005 166 EQLWND-----GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN---IMKMYRKIFKAEYEF 237 (414)
Q Consensus 166 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~ 237 (414)
...... ..-....||..|.+--...+.... ...|+-|+|.+|.++.-|.+||.+-. ..+-+.+|.......
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-RRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQS-RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhh-hhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 432221 123345699999998877766553 78899999999999999999998843 345566776666555
Q ss_pred C-----CCCCHHHHHHHHhhcccCcCCCCCh
Q 015005 238 P-----PWISCDARRLISRILVADPQKRISV 263 (414)
Q Consensus 238 ~-----~~~s~~~~~li~~~L~~dp~~R~s~ 263 (414)
| ..+|.++...+.-|-..--++-|..
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 4 3478888888888877666666653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=205.67 Aligned_cols=244 Identities=21% Similarity=0.333 Sum_probs=195.4
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKV 91 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 91 (414)
+..-.|++++.||+|+||..++|.+..++++||||.-..... ..++..|.+..+.| ..++|...|.+...+.+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 334479999999999999999999999999999999755432 35788999999999 579999999999999899
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-----CeEEeecCCCcc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-----NLKVSDFGLSAL 164 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-----~~kl~DFGla~~ 164 (414)
.+|||++ |.+|.|+..- .+|+...+.-++.|++.-++|+|++.+++|||||+|+||...+ .+.++|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999998 7889888876 5799999999999999999999999999999999999997543 599999999986
Q ss_pred cccccC-----CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC---chHHHHHHHHHhcccC
Q 015005 165 PEQLWN-----DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN---ENIMKMYRKIFKAEYE 236 (414)
Q Consensus 165 ~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~ 236 (414)
+..+.. ........||..||+--...+.... ..-|+-|||-+++++|-|.+||.+ ++..+-|++|-...-.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 543321 1223455699999999998887765 789999999999999999999987 4556667776443322
Q ss_pred CC-----CCCCHHHHHHHHhhcccCcCCCCCh
Q 015005 237 FP-----PWISCDARRLISRILVADPQKRISV 263 (414)
Q Consensus 237 ~~-----~~~s~~~~~li~~~L~~dp~~R~s~ 263 (414)
-| ..+|.++..-++-.-..+-.+-|..
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 22 2356666655555444444555553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=242.50 Aligned_cols=221 Identities=29% Similarity=0.573 Sum_probs=176.6
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
..-..|..+++|..|+||-||+++|+.+.+.+|+| +++...- .|- ++.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li--------lRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI--------LRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh--------hhc--cccccCCccee-------------
Confidence 44567999999999999999999999999999994 4443321 111 33333455544
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc---
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL--- 168 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 168 (414)
|+-...+.. +.++... +.+++|+|+.||+|||+||+|++|+.-|++|++|||+++..--.
T Consensus 136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 343344444 5555554 78999999999999999999999999999999999998642110
Q ss_pred --c--------CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC
Q 015005 169 --W--------NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP 238 (414)
Q Consensus 169 --~--------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 238 (414)
. ..-.....||||.|+|||++..++|. ..+|+|++|+|+|+.+.|..||.+++.++++...+.....+|
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 0 00112345999999999999999994 889999999999999999999999999999999998887777
Q ss_pred CC---CCHHHHHHHHhhcccCcCCCC---ChHHHhcCCcccc
Q 015005 239 PW---ISCDARRLISRILVADPQKRI---SVSEIMINPWFIK 274 (414)
Q Consensus 239 ~~---~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~f~~ 274 (414)
.. .+++++++|.++|+.+|..|. .+-++.+|+||+.
T Consensus 279 E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 279 EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 43 788999999999999999997 5678999999965
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-26 Score=204.35 Aligned_cols=181 Identities=17% Similarity=0.228 Sum_probs=142.3
Q ss_pred hHhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHH------HHHHHHHHHhCCCCCccc
Q 015005 7 DERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQ------IKREISVMRLVKHPNIVE 80 (414)
Q Consensus 7 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~ 80 (414)
.+-..+.+.++|++.++||.|+||.||++.. ++..+|+|++.......+..... +.+|+..+.++.||+|..
T Consensus 22 ~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 22 KEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 3555678899999999999999999999754 46689999997665544444333 579999999999999999
Q ss_pred eEEEEEeC--------CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC
Q 015005 81 LKEVMATK--------TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 81 l~~~~~~~--------~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~ 152 (414)
+.+++... +..+++|||++|.+|.+.. .+++ ....+++.+|..||+.|++|||+||+||+++.+|
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~---~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP---EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhh---hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC
Confidence 99887643 3589999999999997763 2333 2456999999999999999999999999999988
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhh
Q 015005 153 NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLL 212 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll 212 (414)
++|+|||.+..... .... ...+....|. .++|+||||+.+..+.
T Consensus 173 -i~liDfg~~~~~~e---~~a~-----------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQ---RKAK-----------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccc---hhhH-----------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 99999998874321 1100 1134455676 7899999999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-27 Score=242.70 Aligned_cols=259 Identities=32% Similarity=0.534 Sum_probs=221.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECC-CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLV-TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKVF 92 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 92 (414)
...|.+.+.||+|+|+.|-++.+.. +...+|.|.+.... .......++..|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5679999999999999999987644 44567777776554 22334567778999999887 999999999999999999
Q ss_pred EEEEccCCCchHHHH-hc-C-CCCHHHHHHHHHHHHHHHHHHH-hCCcEEecCCCCcEEEcCCC-CeEEeecCCCccccc
Q 015005 93 FVIEYVKGGELFAKV-LK-G-KLKEESARKYFQQLISAVDFCH-SRGVYHRDLKPENLLLDENG-NLKVSDFGLSALPEQ 167 (414)
Q Consensus 93 lv~E~~~gg~L~~~i-~~-~-~~~e~~~~~~~~ql~~al~~lH-~~gi~HrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 167 (414)
++++|..|+++++.+ .. . ..+...+..++.|+..++.|+| ..|+.||||||+|.+++.++ +++++|||+|+....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 65 3 7889999999999999999999 99999999999999999999 999999999998766
Q ss_pred -ccCCCccccccC-CCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHH-HHHHhc--c--cCCCCC
Q 015005 168 -LWNDGLLHTQCG-TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMY-RKIFKA--E--YEFPPW 240 (414)
Q Consensus 168 -~~~~~~~~~~~g-t~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~-~~i~~~--~--~~~~~~ 240 (414)
.+........|| ++.|+|||...+..|.+...|+||+|+++..+++|..||......... ..+... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 556667788899 999999999999888889999999999999999999999887654322 222222 1 223344
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
++..+.+++.+++..+|..|.+.+++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 8889999999999999999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=197.59 Aligned_cols=141 Identities=21% Similarity=0.283 Sum_probs=112.7
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhh-----------------------HHHHHHHHHHHHHhCCCCC
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQG-----------------------LMEQIKREISVMRLVKHPN 77 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn 77 (414)
...||+|++|.||+|.+. +|+.||+|+++........ ......+|++++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999765321110 0123456999999998888
Q ss_pred ccceEEEEEeCCEEEEEEEccCCCchHHH-HhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEEecCCCCcEEEcCCCCeE
Q 015005 78 IVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFC-HSRGVYHRDLKPENLLLDENGNLK 155 (414)
Q Consensus 78 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~-i~~~~~~e~~~~~~~~ql~~al~~l-H~~gi~HrDlkp~NILl~~~~~~k 155 (414)
+.....+... ..++||||++|+++... +..+.+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7544433222 23899999999887655 3457899999999999999999999 799999999999999998 57899
Q ss_pred EeecCCCccc
Q 015005 156 VSDFGLSALP 165 (414)
Q Consensus 156 l~DFGla~~~ 165 (414)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=204.21 Aligned_cols=233 Identities=24% Similarity=0.325 Sum_probs=153.2
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC----------CCccceEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH----------PNIVELKEVMA 86 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~~~ 86 (414)
.+..++.||.|+++.||.+.+..||+.+|+|++...........+++++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35778999999999999999999999999999876664444456777777755554322 22333333332
Q ss_pred e---------C---C-----EEEEEEEccCCCchHHHHhc----CCC----CHHHHHHHHHHHHHHHHHHHhCCcEEecC
Q 015005 87 T---------K---T-----KVFFVIEYVKGGELFAKVLK----GKL----KEESARKYFQQLISAVDFCHSRGVYHRDL 141 (414)
Q Consensus 87 ~---------~---~-----~~~lv~E~~~gg~L~~~i~~----~~~----~e~~~~~~~~ql~~al~~lH~~gi~HrDl 141 (414)
. . + +.+++|+-+. ++|.+.+.. ... .......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 2367888774 677776542 222 12223445589999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhccc--------CCCCCccchhhhhhhhhhhhc
Q 015005 142 KPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK--------GYDGAKSDIWSCGVVLFVLLS 213 (414)
Q Consensus 142 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~~~~~~DiwSlGvil~~ll~ 213 (414)
+|+|++++.+|.++|+||+.....+. .......+..|.+||..... .+ +.+.|.|+||+++|.|.+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~-t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPY-TFATDAWQLGITLYSLWC 245 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE--HHHHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCccccee-eeccCHHHHHHHHHHHHH
Confidence 99999999999999999987764322 11113456789999987543 23 478899999999999999
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCC
Q 015005 214 GFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260 (414)
Q Consensus 214 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 260 (414)
|..||........... .+..-..+|..++.||+++|++||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999987643321111 222112688999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=190.98 Aligned_cols=143 Identities=17% Similarity=0.277 Sum_probs=115.8
Q ss_pred EeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh-----------------------hHHHHHHHHHHHHHhCCCC
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ-----------------------GLMEQIKREISVMRLVKHP 76 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----------------------~~~~~~~~Ei~il~~l~hp 76 (414)
+.+.||+|++|+||+|.+. +|+.||||+++....... .......+|.+.+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999986532100 0123346899999999999
Q ss_pred CccceEEEEEeCCEEEEEEEccCCCchHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCe
Q 015005 77 NIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNL 154 (414)
Q Consensus 77 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~-i~~~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~ 154 (414)
++.....+.... .|+||||++|+++... +...++++.++..++.|++.+|.++|+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 886554444333 4899999998865443 555788999999999999999999999 9999999999999998 8999
Q ss_pred EEeecCCCcccc
Q 015005 155 KVSDFGLSALPE 166 (414)
Q Consensus 155 kl~DFGla~~~~ 166 (414)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=230.11 Aligned_cols=244 Identities=27% Similarity=0.352 Sum_probs=182.8
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc-hhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.|...+.||++.|=+|.+|++. .|. |+||++-+.... .-....+..+|++ ...++|||.+++.-+.++....|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 7899999999999999999864 444 999998765422 1111233334555 56669999999988888888899999
Q ss_pred EccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC--
Q 015005 96 EYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG-- 172 (414)
Q Consensus 96 E~~~gg~L~~~i~~~~-~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 172 (414)
+|.. -+|+|++...+ +...+.+.|+.||+.||..||+.||+|||||.|||||+.-+.+.|+||..-+.. ...++.
T Consensus 101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt-YLPeDNPa 178 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPT-YLPEDNPA 178 (1431)
T ss_pred HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCc-cCCCCCcc
Confidence 9996 58999998755 688889999999999999999999999999999999999999999999876421 111111
Q ss_pred ----ccccccCCCcccCchhhcccC-C---------CCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcccCC
Q 015005 173 ----LLHTQCGTPAYVAPEVLRKKG-Y---------DGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEF 237 (414)
Q Consensus 173 ----~~~~~~gt~~y~APE~~~~~~-~---------~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (414)
...+...-.+|+|||.+.... + -.++.||||+||+++||++ |++||.-...-.. ..++-..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aY----r~~~~~~ 254 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAY----RSGNADD 254 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhH----hccCccC
Confidence 122333445799999975421 1 2467899999999999988 8999965322111 1111111
Q ss_pred C-----CCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 238 P-----PWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 238 ~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
| .--+..++.||..|++.||.+|.++++.|+.
T Consensus 255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1 1124479999999999999999999999875
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=184.59 Aligned_cols=191 Identities=19% Similarity=0.247 Sum_probs=143.0
Q ss_pred EEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhH-HHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEEE
Q 015005 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGL-MEQIKREISVMRLVK-HPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 19 ~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.+...|++|+||+||++.. .+..++.+.+.......... ...+.+|+++|++|. |+++++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678899999999998864 67778877775544322111 225789999999995 5889999886 45799999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecC-CCCcEEEcCCCCeEEeecCCCcccccccCC----
Q 015005 97 YVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDL-KPENLLLDENGNLKVSDFGLSALPEQLWND---- 171 (414)
Q Consensus 97 ~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~~~---- 171 (414)
|+.|.+|......+ ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|........-
T Consensus 79 yI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 79 YLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 99999997544221 2357899999999999999999999 799999999999999999999854321100
Q ss_pred C-------ccccccCCCcccCchhhccc-CCCCCccchhhhhhhhhhhhcCCCCCCCc
Q 015005 172 G-------LLHTQCGTPAYVAPEVLRKK-GYDGAKSDIWSCGVVLFVLLSGFLPFQNE 221 (414)
Q Consensus 172 ~-------~~~~~~gt~~y~APE~~~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 221 (414)
. .......++.|++|+...-. ...-...++++.|+-+|.++|+..|+.++
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 01123378899999875332 11124678899999999999999887554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-24 Score=197.91 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=178.7
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCe-----------------------------------EEEEEEeeccccc-
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQE-----------------------------------SVAIKVINKDQVK- 55 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~-----------------------------------~vaiK~~~~~~~~- 55 (414)
...+++|++++.||+|..+.||.|+-...|. +.|||.+-.-...
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 4567889999999999999999986543210 2455654322111
Q ss_pred -hhhHHHHHHHHHH------HH--------H-------hC-CCCCccceEEEEEe-------------------------
Q 015005 56 -KQGLMEQIKREIS------VM--------R-------LV-KHPNIVELKEVMAT------------------------- 87 (414)
Q Consensus 56 -~~~~~~~~~~Ei~------il--------~-------~l-~hpnIv~l~~~~~~------------------------- 87 (414)
+....+.+-+|.- .+ + +| +|||||++..+|.+
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 1222333444421 11 1 12 59999999877632
Q ss_pred --CCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc--CCC--CeEEeecCC
Q 015005 88 --KTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD--ENG--NLKVSDFGL 161 (414)
Q Consensus 88 --~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~--~~~--~~kl~DFGl 161 (414)
+..+|+||...+ -+|..++-....+....+-++.|+++|+.|||++||.|||+|.+|||+. +++ .+.|+|||.
T Consensus 313 g~~~tlylvMkrY~-~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 313 GEPKTLYLVMKRYR-QTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CCCceEEEehhcch-hhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 235899998775 5888888888889999999999999999999999999999999999994 333 689999998
Q ss_pred Cccccccc----CCCccccccCCCcccCchhhcccC-----CCCCccchhhhhhhhhhhhcCCCCCCCchHHHHH-HHHH
Q 015005 162 SALPEQLW----NDGLLHTQCGTPAYVAPEVLRKKG-----YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMY-RKIF 231 (414)
Q Consensus 162 a~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~-----~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~-~~i~ 231 (414)
+--.+..+ .....-...|...-||||+....+ .+-.++|.|++|.+.||+++...||.......+- +...
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq 471 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ 471 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence 75322210 001112344788899999975432 1125899999999999999999999885433221 1122
Q ss_pred h-cccCCCCCCCHHHHHHHHhhcccCcCCCCChH
Q 015005 232 K-AEYEFPPWISCDARRLISRILVADPQKRISVS 264 (414)
Q Consensus 232 ~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ 264 (414)
. .-+..|+.+++.+++|+..+|+.||++|+++.
T Consensus 472 e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 472 ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 2 23456788999999999999999999999853
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-23 Score=183.73 Aligned_cols=136 Identities=18% Similarity=0.205 Sum_probs=110.7
Q ss_pred EeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-----CCCCccceEEEEEeCC---EE
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-----KHPNIVELKEVMATKT---KV 91 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~ 91 (414)
-.+.||+|+||.||. ++.++.. +||++...... ..+.+.+|+.+++.+ .||||++++++++++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999995 7777665 79998764322 246789999999999 5799999999999874 44
Q ss_pred E-EEEEc--cCCCchHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCcEEecCCCCcEEEcCC----CCeEEeecCCCc
Q 015005 92 F-FVIEY--VKGGELFAKVLKGKLKEESARKYFQQLISAV-DFCHSRGVYHRDLKPENLLLDEN----GNLKVSDFGLSA 163 (414)
Q Consensus 92 ~-lv~E~--~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al-~~lH~~gi~HrDlkp~NILl~~~----~~~kl~DFGla~ 163 (414)
+ +|||| +++|+|.+++.++.+++. ..++.|++.++ +|||++||+||||||+|||++.+ +.++|+||+.+.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 4 78999 568999999988777776 35678888777 99999999999999999999743 379999955443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=180.96 Aligned_cols=144 Identities=17% Similarity=0.228 Sum_probs=115.7
Q ss_pred CEEEeeeeeecCCeEEEEEE-ECCCCeEEEEEEeeccccch---------------------hhHHHHHHHHHHHHHhCC
Q 015005 17 KYEMGRMLGQGTFAKVYYGK-NLVTQESVAIKVINKDQVKK---------------------QGLMEQIKREISVMRLVK 74 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~-~~~~~~~vaiK~~~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 74 (414)
-|.+.+.||+|++|.||+|. +..+|+.||+|++....... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38999999999999999998 77899999999997543210 001234678999999997
Q ss_pred CCC--ccceEEEEEeCCEEEEEEEccCCCchHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC-cEEecCCCCcEEEcC
Q 015005 75 HPN--IVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRG-VYHRDLKPENLLLDE 150 (414)
Q Consensus 75 hpn--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~-~~~~~e~~~~~~~~ql~~al~~lH~~g-i~HrDlkp~NILl~~ 150 (414)
+.+ +.++++. ...|+||||++|++|..... ...+.+.++..++.|++.+|.+||++| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 3444432 23589999999988876653 356777778899999999999999999 99999999999999
Q ss_pred CCCeEEeecCCCccc
Q 015005 151 NGNLKVSDFGLSALP 165 (414)
Q Consensus 151 ~~~~kl~DFGla~~~ 165 (414)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 889999999998743
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=205.77 Aligned_cols=195 Identities=22% Similarity=0.307 Sum_probs=162.5
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC---CCCccceEEEEEeCC
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK---HPNIVELKEVMATKT 89 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~ 89 (414)
+-..+|.|.+.||+|+||+||.|.+.. |+.||+|+-......+--.. .+++.+|+ -+.|..+...+.-.+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHHHccCC
Confidence 345689999999999999999999876 99999999766554432222 23344444 355667777777777
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc-------CCCCeEEeecCC
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD-------ENGNLKVSDFGL 161 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~-------~~~~~kl~DFGl 161 (414)
..++|+||.+.|+|.+++.. +.+++..+..+..|++..|++||..||||+||||+|+||. .+..++|+|||-
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 88999999999999999997 7799999999999999999999999999999999999994 234699999999
Q ss_pred CcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCC
Q 015005 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGF 215 (414)
Q Consensus 162 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~ 215 (414)
|--+............++|-.+-.+|+..|.++. ..+|.|.++.+++.||.|+
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHH
Confidence 9765544344467788899999999999999986 8999999999999999995
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-22 Score=177.26 Aligned_cols=240 Identities=21% Similarity=0.374 Sum_probs=191.8
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
+...+...|.+.-.|..|+|+. .|..++.|++........ ...++..|.-.++.+.||||..+++.|..+.++.++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 3445667788999999999985 556688888876655432 3467888999999999999999999999999999999
Q ss_pred EccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cEEecCCCCcEEEcCCCCeEEe--ecCCCcccccc
Q 015005 96 EYVKGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRG--VYHRDLKPENLLLDENGNLKVS--DFGLSALPEQL 168 (414)
Q Consensus 96 E~~~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~g--i~HrDlkp~NILl~~~~~~kl~--DFGla~~~~~~ 168 (414)
.|++-|+|+..+..+ -....++.+++..++.|++|||+.. |----|....+++|++-+.+|+ |--++- +
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--q-- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q-- 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--e--
Confidence 999999999999874 3788899999999999999999874 4444688899999998776653 322221 1
Q ss_pred cCCCccccccCCCcccCchhhcccCCC--CCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHH--hcccCCCCCCCHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYD--GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF--KAEYEFPPWISCD 244 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~--~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~s~~ 244 (414)
.....-+|.||+||.+..++-+ -.++|+|||++++|+|.|...||..-++.+.--++. .-...+|+.++..
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~h 417 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRH 417 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHH
Confidence 1122347899999999876543 357999999999999999999998877665433332 3356789999999
Q ss_pred HHHHHHhhcccCcCCCCChHHHh
Q 015005 245 ARRLISRILVADPQKRISVSEIM 267 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil 267 (414)
...|++-|+..||.+||.+..|+
T Consensus 418 m~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999987664
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-20 Score=168.19 Aligned_cols=137 Identities=21% Similarity=0.347 Sum_probs=116.0
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh-----hHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ-----GLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
+.||+|++|.||+|.+ .|..+++|+......... .....+.+|+.++..+.|+++.....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999986 777899998654332211 113467889999999999999888778777888999999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 97 YVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 97 ~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988865332 7889999999999999999999999999999999 88999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.6e-20 Score=163.44 Aligned_cols=133 Identities=20% Similarity=0.312 Sum_probs=109.2
Q ss_pred eeeecCCeEEEEEEECCCCeEEEEEEeeccccch-----hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK-----QGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 23 ~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
.||+|++|.||+|. .++..+++|......... .....++.+|+++++.+.|+++.....++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999998 467889999965432211 11235678999999999988766655556667778999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 98 VKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 98 ~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
++|++|.+.+..... .++.|++.+|.+||+.|++|||++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887755321 7899999999999999999999999999999 89999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-21 Score=187.19 Aligned_cols=250 Identities=21% Similarity=0.296 Sum_probs=172.8
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCC---CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEE------
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVT---QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKE------ 83 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~------ 83 (414)
...+.+.+.+..+..+++.+...+-..+ .+.++-+..+..... ......+++-.+....|-+..-+.+
T Consensus 241 ~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~---~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~ 317 (516)
T KOG1033|consen 241 EESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLC---ACKYTFRQLGVLVDSSHSNRSILEDLRPSLF 317 (516)
T ss_pred cccccccccccccccccCCchhhhhcccchhhhhccchhhhccchh---hhhhhhhhhhheeccccCCcccccCCCCchh
Confidence 3445566777777777777776653333 233444444333311 2344455665555554433332222
Q ss_pred -EEE-----eCCEEEEEEEccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC
Q 015005 84 -VMA-----TKTKVFFVIEYVKGGELFAKVLKG----KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN 153 (414)
Q Consensus 84 -~~~-----~~~~~~lv~E~~~gg~L~~~i~~~----~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~ 153 (414)
.+. ...++||.|++|.-.+|.+++... ..+......++.|+..|++| +|.+|||+||.||+...+..
T Consensus 318 ~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 318 ESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred hhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh
Confidence 111 123689999999999999999742 46777889999999999999 99999999999999999999
Q ss_pred eEEeecCCCccccccc----CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHH
Q 015005 154 LKVSDFGLSALPEQLW----NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYR 228 (414)
Q Consensus 154 ~kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~ 228 (414)
+||.|||+.+...... .........||..||+||.+.+..|. .++||||||++|++++. =..+|.. ...+.
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~ 470 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLT 470 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhh
Confidence 9999999987554322 11234566799999999999999996 99999999999999997 2333322 22333
Q ss_pred HHHhcccCCCCC-CCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 229 KIFKAEYEFPPW-ISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 229 ~i~~~~~~~~~~-~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.+..+.++.-.+ --++-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 471 d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 471 DIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 344444331111 12345689999999999999988877777664
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-20 Score=163.72 Aligned_cols=138 Identities=17% Similarity=0.297 Sum_probs=109.7
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh-------------------hHHHHHHHHHHHHHhCCCCC-
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ-------------------GLMEQIKREISVMRLVKHPN- 77 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hpn- 77 (414)
|.+.+.||+|+||.||+|... +|+.||||+++....... .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 889999999999999999864 899999999865431000 01123678899999998774
Q ss_pred -ccceEEEEEeCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEE
Q 015005 78 -IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV 156 (414)
Q Consensus 78 -Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl 156 (414)
++..++ ....+++|||++|++|...... .....++.+++.++.++|+.|++||||||+||+++.++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2456899999999998665331 346678899999999999999999999999999999999999
Q ss_pred eecCCCccc
Q 015005 157 SDFGLSALP 165 (414)
Q Consensus 157 ~DFGla~~~ 165 (414)
+|||++...
T Consensus 167 iDfg~~~~~ 175 (198)
T cd05144 167 IDWPQMVST 175 (198)
T ss_pred EECCccccC
Confidence 999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=178.59 Aligned_cols=198 Identities=25% Similarity=0.370 Sum_probs=156.4
Q ss_pred HHhCCCCCccceEEEEEeCCEEEEEEEccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc-EEecCCCCcE
Q 015005 70 MRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKG--KLKEESARKYFQQLISAVDFCHSRGV-YHRDLKPENL 146 (414)
Q Consensus 70 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi-~HrDlkp~NI 146 (414)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+... .++..-...+++.++.||.|+|+..| +|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45789999999999999999999999999999999999874 56777778889999999999998866 9999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCC------CCCccchhhhhhhhhhhhcCCCCCCC
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY------DGAKSDIWSCGVVLFVLLSGFLPFQN 220 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~------~~~~~DiwSlGvil~~ll~g~~Pf~~ 220 (414)
++|..-.+||+|||+.................-..-|.|||.+..... .+.+.||||+|++++++++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999886542111111122223456999999976422 24579999999999999999999977
Q ss_pred ch----HHHHHHHHHh-cccCCCC------CCCHHHHHHHHhhcccCcCCCCChHHHh
Q 015005 221 EN----IMKMYRKIFK-AEYEFPP------WISCDARRLISRILVADPQKRISVSEIM 267 (414)
Q Consensus 221 ~~----~~~~~~~i~~-~~~~~~~------~~s~~~~~li~~~L~~dp~~R~s~~eil 267 (414)
.. ..+....+.+ +...+-| .+.+++..++++||..+|..||+++++.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 32 2345555555 3322222 2445789999999999999999999885
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.8e-19 Score=181.68 Aligned_cols=139 Identities=19% Similarity=0.274 Sum_probs=112.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc-----hhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-----KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
..|...+.||+|+||+||++... +..+++|........ .....+.+.+|+++++.++|++++....++.+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34566889999999999999864 334555543222111 11123568899999999999999988888877778
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
.++||||++|++|.+.+. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999988775 457789999999999999999999999999999 678999999999974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.2e-19 Score=156.99 Aligned_cols=138 Identities=20% Similarity=0.320 Sum_probs=101.2
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHH---------------------HHHHHHHHHHhCCCCC--
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLME---------------------QIKREISVMRLVKHPN-- 77 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hpn-- 77 (414)
.+.||+|+||+||+|.+. +++.||||++............ ....|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999976 8999999998764322111111 1145666676664433
Q ss_pred ccceEEEEEeCCEEEEEEEccCCCchHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeE
Q 015005 78 IVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLK 155 (414)
Q Consensus 78 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~-i~~~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~k 155 (414)
+.+.++. ...+++|||++|+.+... +..... ..++..++.+++.++.++|+ .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4455543 245899999999544221 111111 16788999999999999999 9999999999999999 89999
Q ss_pred EeecCCCccc
Q 015005 156 VSDFGLSALP 165 (414)
Q Consensus 156 l~DFGla~~~ 165 (414)
|+|||.+...
T Consensus 155 liDfg~a~~~ 164 (187)
T cd05119 155 IIDVPQAVEI 164 (187)
T ss_pred EEECcccccc
Confidence 9999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.8e-18 Score=157.25 Aligned_cols=138 Identities=20% Similarity=0.314 Sum_probs=107.7
Q ss_pred eeeee-ecCCeEEEEEEECCCCeEEEEEEeecccc-----c-----hhhHHHHHHHHHHHHHhCCCCCc--cceEEEEEe
Q 015005 21 GRMLG-QGTFAKVYYGKNLVTQESVAIKVINKDQV-----K-----KQGLMEQIKREISVMRLVKHPNI--VELKEVMAT 87 (414)
Q Consensus 21 ~~~LG-~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-----~-----~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~ 87 (414)
...|| .|+.|+||.+.. .+..+++|.+..... . .......+.+|+.++..+.|++| +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 34677 788888888874 477899998865321 1 01123567899999999998885 667766433
Q ss_pred C-CE---EEEEEEccCC-CchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 88 K-TK---VFFVIEYVKG-GELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 88 ~-~~---~~lv~E~~~g-g~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
. .. .++|||+++| .+|.+.+..+.+++.. +.|++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 22 3599999997 6898888777777654 578999999999999999999999999999999999999998
Q ss_pred cc
Q 015005 163 AL 164 (414)
Q Consensus 163 ~~ 164 (414)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 74
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=142.26 Aligned_cols=132 Identities=20% Similarity=0.308 Sum_probs=113.2
Q ss_pred EeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--CCccceEEEEEeCCEEEEEEEc
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH--PNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~ 97 (414)
+.+.||+|.++.||++... +..+++|....... ...+.+|+.+++.++| +++++++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999864 37899999865432 3467899999999976 5899999998888899999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 98 VKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSR---GVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 98 ~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~---gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
++|+.+... +......++.+++.++.++|.. |++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877544 5566778899999999999984 799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.3e-19 Score=181.95 Aligned_cols=263 Identities=26% Similarity=0.418 Sum_probs=211.6
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.-.+.+.+.+.+-+|+++.++.+.-..+|...++|+..+.........+.+..+-.++-...+|-++.....+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567788889999999999999888888777877765433222222333444444444445677776655566678899
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc---
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL--- 168 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~--- 168 (414)
++++|+.|++|...+.. +..+++-++.++..+..+++|||+..+.|||++|.|+|...+|+.+++|||........
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999999998 77899999999999999999999999999999999999999999999999843211000
Q ss_pred --------------------------cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch
Q 015005 169 --------------------------WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN 222 (414)
Q Consensus 169 --------------------------~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~ 222 (414)
.+........||+.|.|||.+.+... +..+|+|+.|+++++.++|..||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 00012334569999999999988876 478999999999999999999999999
Q ss_pred HHHHHHHHHhcccCCCC---CCCHHHHHHHHhhcccCcCCCCChH---HHhcCCccccCC
Q 015005 223 IMKMYRKIFKAEYEFPP---WISCDARRLISRILVADPQKRISVS---EIMINPWFIKGF 276 (414)
Q Consensus 223 ~~~~~~~i~~~~~~~~~---~~s~~~~~li~~~L~~dp~~R~s~~---eil~hp~f~~~~ 276 (414)
....++++.++..+.|. ..+.++++++.+.|..+|.+|..+. ++..||+|+...
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 99999999998887764 4789999999999999999999887 999999997643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.6e-16 Score=154.34 Aligned_cols=156 Identities=19% Similarity=0.289 Sum_probs=102.6
Q ss_pred hHhhhccccCCEEE--eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch---------------------------h
Q 015005 7 DERVRNILFGKYEM--GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK---------------------------Q 57 (414)
Q Consensus 7 ~~~~~~~~~~~y~~--~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~---------------------------~ 57 (414)
++.+|..+..-|.- .+.||.|++|+||+|+. .+|+.||||+.+...... .
T Consensus 106 ~~elg~~~~~~F~~fd~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~ 184 (437)
T TIGR01982 106 EAALGGPLEELFAEFEEKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPT 184 (437)
T ss_pred HHHhCcCHHHHHhhCCCcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHH
Confidence 44444433333332 35799999999999986 489999999985432110 0
Q ss_pred hH----HH------HHHHHHHHHHhC----C-CCCccceEEEEEeCCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHH
Q 015005 58 GL----ME------QIKREISVMRLV----K-HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKY 120 (414)
Q Consensus 58 ~~----~~------~~~~Ei~il~~l----~-hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~ 120 (414)
.. .. ++.+|+..+.++ + +|++.-..-+....+..++||||++|++|.+.... .... ...+
T Consensus 185 ~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~i 261 (437)
T TIGR01982 185 EVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKAL 261 (437)
T ss_pred HHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHH
Confidence 00 00 234555555554 2 34332111122234457899999999999877643 2222 2345
Q ss_pred HHHHHH-HHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 121 FQQLIS-AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 121 ~~ql~~-al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
..+++. .+..+|..|++|+|+||.||+++.+|.++++|||++....
T Consensus 262 a~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 262 AENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 555555 4788999999999999999999999999999999997544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-16 Score=157.60 Aligned_cols=255 Identities=20% Similarity=0.198 Sum_probs=192.4
Q ss_pred ccCCEEEeeeeee--cCCeEEEEEEE--CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 015005 14 LFGKYEMGRMLGQ--GTFAKVYYGKN--LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATK 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~--G~~g~Vy~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 88 (414)
+...+-+.+.+|. |.+|.||.+.. ..++..+|+|.-...... ......=.+|+...+.+ .|+|.++.+..++..
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~-p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP-PLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC-ccccccccchhhcccccCccccccccCcccccC
Confidence 3445677888999 99999999988 889999999984332211 11112234677777777 599999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc-C-CCCHHHHHHHHHHHHH----HHHHHHhCCcEEecCCCCcEEEcCC-CCeEEeecCC
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-G-KLKEESARKYFQQLIS----AVDFCHSRGVYHRDLKPENLLLDEN-GNLKVSDFGL 161 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~-~~~e~~~~~~~~ql~~----al~~lH~~gi~HrDlkp~NILl~~~-~~~kl~DFGl 161 (414)
+..|+-+|+|. .+|..+... . -+++..++..+.+... ||.++|+.+++|-|+||+||+...+ ...+++|||+
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 99999999995 788787776 4 4899999999999999 9999999999999999999999999 8999999999
Q ss_pred CcccccccCCC---ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc--hHHHHHHHHHhcccC
Q 015005 162 SALPEQLWNDG---LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE--NIMKMYRKIFKAEYE 236 (414)
Q Consensus 162 a~~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~ 236 (414)
...+....-.. .....-|...|++||...+.. +...||+|+|.++.+..+|..+.... +.-...+... -...
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e 346 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLE 346 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchh
Confidence 88655432111 112335788899999987653 47899999999999888876554332 1111111111 0111
Q ss_pred CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 237 FPPWISCDARRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
+-...+.++...+..|++.+|..|++.+.+++|++..
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 1223456677799999999999999999999999875
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.5e-16 Score=158.27 Aligned_cols=145 Identities=19% Similarity=0.362 Sum_probs=100.6
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch---------------------------h----hHHHH
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK---------------------------Q----GLMEQ 62 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~---------------------------~----~~~~~ 62 (414)
++..|+. +.||+|++|+||+|+...+|+.||||+.+...... . +..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456777 89999999999999998889999999997542100 0 11222
Q ss_pred H------HHHHHHHHhC----CCCCccceEEEEEe-CCEEEEEEEccCCCchHHH--Hhc-C----CCCHHHHHHHHHHH
Q 015005 63 I------KREISVMRLV----KHPNIVELKEVMAT-KTKVFFVIEYVKGGELFAK--VLK-G----KLKEESARKYFQQL 124 (414)
Q Consensus 63 ~------~~Ei~il~~l----~hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--i~~-~----~~~e~~~~~~~~ql 124 (414)
+ .+|+..+.++ .+.+.+.+-.++.+ .+..++||||++|+.+.+. +.. + .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 3 3344444333 23333333333322 4567899999999999764 333 3 25555566666666
Q ss_pred HHHHHHHHhCCcEEecCCCCcEEEcCCC----CeEEeecCCCcccc
Q 015005 125 ISAVDFCHSRGVYHRDLKPENLLLDENG----NLKVSDFGLSALPE 166 (414)
Q Consensus 125 ~~al~~lH~~gi~HrDlkp~NILl~~~~----~~kl~DFGla~~~~ 166 (414)
+ ..|++|+|+||.||+++.+| .++++|||++....
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 5 59999999999999999888 99999999987554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.6e-14 Score=141.21 Aligned_cols=218 Identities=18% Similarity=0.272 Sum_probs=152.4
Q ss_pred EEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccCCCchHHHHhcCCCC
Q 015005 34 YGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLK 113 (414)
Q Consensus 34 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~ 113 (414)
.|..+.++.+|.|.+...... .....+.+-++-|+.++||||+++++.++..+.+|+|+|-+. .|...+.+ ++
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--hH
Confidence 455667888999999876654 235667888999999999999999999999999999999885 34444444 23
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhccc
Q 015005 114 EESARKYFQQLISAVDFCH-SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192 (414)
Q Consensus 114 e~~~~~~~~ql~~al~~lH-~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 192 (414)
...+..-+.||+.||.+|| +.+++|++|.-..|+++..|..||++|.++........ ......---.|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 7778888999999999998 66899999999999999999999999998864433211 11112222346677765443
Q ss_pred CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCCCChHH-----Hh
Q 015005 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSE-----IM 267 (414)
Q Consensus 193 ~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e-----il 267 (414)
. -..|.|.|||++++++.|..+-.. +...+..++.....+..+-+--.+..||.... .+
T Consensus 181 ~---~s~D~~~Lg~li~el~ng~~~~~~-------------~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~ 244 (690)
T KOG1243|consen 181 E---WSIDSWGLGCLIEELFNGSLLTKT-------------DLSNTGKIPKALIELYCKKLGATELKRPNKLRFILECRL 244 (690)
T ss_pred c---cchhhhhHHHHHHHHhCcccCcch-------------hhhccCccchhHHHHHHHHhccccccccchhhHHHHHHh
Confidence 3 347999999999999999433111 11222334434444444444455555654322 23
Q ss_pred cCCccccCC
Q 015005 268 INPWFIKGF 276 (414)
Q Consensus 268 ~hp~f~~~~ 276 (414)
-|.||++.+
T Consensus 245 ~~gff~n~f 253 (690)
T KOG1243|consen 245 LGGFFRNDF 253 (690)
T ss_pred ccccccchH
Confidence 477776654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.9e-15 Score=144.59 Aligned_cols=252 Identities=17% Similarity=0.196 Sum_probs=191.8
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEEC-CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNL-VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT 89 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 89 (414)
....+++..+..||.|.|+.|+..... .++..|++|.+.+........+. -..|+.+...+ .|.+++..+..|....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccccc
Confidence 456778999999999999999988655 67889999998766554332222 23566666666 6999999999888888
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC-CCeEEeecCCCccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN-GNLKVSDFGLSALPEQ 167 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 167 (414)
..|+-.|||.|+++...+.- ..+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||..+.+..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 88899999999988766643 678999999999999999999999999999999999999876 7899999999863211
Q ss_pred ccCCCccccccCCCccc-CchhhcccCCCCCccchhhhhhhhhhhhcCC-CCCCCchHHHHHHHHHhcccCCCCCCCHHH
Q 015005 168 LWNDGLLHTQCGTPAYV-APEVLRKKGYDGAKSDIWSCGVVLFVLLSGF-LPFQNENIMKMYRKIFKAEYEFPPWISCDA 245 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~-APE~~~~~~~~~~~~DiwSlGvil~~ll~g~-~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 245 (414)
. .....+.-.+. .+|++........++|++|||.-+.+..+|. +++.+. ....+..+..+..+..+.++
T Consensus 420 --~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~~ 490 (524)
T KOG0601|consen 420 --S---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQL 490 (524)
T ss_pred --e---cccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHhh
Confidence 0 01111233344 2555444433458999999999999999985 333332 23344556566666666889
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 246 RRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
..+.+.+..+++..|+.+.++..|+-|.
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhh
Confidence 9999999999999999999998887654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.2e-13 Score=120.63 Aligned_cols=141 Identities=19% Similarity=0.253 Sum_probs=104.6
Q ss_pred eeeeeecCCeEEEEEEECC------CCeEEEEEEeeccccc-------------------hhhHHH----HHHHHHHHHH
Q 015005 21 GRMLGQGTFAKVYYGKNLV------TQESVAIKVINKDQVK-------------------KQGLME----QIKREISVMR 71 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~------~~~~vaiK~~~~~~~~-------------------~~~~~~----~~~~Ei~il~ 71 (414)
...||.|-=+.||.|.... .+..+|+|+....... .....+ ...+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998543 3578999997432110 011122 2348999999
Q ss_pred hCCC--CCccceEEEEEeCCEEEEEEEccCCCchHH-HHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEEecCCCCcEE
Q 015005 72 LVKH--PNIVELKEVMATKTKVFFVIEYVKGGELFA-KVLKGKLKEESARKYFQQLISAVDFC-HSRGVYHRDLKPENLL 147 (414)
Q Consensus 72 ~l~h--pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~-~i~~~~~~e~~~~~~~~ql~~al~~l-H~~gi~HrDlkp~NIL 147 (414)
++.. -++.+++++ ...++||||+.++.+.. .+....+++.++..++.|++.+|..+ |+.|++|+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9853 456677664 46789999998765532 23334566777888899999999999 8999999999999999
Q ss_pred EcCCCCeEEeecCCCcccc
Q 015005 148 LDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 148 l~~~~~~kl~DFGla~~~~ 166 (414)
++ ++.+.|+|||.+...+
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 96 5789999999987443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.8e-14 Score=122.30 Aligned_cols=127 Identities=20% Similarity=0.293 Sum_probs=97.3
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCcc-ceEEEEEeCCEEEEEEEccC
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIV-ELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lv~E~~~ 99 (414)
++.|+.|.++.||++.. .+..|++|+....... ...+.+|+.+++.+.+.+++ +++... .+..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence 46789999999999985 4788999998654311 12456899999998655544 455443 334579999999
Q ss_pred CCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 100 GGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGV-----YHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 100 gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi-----~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
|.++... .......+.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887543 11123467899999999999985 9999999999998 6789999999986
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.4e-15 Score=137.25 Aligned_cols=202 Identities=19% Similarity=0.324 Sum_probs=142.7
Q ss_pred HHHhCCCCCccceEEEEEeC-----CEEEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--c
Q 015005 69 VMRLVKHPNIVELKEVMATK-----TKVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRG--V 136 (414)
Q Consensus 69 il~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~g--i 136 (414)
.+-++-|.|||+++.+|.+. ....++.||+..|+|..++++ ..+......+|+.||++||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34455799999999998654 458899999999999998875 35888999999999999999999884 9
Q ss_pred EEecCCCCcEEEcCCCCeEEeecCCCcccccccC--CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcC
Q 015005 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN--DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG 214 (414)
Q Consensus 137 ~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g 214 (414)
+|+++..+-|++..+|-+|+.----...-..... ........|-++|.|||.=...... .++|||++|+...+|..|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~-~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTT-GASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccc-cchhhhhhhHHHHHHHHh
Confidence 9999999999999999888742211111000000 1111223467899999986554444 679999999999999887
Q ss_pred CCC-CCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 215 FLP-FQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 215 ~~P-f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..- -...+....-..+.+.-+.. -..--+.++.+||+..|+.||++.+++.||....
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eeccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 643 22222111111111111111 1223457899999999999999999999998754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=6.4e-12 Score=107.93 Aligned_cols=134 Identities=19% Similarity=0.291 Sum_probs=102.2
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhH-----HHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGL-----MEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
..+++|+-+.+|.+.. -|..+++|.=.++....+.. ..+..+|+.++..+.--.|.-.+=+..+++...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999853 45457777644333332222 3556789999999876666555555667778889999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 97 YVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 97 ~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
|.+|-.|.+.+... ...++..+=.-+.-||..||+|+||.++||++...+ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999998888775 245666777778899999999999999999996554 99999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=1e-11 Score=112.82 Aligned_cols=140 Identities=21% Similarity=0.292 Sum_probs=108.3
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--CCccceEEEEEeC---CEEEEEEE
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH--PNIVELKEVMATK---TKVFFVIE 96 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lv~E 96 (414)
+.||.|..+.||++... +|+.+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999864 3688999998654331 123467899999999965 3457777777654 36789999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 015005 97 YVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS------------------------------------------- 133 (414)
Q Consensus 97 ~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~------------------------------------------- 133 (414)
|++|.++.+.+..+.+++.+...+..+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999988765543567777777778888888888873
Q ss_pred -------------CCcEEecCCCCcEEEcC--CCCeEEeecCCCcc
Q 015005 134 -------------RGVYHRDLKPENLLLDE--NGNLKVSDFGLSAL 164 (414)
Q Consensus 134 -------------~gi~HrDlkp~NILl~~--~~~~kl~DFGla~~ 164 (414)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 56789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4e-11 Score=102.67 Aligned_cols=143 Identities=20% Similarity=0.283 Sum_probs=109.4
Q ss_pred EeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhh-----HHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQG-----LMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
....|-+|+-+.|+++. ..|+.+.||.-..+....+. ..++.++|++++.++.--+|.-..-++.+...-.|.
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 56788999999999997 67888888865443333222 245678999999998765665555566666677899
Q ss_pred EEccCC-CchHHHHhc--CCCCHHH-HHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC---CeEEeecCCCcc
Q 015005 95 IEYVKG-GELFAKVLK--GKLKEES-ARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG---NLKVSDFGLSAL 164 (414)
Q Consensus 95 ~E~~~g-g~L~~~i~~--~~~~e~~-~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~---~~kl~DFGla~~ 164 (414)
|||++| .++.+++.. ..-.+++ ...+++++-..+.-||.++++|+||..+||++..+| .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 467777765 2333333 378899999999999999999999999999997665 458999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=113.48 Aligned_cols=211 Identities=18% Similarity=0.276 Sum_probs=157.9
Q ss_pred CCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe----CCEEEEEEEccCC-Cc
Q 015005 28 TFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT----KTKVFFVIEYVKG-GE 102 (414)
Q Consensus 28 ~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~~~g-g~ 102 (414)
--.+.|++....+|..|++|+++..+.... ...-.-+++++++.|+|+|++.+++.+ ...+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 457889999999999999999955443322 122345788999999999999999873 3568999999986 46
Q ss_pred hHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 103 LFAKVLK----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 103 L~~~i~~----------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
|.++.-. .+.+|...|.|+.||..||.++|+.|..-+-|.|.+||++.+-+++|+..|...+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7665321 247889999999999999999999999999999999999988899998888776544
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCC-CCCchHHHH-HHHHHhcccCCCCCCCHH
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLP-FQNENIMKM-YRKIFKAEYEFPPWISCD 244 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~~~~-~~~i~~~~~~~~~~~s~~ 244 (414)
.. . + |.+.+. .+-|.=.||.+++.|.||..- +........ .+.| -+.+|.+
T Consensus 445 ~d---~------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D 497 (655)
T KOG3741|consen 445 ED---P------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTD 497 (655)
T ss_pred CC---C------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHH
Confidence 31 1 0 122222 356888999999999999544 222222222 2222 2347889
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcC
Q 015005 245 ARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
++++|.-+...++++ -++.+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 999999999999887 788888765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=2e-10 Score=101.30 Aligned_cols=127 Identities=21% Similarity=0.348 Sum_probs=85.4
Q ss_pred EEEEEEECCCCeEEEEEEeecccc-----------------------chhhHHHHHHHHHHHHHhCCCC--CccceEEEE
Q 015005 31 KVYYGKNLVTQESVAIKVINKDQV-----------------------KKQGLMEQIKREISVMRLVKHP--NIVELKEVM 85 (414)
Q Consensus 31 ~Vy~a~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~ 85 (414)
.||.|.. ..|..+|+|+...... ...-......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899985 5778999999754210 0111235678999999999765 466666553
Q ss_pred EeCCEEEEEEEccC--CCchHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 86 ATKTKVFFVIEYVK--GGELFAKVLKGKLKEESARKYFQQLISAVDF-CHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 86 ~~~~~~~lv~E~~~--gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~-lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
..+|||||++ |..+. .+....++..+...++.+++..+.. +|+.|++|+||.+.|||++++ .+.|+|||.+
T Consensus 80 ----~~~ivME~I~~~G~~~~-~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLP-RLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp ----TTEEEEE--EETTEEGG-CHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred ----CCEEEEEecCCCccchh-hHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 3369999998 65553 3444344456677788888885555 579999999999999999877 8999999988
Q ss_pred cc
Q 015005 163 AL 164 (414)
Q Consensus 163 ~~ 164 (414)
..
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 63
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.5e-11 Score=120.52 Aligned_cols=154 Identities=18% Similarity=0.315 Sum_probs=113.1
Q ss_pred HHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCccccccc-------CCCccccccCCCcccCchhhcccC
Q 015005 122 QQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW-------NDGLLHTQCGTPAYVAPEVLRKKG 193 (414)
Q Consensus 122 ~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-------~~~~~~~~~gt~~y~APE~~~~~~ 193 (414)
.+.+.|+.|+|.. +++|++|.|++|.++.+|.+||+.|+.+....... .........-.+.|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3444999999965 89999999999999999999999999876433211 111111122456799999998854
Q ss_pred CCCCccchhhhhhhhhhhh-cCCCCCCCchHHHHHHHHH----hcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 194 YDGAKSDIWSCGVVLFVLL-SGFLPFQNENIMKMYRKIF----KAEYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 194 ~~~~~~DiwSlGvil~~ll-~g~~Pf~~~~~~~~~~~i~----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
. +.++|++|+||++|.+. .|+.-+...+....+..-. .+....+..+++++++=+.++|..++..||++.+++.
T Consensus 186 ~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 N-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred c-cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 4 58999999999999999 4555554443222221111 1223345678999999999999999999999999999
Q ss_pred CCccccCC
Q 015005 269 NPWFIKGF 276 (414)
Q Consensus 269 hp~f~~~~ 276 (414)
.|||....
T Consensus 265 ~~ff~D~~ 272 (700)
T KOG2137|consen 265 IPFFSDPG 272 (700)
T ss_pred ccccCCch
Confidence 99997653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.2e-09 Score=101.99 Aligned_cols=138 Identities=14% Similarity=0.075 Sum_probs=98.0
Q ss_pred eeecCCeEEEEEEECCCCeEEEEEEeeccccch---h-----hHHHHHHHHHHHHHhCCCCCc--cceEEEEEe-----C
Q 015005 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK---Q-----GLMEQIKREISVMRLVKHPNI--VELKEVMAT-----K 88 (414)
Q Consensus 24 LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~---~-----~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~-----~ 88 (414)
+-+.....|.... ..|+.|.||......... . .-.....+|...+..|..-+| +.++.+.+. .
T Consensus 30 v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 30 FRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3333334455553 467789999764332110 0 001136789999888854333 344445543 2
Q ss_pred CEEEEEEEccCCC-chHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC-------CCCeEEe
Q 015005 89 TKVFFVIEYVKGG-ELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-------NGNLKVS 157 (414)
Q Consensus 89 ~~~~lv~E~~~gg-~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-------~~~~kl~ 157 (414)
...++|||+++|. +|.+++.. ...++.....++.+++..+..||+.||+|+|++|.|||++. ++.+.++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 3578999999986 78888753 45677788899999999999999999999999999999975 4579999
Q ss_pred ecCCCc
Q 015005 158 DFGLSA 163 (414)
Q Consensus 158 DFGla~ 163 (414)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999886
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.7e-09 Score=96.34 Aligned_cols=138 Identities=22% Similarity=0.325 Sum_probs=104.6
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc-----------------h--hhHHHHHHHHHHHHHhCCCC--
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-----------------K--QGLMEQIKREISVMRLVKHP-- 76 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-----------------~--~~~~~~~~~Ei~il~~l~hp-- 76 (414)
+.++..||-|--|.||.|.+. .|.++|+|.=+..... . .-.....++|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 467789999999999999965 7889999974321100 0 00124467899999999654
Q ss_pred CccceEEEEEeCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEE
Q 015005 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV 156 (414)
Q Consensus 77 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl 156 (414)
.+.+.+++ +...+||||++|-.|...- ++...+..++..|+.-+.-+-..|++|+|+.+-||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 67777665 5678999999997775432 245556667777777777777999999999999999999999999
Q ss_pred eecCCCcc
Q 015005 157 SDFGLSAL 164 (414)
Q Consensus 157 ~DFGla~~ 164 (414)
+||--+..
T Consensus 244 IDwPQ~v~ 251 (304)
T COG0478 244 IDWPQAVP 251 (304)
T ss_pred EeCccccc
Confidence 99987653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.5e-08 Score=91.40 Aligned_cols=104 Identities=20% Similarity=0.372 Sum_probs=84.8
Q ss_pred HHHHHHHHHHHhCCCCC--ccceEEEEEeC----CEEEEEEEccCCC-chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 015005 61 EQIKREISVMRLVKHPN--IVELKEVMATK----TKVFFVIEYVKGG-ELFAKVLK-GKLKEESARKYFQQLISAVDFCH 132 (414)
Q Consensus 61 ~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH 132 (414)
....+|...+..|..-+ +.+.+.+.+.. ...++|+|+++|. +|.+.+.. ...+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 45778888888875433 44556665542 2468999999985 78888876 45778888999999999999999
Q ss_pred hCCcEEecCCCCcEEEcCCC---CeEEeecCCCcc
Q 015005 133 SRGVYHRDLKPENLLLDENG---NLKVSDFGLSAL 164 (414)
Q Consensus 133 ~~gi~HrDlkp~NILl~~~~---~~kl~DFGla~~ 164 (414)
++||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.9e-08 Score=96.36 Aligned_cols=235 Identities=17% Similarity=0.186 Sum_probs=153.4
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEE------EEEeCC-
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKE------VMATKT- 89 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~------~~~~~~- 89 (414)
...++.||+|+-+.+|-.- .-...+.|++.+...... . .-+..|... .||-+-.-+. +..+++
T Consensus 13 i~~gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred cCCCccccCCccceeeecc---hhhchhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 3567889999999999653 222345688877654321 1 122333333 5664332111 111222
Q ss_pred EEEEEEEccCCCch-HHHHhc----C---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCC
Q 015005 90 KVFFVIEYVKGGEL-FAKVLK----G---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL 161 (414)
Q Consensus 90 ~~~lv~E~~~gg~L-~~~i~~----~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGl 161 (414)
.+-+.|..++|..= ..+... . .....-+.+..+.|+.+.+.||+.|-.-+|+.++|+|+++++.+.|.|-..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 37789998887632 122211 1 256677888999999999999999999999999999999999999998654
Q ss_pred CcccccccCCCccccccCCCcccCchhhc-----ccCCCCCccchhhhhhhhhhhhcC-CCCCCCchH-----HHHHHHH
Q 015005 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLR-----KKGYDGAKSDIWSCGVVLFVLLSG-FLPFQNENI-----MKMYRKI 230 (414)
Q Consensus 162 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~-----~~~~~~i 230 (414)
-.+. .++......+|.+.|.+||.-. +-+- +...|.|.||+++|++|.| +.||.+-.. ...-..|
T Consensus 164 fqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 164 FQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred eeec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 3321 2344445667999999999864 2222 3568999999999999886 999976311 0011122
Q ss_pred Hhcc-----------cCC---CCC--CCHHHHHHHHhhccc--CcCCCCChHH
Q 015005 231 FKAE-----------YEF---PPW--ISCDARRLISRILVA--DPQKRISVSE 265 (414)
Q Consensus 231 ~~~~-----------~~~---~~~--~s~~~~~li~~~L~~--dp~~R~s~~e 265 (414)
..+. .+- ++| +++++..|..+|+.. ++.-|||++.
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 2211 111 122 688999999999875 3668999754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.8e-08 Score=87.32 Aligned_cols=148 Identities=18% Similarity=0.273 Sum_probs=100.8
Q ss_pred hhHhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHH------HHHHHHHHHhCC---CC
Q 015005 6 MDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQ------IKREISVMRLVK---HP 76 (414)
Q Consensus 6 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~------~~~Ei~il~~l~---hp 76 (414)
..+-....+.++|.+.+++-......|.+.. ..|+.+++|.........+..... ..+++..+..+. -.
T Consensus 21 y~~l~~~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~ 98 (229)
T PF06176_consen 21 YLELGEKILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFT 98 (229)
T ss_pred HHHHHHHHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence 3445566788999999999999988888876 577889999986544332211111 223444344442 23
Q ss_pred CccceEEEEEeC-----CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC
Q 015005 77 NIVELKEVMATK-----TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN 151 (414)
Q Consensus 77 nIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~ 151 (414)
....++-+.+-. ...+++|||++|.+|.+... +++. +...+..++.-+|+.|++|+|.+|.|++++.+
T Consensus 99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred ccccceeeeeeeeccceeEEEEEEEEecCeecccchh---cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC
Confidence 333433333322 34568999999988865432 2332 44567788999999999999999999999855
Q ss_pred CCeEEeecCCCc
Q 015005 152 GNLKVSDFGLSA 163 (414)
Q Consensus 152 ~~~kl~DFGla~ 163 (414)
+ ++++||+..+
T Consensus 172 ~-i~iID~~~k~ 182 (229)
T PF06176_consen 172 G-IRIIDTQGKR 182 (229)
T ss_pred c-EEEEECcccc
Confidence 4 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.4e-10 Score=111.68 Aligned_cols=238 Identities=18% Similarity=0.158 Sum_probs=167.9
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC-ccceEEEEEeCCEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN-IVELKEVMATKTKVFFVI 95 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv~ 95 (414)
.|....-+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-++.++...+.|
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 4566677899999999999876665555 6666543 23446889999999999 777778888889999999
Q ss_pred EccCCC-chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 96 EYVKGG-ELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 96 E~~~gg-~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
+++.++ +-...... -.+.+-+.....+.-+.+++++|+.-=+||| ||+..+ +..+..||+....... ..
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~---~~ 385 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR---TM 385 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc---cc
Confidence 999887 22221111 2344444555666778899999998878998 877644 7799999998874432 12
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC------CCCCHHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP------PWISCDAR 246 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~------~~~s~~~~ 246 (414)
...+..+|+.++|||+.....+. ...|.|++|+--.++.-|..|-..+.... ..+ ...+..| .|-+..-+
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~~--~~~-g~~p~s~~L~~~~aw~~~~~~ 461 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAVL--PMI-GNGPNSPMLTDKSAWSPVFHR 461 (829)
T ss_pred ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCcccc--CCC-CCCCCccccchhhhcCccccc
Confidence 34566799999999999888887 78999999998778888877755421100 000 0000011 12222223
Q ss_pred HHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 247 RLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++...|+..-|..|+.....+.|.+|...
T Consensus 462 ~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 462 DFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred CCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 57788999999999999999988888544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.4e-07 Score=84.06 Aligned_cols=137 Identities=13% Similarity=0.114 Sum_probs=98.6
Q ss_pred eecCCeEEEEEEECCCCeEEEEEEeeccccch---hhHHHHHHHHHHHHHhCCCCC--ccceEEEEEe--C--CEEEEEE
Q 015005 25 GQGTFAKVYYGKNLVTQESVAIKVINKDQVKK---QGLMEQIKREISVMRLVKHPN--IVELKEVMAT--K--TKVFFVI 95 (414)
Q Consensus 25 G~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~--~--~~~~lv~ 95 (414)
|+||.+.|+.... .|+.+=+|.-....... +.-...+.+|+..+..|..-+ +.++...... + -..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688888988763 44467777653111110 112457889999999885322 4444422211 1 2478999
Q ss_pred EccCC-CchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC--eEEeecCCCc
Q 015005 96 EYVKG-GELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN--LKVSDFGLSA 163 (414)
Q Consensus 96 E~~~g-g~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~--~kl~DFGla~ 163 (414)
|-++| -+|.+++... +.++.....++.+++..+.-||+.|+.|+|+.|.||+++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97764 4888887663 4578888899999999999999999999999999999987777 9999998765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2e-07 Score=84.32 Aligned_cols=140 Identities=17% Similarity=0.234 Sum_probs=100.8
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh---------------------hHHHHHHHHHHHHHhCC--CCC
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ---------------------GLMEQIKREISVMRLVK--HPN 77 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---------------------~~~~~~~~Ei~il~~l~--hpn 77 (414)
...|+.|--+.||+|.. .++..+|+|++......-. .......+|...|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677788889999974 5788999999864332111 11234567888888884 445
Q ss_pred ccceEEEEEeCCEEEEEEEccCCCchHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeE
Q 015005 78 IVELKEVMATKTKVFFVIEYVKGGELFA-KVLKGKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLK 155 (414)
Q Consensus 78 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~-~i~~~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~k 155 (414)
+.+.+.+. .-.+||||+....+-. .+..-++...++..+..+++..+.-|-. .|++|+||+.-|||+. ++.+.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 55666665 3458999996542211 1222344555799999999999988887 8999999999999998 88999
Q ss_pred EeecCCCcccc
Q 015005 156 VSDFGLSALPE 166 (414)
Q Consensus 156 l~DFGla~~~~ 166 (414)
|+|||-|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999987543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=8.5e-08 Score=97.02 Aligned_cols=158 Identities=16% Similarity=0.261 Sum_probs=101.7
Q ss_pred hhHhhhccccCCEEEe--eeeeecCCeEEEEEEECCCCeEEEEEEeeccccch---------------------------
Q 015005 6 MDERVRNILFGKYEMG--RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK--------------------------- 56 (414)
Q Consensus 6 ~~~~~~~~~~~~y~~~--~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--------------------------- 56 (414)
+++.+|....+.|.-. ..|+.++-|+||.|+. .+|+.||||+.+..-...
T Consensus 113 ie~eLG~~iee~F~eF~~~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~ 191 (517)
T COG0661 113 IEEELGRPIEELFSEFEPEPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDL 191 (517)
T ss_pred HHHHhCCCHHHHHHHcCCCchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCCh
Confidence 4555565444444322 5799999999999986 469999999975421100
Q ss_pred h----hHHHH------HHHHHHHHHhCC-----CCCccceEEEEEeCCEEEEEEEccCCCchHHHH--hcCCCCHHHHHH
Q 015005 57 Q----GLMEQ------IKREISVMRLVK-----HPNIVELKEVMATKTKVFFVIEYVKGGELFAKV--LKGKLKEESARK 119 (414)
Q Consensus 57 ~----~~~~~------~~~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i--~~~~~~e~~~~~ 119 (414)
. +..+. +.+|...+.++. .|++.-..=+++-.+.-.++|||++|-.+.+.. ...+++...+..
T Consensus 192 ~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~ 271 (517)
T COG0661 192 VEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAE 271 (517)
T ss_pred HHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHH
Confidence 0 01111 234555544442 344433333444456678999999999887763 445566444333
Q ss_pred HHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 120 YFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 120 ~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
.+.++. +..+-..|++|.|.+|.||+++.+|.+.+.|||+.....
T Consensus 272 ~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 272 LLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 333222 333445899999999999999999999999999987544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.3e-07 Score=82.99 Aligned_cols=133 Identities=19% Similarity=0.174 Sum_probs=85.5
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--ccceEEEEEeCCEEEEEEEccC
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN--IVELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~ 99 (414)
..||+|..+.||+. .+..+++|....... ...+.+|.++++.+..-+ +.+.+++.+..+...++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~-----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD-----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCC-----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999973 255688899864321 245789999999986433 4678888888888899999999
Q ss_pred CCc-hH--------------HH-------HhcC---CCCHHH-HHHHHHHH----------HH-HHHHHH----hCCcEE
Q 015005 100 GGE-LF--------------AK-------VLKG---KLKEES-ARKYFQQL----------IS-AVDFCH----SRGVYH 138 (414)
Q Consensus 100 gg~-L~--------------~~-------i~~~---~~~e~~-~~~~~~ql----------~~-al~~lH----~~gi~H 138 (414)
|.. +. .. +..- ..+... ...+..++ .. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11 00 1110 011000 01111111 01 112222 125789
Q ss_pred ecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 139 RDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 139 rDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
+|+.|.||++++++ +.++||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.7e-08 Score=70.13 Aligned_cols=55 Identities=51% Similarity=0.632 Sum_probs=45.0
Q ss_pred CCcccccccCCCCCCCchhhhhhhc----cCccccccCChhHHHHHHHHHHHHcCCeEEE
Q 015005 287 GDNRDFISSMSSGFDLSSLFESERK----SGSMFTSKCSSSAIMGKLESLAKKLNLGVCV 342 (414)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (414)
.|+|++|+ +|+|+|||.+|+.... +.+||+|..+++.|+++++++++.+|+.|.+
T Consensus 5 lNAFdiIS-~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 5 LNAFDIIS-LSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp --HHHHHC-TSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred ccHHHHHH-hccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 47899996 9999999999986543 4699999999999999999999999998864
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.1e-06 Score=80.00 Aligned_cols=136 Identities=20% Similarity=0.289 Sum_probs=82.6
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC--CccceEEEE---EeCCEEEEEE
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP--NIVELKEVM---ATKTKVFFVI 95 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lv~ 95 (414)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4689999999999998644 48999997654 1245677899998888533 345666644 3344689999
Q ss_pred EccCCCchHH----------------HHh---cC--C---CCHHH------HHHH---------------HHHHHH-HHH
Q 015005 96 EYVKGGELFA----------------KVL---KG--K---LKEES------ARKY---------------FQQLIS-AVD 129 (414)
Q Consensus 96 E~~~gg~L~~----------------~i~---~~--~---~~e~~------~~~~---------------~~ql~~-al~ 129 (414)
++++|..+.. .+. .. . +.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 111 10 0 00000 0000 111222 233
Q ss_pred HHH-------hCCcEEecCCCCcEEEc-CCCCeEEeecCCCc
Q 015005 130 FCH-------SRGVYHRDLKPENLLLD-ENGNLKVSDFGLSA 163 (414)
Q Consensus 130 ~lH-------~~gi~HrDlkp~NILl~-~~~~~kl~DFGla~ 163 (414)
.++ ..+++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 24699999999999999 56667899999876
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.48 E-value=9.6e-07 Score=94.34 Aligned_cols=202 Identities=18% Similarity=0.220 Sum_probs=144.2
Q ss_pred HHHHHHHHHHHhCCCCCccceEEEEEeCCE----EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015005 61 EQIKREISVMRLVKHPNIVELKEVMATKTK----VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRG 135 (414)
Q Consensus 61 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~g 135 (414)
.....|+..+....|+|++.++.+...... ..+..|+|++-++.+.+.. +..+...++.+..+++.|+.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 344556677788899999999988755433 3345689999999999887 89999999999999999999999996
Q ss_pred cEEecCCCC---cEEEcCCCCeEEe--ecCCCcccccccCCCccccccCCCcccCchhhcccCCC-CCccchhhhhhhhh
Q 015005 136 VYHRDLKPE---NLLLDENGNLKVS--DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD-GAKSDIWSCGVVLF 209 (414)
Q Consensus 136 i~HrDlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~~~~DiwSlGvil~ 209 (414)
..|.-+... +--.+..+...++ ||+.+..... ........-+..+.|||......+. ....|+|.+|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 666655554 4444556667776 8888775432 2223334456678889887765543 22369999999999
Q ss_pred hhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 210 VLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 210 ~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.+..|..+-...... ..+ .+.....+..+++.+|+.-++++|+++.+++.|||..-
T Consensus 384 ~~~~~~~i~~~~~~~---~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVP---VSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhcCcccccccch---hhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 998876542211110 000 01112226788999999999999999999999999754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.1e-06 Score=79.33 Aligned_cols=133 Identities=17% Similarity=0.153 Sum_probs=84.0
Q ss_pred eeecCC-eEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEEEccCCC
Q 015005 24 LGQGTF-AKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 24 LG~G~~-g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (414)
|..|.. +.||++.. .+..+.+|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 445555 88999864 34678899986543 234668999988883 444667888887777889999999997
Q ss_pred chHHHH----------------hc-CCCCH-------H------HHHHHHH----------------HHHHHHHHH----
Q 015005 102 ELFAKV----------------LK-GKLKE-------E------SARKYFQ----------------QLISAVDFC---- 131 (414)
Q Consensus 102 ~L~~~i----------------~~-~~~~e-------~------~~~~~~~----------------ql~~al~~l---- 131 (414)
+|.... .+ ..++. . .....+. .+...+..|
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 664321 00 01110 0 0000000 011112222
Q ss_pred ---HhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 132 ---HSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 132 ---H~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123589999999999999987788999998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.6e-06 Score=90.47 Aligned_cols=144 Identities=15% Similarity=0.318 Sum_probs=92.5
Q ss_pred EeeeeeecCCeEEEEEEECCCC--eEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCc--cceEEEEEeC---CEE
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQ--ESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNI--VELKEVMATK---TKV 91 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~ 91 (414)
-.+.|+.|.+..+|+......+ ..+++|+........ ....+.+|+++++.+. |+++ .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998764432 467888765432211 1346789999999995 6765 7778887764 468
Q ss_pred EEEEEccCCCchHH--------------------HHhc-CCC----------------CHHHHHHHHHH-----------
Q 015005 92 FFVIEYVKGGELFA--------------------KVLK-GKL----------------KEESARKYFQQ----------- 123 (414)
Q Consensus 92 ~lv~E~~~gg~L~~--------------------~i~~-~~~----------------~e~~~~~~~~q----------- 123 (414)
|+||||++|..+.+ .+.. ..+ ...++..|..|
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999999864321 1110 010 01223222222
Q ss_pred ----HHHHHHHHHh-----------CCcEEecCCCCcEEEcCC-C-CeEEeecCCCccc
Q 015005 124 ----LISAVDFCHS-----------RGVYHRDLKPENLLLDEN-G-NLKVSDFGLSALP 165 (414)
Q Consensus 124 ----l~~al~~lH~-----------~gi~HrDlkp~NILl~~~-~-~~kl~DFGla~~~ 165 (414)
+...+.+|.. ..++|+|++|.|++++.+ + ..-|.||.++..-
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2233556632 259999999999999853 3 3579999998753
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.6e-06 Score=86.10 Aligned_cols=157 Identities=18% Similarity=0.238 Sum_probs=102.4
Q ss_pred hhHhhhccccCCEEEe--eeeeecCCeEEEEEEECCCCeEEEEEEeeccccch---------------------------
Q 015005 6 MDERVRNILFGKYEMG--RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK--------------------------- 56 (414)
Q Consensus 6 ~~~~~~~~~~~~y~~~--~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--------------------------- 56 (414)
+++.+|..+.+-|... +.||.-+.|+||+|+.+ +|+.||||+-+..-...
T Consensus 149 ~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~l 227 (538)
T KOG1235|consen 149 FEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWL 227 (538)
T ss_pred HHHHhCCCHHHHHHhcCcchhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhH
Confidence 4566677666666444 68999999999999965 49999999964321110
Q ss_pred -hhHHHH------HHHHHHHHHh----CCCCC------ccceEEEEEeCCEEEEEEEccCCCchHH--HHhcCCCCHHHH
Q 015005 57 -QGLMEQ------IKREISVMRL----VKHPN------IVELKEVMATKTKVFFVIEYVKGGELFA--KVLKGKLKEESA 117 (414)
Q Consensus 57 -~~~~~~------~~~Ei~il~~----l~hpn------Iv~l~~~~~~~~~~~lv~E~~~gg~L~~--~i~~~~~~e~~~ 117 (414)
.+..+. +.+|++...+ +.|-+ |.++|-.+ .+.-.++||||+|..+.| .+.+..++...+
T Consensus 228 vdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i 305 (538)
T KOG1235|consen 228 VDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDI 305 (538)
T ss_pred HHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHH
Confidence 001111 2234433333 34555 44443322 346789999999986644 455667777765
Q ss_pred HHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC----CCCeEEeecCCCccccc
Q 015005 118 RKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE----NGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 118 ~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~----~~~~kl~DFGla~~~~~ 167 (414)
...+.+.. +..+-..|++|+|=+|.||++.. ++.+.+-|||+......
T Consensus 306 ~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 306 LNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 55444432 34455679999999999999984 56899999999875443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.9e-06 Score=71.44 Aligned_cols=130 Identities=22% Similarity=0.355 Sum_probs=93.8
Q ss_pred EEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCcc-ceEEEEEeCCEEEEEEEc
Q 015005 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIV-ELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 19 ~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lv~E~ 97 (414)
+..+.||+|.+|.||++. ..|..+|+|+-..+.. ...+..|++++..+.--++. +++.+.++ ++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEee--ccCceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 345789999999999998 4566899999765443 35688999999999876664 45555433 355999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCC-CCcEEEcCCCCeEEeecCCCccc
Q 015005 98 VKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLK-PENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 98 ~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlk-p~NILl~~~~~~kl~DFGla~~~ 165 (414)
+.|-.|...-..+ -++-...++.+---|-..||-|+.|. |...++-.++.+.|+||.-|+..
T Consensus 94 i~G~~L~~~~~~~------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 94 IDGRPLGKLEIGG------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hcCcchhhhhhcc------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9998886544322 13334455666666777899999986 55555556669999999998843
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.28 E-value=2e-05 Score=70.17 Aligned_cols=131 Identities=20% Similarity=0.301 Sum_probs=96.4
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc-------------hhhHHHHHHHHHHHHHhCC------CCCccce
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-------------KQGLMEQIKREISVMRLVK------HPNIVEL 81 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~~~Ei~il~~l~------hpnIv~l 81 (414)
...||+|+.-.||.- ......+||+....... ......+..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357999999999953 34455889998766500 0112355667777766665 7889999
Q ss_pred EEEEEeCCEEEEEEEccCC------CchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC---
Q 015005 82 KEVMATKTKVFFVIEYVKG------GELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG--- 152 (414)
Q Consensus 82 ~~~~~~~~~~~lv~E~~~g------g~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~--- 152 (414)
+|+.++..-.-+|+|.+.. -+|.+++..+.+++ .....+ -.-..||-+.+|+.+|++|.||++..++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~L---~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQAL---DEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHHH---HHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999998732 37888888888887 444433 4456788999999999999999997432
Q ss_pred -CeEEee
Q 015005 153 -NLKVSD 158 (414)
Q Consensus 153 -~~kl~D 158 (414)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 466766
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.4e-05 Score=70.73 Aligned_cols=128 Identities=20% Similarity=0.291 Sum_probs=93.2
Q ss_pred CCEEEeeeeeecCC-eEEEEEEECCCCeEEEEEEeec---cc-------cc-h-------hhHHHHHHHHHHHHHhCC--
Q 015005 16 GKYEMGRMLGQGTF-AKVYYGKNLVTQESVAIKVINK---DQ-------VK-K-------QGLMEQIKREISVMRLVK-- 74 (414)
Q Consensus 16 ~~y~~~~~LG~G~~-g~Vy~a~~~~~~~~vaiK~~~~---~~-------~~-~-------~~~~~~~~~Ei~il~~l~-- 74 (414)
.+++.++.||.|+- |.||++. -.|+.||+|++.. .. .. . ......+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 9999998 5788999999322 00 00 0 023456788998888774
Q ss_pred -CCCc--cceEEEEEeC------------------CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 015005 75 -HPNI--VELKEVMATK------------------TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS 133 (414)
Q Consensus 75 -hpnI--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~ 133 (414)
+.++ |+.+++..-. ....||-||++... .+ ...-+.+|.+-+..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~----~~~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PL----QIRDIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------cc----chhHHHHHHHHHHHHHH
Confidence 4556 8888887322 12467888776543 12 33345677788899999
Q ss_pred CCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 134 RGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 134 ~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
.||+-+|+++.|.. .-||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999986 3489999865
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=8.6e-08 Score=104.08 Aligned_cols=210 Identities=17% Similarity=0.116 Sum_probs=151.2
Q ss_pred HHHHHHHHHHhCCCCCccceEEEEEe--CCEEEEEEEccCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC
Q 015005 62 QIKREISVMRLVKHPNIVELKEVMAT--KTKVFFVIEYVKGGELFAKVLKG-----KLKEESARKYFQQLISAVDFCHSR 134 (414)
Q Consensus 62 ~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~-----~~~e~~~~~~~~ql~~al~~lH~~ 134 (414)
....|...++...|+++...+.-... ....|..++|+.+|.+++.+.+| ...+.-+....++.+.+..-+|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 34455556666789998877665533 34578999999999999999874 344555655666668888888865
Q ss_pred -----CcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhh
Q 015005 135 -----GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLF 209 (414)
Q Consensus 135 -----gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~ 209 (414)
-.+|+++|+-|.+|..+.++|+.++|+.+...+ .........+++.|++|++...-.+. .++|+|+.|+-+|
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLY 1431 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHH
Confidence 278999999999999999999999999984322 12234556788999999999887775 5599999999999
Q ss_pred hhhcCCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 210 VLLSGFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 210 ~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
....|..||.......+...+.++. ...+...|.++-.+...+|-..-..||.-..++.-+.|.-
T Consensus 1432 ~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 9999988875433333322222222 2333444556666666667777789999888888777643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=5e-05 Score=67.26 Aligned_cols=98 Identities=22% Similarity=0.303 Sum_probs=80.4
Q ss_pred HHHHHHHHhCCC-CCccceEEEEEeCCEEEEEEEccCCCchHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 015005 64 KREISVMRLVKH-PNIVELKEVMATKTKVFFVIEYVKGGELFAK----VLKGKLKEESARKYFQQLISAVDFCHS---RG 135 (414)
Q Consensus 64 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~----i~~~~~~e~~~~~~~~ql~~al~~lH~---~g 135 (414)
..|.-+++.+++ +++++++|+|- .+++.||...+++... ..-...+.....+++.+++..+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 368888999976 69999999983 2568999987766532 122457889999999999999999998 35
Q ss_pred cEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 136 VYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 136 i~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
+.-.|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.8e-05 Score=72.73 Aligned_cols=73 Identities=8% Similarity=0.078 Sum_probs=46.3
Q ss_pred eeeeeecCCe-EEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC---CccceEEEEEeC---CEEEE
Q 015005 21 GRMLGQGTFA-KVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP---NIVELKEVMATK---TKVFF 93 (414)
Q Consensus 21 ~~~LG~G~~g-~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~l 93 (414)
++.|+.|+.. .||+.. ..+++|+..... ....+.+|.++++.+... -+.++++..... ...++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567767766 588752 357788765422 134788999999888532 244555444332 24588
Q ss_pred EEEccCCCch
Q 015005 94 VIEYVKGGEL 103 (414)
Q Consensus 94 v~E~~~gg~L 103 (414)
+||+++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00015 Score=69.25 Aligned_cols=80 Identities=10% Similarity=0.114 Sum_probs=57.5
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC---CCccceEEEEEeC---CE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH---PNIVELKEVMATK---TK 90 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~---~~ 90 (414)
+-.-.+.||.|..+.||.... ++..+.+|.... ... ...+.+|...++.+.- -.+.++++++..+ +.
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~-~~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARS-FST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred hhheeeecCCccceeEEEEEc--CCCCEEEEEecc-ccc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 455567899999999999863 223577788432 111 2467899999998843 3577888887543 67
Q ss_pred EEEEEEccCCCch
Q 015005 91 VFFVIEYVKGGEL 103 (414)
Q Consensus 91 ~~lv~E~~~gg~L 103 (414)
.++|||+++|+++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.4e-05 Score=68.16 Aligned_cols=75 Identities=17% Similarity=0.266 Sum_probs=49.0
Q ss_pred eeeeeecCCeEEEEEEECC-CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEEEEEcc
Q 015005 21 GRMLGQGTFAKVYYGKNLV-TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI-VELKEVMATKTKVFFVIEYV 98 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~ 98 (414)
++.|..|-...+|++.... .++.|++|+....... .-...+|+.+++.+...++ ++++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4678888899999987433 3578999987543211 1233578999988854443 44444332 2 3799999
Q ss_pred CCCch
Q 015005 99 KGGEL 103 (414)
Q Consensus 99 ~gg~L 103 (414)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.5e-05 Score=71.05 Aligned_cols=132 Identities=16% Similarity=0.185 Sum_probs=78.7
Q ss_pred eeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEEEEEccCCC
Q 015005 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI-VELKEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 23 ~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~gg 101 (414)
.+..|-...+|+.. .+++.+++|+....... ..-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45678888999886 45678889986543211 00124678999998854333 34444432 26899999986
Q ss_pred chHH--------------H---HhcCC-----CCH-HHHHHHHHHH---------HHHHHHHHh--------CCcEEecC
Q 015005 102 ELFA--------------K---VLKGK-----LKE-ESARKYFQQL---------ISAVDFCHS--------RGVYHRDL 141 (414)
Q Consensus 102 ~L~~--------------~---i~~~~-----~~e-~~~~~~~~ql---------~~al~~lH~--------~gi~HrDl 141 (414)
.+.. . +...+ ++. .....+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5421 1 11111 111 1222332222 111222211 25899999
Q ss_pred CCCcEEEcCCCCeEEeecCCCcc
Q 015005 142 KPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 142 kp~NILl~~~~~~kl~DFGla~~ 164 (414)
.|.||++++++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00014 Score=69.74 Aligned_cols=139 Identities=17% Similarity=0.183 Sum_probs=83.2
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--ccceEEE------EEeCC
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN--IVELKEV------MATKT 89 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~ 89 (414)
....+.++.|....+|++.. ++..+++|+...... .+.+..|++++..|...+ +.+++.. ....+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~-----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVK-----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEe--CCCcEEEEEecCCCC-----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 44467788888889999863 334688898754321 234556777777774322 3344331 12346
Q ss_pred EEEEEEEccCCCchH----H----------HHhc--CCCC--------HHHHH---------------HHHHHHHHHHHH
Q 015005 90 KVFFVIEYVKGGELF----A----------KVLK--GKLK--------EESAR---------------KYFQQLISAVDF 130 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~----~----------~i~~--~~~~--------e~~~~---------------~~~~ql~~al~~ 130 (414)
..++++||++|.++. . .+.. ..++ ..... .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 789999999985431 0 0111 0110 00000 001122334555
Q ss_pred HH-------hCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 131 CH-------SRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 131 lH-------~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
+. ..+++|+|+++.|++++.++...|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 54 2689999999999999988877899999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.93 E-value=3e-05 Score=51.70 Aligned_cols=43 Identities=23% Similarity=0.485 Sum_probs=36.4
Q ss_pred cceEEEEEEEEec-CceEEEEEEecCCChHhHHHHhhhhhhhhcc
Q 015005 358 GKLAVTAEVYEVA-PEVAVVEFSKSAGDTLEYKKFCEEDVRPALK 401 (414)
Q Consensus 358 ~~l~~~~ei~~~~-~~~~~v~~~k~~Gd~le~~~~~~~~l~~~l~ 401 (414)
..+.|.+||+++. ++++.|+|+|.+||.+.|+++|. +|-..|+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~-~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCS-KILNELR 46 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHH-HHHHHTT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHH-HHHHHcc
Confidence 4578999999996 89999999999999999999998 6766654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00031 Score=69.33 Aligned_cols=81 Identities=12% Similarity=0.141 Sum_probs=55.8
Q ss_pred EeeeeeecCCeEEEEEEECCCCeEEEEEEeecccc---ch-hhHHHHHHHHHHHHHhCC---CCCccceEEEEEeCCEEE
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV---KK-QGLMEQIKREISVMRLVK---HPNIVELKEVMATKTKVF 92 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~---~~-~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 92 (414)
-.+.||.|.+..||++.....++.++||.-..... .. .-..++...|.+.|+.+. ..++++++.+ +.+..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 34789999999999999764446899998542110 00 112456778888888762 3456777766 446678
Q ss_pred EEEEccCCCc
Q 015005 93 FVIEYVKGGE 102 (414)
Q Consensus 93 lv~E~~~gg~ 102 (414)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998743
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00031 Score=67.68 Aligned_cols=135 Identities=15% Similarity=0.197 Sum_probs=76.0
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--ccceEE------EEEeCCEEE
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN--IVELKE------VMATKTKVF 92 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~~ 92 (414)
.+.|+.|....+|+... ++..+++|++.. .. .+.+..|+.+++.|...+ +.+++. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g~~vLK~~~~--~~----~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQGEYVLTLFER--LT----AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe--CCCcEEEEEecc--CC----hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 45677888889999874 233689998752 11 123445666666653222 333332 223356789
Q ss_pred EEEEccCCCchH-----------HH---Hhc--CCCC----------H--HHHH-----------HHHHHHH-HHHHHHH
Q 015005 93 FVIEYVKGGELF-----------AK---VLK--GKLK----------E--ESAR-----------KYFQQLI-SAVDFCH 132 (414)
Q Consensus 93 lv~E~~~gg~L~-----------~~---i~~--~~~~----------e--~~~~-----------~~~~ql~-~al~~lH 132 (414)
+++||++|..+. .. +.. ..++ . .... ..+.+.+ ..++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999987431 00 110 0110 0 0000 0111111 1122222
Q ss_pred -------hCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 133 -------SRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 133 -------~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
..|+||+|+.|.||+++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2489999999999999866556899999886
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00023 Score=67.76 Aligned_cols=140 Identities=16% Similarity=0.193 Sum_probs=86.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--ccceEE------EEEe
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN--IVELKE------VMAT 87 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~ 87 (414)
++..-.+.|..|....+|+... .+..+++|+.... . ...+..|++++..+.+.+ +.+++. +...
T Consensus 14 ~~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~ 85 (296)
T cd05153 14 GELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSEL 85 (296)
T ss_pred CchhheecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeee
Confidence 3444467788888899999863 3457999987641 1 245667888888874332 444433 2234
Q ss_pred CCEEEEEEEccCCCchHH--------------HHhc--CCCCH--------HHHH------------HHHHHHHHHHHHH
Q 015005 88 KTKVFFVIEYVKGGELFA--------------KVLK--GKLKE--------ESAR------------KYFQQLISAVDFC 131 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~--------------~i~~--~~~~e--------~~~~------------~~~~ql~~al~~l 131 (414)
.+..++++++++|..+.. .+.. ..+.. .... .....+..++.++
T Consensus 86 ~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 165 (296)
T cd05153 86 AGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQ 165 (296)
T ss_pred CCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHH
Confidence 567789999999876421 0110 00100 0000 0111122334444
Q ss_pred Hh-------CCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 132 HS-------RGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 132 H~-------~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
.+ .+++|+|+.|.|++++.++.+.|+||+.+.
T Consensus 166 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 166 DAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 43 479999999999999988777899999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00053 Score=65.45 Aligned_cols=75 Identities=16% Similarity=0.169 Sum_probs=49.1
Q ss_pred eeeeeecCCeEEEEEEECC------CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEE
Q 015005 21 GRMLGQGTFAKVYYGKNLV------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI-VELKEVMATKTKVFF 93 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~l 93 (414)
++.|..|-...+|++.... +++.+++|+....... .....+|..+++.+...++ .+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4567778888999887533 2578999997553211 2345688888888853333 455555542 35
Q ss_pred EEEccCCCch
Q 015005 94 VIEYVKGGEL 103 (414)
Q Consensus 94 v~E~~~gg~L 103 (414)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0007 Score=64.89 Aligned_cols=143 Identities=20% Similarity=0.275 Sum_probs=101.1
Q ss_pred EEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc----------------------hhhH-HHHHHHHHHHHHhCCC
Q 015005 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK----------------------KQGL-MEQIKREISVMRLVKH 75 (414)
Q Consensus 19 ~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~----------------------~~~~-~~~~~~Ei~il~~l~h 75 (414)
.+...|..|--+-||.|.. .+|..+|||++..+... ...+ .-...+|++.|+++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4556788899999999974 67888999997432110 0111 2345678888998876
Q ss_pred CCccceEEEEEeCCEEEEEEEccCCCchH-HHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEEecCCCCcEEEcCCCC
Q 015005 76 PNIVELKEVMATKTKVFFVIEYVKGGELF-AKVLKGKLKEESARKYFQQLISAVDFCH-SRGVYHRDLKPENLLLDENGN 153 (414)
Q Consensus 76 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~-~~i~~~~~~e~~~~~~~~ql~~al~~lH-~~gi~HrDlkp~NILl~~~~~ 153 (414)
.+|.-.--+.. ....|||+|+.+...- -.+....++...+..+-.|++.-+.-|- .+++||.||.--|+|+ .+|.
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 66443222221 2346899999643222 2333467888899999999998887775 5699999999999998 5688
Q ss_pred eEEeecCCCccc
Q 015005 154 LKVSDFGLSALP 165 (414)
Q Consensus 154 ~kl~DFGla~~~ 165 (414)
+.++|-+-|...
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 999999988643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00078 Score=64.27 Aligned_cols=141 Identities=16% Similarity=0.241 Sum_probs=85.2
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--CCccceEEEEEeCC--EEEE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH--PNIVELKEVMATKT--KVFF 93 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~--~~~l 93 (414)
..+++.+..|..-.+|..... ++.+++. .+. ............+|..+++.+.- .-+...++.|.++. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 345555555555555655533 7778888 321 11112235677889999988743 22345566666655 7799
Q ss_pred EEEccCCCchHHHHhcCCCCHHHHHHHH-HHHHHHHH-------------------------------------------
Q 015005 94 VIEYVKGGELFAKVLKGKLKEESARKYF-QQLISAVD------------------------------------------- 129 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~~~~~e~~~~~~~-~ql~~al~------------------------------------------- 129 (414)
||+|++|..+.+.......+ ..+. ..+...|.
T Consensus 103 v~~~veGe~~~~~~~~~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred EEEEecceeccCcCCcccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 99999985332222111111 0111 12333333
Q ss_pred -------HHHh--------CCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 130 -------FCHS--------RGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 130 -------~lH~--------~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
|++. ..++|+|+++.|++++.++-+=+.||+++.+-+
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 3332 258999999999999999889999999998644
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00011 Score=69.03 Aligned_cols=137 Identities=16% Similarity=0.245 Sum_probs=97.8
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeecccc-----ch------------hhHH--HHHHHHHHHHHhCC-CC
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV-----KK------------QGLM--EQIKREISVMRLVK-HP 76 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-----~~------------~~~~--~~~~~Ei~il~~l~-hp 76 (414)
-|.+++.||-|--+-||.+-+ ..|.+.++|+-..... .+ .-.+ -...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367889999999999999985 5688889886422111 00 0011 22468999999884 32
Q ss_pred -CccceEEEEEeCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeE
Q 015005 77 -NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLK 155 (414)
Q Consensus 77 -nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~k 155 (414)
-+.+.+++ +..++|||++.|-.|...-. -..+..+...+..-+--|..+|++|+|..-=||++++++.++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 24445444 57889999999877754321 122445566677777888999999999999999999999999
Q ss_pred EeecCCCc
Q 015005 156 VSDFGLSA 163 (414)
Q Consensus 156 l~DFGla~ 163 (414)
++||--+.
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99997654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0025 Score=61.72 Aligned_cols=77 Identities=12% Similarity=0.062 Sum_probs=50.3
Q ss_pred eeeecCCeEEEEEEECCCCeEEEEEEeeccccc---h-hhHHHHHHHHHHHHHhCC--CC-CccceEEEEEeCCEEEEEE
Q 015005 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK---K-QGLMEQIKREISVMRLVK--HP-NIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 23 ~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~---~-~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv~ 95 (414)
.||.|....||++.+...++.++||--...... . +-..++..-|...|+... .| .++++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997544478999975321110 0 112456667888887763 35 34555433 456667999
Q ss_pred EccCCC
Q 015005 96 EYVKGG 101 (414)
Q Consensus 96 E~~~gg 101 (414)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0032 Score=62.10 Aligned_cols=77 Identities=17% Similarity=0.108 Sum_probs=52.5
Q ss_pred EeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc-hh---hHHHHHHHHHHHHHhCC---CCCccceEEEEEeCCEEE
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-KQ---GLMEQIKREISVMRLVK---HPNIVELKEVMATKTKVF 92 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-~~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 92 (414)
..+.||.|....||+..+ .+..++||.-...... .. ....+...|...|+.+. ..++.+++.+++ +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 467889999999999886 3456999987522110 00 12345556677776663 247788888876 4467
Q ss_pred EEEEccCC
Q 015005 93 FVIEYVKG 100 (414)
Q Consensus 93 lv~E~~~g 100 (414)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999987
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0027 Score=59.81 Aligned_cols=30 Identities=27% Similarity=0.502 Sum_probs=25.6
Q ss_pred CcEEecCCCCcEEEcCCCC-eEEeecCCCcc
Q 015005 135 GVYHRDLKPENLLLDENGN-LKVSDFGLSAL 164 (414)
Q Consensus 135 gi~HrDlkp~NILl~~~~~-~kl~DFGla~~ 164 (414)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0084 Score=57.34 Aligned_cols=29 Identities=34% Similarity=0.608 Sum_probs=26.0
Q ss_pred CCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 134 ~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
.|++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 58999999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0039 Score=60.79 Aligned_cols=138 Identities=14% Similarity=0.192 Sum_probs=82.2
Q ss_pred EEeeeeeecCCeEEEEEEECC----CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEE
Q 015005 19 EMGRMLGQGTFAKVYYGKNLV----TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI-VELKEVMATKTKVFF 93 (414)
Q Consensus 19 ~~~~~LG~G~~g~Vy~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~l 93 (414)
.-.+.|..|-.-.+|++.... +++.|++|+..... ...++ ..+|..+++.+..-++ .++++.+..+ .
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~ 110 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----R 110 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence 344566668889999986432 34689999886542 11222 2679999988854444 3566665433 5
Q ss_pred EEEccCCCchHHH-----------------HhcCC------C-CHHHHHHHHHHH-----------------HHHHHHH-
Q 015005 94 VIEYVKGGELFAK-----------------VLKGK------L-KEESARKYFQQL-----------------ISAVDFC- 131 (414)
Q Consensus 94 v~E~~~gg~L~~~-----------------i~~~~------~-~e~~~~~~~~ql-----------------~~al~~l- 131 (414)
|.||++|.+|... +.... . ....+..+..++ ...+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 7999987665211 11101 0 112222333221 1111111
Q ss_pred -------HhCCcEEecCCCCcEEEcC-CCCeEEeecCCCcc
Q 015005 132 -------HSRGVYHRDLKPENLLLDE-NGNLKVSDFGLSAL 164 (414)
Q Consensus 132 -------H~~gi~HrDlkp~NILl~~-~~~~kl~DFGla~~ 164 (414)
+...++|+|+++.|||+++ ++.+.++||..+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1236899999999999986 47899999998863
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0034 Score=62.70 Aligned_cols=163 Identities=23% Similarity=0.286 Sum_probs=104.9
Q ss_pred HHHHHHHHHHHhCCCCCccceEEEEEeC-CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEe
Q 015005 61 EQIKREISVMRLVKHPNIVELKEVMATK-TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHR 139 (414)
Q Consensus 61 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~Hr 139 (414)
.++.-..++++.+.|+|...++++.... ....+|||++ +.+|.+....+.+...... .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~--------------~~~~~~- 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLL--------------AHGVLH- 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhc--------------ccccce-
Confidence 4566678899999999999999887653 4578899998 5788888776543222111 222222
Q ss_pred cCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCC
Q 015005 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQ 219 (414)
Q Consensus 140 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~ 219 (414)
-| .++.+| -+++ . | | ...++++||||+|.++.++.-|..-|.
T Consensus 91 ----~~-------~~~~td-~~~t-------~-----------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 91 ----LN-------IIYITD-HFLT-------K-----------Y--P------SPIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred ----eh-------hhhccc-cccc-------c-----------C--C------CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 12 233333 1111 0 0 0 111248999999999999999987776
Q ss_pred CchHHHHHHHHHhcccC------------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 220 NENIMKMYRKIFKAEYE------------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 220 ~~~~~~~~~~i~~~~~~------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
.....+....+.+-... +--..+.....+..+|+-..|..||...++.+++-|.....
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 55444433333221110 01124566788999999999999999999999999866543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.012 Score=56.89 Aligned_cols=137 Identities=15% Similarity=0.228 Sum_probs=79.1
Q ss_pred EeeeeeecCCeEEEEEEECCC---CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEEEE
Q 015005 20 MGRMLGQGTFAKVYYGKNLVT---QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI-VELKEVMATKTKVFFVI 95 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~ 95 (414)
-.+.|..|-.-.+|+...... +..|++|+...... ..+ .-.+|..+++.+..-++ .++++++.. + +|.
T Consensus 18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~ 89 (330)
T PLN02421 18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVI-DRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQ 89 (330)
T ss_pred EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEe-chHHHHHHHHHHHhcCCCCceeEEeCC-c---Eee
Confidence 345555588888998864432 34789998754321 111 23578889988865444 456655532 2 588
Q ss_pred EccCCCchHH----------H-------HhcCCC-------CHHHHHHHHHHH----------------------HHHHH
Q 015005 96 EYVKGGELFA----------K-------VLKGKL-------KEESARKYFQQL----------------------ISAVD 129 (414)
Q Consensus 96 E~~~gg~L~~----------~-------i~~~~~-------~e~~~~~~~~ql----------------------~~al~ 129 (414)
+|++|-.|.. . +....+ ....+..++.++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 9987765411 0 111111 112223333222 11111
Q ss_pred H---HH-hC----CcEEecCCCCcEEEcC-CCCeEEeecCCCcc
Q 015005 130 F---CH-SR----GVYHRDLKPENLLLDE-NGNLKVSDFGLSAL 164 (414)
Q Consensus 130 ~---lH-~~----gi~HrDlkp~NILl~~-~~~~kl~DFGla~~ 164 (414)
. +. +. -.+|.|+.|.|||+++ ++.++++||..|..
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11 12 2799999999999975 57899999998863
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0089 Score=58.74 Aligned_cols=79 Identities=16% Similarity=0.163 Sum_probs=53.2
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc--h-hhHHHHHHHHHHHHHhCC--CC-CccceEEEEEeCCEEEEE
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK--K-QGLMEQIKREISVMRLVK--HP-NIVELKEVMATKTKVFFV 94 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~-~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv 94 (414)
.+.||.|.-.-||++.+...++.|+||--...... + +-..++..-|.+.|+... .| +++++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 67899999999999997444678999975321111 1 112567778888888763 35 45556443 45667789
Q ss_pred EEccCCC
Q 015005 95 IEYVKGG 101 (414)
Q Consensus 95 ~E~~~gg 101 (414)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9999653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.0087 Score=53.91 Aligned_cols=31 Identities=32% Similarity=0.653 Sum_probs=22.2
Q ss_pred CCcEEecCCCCcEEE-cCCCCeEEeecCCCcc
Q 015005 134 RGVYHRDLKPENLLL-DENGNLKVSDFGLSAL 164 (414)
Q Consensus 134 ~gi~HrDlkp~NILl-~~~~~~kl~DFGla~~ 164 (414)
..++|+|+.|.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 368999999999999 8889999999999863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.064 Score=51.38 Aligned_cols=29 Identities=21% Similarity=0.239 Sum_probs=27.5
Q ss_pred CcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 135 GVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 135 gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
|+||+|+.+.|+|++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999876
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.013 Score=57.25 Aligned_cols=62 Identities=23% Similarity=0.206 Sum_probs=46.7
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEEecCCCCcEEEcCCC
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFC-HSRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~l-H~~gi~HrDlkp~NILl~~~~ 152 (414)
..++-+|..|-++..++.....+|+..+++..-.+.|+-.+ --.+.+|.|+.|.||++-.+.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 45677788898988888877777777777766666665443 346899999999999996443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.024 Score=55.99 Aligned_cols=77 Identities=17% Similarity=0.259 Sum_probs=46.2
Q ss_pred EEeeeeeecCCeEEEEEEECCC-CeE-----EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEE
Q 015005 19 EMGRMLGQGTFAKVYYGKNLVT-QES-----VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI-VELKEVMATKTKV 91 (414)
Q Consensus 19 ~~~~~LG~G~~g~Vy~a~~~~~-~~~-----vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~ 91 (414)
...+.|..|-...+|++..... +.. |.+...... ....-.-.+|+.+++.+...++ .++++.+..
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~---- 124 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD---- 124 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence 3455676788999999864332 222 333332111 1111123578999999965544 456666642
Q ss_pred EEEEEccCCCch
Q 015005 92 FFVIEYVKGGEL 103 (414)
Q Consensus 92 ~lv~E~~~gg~L 103 (414)
+++.||++|-+|
T Consensus 125 g~l~efIeGr~l 136 (383)
T PTZ00384 125 FTIQEWVEGNTM 136 (383)
T ss_pred EEEEEEeccccC
Confidence 589999998765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.034 Score=52.62 Aligned_cols=87 Identities=11% Similarity=0.167 Sum_probs=53.6
Q ss_pred hHhhhccccCC--EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC---CCCccce
Q 015005 7 DERVRNILFGK--YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK---HPNIVEL 81 (414)
Q Consensus 7 ~~~~~~~~~~~--y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l 81 (414)
.+.+.+.+... -+-.+.++.|....+|+.. .+++.+.+|+-.... ...+..|..-|+.|. .-.+.++
T Consensus 6 ~~~~~~~~~~~~~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~v 77 (288)
T PF03881_consen 6 EQQISEQLGADFKITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKV 77 (288)
T ss_dssp HHHHHHHHTS-----EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--E
T ss_pred HHHHHHHhCCCCceeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeE
Confidence 34444555544 3455779999999999987 778889999986322 235677888888873 3457788
Q ss_pred EEEEEeCCEEEEEEEccCCC
Q 015005 82 KEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 82 ~~~~~~~~~~~lv~E~~~gg 101 (414)
+.+....+..|++|||++.+
T Consensus 78 i~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 78 IAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEE-SSCCEEEEE-----
T ss_pred EEEEeecCCceEEEEeecCC
Confidence 99888887889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.088 Score=50.81 Aligned_cols=134 Identities=18% Similarity=0.241 Sum_probs=79.4
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-C--CCccc---e----EEEEEeCCEE
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-H--PNIVE---L----KEVMATKTKV 91 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~---l----~~~~~~~~~~ 91 (414)
..|.+ .-..+|+... ..|+ +++|+.... .. ..++.-|+..+..|. + |-.++ + +.....+.+.
T Consensus 32 ~~l~s-~eN~~f~~~~-~~g~-~iLki~~~~-~~----~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 32 RGLNS-EENSNFRVQT-EDGR-YILKIYRPG-WT----RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred ccccc-ccCceEEEEe-cCCC-eEEEEecCC-CC----HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 34444 5567888874 3343 499999776 22 245667888888773 2 11112 1 2222222488
Q ss_pred EEEEEccCCCchHH-H--------------Hhc--CCCC-----------HH----H---------HHHHHHHHHHHHHH
Q 015005 92 FFVIEYVKGGELFA-K--------------VLK--GKLK-----------EE----S---------ARKYFQQLISAVDF 130 (414)
Q Consensus 92 ~lv~E~~~gg~L~~-~--------------i~~--~~~~-----------e~----~---------~~~~~~ql~~al~~ 130 (414)
+-+.+|++|..+.. . +.. ..++ .. . ......++...+..
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 89999999987751 0 000 0111 11 0 01122334444444
Q ss_pred HHh-------CC---cEEecCCCCcEEEcCCCC-eEEeecCCCc
Q 015005 131 CHS-------RG---VYHRDLKPENLLLDENGN-LKVSDFGLSA 163 (414)
Q Consensus 131 lH~-------~g---i~HrDlkp~NILl~~~~~-~kl~DFGla~ 163 (414)
+.+ .+ ++|+|+.|.||+++.+.. .-++||+-+.
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 443 24 999999999999998885 8999999875
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.25 Score=47.74 Aligned_cols=71 Identities=14% Similarity=0.061 Sum_probs=42.9
Q ss_pred cCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--ccceE---E--EEEeCCEEEEEEEccC
Q 015005 27 GTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN--IVELK---E--VMATKTKVFFVIEYVK 99 (414)
Q Consensus 27 G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~---~--~~~~~~~~~lv~E~~~ 99 (414)
+.-..||+... .++..+++|+.+..... ...+..|++.+..|.... ++... + ....++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~----~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWS----DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCC----HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 44566888863 45677999998543321 345667888877663211 22211 1 2233567889999998
Q ss_pred CCc
Q 015005 100 GGE 102 (414)
Q Consensus 100 gg~ 102 (414)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 763
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.13 Score=57.38 Aligned_cols=31 Identities=29% Similarity=0.479 Sum_probs=26.7
Q ss_pred CCcEEecCCCCcEEEcCCC--CeE-EeecCCCcc
Q 015005 134 RGVYHRDLKPENLLLDENG--NLK-VSDFGLSAL 164 (414)
Q Consensus 134 ~gi~HrDlkp~NILl~~~~--~~k-l~DFGla~~ 164 (414)
.+++|+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5899999999999999775 555 999999863
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.035 Score=53.50 Aligned_cols=85 Identities=26% Similarity=0.386 Sum_probs=58.7
Q ss_pred CCCccceEEEEEe-CCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCC
Q 015005 75 HPNIVELKEVMAT-KTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENG 152 (414)
Q Consensus 75 hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~ 152 (414)
-++..+.+-+-.+ .-+.|++|++- |+.+ ..+. --..+++..++.+.+..++-+..+ ..-|||+.-.||||+ +|
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~i-s~ik--~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G 358 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPI-SIIK--ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Ccee-eeee--cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence 3444444333322 23567788875 4444 2222 234566778888888877777655 689999999999999 99
Q ss_pred CeEEeecCCCcc
Q 015005 153 NLKVSDFGLSAL 164 (414)
Q Consensus 153 ~~kl~DFGla~~ 164 (414)
++.|+||-++++
T Consensus 359 nvtLIDfklsRl 370 (488)
T COG5072 359 NVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEeeeeec
Confidence 999999999984
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 414 | ||||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-59 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-59 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-59 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-58 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-58 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-57 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-56 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-55 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-54 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-54 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-53 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-53 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-53 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-52 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-52 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-52 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-52 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-51 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-50 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-50 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-50 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-50 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-50 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-49 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-47 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-46 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-46 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-46 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-46 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-45 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-45 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-45 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-45 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-45 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-44 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-44 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-44 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-44 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-44 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-44 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-44 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-44 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-44 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-44 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-44 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-44 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-44 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-44 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-44 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-44 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-44 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-44 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-44 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-44 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-44 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-44 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-43 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-43 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-43 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-43 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-43 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-42 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-42 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-42 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-41 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-41 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-41 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-40 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-39 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-39 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-39 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-39 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-39 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-39 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-39 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-38 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-38 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-38 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-38 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-38 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-38 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-38 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-38 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-38 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-38 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-38 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-38 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-38 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-38 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-38 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-38 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-38 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-38 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-38 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-38 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-37 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-37 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-37 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-37 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-37 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-37 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-37 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-37 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-37 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-37 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-37 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-37 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-37 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-37 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-37 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-37 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-37 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-37 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-37 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-37 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-37 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-36 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-36 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-36 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-36 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-36 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-36 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-36 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-36 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-36 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-36 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-36 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-36 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-36 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-36 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-36 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-36 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-36 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-36 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-36 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-36 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-36 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-36 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-36 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-36 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-35 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-35 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-35 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-35 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-35 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-35 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-35 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-35 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-35 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-35 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-35 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-35 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-35 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-35 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-35 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-35 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-35 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-35 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-35 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-35 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-35 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-34 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-34 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-34 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-34 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-34 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-34 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-34 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-34 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-34 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-34 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-34 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-34 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-34 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-34 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-34 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-34 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-34 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-34 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-34 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-34 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-34 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-34 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-34 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-34 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-34 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-34 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-34 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-34 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-34 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-34 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-34 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-34 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-34 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-34 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-33 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-33 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-33 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-33 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-33 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-33 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-33 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-33 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-33 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-33 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-33 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-33 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-33 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-33 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-33 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-33 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-33 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-33 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-33 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-33 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-33 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-33 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-33 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-33 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-33 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-33 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-33 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-33 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-33 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-33 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-32 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-32 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-32 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-32 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-32 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-32 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-32 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-32 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-32 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-32 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-32 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-32 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-32 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-32 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-32 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-32 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-32 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-32 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-32 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-32 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-32 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-32 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-32 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-31 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-31 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-31 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-31 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-31 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-31 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-31 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-31 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-31 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-31 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-31 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-31 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-31 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-31 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-30 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-30 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-30 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-30 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-30 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-29 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-29 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-29 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-29 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-29 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-29 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-29 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-29 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-29 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-29 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-29 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-29 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-29 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-29 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-29 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-29 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-29 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-29 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-29 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-29 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-29 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-29 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-29 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-29 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-29 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-29 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-29 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-29 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-29 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-29 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-29 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-29 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-29 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-29 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-29 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-29 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-29 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-29 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-29 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-29 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-29 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-29 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-29 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-29 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-29 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-28 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-28 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-27 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-27 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-27 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-27 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-27 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-27 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-27 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-26 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-26 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-26 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-25 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-25 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-25 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-25 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-25 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-25 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-25 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-25 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-25 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-25 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-25 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-25 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-24 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-24 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-24 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-24 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-24 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-24 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-24 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-24 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-24 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-24 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-24 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-24 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-24 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-24 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-24 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-24 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-24 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-24 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-24 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-24 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-24 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-24 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-24 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-24 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-24 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-24 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-24 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-24 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-24 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-24 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-24 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-24 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-24 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-24 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-24 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-24 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-24 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-24 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-24 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-23 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-23 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-23 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-23 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-23 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-23 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-23 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-23 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-23 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-23 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-23 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-22 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-22 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-22 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-22 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-21 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-21 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-21 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-21 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-21 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-21 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-21 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-19 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-19 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-18 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-17 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-17 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-16 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-16 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-16 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-16 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-16 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-13 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-13 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-13 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-13 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-13 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-13 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-13 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-13 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-13 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-13 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-12 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-12 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-12 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-12 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-12 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-12 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-12 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-12 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-12 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-12 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-12 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-12 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-10 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-09 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 9e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 5e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 9e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 6e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 8e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-06 |
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-169
Identities = 100/315 (31%), Positives = 166/315 (52%), Gaps = 11/315 (3%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
+++ + LG+G + +V N VT+E+VA+K+++ + E IK+EI + +++
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKML 62
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCH 132
H N+V+ + +EY GGELF + + E A+++F QL++ V + H
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
G+ HRD+KPENLLLDE NLK+SDFGL+ + + LL+ CGT YVAPE+L+++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPF-QNENIMKMYRKIFKAEYEFPPW--ISCDARRLI 249
+ D+WSCG+VL +L+G LP+ Q + + Y + + PW I L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 250 SRILVADPQKRISVSEIMINPWFIKGFSK-----PVAVCIDDGDNRDFISSMSSGFDLSS 304
+ILV +P RI++ +I + W+ K K V F + S D S
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSP 302
Query: 305 LFESERKSGSMFTSK 319
+ + R GS ++ +
Sbjct: 303 VNSASRTPGSGWSKE 317
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 473 bits (1219), Expect = e-168
Identities = 97/303 (32%), Positives = 156/303 (51%), Gaps = 8/303 (2%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLME-QIKREISVMRL 72
L GKY MG +LG+G++ KV + T A+K++ K ++++ E +K+EI ++R
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 73 VKHPNIVELKEVM--ATKTKVFFVIEYVKGG--ELFAKVLKGKLKEESARKYFQQLISAV 128
++H N+++L +V+ K K++ V+EY G E+ V + + A YF QLI +
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
++ HS+G+ H+D+KP NLLL G LK+S G++ D T G+PA+ PE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 189 LR-KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARR 247
+ G K DIWS GV L+ + +G PF+ +NI K++ I K Y P
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 248 LISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCID--DGDNRDFISSMSSGFDLSSL 305
L+ +L +P KR S+ +I + WF K A D +D SM+ L L
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDL 302
Query: 306 FES 308
+
Sbjct: 303 HGA 305
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 470 bits (1212), Expect = e-168
Identities = 110/274 (40%), Positives = 172/274 (62%), Gaps = 4/274 (1%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREI 67
+ + G Y +G LG GTF KV G++ +T VA+K++N+ +++ ++ +IKREI
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLIS 126
++L +HP+I++L +V++T T F V+EYV GGELF G+++E AR+ FQQ++S
Sbjct: 63 QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
AVD+CH V HRDLKPEN+LLD + N K++DFGLS + L T CG+P Y AP
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSPNYAAP 179
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDAR 246
EV+ + Y G + DIWSCGV+L+ LL G LPF +E++ +++KI + P +++
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 247 RLISRILVADPQKRISVSEIMINPWFIKGFSKPV 280
L+ +L DP KR ++ +I + WF + +
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 468 bits (1208), Expect = e-167
Identities = 92/269 (34%), Positives = 152/269 (56%), Gaps = 6/269 (2%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
+++ + LG+G + +V N VT+E+VA+K+++ + E IK+EI + +++
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKML 62
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCH 132
H N+V+ + +EY GGELF + + E A+++F QL++ V + H
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
G+ HRD+KPENLLLDE NLK+SDFGL+ + + LL+ CGT YVAPE+L+++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPF-QNENIMKMYRKIFKAEYEFPPW--ISCDARRLI 249
+ D+WSCG+VL +L+G LP+ Q + + Y + + PW I L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 250 SRILVADPQKRISVSEIMINPWFIKGFSK 278
+ILV +P RI++ +I + W+ K K
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKK 271
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 462 bits (1190), Expect = e-161
Identities = 110/314 (35%), Positives = 179/314 (57%), Gaps = 14/314 (4%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREI 67
+ + G Y +G LG GTF KV GK+ +T VA+K++N+ +++ ++ +I+REI
Sbjct: 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLIS 126
++L +HP+I++L +V++T + +F V+EYV GGELF G+L E+ +R+ FQQ++S
Sbjct: 68 QNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
VD+CH V HRDLKPEN+LLD + N K++DFGLS + L T CG+P Y AP
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSPNYAAP 184
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDAR 246
EV+ + Y G + DIWS GV+L+ LL G LPF ++++ +++KI + P +++
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244
Query: 247 RLISRILVADPQKRISVSEIMINPWFIKGFSKPV--------AVCIDDGDNRDFISSMSS 298
L+ +L DP KR ++ +I + WF + K + + IDD ++
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKF-- 302
Query: 299 GFDLSSLFESERKS 312
+
Sbjct: 303 ECSEEEVLSCLYNR 316
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 18/147 (12%), Positives = 51/147 (34%), Gaps = 2/147 (1%)
Query: 243 CDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRDFISSMSSGFDL 302
D RR+++ S + + + + + R + ++
Sbjct: 330 IDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSK 389
Query: 303 SSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNLGVCVK-EFKVKMQGKDEGRKGKLA 361
+ K S+ + IM ++ K+L+ V + ++++ K+
Sbjct: 390 HQ-GVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSK 448
Query: 362 VTAEVYEVAPEVAVVEFSKSAGDTLEY 388
++ ++Y+V +++F + LE
Sbjct: 449 MSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 456 bits (1175), Expect = e-161
Identities = 121/302 (40%), Positives = 186/302 (61%), Gaps = 10/302 (3%)
Query: 6 MDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR 65
M R+I G Y + LG+G+F KV + TQ+ VA+K I++ +KK + +++R
Sbjct: 1 MAISKRHI--GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER 58
Query: 66 EISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQL 124
EIS ++L++HP+I++L +V+ T T + VIEY GGELF V K ++ E+ R++FQQ+
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 125 ISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV 184
I A+++CH + HRDLKPENLLLD+N N+K++DFGLS + L T CG+P Y
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---GNFLKTSCGSPNYA 174
Query: 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCD 244
APEV+ K Y G + D+WSCG+VL+V+L G LPF +E I +++K+ Y P ++S
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPG 234
Query: 245 ARRLISRILVADPQKRISVSEIMINPWFIKGFS---KPVAVCIDDGDNRDFISSMSSGFD 301
A+ LI R++VADP +RI++ EI +PWF +P+ + +S +
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMG 294
Query: 302 LS 303
S
Sbjct: 295 FS 296
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 451 bits (1163), Expect = e-159
Identities = 117/341 (34%), Positives = 167/341 (48%), Gaps = 45/341 (13%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+Y+ + +G G F ++ +T+E VA+K I + + E ++REI R ++H
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRH 75
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCHSR 134
PNIV KEV+ T T + ++EY GGEL+ + G+ E+ AR +FQQL+S V +CHS
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 135 GVYHRDLKPENLLLDEN--GNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ HRDLK EN LLD + LK+ DFG S + GTPAY+APEVL ++
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRQ 192
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRK----IFKAEYEFPP--WISCDAR 246
YDG +D+WSCGV L+V+L G PF++ + YRK I +Y P IS +
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252
Query: 247 RLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGD------------------ 288
LISRI VADP RIS+ EI + WF+K + + G
Sbjct: 253 HLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQI 312
Query: 289 ----------NRDFISSMSSGFDLSSLFESERKSGSM-FTS 318
NR M+ DL + + S
Sbjct: 313 ISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDS 353
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 448 bits (1155), Expect = e-159
Identities = 89/262 (33%), Positives = 138/262 (52%), Gaps = 4/262 (1%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+Y GR LG+G FAK + + T+E A K++ K + K E++ EIS+ R + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCHSR 134
++V VF V+E + L + L E AR Y +Q++ + H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
V HRDLK NL L+E+ +K+ DFGL+ E + CGTP Y+APEVL KKG+
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 195 DGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILV 254
+ D+WS G +++ LL G PF+ + + Y +I K EY P I+ A LI ++L
Sbjct: 193 SF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 251
Query: 255 ADPQKRISVSEIMINPWFIKGF 276
DP R +++E++ + +F G+
Sbjct: 252 TDPTARPTINELLNDEFFTSGY 273
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 449 bits (1158), Expect = e-159
Identities = 89/262 (33%), Positives = 138/262 (52%), Gaps = 4/262 (1%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+Y GR LG+G FAK + + T+E A K++ K + K E++ EIS+ R + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCHSR 134
++V VF V+E + L + L E AR Y +Q++ + H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
V HRDLK NL L+E+ +K+ DFGL+ E + CGTP Y+APEVL KKG+
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 195 DGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILV 254
+ D+WS G +++ LL G PF+ + + Y +I K EY P I+ A LI ++L
Sbjct: 219 SF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277
Query: 255 ADPQKRISVSEIMINPWFIKGF 276
DP R +++E++ + +F G+
Sbjct: 278 TDPTARPTINELLNDEFFTSGY 299
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 445 bits (1147), Expect = e-158
Identities = 87/266 (32%), Positives = 153/266 (57%), Gaps = 5/266 (1%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+++G +LG+G+FA VY +++ T VAIK+I+K + K G++++++ E+ + +KH
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHS 133
P+I+EL V+ V+E GE+ + E AR + Q+I+ + + HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKG 193
G+ HRDL NLLL N N+K++DFGL+ + +T CGTP Y++PE+ +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIATRSA 188
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRIL 253
+ G +SD+WS G + + LL G PF + + K+ A+YE P ++S +A+ LI ++L
Sbjct: 189 H-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL 247
Query: 254 VADPQKRISVSEIMINPWFIKGFSKP 279
+P R+S+S ++ +P+ + S
Sbjct: 248 RRNPADRLSLSSVLDHPFMSRNSSTK 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 440 bits (1133), Expect = e-155
Identities = 95/297 (31%), Positives = 159/297 (53%), Gaps = 31/297 (10%)
Query: 7 DERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ--------- 57
+ +Y + +G+G++ V N A+KV++K ++ +Q
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 58 --------------GLMEQIKREISVMRLVKHPNIVELKEVM--ATKTKVFFVIEYVKGG 101
G +EQ+ +EI++++ + HPN+V+L EV+ + ++ V E V G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 102 ELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL 161
+ L E+ AR YFQ LI +++ H + + HRD+KP NLL+ E+G++K++DFG+
Sbjct: 124 PVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLR--KKGYDGAKSDIWSCGVVLFVLLSGFLPFQ 219
S + +D LL GTPA++APE L +K + G D+W+ GV L+ + G PF
Sbjct: 184 SNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
Query: 220 NENIMKMYRKIFKAEYEFP--PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274
+E IM ++ KI EFP P I+ D + LI+R+L +P+ RI V EI ++PW +
Sbjct: 242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 438 bits (1129), Expect = e-155
Identities = 86/269 (31%), Positives = 154/269 (57%), Gaps = 6/269 (2%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
R +++GR LG+G F VY + + +A+KV+ K Q++K+G+ Q++REI +
Sbjct: 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ 68
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVD 129
++HPNI+ + + +++ ++E+ GEL+ ++ K G+ E+ + + ++L A+
Sbjct: 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
+CH R V HRD+KPENLL+ G LK++DFG S T CGT Y+ PE++
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRTMCGTLDYLPPEMI 184
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249
K +D K D+W GV+ + L G PF + + + +R+I + +FPP++S ++ LI
Sbjct: 185 EGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 243
Query: 250 SRILVADPQKRISVSEIMINPWFIKGFSK 278
S++L P +R+ + +M +PW +
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 432 bits (1112), Expect = e-152
Identities = 94/281 (33%), Positives = 157/281 (55%), Gaps = 6/281 (2%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
R +E+GR LG+G F VY + ++ +A+KV+ K Q++K G+ Q++RE+ +
Sbjct: 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVD 129
++HPNI+ L T+V+ ++EY G ++ ++ K K E+ Y +L +A+
Sbjct: 64 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
+CHS+ V HRD+KPENLLL G LK++DFG S CGT Y+ PE++
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMI 179
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249
+ +D K D+WS GV+ + L G PF+ + Y++I + E+ FP +++ AR LI
Sbjct: 180 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 250 SRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNR 290
SR+L +P +R + E++ +PW SKP + ++
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 417 bits (1075), Expect = e-146
Identities = 110/304 (36%), Positives = 180/304 (59%), Gaps = 10/304 (3%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
G Y + + +G+G FAKV ++++T VAIK+I+K Q+ ++++ RE+ +M
Sbjct: 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS-LQKLFREVRIM 68
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVD 129
+++ HPNIV+L EV+ T+ ++ ++EY GGE+F V G++KE+ AR F+Q++SAV
Sbjct: 69 KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
+CH + + HRDLK ENLLLD + N+K++DFG S G L CG P Y APE+
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV---GGKLDAFCGAPPYAAPELF 185
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249
+ K YDG + D+WS GV+L+ L+SG LPF +N+ ++ ++ + +Y P ++S D L+
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLL 245
Query: 250 SRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDD----GDNRDFISSMSS-GFDLSS 304
R LV +P KR ++ +IM + W G + + ++ I M G+
Sbjct: 246 KRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEE 305
Query: 305 LFES 308
+ ES
Sbjct: 306 IQES 309
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 410 bits (1056), Expect = e-143
Identities = 88/279 (31%), Positives = 139/279 (49%), Gaps = 20/279 (7%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQ---IKREI 67
R +Y +G +LG+G F V+ G L + VAIKVI +++V + E+
Sbjct: 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 68 SVMRLV----KHPNIVELKEVMATKTKVFFVIEY-VKGGELFAK-VLKGKLKEESARKYF 121
+++ V HP ++ L + T+ V+E + +LF KG L E +R +F
Sbjct: 86 ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 122 QQLISAVDFCHSRGVYHRDLKPENLLLD-ENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180
Q+++A+ CHSRGV HRD+K EN+L+D G K+ DFG AL D GT
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYTDFDGT 201
Query: 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW 240
Y PE + + Y + +WS G++L+ ++ G +PF+ + ++I +AE FP
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAH 255
Query: 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
+S D LI R L P R S+ EI+++PW
Sbjct: 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 409 bits (1052), Expect = e-142
Identities = 83/316 (26%), Positives = 148/316 (46%), Gaps = 20/316 (6%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLME-----Q 62
KY LG G F V+ + + V +K I K++V + +E +
Sbjct: 16 AACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 63 IKREISVMRLVKHPNIVELKEVMATKTKVFFVIE-YVKGGELFAK-VLKGKLKEESARKY 120
+ EI+++ V+H NI+++ ++ + V+E + G +LFA +L E A
Sbjct: 76 VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 121 FQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180
F+QL+SAV + + + HRD+K EN+++ E+ +K+ DFG +A E+ L +T CGT
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER---GKLFYTFCGT 192
Query: 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW 240
Y APEVL Y G + ++WS GV L+ L+ PF + +A P
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYL 246
Query: 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPV----AVCIDDGDNRDFISSM 296
+S + L+S +L P++R ++ +++ +PW + + V + +S+
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAA 306
Query: 297 SSGFDLSSLFESERKS 312
S SL + +
Sbjct: 307 SLEMGNRSLSDVAQAQ 322
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 403 bits (1038), Expect = e-141
Identities = 82/277 (29%), Positives = 137/277 (49%), Gaps = 18/277 (6%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLM---EQIKREI 67
+ L +Y++G +LG G F VY G + VAIK + KD++ G + ++ E+
Sbjct: 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 68 SVMRLVKH--PNIVELKEVMATKTKVFFVIEYVKG-GELFAK-VLKGKLKEESARKYFQQ 123
+++ V ++ L + ++E + +LF +G L+EE AR +F Q
Sbjct: 98 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 124 LISAVDFCHSRGVYHRDLKPENLLLDEN-GNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
++ AV CH+ GV HRD+K EN+L+D N G LK+ DFG AL + D + GT
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRV 213
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWIS 242
Y PE +R Y G + +WS G++L+ ++ G +PF+++ +I + + F +S
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVS 267
Query: 243 CDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
+ + LI L P R + EI +PW
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 304
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 387 bits (995), Expect = e-134
Identities = 62/319 (19%), Positives = 136/319 (42%), Gaps = 51/319 (15%)
Query: 7 DERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ--------- 57
+ ++ Y + R L QG F K+ + + A+K K ++K+
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 58 -----GLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELF-------- 104
+ K E+ ++ +K+ + + ++ +V+ + EY++ +
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 105 -AKVLKGKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLS 162
K + + + + ++++ + H+ + + HRD+KP N+L+D+NG +K+SDFG S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 163 ALPEQLWNDGLLHTQCGTPAYVAPEVL-RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE 221
D + GT ++ PE + Y+GAK DIWS G+ L+V+ +PF +
Sbjct: 200 EYMV----DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
Query: 222 -NIMKMYRKIFKAEYEFP-------------------PWISCDARRLISRILVADPQKRI 261
++++++ I E+P ++S + + L +P +RI
Sbjct: 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 262 SVSEIMINPWFIKGFSKPV 280
+ + + + W + +
Sbjct: 316 TSEDALKHEWLADTNIEDL 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-114
Identities = 72/295 (24%), Positives = 127/295 (43%), Gaps = 37/295 (12%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+E +LGQG F +V +N + AIK I + K I E+ ++ + H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL----STILSEVMLLASLNHQ 62
Query: 77 NIVELKEV-------------MATKTKVFFVIEYVKGGELFAKVLKGKLK--EESARKYF 121
+V + K+ +F +EY + G L+ + L + + F
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 122 QQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ------------LW 169
+Q++ A+ + HS+G+ HRDLKP N+ +DE+ N+K+ DFGL+ +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRK 229
+ L + GT YVA EVL G+ K D++S G++ F ++ + + +K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKK 240
Query: 230 IFKAEYEFPPW----ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPV 280
+ EFPP +++I ++ DP KR ++ + W V
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV 295
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 322 bits (828), Expect = e-109
Identities = 90/264 (34%), Positives = 153/264 (57%), Gaps = 13/264 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y++ LG+G F+ V + T A K+IN ++ + ++++RE + R ++HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHP 65
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCHSRG 135
NIV L + + ++ + V + V GGELF V + E A QQ++ ++ +CHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 136 VYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ HR+LKPENLLL + +K++DFGL+ ++ + H GTP Y++PEVL+K
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
Y DIW+CGV+L++LL G+ PF +E+ ++Y +I Y++ P W ++ +A+ L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 249 ISRILVADPQKRISVSEIMINPWF 272
I +L +P+KRI+ + + PW
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWI 265
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-108
Identities = 98/319 (30%), Positives = 162/319 (50%), Gaps = 23/319 (7%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV-----KKQGLMEQIKREIS 68
L +Y M + LG G +V T + VAIK+I+K + ++ ++ EI
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 69 VMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISA 127
+++ + HP I+++K + + V+E ++GGELF K V +LKE + + YF Q++ A
Sbjct: 68 ILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 128 VDFCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV 184
V + H G+ HRDLKPEN+LL +E+ +K++DFG S + L+ T CGTP Y+
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYL 183
Query: 185 APEVLR---KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI-MKMYRKIFKAEYEF--P 238
APEVL GY D WS GV+LF+ LSG+ PF + + +I +Y F
Sbjct: 184 APEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 239 PW--ISCDARRLISRILVADPQKRISVSEIMINPWFI-KGFSKPVAVCIDDGDNRDFISS 295
W +S A L+ ++LV DP+ R + E + +PW + + + + + +
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQ 302
Query: 296 MSSGFDLSSLFESERKSGS 314
+ + S E ++
Sbjct: 303 VLAQPSTSRKRPREGEAEG 321
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 319 bits (820), Expect = e-108
Identities = 101/271 (37%), Positives = 156/271 (57%), Gaps = 17/271 (6%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+ +LG G F++V+ K +T + A+K I K + ++ EI+V++ +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHE 66
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCHSRG 135
NIV L+++ + T + V++ V GGELF + + +G E+ A QQ++SAV + H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 136 VYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ HRDLKPENLL +EN + ++DFGLS + + +G++ T CGTP YVAPEVL +K
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQK 182
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
Y D WS GV+ ++LL G+ PF E K++ KI + YEF P W IS A+
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSKP 279
I +L DP +R + + + +PW I G +
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPW-IDGNTAL 271
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-107
Identities = 93/275 (33%), Positives = 151/275 (54%), Gaps = 21/275 (7%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK-----QGLMEQIKREISVMR 71
KY+ ++G+G + V + T A+K++ + + + E +RE ++R
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 72 LVK-HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVD 129
V HP+I+ L + + + +F V + ++ GELF + K L E+ R + L+ AV
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
F H+ + HRDLKPEN+LLD+N +++SDFG S L L CGTP Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271
Query: 190 R------KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW- 240
+ GY G + D+W+CGV+LF LL+G PF + + M R I + +Y+F P W
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 241 -ISCDARRLISRILVADPQKRISVSEIMINPWFIK 274
S + LISR+L DP+ R++ + + +P+F +
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-107
Identities = 101/282 (35%), Positives = 150/282 (53%), Gaps = 22/282 (7%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK------QGLMEQIKREISVM 70
YE +LG+G + V + T + A+K+I+ Q L E +E+ ++
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 71 RLVK-HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAV 128
R V HPNI++LK+ T T F V + +K GELF + K L E+ RK + L+ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
H + HRDLKPEN+LLD++ N+K++DFG S QL L CGTP+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 194
Query: 189 LR------KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW 240
+ GY G + D+WS GV+++ LL+G PF + M M R I Y+F P W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 241 --ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPV 280
S + L+SR LV PQKR + E + +P+F + + V
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-107
Identities = 93/271 (34%), Positives = 145/271 (53%), Gaps = 16/271 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y + +G+G++ +V T+ A K I K V+ ++ K+EI +M+ + HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---DRFKQEIEIMKSLDHP 66
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRG 135
NI+ L E T ++ V+E GGELF +V+ K +E A + + ++SAV +CH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 136 VYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
V HRDLKPEN L + LK+ DFGL+A + ++ T+ GTP YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGTPYYVSPQVLEGL 183
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
Y G + D WS GV+++VLL G+ PF ++ KI + + F W +S A L
Sbjct: 184 -Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSKP 279
I R+L P++RI+ + + + WF K S
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-106
Identities = 90/264 (34%), Positives = 153/264 (57%), Gaps = 13/264 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y++ LG+G F+ V + T A K+IN ++ + ++++RE + R ++HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHP 88
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCHSRG 135
NIV L + + ++ + V + V GGELF V + E A QQ++ ++ +CHS G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 136 VYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ HR+LKPENLLL + +K++DFGL+ ++ + H GTP Y++PEVL+K
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
Y DIW+CGV+L++LL G+ PF +E+ ++Y +I Y++ P W ++ +A+ L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 249 ISRILVADPQKRISVSEIMINPWF 272
I +L +P+KRI+ + + PW
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWI 288
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-105
Identities = 95/276 (34%), Positives = 150/276 (54%), Gaps = 22/276 (7%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV-----KKQGLMEQIKREIS 68
L +Y M + LG G +V T + VAI++I+K + ++ ++ EI
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 69 VMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISA 127
+++ + HP I+++K + + V+E ++GGELF K V +LKE + + YF Q++ A
Sbjct: 193 ILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251
Query: 128 VDFCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV 184
V + H G+ HRDLKPEN+LL +E+ +K++DFG S + L+ T CGTP Y+
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYL 308
Query: 185 APEVLR---KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI-MKMYRKIFKAEYEF--P 238
APEVL GY D WS GV+LF+ LSG+ PF + + +I +Y F
Sbjct: 309 APEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367
Query: 239 PW--ISCDARRLISRILVADPQKRISVSEIMINPWF 272
W +S A L+ ++LV DP+ R + E + +PW
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-105
Identities = 96/270 (35%), Positives = 159/270 (58%), Gaps = 14/270 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y + MLG+G+F +V K+ +TQ+ A+KVINK K + I RE+ +++ + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHP 81
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRG 135
NI++L E++ + + V E GGELF +++ + + E A + +Q+ S + + H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 136 VYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ HRDLKPEN+LL +++ ++K+ DFGLS + + + + GT Y+APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEVLRGT 198
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
Y K D+WS GV+L++LLSG PF +N + +++ +Y F P W IS DA+ L
Sbjct: 199 -Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSK 278
I ++L P RI+ ++ + +PW K S+
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-105
Identities = 85/270 (31%), Positives = 146/270 (54%), Gaps = 18/270 (6%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+ R LG G F V+ + + IK INKD+ + MEQI+ EI V++ + HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHP 80
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL-----KGKLKEESARKYFQQLISAVDFC 131
NI+++ EV ++ V+E +GGEL +++ L E + +Q+++A+ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 132 HSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
HS+ V H+DLKPEN+L + +K+ DFGL+ L + +D GT Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK---SDEHSTNAAGTALYMAPEV 197
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP--PW-ISCDA 245
++ K DIWS GVV++ LL+G LPF ++ ++ +K E + ++ A
Sbjct: 198 FKRD-V-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 246 RRLISRILVADPQKRISVSEIMINPWFIKG 275
L+ ++L DP++R S ++++ + WF +
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-103
Identities = 93/264 (35%), Positives = 156/264 (59%), Gaps = 12/264 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y++ LG+G F+ V ++ + A +IN ++ + ++++RE + RL+KHP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHP 70
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRG 135
NIV L + ++ + + + + V GGELF ++ + E A QQ++ AV CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 136 VYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
V HR+LKPENLLL + +K++DFGL+ E GTP Y++PEVLRK
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKD 188
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
Y G D+W+CGV+L++LL G+ PF +E+ ++Y++I Y+F P W ++ +A+ L
Sbjct: 189 PY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 249 ISRILVADPQKRISVSEIMINPWF 272
I+++L +P KRI+ +E + +PW
Sbjct: 248 INKMLTINPSKRITAAEALKHPWI 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-102
Identities = 71/272 (26%), Positives = 130/272 (47%), Gaps = 20/272 (7%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y + + +G G +KV+ N ++ AIK +N ++ Q ++ + EI+ + ++
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 86
Query: 77 N--IVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCHS 133
+ I+ L + T ++ V+E +L + K + + Y++ ++ AV H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKG 193
G+ H DLKP N L+ +G LK+ DFG++ + + +Q GT Y+ PE ++
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 194 YD----------GAKSDIWSCGVVLFVLLSGFLPFQ--NENIMKMYRKI-FKAEYEFPPW 240
KSD+WS G +L+ + G PFQ I K++ I E EFP
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 241 ISCDARRLISRILVADPQKRISVSEIMINPWF 272
D + ++ L DP++RIS+ E++ +P+
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-101
Identities = 106/268 (39%), Positives = 160/268 (59%), Gaps = 19/268 (7%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+E+ LG+G + VY K TQ+ A+KV+ K K + ++ EI V+ + HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-----KIVRTEIGVLLRLSHP 108
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCHSRG 135
NI++LKE+ T T++ V+E V GGELF + V KG E A +Q++ AV + H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 136 VYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ HRDLKPENLL + LK++DFGLS + E + L+ T CGTP Y APE+LR
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQVLMKTVCGTPGYCAPEILRGC 225
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNE-NIMKMYRKIFKAEYEF--PPW--ISCDARR 247
Y G + D+WS G++ ++LL GF PF +E M+R+I EY F P W +S +A+
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 248 LISRILVADPQKRISVSEIMINPWFIKG 275
L+ +++V DP+KR++ + + +PW + G
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPW-VTG 311
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-101
Identities = 86/270 (31%), Positives = 153/270 (56%), Gaps = 18/270 (6%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLM--EQIKREISVMRLVK 74
YE+ ++G+G F+ V N T + A+K+++ + + E +KRE S+ ++K
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVD 129
HP+IVEL E ++ ++ V E++ G +L +++K E A Y +Q++ A+
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 130 FCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
+CH + HRD+KP +LL + + +K+ FG++ + + + + GTP ++AP
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGGRVGTPHFMAP 202
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--IS 242
EV++++ Y G D+W CGV+LF+LLSG LPF +++ I K +Y+ W IS
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260
Query: 243 CDARRLISRILVADPQKRISVSEIMINPWF 272
A+ L+ R+L+ DP +RI+V E + +PW
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWL 290
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = e-100
Identities = 91/276 (32%), Positives = 149/276 (53%), Gaps = 16/276 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ---GLMEQIKREISVMRLV 73
YEMG LG G FA V + T + A K I K ++ E+I+RE++++R +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCH 132
+HPNI+ L ++ KT V ++E V GGELF + K L E+ A ++ +Q++ V + H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 133 SRGVYHRDLKPENLLL----DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
S+ + H DLKPEN++L N +K+ DFG++ E GTP +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNIFGTPEFVAPEI 182
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCD 244
+ + G ++D+WS GV+ ++LLSG PF E + I Y+F + S
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 245 ARRLISRILVADPQKRISVSEIMINPWFIKGFSKPV 280
A+ I R+LV DP++R+++++ + + W + V
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = e-100
Identities = 64/310 (20%), Positives = 120/310 (38%), Gaps = 51/310 (16%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
++ + + +LGQG A V+ G++ T + AIKV N + ++ RE V+
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVL 61
Query: 71 RLVKHPNIVELKEVMATKTK--VFFVIEYVKGGELFAKVLK----GKLKEESARKYFQQL 124
+ + H NIV+L + T ++E+ G L+ + + L E + +
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 125 ISAVDFCHSRGVYHRDLKPENLLL----DENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180
+ ++ G+ HR++KP N++ D K++DFG + +L +D + GT
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGT 178
Query: 181 PAYVAPEVLRKKGYD-------GAKSDIWSCGVVLFVLLSGFLPF----QNENIMKMYRK 229
Y+ P++ + GA D+WS GV + +G LPF ++ K
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238
Query: 230 IFKAEY-------------------EFPPW------ISCDARRLISRILVADPQKRISVS 264
I + + P + +++ IL AD +K
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298
Query: 265 EIMINPWFIK 274
+ I
Sbjct: 299 QFFAETSDIL 308
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 2e-99
Identities = 87/287 (30%), Positives = 148/287 (51%), Gaps = 24/287 (8%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKH 75
YE+ +G G+++ + T A+K+I+K EI ++ R +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-------KRDPTEEIEILLRYGQH 75
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSR 134
PNI+ LK+V V+ V E +KGGEL K+L + E A + V++ H++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 135 GVYHRDLKPENLLL----DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
GV HRDLKP N+L ++++ DFG + +GLL T C T +VAPEVL
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLLMTPCYTANFVAPEVLE 193
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPF---QNENIMKMYRKIFKAEYEF--PPW--ISC 243
++GYD A DIWS GV+L+ +L+G+ PF ++ ++ +I ++ W +S
Sbjct: 194 RQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 244 DARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNR 290
A+ L+S++L DP +R++ + ++ +PW I + + ++ D
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPW-IVHWDQLPQYQLNRQDAP 298
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 299 bits (766), Expect = 2e-99
Identities = 86/318 (27%), Positives = 142/318 (44%), Gaps = 52/318 (16%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK--QGLMEQIKREISVMRLVK 74
KY + +GQG++ V T+ AIK++NK+++++ +E+IK E+ +M+ +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK------------------------- 109
HPNI L EV + + V+E GG L K+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 110 ----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL--DEN 151
+E+ +Q+ SA+ + H++G+ HRD+KPEN L +++
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 152 GNLKVSDFGLSAL--PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD-GAKSDIWSCGVVL 208
+K+ DFGLS + T+ GTP +VAPEVL G K D WS GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 209 FVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRLISRILVADPQKRISVS 264
+LL G +PF N ++ + F P + +S AR L+S +L + +R
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326
Query: 265 EIMINPWFIKGFSKPVAV 282
+ +PW + K +
Sbjct: 327 RALQHPWISQFSDKIYKM 344
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 3e-98
Identities = 97/288 (33%), Positives = 164/288 (56%), Gaps = 15/288 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y + MLG+G+F +V K+ +TQ+ A+KVINK K + I RE+ +++ + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDHP 81
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRG 135
NI++L E++ + + V E GGELF +++ + + E A + +Q+ S + + H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 136 VYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ HRDLKPEN+LL +++ ++K+ DFGLS + + + GT Y+APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
Y K D+WS GV+L++LLSG PF +N + +++ +Y F P W IS DA+ L
Sbjct: 199 -Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRDFISSM 296
I ++L P RI+ ++ + +PW I+ +S D ++++
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPW-IQKYSSETPTISDLPSLESAMTNI 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 6e-98
Identities = 70/273 (25%), Positives = 129/273 (47%), Gaps = 20/273 (7%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
Y + + +G G +KV+ N ++ AIK +N ++ Q ++ + EI+ + ++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQ 113
Query: 76 PN--IVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCH 132
+ I+ L + T ++ V+E +L + K + + Y++ ++ AV H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
G+ H DLKP N L+ +G LK+ DFG++ + + +Q G Y+ PE ++
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 193 GYD----------GAKSDIWSCGVVLFVLLSGFLPFQ--NENIMKMYRKI-FKAEYEFPP 239
KSD+WS G +L+ + G PFQ I K++ I E EFP
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 240 WISCDARRLISRILVADPQKRISVSEIMINPWF 272
D + ++ L DP++RIS+ E++ +P+
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 300 bits (769), Expect = 7e-98
Identities = 97/288 (33%), Positives = 161/288 (55%), Gaps = 15/288 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y+ R+LG+G+F +V K+ +T + A+KVI+K QVK++ E + RE+ +++ + HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRG 135
NI++L E K + V E GGELF +++ + + E A + +Q++S + + H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 136 VYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ HRDLKPENLLL ++ N+++ DFGLS + + GT Y+APEVL
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVLHGT 203
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
Y K D+WS GV+L++LLSG PF N + +K+ K +Y F P W +S A+ L
Sbjct: 204 -Y-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRDFISSM 296
I ++L P RIS + + + W + ++ +D + I ++
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQIS--VDVPSLDNAILNI 307
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 2e-97
Identities = 71/272 (26%), Positives = 130/272 (47%), Gaps = 20/272 (7%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y + + +G G +KV+ N ++ AIK +N ++ Q ++ + EI+ + ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 67
Query: 77 N--IVELKEVMATKTKVFFVIEYVKGGELFAK-VLKGKLKEESARKYFQQLISAVDFCHS 133
+ I+ L + T ++ V+E +L + K + + Y++ ++ AV H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKG 193
G+ H DLKP N L+ +G LK+ DFG++ + + +Q GT Y+ PE ++
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 194 YD----------GAKSDIWSCGVVLFVLLSGFLPFQ--NENIMKMYRKI-FKAEYEFPPW 240
KSD+WS G +L+ + G PFQ I K++ I E EFP
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 241 ISCDARRLISRILVADPQKRISVSEIMINPWF 272
D + ++ L DP++RIS+ E++ +P+
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 2e-97
Identities = 91/276 (32%), Positives = 145/276 (52%), Gaps = 16/276 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLM---EQIKREISVMRLV 73
Y+ G LG G FA V + T A K I K + K E I+RE+S+++ +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCH 132
+HPN++ L EV KT V ++E V GGELF + K L EE A ++ +Q+++ V + H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 133 SRGVYHRDLKPENLLL----DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
S + H DLKPEN++L +K+ DFGL+ + GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIFGTPEFVAPEI 188
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCD 244
+ + G ++D+WS GV+ ++LLSG PF + + + YEF + S
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 245 ARRLISRILVADPQKRISVSEIMINPWFIKGFSKPV 280
A+ I R+LV DP+KR+++ + + +PW ++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 3e-97
Identities = 87/275 (31%), Positives = 147/275 (53%), Gaps = 16/275 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK---QGLMEQIKREISVMRLV 73
Y++G LG G FA V + T A K I K Q + E+I+RE+S++R V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCH 132
H N++ L +V +T V ++E V GGELF + K L EE A + +Q++ V++ H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 133 SRGVYHRDLKPENLLL----DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
++ + H DLKPEN++L ++K+ DFGL+ ++ + GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEI 189
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCD 244
+ + G ++D+WS GV+ ++LLSG PF + + I Y+F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 245 ARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
A+ I ++LV + +KR+++ E + +PW ++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 4e-97
Identities = 63/310 (20%), Positives = 118/310 (38%), Gaps = 51/310 (16%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM 70
++ + + +LGQG A V+ G++ T + AIKV N + ++ RE V+
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVL 61
Query: 71 RLVKHPNIVELKEVMATKTK--VFFVIEYVKGGELFAKVLK----GKLKEESARKYFQQL 124
+ + H NIV+L + T ++E+ G L+ + + L E + +
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 125 ISAVDFCHSRGVYHRDLKPENLLL----DENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180
+ ++ G+ HR++KP N++ D K++DFG + +L +D + GT
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGT 178
Query: 181 PAYVAPEVLRKKGYD-------GAKSDIWSCGVVLFVLLSGFLPF----QNENIMKMYRK 229
Y+ P++ + GA D+WS GV + +G LPF ++ K
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238
Query: 230 IFKAEY-------------------------EFPPWISCDARRLISRILVADPQKRISVS 264
I + + +++ IL AD +K
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298
Query: 265 EIMINPWFIK 274
+ I
Sbjct: 299 QFFAETSDIL 308
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 5e-97
Identities = 89/275 (32%), Positives = 148/275 (53%), Gaps = 16/275 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK---QGLMEQIKREISVMRLV 73
Y++G LG G FA V + T A K I K Q + E+I+RE+S++R V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCH 132
HPNI+ L +V +T V ++E V GGELF + K L EE A + +Q++ V++ H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 133 SRGVYHRDLKPENLLL----DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
++ + H DLKPEN++L ++K+ DFGL+ ++ + GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEI 189
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCD 244
+ + G ++D+WS GV+ ++LLSG PF + + I Y+F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 245 ARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
A+ I ++LV + +KR+++ E + +PW ++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQ 283
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 8e-97
Identities = 96/282 (34%), Positives = 153/282 (54%), Gaps = 28/282 (9%)
Query: 17 KYEMG---RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
Y++ + LG+G+F+ + + ++ A+K+I+K ++EI+ ++L
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLC 62
Query: 74 K-HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFC 131
+ HPNIV+L EV + F V+E + GGELF ++ K E A ++L+SAV
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 132 HSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
H GV HRDLKPENLL ++N +K+ DFG + L ++ L T C T Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-------IMKMYRKIFKAEYEF--PP 239
L + GYD D+WS GV+L+ +LSG +PFQ+ + +++ +KI K ++ F
Sbjct: 181 LNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 240 W--ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
W +S +A+ LI +L DP KR+ +S + N W G
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = 1e-96
Identities = 74/294 (25%), Positives = 117/294 (39%), Gaps = 43/294 (14%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
G +EM LG G F V + T E VAIK ++ K E+ EI +M+ + H
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNH 71
Query: 76 PNIVELKEVMATKTKV------FFVIEYVKGGELFAKVLK----GKLKEESARKYFQQLI 125
PN+V +EV K+ +EY +GG+L + + LKE R +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGN---LKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
SA+ + H + HRDLKPEN++L K+ D G + +Q L GT
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---GELCTEFVGTLQ 188
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW-- 240
Y+APE+L +K Y D WS G + F ++GF PF + + +
Sbjct: 189 YLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 241 ----------------------ISCDARRLISRILVADPQKRISVSEIMINPWF 272
++ R + +L+ ++R + + F
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 1e-95
Identities = 103/271 (38%), Positives = 159/271 (58%), Gaps = 14/271 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y+ + LG G + +V ++ VT AIK+I K V ++ E++V++L+ HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHP 96
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRG 135
NI++L + K + V+E KGGELF +++ + K E A +Q++S V + H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 136 VYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ HRDLKPENLLL +++ +K+ DFGLSA+ E N + + GT Y+APEVLRKK
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---NQKKMKERLGTAYYIAPEVLRKK 213
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
Y K D+WS GV+LF+LL+G+ PF + ++ RK+ K +Y F P W +S A+ L
Sbjct: 214 -Y-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSKP 279
I ++L D Q+RIS + + +PW + SK
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 1e-95
Identities = 88/291 (30%), Positives = 151/291 (51%), Gaps = 39/291 (13%)
Query: 17 KYEMGR-MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK- 74
Y++ +LG+G A+V NL+T + A+K+I K + ++ RE+ ++ +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQG 69
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHS 133
H N++EL E + + + V E ++GG + + + + E A Q + SA+DF H+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 134 RGVYHRDLKPENLLL---DENGNLKVSDFGLSAL--PEQLWND---GLLHTQCGTPAYVA 185
+G+ HRDLKPEN+L ++ +K+ DF L + + L T CG+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 186 PEVLRK-----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI---------------MK 225
PEV+ YD + D+WS GV+L++LLSG+ PF
Sbjct: 190 PEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 226 MYRKIFKAEYEF--PPW--ISCDARRLISRILVADPQKRISVSEIMINPWF 272
++ I + +YEF W ISC A+ LIS++LV D ++R+S ++++ +PW
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 2e-95
Identities = 99/283 (34%), Positives = 149/283 (52%), Gaps = 23/283 (8%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK----------QGLMEQIKRE 66
Y R LG G + +V K AIKVI K Q K + E+I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 67 ISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLI 125
IS+++ + HPNI++L +V K + V E+ +GGELF +++ + K E A +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 126 SAVDFCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
S + + H + HRD+KPEN+LL + N+K+ DFGLS D L + GT
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFSKDYKLRDRLGTAY 213
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW 240
Y+APEVL+KK Y K D+WSCGV++++LL G+ PF +N + +K+ K +Y F W
Sbjct: 214 YIAPEVLKKK-Y-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 241 --ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVA 281
IS +A+ LI +L D KR + E + + W K +
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK 314
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 6e-95
Identities = 74/275 (26%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 17 KYEM-GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
Y + + LG+G FA V + T + A K + K + + +I EI+V+ L K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILHEIAVLELAKS 87
Query: 76 -PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFC 131
P ++ L EV +++ ++EY GGE+F+ L + E + +Q++ V +
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 132 HSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
H + H DLKP+N+LL G++K+ DFG+S ++ + L GTP Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIMGTPEYLAPEI 204
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCD 244
L +D+W+ G++ ++LL+ PF E+ + Y I + ++ + +S
Sbjct: 205 LNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 245 ARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
A I +LV +P+KR + + + W + +
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 2e-94
Identities = 74/274 (27%), Positives = 134/274 (48%), Gaps = 17/274 (6%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KY + LG+G F V+ ++++ K + + +K+EIS++ + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL--KGKLKEESARKYFQQLISAVDFCHSR 134
NI+ L E + ++ + E++ G ++F ++ +L E Y Q+ A+ F HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 135 GVYHRDLKPENLLL--DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ H D++PEN++ + +K+ +FG + QL P Y APEV +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
+D+WS G +++VLLSG PF E ++ I AEY F + IS +A
Sbjct: 179 VV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSKPVAV 282
+ R+LV + + R++ SE + +PW +K + V+
Sbjct: 238 VDRLLVKERKSRMTASEALQHPW-LKQKIERVST 270
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 2e-93
Identities = 73/271 (26%), Positives = 136/271 (50%), Gaps = 15/271 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y++ LG G F V+ T K IN + +K EIS+M + HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHP 108
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSR 134
++ L + K ++ ++E++ GGELF ++ K+ E Y +Q + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 135 GVYHRDLKPENLLL--DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ H D+KPEN++ + ++K+ DFGL+ +L D ++ T + APE++ ++
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
G +D+W+ GV+ +VLLSG PF E+ ++ + + + ++EF + +S +A+
Sbjct: 226 PV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSKP 279
I +L +P+KR++V + + +PW S
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 289 bits (740), Expect = 1e-92
Identities = 92/388 (23%), Positives = 159/388 (40%), Gaps = 16/388 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y++ LG G F V+ T + A K + + E +++EI M +++HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRHP 214
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL--KGKLKEESARKYFQQLISAVDFCHSR 134
+V L + ++ + E++ GGELF KV K+ E+ A +Y +Q+ + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 135 GVYHRDLKPENLLL--DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
H DLKPEN++ + LK+ DFGL+A L + GT + APEV K
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDARRL 248
G +D+WS GV+ ++LLSG PF EN + R + ++ + IS D +
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRDFISSMSSGFDLSSLFES 308
I ++L+ADP R+++ + + +PW G + I S+ + +D
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLP 450
Query: 309 ERKSGSMFTSKCSSSAIMGKLESLAKKLNLGVCVKEFKVKMQGKDEGRKGKLAVTAEVYE 368
S ++S + + K EG+
Sbjct: 451 PLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVGEGQSANFYCRVIASS 510
Query: 369 VAPEVAVVEFSKSAGDTLEYKKFCEEDV 396
P V + + +++Y K +
Sbjct: 511 -PPVVTWHKDDRELKQSVKYMKRYNGND 537
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 2e-92
Identities = 84/284 (29%), Positives = 140/284 (49%), Gaps = 18/284 (6%)
Query: 17 KYEMGRM--LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
Y + + LG G F +V+ + T +A K+I +K + E++K EISVM +
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLD 144
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL--KGKLKEESARKYFQQLISAVDFCH 132
H N+++L + +K + V+EYV GGELF +++ L E + +Q+ + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 133 SRGVYHRDLKPENLLL--DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
+ H DLKPEN+L + +K+ DFGL+ + L GTP ++APEV+
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNFGTPEFLAPEVVN 261
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPW--ISCDAR 246
+D+WS GV+ ++LLSG PF +N + I ++ + IS +A+
Sbjct: 262 YDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 247 RLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNR 290
IS++L+ + RIS SE + +PW + + NR
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPW-LSDHKLHSRLSAQKKKNR 363
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 5e-92
Identities = 87/283 (30%), Positives = 147/283 (51%), Gaps = 33/283 (11%)
Query: 17 KYEMGR-MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVK 74
Y++ + +LG G KV + T + A+K++ + ++E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDHHWQASG 80
Query: 75 HPNIVELKEV----MATKTKVFFVIEYVKGGELFAKVLKGKLK---EESARKYFQQLISA 127
P+IV + +V K + ++E ++GGELF+++ + + E A + + + +A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 128 VDFCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV 184
+ F HS + HRD+KPENLL +++ LK++DFG + Q L T C TP YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYV 196
Query: 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPF----QNENIMKMYRKIFKAEYEF--P 238
APEVL + YD D+WS GV++++LL GF PF M R+I +Y F P
Sbjct: 197 APEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 239 PW--ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
W +S DA++LI +L DP +R+++++ M +PW + P
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 1e-91
Identities = 88/281 (31%), Positives = 144/281 (51%), Gaps = 31/281 (11%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHP 76
++LG G KV N TQE A+K++ + +RE+ + R + P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115
Query: 77 NIVELKEV----MATKTKVFFVIEYVKGGELFAKVLKGKLK---EESARKYFQQLISAVD 129
+IV + +V A + + V+E + GGELF+++ + E A + + + A+
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 130 FCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
+ HS + HRD+KPENLL N LK++DFG + L T C TP YVAP
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAP 232
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM----KMYRKIFKAEYEF--PPW 240
EVL + YD D+WS GV++++LL G+ PF + + + M +I +YEF P W
Sbjct: 233 EVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 241 --ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
+S + + LI +L +P +R++++E M +PW ++ P
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 3e-90
Identities = 85/262 (32%), Positives = 148/262 (56%), Gaps = 8/262 (3%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
++ G++LG+G+F+ V + L T AIK++ K + K+ + + RE VM + HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
V+L K++F + Y K GEL + K G E R Y +++SA+++ H +G+
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
HRDLKPEN+LL+E+ +++++DFG + + ++ GT YV+PE+L +K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVAD 256
+ SD+W+ G +++ L++G PF+ N +++KI K EY+FP AR L+ ++LV D
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 257 PQKRI------SVSEIMINPWF 272
KR+ + +P+F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFF 292
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 4e-90
Identities = 49/300 (16%), Positives = 96/300 (32%), Gaps = 54/300 (18%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-- 74
G +LGQ + T ES + V + ++Q+K E+ +RL++
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 75 -----------------------HPNIVELKEVMATKTKVFFVIEY--------VKGGEL 103
++ ++ + Y G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 104 FAKVLKGKLKEESARKY-FQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162
+ K AR Q+I + H G+ H L+P +++LD+ G + ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 163 ALPEQLWNDGLLHTQCGTPAYVAPEVL----------RKKGYDGAKSDIWSCGVVLFVLL 212
DG + + PE+ ++ D W+ G+V++ +
Sbjct: 254 VR------DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 213 SGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272
LP + + IF++ P R L+ L + R+ + M P +
Sbjct: 308 CADLPITKDAALGGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDRLLPLQAMETPEY 363
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 8e-87
Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVKH 75
+ + R+L +G FA VY +++ + A+K + ++ +K I +E+ M+ L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGH 85
Query: 76 PNIVEL-------KEVMATKTKVFFVIEYVKGGELF----AKVLKGKLKEESARKYFQQL 124
PNIV+ KE T F ++ + G+L +G L ++ K F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 125 ISAVDFCHSRG--VYHRDLKPENLLLDENGNLKVSDFGLSALP----------EQLWNDG 172
AV H + + HRDLK ENLLL G +K+ DFG + ++
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 173 LLHTQCGTPAYVAPEV--LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI 230
T+ TP Y PE+ L G K DIW+ G +L++L PF++ + +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RI 261
Query: 231 FKAEYEFPPW--ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
+Y PP LI +L +P++R+S++E++ I
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 2e-85
Identities = 62/280 (22%), Positives = 113/280 (40%), Gaps = 24/280 (8%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y + LG+G F+ V + L A+K I + + + E+ +RE + RL HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNHP 86
Query: 77 NIVELKEV----MATKTKVFFVIEYVKGGELF-----AKVLKGKLKEESARKYFQQLISA 127
NI+ L K + + ++ + K G L+ K L E+ +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP-------EQLWNDGLLHTQCGT 180
++ H++G HRDLKP N+LL + G + D G Q Q T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 181 PAYVAPEVLRKKGYD--GAKSDIWSCGVVLFVLLSGFLPFQNENI-MKMYRKIFKAEYEF 237
+Y APE+ + + ++D+WS G VL+ ++ G P+ + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 238 PPW--ISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275
P S +L++ ++ DP +R + ++ ++
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 3e-84
Identities = 80/282 (28%), Positives = 145/282 (51%), Gaps = 17/282 (6%)
Query: 1 MKFETMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLM 60
+ F++M+ KY + +G+G+F K K+ IK IN ++ +
Sbjct: 18 LYFQSME---------KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER- 67
Query: 61 EQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK---LKEESA 117
E+ +RE++V+ +KHPNIV+ +E ++ V++Y +GG+LF ++ K +E+
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 118 RKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ 177
+F Q+ A+ H R + HRD+K +N+ L ++G +++ DFG++ + L
Sbjct: 128 LDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARAC 185
Query: 178 CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE- 236
GTP Y++PE+ K Y+ KSDIW+ G VL+ L + F+ ++ + KI +
Sbjct: 186 IGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP 244
Query: 237 FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSK 278
S D R L+S++ +P+ R SV+ I+ + K K
Sbjct: 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 1e-83
Identities = 81/271 (29%), Positives = 138/271 (50%), Gaps = 17/271 (6%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
YE+ +G G++ + + + + K ++ + + + + E++++R +KHP
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 65
Query: 77 NIVELKE--VMATKTKVFFVIEYVKGGELFAKVLKGK-----LKEESARKYFQQLISAVD 129
NIV + + T T ++ V+EY +GG+L + + KG L EE + QL A+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 130 FCHSRG-----VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV 184
CH R V HRDLKP N+ LD N+K+ DFGL+ + + T GTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYM 183
Query: 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF-PPWISC 243
+PE + + Y+ KSDIWS G +L+ L + PF + ++ KI + ++ P S
Sbjct: 184 SPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242
Query: 244 DARRLISRILVADPQKRISVSEIMINPWFIK 274
+ +I+R+L R SV EI+ NP ++
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 2e-82
Identities = 88/262 (33%), Positives = 156/262 (59%), Gaps = 14/262 (5%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+++ R LG G+F +V+ ++ A+KV+ K+ V + +E E ++ +V HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
I+ + ++F +++Y++GGELF+ + K + A+ Y ++ A+++ HS+ +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
+RDLKPEN+LLD+NG++K++DFG + + +T CGTP Y+APEV+ K Y+
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYTLCGTPDYIAPEVVSTKPYN- 181
Query: 197 AKS-DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255
KS D WS G++++ +L+G+ PF + N MK Y KI AE FPP+ + D + L+SR++
Sbjct: 182 -KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR 240
Query: 256 DPQKRI-----SVSEIMINPWF 272
D +R+ ++ +PWF
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPWF 262
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-81
Identities = 84/261 (32%), Positives = 146/261 (55%), Gaps = 12/261 (4%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
++ + LG G+F +V K+ + A+K+++K +V K +E E +++ V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
+V+L+ + ++ V+EYV GGE+F+ + + G+ E AR Y Q++ ++ HS +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
+RDLKPENLL+D+ G ++V+DFG + G T CGTP +APE++ KGY+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVAD 256
A D W+ GV+++ + +G+ PF + +++Y KI + FP S D + L+ +L D
Sbjct: 218 A-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 257 PQKRI-----SVSEIMINPWF 272
KR V++I + WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 2e-81
Identities = 59/259 (22%), Positives = 108/259 (41%), Gaps = 11/259 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
++ LG G++ +V+ ++ A+K + ++ S ++ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSR 134
V L++ ++ E G L L E Y + + A+ HS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
G+ H D+KP N+ L G K+ DFGL +L G Q G P Y+APE+L+ Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQ-GSY 232
Query: 195 DGAKSDIWSCGVVLFVLLSGF-LPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRIL 253
+D++S G+ + + LP E ++ + EF +S + R ++ +L
Sbjct: 233 G-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP--EFTAGLSSELRSVLVMML 289
Query: 254 VADPQKRISVSEIMINPWF 272
DP+ R + ++ P
Sbjct: 290 EPDPKLRATAEALLALPVL 308
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 3e-81
Identities = 75/361 (20%), Positives = 131/361 (36%), Gaps = 73/361 (20%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVKH 75
++LG G+ V + + VA+K + D + EI ++ H
Sbjct: 16 LVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDH 68
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--------GKLKEESARKYFQQLISA 127
PN++ T ++ +E L V KE + +Q+ S
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 128 VDFCHSRGVYHRDLKPENLLLD-------------ENGNLKVSDFGLSAL--PEQLWNDG 172
V HS + HRDLKP+N+L+ EN + +SDFGL Q
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 173 LLHTQCGTPAYVAPEVLRKKGYD------GAKSDIWSCGVVLFVLLS-GFLPFQNENIMK 225
L+ GT + APE+L + DI+S G V + +LS G PF ++ +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 226 MYRKIFKAEYEFPPW-------ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSK 278
I + + + +A LIS+++ DP KR + +++ +P F
Sbjct: 248 S--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF------ 299
Query: 279 PVAVCIDDGDNRDFISSMSSGFDLSSLFESERKSGSMFTSKCSSSAIMGKLESLAKKLNL 338
+F+ +S E E + SA++ K ++ + +
Sbjct: 300 -----WPKSKKLEFLL------KVSDRLEIENRD--------PPSALLMKFDAGSDFVIP 340
Query: 339 G 339
Sbjct: 341 S 341
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 3e-81
Identities = 67/291 (23%), Positives = 122/291 (41%), Gaps = 40/291 (13%)
Query: 4 ETMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQI 63
T+D+R ++ ++G G F +V+ K+ + ++ IK + + E+
Sbjct: 3 HTVDKRFGM----DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKA 51
Query: 64 KREISVMRLVKHPNIVELKE----------------VMATKTKVFFVIEYVKGGELFAKV 107
+RE+ + + H NIV + +F +E+ G L +
Sbjct: 52 EREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI 111
Query: 108 LKGK---LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164
K + L + A + F+Q+ VD+ HS+ + +RDLKP N+ L + +K+ DFGL
Sbjct: 112 EKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT- 170
Query: 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENI 223
L NDG GT Y++PE + + Y + D+++ G++L LL F+
Sbjct: 171 --SLKNDGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETSKF 227
Query: 224 MKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274
R + L+ ++L P+ R + SEI+ K
Sbjct: 228 FTDLRDG-----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 4e-80
Identities = 80/281 (28%), Positives = 135/281 (48%), Gaps = 52/281 (18%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHP 76
++LG G KV N TQE A+K++ + +RE+ + R + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 77 NIVELKEV----MATKTKVFFVIEYVKGGELFAKVL-KGKLK--EESARKYFQQLISAVD 129
+IV + +V A + + V+E + GGELF+++ +G E A + + + A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 130 FCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
+ HS + HRD+KPENLL N LK++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM----KMYRKIFKAEYEF--PPW 240
E +K YD D+WS GV++++LL G+ PF + + + M +I +YEF P W
Sbjct: 169 ETTGEK-YD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 241 --ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
+S + + LI +L +P +R++++E M +PW ++ P
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 1e-79
Identities = 69/287 (24%), Positives = 112/287 (39%), Gaps = 27/287 (9%)
Query: 4 ETMDERVRNILFGK--YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLME 61
+ DE ++ GK + +LG G + Y + + VA+K I +
Sbjct: 10 DDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC------FS 62
Query: 62 QIKREISVMR-LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESAR 118
RE+ ++R +HPN++ + + IE L V +
Sbjct: 63 FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPI 121
Query: 119 KYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN-----LKVSDFGLSA-LPEQLWNDG 172
QQ S + HS + HRDLKP N+L+ +SDFGL L +
Sbjct: 122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181
Query: 173 LLHTQCGTPAYVAPEVLR---KKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYR 228
GT ++APE+L K+ DI+S G V + ++S G PF +
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI 240
Query: 229 KIFKAEYEFPPW---ISCDARRLISRILVADPQKRISVSEIMINPWF 272
+ + AR LI +++ DPQKR S ++ +P+F
Sbjct: 241 LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 3e-78
Identities = 88/261 (33%), Positives = 151/261 (57%), Gaps = 13/261 (4%)
Query: 22 RMLGQGTFAKVYYGKNLV---TQESVAIKVINKDQ-VKKQGLMEQIKREISVMRLVKHPN 77
R+LG+G + KV+ + + T + A+KV+ K V+ K E +++ VKHP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGV 136
IV+L T K++ ++EY+ GGELF ++ + G E++A Y ++ A+ H +G+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
+RDLKPEN++L+ G++K++DFGL E + + + HT CGT Y+APE+L + G++
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVAD 256
A D WS G +++ +L+G PF EN K KI K + PP+++ +AR L+ ++L +
Sbjct: 201 A-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRN 259
Query: 257 PQKRI-----SVSEIMINPWF 272
R+ E+ +P+F
Sbjct: 260 AASRLGAGPGDAGEVQAHPFF 280
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 6e-78
Identities = 53/305 (17%), Positives = 103/305 (33%), Gaps = 46/305 (15%)
Query: 9 RVRNILFGKY---EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR 65
RV + L + G +LGQ + T ES + V + ++Q+K
Sbjct: 68 RVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 127
Query: 66 EISVMRL----------------------VKHPNIVELKEVMATKTKVFFVIEYV----- 98
E+ +RL VK P ++ V + ++ + +
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 99 ------KGGELFAKVLKGKLKEESARKYF-QQLISAVDFCHSRGVYHRDLKPENLLLDEN 151
G L + K AR Q+I + H G+ H L+P +++LD+
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 247
Query: 152 GNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAK----SDIWSCGVV 207
G + ++ F + + + P A +L + D W+ G+
Sbjct: 248 GGVFLTGFEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 208 LFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIM 267
++ + LP ++ + IF++ P R L+ L + R+ + M
Sbjct: 307 IYWIWCADLPNTDDAALGGSEWIFRSCKNIPQP----VRALLEGFLRYPKEDRLLPLQAM 362
Query: 268 INPWF 272
P +
Sbjct: 363 ETPEY 367
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 2e-77
Identities = 44/301 (14%), Positives = 85/301 (28%), Gaps = 48/301 (15%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
K ++ L G + V+ +++ E A+KV + +E++ +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 77 NIVELKEVM--------------------------ATKTKVFFVIEYVKG-----GELFA 105
+ E ++ ++
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 106 KVL--KGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163
V +G + QLI S+G+ H P+NL + +G L + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD-GAKSDIWSCGVVLFVLLSGFLPF--QN 220
Y E L + W G+ ++ + FLPF
Sbjct: 243 KVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 221 ENIMKMYRKIFKAEYEFPPW-------ISCDARRLISRILVADPQKRISVSEIMINPWFI 273
I +++ + + LI R L D ++R+ E M P F+
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 274 K 274
+
Sbjct: 358 Q 358
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 4e-77
Identities = 90/257 (35%), Positives = 150/257 (58%), Gaps = 9/257 (3%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
++LG+GTF KV + T A+K++ K+ + + + E V++ +HP + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
K T ++ FV+EY GGELF + + EE AR Y +++SA+++ HSR V +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSD 200
+K ENL+LD++G++K++DFGL E + + + T CGTP Y+APEVL Y A D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VD 187
Query: 201 IWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKR 260
W GVV++ ++ G LPF N++ +++ I E FP +S +A+ L++ +L DP++R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 261 I-----SVSEIMINPWF 272
+ E+M + +F
Sbjct: 248 LGGGPSDAKEVMEHRFF 264
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 4e-77
Identities = 89/260 (34%), Positives = 155/260 (59%), Gaps = 13/260 (5%)
Query: 22 RMLGQGTFAKVY---YGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
++LGQG+F KV+ ++ A+KV+ K +K + + K E ++ V HP I
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVNHPFI 88
Query: 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVY 137
V+L T+ K++ ++++++GG+LF ++ K EE + Y +L A+D HS G+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 138 HRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGA 197
+RDLKPEN+LLDE G++K++DFGLS E + ++ ++ CGT Y+APEV+ ++G+ +
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 198 KSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADP 257
+D WS GV++F +L+G LPFQ ++ + I KA+ P ++S +A+ L+ + +P
Sbjct: 207 -ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265
Query: 258 QKRI-----SVSEIMINPWF 272
R+ V EI + +F
Sbjct: 266 ANRLGAGPDGVEEIKRHSFF 285
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 8e-77
Identities = 68/258 (26%), Positives = 140/258 (54%), Gaps = 10/258 (3%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
R +G+G+F KV + T++ A+K +NK + ++ + + +E+ +M+ ++HP +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRD 140
+ +F V++ + GG+L + + KEE+ + + +L+ A+D+ ++ + HRD
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 141 LKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG-AKS 199
+KP+N+LLDE+G++ ++DF ++A L + + T GT Y+APE+ + G + +
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA 197
Query: 200 -DIWSCGVVLFVLLSGFLPF---QNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255
D WS GV + LL G P+ + + ++ +P S + L+ ++L
Sbjct: 198 VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEP 257
Query: 256 DPQKRI-SVSEIMINPWF 272
+P +R +S++ P+
Sbjct: 258 NPDQRFSQLSDVQNFPYM 275
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 1e-76
Identities = 92/257 (35%), Positives = 143/257 (55%), Gaps = 9/257 (3%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHPNIVE 80
+++G+G+F KV ++ + A+KV+ K + K+ + I E +V+ + VKHP +V
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L T K++FV++Y+ GGELF + + E AR Y ++ SA+ + HS + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLKPEN+LLD G++ ++DFGL E + ++ T CGTP Y+APEVL K+ YD
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT-V 220
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W G VL+ +L G PF + N +MY I + P I+ AR L+ +L D K
Sbjct: 221 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 280
Query: 260 RI----SVSEIMINPWF 272
R+ EI + +F
Sbjct: 281 RLGAKDDFMEIKSHVFF 297
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 3e-76
Identities = 75/275 (27%), Positives = 134/275 (48%), Gaps = 16/275 (5%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+ + + +G+G F++VY L+ VA+K + + +EI +++ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK-----LKEESARKYFQQLISAVDF 130
PN+++ ++ V+E G+L + K + E + KYF QL SA++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
HSR V HRD+KP N+ + G +K+ D GL H+ GTP Y++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIH 209
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE--NIMKMYRKIFKAEYEFPPW----ISCD 244
+ GY+ KSDIWS G +L+ + + PF + N+ + +KI + +Y PP S +
Sbjct: 210 ENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEE 266
Query: 245 ARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
R+L++ + DP+KR V+ + + +
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 7e-76
Identities = 86/254 (33%), Positives = 145/254 (57%), Gaps = 6/254 (2%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
+MLG+G+F KV+ + T + AIK + KD V +E E V+ L +HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHR 139
+ TK +FFV+EY+ GG+L + K A Y ++I + F HS+G+ +R
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD++G++K++DFG+ E + D +T CGTP Y+APE+L + Y+ +
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-V 199
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D WS GV+L+ +L G PF ++ +++ I +P W+ +A+ L+ ++ V +P+K
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEK 259
Query: 260 RI-SVSEIMINPWF 272
R+ +I +P F
Sbjct: 260 RLGVRGDIRQHPLF 273
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 1e-74
Identities = 88/259 (33%), Positives = 143/259 (55%), Gaps = 11/259 (4%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
R+LG+G+F KV + T + A+KV+ KD + + +E E ++ L HP + +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L T ++FFV+E+V GG+L + K + E AR Y ++ISA+ F H +G+ +R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD G+ K++DFG+ E + N T CGTP Y+APE+L++ Y A
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEMLYGPA-V 205
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W+ GV+L+ +L G PF+ EN ++ I E +P W+ DA ++ + +P
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTM 265
Query: 260 RI------SVSEIMINPWF 272
R+ I+ +P+F
Sbjct: 266 RLGSLTQGGEHAILRHPFF 284
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-74
Identities = 80/258 (31%), Positives = 143/258 (55%), Gaps = 10/258 (3%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
+LG+G+F KV + T E A+K++ KD V + +E E V+ L K P + +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L T +++FV+EYV GG+L + + G+ KE A Y ++ + F S+G+ +R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N++LD G++K++DFG+ E +W+ T CGTP Y+APE++ + Y +
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-V 202
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W+ GV+L+ +L+G PF+ E+ ++++ I + +P +S +A + ++ P K
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 262
Query: 260 RI-----SVSEIMINPWF 272
R+ +I + +F
Sbjct: 263 RLGCGPEGERDIKEHAFF 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 2e-73
Identities = 93/258 (36%), Positives = 149/258 (57%), Gaps = 10/258 (3%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
++LG+GTF KV K T A+K++ K+ + + + E V++ +HP + L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 82 KEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHS-RGVYHR 139
K T ++ FV+EY GGELF + + E+ AR Y +++SA+D+ HS + V +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK ENL+LD++G++K++DFGL E + + + T CGTP Y+APEVL Y A
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA-V 330
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W GVV++ ++ G LPF N++ K++ I E FP + +A+ L+S +L DP++
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 390
Query: 260 RI-----SVSEIMINPWF 272
R+ EIM + +F
Sbjct: 391 RLGGGSEDAKEIMQHRFF 408
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-73
Identities = 85/268 (31%), Positives = 146/268 (54%), Gaps = 20/268 (7%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
R++G+G++AKV + T A+KV+ K+ V ++ ++ E V HP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L T++++FFVIEYV GG+L + + KL EE AR Y ++ A+++ H RG+ +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD G++K++D+G+ E L T CGTP Y+APE+LR + Y +
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-V 191
Query: 200 DIWSCGVVLFVLLSGFLPF---------QNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250
D W+ GV++F +++G PF +++ I + + P +S A ++
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251
Query: 251 RILVADPQKRI------SVSEIMINPWF 272
L DP++R+ ++I +P+F
Sbjct: 252 SFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 5e-73
Identities = 87/285 (30%), Positives = 156/285 (54%), Gaps = 18/285 (6%)
Query: 2 KFETMDERVRNILFGK--YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGL 59
+++ ++R++ YE+ +++G+G F +V ++ T++ A+K+++K ++ K+
Sbjct: 53 RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 112
Query: 60 MEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARK 119
E +M P +V+L ++ V+EY+ GG+L + + E+ AR
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 172
Query: 120 YFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ-- 177
Y +++ A+D HS G HRD+KP+N+LLD++G+LK++DFG ++ +G++
Sbjct: 173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTA 229
Query: 178 CGTPAYVAPEVLRKKGYD---GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI--FK 232
GTP Y++PEVL+ +G D G + D WS GV L+ +L G PF ++++ Y KI K
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289
Query: 233 AEYEFP--PWISCDARRLISRILVADPQKRI---SVSEIMINPWF 272
FP IS +A+ LI L D + R+ V EI + +F
Sbjct: 290 NSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFF 333
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-72
Identities = 40/288 (13%), Positives = 96/288 (33%), Gaps = 35/288 (12%)
Query: 17 KYEMGRMLGQGTFAKVYYGK-----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
+ +LG+G FA+VY + ++ +KV + + + ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMERLK 122
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK------LKEESARKYFQQLI 125
++ + V E G L + K + + + +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 126 SAVDFCHSRGVYHRDLKPENLLL-----------DENGNLKVSDFGLSALPEQLWNDGLL 174
++ H + H D+KP+N +L D + L + D G S + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 175 HTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG-FLPFQNENIMKMYRKIFKA 233
+C T + E+L K ++ + D + ++ +L G ++ +NE +F+
Sbjct: 243 TAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 234 EYEFPPWISCDARRLISRILVADPQKRISVSEI---MINPWFIKGFSK 278
W +L + ++ + F + ++
Sbjct: 302 LPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 3e-72
Identities = 84/268 (31%), Positives = 146/268 (54%), Gaps = 20/268 (7%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
R++G+G++AKV + T A++V+ K+ V ++ ++ E V HP +V
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L T++++FFVIEYV GG+L + + KL EE AR Y ++ A+++ H RG+ +R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N+LLD G++K++D+G+ E L T CGTP Y+APE+LR + Y +
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-V 234
Query: 200 DIWSCGVVLFVLLSGFLPF---------QNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250
D W+ GV++F +++G PF +++ I + + P +S A ++
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 294
Query: 251 RILVADPQKRI------SVSEIMINPWF 272
L DP++R+ ++I +P+F
Sbjct: 295 SFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 9e-72
Identities = 86/269 (31%), Positives = 152/269 (56%), Gaps = 21/269 (7%)
Query: 22 RMLGQGTFAKVYYGKNLV---TQESVAIKVINKDQ-VKKQGLMEQIKREISVMRLVKH-P 76
++LG G + KV+ + + T + A+KV+ K V+K E + E V+ ++ P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRG 135
+V L T+TK+ +++Y+ GGELF + + + E + Y +++ A++ H G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL-HTQCGTPAYVAPEVLR--KK 192
+ +RD+K EN+LLD NG++ ++DFGLS E + ++ + CGT Y+AP+++R
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYMAPDIVRGGDS 237
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPF----QNENIMKMYRKIFKAEYEFPPWISCDARRL 248
G+D A D WS GV+++ LL+G PF + + ++ R+I K+E +P +S A+ L
Sbjct: 238 GHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDL 296
Query: 249 ISRILVADPQKRI-----SVSEIMINPWF 272
I R+L+ DP+KR+ EI + +F
Sbjct: 297 IQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 3e-71
Identities = 80/258 (31%), Positives = 143/258 (55%), Gaps = 10/258 (3%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVE 80
+LG+G+F KV + T E A+K++ KD V + +E E V+ L K P + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHR 139
L T +++FV+EYV GG+L + + G+ KE A Y ++ + F S+G+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS 199
DLK +N++LD G++K++DFG+ E +W+ T CGTP Y+APE++ + Y +
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-V 523
Query: 200 DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQK 259
D W+ GV+L+ +L+G PF+ E+ ++++ I + +P +S +A + ++ P K
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 583
Query: 260 RI-----SVSEIMINPWF 272
R+ +I + +F
Sbjct: 584 RLGCGPEGERDIKEHAFF 601
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 4e-71
Identities = 67/291 (23%), Positives = 110/291 (37%), Gaps = 34/291 (11%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+E + LG+G F V+ KN V + AIK I + E++ RE+ + ++HP
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEHP 63
Query: 77 NIVELKEV------------MATKTKVFFVIEYVKGGELFAKVLKGKLK----EESARKY 120
IV + K ++ ++ + L +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 121 FQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL----------PEQLWN 170
F Q+ AV+F HS+G+ HRDLKP N+ + +KV DFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRK 229
Q GT Y++PE + Y K DI+S G++LF LL PF + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239
Query: 230 IFKAEY-EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
+ ++ ++ +L P +R I+ N F
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 9e-71
Identities = 73/265 (27%), Positives = 131/265 (49%), Gaps = 17/265 (6%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
R+LG+G F +V+ + T + A K +NK ++KK+ + E ++ V IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 82 KEVMATKTKVFFVIEYVKGGELF-----AKVLKGKLKEESARKYFQQLISAVDFCHSRGV 136
TKT + V+ + GG++ +E A Y Q++S ++ H R +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
+RDLKPEN+LLD++GN+++SD GL+ E GTP ++APE+L + YD
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNEN----IMKMYRKIFKAEYEFPPWISCDARRLISRI 252
+ D ++ GV L+ +++ PF+ ++ +++ + +P S ++ +
Sbjct: 369 S-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427
Query: 253 LVADPQKRI-----SVSEIMINPWF 272
L DP+KR+ S + +P F
Sbjct: 428 LQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 7e-70
Identities = 79/291 (27%), Positives = 144/291 (49%), Gaps = 24/291 (8%)
Query: 2 KFETMDERVRNILFGK--YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGL 59
E + R++ + + +E+ +++G+G F++V K T + A+K++NK + K+G
Sbjct: 45 WAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE 104
Query: 60 MEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESA 117
+ + E V+ I +L + ++ V+EY GG+L + K ++ E A
Sbjct: 105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA 164
Query: 118 RKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ 177
R Y +++ A+D H G HRD+KP+N+LLD G+++++DFG +L DG + +
Sbjct: 165 RFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSL 221
Query: 178 --CGTPAYVAPEVLRKKGYDGAKS------DIWSCGVVLFVLLSGFLPFQNENIMKMYRK 229
GTP Y++PE+L+ G D W+ GV + + G PF ++ + Y K
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK 281
Query: 230 I--FKAEYEFP---PWISCDARRLISRILVADPQKRI---SVSEIMINPWF 272
I +K P + +AR I R L+ P+ R+ + +P+F
Sbjct: 282 IVHYKEHLSLPLVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 225 bits (574), Expect = 2e-69
Identities = 82/290 (28%), Positives = 150/290 (51%), Gaps = 24/290 (8%)
Query: 2 KFETMDERVRNILFGK--YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGL 59
+ +V+ + + +E+ +++G+G F +V K + A+K++NK ++ K+
Sbjct: 58 WAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE 117
Query: 60 MEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESA 117
+ E V+ I L ++ V++Y GG+L + K +L EE A
Sbjct: 118 TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA 177
Query: 118 RKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ 177
R Y +++ A+D H HRD+KP+N+L+D NG+++++DFG +L DG + +
Sbjct: 178 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSS 234
Query: 178 --CGTPAYVAPEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI 230
GTP Y++PE+L+ K Y G + D WS GV ++ +L G PF E++++ Y KI
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
Query: 231 --FKAEYEFPPW---ISCDARRLISRILVADPQKRI---SVSEIMINPWF 272
K ++FP +S +A+ LI R L+ + R+ + + +P+F
Sbjct: 294 MNHKERFQFPTQVTDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFF 342
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-69
Identities = 77/295 (26%), Positives = 136/295 (46%), Gaps = 28/295 (9%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
R+LG+G F +V + T + A K + K ++KK+ E ++ V +V L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 82 KEVMATKTKVFFVIEYVKGGELF---AKVLKGKLKEESARKYFQQLISAVDFCHSRGVYH 138
TK + V+ + GG+L + + E A Y ++ ++ H + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 139 RDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAK 198
RDLKPEN+LLD++G++++SD GL+ + + + GT Y+APEV++ + Y +
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 365
Query: 199 SDIWSCGVVLFVLLSGFLPFQNEN----IMKMYRKIFKAEYEFPPWISCDARRLISRILV 254
D W+ G +L+ +++G PFQ ++ R + + E+ S AR L S++L
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 255 ADPQKRI-----SVSEIMINPWF------------IKGFSKPVAVCIDDGDNRDF 292
DP +R+ S E+ +P F ++ KP I D D
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDI 480
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 4e-66
Identities = 80/264 (30%), Positives = 134/264 (50%), Gaps = 18/264 (6%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK---HPNI 78
R++G+G F +VY + T + A+K ++K ++K + E ++ LV P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVY 137
V + T K+ F+++ + GG+L + + G E R Y ++I ++ H+R V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 138 HRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK-GYDG 196
+RDLKP N+LLDE+G++++SD GL+ ++ H GT Y+APEVL+K YD
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNENIMK---MYRKIFKAEYEFPPWISCDARRLISRIL 253
+ +D +S G +LF LL G PF+ + R E P S + R L+ +L
Sbjct: 371 S-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 429
Query: 254 VADPQKRI-----SVSEIMINPWF 272
D +R+ E+ +P+F
Sbjct: 430 QRDVNRRLGCLGRGAQEVKESPFF 453
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 5e-62
Identities = 48/288 (16%), Positives = 97/288 (33%), Gaps = 36/288 (12%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
++ +G G F V+ + AIK K ++ + L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFC 131
++V A + EY GG L + + KE + Q+ + +
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 132 HSRGVYHRDLKPENLLLDENGNL-------------------KVSDFGLSALPEQLWNDG 172
HS + H D+KP N+ + K+ D G
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR------IS 185
Query: 173 LLHTQCGTPAYVAPEVLR-KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF 231
+ G ++A EVL+ + K+DI++ + + +N + + +I
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGD---QWHEIR 241
Query: 232 KAEY-EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSK 278
+ P +S + L+ ++ DP++R S ++ + + K
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-59
Identities = 69/266 (25%), Positives = 117/266 (43%), Gaps = 25/266 (9%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+G+G+F +V+ K+ T A+K + + + + E+ + P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPR 111
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRG 135
IV L + V +E ++GG L +++K G L E+ A Y Q + +++ H+R
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 136 VYHRDLKPENLLLDENGNL-KVSDFGLSALPEQLWNDGLLHTQC------GTPAYVAPEV 188
+ H D+K +N+LL +G+ + DFG + L DGL + GT ++APEV
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHAL---CLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE---YEFPPWISCDA 245
+ K D AK DIWS ++ +L+G P+ + KI E PP +
Sbjct: 228 VMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286
Query: 246 RRLISRILVADPQKRISVSEIMINPW 271
+ I L +P R S E+
Sbjct: 287 AQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-59
Identities = 88/306 (28%), Positives = 140/306 (45%), Gaps = 72/306 (23%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KYE +G+GT+ V+ KN T E VA+K + D +G+ REI +++ +KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 61
Query: 77 NIVELKEVMATKTKVFFVIEYV----KGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
NIV L +V+ + K+ V E+ K + G L E + + QL+ + FCH
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ--------LWNDGLLHTQCGTP 181
SR V HRDLKP+NLL++ NG LK+++FGL+ +P + LW
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW------------ 166
Query: 182 AYVAPEVLRKKGYDGAKS-----DIWSCGVVLFVLLSGFLP-FQNENIMKMYRKIFKA-- 233
Y P+VL GAK D+WS G + L + P F ++ ++IF+
Sbjct: 167 -YRPPDVLF-----GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 234 --------------EY-EFPPW------------ISCDARRLISRILVADPQKRISVSEI 266
+Y +P + ++ R L+ +L +P +RIS E
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
Query: 267 MINPWF 272
+ +P+F
Sbjct: 281 LQHPYF 286
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 8e-58
Identities = 75/269 (27%), Positives = 135/269 (50%), Gaps = 20/269 (7%)
Query: 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+ + +LG+GT+ VY G++L Q +AIK I + + + EI++ + +K
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK 77
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK-----LKEESARKYFQQLISAVD 129
H NIV+ + + +E V GG L + +L+ K E++ Y +Q++ +
Sbjct: 78 HKNIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 130 FCHSRGVYHRDLKPENLLLD-ENGNLKVSDFGLSALPEQLWN-DGLLHTQCGTPAYVAPE 187
+ H + HRD+K +N+L++ +G LK+SDFG S +L + T GT Y+APE
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPE 193
Query: 188 VLRK--KGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIFKAEY--EFPPWIS 242
++ K +GY G +DIWS G + + +G PF K+ + E P +S
Sbjct: 194 IIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252
Query: 243 CDARRLISRILVADPQKRISVSEIMINPW 271
+A+ I + DP KR ++++++ +
Sbjct: 253 AEAKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-57
Identities = 84/305 (27%), Positives = 144/305 (47%), Gaps = 72/305 (23%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KY +G+GT+ VY +N E+ A+K I ++ + +G+ REIS+++ +KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60
Query: 77 NIVELKEVMATKTKVFFVIEYV----KGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
NIV+L +V+ TK ++ V E++ K V +G L+ +A+ + QL++ + +CH
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ--------LWNDGLLHTQCGTP 181
R V HRDLKP+NLL++ G LK++DFGL+ +P + LW
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW------------ 165
Query: 182 AYVAPEVLRKKGYDGAKS-----DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--- 233
Y AP+VL G+K DIWS G + +++G F + +IF+
Sbjct: 166 -YRAPDVLM-----GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219
Query: 234 -------------EY--EFPPW-----------ISCDARRLISRILVADPQKRISVSEIM 267
+Y F + + L+S++L DP +RI+ + +
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 268 INPWF 272
+ +F
Sbjct: 280 EHAYF 284
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-57
Identities = 78/321 (24%), Positives = 131/321 (40%), Gaps = 82/321 (25%)
Query: 3 FETMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQ----VKKQG 58
F++M+ KYE ++G+G++ V +N T VAIK + VKK
Sbjct: 21 FQSME---------KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA 71
Query: 59 LMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYV----KGGELFAKVLKGKLKE 114
+ REI +++ ++H N+V L EV K + + V E+V ++ L
Sbjct: 72 M-----REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILD---DLELFPNGLDY 123
Query: 115 ESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ---- 167
+ +KY Q+I+ + FCHS + HRD+KPEN+L+ ++G +K+ DFG + A P +
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 168 ----LWNDGLLHTQCGTPAYVAPEVL-RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN 222
W Y APE+L Y A D+W+ G ++ + G F ++
Sbjct: 184 EVATRW-------------YRAPELLVGDVKYGKA-VDVWAIGCLVTEMFMGEPLFPGDS 229
Query: 223 IMKMYRKIFKA-------------------EYEFPPW------------ISCDARRLISR 251
+ I P +S L +
Sbjct: 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289
Query: 252 ILVADPQKRISVSEIMINPWF 272
L DP KR +E++ + +F
Sbjct: 290 CLHIDPDKRPFCAELLHHDFF 310
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-57
Identities = 82/312 (26%), Positives = 131/312 (41%), Gaps = 76/312 (24%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+++ LG GT+A VY G N T VA+K + D ++G REIS+M+ +KH
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHE 63
Query: 77 NIVELKEVMATKTKVFFVIEYV----KG--GELFAKVLKGKLKEESARKYFQQLISAVDF 130
NIV L +V+ T+ K+ V E++ K L+ + + QL+ + F
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ--------LWNDGLLHTQCG 179
CH + HRDLKP+NLL+++ G LK+ DFGL+ +P LW
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW---------- 173
Query: 180 TPAYVAPEVLRKKGYDGAKS-----DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA- 233
Y AP+VL G+++ DIWSCG +L +++G F N + + IF
Sbjct: 174 ---YRAPDVLM-----GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 234 -----------------EYEFPPW----------------ISCDARRLISRILVADPQKR 260
+ + + +L +P R
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285
Query: 261 ISVSEIMINPWF 272
+S + + +PWF
Sbjct: 286 LSAKQALHHPWF 297
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 4e-57
Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 73/306 (23%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KY+ +G+GT+ VY K+ VA+K I D + +G+ REIS+++ + HP
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHP 79
Query: 77 NIVELKEVMATKTKVFFVIEYV----KGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
NIV L +V+ ++ + V E++ K K L++ + Y QL+ V CH
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEKDLKK---VLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ--------LWNDGLLHTQCGTP 181
+ HRDLKP+NLL++ +G LK++DFGL+ +P + LW
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW------------ 184
Query: 182 AYVAPEVLRKKGYDGAKS-----DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--- 233
Y AP+VL G+K DIWS G + +++G F KIF
Sbjct: 185 -YRAPDVLM-----GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238
Query: 234 ----------------EYEFPPW-----------ISCDARRLISRILVADPQKRISVSEI 266
+ F + + L+S +L DP KRIS +
Sbjct: 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298
Query: 267 MINPWF 272
M +P+F
Sbjct: 299 MNHPYF 304
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 4e-57
Identities = 78/307 (25%), Positives = 125/307 (40%), Gaps = 73/307 (23%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVI----NKDQVKKQGLMEQIKREISVMRL 72
KYE +G+G++ V+ +N T + VAIK + +KK L REI +++
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-----REIRMLKQ 58
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYV----KGGELFAKVLKGKLKEESARKYFQQLISAV 128
+KHPN+V L EV K ++ V EY + + E + Q + AV
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLH---ELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ--------LWNDGLLHTQ 177
+FCH HRD+KPEN+L+ ++ +K+ DFG + P W
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-------- 167
Query: 178 CGTPAYVAPEVL-RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--- 233
Y +PE+L Y G D+W+ G V LLSG + ++ + I K
Sbjct: 168 -----YRSPELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD 221
Query: 234 ----------------EYEFPPW------------ISCDARRLISRILVADPQKRISVSE 265
+ P IS A L+ L DP +R++ +
Sbjct: 222 LIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281
Query: 266 IMINPWF 272
++ +P+F
Sbjct: 282 LLHHPYF 288
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 6e-57
Identities = 77/306 (25%), Positives = 137/306 (44%), Gaps = 73/306 (23%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y LG+GT+A VY GK+ +T VA+K I + ++G RE+S+++ +KH
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHA 60
Query: 77 NIVELKEVMATKTKVFFVIEYV----KGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
NIV L +++ T+ + V EY+ K + + + + + QL+ + +CH
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLKQ---YLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ--------LWNDGLLHTQCGTP 181
+ V HRDLKP+NLL++E G LK++DFGL+ ++P + LW
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW------------ 165
Query: 182 AYVAPEVLRKKGYDGAKS-----DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--- 233
Y P++L G+ D+W G + + + +G F + + IF+
Sbjct: 166 -YRPPDILL-----GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219
Query: 234 ----------------EYEFPPW-----------ISCDARRLISRILVADPQKRISVSEI 266
Y +P + + D L++++L + + RIS +
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279
Query: 267 MINPWF 272
M +P+F
Sbjct: 280 MKHPFF 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-56
Identities = 80/308 (25%), Positives = 128/308 (41%), Gaps = 75/308 (24%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVI--NKDQVKKQGLMEQIKREISVMRLVK 74
+YE LG+G FA VY ++ T + VAIK I K G+ REI +++ +
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 75 HPNIVELKEVMATKTKVFFVIEYV----KGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
HPNI+ L + K+ + V +++ + K L + Y + +++
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ--------LWNDGLLHTQCG 179
H + HRDLKP NLLLDENG LK++DFGL+ P + W
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRW---------- 177
Query: 180 TPAYVAPEVLRKKGYDGAKS-----DIWSCGVVLFVLLSG--FLPFQNENIMKMYRKIFK 232
Y APE+L GA+ D+W+ G +L LL FLP ++ + +IF+
Sbjct: 178 ---YRAPELLF-----GARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFE 227
Query: 233 A----------------EY-EFPPW-----------ISCDARRLISRILVADPQKRISVS 264
+Y F + D LI + + +P RI+ +
Sbjct: 228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 287
Query: 265 EIMINPWF 272
+ + +F
Sbjct: 288 QALKMKYF 295
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-55
Identities = 83/309 (26%), Positives = 136/309 (44%), Gaps = 74/309 (23%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y LG+GT+ +VY + VT E+VAIK I + +++G+ RE+S+++ ++H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHR 93
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL--KGKLKEESARKYFQQLISAVDFCHSR 134
NI+ELK V+ ++ + EY + +L K + + + + QLI+ V+FCHSR
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DL-KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 135 GVYHRDLKPENLLLD-----ENGNLKVSDFGLS---ALPEQ--------LWNDGLLHTQC 178
HRDLKP+NLLL E LK+ DFGL+ +P + LW
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW--------- 202
Query: 179 GTPAYVAPEVLRKKGYDGAKS-----DIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA 233
Y PE+L G++ DIWS + +L F ++ + KIF+
Sbjct: 203 ----YRPPEILL-----GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253
Query: 234 ------------------------------EYEFPPWISCDARRLISRILVADPQKRISV 263
+ + + L++ +L DP KRIS
Sbjct: 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA 313
Query: 264 SEIMINPWF 272
+ +P+F
Sbjct: 314 KNALEHPYF 322
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-54
Identities = 78/274 (28%), Positives = 143/274 (52%), Gaps = 17/274 (6%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+ +G+G+F +V+ G + TQ+ VAIK+I+ ++ + + +E I++EI+V+ P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPY 81
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVY 137
+ + TK++ ++EY+ GG + G L E ++++ +D+ HS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 141
Query: 138 HRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL-HTQCGTPAYVAPEVLRKKGYDG 196
HRD+K N+LL E+G +K++DFG++ QL + + +T GTP ++APEV+++ YD
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD- 197
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP-----WISCDARRLISR 251
+K+DIWS G+ L G P + MK+ I K PP + S + +
Sbjct: 198 SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNY-SKPLKEFVEA 253
Query: 252 ILVADPQKRISVSEIMINPWFIKGFSKPVAVCID 285
L +P R + E++ + FI +K + +
Sbjct: 254 CLNKEPSFRPTAKELLKHK-FILRNAKKTSYLTE 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-53
Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 22/268 (8%)
Query: 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
+I + + +G G+F V+ + VA+K++ + + + + RE+++M+
Sbjct: 33 DIPWCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAE-RVNEFLREVAIMK 89
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARK--YFQQLISAVD 129
++HPNIV + + V EY+ G L+ ++L K + + ++L A D
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLH---KSGAREQLDERRRLSMAYD 145
Query: 130 FC------HSRG--VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP 181
H+R + HR+LK NLL+D+ +KV DFGLS L + GTP
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTP 203
Query: 182 AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY--EFPP 239
++APEVLR + + KSD++S GV+L+ L + P+ N N ++ + E P
Sbjct: 204 EWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR 262
Query: 240 WISCDARRLISRILVADPQKRISVSEIM 267
++ +I +P KR S + IM
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIM 290
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-53
Identities = 66/267 (24%), Positives = 125/267 (46%), Gaps = 19/267 (7%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
I G+ +G+ +G G+F VY GK VA+K++N Q ++ K E+ V+R
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQ-QLQAFKNEVGVLRK 76
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFA--KVLKGKLKEESARKYFQQLISAVDF 130
+H NI+ T ++ V ++ +G L+ + K + + +Q +D+
Sbjct: 77 TRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
H++ + HRDLK N+ L E+ +K+ DFGL+ + G+ ++APEV+R
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 191 KKGYD--GAKSDIWSCGVVLFVLLSGFLPFQNEN--------IMKMYRKIFKAEYEFPPW 240
+ + +SD+++ G+VL+ L++G LP+ N N + + + +
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS--KVRSN 253
Query: 241 ISCDARRLISRILVADPQKRISVSEIM 267
+RL++ L +R S I+
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRIL 280
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-53
Identities = 78/314 (24%), Positives = 123/314 (39%), Gaps = 67/314 (21%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK--REISVMRLVK 74
+YE +G G + VY ++ + VA+K + G I RE++++R ++
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 75 ---HPNIVELKEVMATK-----TKVFFVIEYV----KGGELFAKVLKGKLKEESARKYFQ 122
HPN+V L +V AT KV V E+V + K L E+ + +
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPGLPAETIKDLMR 127
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ-------LWNDG 172
Q + +DF H+ + HRDLKPEN+L+ G +K++DFGL+ + LW
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW--- 184
Query: 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK 232
Y APEVL + Y D+WS G + + F + KIF
Sbjct: 185 ----------YRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233
Query: 233 A----------------EYEFPPW-----------ISCDARRLISRILVADPQKRISVSE 265
FPP + +L+ +L +P KRIS
Sbjct: 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293
Query: 266 IMINPWFIKGFSKP 279
+ + + K P
Sbjct: 294 ALQHSYLHKDEGNP 307
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 4e-52
Identities = 59/271 (21%), Positives = 128/271 (47%), Gaps = 20/271 (7%)
Query: 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
+I F + E+G ++G+G F +VY+G+ VAI++I+ ++ + ++ KRE+ R
Sbjct: 29 DIPFEQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNED-QLKAFKREVMAYR 84
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFA--KVLKGKLKEESARKYFQQLISAVD 129
+H N+V + + + KG L++ + K L R+ Q+++ +
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMG 144
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQLWNDGLLHTQCGTPAYVAP 186
+ H++G+ H+DLK +N+ D NG + ++DFGL + + + L Q G ++AP
Sbjct: 145 YLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 187 EVLRKKGYDGA--------KSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP 238
E++R+ D SD+++ G + + L + PF+ + + ++
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263
Query: 239 PWISCDA--RRLISRILVADPQKRISVSEIM 267
I ++ + ++R + +++M
Sbjct: 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLM 294
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-51
Identities = 77/306 (25%), Positives = 128/306 (41%), Gaps = 67/306 (21%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNL-VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK- 74
+YE +G+G + KV+ ++L VA+K + ++G+ RE++V+R ++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLET 70
Query: 75 --HPNIVELKEVMAT-----KTKVFFVIEYV----KGGELFAKVLKGKLKEESARKYFQQ 123
HPN+V L +V +TK+ V E+V KV + + E+ + Q
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQ 128
Query: 124 LISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ-------LWNDGL 173
L+ +DF HS V HRDLKP+N+L+ +G +K++DFGL+ + LW
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW---- 184
Query: 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA 233
Y APEVL + Y D+WS G + + F+ + + KI
Sbjct: 185 ---------YRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234
Query: 234 ----------------EYEFPPW-----------ISCDARRLISRILVADPQKRISVSEI 266
F I + L+ + L +P KRIS
Sbjct: 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 267 MINPWF 272
+ +P+F
Sbjct: 295 LSHPYF 300
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-51
Identities = 62/270 (22%), Positives = 128/270 (47%), Gaps = 21/270 (7%)
Query: 16 GKYE-MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
G++ +G+G+F VY G + T VA + ++ K ++ K E +++ ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 83
Query: 75 HPNIVEL----KEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAV 128
HPNIV + + K + V E + G L LK +K + R + +Q++ +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGL 142
Query: 129 DFCHSRG--VYHRDLKPENLLLD-ENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVA 185
F H+R + HRDLK +N+ + G++K+ D GL+ L GTP ++A
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMA 198
Query: 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIFKAE--YEFPPWIS 242
PE+ ++ YD D+++ G+ + + + P+ +N ++YR++ F
Sbjct: 199 PEMY-EEKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256
Query: 243 CDARRLISRILVADPQKRISVSEIMINPWF 272
+ + +I + + +R S+ +++ + +F
Sbjct: 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-51
Identities = 71/267 (26%), Positives = 147/267 (55%), Gaps = 12/267 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+ +G+G+ V + + VA+K+++ ++KQ E + E+ +MR +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHF 102
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGV 136
N+VE+ + +++ ++E+++GG L V + +L EE + ++ A+ + H++GV
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL-LHTQCGTPAYVAPEVLRKKGYD 195
HRD+K +++LL +G +K+SDFG A Q+ D + GTP ++APEV+ + Y
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA---EYEFPPWISCDARRLISRI 252
+ DIWS G+++ ++ G P+ +++ ++ +++ + + + +S R + R+
Sbjct: 220 -TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278
Query: 253 LVADPQKRISVSEIMINPWFIKGFSKP 279
LV DPQ+R + E++ +P F+ P
Sbjct: 279 LVRDPQERATAQELLDHP-FLLQTGLP 304
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-50
Identities = 87/262 (33%), Positives = 140/262 (53%), Gaps = 12/262 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KY +GQG VY ++ T + VAI+ +N +++Q E I EI VMR K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNP 77
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGV 136
NIV + +++ V+EY+ GG L V + + E ++ + A++F HS V
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL-LHTQCGTPAYVAPEVLRKKGYD 195
HRD+K +N+LL +G++K++DFG A Q+ + T GTP ++APEV+ +K Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA---EYEFPPWISCDARRLISRI 252
K DIWS G++ ++ G P+ NEN ++ I E + P +S R ++R
Sbjct: 195 P-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 253 LVADPQKRISVSEIMINPWFIK 274
L D +KR S E++ + F+K
Sbjct: 254 LEMDVEKRGSAKELLQHQ-FLK 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-50
Identities = 52/259 (20%), Positives = 92/259 (35%), Gaps = 18/259 (6%)
Query: 29 FAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88
E + M+ +I M N V + + K
Sbjct: 74 LETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPK 133
Query: 89 TKVFFVIEYVKGGELFAKVLKGK----LKEESARKYFQQLISAVDFCHSRGVYHRDLKPE 144
++ ++ + L + + + F Q+ AV+F HS+G+ HRDLKP
Sbjct: 134 VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPS 193
Query: 145 NLLLDENGNLKVSDFGLSA----------LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
N+ + +KV DFGL + + Q GT Y++PE + Y
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253
Query: 195 DGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW-ISCDARRLISRIL 253
K DI+S G++LF LL F ++ + ++ ++ +L
Sbjct: 254 S-HKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKFPLLFTQKYPQEHMMVQDML 310
Query: 254 VADPQKRISVSEIMINPWF 272
P +R ++I+ N F
Sbjct: 311 SPSPTERPEATDIIENAIF 329
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 19/63 (30%), Positives = 33/63 (52%), Gaps = 2/63 (3%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+E + +G+G F V+ KN V + AIK I ++ E++ RE+ + ++HP
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NRELAREKVMREVKALAKLEHP 64
Query: 77 NIV 79
IV
Sbjct: 65 GIV 67
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-49
Identities = 53/270 (19%), Positives = 107/270 (39%), Gaps = 27/270 (10%)
Query: 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
I F + L + +++ G+ + +KV+ + E +R
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTR-KSRDFNEECPRLR 62
Query: 72 LVKHPNIVELKEVMATKTKVFFVI--EYVKGGELFAKVLKGKLKEESARKYFQQLISAVD 129
+ HPN++ + + + ++ G L+ + +G Q + A+D
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQS---QAVKFALD 119
Query: 130 ------FCHSRG--VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP 181
F H+ + L ++++DE+ ++S + + + P
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAP 172
Query: 182 AYVAPEVLRKKGYDGA--KSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY--EF 237
A+VAPE L+KK D +D+WS V+L+ L++ +PF + + M++ K+
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 238 PPWISCDARRLISRILVADPQKRISVSEIM 267
PP IS +L+ + DP KR I+
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIV 262
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-49
Identities = 64/280 (22%), Positives = 119/280 (42%), Gaps = 29/280 (10%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINK----DQVKKQGLMEQI 63
R+ + + E + +G+G F V+ G+ + + VAIK + + + ++
Sbjct: 11 SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 64 KREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQ 123
+RE+ +M + HPNIV+L V+E+V G+L+ L K +
Sbjct: 71 QREVFIMSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLY-HRLLDKAHPIKWSVKLRL 127
Query: 124 LI---SAVDFCHSRG--VYHRDLKPENLLLDENG-----NLKVSDFGLSALPEQLWNDGL 173
++ +++ ++ + HRDL+ N+ L KV+DFGLS +
Sbjct: 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHS 182
Query: 174 LHTQCGTPAYVAPEVL--RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF 231
+ G ++APE + ++ Y K+D +S ++L+ +L+G PF + K+
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241
Query: 232 KAEY----EFPPWISCDARRLISRILVADPQKRISVSEIM 267
E P R +I DP+KR S I+
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-49
Identities = 84/279 (30%), Positives = 136/279 (48%), Gaps = 29/279 (10%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+E+ LG G F KVY KN T A KVI K + +E EI ++ HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHP 76
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSR 134
IV+L K++ +IE+ GG + L L E + +Q++ A++F HS+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL--HTQCGTPAYVAPEV---- 188
+ HRDLK N+L+ G+++++DFG+SA + L + GTP ++APEV
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KN-LKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 189 -LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP-------W 240
++ YD K+DIWS G+ L + P N M++ KI K++ PP W
Sbjct: 193 TMKDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---PPTLLTPSKW 248
Query: 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
S + R + L +P+ R S ++++ +P F+ +
Sbjct: 249 -SVEFRDFLKIALDKNPETRPSAAQLLEHP-FVSSITSN 285
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-49
Identities = 79/312 (25%), Positives = 139/312 (44%), Gaps = 64/312 (20%)
Query: 10 VRNILFG---KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKRE 66
+ +G Y++ R LG+G +++V+ N+ E V +K++ + KK IKRE
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKRE 80
Query: 67 ISVMR-LVKHPNIVELKEVM--ATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQ 123
I ++ L PNI+ L +++ V E+V + K L L + R Y +
Sbjct: 81 IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYE 138
Query: 124 LISAVDFCHSRGVYHRDLKPENLLLD-ENGNLKVSDFGL--SALPEQLWNDGLLHTQCGT 180
++ A+D+CHS G+ HRD+KP N+++D E+ L++ D+GL P Q +N + +
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-----RVAS 193
Query: 181 PAYVAPEVL-RKKGYDGAKSDIWSCGVVLFVLLSGFLPF--------QNENIMKM----- 226
+ PE+L + YD + D+WS G +L ++ PF Q I K+
Sbjct: 194 RYFKGPELLVDYQMYDYS-LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 227 ---------------YRKIFKAEYEFPPW-----------ISCDARRLISRILVADPQKR 260
+ I + W +S +A + ++L D Q R
Sbjct: 253 LYDYIDKYNIELDPRFNDILG-RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311
Query: 261 ISVSEIMINPWF 272
++ E M +P+F
Sbjct: 312 LTAREAMEHPYF 323
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-49
Identities = 71/268 (26%), Positives = 113/268 (42%), Gaps = 30/268 (11%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
I + + E+ ++G+G F V K + VAIK I + + E+ +
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESES-----ERKAFIVELRQLSR 57
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFC- 131
V HPNIV+L A V V+EY +GG L+ VL G + + +
Sbjct: 58 VNHPNIVKL--YGACLNPVCLVMEYAEGGSLY-NVLHGA-EPLPYYTAAHAMSWCLQCSQ 113
Query: 132 -----HSR---GVYHRDLKPENLLLDENGN-LKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
HS + HRDLKP NLLL G LK+ DFG + + G+ A
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMT-NNKGSAA 168
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN--ENIMKMYRKIFKAEY-EFPP 239
++APEV Y K D++S G++L+ +++ PF ++ +
Sbjct: 169 WMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK 227
Query: 240 WISCDARRLISRILVADPQKRISVSEIM 267
+ L++R DP +R S+ EI+
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIV 255
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-49
Identities = 69/269 (25%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKD-QVKKQGLMEQIKREISVMR 71
I F + + ++G G F KVY + + VA+K D +E +++E +
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFC 131
++KHPNI+ L+ V + + V+E+ +GG L + ++ + + Q+ +++
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYL 121
Query: 132 HSRGVY---HRDLKPENLLLDE--------NGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180
H + HRDLK N+L+ + N LK++DFGL+ + W+ + G
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGA 177
Query: 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY--EFP 238
A++APEV+R + SD+WS GV+L+ LL+G +PF+ + + + + + P
Sbjct: 178 YAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236
Query: 239 PWISCDARRLISRILVADPQKRISVSEIM 267
+L+ DP R S + I+
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRPSFTNIL 265
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-48
Identities = 80/305 (26%), Positives = 127/305 (41%), Gaps = 68/305 (22%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y +++G G+F VY K + E VAIK + +D+ K RE+ +MR + H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHC 107
Query: 77 NIVELKEVMATKT------KVFFVIEYVKGGELFAKVLKG------KLKEESARKYFQQL 124
NIV L+ + + V++YV E +V + L + Y QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 125 ISAVDFCHSRGVYHRDLKPENLLLDEN-GNLKVSDFGLSALPEQLWNDGLLHTQCGTPAY 183
++ + HS G+ HRD+KP+NLLLD + LK+ DFG + L+ + +Y
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--------QLVRGEPNV-SY 216
Query: 184 V------APEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK---- 232
+ APE+ Y + D+WS G VL LL G F ++ + +I K
Sbjct: 217 ICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 233 -------------AEYEFPPW------------ISCDARRLISRILVADPQKRISVSEIM 267
E++FP +A L SR+L P R++ E
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 268 INPWF 272
+ +F
Sbjct: 336 AHSFF 340
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-48
Identities = 86/308 (27%), Positives = 134/308 (43%), Gaps = 75/308 (24%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y +++G G+F V+ K + + E VAIK + +D+ RE+ +MR+VKHP
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-------RFKNRELQIMRIVKHP 92
Query: 77 NIVELKEVMAT------KTKVFFVIEYV-----KGGELFAKVLKGKLKEESARKYFQQLI 125
N+V+LK + + + V+EYV + +AK LK + + Y QL+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQLL 151
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDEN-GNLKVSDFGL--SALPEQ--------LWNDGLL 174
++ + HS G+ HRD+KP+NLLLD G LK+ DFG + + +
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY----- 206
Query: 175 HTQCGTPAYVAPEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK- 232
Y APE+ Y DIWS G V+ L+ G F E+ + +I K
Sbjct: 207 --------YRAPELIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257
Query: 233 ----------------AEYEFPPW------------ISCDARRLISRILVADPQKRISVS 264
E++FP DA LISR+L P R++
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317
Query: 265 EIMINPWF 272
E + +P+F
Sbjct: 318 EALCHPFF 325
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-48
Identities = 69/320 (21%), Positives = 123/320 (38%), Gaps = 86/320 (26%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KYE +GQGTF +V+ ++ T + VA+K + + +K+G REI +++L+KH
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHE 76
Query: 77 NIVELKEVM--------ATKTKVFFVIEYV----KGGELFAKVLKGKLKEESARKYFQQL 124
N+V L E+ K ++ V ++ G + K ++ Q L
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQML 133
Query: 125 ISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---ALPEQ------------LW 169
++ + + H + HRD+K N+L+ +G LK++DFGL+ +L + LW
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKS-----DIWSCGVVLFVLLSGFLPFQNENIM 224
Y PE+L G + D+W G ++ + + Q
Sbjct: 194 -------------YRPPELLL-----GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235
Query: 225 KMYRKIFKA-------------------EYEFPPW-------------ISCDARRLISRI 252
I + + E A LI ++
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 295
Query: 253 LVADPQKRISVSEIMINPWF 272
LV DP +RI + + + +F
Sbjct: 296 LVLDPAQRIDSDDALNHDFF 315
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-48
Identities = 71/269 (26%), Positives = 137/269 (50%), Gaps = 26/269 (9%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+++ LG+G++ VY + T + VAIK + V+ +++I +EIS+M+ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESD--LQEIIKEISIMQQCDSP 84
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSR 134
++V+ T ++ V+EY G + ++ L E+ Q + +++ H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL--HTQCGTPAYVAPEVLRKK 192
HRD+K N+LL+ G+ K++DFG++ QL D + +T GTP ++APEV+++
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG---QL-TDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP-------WISCDA 245
GY+ +DIWS G+ + G P+ + + M+ I PP W S +
Sbjct: 201 GYNC-VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP---PPTFRKPELW-SDNF 255
Query: 246 RRLISRILVADPQKRISVSEIMINPWFIK 274
+ + LV P++R + ++++ +P F++
Sbjct: 256 TDFVKQCLVKSPEQRATATQLLQHP-FVR 283
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-47
Identities = 79/283 (27%), Positives = 137/283 (48%), Gaps = 33/283 (11%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
YE+ ++G G A V +E VAIK IN ++ + M+++ +EI M HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHHPN 74
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELF---------AKVLKGKLKEESARKYFQQLISAV 128
IV K +++ V++ + GG + + G L E + ++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQC------GTPA 182
++ H G HRD+K N+LL E+G+++++DFG+SA L G + GTP
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA---FLATGGDITRNKVRKTFVGTPC 191
Query: 183 YVAPEVL-RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------- 232
++APEV+ + +GYD K+DIWS G+ L +G P+ MK+ +
Sbjct: 192 WMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 233 -AEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274
+ E R++IS L DP+KR + +E++ + F +
Sbjct: 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK-FFQ 292
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 22/268 (8%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+ R +G G+F VY+ +++ E VAIK ++ + + I +E+ ++ ++HP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGEL-FAKVLKGKLKEESARKYFQQLISAVDFCHSRG 135
N ++ + + + V+EY G +V K L+E + + + HS
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV---LRKK 192
+ HRD+K N+LL E G +K+ DFG ++ + ++ GTP ++APEV + +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSAS---IM---APANSFVGTPYWMAPEVILAMDEG 228
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP------WISCDAR 246
YDG K D+WS G+ L P N N M I + E P W S R
Sbjct: 229 QYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---SPALQSGHW-SEYFR 283
Query: 247 RLISRILVADPQKRISVSEIMINPWFIK 274
+ L PQ R + ++ + F+
Sbjct: 284 NFVDSCLQKIPQDRPTSEVLLKHR-FVL 310
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-47
Identities = 73/259 (28%), Positives = 125/259 (48%), Gaps = 18/259 (6%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREI-SVMR 71
I+ +Y++ LG G + VY ++ + VAIK I +K+ +++ +RE+ + +
Sbjct: 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL--KGKLKEESARKYFQQLISAVD 129
L H NIV + +V + V+EY++G L ++ + G L ++A + Q++ +
Sbjct: 68 L-SHQNIVSMIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQC--GTPAYVAP 186
H + HRD+KP+N+L+D N LK+ DFG++ AL E L T GT Y +P
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET----SLTQTNHVLGTVQYFSP 181
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-----IMKMYRKIFKAEYEFPPWI 241
E + + D +DI+S G+VL+ +L G PF E I + + + I
Sbjct: 182 EQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240
Query: 242 SCDARRLISRILVADPQKR 260
+I R D R
Sbjct: 241 PQSLSNVILRATEKDKANR 259
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-47
Identities = 67/270 (24%), Positives = 119/270 (44%), Gaps = 29/270 (10%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
G +LG+G F + + T E + +K + + + +E+ VMR ++HPN+
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEHPNV 69
Query: 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFC------H 132
++ V+ ++ F+ EY+KGG L ++K +S + Q++ A D H
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRG-IIK---SMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND------------GLLHTQCGT 180
S + HRDL N L+ EN N+ V+DFGL+ L +T G
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKM-YRKIFKAEYEFPP 239
P ++APE++ + YD K D++S G+VL ++ + M + + +
Sbjct: 186 PYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 240 WISCDA--RRLISRILVADPQKRISVSEIM 267
+C + R DP+KR S ++
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLE 274
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-46
Identities = 54/232 (23%), Positives = 104/232 (44%), Gaps = 20/232 (8%)
Query: 16 GKYEMGRMLGQG--TFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
G YE+ ++G+G V + T E V ++ IN + + + ++ E+ V +L
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV-TFLQGELHVSKLF 83
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGG---ELFAKVLKGKLKEESARKYFQQLISAVDF 130
HPNIV + +++ V ++ G +L + E + Q ++ A+D+
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG--------LLHTQCGTPA 182
H G HR +K ++L+ +G + +S + + + G
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNL---SMISHGQRQRVVHDFPKYSVKVLP 200
Query: 183 YVAPEVLR--KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK 232
+++PEVL+ +GYD AKSDI+S G+ L +G +PF++ +M +
Sbjct: 201 WLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-46
Identities = 67/256 (26%), Positives = 125/256 (48%), Gaps = 16/256 (6%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKRE-ISVMRL 72
FG Y + R++G+G VY ++ V + VA+K++++ +++RE + RL
Sbjct: 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL 91
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDF 130
+ P++V + + +++ + + G +L A +L+ G L A +Q+ SA+D
Sbjct: 92 -QEPHVVPIHDFGEIDGQLYVDMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGL-SALPEQLWNDGLLHTQC--GTPAYVAPE 187
H+ G HRD+KPEN+L+ + + DFG+ SA ++ L GT Y+APE
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE----KLTQLGNTVGTLYYMAPE 205
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK---AEYEFPPWISCD 244
+ ++DI++ VL+ L+G P+Q + + M I + P I
Sbjct: 206 RFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264
Query: 245 ARRLISRILVADPQKR 260
+I+R + +P+ R
Sbjct: 265 FDAVIARGMAKNPEDR 280
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-45
Identities = 70/262 (26%), Positives = 125/262 (47%), Gaps = 19/262 (7%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKRE-ISVMR 71
L +YE+G +LG G ++V+ ++L VA+KV+ D + + +RE +
Sbjct: 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 72 LVKHPNIVEL----KEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLI 125
L HP IV + + + V+EYV G L ++ G + + A +
Sbjct: 69 L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADAC 126
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQC--GTPA 182
A++F H G+ HRD+KP N+++ +KV DFG++ A+ + + + T GT
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS--GNSVTQTAAVIGTAQ 184
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN----IMKMYRKIFKAEYEFP 238
Y++PE R D A+SD++S G VL+ +L+G PF ++ + R+
Sbjct: 185 YLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 239 PWISCDARRLISRILVADPQKR 260
+S D ++ + L +P+ R
Sbjct: 244 EGLSADLDAVVLKALAKNPENR 265
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 35/291 (12%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVK 74
G +E+ ++G GT+ +VY G+++ T + AIKV++ ++ E+IK+EI++++
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSH 79
Query: 75 HPNIVEL------KEVMATKTKVFFVIEYVKGG---ELFAKVLKGKLKEESARKYFQQLI 125
H NI K +++ V+E+ G +L LKEE ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN-DGLLHTQCGTPAYV 184
+ H V HRD+K +N+LL EN +K+ DFG+SA QL G +T GTP ++
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWM 196
Query: 185 APEVLRKK-----GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP 239
APEV+ YD KSD+WS G+ + G P + + M+ I + P
Sbjct: 197 APEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---AP 252
Query: 240 ------WISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCI 284
W S + I LV + +R + ++M +P FI+ V I
Sbjct: 253 RLKSKKW-SKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQPNERQVRI 301
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 8e-44
Identities = 62/254 (24%), Positives = 101/254 (39%), Gaps = 24/254 (9%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNL-VTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
I+ G+YE+ + G +Y + V V +K + E +
Sbjct: 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLA 134
Query: 72 LVKHPNIVEL-----KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLIS 126
V HP+IV++ + V+EYV G L + KL A Y +++
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKLPVAEAIAYLLEILP 193
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
A+ + HS G+ + DLKPEN++L E LK+ D G + G L GTP + AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINS---FGYL---YGTPGFQAP 246
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDAR 246
E++R +DI++ G L L + + E +
Sbjct: 247 EIVR--TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYDSYG 298
Query: 247 RLISRILVADPQKR 260
RL+ R + DP++R
Sbjct: 299 RLLRRAIDPDPRQR 312
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 76/293 (25%), Positives = 136/293 (46%), Gaps = 24/293 (8%)
Query: 5 TMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK 64
T+ + E +G GT +V+ + T +A+K + + K++ ++I
Sbjct: 14 TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRIL 71
Query: 65 REISV-MRLVKHPNIVELKEVMATKTKVFFVIEYVKGG-ELFAKVLKGKLKEESARKYFQ 122
++ V ++ P IV+ T T VF +E + E K ++G + E K
Sbjct: 72 MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 123 QLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP 181
++ A+ + GV HRD+KP N+LLDE G +K+ DFG+S +L +D G
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCA 188
Query: 182 AYVAPEVL-----RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIFKAEY 235
AY+APE + K YD ++D+WS G+ L L +G P++N + ++ K+ + E
Sbjct: 189 AYMAPERIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE- 246
Query: 236 EFPP------WISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAV 282
PP S D + + L D +KR ++++ + + + + V V
Sbjct: 247 --PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDV 297
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-42
Identities = 59/290 (20%), Positives = 117/290 (40%), Gaps = 47/290 (16%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
+ +G+G + +V+ G E+VA+K+ + +K E E+ +++H NI
Sbjct: 11 TLLECVGKGRYGEVWRGS--WQGENVAVKIF-SSRDEKSWFRET---ELYNTVMLRHENI 64
Query: 79 VEL----KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSR 134
+ + T+++ + Y + G L+ + L S + + S + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 135 --------GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL--HTQCGTPAYV 184
+ HRDLK +N+L+ +NG ++D GL+ + Q N + + + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 185 APEVLRKKGYDGA-----KSDIWSCGVVLFVLLSGF----------LPFQNEN-----IM 224
APEVL + + DIW+ G+VL+ + PF +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 225 KMYRKIFKAEY--EFPP-WISCDARRLISRILV----ADPQKRISVSEIM 267
M + + + P W S +++++ +P R++ I
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 64/248 (25%), Positives = 113/248 (45%), Gaps = 11/248 (4%)
Query: 3 FETMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQ 62
F T ++V + +E LG G V+ + + +A K+I+ + K + Q
Sbjct: 20 FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQ 77
Query: 63 IKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKY 120
I RE+ V+ P IV + ++ +E++ GG L +VLK G++ E+ K
Sbjct: 78 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKV 136
Query: 121 FQQLISAVDFCHSRG-VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG 179
+I + + + + HRD+KP N+L++ G +K+ DFG+S QL D + ++ G
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QL-IDSMANSFVG 192
Query: 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP 239
T +Y++PE L+ Y +SDIWS G+ L + G P + ++
Sbjct: 193 TRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 240 WISCDARR 247
R
Sbjct: 252 ETPPRPRT 259
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-42
Identities = 77/356 (21%), Positives = 131/356 (36%), Gaps = 111/356 (31%)
Query: 1 MKFETMDERVRNILFGKYE-MGRMLGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQ 57
+K + ERV + +E G +G+GT+ VY K+ + A+K I +
Sbjct: 9 VKLSSERERVED----LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS 64
Query: 58 GLMEQIKREISVMRLVKHPNIVELKEVMATKT--KVFFVIEYV---------KGGELFAK 106
REI+++R +KHPN++ L++V + KV+ + +Y A
Sbjct: 65 AC-----REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119
Query: 107 VLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL----DENGNLKVSDFGLS 162
+L + Q++ + + H+ V HRDLKP N+L+ E G +K++D G +
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
Query: 163 ---ALPEQ-----------LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKS-----DIWS 203
P + W Y APE+L GA+ DIW+
Sbjct: 180 RLFNSPLKPLADLDPVVVTFW-------------YRAPELLL-----GARHYTKAIDIWA 221
Query: 204 CGVVLFVLLSG--FLPFQNENIMKMYR-------KIFKA----------------EYE-- 236
G + LL+ + E+I +IF E+
Sbjct: 222 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTL 281
Query: 237 FPPW--------------------ISCDARRLISRILVADPQKRISVSEIMINPWF 272
+ A L+ ++L DP KRI+ + M +P+F
Sbjct: 282 MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 66/279 (23%), Positives = 122/279 (43%), Gaps = 29/279 (10%)
Query: 24 LGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISV-MRLVKHPNIVELK 82
+G+G + V + + + +A+K I + +Q+ ++ V MR P IV+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 83 EVMATKTKVFFVIEYVKGG-----ELFAKVLKGKLKEESARKYFQQLISAVDFCHS-RGV 136
+ + + +E + + VL + EE K + A++ +
Sbjct: 88 GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL----RKK 192
HRD+KP N+LLD +GN+K+ DFG+S QL + G Y+APE + ++
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP---------WISC 243
GYD +SD+WS G+ L+ L +G P+ ++ ++ + PP + S
Sbjct: 205 GYD-VRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSEEREF-SP 260
Query: 244 DARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAV 282
++ L D KR E++ +P+ + + V V
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-41
Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 27/282 (9%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISV-MRLVKHP 76
E LG+G + V +++ + + +A+K I +++ ++ + MR V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCP 66
Query: 77 NIVELKEVMATKTKVFFVIEYVKGG--ELFAKVLK--GKLKEESARKYFQQLISAVDFCH 132
V + + V+ +E + + + +V+ + E+ K ++ A++ H
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 133 S-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV--- 188
S V HRD+KP N+L++ G +K+ DFG+S L +D G Y+APE
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINP 183
Query: 189 -LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIFKAEYEFPP------W 240
L +KGY KSDIWS G+ + L P+ + + + + E P +
Sbjct: 184 ELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQ---LKQVVEEPSPQLPADKF 239
Query: 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAV 282
S + S+ L + ++R + E+M +P+F SK V
Sbjct: 240 -SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-41
Identities = 81/314 (25%), Positives = 134/314 (42%), Gaps = 77/314 (24%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL---V 73
++++ RM GQGTF V GK T SVAIK + +D + RE+ +M+ +
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVL 76
Query: 74 KHPNIVELKEVMATKTKVFF-------VIEYVKGGELFAKVLKGKLKEESA-----RKYF 121
HPNIV+L+ T + V+EYV + + + + + A K F
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 122 Q-QLISAVDFCH--SRGVYHRDLKPENLLLD-ENGNLKVSDFGLSALPEQLWNDGLLHTQ 177
QLI ++ H S V HRD+KP N+L++ +G LK+ DFG + L ++
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--------KLSPSE 186
Query: 178 CGTPAYV------APEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI 230
AY+ APE+ + Y A DIWS G + ++ G F+ +N +I
Sbjct: 187 PNV-AYICSRYYRAPELIFGNQHYTTA-VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244
Query: 231 FK-----------------AEYEFP-----PW----------ISCDARRLISRILVADPQ 258
+ + + PW + +A L+S +L P+
Sbjct: 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304
Query: 259 KRISVSEIMINPWF 272
+R+ E + +P+F
Sbjct: 305 ERMKPYEALCHPYF 318
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-41
Identities = 66/299 (22%), Positives = 130/299 (43%), Gaps = 47/299 (15%)
Query: 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISV 69
V+ + + +G+G F +V+ GK E VA+K+ + ++ E EI
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIF-SSREERSWFREA---EIYQ 89
Query: 70 MRLVKHPNIVEL----KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLI 125
+++H NI+ + T T+++ V +Y + G LF + + + E K
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTA 149
Query: 126 SAVDFCHSR--------GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN--DGLLH 175
S + H + HRDLK +N+L+ +NG ++D GL+ + + D +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 176 TQCGTPAYVAPEVLRKKGYDGA-----KSDIWSCGVVLFVLLSGF----------LPFQN 220
+ GT Y+APEVL ++DI++ G+V + + LP+ +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 221 E-----NIMKMYRKIFKAEY--EFPP-WISCDARRLISRILV----ADPQKRISVSEIM 267
++ +M + + + + P W SC+A R++++I+ A+ R++ I
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 74/349 (21%), Positives = 123/349 (35%), Gaps = 104/349 (29%)
Query: 3 FETMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQ 62
ET ++ Y +G+ LG G+F V ++ + + A+K + +D K
Sbjct: 2 LETSSKK--------YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------ 47
Query: 63 IKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESAR---- 118
RE+ +M+++ H NI++L + T +
Sbjct: 48 -NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVN 106
Query: 119 -------------------------------------KYFQ-QLISAVDFCHSRGVYHRD 140
+ QL AV F HS G+ HRD
Sbjct: 107 PSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRD 166
Query: 141 LKPENLLLD-ENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV------APEV-LRKK 192
+KP+NLL++ ++ LK+ DFG + L+ ++ AY+ APE+ L
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAK--------KLIPSEPSV-AYICSRFYRAPELMLGAT 217
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK-----------------AEY 235
Y + D+WS G V L+ G F E + +I + E
Sbjct: 218 EYTPS-IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV 276
Query: 236 EFPPWISC------------DARRLISRILVADPQKRISVSEIMINPWF 272
FP + A L+ +IL +P RI+ E M +P+F
Sbjct: 277 RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 139 bits (350), Expect = 5e-40
Identities = 39/125 (31%), Positives = 71/125 (56%), Gaps = 4/125 (3%)
Query: 293 ISSMSSGFDLSSLFESER---KSGSMFTSKCSSSAIMGKLESLAKKLNLGVCVKEFKVKM 349
+ ++S G +LS+LF+ + K + F S+ S I+ +E++A + + FK ++
Sbjct: 12 MITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRL 71
Query: 350 QGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVWSWQG 409
+G + G+LAV E+YEVAP + +V+ K+AG+TLEY KF ++ + L++I+W
Sbjct: 72 EGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKK-LCSKLENIIWRATE 130
Query: 410 ENNSQ 414
Sbjct: 131 GIPKS 135
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 40/255 (15%), Positives = 79/255 (30%), Gaps = 38/255 (14%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
I G+Y + G + + + VA+ ++ V ++++ +
Sbjct: 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR 87
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
+ P + + +V+ T+ V E+++GG L +V A + Q L +A D H
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSL-QEVADTSPSPVGAIRAMQSLAAAADAAH 146
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
GV P + + +G++ + PA +
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVL----------------------AYPATMPDA----- 179
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP-------PWISCDA 245
+ DI G L+ LL P + + P I
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236
Query: 246 RRLISRILVADPQKR 260
+ +R + D R
Sbjct: 237 SAVAARSVQGDGGIR 251
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 63/300 (21%), Positives = 124/300 (41%), Gaps = 49/300 (16%)
Query: 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISV 69
V+ + + +M + +G+G + +V+ GK E VA+KV + + EI
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEA----SWFRETEIYQ 84
Query: 70 MRLVKHPNIVEL----KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLI 125
L++H NI+ + + T+++ + +Y + G L+ + L +S K +
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSV 144
Query: 126 SAVDFCHSR--------GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN--DGLLH 175
S + H+ + HRDLK +N+L+ +NG ++D GL+ N D +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 176 TQCGTPAYVAPEVL------RKKGYDGAKSDIWSCGVVLFVLLSGF----------LPFQ 219
T+ GT Y+ PEVL +D++S G++L+ + LP+
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 220 NEN-----IMKMYRKIFKAEY--EFPP-WISCDARRLISRILV----ADPQKRISVSEIM 267
+ M + + FP W S + R + +++ +P R++ +
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-39
Identities = 80/316 (25%), Positives = 133/316 (42%), Gaps = 57/316 (18%)
Query: 4 ETMDERVRNILFG---KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLM 60
E VR +F +Y +G+G + V + + + VAIK I+ + Q
Sbjct: 12 AAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYC 69
Query: 61 EQIKREISVMRLVKHPNIVELKEVMATKTK-----VFFVIEYVKGGELFAKVLKGKLKEE 115
++ REI ++ +H NI+ + +++ T V+ V + + +L K+LK +
Sbjct: 70 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSN 127
Query: 116 SARKYFQ-QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174
YF Q++ + + HS V HRDLKP NLLL+ +LK+ DFGL+ + + +
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 175 HTQCGTPAYV------APEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMY 227
T+ YV APE+ L KGY + DIWS G +L +LS F ++ +
Sbjct: 188 LTE-----YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQL 241
Query: 228 RKIFK------------------AEY-------------EFPPWISCDARRLISRILVAD 256
I Y P A L+ ++L +
Sbjct: 242 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 301
Query: 257 PQKRISVSEIMINPWF 272
P KRI V + + +P+
Sbjct: 302 PHKRIEVEQALAHPYL 317
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-39
Identities = 71/310 (22%), Positives = 131/310 (42%), Gaps = 62/310 (20%)
Query: 10 VRNILF---GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKRE 66
V + Y +G G + V + + E VAIK ++ + + ++ RE
Sbjct: 15 VNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRE 73
Query: 67 ISVMRLVKHPNIVELKEVMATKTK------VFFVIEYVKGGELFAKVLKGKLKEESARKY 120
+ +++ ++H N++ L +V + + V+ ++ +L K++ K EE +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKFSEEKIQYL 131
Query: 121 FQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180
Q++ + + HS GV HRDLKP NL ++E+ LK+ DFGL+ +
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--------- 182
Query: 181 PAYV------APEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK- 232
YV APEV L Y+ DIWS G ++ +L+G F+ ++ + +I K
Sbjct: 183 --YVVTRWYRAPEVILSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239
Query: 233 -----------------AEY-------------EFPPWISCDARRLISRILVADPQKRIS 262
Y + P S A L+ ++L D KR++
Sbjct: 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
Query: 263 VSEIMINPWF 272
++ + +P+F
Sbjct: 300 AAQALTHPFF 309
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 59/292 (20%), Positives = 108/292 (36%), Gaps = 47/292 (16%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
++ + +G F V+ + + E VA+K+ + Q + E+ + +KH
Sbjct: 25 PLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQ----SWQNEYEVYSLPGMKHE 78
Query: 77 NIVEL----KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARK----------YFQ 122
NI++ K + ++ + + + G L + + Y
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH 138
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
+ I + H + HRD+K +N+LL N ++DFGL+ E + G H Q GT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 183 YVAPEVLRKKGYDGA----KSDIWSCGVVLFVLLSGF-----------LPFQNE------ 221
Y+APEVL + D+++ G+VL+ L S LPF+ E
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258
Query: 222 -NIMKMYRKIFKAEYEFPP-WISCDARRLISRILV----ADPQKRISVSEIM 267
M+ K W ++ + D + R+S +
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 75/306 (24%), Positives = 127/306 (41%), Gaps = 59/306 (19%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y+ + +G G V + + + +VAIK ++ + Q ++ RE+ +M+ V H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 77 NIVELKEVMATKTK------VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
NI+ L V + V+ V+E + L +V++ +L E Q++ +
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIKH 142
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGL--SALPEQLWNDGLLHTQCGTPAYVAPEV 188
HS G+ HRDLKP N+++ + LK+ DFGL +A + + T Y APEV
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV-----VTRYYRAPEV 197
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSG--------------------------FLPFQNEN 222
+ GY DIWS G ++ ++ G F+
Sbjct: 198 ILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 223 IMKMYRKI----------------FKAEYEFPPWISCDARRLISRILVADPQKRISVSEI 266
+ F A+ E + AR L+S++LV D KRISV E
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 267 MINPWF 272
+ +P+
Sbjct: 317 LQHPYI 322
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 83/316 (26%), Positives = 129/316 (40%), Gaps = 56/316 (17%)
Query: 6 MDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVIN--KDQVKKQGLMEQI 63
M +R+ + +++ +LG+G + V + T E VAIK I + +
Sbjct: 1 MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL----RT 56
Query: 64 KREISVMRLVKHPNIVELKEVMATKTK-----VFFVIEYVKGGELFAKVLKGKLKEESAR 118
REI +++ KH NI+ + + + V+ + E + +L +V+ ++ +
Sbjct: 57 LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHI 114
Query: 119 KYFQ-QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL--SALPEQLWNDGLLH 175
+YF Q + AV H V HRDLKP NLL++ N +LKV DFGL N
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 176 TQCGTPAYV------APEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYR 228
Q G +V APEV L Y A D+WSCG +L L F +
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRA-MDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 229 KIFK-------------------AEY-------------EFPPWISCDARRLISRILVAD 256
IF EY + P ++ L+ R+LV D
Sbjct: 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293
Query: 257 PQKRISVSEIMINPWF 272
P KRI+ E + +P+
Sbjct: 294 PAKRITAKEALEHPYL 309
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 59/306 (19%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y+ + +G G V + V +VAIK ++ + Q ++ RE+ +M+ V H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 77 NIVELKEVMATKTK------VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
NI+ L V + V+ V+E + L +V++ +L E Q++ +
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGL--SALPEQLWNDGLLHTQCGTPAYVAPEV 188
HS G+ HRDLKP N+++ + LK+ DFGL +A + T Y APEV
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-----YVVTRYYRAPEV 234
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSG--------------------------FLPFQNEN 222
+ GY DIWS G ++ ++ F+
Sbjct: 235 ILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293
Query: 223 IMKM-----------YRKIF-----KAEYEFPPWISCDARRLISRILVADPQKRISVSEI 266
+ + K+F A+ E + AR L+S++LV DP KRISV +
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 267 MINPWF 272
+ +P+
Sbjct: 354 LQHPYI 359
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 68/313 (21%), Positives = 130/313 (41%), Gaps = 63/313 (20%)
Query: 8 ERVRNILF---GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK 64
+ V + Y + +G G + V + T VAIK + + + ++
Sbjct: 14 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAY 72
Query: 65 REISVMRLVKHPNIVELKEVMATKTK------VFFVIEYVKGGELFAKVLKGKLKEESAR 118
RE+ +++ ++H N++ L +V + V+ ++ G +L K++K + E
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRI 130
Query: 119 KYFQ-QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ 177
++ Q++ + + H+ G+ HRDLKP NL ++E+ LK+ DFGL+ +
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG------ 184
Query: 178 CGTPAYV------APEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKI 230
YV APEV L Y DIWS G ++ +++G F+ + + ++I
Sbjct: 185 -----YVVTRWYRAPEVILNWMRYTQT-VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
Query: 231 FK------------------AEY-------------EFPPWISCDARRLISRILVADPQK 259
K Y S A L+ ++LV D ++
Sbjct: 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 298
Query: 260 RISVSEIMINPWF 272
R++ E + +P+F
Sbjct: 299 RVTAGEALAHPYF 311
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-36
Identities = 31/116 (26%), Positives = 55/116 (47%), Gaps = 7/116 (6%)
Query: 293 ISSMSSGFDLSSLFES--ERKSGSMFTSKCSSSAIMGKLESLAKKLNLGVCVKE-FKVKM 349
I S S GF+LS LF + F S ++ ++ +LE + NL V KE + +K+
Sbjct: 11 IISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETWGMKI 70
Query: 350 QGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVW 405
EG+KG A+ E+ ++ E+ ++E K + + +RP ++V
Sbjct: 71 ----EGQKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVH 122
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-36
Identities = 65/301 (21%), Positives = 122/301 (40%), Gaps = 60/301 (19%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y+ +G G + V + T VA+K ++ + ++ RE+ +++ +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 77 NIVELKEVMATKTK------VFFVIEYVKGGELFAKVLKGKLKEESARKYFQ-QLISAVD 129
N++ L +V V+ V + G +L ++K + + ++ Q++ +
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV----- 184
+ HS + HRDLKP NL ++E+ LK+ DFGL+ YV
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----------YVATRWY 195
Query: 185 -APEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK---------- 232
APE+ L Y+ DIWS G ++ LL+G F + + + I +
Sbjct: 196 RAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 233 --------AEY-------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPW 271
Y + A L+ ++LV D KRI+ ++ + + +
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 272 F 272
F
Sbjct: 315 F 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 54/292 (18%), Positives = 106/292 (36%), Gaps = 44/292 (15%)
Query: 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
++ ++ ++G+G + VY G + + VA+KV + + E ++ R
Sbjct: 9 SLDLDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFAN------RQNFINEKNIYR 60
Query: 72 LVK--HPNIVEL-----KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQL 124
+ H NI + + + V+EY G L + S+ + +
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSV 120
Query: 125 ISAVDFCHS---------RGVYHRDLKPENLLLDENGNLKVSDFGLS------ALPEQLW 169
+ + H+ + HRDL N+L+ +G +SDFGLS L
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 170 NDGLLHTQCGTPAYVAPEVLR------KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI 223
D ++ GT Y+APEVL + D+++ G++ + +
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 224 MKMYRKIFKAEYEFPP-------WISCDARRL-ISRILVADPQKRISVSEIM 267
+ Y+ F+ E P +S + +R + S+ E +
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 74/315 (23%), Positives = 132/315 (41%), Gaps = 63/315 (20%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y + LG G V+ + + VAIK K + ++ REI ++R + H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 77 NIVELKEVMATKTK--------------VFFVIEYVKGGELFAKVLKGKLKEESARKYFQ 122
NIV++ E++ V+ V EY+ +L + +G L EE AR +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMY 127
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLD-ENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP 181
QL+ + + HS V HRDLKP NL ++ E+ LK+ DFGL+ + + ++ ++
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE---- 183
Query: 182 AYV------APEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK-- 232
+ +P + L Y A D+W+ G + +L+G F + ++ + I +
Sbjct: 184 -GLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 233 ---------------AEY-------------EFPPWISCDARRLISRILVADPQKRISVS 264
Y + P IS +A + +IL P R++
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301
Query: 265 EIMINPWFIKGFSKP 279
E + +P+ +S P
Sbjct: 302 EALSHPYM-SIYSFP 315
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 64/305 (20%), Positives = 120/305 (39%), Gaps = 56/305 (18%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLME--------QIKREIS 68
Y + R + G++ V G + VAIK + + + ++ REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 69 VMRLVKHPNIVELKEVMATKTK-----VFFVIEYVKGGELFAKVLK---GKLKEESARKY 120
++ HPNI+ L+++ + ++ V E + +L A+V+ + + + +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDL-AQVIHDQRIVISPQHIQYF 139
Query: 121 FQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT 180
++ + H GV HRDL P N+LL +N ++ + DF L+ + D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTHYVTH 196
Query: 181 PAYVAPEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------ 233
Y APE+ ++ KG+ D+WS G V+ + + F+ KI +
Sbjct: 197 RWYRAPELVMQFKGFTKL-VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 234 ---------------EYEFP-----------PWISCDARRLISRILVADPQKRISVSEIM 267
P A LI+++L +PQ+RIS + +
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315
Query: 268 INPWF 272
+P+F
Sbjct: 316 RHPYF 320
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-33
Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 37/222 (16%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+YE+ ++G G++ V + + + VAIK I + + ++I REI+++ + H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHD 112
Query: 77 NIVELKEVMATKT-----KVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVD 129
++V++ +++ K +++ V+E + K+ + L E + L+ V
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS-----------ALPEQLWNDGLLHTQC 178
+ HS G+ HRDLKP N L++++ ++KV DFGL+ LP D +
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 179 GTPA--------YV------APEV-LRKKGYDGAKSDIWSCG 205
+V APE+ L ++ Y A D+WS G
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA-IDVWSIG 271
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 78/327 (23%), Positives = 129/327 (39%), Gaps = 75/327 (22%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVKH 75
KYE+ + LG+G + V+ + T E VA+K I D + ++ REI ++ L H
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREIMILTELSGH 68
Query: 76 PNIVELKEVMATKTK--VFFVIEYVKGGELFAKVLKGKLKEESARKYFQ-QLISAVDFCH 132
NIV L V+ V+ V +Y+ +L V++ + E ++Y QLI + + H
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA---------- 182
S G+ HRD+KP N+LL+ ++KV+DFGLS +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 183 ---YV------APEV-LRKKGYDGAKSDIWSCGVVLFVLLSG---F-------------- 215
YV APE+ L Y D+WS G +L +L G F
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKG-IDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 216 ------------------------------LPFQNENIMKMYRKIFKAEYEFPPWISCDA 245
+ N+ + K + + +A
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 246 RRLISRILVADPQKRISVSEIMINPWF 272
L+ ++L +P KRIS ++ + +P+
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 66/343 (19%), Positives = 130/343 (37%), Gaps = 85/343 (24%)
Query: 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVI-NKDQVKKQGLMEQIKREI 67
+ + +YE+ +++G+G+F +V + + VA+K++ N+ + +Q E I
Sbjct: 90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-----I 144
Query: 68 SVMRLVKH------PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK----LKEESA 117
++ ++ N++ + E + + E + L+ +++K
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLY-ELIKKNKFQGFSLPLV 202
Query: 118 RKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG--NLKVSDFGLSALPEQLWNDGLLH 175
RK+ ++ +D H + H DLKPEN+LL + G +KV DFG S Q ++
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VY 257
Query: 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-------IM---- 224
T + Y APEV+ Y D+WS G +L LL+G+ E+ ++
Sbjct: 258 TYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316
Query: 225 ----KMYRKIFKAEYEF-----PPWISCDARR---------------------------- 247
K+ +A+ P + +
Sbjct: 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376
Query: 248 -----------LISRILVADPQKRISVSEIMINPWFIKGFSKP 279
+ + L DP R++ + + +PW + KP
Sbjct: 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 68/332 (20%), Positives = 123/332 (37%), Gaps = 88/332 (26%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVI-NKDQVKKQGLMEQIKREISVMRLVK 74
+Y + R LG G F+ V+ K++V VA+K++ + E I +++ V
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE-----IKLLQRVN 73
Query: 75 -----------HPNIVELKEV----MATKTKVFFVIEYVKGGELFAKVLK----GKLKEE 115
+I++L + V V E V G L ++K +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLL-ALIKKYEHRGIPLI 131
Query: 116 SARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDE------NGNLKVSDFGLSALPEQL 168
++ +QL+ +D+ H R G+ H D+KPEN+L++ +K++D G +
Sbjct: 132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----- 186
Query: 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN------ 222
W D T Y +PEVL + +DIWS ++F L++G F+ +
Sbjct: 187 WYDEHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 223 -------IM--------KMYRKIFKAEYEF------------------------PPWISC 243
I+ + R F +
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 244 DARR---LISRILVADPQKRISVSEIMINPWF 272
+A+ +S +L DP+KR ++ +PW
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-30
Identities = 70/320 (21%), Positives = 134/320 (41%), Gaps = 45/320 (14%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y + ++G+G++ VY + T+++VAIK +N + ++I REI+++ +K
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNRLKSD 85
Query: 77 NIVELKEVMATKTK-----VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVD 129
I+ L +++ ++ V+E +L K+ K L EE + L+ +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIA-DSDL-KKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS-----------ALPEQLWNDGLLHTQC 178
F H G+ HRDLKP N LL+++ ++KV DFGL+ + + H +
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 179 GTPA---YV------APEV-LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYR 228
+V APE+ L ++ Y + DIWS G + LL+ N+ +
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKS-IDIWSTGCIFAELLNMLQSHINDPTNR--F 260
Query: 229 KIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGD 288
+F FP +++++ + D I I+ P ++ I+ +
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNR-DQLNII--FNIIGTP------TEDDLKNINKPE 311
Query: 289 NRDFISSM--SSGFDLSSLF 306
+I +L +
Sbjct: 312 VIKYIKLFPHRKPINLKQKY 331
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 27/262 (10%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
+G +G+G F +V+ G+ VA+K + + +E +++ HPNI
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNI 174
Query: 79 VELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRGV 136
V L V K ++ V+E V+GG+ F + +L+ ++ + + +++ S+
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAY----VAPEVLRKK 192
HRDL N L+ E LK+SDFG+S + DG+ G APE L
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 193 GYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYRKIFKAEYEFPPWISCD 244
Y ++SD+WS G++L+ S G P+ N E + K R P
Sbjct: 291 RYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR------LPCPELCPDA 343
Query: 245 ARRLISRILVADPQKRISVSEI 266
RL+ + +P +R S S I
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTI 365
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 23/224 (10%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
M LG G + +VY G +VA+K + +D ++ + ++ E +VM+ +KHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNL 278
Query: 79 VELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGK-LKEESARKYFQQLISAVDFCHSRG 135
V+L V + + + E++ G L + + + + Q+ SA+++ +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV---APEVLRKK 192
HR+L N L+ EN +KV+DFGLS +L G + APE L
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 193 GYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
+ KSD+W+ GV+L+ + + G P+ E + K YR
Sbjct: 395 KFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 437
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 34/235 (14%)
Query: 16 GKYE-------MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK--RE 66
GK+ + +G G F V+ G + ++ VAIK I ++G M + E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI------REGAMSEEDFIEE 53
Query: 67 ISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQL 124
VM + HP +V+L V + + V E+++ G L + + +G E+ +
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 125 ISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT--PA 182
+ + V HRDL N L+ EN +KVSDFG++ D + GT P
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTSSTGTKFPV 169
Query: 183 -YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
+ +PEV Y +KSD+WS GV+++ + S G +P++N E+I +R
Sbjct: 170 KWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR 223
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 65/345 (18%), Positives = 122/345 (35%), Gaps = 94/345 (27%)
Query: 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVI-NKDQVKKQGLMEQIKREI 67
+ +L + + R +G GTF +V +++ ++ A+KV+ N + + +E
Sbjct: 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----A 82
Query: 68 SVMRLVKH-----PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK----LKEESAR 118
+++ +++ NIV+ + + E G L+ +++ E +
Sbjct: 83 DILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLY-EIITRNNYNGFHIEDIK 140
Query: 119 KYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-------------------------N 153
Y +++ A+++ + H DLKPEN+LLD+
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 154 LKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS 213
+K+ DFG A + + T Y APEV+ G+D + SD+WS G VL L +
Sbjct: 201 IKLIDFG-CATFK----SDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYT 254
Query: 214 GFLPFQNEN-------IM--------KMYRKIFKAEYEF--------------------- 237
G L F+ + M + K
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314
Query: 238 PPWISCDARR----------LISRILVADPQKRISVSEIMINPWF 272
C + IL DP R S +E++ + +
Sbjct: 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 68/254 (26%), Positives = 111/254 (43%), Gaps = 28/254 (11%)
Query: 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVI-NKDQVKKQGLMEQIKREI 67
+ +YE+ ++G+G+F +V + V QE VAIK+I NK Q +E +
Sbjct: 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-----V 101
Query: 68 SVMRLVKHP------NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK----LKEESA 117
++ L+ IV LK + + V E + L+ +L+ +
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLY-DLLRNTNFRGVSLNLT 159
Query: 118 RKYFQQLISAVDFCHSR--GVYHRDLKPENLLLDENGN--LKVSDFGLSALPEQLWNDGL 173
RK+ QQ+ +A+ F + + H DLKPEN+LL +K+ DFG S+
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQL----GQR 214
Query: 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA 233
++ + Y +PEVL YD A D+WS G +L + +G F N + KI +
Sbjct: 215 IYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273
Query: 234 EYEFPPWISCDARR 247
P I A +
Sbjct: 274 LGIPPAHILDQAPK 287
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 77/346 (22%), Positives = 128/346 (36%), Gaps = 88/346 (25%)
Query: 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLV-TQESVAIKVI-NKDQVKKQGLMEQIKRE 66
R+ + L +YE+ LG+GTF KV + + VA+K+I N + ++ +E
Sbjct: 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----- 66
Query: 67 ISVMRLVKHP------NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK----LKEES 116
I+V++ +K V + + + E + G F + LK
Sbjct: 67 INVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTF-EFLKENNFQPYPLPH 124
Query: 117 ARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN-------------------LKVS 157
R QL A+ F H + H DLKPEN+L + ++V+
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 158 DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLP 217
DFG SA + T T Y PEV+ + G+ D+WS G +LF GF
Sbjct: 185 DFG-SATFD----HEHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTL 238
Query: 218 FQNEN-------IM--------KMYRKIFKAEYEF---PPWISCDARR------------ 247
FQ + M + K +Y + W +
Sbjct: 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298
Query: 248 --------------LISRILVADPQKRISVSEIMINPWFIKGFSKP 279
L+ R+L DP +RI+++E +++P+F +
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 13/211 (6%)
Query: 19 EMGRMLGQGTFAKVYYGK-NLVTQES--VAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+ LG G+F V G+ + + ++ VA+K + D + + M+ RE++ M + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHS 133
N++ L V + V E G L + +G + +Y Q+ + + S
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP---AYVAPEVLR 190
+ HRDL NLLL +K+ DFGL Q ND Q A+ APE L+
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPFAWCAPESLK 197
Query: 191 KKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN 220
+ + SD W GV L+ + + G P+
Sbjct: 198 TRTFS-HASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 80/339 (23%), Positives = 126/339 (37%), Gaps = 88/339 (25%)
Query: 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQ-ESVAIKVI-NKDQVKKQGLMEQIKRE 66
+ ++L +YE+ LG+G F KV + VA+K++ N D+ + E
Sbjct: 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----- 61
Query: 67 ISVMRLVKHP------NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK----LKEES 116
I V+ + V++ E + V E + G + +K + +
Sbjct: 62 IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTY-DFIKENGFLPFRLDH 119
Query: 117 ARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN-------------------LKVS 157
RK Q+ +V+F HS + H DLKPEN+L ++ +KV
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 158 DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLP 217
DFG SA + D T T Y APEV+ G+ D+WS G +L GF
Sbjct: 180 DFG-SATYD----DEHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTV 233
Query: 218 FQNEN-------IM--------KMYRKIFKAEYEF---PPW-ISCDARR----------- 247
F + + M +K K +Y W A R
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293
Query: 248 --------------LISRILVADPQKRISVSEIMINPWF 272
LI ++L DP KRI++ E + +P+F
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-26
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 27/224 (12%)
Query: 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK--REISVMRLVKHPN 77
+ + LG G F V GK Q VA+K+I K+G M + + +E M + HP
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVKMI------KEGSMSEDEFFQEAQTMMKLSHPK 64
Query: 78 IVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRG 135
+V+ V + + ++ V EY+ G L + + L+ + + + F S
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT--PA-YVAPEVLRKK 192
HRDL N L+D + +KVSDFG++ D + GT P + APEV
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL----DDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 193 GYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
Y +KSD+W+ G++++ + S G +P+ + + +R
Sbjct: 181 KYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 22/226 (9%)
Query: 19 EMGRMLGQGTFAKVYYG----KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+ ++LG G F VY G + + VAIK + + K ++I E VM V
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMASVD 75
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCH 132
+P++ L + + V + + + G L + + K + + + Q+ +++
Sbjct: 76 NPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG-TP-AYVAPEVLR 190
R + HRDL N+L+ ++K++DFGL+ L + H + G P ++A E +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESIL 192
Query: 191 KKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM----YR 228
+ Y +SD+WS GV ++ L++ G P+ I + R
Sbjct: 193 HRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK--REISVMRLVKHP 76
M LG G + +VY G +VA+K + K+ ME + +E +VM+ +KHP
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHP 69
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFA---KVLKGKLKEESARKYFQQLISAVDFCHS 133
N+V+L V + + + E++ G L + + ++ Q+ SA+++
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT--PA-YVAPEVLR 190
+ HRDL N L+ EN +KV+DFGLS +L G P + APE L
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 191 KKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM----YR 228
+ KSD+W+ GV+L+ + + G P+ + ++ YR
Sbjct: 186 YNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 230
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-26
Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 27/225 (12%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK--REISVMRLVKHP 76
+ LG G F V YGK Q VAIK+I K+G M + + E VM + H
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMI------KEGSMSEDEFIEEAKVMMNLSHE 79
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSR 134
+V+L V + +F + EY+ G L + + ++ + + + + + + A+++ S+
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT--PA-YVAPEVLRK 191
HRDL N L+++ G +KVSDFGLS D + G+ P + PEVL
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 192 KGYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
+ +KSDIW+ GV+++ + S G +P++ E+I + R
Sbjct: 196 SKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 239
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 25/224 (11%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
++ LG G F +V+ G VA+K + + + + E ++M+ ++H +
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRL 70
Query: 79 VELKEVMATKTKVFFVIEYVKGGEL--FAKVLKG-KLKEESARKYFQQLISAVDFCHSRG 135
V L V T+ ++ + EY++ G L F K G KL Q+ + F R
Sbjct: 71 VRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV---APEVLRKK 192
HRDL+ N+L+ + + K++DFGL+ +L D + G + APE +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLA----RLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 193 GYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
+ KSD+WS G++L +++ G +P+ +N+ + YR
Sbjct: 186 TFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
+ LGQG F +V+ G VAIK + + + ++ E VM+ ++H +
Sbjct: 270 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 324
Query: 79 VELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGK-LKEESARKYFQQLISAVDFCHSRG 135
V+L V ++ ++ V EY+ G L F K GK L+ Q+ S + +
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP-AYVAPEVLRKKGY 194
HRDL+ N+L+ EN KV+DFGL+ L E N+ P + APE +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 195 DGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
KSD+WS G++L L + G +P+ + + + YR
Sbjct: 442 T-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 482
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 30/230 (13%)
Query: 20 MGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIK----REISVMR 71
+++G G F +VY G + + VAIK + K G E+ + E +M
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL------KAGYTEKQRVDFLGEAGIMG 101
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVD 129
H NI+ L+ V++ + + EY++ G L F + G+ + + + +
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV---AP 186
+ + HRDL N+L++ N KVSDFGLS + E + +T G + AP
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAP 219
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
E + + + + SD+WS G+V++ +++ G P+ + I +R
Sbjct: 220 EAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 268
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
+ LGQG F +V+ G VAIK + + + ++ E VM+ ++H +
Sbjct: 187 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 241
Query: 79 VELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGK-LKEESARKYFQQLISAVDFCHSRG 135
V+L V ++ ++ V EY+ G L F K GK L+ Q+ S + +
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTP-AYVAPEVLRKKGY 194
HRDL+ N+L+ EN KV+DFGL+ L E N+ P + APE +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 195 DGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
KSD+WS G++L L + G +P+ + + + YR
Sbjct: 359 T-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQE---SVAIKVINKDQVKKQGLMEQIK----REISVMR 71
+ +++G G +V YG+ V + VAIK + K G E+ + E S+M
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL------KAGYTERQRRDFLSEASIMG 105
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVD 129
HPNI+ L+ V+ V EY++ G L F + G+ + + + +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV---AP 186
+ G HRDL N+L+D N KVSDFGLS + E + +T G + AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAP 223
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
E + + + + SD+WS GVV++ +L+ G P+ N ++ + YR
Sbjct: 224 EAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR 272
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 53/224 (23%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI 78
++ + LG G F +V+ VA+K + + + + E +VM+ ++H +
Sbjct: 191 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 245
Query: 79 VELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGK-LKEESARKYFQQLISAVDFCHSRG 135
V+L V TK ++ + E++ G L F K +G + Q+ + F R
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV---APEVLRKK 192
HRDL+ N+L+ + K++DFGL+ ++ D + G + APE +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 193 GYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
+ KSD+WS G++L +++ G +P+ + + YR
Sbjct: 361 SFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR 403
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 64/229 (27%), Positives = 109/229 (47%), Gaps = 29/229 (12%)
Query: 20 MGRMLGQGTFAKVYYGK-NLVTQE--SVAIKVINKDQVKKQGLMEQIKR----EISVMRL 72
+ +++G G F +V G+ L +++ SVAIK + K G E+ +R E S+M
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL------KVGYTEKQRRDFLGEASIMGQ 102
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDF 130
HPNI+ L+ V+ V V EY++ G L F + + + + S + +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV---APE 187
G HRDL N+L++ N KVSDFGL + E + +T G + +PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED--DPEAAYTTRGGKIPIRWTSPE 220
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
+ + + + SD+WS G+VL+ ++S G P+ + + + YR
Sbjct: 221 AIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR 268
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 19 EMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIK---REISVMR 71
+ + LG+G F V + T E VA+K + + E ++ REI +++
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILK 66
Query: 72 LVKHPNIVELKEVMATKTK--VFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISA 127
++H NIV+ K V + + + ++EY+ G L + + K ++ +Y Q+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGT--P-AY 183
+++ ++ HRDL N+L++ +K+ DFGL+ LP+ + + P +
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ---DKEFFKVKEPGESPIFW 183
Query: 184 VAPEVLRKKGYDGAKSDIWSCGVVL 208
APE L + + SD+WS GVVL
Sbjct: 184 YAPESLTESKFS-VASDVWSFGVVL 207
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 43/214 (20%)
Query: 19 EMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIK---REISVMR 71
+ + LG+G F V + T E VA+K + + E ++ REI +++
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILK 97
Query: 72 LVKHPNIVELKEV--MATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISA 127
++H NIV+ K V A + + ++EY+ G L + + K ++ +Y Q+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGTPAYV-- 184
+++ ++ HRDL N+L++ +K+ DFGL+ LP+ Y
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ------------DKEYYKVK 205
Query: 185 ----------APEVLRKKGYDGAKSDIWSCGVVL 208
APE L + + SD+WS GVVL
Sbjct: 206 EPGESPIFWYAPESLTESKFS-VASDVWSFGVVL 238
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 22/226 (9%)
Query: 19 EMGRMLGQGTFAKVYYG----KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+ ++LG G F VY G + + VAIK + + K ++I E VM V
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMASVD 75
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCH 132
+P++ L + + V + + + G L + + K + + + Q+ +++
Sbjct: 76 NPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG-TP-AYVAPEVLR 190
R + HRDL N+L+ ++K++DFGL+ L + H + G P ++A E +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESIL 192
Query: 191 KKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM----YR 228
+ Y +SD+WS GV ++ L++ G P+ I + R
Sbjct: 193 HRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 25/232 (10%)
Query: 12 NILFGKYEMGRMLGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQGLMEQIKREISV 69
N+L E LG G F V G + Q VAIKV+ + K E++ RE +
Sbjct: 10 NLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQI 63
Query: 70 MRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISA 127
M + +P IV L V + V+E GG L F + ++ + + Q+
Sbjct: 64 MHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT--P-AYV 184
+ + + HRDL N+LL K+SDFGLS +D + P +
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWY 180
Query: 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM----YR 228
APE + + + ++SD+WS GV ++ LS G P++ +M R
Sbjct: 181 APECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 231
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 19 EMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+ R LG+G F KV + T E VA+K + + + +K+EI ++R +
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLY 81
Query: 75 HPNIVELKEVMATKTK--VFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDF 130
H NIV+ K + + ++E++ G L + K K+ + KY Q+ +D+
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGTPAYV---AP 186
SR HRDL N+L++ +K+ DFGL+ A+ + + + V AP
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET---DKEYYTVKDDRDSPVFWYAP 198
Query: 187 EVLRKKGYDGAKSDIWSCGVVL 208
E L + + SD+WS GV L
Sbjct: 199 ECLMQSKFY-IASDVWSFGVTL 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 19/223 (8%)
Query: 20 MGRMLGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+ LG G F V G + ++VA+K++ + L +++ E +VM+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA-LKDELLAEANVMQQLDNPY 79
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRGV 136
IV + + V+E + G L + + + +K+++ + Q+ + +
Sbjct: 80 IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT--P-AYVAPEVLRKKG 193
HRDL N+LL K+SDFGLS ++ Q P + APE +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 194 YDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM----YR 228
+ +KSD+WS GV+++ S G P++ + M R
Sbjct: 197 FS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 238
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 23/221 (10%)
Query: 24 LGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
LG G F V G + Q VAIKV+ + K E++ RE +M + +P IV L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRL 401
Query: 82 KEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHR 139
V + V+E GG L F + ++ + + Q+ + + + HR
Sbjct: 402 IGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 140 DLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGT--P-AYVAPEVLRKKGYD 195
+L N+LL K+SDFGLS AL +D + P + APE + + +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 196 GAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM----YR 228
++SD+WS GV ++ LS G P++ +M R
Sbjct: 518 -SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 557
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 22/226 (9%)
Query: 19 EMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
++LG G F V+ G + V IKVI ++ + + + + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--FQAVTDHMLAIGSLD 73
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFCH 132
H +IV L + + + V +Y+ G L + +G L + + Q+ + +
Sbjct: 74 HAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG-TP-AYVAPEVLR 190
G+ HR+L N+LL ++V+DFG++ L +D L TP ++A E +
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP--DDKQLLYSEAKTPIKWMALESIH 190
Query: 191 KKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM----YR 228
Y +SD+WS GV ++ L++ G P+ + + R
Sbjct: 191 FGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER 235
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 32/230 (13%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQE---SVAIKVINKDQVKKQGLMEQIK----REISVMR 71
E+GR +G+G F V+ G + + +VAIK K + ++ +E MR
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC------KNCTSDSVREKFLQEALTMR 71
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVD 129
HP+IV+L V T+ V+ ++E GEL F +V K L S Y QL +A+
Sbjct: 72 QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT--PA-YVAP 186
+ S+ HRD+ N+L+ N +K+ DFGLS E D + P ++AP
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME----DSTYYKASKGKLPIKWMAP 186
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM----YR 228
E + + + + SD+W GV ++ +L G PFQ N +++ R
Sbjct: 187 ESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 19 EMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+ R LG+G F KV N T E VA+K + D + K+EI ++R +
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH--RSGWKQEIDILRTLY 91
Query: 75 HPNIVELKEVMATKTK--VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH 132
H +I++ K + V+EYV G L + + + + QQ+ + + H
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGT--P-AYVAPEV 188
++ HRDL N+LLD + +K+ DFGL+ A+PE + P + APE
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYAPEC 208
Query: 189 LRKKGYDGAKSDIWSCGVVL 208
L++ + SD+WS GV L
Sbjct: 209 LKEYKFY-YASDVWSFGVTL 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 43/214 (20%)
Query: 19 EMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIK---REISVMR 71
+ LG+G F V + T VA+K + + +Q + REI +++
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL------QHSGPDQQRDFQREIQILK 79
Query: 72 LVKHPNIVELKEV-MATKTKVFFVI-EYVKGGEL--FAKVLKGKLKEESARKYFQQLISA 127
+ IV+ + V + ++ EY+ G L F + + +L Y Q+
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGTPAYV-- 184
+++ SR HRDL N+L++ ++K++DFGL+ LP YV
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL------------DKDYYVVR 187
Query: 185 ----------APEVLRKKGYDGAKSDIWSCGVVL 208
APE L + +SD+WS GVVL
Sbjct: 188 EPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVL 220
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 59/228 (25%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
R++G+G F VY+G+ + ++ AIK +++ +Q +E RE +MR + H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ--VEAFLREGLLMRGLNH 81
Query: 76 PNIVELKEVMATKTKVFFVI-EYVKGGELFAKVLKGKLKEESARKYFQQLIS-AVDFCH- 132
PN++ L +M + V+ Y+ G+L ++ + LIS +
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDL-----LQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 133 -----SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV--- 184
+ HRDL N +LDE+ +KV+DFGL+ + + Q A +
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA---RDILDREYYSVQQHRHARLPVK 193
Query: 185 --APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM 226
A E L+ + KSD+WS GV+L+ LL+ G P++ ++
Sbjct: 194 WTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQE-SVAIKVINKDQVKKQGLMEQIK----REISVMR 71
+ R+LG+G F +VY G N ++ +VA+K K+ K E +M+
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC------KKDCTLDNKEKFMSEAVIMK 68
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVD 129
+ HP+IV+L ++ + + ++E GEL + + K LK + Y Q+ A+
Sbjct: 69 NLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT--P-AYVAP 186
+ S HRD+ N+L+ +K+ DFGLS E D + T P +++P
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE----DEDYYKASVTRLPIKWMSP 183
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM----YR 228
E + + + SD+W V ++ +LS G PF N++++ + R
Sbjct: 184 ESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR 232
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 31/228 (13%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
++G+G F VY+G L A+K +N+ + + Q E +M+ H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSH 85
Query: 76 PNIVELKEVMATKTKVFFVI-EYVKGGELFAKVLKGKLKEESARKYFQQLIS-AVDFCH- 132
PN++ L + V+ Y+K G+L + ++ E+ + LI +
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIGFGLQVAKG 140
Query: 133 -----SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV--- 184
S+ HRDL N +LDE +KV+DFGL+ +++ T A +
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA---RDMYDKEYYSVHNKTGAKLPVK 197
Query: 185 --APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM 226
A E L+ + + KSD+WS GV+L+ L++ G P+ +I
Sbjct: 198 WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-23
Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 35/227 (15%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQ-IKREISVMRLVKHPN 77
++ + +G+G F V G + VA+K I K Q E SVM ++H N
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCI------KNDATAQAFLAEASVMTQLRHSN 75
Query: 78 IVELKEVMATKTK--VFFVIEYVKGGEL--FAKVLKGK-LKEESARKYFQQLISAVDFCH 132
+V+L V + K ++ V EY+ G L + + L + K+ + A+++
Sbjct: 76 LVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV---APEVL 189
HRDL N+L+ E+ KVSDFGL+ + G L P V APE L
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEAL 186
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
R+K + KSD+WS G++L+ + S G +P+ + K Y+
Sbjct: 187 REKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 232
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 32/209 (15%)
Query: 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81
++G G F KVY G L VA+K + QG+ E + EI + +HP++V L
Sbjct: 45 FLIGHGVFGKVYKGV-LRDGAKVALKRRTPE--SSQGIEE-FETEIETLSFCRHPHLVSL 100
Query: 82 ------KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVD------ 129
+ M + +Y++ G L + L G + + Q+L +
Sbjct: 101 IGFCDERNEMI------LIYKYMENGNL-KRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL-PEQLWNDGLLH--TQC-GTPAYVA 185
+ H+R + HRD+K N+LLDEN K++DFG+S E H T GT Y+
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE----LDQTHLSTVVKGTLGYID 209
Query: 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLSG 214
PE KG KSD++S GVVLF +L
Sbjct: 210 PEYFI-KGRLTEKSDVYSFGVVLFEVLCA 237
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 58/244 (23%), Positives = 102/244 (41%), Gaps = 31/244 (12%)
Query: 3 FETMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQES---VAIKVINKDQVKKQGL 59
+ + V ++G+G F VY+G L A+K +N+ +
Sbjct: 76 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-- 133
Query: 60 MEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI-EYVKGGELFAKVLKGKLKEESAR 118
+ Q E +M+ HPN++ L + V+ Y+K G+L + ++ E+
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHN 188
Query: 119 KYFQQLIS-AVDFCH------SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171
+ LI + S+ HRDL N +LDE +KV+DFGL+ +++
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA---RDMYDK 245
Query: 172 GLLHTQCGTPAYV-----APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NEN 222
T A + A E L+ + + KSD+WS GV+L+ L++ G P+ +
Sbjct: 246 EFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
Query: 223 IMKM 226
I
Sbjct: 305 ITVY 308
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-22
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQE-SVAIKVINKDQVKKQGLMEQIK----REISVMR 71
E+GR +G+G F V+ G + +VAIK K + ++ +E MR
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC------KNCTSDSVREKFLQEALTMR 446
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVD 129
HP+IV+L V T+ V+ ++E GEL F +V K L S Y QL +A+
Sbjct: 447 QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCG-TPA-YVAPE 187
+ S+ HRD+ N+L+ N +K+ DFGLS + + G P ++APE
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPE 562
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM 226
+ + + + SD+W GV ++ +L G PFQ N +++
Sbjct: 563 SINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 28/231 (12%)
Query: 19 EMGRMLGQGTFAKVYYGK---NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+GRMLG+G F V + + VA+K++ D + +E+ RE + M+ H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS-DIEEFLREAACMKEFDH 84
Query: 76 PNIVEL------KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLIS-AV 128
P++ +L ++ ++K G+L A +L ++ E Q L+ V
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 129 DFCH------SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
D SR HRDL N +L E+ + V+DFGLS ++++ C +
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS---RKIYSGDYYRQGCASKL 201
Query: 183 YV---APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM 226
V A E L Y SD+W+ GV ++ +++ G P+ N I
Sbjct: 202 PVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 69/385 (17%), Positives = 128/385 (33%), Gaps = 140/385 (36%)
Query: 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREIS 68
++ ++ G+Y + R LG G F+ V+ ++ ++ VA+KV+ + E EI
Sbjct: 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT----ETALDEIR 85
Query: 69 VMRLVK-----HPN---IVELKEVMATKTKVFFVIEYVKG----------GELFAKVLK- 109
+++ V+ PN +V+L + F I V G G K +
Sbjct: 86 LLKSVRNSDPNDPNREMVVQLLDD--------FKISGVNGTHICMVFEVLGHHLLKWIIK 137
Query: 110 ---GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLL----------------- 148
L +K QQ++ +D+ H++ + H D+KPEN+LL
Sbjct: 138 SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEW 197
Query: 149 --------------------------------DENGNLKVSDFGLSALPEQLWNDGLLHT 176
E +K++D G + + T
Sbjct: 198 QRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FT 251
Query: 177 QCGTP-AYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMY-------- 227
+ Y + EVL GY+ +DIWS + F L +G F+ + +
Sbjct: 252 EDIQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL 310
Query: 228 -------------------RKIFKAEYEF------PPWISCDAR---------------R 247
++ F + + PW +
Sbjct: 311 IIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTD 370
Query: 248 LISRILVADPQKRISVSEIMINPWF 272
+ +L P+KR + +E + +PW
Sbjct: 371 FLLPMLELIPEKRATAAECLRHPWL 395
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQ-IKREISVMRLVKHPN 77
++ + +G+G F V G + VA+K I K Q E SVM ++H N
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCI------KNDATAQAFLAEASVMTQLRHSN 247
Query: 78 IVELKEVMATKTKVFFVI-EYVKGGEL--FAKVLKGKLKEESARKYF-QQLISAVDFCHS 133
+V+L V+ + +++ EY+ G L + + + F + A+++
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA-YVAPEVLRKK 192
HRDL N+L+ E+ KVSDFGL+ + G L P + APE LR+K
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREK 361
Query: 193 GYDGAKSDIWSCGVVLFVLLS-GFLPFQN-------ENIMKMYR 228
+ KSD+WS G++L+ + S G +P+ + K Y+
Sbjct: 362 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 404
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 54/240 (22%), Positives = 91/240 (37%), Gaps = 46/240 (19%)
Query: 19 EMGRMLGQGTFAKVYYGK-------NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
LGQGTF K++ G + + V +KV++K E S+M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASMMS 67
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVD 129
+ H ++V V + V E+VK G L + K K + + +QL +A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 130 FCHSRGVYHRDLKPENLLLD--------ENGNLKVSDFGLS--ALPEQL------WNDGL 173
F + H ++ +N+LL +K+SD G+S LP+ + W
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW---- 183
Query: 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKMYRK 229
V PE + +D WS G L+ + S G P ++ ++ Y
Sbjct: 184 ----------VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELK 82
+LG+G F KVY G+ L VA+K + ++ + QG Q + E+ ++ + H N++ L+
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEE--RTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 83 EVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAV----------DFCH 132
T T+ V Y+ G + A L+ + + + + ++ A+ D C
Sbjct: 94 GFCMTPTERLLVYPYMANGSV-ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH--TQ-CGTPAYVAPEVL 189
+ + HRD+K N+LLDE V DFGL+ +L + H T GT ++APE L
Sbjct: 153 PK-IIHRDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYL 207
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSG 214
G K+D++ GV+L L++G
Sbjct: 208 S-TGKSSEKTDVFGYGVMLLELITG 231
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 31/232 (13%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQE-SVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+G++LG+G F V G K VA+K + D ++ + E E + M+ H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-FLSEAACMKDFSH 95
Query: 76 PNIVEL-----KEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLIS-AVD 129
PN++ L + K ++ ++K G+L +L +L+ Q L+ VD
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 130 FCH------SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAY 183
+R HRDL N +L ++ + V+DFGLS D + + G A
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS--GD---YYRQGRIAK 210
Query: 184 V-----APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM 226
+ A E L + Y +KSD+W+ GV ++ + + G P+ N +
Sbjct: 211 MPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-21
Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 53/243 (21%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMRLV 73
M R LGQG+F VY G K +V E VAIK +N+ ++ + E SVM+
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVMKEF 85
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKY--FQQLIS-AV 128
++V L V++ ++E + G+L + + L+ + ++I A
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 129 D------FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS---------------ALPEQ 167
+ + ++ HRDL N ++ E+ +K+ DFG++ LP +
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENI 223
W ++PE L+ + SD+WS GVVL+ + + P+Q NE +
Sbjct: 206 -W--------------MSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 224 MKM 226
++
Sbjct: 250 LRF 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 62/249 (24%), Positives = 98/249 (39%), Gaps = 47/249 (18%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIKREISVM-RL 72
G+ LG G F KV L+ ++ VA+K++ + E + E+ V+ L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYL 83
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGEL------------FAKVLKGKLKEESARKY 120
H NIV L + EY G+L +K ++++
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 121 FQQLIS-------AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG- 172
+ L+S + F S+ HRDL N+LL K+ DFGL+ + ND
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIKNDSN 200
Query: 173 -LLHTQCGTPAYV---APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ----NENI 223
++ P V APE + Y +SD+WS G+ L+ L S G P+ +
Sbjct: 201 YVVKGNARLP--VKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 224 MKM----YR 228
KM +R
Sbjct: 258 YKMIKEGFR 266
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 37/215 (17%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK--KQGLMEQIKREISVMRLVKHP 76
G +G+G F VY G V +VA+K + ++ + +EI VM +H
Sbjct: 34 VGGNKMGEGGFGVVYKG--YVNNTTVAVKKLAAMVDITTEELKQQ-FDQEIKVMAKCQHE 90
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEE-------------SARKYFQQ 123
N+VEL + + V Y+ G L L +A
Sbjct: 91 NLVELLGFSSDGDDLCLVYVYMPNGSL-LDRLSCLDGTPPLSWHMRCKIAQGAAN----- 144
Query: 124 LISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL-PEQLWNDGLLH--TQ-CG 179
++F H HRD+K N+LLDE K+SDFGL+ + ++ G
Sbjct: 145 ---GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK----FAQTVMTSRIVG 197
Query: 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG 214
T AY+APE LR G KSDI+S GVVL +++G
Sbjct: 198 TTAYMAPEALR--GEITPKSDIYSFGVVLLEIITG 230
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 54/227 (23%), Positives = 82/227 (36%), Gaps = 60/227 (26%)
Query: 20 MGRMLGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQGLMEQIK----REISVM-RL 72
++G+G F +V K + AIK + K+ + E+ V+ +L
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM------KEYASKDDHRDFAGELEVLCKL 82
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISA----- 127
HPNI+ L + ++ IEY G L L+ E+ + +A
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 128 ---VDFCH----------SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLL 174
+ F + HRDL N+L+ EN K++DFGLS E
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------- 193
Query: 175 HTQCGTPAYV------------APEVLRKKGYDGAKSDIWSCGVVLF 209
YV A E L Y SD+WS GV+L+
Sbjct: 194 -------VYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLW 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 67/247 (27%), Positives = 105/247 (42%), Gaps = 37/247 (14%)
Query: 6 MDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR 65
M+ RV K+ +GR +G G+F ++Y G N+ T E VAIK+ N K Q+
Sbjct: 1 MEPRVG----NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHP----QLLY 51
Query: 66 EISVMR-LVKHPNIVELKEVMATKTKVFFVIEYVKG---GELFAKVLKGKLKEESARKYF 121
E + R L I ++ V++ + G +LF KL ++
Sbjct: 52 ESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLF-NFCSRKLSLKTVLMLA 109
Query: 122 QQLISAVDFCHSRGVYHRDLKPENLLLDENGN---LKVSDFGLSALPEQLWNDGLLHTQ- 177
Q+I+ V+F HS+ HRD+KP+N L+ + + DFGL+ + + D H
Sbjct: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA----KKYRDTSTHQHI 165
Query: 178 --------CGTPAYVAPEVLRKKGYD-GAKSDIWSCGVVLFVLLSGFLPFQN---ENIMK 225
GT Y + G + + D+ S G VL L G LP+Q +
Sbjct: 166 PYRENKNLTGTARYASVNTH--LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223
Query: 226 MYRKIFK 232
Y KI +
Sbjct: 224 KYEKISE 230
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-19
Identities = 61/248 (24%), Positives = 95/248 (38%), Gaps = 57/248 (22%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIK----REISV 69
LG+ F KVY G E VAIK + K ++ E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL------KDKAEGPLREEFRHEAML 65
Query: 70 MRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--F--AKVLKGKLKEESARKYFQQLI 125
++HPN+V L V+ + + Y G+L F + + + + +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 126 SAVDFCH-------------SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND- 171
DF H S V H+DL N+L+ + N+K+SD GL D
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA--ADY 183
Query: 172 ------GLLHTQCGTPAYV---APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ-- 219
LL P + APE + + SDIWS GVVL+ + S G P+
Sbjct: 184 YKLLGNSLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGY 234
Query: 220 -NENIMKM 226
N+++++M
Sbjct: 235 SNQDVVEM 242
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 41/237 (17%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIK----REISV 69
+ R LG G F +VY G + S VA+K + + EQ + E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL------PEVCSEQDELDFLMEALI 86
Query: 70 MRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISA 127
+ H NIV V F ++E + GG+L F + + + + S+ L A
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 128 VDFCH------SRGVYHRDLKPENLLLDENGN---LKVSDFGLSALPEQLWNDGLLHTQC 178
D HRD+ N LL G K+ DFG++ ++ + +
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RDIYRAS--YYRK 201
Query: 179 GTPAYV-----APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM 226
G A + PE + + +K+D WS GV+L+ + S G++P+ N+ +++
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 56/240 (23%), Positives = 97/240 (40%), Gaps = 37/240 (15%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVK 74
+ +G+ +G G F ++ GKNL T E VAIK+ + Q+ E + L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-----EPMKSRAPQLHLEYRFYKQLGS 63
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGG----ELFAKVLKGKLKEESARKYFQQLISAVDF 130
I ++ V+E + G +LF + ++ QLIS +++
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLF-DLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVS-----DFGLSALPEQLWNDGLLHTQ-------- 177
HS+ + +RD+KPEN L+ GN DF L+ + + D
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA----KEYIDPETKKHIPYREHKS 176
Query: 178 -CGTPAYVAPEVLRKKGYD-GAKSDIWSCGVVLFVLLSGFLPFQN---ENIMKMYRKIFK 232
GT Y++ G + + D+ + G + L G LP+Q + + + Y+KI
Sbjct: 177 LTGTARYMSINTH--LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 62/248 (25%), Positives = 97/248 (39%), Gaps = 57/248 (22%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKD--QVKKQGLMEQIKREISVM- 70
+ G+ LG G F KV L +++ VA+K++ +K+ LM E+ +M
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM----SELKIMS 104
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISA- 127
L +H NIV L V + EY G+L F + L+ + A S
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 128 --VDFCH----------SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175
+ F S+ HRD+ N+LL K+ DFGL+ + ND
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMND---- 217
Query: 176 TQCGTPAYV------------APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ--- 219
Y+ APE + Y +SD+WS G++L+ + S G P+
Sbjct: 218 -----SNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGIL 271
Query: 220 -NENIMKM 226
N K+
Sbjct: 272 VNSKFYKL 279
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 37/248 (14%)
Query: 5 TMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK 64
+M+ RV +Y +GR +G G+F +Y G ++ E VAIK + + K Q+
Sbjct: 2 SMELRVG----NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHP----QLH 52
Query: 65 REISVMR-LVKHPNIVELKEVMATKTKVFFVIEYVKG---GELFAKVLKGKLKEESARKY 120
E + + + I ++ A V+E + G +LF K ++
Sbjct: 53 IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLL 110
Query: 121 FQQLISAVDFCHSRGVYHRDLKPENLLLDENGN---LKVSDFGLSALPEQLWNDGLLHTQ 177
Q+IS +++ HS+ HRD+KP+N L+ + + DFGL+ + + D H
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA----KKYRDARTHQH 166
Query: 178 ---------CGTPAYVAPEVLRKKGYD-GAKSDIWSCGVVLFVLLSGFLPFQN---ENIM 224
GT Y + G + + D+ S G VL G LP+Q
Sbjct: 167 IPYRENKNLTGTARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 224
Query: 225 KMYRKIFK 232
+ Y +I +
Sbjct: 225 QKYERISE 232
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 33/233 (14%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMRLV 73
+ R LG G F +VY G + S VA+K + + ++ E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKF 131
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLISAVDFC 131
H NIV V F ++E + GG+L F + + + + S+ L A D
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 132 H------SRGVYHRDLKPENLLLDENGN---LKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
HRD+ N LL G K+ DFG++ ++ G + + G A
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RDIYRAG--YYRKGGCA 246
Query: 183 YV-----APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIMKM 226
+ PE + + +K+D WS GV+L+ + S G++P+ N+ +++
Sbjct: 247 MLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 47/242 (19%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIK---REISVM 70
+ LG+G F KV+ NL+ ++ VA+K + K+ + RE ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL------KEASESARQDFQREAELL 97
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL---------FAKVLKGKLKEESARKYF 121
+++H +IV V + V EY++ G+L AK+L G
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 122 QQLIS-AVDFCH------SRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGL 173
QL++ A HRDL N L+ + +K+ DFG+S + D
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS---TD-- 212
Query: 174 LHTQCGTPAYV-----APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ---NENIM 224
+ + G + PE + + + +SD+WS GVVL+ + + G P+ N +
Sbjct: 213 -YYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 225 KM 226
Sbjct: 271 DC 272
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 57/260 (21%), Positives = 95/260 (36%), Gaps = 73/260 (28%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMRLV 73
E R +G+G F +V+ L+ E VA+K++ ++ +RE ++M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEF 107
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGEL------------FAKVLKGKLKEESARKYF 121
+PNIV+L V A + + EY+ G+L +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 122 QQLISAVDFCH-------------SRGVYHRDLKPENLLLDENGNLKVSDFGLS------ 162
+S + R HRDL N L+ EN +K++DFGLS
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 163 ---------ALPEQLWNDGLLHTQCGTPAYV---APEVLRKKGYDGAKSDIWSCGVVLFV 210
A+P + PE + Y +SD+W+ GVVL+
Sbjct: 228 DYYKADGNDAIP------------------IRWMPPESIFYNRYT-TESDVWAYGVVLWE 268
Query: 211 LLS-GFLPFQ---NENIMKM 226
+ S G P+ +E ++
Sbjct: 269 IFSYGLQPYYGMAHEEVIYY 288
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 46/244 (18%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIK----REISV 69
++G+ LG+G F +V + + VA+K++ K+G E+ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML------KEGATHSEHRALMSELKI 83
Query: 70 M-RLVKHPNIVELKEVMATKTKVFFVI-EYVKGGEL----------FAKVLKGKLKEESA 117
+ + H N+V L VI E+ K G L F
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 118 RKYFQQLIS-AVD------FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170
+ LI + F SR HRDL N+LL E +K+ DFGL+ ++
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYK 200
Query: 171 DGLLHTQCGTPAYV---APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ----NEN 222
D + + APE + + Y +SD+WS GV+L+ + S G P+ +E
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 223 IMKM 226
+
Sbjct: 260 FCRR 263
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 56/249 (22%), Positives = 97/249 (38%), Gaps = 60/249 (24%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIK---REISVM 70
+ R LG+G F KV+ NL + VA+K + K + K RE ++
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL------KDPTLAARKDFQREAELL 71
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL----------FAKVLKGKLKEESARKY 120
++H +IV+ V + V EY+K G+L ++ G+ ++
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 121 FQQLIS-AVDFCH------SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173
Q++ A S+ HRDL N L+ N +K+ DFG+S
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS------ 185
Query: 174 LHTQCGTPAYV------------APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ- 219
T Y PE + + + +SD+WS GV+L+ + + G P+
Sbjct: 186 ------TDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQ 238
Query: 220 --NENIMKM 226
N +++
Sbjct: 239 LSNTEVIEC 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 62/252 (24%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES-----VAIKVINKDQVKKQGLMEQIKREISVM- 70
+G+ LG+G F +V + + VA+K++ D +K + + E+ +M
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMK 95
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL----------FAKVLKGKLKEESARKY 120
+ KH NI+ L ++ ++EY G L + + +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 121 FQQLIS-AVD------FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS----------- 162
F+ L+S + S+ HRDL N+L+ EN +K++DFGL+
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 163 ----ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLP 217
LP + W +APE L + Y +SD+WS GV+++ + + G P
Sbjct: 216 TTNGRLPVK-W--------------MAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSP 259
Query: 218 FQ---NENIMKM 226
+ E + K+
Sbjct: 260 YPGIPVEELFKL 271
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 55/254 (21%), Positives = 104/254 (40%), Gaps = 35/254 (13%)
Query: 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
N++ Y++GR +G+G+F ++ G NL+ + VAIK + Q++ E +
Sbjct: 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAP----QLRDEYRTYK 60
Query: 72 -LVKHPNIVELKEVMATKTKVFFVIEYVKG---GELFAKVLKGKLKEESARKYFQQLISA 127
L I + VI+ + G +L + K ++ +Q+++
Sbjct: 61 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLL-DLCGRKFSVKTVAMAAKQMLAR 118
Query: 128 VDFCHSRGVYHRDLKPENLLL----DENGN-LKVSDFGLSALPEQLWNDGLLHTQ----- 177
V H + + +RD+KP+N L+ +N N + V DFG+ + + D +
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV----KFYRDPVTKQHIPYRE 174
Query: 178 ----CGTPAYVAPEVLRKKGYD-GAKSDIWSCGVVLFVLLSGFLPFQN---ENIMKMYRK 229
GT Y++ G + + D+ + G V L G LP+Q + Y +
Sbjct: 175 KKNLSGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232
Query: 230 IFKAEYEFPPWISC 243
I + + P C
Sbjct: 233 IGEKKQSTPLRELC 246
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 62/252 (24%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES-----VAIKVINKDQVKKQGLMEQIKREISVM- 70
+G+ LG+G F +V + + VA+K++ D +K + + E+ +M
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMK 141
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL----------FAKVLKGKLKEESARKY 120
+ KH NI+ L ++ ++EY G L + + +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 121 FQQLIS-AVD------FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS----------- 162
F+ L+S + S+ HRDL N+L+ EN +K++DFGL+
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 163 ----ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLP 217
LP + W +APE L + Y +SD+WS GV+++ + + G P
Sbjct: 262 TTNGRLPVK-W--------------MAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSP 305
Query: 218 FQ---NENIMKM 226
+ E + K+
Sbjct: 306 YPGIPVEELFKL 317
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 58/261 (22%), Positives = 98/261 (37%), Gaps = 66/261 (25%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIKREISVM-RL 72
E G++LG G F KV + VA+K++ + + E + E+ +M +L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMTQL 105
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGEL------------FAKVLKGKLKEESARKY 120
H NIV L ++ + EY G+L ++ K +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 121 FQQLISA--VDFCH----------SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168
L + F + + HRDL N+L+ +K+ DFGL+ +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA---RDI 222
Query: 169 WNDGLLHTQCGTPAYV------------APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GF 215
+D YV APE L + Y KSD+WS G++L+ + S G
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGV 272
Query: 216 LPFQ----NENIMKM----YR 228
P+ + N K+ ++
Sbjct: 273 NPYPGIPVDANFYKLIQNGFK 293
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 60/251 (23%), Positives = 99/251 (39%), Gaps = 60/251 (23%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES-----VAIKVINKDQVKKQGLMEQIK----REI 67
+G+ LG+G F +V L + VA+K++ K E+ E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML------KSDATEKDLSDLISEM 125
Query: 68 SVM-RLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL----------FAKVLKGKLKEES 116
+M + KH NI+ L ++ ++EY G L +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 117 ARKYFQQLIS-AVDFCH------SRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169
+ + L+S A S+ HRDL N+L+ E+ +K++DFGL+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-- 243
Query: 170 ND-------GLLHTQCGTPAYV---APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPF 218
D G L P V APE L + Y +SD+WS GV+L+ + + G P+
Sbjct: 244 IDYYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPY 294
Query: 219 Q---NENIMKM 226
E + K+
Sbjct: 295 PGVPVEELFKL 305
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 56/257 (21%), Positives = 102/257 (39%), Gaps = 67/257 (26%)
Query: 19 EMGRMLGQGTFAKVYYG--KNLVTQES---VAIKVINKDQVKKQGLMEQIKREISVMRLV 73
+G+ LG+G F KV +L + VA+K++ ++ + + + E +V++ V
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE--LRDLLSEFNVLKQV 83
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGEL------------------FAKVLKGKLKEE 115
HP++++L + + ++EY K G L ++ +
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 116 SARKYFQQLIS-AVD------FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS------ 162
LIS A + + HRDL N+L+ E +K+SDFGLS
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 163 ---------ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS 213
+P + W +A E L Y +SD+WS GV+L+ +++
Sbjct: 204 DSYVKRSQGRIPVK-W--------------MAIESLFDHIYT-TQSDVWSFGVLLWEIVT 247
Query: 214 -GFLPFQ---NENIMKM 226
G P+ E + +
Sbjct: 248 LGGNPYPGIPPERLFNL 264
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 47/274 (17%), Positives = 92/274 (33%), Gaps = 47/274 (17%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREI 67
+ + ++ ++ +G+ +G G F +Y E A V+ K + ++ G + E+
Sbjct: 29 KVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV-KVEYQENG---PLFSEL 84
Query: 68 SV-MRLVKHPNIVELKEVMATKTK-----VFFVIEYVKGGELFAKVL------------- 108
R+ K I + E + KG V+
Sbjct: 85 KFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ 144
Query: 109 KGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV--SDFGLSALPE 166
G K+ + + +++ +++ H H D+K NLLL +V +D+GLS
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS---- 200
Query: 167 QLWNDGLLHTQ---------CGTPAYVAPEVLRKKGYD-GAKSDIWSCGVVLFVLLSGFL 216
+ H Q GT + + + KG +SD+ G + L G L
Sbjct: 201 YRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH--KGVALSRRSDVEILGYCMLRWLCGKL 258
Query: 217 PFQN-----ENIMKM-YRKIFKAEYEFPPWISCD 244
P++ + + + W
Sbjct: 259 PWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSG 292
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 40/262 (15%), Positives = 88/262 (33%), Gaps = 55/262 (20%)
Query: 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVT--------QESVAIKVINKDQVKKQGLME 61
+ + ++++ + +Y T ++ ++K+ KD
Sbjct: 36 LTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG-------- 87
Query: 62 QIKREISV-MRLVKHPNIVELKEVMATKTKVFFVIEY--VKGGELFAKVLK------GKL 112
++ E + R K + + K++ +T V + VL
Sbjct: 88 RLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA 147
Query: 113 KEESARKYF---------QQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV--SDFGL 161
+ S + +L+ A++F H H ++ EN+ +D +V + +G
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGF 207
Query: 162 SALPEQLWNDGLLHTQ---------CGTPAYVAPEVLRKKGYDGA-KSDIWSCGVVLFVL 211
+ + H G +++ ++ KG + +SD+ S G +
Sbjct: 208 A----FRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH--KGCGPSRRSDLQSLGYCMLKW 261
Query: 212 LSGFLPFQN---ENIMKMYRKI 230
L GFLP+ N M +K
Sbjct: 262 LYGFLPWTNCLPNTEDIMKQKQ 283
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.8 bits (188), Expect = 1e-15
Identities = 33/191 (17%), Positives = 61/191 (31%), Gaps = 47/191 (24%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVI-----NKDQVKKQGLMEQIKREISVMR 71
K + +G+G F +V+ VAIK+I + Q E+I EI + +
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 72 LV---------KHPNIVELKEV------------------------------MATKTKVF 92
+ + + L V ++F
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 93 FVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEN 151
V+E+ GG ++ +A+ QL +++ + HRDL N+LL +
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 152 GNLKVSDFGLS 162
K+
Sbjct: 199 SLKKLHYTLNG 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 43/263 (16%), Positives = 92/263 (34%), Gaps = 53/263 (20%)
Query: 8 ERVRNILFGKYEMGRMLGQGTFAKVYYG-----KNLVTQESVAIKVINKDQVKKQGLMEQ 62
E + ++ +++G +GQG F +Y +++ + +KV D
Sbjct: 27 EIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-------GP 79
Query: 63 IKREISV-MRLVKHPNIVELKEVMATKTK-----VFFVIEYVKGGELFAKVLK------G 110
+ E+ R K I + K + G ++
Sbjct: 80 LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ 139
Query: 111 KLKEESARKYFQ--------QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV--SDFG 160
K+ E +A+++ + +++ +++ H H D+K NLLL+ +V D+G
Sbjct: 140 KIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 161 LSALPEQLWNDGLLHTQ---------CGTPAYVAPEVLRKKGYD-GAKSDIWSCGVVLFV 210
L+ + +H GT + + + G + D+ G +
Sbjct: 200 LA----YRYCPEGVHKAYAADPKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQ 253
Query: 211 LLSGFLPFQN---ENIMKMYRKI 230
L+G LP+++ + KI
Sbjct: 254 WLTGHLPWEDNLKDPKYVRDSKI 276
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 12/115 (10%)
Query: 123 QLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPA 182
Q+ ++F SR HRDL N+LL E +K+ DFGL+ ++ D +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKDPDYVRKGDARL 257
Query: 183 YV---APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQ----NENIMKMYRK 229
+ APE + + Y +SD+WS GV+L+ + S G P+ +E + ++
Sbjct: 258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 21/92 (22%), Positives = 38/92 (41%), Gaps = 9/92 (9%)
Query: 19 EMGRMLGQGTFAKVYYGK-----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RL 72
++G+ LG+G F +V T +VA+K++ + + E+ ++ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 82
Query: 73 VKHPNIVELKEVMATKTKVFFVI-EYVKGGEL 103
H N+V L VI E+ K G L
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 114
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 37/188 (19%), Positives = 66/188 (35%), Gaps = 33/188 (17%)
Query: 4 ETMDERVRNILFG------KYEMGRMLGQGTFAKVYYGKNLVTQE--SVAIKV------- 48
E +D R L+ MG ++ G A V+Y + + ++A+K+
Sbjct: 29 EVLDGRTLKTLYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSE 88
Query: 49 INKDQVKKQGLMEQIKREISVMRLVK------HPNIVELKEVMATKTKVFF------VIE 96
+K G R IS V N+ KE + + + ++E
Sbjct: 89 FDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLME 148
Query: 97 YVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENG 152
++ EL A L +LKE F ++ V + + H DL N++ +
Sbjct: 149 FIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID-- 206
Query: 153 NLKVSDFG 160
+ D G
Sbjct: 207 KVYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.52 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.19 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.94 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.77 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.69 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.57 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.51 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.4 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.34 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.07 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.0 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.97 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.93 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.92 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.9 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.77 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.74 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 97.69 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 97.63 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.6 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 97.57 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.45 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 97.44 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.4 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.14 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.85 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 96.65 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.56 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.68 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.52 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.13 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-70 Score=521.79 Aligned_cols=261 Identities=33% Similarity=0.625 Sum_probs=243.7
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
...++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+++|++++|||||++++++++++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 44567999999999999999999999999999999999877655556788999999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
||||||+||+|++++.+ +.++|.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999987 89999999999999999999999999999999999999999999999999999876544445
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 251 (414)
....+.||||.|||||++.+.+|+ .++|||||||++|+|++|..||.+.+..+++.++..+.+.+|..+|+++++||++
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 566788999999999999998885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCCChHH------HhcCCcccc
Q 015005 252 ILVADPQKRISVSE------IMINPWFIK 274 (414)
Q Consensus 252 ~L~~dp~~R~s~~e------il~hp~f~~ 274 (414)
||++||++|||++| |++||||..
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 99999999999988 589999964
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-70 Score=509.22 Aligned_cols=259 Identities=44% Similarity=0.848 Sum_probs=223.4
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
.+|+|++.+.||+|+||+||+|++..+|+.||||++++.........+.+.+|+++|+.++|||||++++++++++.+|+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 35899999999999999999999999999999999988776655556789999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 94 VIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
||||| +|+|.+.+.+ +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---CC
Confidence 99999 6899998876 8899999999999999999999999999999999999999999999999999986432 33
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRI 252 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 252 (414)
...+.+||+.|||||++.+..|++.++|||||||++|+|++|+.||.+.+...+++.+..+.+.+|..+|+++++||++|
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 45678999999999999999887789999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCCChHHHhcCCccccCC
Q 015005 253 LVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
|++||++|||++|+++||||+...
T Consensus 247 L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp SCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred ccCChhHCcCHHHHHcCcccccCC
Confidence 999999999999999999997643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-67 Score=508.64 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=232.4
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
..|++.+.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++++++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999998665433 356789999999999999999999999999999999
Q ss_pred EccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 96 EYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 96 E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
|||+||+|++++.++++++.+++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... ......
T Consensus 151 Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~ 228 (346)
T 4fih_A 151 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRK 228 (346)
T ss_dssp CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBC
T ss_pred eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999986543 233456
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc---CCCCCCCHHHHHHHHhh
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY---EFPPWISCDARRLISRI 252 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~ 252 (414)
+.|||+.|||||++.+.+|+ .++|||||||++|+|++|..||.+.+..+.+..+..... ..+..+|+++++||.+|
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 78999999999999998885 899999999999999999999999998888888876543 23345899999999999
Q ss_pred cccCcCCCCChHHHhcCCccccCC
Q 015005 253 LVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
|++||++|||++|+|+||||.+..
T Consensus 308 L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 308 LVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-68 Score=511.26 Aligned_cols=259 Identities=29% Similarity=0.542 Sum_probs=229.9
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++++.||+|+||+||+|++..+|+.||||++.+...... ..+.+.+|+++|++++|||||++++++++++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH-HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4799999999999999999999999999999999987765433 467899999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 95 IEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
||||+||+|++++.. ..+++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+..... .
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--V 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--H
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--c
Confidence 999999999999964 35799999999999999999999999999999999999999999999999999865431 1
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLIS 250 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 250 (414)
....+.+||+.|||||++.+.+|+ .++|||||||+||+|++|+.||.+.+..+++.++..+.+ +.+..+|+++++||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 234567899999999999998886 899999999999999999999999999999999988776 456779999999999
Q ss_pred hhcccCcCCCCChHHHhcCCccccCCC
Q 015005 251 RILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
+||++||++|||++|+|+||||.+...
T Consensus 259 ~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 999999999999999999999987544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-67 Score=499.13 Aligned_cols=255 Identities=35% Similarity=0.654 Sum_probs=226.8
Q ss_pred CCEEEeeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
++|++++.||+|+||+||+|++. .+++.||+|++++....... ...+.+|+++|++++|||||++++++++++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 57999999999999999999874 46889999999876544322 246788999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+|||||+||+|++++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~ 180 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HE 180 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--CC
Confidence 99999999999999987 8899999999999999999999999999999999999999999999999999985432 23
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 251 (414)
....+.|||+.|||||++.+.+|+ .++|||||||++|+|++|..||.+.+..+.+.++.++.+.+|..+|+++++||++
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 259 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 445678999999999999998886 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCCC-----hHHHhcCCcccc
Q 015005 252 ILVADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 252 ~L~~dp~~R~s-----~~eil~hp~f~~ 274 (414)
||++||++||| ++|+++||||..
T Consensus 260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 260 LFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 99999999998 479999999964
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-66 Score=509.32 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=232.9
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.+|++.+.||+|+||+||+|+++.+|+.||||++.+..... .+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998765433 356889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 96 EYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 96 E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
|||+||+|.+++..+++++.+++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... ......
T Consensus 228 Ey~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~ 305 (423)
T 4fie_A 228 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRK 305 (423)
T ss_dssp ECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCBC
T ss_pred eCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCcccc
Confidence 999999999999989999999999999999999999999999999999999999999999999999986543 234456
Q ss_pred cccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc---CCCCCCCHHHHHHHHhh
Q 015005 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY---EFPPWISCDARRLISRI 252 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~ 252 (414)
+.|||+.|||||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+..... ..+..+|+++++||.+|
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 78999999999999998885 899999999999999999999999998888888876543 34456899999999999
Q ss_pred cccCcCCCCChHHHhcCCccccCC
Q 015005 253 LVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
|+.||++|||++|+|+||||.+..
T Consensus 385 L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 385 LVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-65 Score=479.50 Aligned_cols=257 Identities=23% Similarity=0.474 Sum_probs=223.9
Q ss_pred hccccCCE-EEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe--
Q 015005 11 RNILFGKY-EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT-- 87 (414)
Q Consensus 11 ~~~~~~~y-~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 87 (414)
+....++| ++.+.||+|+||+||+|.+..++..||+|++.+...... ..+.+.+|+++|++++|||||++++++++
T Consensus 20 ~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred CcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 44556777 788899999999999999999999999999987654432 35789999999999999999999999976
Q ss_pred --CCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEEecCCCCcEEEcC-CCCeEEeecCC
Q 015005 88 --KTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRG--VYHRDLKPENLLLDE-NGNLKVSDFGL 161 (414)
Q Consensus 88 --~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~g--i~HrDlkp~NILl~~-~~~~kl~DFGl 161 (414)
+..+|||||||+||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+||||+. +|.+||+|||+
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 3568999999999999999987 78999999999999999999999999 999999999999984 79999999999
Q ss_pred CcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc-hHHHHHHHHHhccc--CCC
Q 015005 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE-NIMKMYRKIFKAEY--EFP 238 (414)
Q Consensus 162 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~--~~~ 238 (414)
|+... .....+.+|||.|||||++.+ +|+ .++|||||||+||+|+||..||.+. +...++..+..+.. .++
T Consensus 179 a~~~~----~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 179 ATLKR----ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp GGGCC----TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred CEeCC----CCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC
Confidence 98532 345567899999999999875 575 8999999999999999999999764 45566666665543 345
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..+++++++||.+||++||++|||++|+|+||||++
T Consensus 253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 568899999999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-64 Score=483.94 Aligned_cols=251 Identities=26% Similarity=0.350 Sum_probs=222.3
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.+.|++.+.||+|+||+||+|+++.+|+.||||+++++... .+|+.+|+.++|||||++++++++++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45799999999999999999999999999999999865432 3699999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-CeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-NLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~ 172 (414)
||||+||+|++++.+ +.+++.+++.|+.|++.||+|||++||+||||||+||||+.+| ++||+|||+|+.........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999999987 8999999999999999999999999999999999999999988 69999999998654321111
Q ss_pred ---ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc---CCCCCCCHHHH
Q 015005 173 ---LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY---EFPPWISCDAR 246 (414)
Q Consensus 173 ---~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~ 246 (414)
.....|||+.|||||++.+.+|+ .++|||||||++|+|++|..||.+.+..+++.++..... .+|+.+|+++.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 22346899999999999998886 899999999999999999999998877777777777654 36778999999
Q ss_pred HHHHhhcccCcCCCCChHHH-------------hcCCcccc
Q 015005 247 RLISRILVADPQKRISVSEI-------------MINPWFIK 274 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~ei-------------l~hp~f~~ 274 (414)
+||.+||++||.+|||+.|+ ++|||+.+
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 99999999999999999997 57999865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-62 Score=480.85 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=224.7
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe------
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT------ 87 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 87 (414)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+++|+.++|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 3468999999999999999999999999999999997654332 335678899999999999999999999864
Q ss_pred CCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
.+.+|||||||+ |+|++.+.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 367999999996 679998887 789999999999999999999999999999999999999999999999999998653
Q ss_pred cc--cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCC-------
Q 015005 167 QL--WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF------- 237 (414)
Q Consensus 167 ~~--~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~------- 237 (414)
.. .......+.+||+.|||||++.+..+++.++||||+||++|+|++|..||.+.+..+++..|.......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22 123345678999999999999887776789999999999999999999999998888887775432111
Q ss_pred ------------------------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 238 ------------------------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 238 ------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+.+|+++.+||++||+.||.+|||++|+|+||||.+.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 12468899999999999999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-61 Score=484.51 Aligned_cols=377 Identities=33% Similarity=0.630 Sum_probs=305.8
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
.-+....++|++++.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 34677899999999999999999999999999999999999876554444567899999999999999999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
+.+|+||||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999999999987 7899999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARR 247 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 247 (414)
.....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++..+.+..|..+++++.+
T Consensus 169 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 169 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS 245 (476)
T ss_dssp ---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred ---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHH
Confidence 33456778999999999999888877899999999999999999999999988899999999988999999999999
Q ss_pred HHHhhcccCcCCCCChHHHhcCCccccCCCCCc---eec-------------------cCC---------CCcc------
Q 015005 248 LISRILVADPQKRISVSEIMINPWFIKGFSKPV---AVC-------------------IDD---------GDNR------ 290 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp~f~~~~~~~~---~~~-------------------~~~---------~~~~------ 290 (414)
||++||+.||.+|||+.|+++||||.+...... ... .+. .+..
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 325 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVA 325 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC------------------------
T ss_pred HHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHH
Confidence 999999999999999999999999976543210 000 000 0000
Q ss_pred ---------------cc---------------cccC-CCCC------------CCchhh--------hhhhccCcccccc
Q 015005 291 ---------------DF---------------ISSM-SSGF------------DLSSLF--------ESERKSGSMFTSK 319 (414)
Q Consensus 291 ---------------~~---------------~~~~-~~~~------------~~~~~~--------~~~~~~~~~~~~~ 319 (414)
++ .+.. .... .+++.. ....+....+.|+
T Consensus 326 y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~ 405 (476)
T 2y94_A 326 YHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQ 405 (476)
T ss_dssp -------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEEC
T ss_pred HHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCccC
Confidence 00 0000 0000 000000 0111222356677
Q ss_pred CChhHHHHHHHHHHHHcCCeEEEe-ceEEEEEeeecCCCcceEEEEEEEEecCceEEEEEEecCCChHhH
Q 015005 320 CSSSAIMGKLESLAKKLNLGVCVK-EFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEY 388 (414)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~l~~~~ei~~~~~~~~~v~~~k~~Gd~le~ 388 (414)
..+.+++..+.++++.||+.|+.. .+.|++..........+.|.+++|++.++.++|||++..|+.++|
T Consensus 406 ~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 406 SRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp SCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred CCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 788999999999999999999975 588888643222234567999999999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=497.74 Aligned_cols=258 Identities=30% Similarity=0.519 Sum_probs=229.6
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHH---HHHHHhCCCCCccceEEEEEeC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKRE---ISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E---i~il~~l~hpnIv~l~~~~~~~ 88 (414)
.+-+++|+++++||+|+||+||+|+++.+|+.||||++.+...........+.+| +.+++.++|||||++++++++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 4557899999999999999999999999999999999988765443333344444 6667778999999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
+.+|+|||||+||+|++++.+ +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~- 343 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS- 343 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC-
Confidence 999999999999999999987 899999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCCccccccCCCcccCchhhcc-cCCCCCccchhhhhhhhhhhhcCCCCCCCc---hHHHHHHHHHhcccCCCCCCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRK-KGYDGAKSDIWSCGVVLFVLLSGFLPFQNE---NIMKMYRKIFKAEYEFPPWISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~ 243 (414)
.....+.||||.|||||++.+ .+| +.++|||||||+||+|++|.+||.+. +...+++.+....+.+|..+|+
T Consensus 344 ---~~~~~t~~GTp~YmAPEvl~~~~~y-~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 344 ---KKKPHASVGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp ---SCCCCSCCSCGGGCCHHHHSTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred ---CCCCCCccCCcCccCHHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence 234567899999999999975 456 48999999999999999999999764 3456677888889999999999
Q ss_pred HHHHHHHhhcccCcCCCCC-----hHHHhcCCcccc
Q 015005 244 DARRLISRILVADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s-----~~eil~hp~f~~ 274 (414)
++++||++||+.||.+|++ ++||++||||..
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999998 799999999964
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-61 Score=457.06 Aligned_cols=254 Identities=27% Similarity=0.399 Sum_probs=202.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-----
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT----- 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 89 (414)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 3569999999999999999999999999999999976542 233567899999999999999999999997544
Q ss_pred -------EEEEEEEccCCCchHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEee
Q 015005 90 -------KVFFVIEYVKGGELFAKVLK-GK---LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSD 158 (414)
Q Consensus 90 -------~~~lv~E~~~gg~L~~~i~~-~~---~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~D 158 (414)
.+|+|||||+||+|.+++.. +. .++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999986 33 45667899999999999999999999999999999999999999999
Q ss_pred cCCCcccccccCC----------CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHH
Q 015005 159 FGLSALPEQLWND----------GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMY 227 (414)
Q Consensus 159 FGla~~~~~~~~~----------~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~ 227 (414)
||+|+........ ....+.|||+.|||||++.+..|+ .++|||||||++|+|++ ||...... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999865432111 123456899999999999998886 89999999999999996 88764332 333
Q ss_pred HHHHhcccC-CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 228 RKIFKAEYE-FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 228 ~~i~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..+....++ .++..++.+.+||++||++||.+|||+.|+++||||..
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 333333221 11235677899999999999999999999999999965
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-61 Score=455.06 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=223.5
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEE
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEV 84 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 84 (414)
+..+-.++|.+.+.||+|+||+||+|++. .++..||||+++... ....+.+.+|+++|++++|||||+++++
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~ 83 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGV 83 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 34455678999999999999999999865 367899999997543 2335789999999999999999999999
Q ss_pred EEeCCEEEEEEEccCCCchHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC
Q 015005 85 MATKTKVFFVIEYVKGGELFAKVLK--------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE 150 (414)
Q Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~i~~--------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~ 150 (414)
+.+++.+|||||||+||+|.+++.. ..+++.++..++.|++.||+|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 84 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 163 (299)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC
Confidence 9999999999999999999999865 25999999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHH
Q 015005 151 NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRK 229 (414)
Q Consensus 151 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~ 229 (414)
++++||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..+....
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 242 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999864432222233445799999999999998886 89999999999999998 9999999988888888
Q ss_pred HHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 230 IFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 230 i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
+..+. .+.|..+|+++.+|+.+||+.||++|||+.|| ++|+.
T Consensus 243 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 243 ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 87765 46788899999999999999999999999999 45654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-60 Score=461.84 Aligned_cols=254 Identities=26% Similarity=0.458 Sum_probs=209.3
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT 89 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 89 (414)
+.++|++.+.||+|+||+||+|+++ .+++.||+|.+.+... ..++.+|+++|+.+ +|||||++++++++.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 5688999999999999999999875 4678999999865432 34678999999998 6999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC-CCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN-GNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 168 (414)
++|+|||||+||+|.+.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 94 ~~~lvmE~~~g~~L~~~~--~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDIL--NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEEECCCCCCHHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCcccHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999999988 469999999999999999999999999999999999999877 79999999999743221
Q ss_pred c--------------------------CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC-c
Q 015005 169 W--------------------------NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-E 221 (414)
Q Consensus 169 ~--------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~ 221 (414)
. ......+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.. .
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 0 112234568999999999998876556899999999999999999999954 3
Q ss_pred hHHHHHHHHHh--------------------------------------ccc----------------CCCCCCCHHHHH
Q 015005 222 NIMKMYRKIFK--------------------------------------AEY----------------EFPPWISCDARR 247 (414)
Q Consensus 222 ~~~~~~~~i~~--------------------------------------~~~----------------~~~~~~s~~~~~ 247 (414)
+..+....+.. ... .....+|+++++
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 33333322211 000 111347899999
Q ss_pred HHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 248 LISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
||++||+.||++|||++|+|+||||++
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-60 Score=486.67 Aligned_cols=259 Identities=30% Similarity=0.581 Sum_probs=235.9
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
+.++++|++++.||+|+||+||+|.++.+|+.||+|++.+..... .+.+.+|+++|+.++|||||++++++++.+.+
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~---~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 345689999999999999999999999999999999997755332 46788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC--CCeEEeecCCCccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN--GNLKVSDFGLSALPEQ 167 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~--~~~kl~DFGla~~~~~ 167 (414)
|||||||+||+|++++.. +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~- 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD- 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC-
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc-
Confidence 999999999999999964 689999999999999999999999999999999999999854 899999999998654
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 243 (414)
......+.|||+.|||||++.+.+|+ .++|||||||++|+|++|..||.+.+..+.+..+....+.++ ..+|+
T Consensus 309 --~~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 309 --PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp --TTSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred --CCCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 34456678999999999999999885 899999999999999999999999999999999988877665 35899
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
++++||++||+.||.+|||+.|+|+||||+....
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999999999999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=452.27 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=214.3
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
-..+|.+.+.||+|+||+||+|+.. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+.
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3457999999999999999999864 368899999997543 23357899999999999999999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC
Q 015005 89 TKVFFVIEYVKGGELFAKVLK----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~----------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~ 152 (414)
+.+|||||||+||+|.+++.. +++++.++..++.|++.||+|||++||+||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 999999999999999998864 3589999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHH
Q 015005 153 NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIF 231 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 231 (414)
++||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..+....+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999865443233344567899999999999998886 89999999999999999 999999988888888887
Q ss_pred hc-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 232 KA-EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 232 ~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.+ .++.|..+|+++.+|+.+||+.||++|||+.||+++
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 65 467788899999999999999999999999999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=448.58 Aligned_cols=257 Identities=24% Similarity=0.348 Sum_probs=225.6
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEE
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEV 84 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 84 (414)
+.++-.+.+++.+.||+|+||+||+|... .+++.||||+++.... ....+.+.+|+.+|++++|||||+++++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~--~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC--C-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC--hHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 44566788999999999999999999853 4678999999965432 2235789999999999999999999999
Q ss_pred EEeCCEEEEEEEccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEE
Q 015005 85 MATKTKVFFVIEYVKGGELFAKVLK-----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLL 147 (414)
Q Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~i~~-----------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NIL 147 (414)
+.+++.+|||||||++|+|.+++.. +.+++.++..++.|++.||+|||+++|+||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 9999999999999999999999853 35899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHH
Q 015005 148 LDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKM 226 (414)
Q Consensus 148 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 226 (414)
|+.++++||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..+.
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999865543334445667899999999999988886 89999999999999998 8999999988888
Q ss_pred HHHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 227 YRKIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 227 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
...+..+. .+.|+.+|+++.+|+.+||+.||.+|||+.||+++
T Consensus 257 ~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88887665 46788899999999999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-59 Score=444.71 Aligned_cols=251 Identities=23% Similarity=0.411 Sum_probs=205.5
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
-.+++++.+.||+|+||+||+|++. ..||||+++..... ....+.+.+|+.+|++++|||||++++++.. +.+||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3567889999999999999999853 35999999754433 2346789999999999999999999998854 56899
Q ss_pred EEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 94 VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
|||||+||+|.+++.. +++++.++..++.|++.||+|||++||+||||||+||||+.++++||+|||+|+........
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999999965 67999999999999999999999999999999999999999999999999999876543334
Q ss_pred CccccccCCCcccCchhhccc---CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc------CCCCCCC
Q 015005 172 GLLHTQCGTPAYVAPEVLRKK---GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY------EFPPWIS 242 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------~~~~~~s 242 (414)
....+.+||+.|||||++.+. .| +.++|||||||+||+|+||+.||.+.+.......+..... ..++.+|
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y-~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPF-SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred eeecccccCCCccCHHHhhccCCCCC-CcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence 455677999999999999753 35 4799999999999999999999988655444444433322 2345689
Q ss_pred HHHHHHHHhhcccCcCCCCChHHHhcCC
Q 015005 243 CDARRLISRILVADPQKRISVSEIMINP 270 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s~~eil~hp 270 (414)
+++.+||.+||+.||++|||+.||+++.
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999886553
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=438.61 Aligned_cols=262 Identities=40% Similarity=0.798 Sum_probs=241.9
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.....++|++.+.||+|+||+||+|.+..+|+.||+|++.+..... ...+.+.+|+++++.++||||+++++++.+.+.
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 3567899999999999999999999999999999999998765432 345678899999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+||||++||+|.+++.. +.+++.+++.++.|++.||+|||++||+||||||+|||++.++++||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~--- 165 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT--- 165 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS---
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC---
Confidence 9999999999999999876 889999999999999999999999999999999999999999999999999997543
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
........+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+.......+..+.+..|..+++++.+||
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 245 (328)
T 3fe3_A 166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLL 245 (328)
T ss_dssp SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 23456678899999999999998887789999999999999999999999999999999999999999999999999999
Q ss_pred HhhcccCcCCCCChHHHhcCCccccCC
Q 015005 250 SRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
++||+.||.+|||++|+++||||....
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999997653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=442.26 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=216.2
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCC-----CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-CCccceEEEEEe
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVT-----QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH-PNIVELKEVMAT 87 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~ 87 (414)
-.++|++++.||+|+||+||+|.+..+ ++.||||.+....... ..+.+.+|+++|++++| ||||+++++|..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~--~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH--HHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 357899999999999999999987654 4689999997654332 35678999999999965 999999999965
Q ss_pred -CCEEEEEEEccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc
Q 015005 88 -KTKVFFVIEYVKGGELFAKVLK-----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD 149 (414)
Q Consensus 88 -~~~~~lv~E~~~gg~L~~~i~~-----------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~ 149 (414)
++.+|||||||+||+|.+++.. ..+++.++..++.|++.||+|||+++|+||||||+|||++
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 4679999999999999999864 2389999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHH-HHH
Q 015005 150 ENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIM-KMY 227 (414)
Q Consensus 150 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~~ 227 (414)
.++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+.. ...
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999865432222234566899999999999998886 89999999999999998 99999886543 344
Q ss_pred HHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 228 RKIFKA-EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 228 ~~i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
..+..+ .++.|+.+++++.+||.+||+.||++|||+.||++|
T Consensus 299 ~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 444443 456788899999999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-57 Score=438.11 Aligned_cols=260 Identities=33% Similarity=0.627 Sum_probs=232.6
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 90 (414)
..-.++|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45578999999999999999999999999999999999877655555567788999999988 79999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-- 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-- 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--
Confidence 9999999999999999987 8899999999999999999999999999999999999999999999999999985332
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.++..+...+|.++++++.+||
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 23345677899999999999988885 89999999999999999999999999999999999999999999999999999
Q ss_pred HhhcccCcCCCCCh------HHHhcCCcccc
Q 015005 250 SRILVADPQKRISV------SEIMINPWFIK 274 (414)
Q Consensus 250 ~~~L~~dp~~R~s~------~eil~hp~f~~ 274 (414)
++||+.||.+||++ .|+++||||..
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 99999999999998 89999999965
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=431.75 Aligned_cols=259 Identities=34% Similarity=0.645 Sum_probs=238.0
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+-.++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 34678999999999999999999999999999999998765444444677889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+||||++||+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 99999999999999887 7899999999999999999999999999999999999999999999999999985322 23
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 251 (414)
....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||++
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 345677899999999999988885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCC-----ChHHHhcCCcccc
Q 015005 252 ILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 252 ~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
||+.||.+|| ++.|+++||||..
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999 8999999999964
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-56 Score=431.13 Aligned_cols=261 Identities=33% Similarity=0.618 Sum_probs=236.8
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 89 (414)
.....++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 346678999999999999999999999999999999999876544344466788999999877 9999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 99999999999999999987 8899999999999999999999999999999999999999999999999999975322
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRL 248 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 248 (414)
........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+......+|.++++++.+|
T Consensus 171 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 171 -GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 23345677899999999999988885 8999999999999999999999999999999999999999999999999999
Q ss_pred HHhhcccCcCCCCChH-HHhcCCcccc
Q 015005 249 ISRILVADPQKRISVS-EIMINPWFIK 274 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~-eil~hp~f~~ 274 (414)
|++||+.||.+||++. ++++||||..
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccC
Confidence 9999999999999998 9999999965
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=423.89 Aligned_cols=256 Identities=34% Similarity=0.692 Sum_probs=237.0
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.-.++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 44678999999999999999999999999999999998765544444677889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+||||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 99999999999999987 7899999999999999999999999999999999999999999999999999985432
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 251 (414)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+.++......+|+.+++++.+||++
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 34567899999999999988885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCC-----ChHHHhcCCcccc
Q 015005 252 ILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 252 ~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
||+.||.+|| +++++++||||..
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999 8999999999964
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-57 Score=436.56 Aligned_cols=263 Identities=43% Similarity=0.842 Sum_probs=236.2
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.....++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999987655444445678999999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+||||+ +|+|.+.+.. +.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~-- 160 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-- 160 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT--
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC--
Confidence 99999999 6888888876 8899999999999999999999999999999999999999999999999999986542
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+......+..+..+.+..|..+|+++.+||
T Consensus 161 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 161 -GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp -SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHH
T ss_pred -CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 3345667899999999999988876689999999999999999999999877666666666667778889999999999
Q ss_pred HhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 250 SRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
++||+.||.+|||++|+++||||....+
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred HHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 9999999999999999999999987543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=435.10 Aligned_cols=260 Identities=32% Similarity=0.604 Sum_probs=231.9
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 90 (414)
..-.++|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|..++.++ +||||+++++++.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45578999999999999999999999999999999999887665544456788999999887 89999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+||||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-- 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--
Confidence 9999999999999999887 8899999999999999999999999999999999999999999999999999985322
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc---------hHHHHHHHHHhcccCCCCC
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE---------NIMKMYRKIFKAEYEFPPW 240 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---------~~~~~~~~i~~~~~~~~~~ 240 (414)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||... .....++.+......+|..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred CCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 23456678999999999999998885 8999999999999999999999642 3345677888889999999
Q ss_pred CCHHHHHHHHhhcccCcCCCCCh------HHHhcCCcccc
Q 015005 241 ISCDARRLISRILVADPQKRISV------SEIMINPWFIK 274 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~------~eil~hp~f~~ 274 (414)
+++++.+||++||+.||.+||++ +||++||||..
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 99999999999999999999985 79999999964
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-55 Score=428.32 Aligned_cols=260 Identities=34% Similarity=0.599 Sum_probs=235.1
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh---hHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ---GLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
...+.++|++.+.||+|+||+||+|.+..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 45678899999999999999999999999999999999987654321 124678999999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC----CeEEeecCCC
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG----NLKVSDFGLS 162 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~----~~kl~DFGla 162 (414)
.+.+|+||||++||+|++++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999987 7899999999999999999999999999999999999998777 7999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP---- 238 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 238 (414)
..... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+....+.++
T Consensus 167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp EECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eEcCC---CCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 86443 2344567899999999999888775 899999999999999999999999999999999988887766
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+.+++++++||++||.+||.+|||+.|+++||||..
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 458999999999999999999999999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=427.64 Aligned_cols=261 Identities=30% Similarity=0.557 Sum_probs=237.0
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 89 (414)
.....++|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|..++..+ +||||+++++++++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 346678999999999999999999999999999999999876554444567788999999988 8999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.+|+||||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 99999999999999999987 8899999999999999999999999999999999999999999999999999985322
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRL 248 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 248 (414)
........+||+.|+|||++.+.+|. .++|||||||++|+|++|..||.+.+..+.++.+......+|..+++++.+|
T Consensus 174 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 174 -DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 23345677899999999999988885 8999999999999999999999999999999999999999999999999999
Q ss_pred HHhhcccCcCCCCC-----hHHHhcCCcccc
Q 015005 249 ISRILVADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 249 i~~~L~~dp~~R~s-----~~eil~hp~f~~ 274 (414)
|++||+.||.+||+ +.++++||||..
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999999995 699999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-55 Score=423.33 Aligned_cols=260 Identities=32% Similarity=0.606 Sum_probs=234.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 90 (414)
..-.++|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 34578899999999999999999999999999999999887665555567889999999988 89999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 9999999999999999987 7899999999999999999999999999999999999999999999999999985322
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC---------chHHHHHHHHHhcccCCCCC
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN---------ENIMKMYRKIFKAEYEFPPW 240 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---------~~~~~~~~~i~~~~~~~~~~ 240 (414)
........+||+.|+|||++.+..|. .++|||||||++|+|++|..||.. ......++.+......+|..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 23345677899999999999988885 899999999999999999999975 33455677788888899999
Q ss_pred CCHHHHHHHHhhcccCcCCCCCh------HHHhcCCcccc
Q 015005 241 ISCDARRLISRILVADPQKRISV------SEIMINPWFIK 274 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~------~eil~hp~f~~ 274 (414)
++.++.+||++||+.||.+||++ .|+++||||..
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999999999999995 79999999964
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-55 Score=425.55 Aligned_cols=257 Identities=32% Similarity=0.636 Sum_probs=238.4
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
....++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 35678999999999999999999999999999999999876654444567889999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 999999999999999987 8899999999999999999999999999999999999999999999999999985432
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 250 (414)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+..+...+|..+++++.+||+
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 23467899999999999988885 899999999999999999999999999999999999999999999999999999
Q ss_pred hhcccCcCCCCC-----hHHHhcCCcccc
Q 015005 251 RILVADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 251 ~~L~~dp~~R~s-----~~eil~hp~f~~ 274 (414)
+||+.||.+||+ +++|++||||..
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999999999998 999999999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=435.21 Aligned_cols=263 Identities=35% Similarity=0.674 Sum_probs=232.8
Q ss_pred HhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 8 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
......+.++|++.+.||+|+||+||+|.+..+|+.||+|++.+..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 81 (444)
T 3soa_A 3 TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISE 81 (444)
T ss_dssp ----CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEEC
T ss_pred ccccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEE
Confidence 3445667789999999999999999999999999999999998765443 235678999999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc---CCCCeEEeecCCCc
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD---ENGNLKVSDFGLSA 163 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~---~~~~~kl~DFGla~ 163 (414)
.+..|+||||++||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 82 EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp SSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred CCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999999999999887 7899999999999999999999999999999999999998 45789999999997
Q ss_pred ccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC----
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP---- 239 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~---- 239 (414)
.... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+..+.+.+|.
T Consensus 162 ~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (444)
T 3soa_A 162 EVEG--EQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD 238 (444)
T ss_dssp CCCT--TCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred EecC--CCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccc
Confidence 6543 23334567899999999999988885 8999999999999999999999999999999999888776653
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.+++++.+||.+||+.||.+|||+.|+|+||||..
T Consensus 239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 47999999999999999999999999999999965
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=411.04 Aligned_cols=256 Identities=33% Similarity=0.501 Sum_probs=228.5
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
..++|++.+.||+|+||+||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 4578999999999999999999999999999999997654333 4678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 94 VIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||||++||+|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 172 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC--cccc
Confidence 99999999999999988999999999999999999999999999999999999999999999999999876443 2233
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc---ccCCCCCCCHHHHHHHH
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA---EYEFPPWISCDARRLIS 250 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~ 250 (414)
....+||+.|+|||++.+..|+ .++|||||||++|+|++|..||...+.......+... ....|..++..+.+||.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 4566899999999999988885 8999999999999999999999988776665555433 23446678999999999
Q ss_pred hhcccCcCCCCChHHHhcCCccccC
Q 015005 251 RILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+||+.||.+|||+.|+++||||...
T Consensus 252 ~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHccCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=424.89 Aligned_cols=261 Identities=27% Similarity=0.535 Sum_probs=235.4
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
-+.+..++|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 35677899999999999999999999999999999999998776555555678899999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-- 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--
Confidence 99999999999999999987 689999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCccccccCCCcccCchhhcc---cCCCCCccchhhhhhhhhhhhcCCCCCCC---chHHHHHHHHHhcccCCCCCCC
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRK---KGYDGAKSDIWSCGVVLFVLLSGFLPFQN---ENIMKMYRKIFKAEYEFPPWIS 242 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~~~~~~s 242 (414)
........+||+.|+|||++.+ .+| +.++|||||||++|+|++|..||.. .........+......+|..++
T Consensus 167 -~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 167 -RETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp -TTCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred -CCCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 2344567889999999999864 345 4799999999999999999999974 3455667777778888999999
Q ss_pred HHHHHHHHhhcccCcCCCCC-hHHHhcCCcccc
Q 015005 243 CDARRLISRILVADPQKRIS-VSEIMINPWFIK 274 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s-~~eil~hp~f~~ 274 (414)
.++.+||++||+.||.+||+ ++++++||||..
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 99999999999999999998 899999999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=424.15 Aligned_cols=260 Identities=35% Similarity=0.606 Sum_probs=228.0
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHH-HHhCCCCCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISV-MRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~ 90 (414)
....++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3456789999999999999999999999999999999988766554445667778877 577899999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 9999999999999999987 7899999999999999999999999999999999999999999999999999985322
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.++......+|+.++.++.+||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 23345677899999999999988885 89999999999999999999999999999999999999999999999999999
Q ss_pred HhhcccCcCCCCCh----HHHhcCCcccc
Q 015005 250 SRILVADPQKRISV----SEIMINPWFIK 274 (414)
Q Consensus 250 ~~~L~~dp~~R~s~----~eil~hp~f~~ 274 (414)
++||+.||.+||++ .++++||||..
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999999987 69999999964
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-55 Score=431.85 Aligned_cols=262 Identities=32% Similarity=0.537 Sum_probs=231.5
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
...++|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 45679999999999999999999999999999999998754433333456789999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 93 FVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
+||||++||+|.+++....+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|...... ...
T Consensus 146 lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~-~~~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMV 224 (410)
T ss_dssp EEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-SEE
T ss_pred EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC-Ccc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999999754321 111
Q ss_pred ccccccCCCcccCchhhcccC---CCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCCCC--CCCHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKG---YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFPP--WISCDA 245 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~ 245 (414)
...+.+||+.|+|||++.+.+ +.+.++|||||||++|+|++|..||.+.+....+.++.... ..+|. .+|.++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 234678999999999998765 12479999999999999999999999999999999887653 44554 689999
Q ss_pred HHHHHhhcccCcCC--CCChHHHhcCCccccC
Q 015005 246 RRLISRILVADPQK--RISVSEIMINPWFIKG 275 (414)
Q Consensus 246 ~~li~~~L~~dp~~--R~s~~eil~hp~f~~~ 275 (414)
++||++||+.+|.+ |++++||++||||...
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999998 9999999999999763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=417.05 Aligned_cols=263 Identities=33% Similarity=0.633 Sum_probs=226.0
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 47889999999999999999999999999999999997654322 2356889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+||||++||+|.+++.. +.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999999987 57999999999999999999999999999999999999999999999999999865433333
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHHHhcccCCC--CCCCHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKIFKAEYEFP--PWISCDARRL 248 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~l 248 (414)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++++.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 44556789999999999988877667899999999999999999999876543 33333333333333 3489999999
Q ss_pred HHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 249 ISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
|.+||+.||.+|||+.|+++||||.+...
T Consensus 242 i~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999999999999999999987544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=414.77 Aligned_cols=255 Identities=28% Similarity=0.530 Sum_probs=231.1
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc----cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 357899999999999999999999999999999999975432 2456889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC--CCCeEEeecCCCcccccc
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--NGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 168 (414)
+||||++||+|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~- 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC-
Confidence 99999999999999986 36999999999999999999999999999999999999987 78999999999986532
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCCCHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISCD 244 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 244 (414)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+..+.+.++ +.+|.+
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 157 --GDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred --CCccccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 3345567899999999999887664 899999999999999999999999999899999988887766 368999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 245 ARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+.+||.+||+.||.+|||+.|+++||||.+.
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-54 Score=413.18 Aligned_cols=261 Identities=33% Similarity=0.630 Sum_probs=224.8
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccch-hhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVKK-QGLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
..+..++|++.+.||+|+||+||+|++. .+++.||+|++.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4567789999999999999999999985 689999999998764322 223456789999999999999999999999
Q ss_pred eCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
+.+.+|+||||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999986 78999999999999999999999999999999999999999999999999999753
Q ss_pred ccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHH
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDA 245 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 245 (414)
.. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+......+|+.+++++
T Consensus 172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 248 (327)
T 3a62_A 172 IH--DGTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred cc--CCccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 32 22334567899999999999887775 8999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcccCcCCCC-----ChHHHhcCCcccc
Q 015005 246 RRLISRILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
.+||.+||+.||.+|| ++.|+++||||..
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 9999999999999999 8899999999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-54 Score=418.93 Aligned_cols=259 Identities=34% Similarity=0.687 Sum_probs=232.7
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 4456678999999999999999999999999999999998765433 235678999999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC---CeEEeecCCCcccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG---NLKVSDFGLSALPE 166 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~---~~kl~DFGla~~~~ 166 (414)
.|+||||++||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999999999876 6799999999999999999999999999999999999998654 59999999998654
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC----CCC
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP----WIS 242 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s 242 (414)
. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+..+.+.+|. .++
T Consensus 183 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (362)
T 2bdw_A 183 D---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258 (362)
T ss_dssp T---CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred C---CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 2 2334567899999999999888775 8999999999999999999999999988888888888776653 479
Q ss_pred HHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 243 CDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+++.+||.+||+.||.+|||+.|+++||||..
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999964
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=413.83 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=195.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----E
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT----K 90 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 90 (414)
..+|.+.+.||+|+||+||+|++ +|+.||||+++..... ......|+..+.+++|||||++++++..++ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 45799999999999999999986 6899999999754321 122345666677889999999999997653 6
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSR--------GVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~--------gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
+|||||||+||+|.+++...++++..+..++.|++.||+|||++ ||+||||||+|||++.++++||+|||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 89999999999999999999999999999999999999999987 9999999999999999999999999999
Q ss_pred cccccccC--CCccccccCCCcccCchhhcccCC-----CCCccchhhhhhhhhhhhcCCCCCCCc--------------
Q 015005 163 ALPEQLWN--DGLLHTQCGTPAYVAPEVLRKKGY-----DGAKSDIWSCGVVLFVLLSGFLPFQNE-------------- 221 (414)
Q Consensus 163 ~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~-------------- 221 (414)
+....... .......+||+.|||||++.+... .+.++|||||||+||||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86543211 112345689999999999976421 136899999999999999997765321
Q ss_pred -hHHHHHHHHHhcc--cCCCCC-----CCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 222 -NIMKMYRKIFKAE--YEFPPW-----ISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 222 -~~~~~~~~i~~~~--~~~~~~-----~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
........+.... +.+|.. .+..+.+|+.+||+.||++|||+.||++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2233444443332 233332 23467899999999999999999999763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=408.96 Aligned_cols=261 Identities=36% Similarity=0.668 Sum_probs=224.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch-----------------------hhHHHHHHHHHH
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK-----------------------QGLMEQIKREIS 68 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~~~~~Ei~ 68 (414)
....++|++.+.||+|+||+||+|.+..+++.||+|++.+..... ....+.+.+|++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 356789999999999999999999999999999999997654321 112356889999
Q ss_pred HHHhCCCCCccceEEEEEe--CCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcE
Q 015005 69 VMRLVKHPNIVELKEVMAT--KTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENL 146 (414)
Q Consensus 69 il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NI 146 (414)
+++.++||||+++++++.+ ...+|+||||+++++|.+....+.+++.++..++.|++.||.|||++||+||||||+||
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 9999999999999999987 67899999999999998877778899999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCC--CCCccchhhhhhhhhhhhcCCCCCCCchHH
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY--DGAKSDIWSCGVVLFVLLSGFLPFQNENIM 224 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~ 224 (414)
|++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|..||...+..
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 999999999999999986443 2233456689999999999976542 356899999999999999999999998888
Q ss_pred HHHHHHHhcccCCC--CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 225 KMYRKIFKAEYEFP--PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 225 ~~~~~i~~~~~~~~--~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.....+......+| +.+++++.+||.+||+.||++|||+.|+++||||.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 77777777666555 468999999999999999999999999999999963
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=431.97 Aligned_cols=260 Identities=35% Similarity=0.640 Sum_probs=227.2
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
....++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999876544444456788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+||||++||+|.+.+.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 999999999999999886 789999999999999999999998 9999999999999999999999999999985332
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 23345667899999999999888885 89999999999999999999999999999999999999999999999999999
Q ss_pred HhhcccCcCCCC-----ChHHHhcCCcccc
Q 015005 250 SRILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 250 ~~~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
.+||+.||.+|| |+.|+++||||..
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999 9999999999965
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=401.62 Aligned_cols=262 Identities=35% Similarity=0.693 Sum_probs=236.3
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.+...++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 45678899999999999999999999999999999999987665554456788999999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
.|+||||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence 9999999999999999887 8899999999999999999999999999999999999999999999999999864332
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+......+|..++.++.+||
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (279)
T 3fdn_A 162 --SRRTDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred --ccccccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence 223456799999999999887764 89999999999999999999999999999999888888899999999999999
Q ss_pred HhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 250 SRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
.+||+.||.+|||+.|+++||||.....
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHhccChhhCCCHHHHhhCccccCCcc
Confidence 9999999999999999999999976543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=410.08 Aligned_cols=259 Identities=34% Similarity=0.602 Sum_probs=231.4
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh---hHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ---GLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3566789999999999999999999999999999999987554321 1256788999999999999999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC----CeEEeecCCCc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG----NLKVSDFGLSA 163 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~----~~kl~DFGla~ 163 (414)
..+|+||||++||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999999976 7899999999999999999999999999999999999999887 89999999998
Q ss_pred ccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----C
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----P 239 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~ 239 (414)
.... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+....+.++ +
T Consensus 167 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 167 KIDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp ECCT---TSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred ECCC---CCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 6542 2234566899999999999887775 899999999999999999999999888888888877766655 4
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.++..+.+||++||+.||.+|||+.|+++||||..
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 58999999999999999999999999999999964
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=400.86 Aligned_cols=257 Identities=32% Similarity=0.518 Sum_probs=218.1
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 46899999999999999999999999999999999866533 33456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|||++|+.+...... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 157 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCSC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--cccc
Confidence 999987544444443 7899999999999999999999999999999999999999999999999999986543 2233
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCC-CCCchHHHHHHHHHhccc-----------------
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLP-FQNENIMKMYRKIFKAEY----------------- 235 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~~~~~~~i~~~~~----------------- 235 (414)
....+||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+.......+.....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 45667999999999998776446899999999999999988777 566666666555543100
Q ss_pred ------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 236 ------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 236 ------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..++.++.++++||++||+.||++|||++|+++||||.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 112347889999999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-54 Score=427.75 Aligned_cols=261 Identities=29% Similarity=0.538 Sum_probs=229.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
....++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 34567999999999999999999999999999999999875544333344588999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+||||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~- 228 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED- 228 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-
Confidence 999999999999999986 68999999999999999999999999999999999999999999999999999754321
Q ss_pred CCCccccccCCCcccCchhhc-----ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--ccCCCCC--
Q 015005 170 NDGLLHTQCGTPAYVAPEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EYEFPPW-- 240 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~-- 240 (414)
........+||+.|+|||++. ...| +.++|||||||++|+|++|..||.+.+..+.+.++... .+.+|..
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 112234468999999999987 3345 58999999999999999999999999999988888754 3455544
Q ss_pred -CCHHHHHHHHhhcccCcCC--CCChHHHhcCCcccc
Q 015005 241 -ISCDARRLISRILVADPQK--RISVSEIMINPWFIK 274 (414)
Q Consensus 241 -~s~~~~~li~~~L~~dp~~--R~s~~eil~hp~f~~ 274 (414)
+|+++++||++||..+|++ |++++|+++||||..
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 8999999999999998888 999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=415.00 Aligned_cols=259 Identities=33% Similarity=0.654 Sum_probs=225.7
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh--hHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ--GLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3556789999999999999999999999999999999976543211 12467899999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC---eEEeecCC
Q 015005 90 KVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN---LKVSDFGL 161 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~---~kl~DFGl 161 (414)
.+|+|||||+||+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999999887754 24899999999999999999999999999999999999987655 99999999
Q ss_pred CcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC---
Q 015005 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP--- 238 (414)
Q Consensus 162 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 238 (414)
+..... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.. ...+..+..+.+..+
T Consensus 180 a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 180 AIQLGE--SGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp CEECCT--TSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHH
T ss_pred eeEecC--CCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccc
Confidence 986543 22234566899999999999988775 89999999999999999999998864 456677777766654
Q ss_pred -CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 239 -PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 239 -~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+.++.++.+||++||+.||.+|||+.|+++||||..
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 458999999999999999999999999999999965
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=415.98 Aligned_cols=258 Identities=42% Similarity=0.743 Sum_probs=216.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
...++|++.+.||+|+||+||+|++..+++.||+|++....... +.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 34689999999999999999999999999999999997654332 46789999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC--eEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN--LKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~--~kl~DFGla~~~~~~~ 169 (414)
+||||++||+|.+++.. +++++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~--- 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--- 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence 99999999999999876 88999999999999999999999999999999999999987765 9999999997432
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH----HHHHHHHHhcccCCCC--CCCH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI----MKMYRKIFKAEYEFPP--WISC 243 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~--~~s~ 243 (414)
........+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+... ......+....+.+|. .+++
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 223345567999999999999888875569999999999999999999987543 4555666666666665 4799
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
++.+||++||+.||.+|||+.|+++||||.+...
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 9999999999999999999999999999987644
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=398.40 Aligned_cols=265 Identities=42% Similarity=0.814 Sum_probs=231.4
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
-+.+..++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 46788899999999999999999999999999999999998765444445678899999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
..|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~- 163 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 163 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC-
Confidence 99999999999999999986 7899999999999999999999999999999999999999999999999999986432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRL 248 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 248 (414)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+..+....|..++.++.+|
T Consensus 164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 241 (276)
T 2h6d_A 164 --GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred --CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence 223445679999999999988776557899999999999999999999999888888888888888888999999999
Q ss_pred HHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 249 ISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
|.+||+.||.+|||+.++++||||.+..+
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHccCChhhCCCHHHHHhChhhccCch
Confidence 99999999999999999999999987543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=405.70 Aligned_cols=264 Identities=31% Similarity=0.472 Sum_probs=217.5
Q ss_pred hhHhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEE
Q 015005 6 MDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVM 85 (414)
Q Consensus 6 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 85 (414)
++...++.+.++|++.+.||+|+||+||+|.+. +++.||+|++...... ......+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 88 (311)
T 3niz_A 11 RENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVI 88 (311)
T ss_dssp ----CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 355567899999999999999999999999985 5899999999765432 33456788999999999999999999999
Q ss_pred EeCCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 86 ATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
.++..+|+||||++| +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp CCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence 999999999999985 77777765 469999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--cc------
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EY------ 235 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~------ 235 (414)
.... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 168 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 168 AFGI--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp ETTS--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred ecCC--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 6542 2233455679999999999987554468999999999999999999999886655554444321 00
Q ss_pred ----------------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 236 ----------------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 236 ----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
...+.+++++.+||++||+.||.+|||+.|+++||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 012346789999999999999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=421.14 Aligned_cols=260 Identities=28% Similarity=0.519 Sum_probs=227.2
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
....++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.++..++||||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34568899999999999999999999999999999999875544333445688999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+||||++||+|.+++.+ ..+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||++......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~- 215 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD- 215 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC-
Confidence 999999999999999986 47999999999999999999999999999999999999999999999999999754321
Q ss_pred CCCccccccCCCcccCchhhcc-------cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCCC--
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRK-------KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEFP-- 238 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~-------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~-- 238 (414)
........+||+.|+|||++.. ..| +.++|||||||++|+|++|..||.+.+..+.+.++.... ..+|
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 1112345689999999999973 345 489999999999999999999999999988888887633 3444
Q ss_pred -CCCCHHHHHHHHhhcccCcCCC---CChHHHhcCCcccc
Q 015005 239 -PWISCDARRLISRILVADPQKR---ISVSEIMINPWFIK 274 (414)
Q Consensus 239 -~~~s~~~~~li~~~L~~dp~~R---~s~~eil~hp~f~~ 274 (414)
..+|+++++||++||. +|.+| ++++|+++||||..
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 5699999999999999 99998 59999999999965
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=396.23 Aligned_cols=261 Identities=33% Similarity=0.702 Sum_probs=237.6
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
+....++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 45667899999999999999999999999999999999987655444445788999999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
.|+||||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-- 166 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 166 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence 9999999999999999887 7899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLI 249 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 249 (414)
......+||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+......+|+.++.++.+||
T Consensus 167 --~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (284)
T 2vgo_A 167 --LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 243 (284)
T ss_dssp --SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred --cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHH
Confidence 223456799999999999887775 89999999999999999999999988888888888888889999999999999
Q ss_pred HhhcccCcCCCCChHHHhcCCccccCC
Q 015005 250 SRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.+||+.||.+|||+.++++||||....
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 999999999999999999999997643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=417.40 Aligned_cols=263 Identities=29% Similarity=0.426 Sum_probs=213.1
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeC
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATK 88 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 88 (414)
++..+.++|++.+.||+|+||+||+|.+..+|+.||+|++.+.... ....+.+.+|+.+++.+. ||||+++++++...
T Consensus 3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 4567889999999999999999999999999999999999654322 234567889999999997 99999999999865
Q ss_pred C--EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 T--KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 ~--~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
+ .+|+||||++ |+|...+..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred CCCEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 4 7999999997 589999988999999999999999999999999999999999999999999999999999997543
Q ss_pred cc-------------------cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHH
Q 015005 167 QL-------------------WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMY 227 (414)
Q Consensus 167 ~~-------------------~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~ 227 (414)
.. .........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 01223445689999999999987444458999999999999999999999998877766
Q ss_pred HHHHhccc-----------------------------------------------CCCCCCCHHHHHHHHhhcccCcCCC
Q 015005 228 RKIFKAEY-----------------------------------------------EFPPWISCDARRLISRILVADPQKR 260 (414)
Q Consensus 228 ~~i~~~~~-----------------------------------------------~~~~~~s~~~~~li~~~L~~dp~~R 260 (414)
..+...-. ..+..+++++.+||++||+.||.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 66542100 0112578899999999999999999
Q ss_pred CChHHHhcCCcccc
Q 015005 261 ISVSEIMINPWFIK 274 (414)
Q Consensus 261 ~s~~eil~hp~f~~ 274 (414)
||++|+|+||||..
T Consensus 321 ~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 321 ISANDALKHPFVSI 334 (388)
T ss_dssp CCHHHHTTSTTTTT
T ss_pred CCHHHHhCCHHHHH
Confidence 99999999999965
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=395.28 Aligned_cols=263 Identities=34% Similarity=0.564 Sum_probs=239.4
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
....++|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 45678999999999999999999999999999999999877655555567889999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+||||++|++|.+.+.. +.+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... .
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--~ 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--D 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--T
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc--C
Confidence 999999999999998887 7899999999999999999999999999999999999999999999999999986442 2
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 250 (414)
.......+||+.|+|||++.+..+. .++||||||+++|+|++|..||......+.+..+.......|..+++.+.+||.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence 2234456799999999999887775 899999999999999999999999988888888888888899999999999999
Q ss_pred hhcccCcCCCCChHHHhcCCccccCCC
Q 015005 251 RILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
+||+.||.+|||+.|+++||||.....
T Consensus 248 ~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 248 KMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHcccChhhCcCHHHHhhChheecCCc
Confidence 999999999999999999999987643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=443.56 Aligned_cols=259 Identities=30% Similarity=0.564 Sum_probs=237.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKV 91 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 91 (414)
...++|++.+.||+|+||+||+|++..+++.||||++.+.........+.+.+|..++..+ +||||+++++++++.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4577899999999999999999999999999999999876554444567788999999988 799999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+||||++||+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... .
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--T
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--C
Confidence 999999999999999987 8999999999999999999999999999999999999999999999999999985322 2
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLIS 250 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 250 (414)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++++.+......+|..+++++.+||+
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 3345678899999999999988885 899999999999999999999999999999999999999999999999999999
Q ss_pred hhcccCcCCCCCh-----HHHhcCCcccc
Q 015005 251 RILVADPQKRISV-----SEIMINPWFIK 274 (414)
Q Consensus 251 ~~L~~dp~~R~s~-----~eil~hp~f~~ 274 (414)
+||+.||.+||++ +||++||||..
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 9999999999998 99999999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=410.71 Aligned_cols=253 Identities=34% Similarity=0.651 Sum_probs=223.2
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 90 (414)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++.+.... ..+|++++.++ +||||+++++++.+...
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 35678899999999999999999999999999999999775432 34688888887 79999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC-C---CeEEeecCCCccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN-G---NLKVSDFGLSALP 165 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~-~---~~kl~DFGla~~~ 165 (414)
+|+||||++||+|.+.+.. +.+++.++..++.|++.||.|||++||+||||||+|||+..+ + .+||+|||++...
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999999999987 779999999999999999999999999999999999998543 3 4999999999864
Q ss_pred ccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC---chHHHHHHHHHhcccCCC----
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN---ENIMKMYRKIFKAEYEFP---- 238 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~~~---- 238 (414)
.. ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.. .+..+.+..+..+.+.++
T Consensus 171 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 171 RA--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp BC--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred cC--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 43 23345677899999999999887775 799999999999999999999986 456677888887777655
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+.+|+++.+||++||+.||.+|||+.++++||||..
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 458999999999999999999999999999999965
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=431.12 Aligned_cols=259 Identities=29% Similarity=0.473 Sum_probs=233.3
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
....++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 35677899999999999999999999999999999999876655444467788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 92 FFVIEYVKGGELFAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
|+||||++||+|.+++.. + .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 999999999999999876 3 399999999999999999999999999999999999999999999999999985432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc----hHHHHHHHHHhcccCCCCCCCHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE----NIMKMYRKIFKAEYEFPPWISCD 244 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~ 244 (414)
.......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||... ........+......+|..+|++
T Consensus 339 --~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 339 --GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp --TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred --CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 3344567899999999999887775 8999999999999999999999875 34566777777778888899999
Q ss_pred HHHHHHhhcccCcCCCC-----ChHHHhcCCcccc
Q 015005 245 ARRLISRILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
+.+||++||+.||.+|| +++|+++||||..
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 99999999999999999 7899999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=427.81 Aligned_cols=260 Identities=27% Similarity=0.450 Sum_probs=233.8
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
....++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35568999999999999999999999999999999999877655444567888999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 92 FFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999998875 259999999999999999999999999999999999999999999999999998643
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc----hHHHHHHHHHhcccCCCCCCC
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE----NIMKMYRKIFKAEYEFPPWIS 242 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s 242 (414)
. ........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+. ......+.+......+|..++
T Consensus 341 ~--~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s 417 (543)
T 3c4z_A 341 A--GQTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417 (543)
T ss_dssp T--TCCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred C--CCcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence 2 12233456899999999999988885 8999999999999999999999875 456777888888888999999
Q ss_pred HHHHHHHHhhcccCcCCCCC-----hHHHhcCCcccc
Q 015005 243 CDARRLISRILVADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s-----~~eil~hp~f~~ 274 (414)
+++.+||++||+.||.+||+ +++|++||||..
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 99999999999999999996 589999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=398.73 Aligned_cols=253 Identities=26% Similarity=0.479 Sum_probs=225.2
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.|+..+.||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 489999999999999999999999999999999765432 24678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcccc
Q 015005 97 YVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT 176 (414)
Q Consensus 97 ~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 176 (414)
|++|++|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .......
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~ 200 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKS 200 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc--Ccccccc
Confidence 99999999999888999999999999999999999999999999999999999999999999999976443 1223355
Q ss_pred ccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC---CCCCCCHHHHHHHHhhc
Q 015005 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE---FPPWISCDARRLISRIL 253 (414)
Q Consensus 177 ~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li~~~L 253 (414)
.+||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+.....+ .+..+++++.+||.+||
T Consensus 201 ~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred ccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 6899999999999887775 8999999999999999999999988877777766655432 23458899999999999
Q ss_pred ccCcCCCCChHHHhcCCccccC
Q 015005 254 VADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 254 ~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+.||++|||+.|+++||||.+.
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGGC
T ss_pred cCChhhCcCHHHHhcChhhccC
Confidence 9999999999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=411.04 Aligned_cols=257 Identities=27% Similarity=0.557 Sum_probs=229.5
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.+.++|++.+.||+|+||+||+|.+..+|+.||+|++....... ...+.+|+.+++.++||||+++++++.+...+|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh---HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 45689999999999999999999999999999999997654322 357889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC--CCCeEEeecCCCcccccc
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--NGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 168 (414)
+||||++||+|.+.+.. ..+++.++..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~- 203 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 203 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC-
Confidence 99999999999999876 37999999999999999999999999999999999999974 46899999999986432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCCCHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISCD 244 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 244 (414)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+......++ ..++++
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 204 --DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred --CcceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 3344566899999999999887775 899999999999999999999999988888888877765544 357999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 245 ARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
+.+||.+||+.||.+|||+.|+++||||....
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 99999999999999999999999999997653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=396.48 Aligned_cols=259 Identities=33% Similarity=0.646 Sum_probs=207.5
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 45689999999999999999999999999999999987655444456789999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 94 VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--H 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC--C
Confidence 9999999999999886 57999999999999999999999999999999999999999999999999999864421 2
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 251 (414)
......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+....+..|..++.++.+||.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence 223456799999999999887664 8999999999999999999999987766666666666777888899999999999
Q ss_pred hcccCcCCCCChHHHhcCCccccC
Q 015005 252 ILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
||+.||.+|||+.++++||||.+.
T Consensus 246 ~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HcccCHhhCCCHHHHhcCccccCC
Confidence 999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=391.30 Aligned_cols=259 Identities=34% Similarity=0.686 Sum_probs=231.8
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 356789999999999999999999999999999999998765433 2356788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC---eEEeecCCCccccc
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN---LKVSDFGLSALPEQ 167 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~---~kl~DFGla~~~~~ 167 (414)
|+||||++|++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999888876 78999999999999999999999999999999999999987665 99999999975432
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 243 (414)
........||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..+....| ..+++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 161 ---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ---SCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ---CccccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 2334456799999999999888775 899999999999999999999999988888888887766555 35799
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++.+||.+||++||.+|||+.|+++||||.+.
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=429.69 Aligned_cols=261 Identities=37% Similarity=0.648 Sum_probs=234.7
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
.+..+.++|++.+.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+.+
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34567789999999999999999999999999999999998766544444678999999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE---cCCCCeEEeecCCCccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALP 165 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl---~~~~~~kl~DFGla~~~ 165 (414)
.+|+||||+.||+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999998876 789999999999999999999999999999999999999 46789999999999754
Q ss_pred ccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCC
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWI 241 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 241 (414)
.. .......+||+.|+|||++.+ .|+ .++|||||||++|+|++|..||.+.+..+....+..+.+.++ ..+
T Consensus 180 ~~---~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 180 EA---SKKMKDKIGTAYYIAPEVLHG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp CC---CCSHHHHTTGGGTCCHHHHHT-CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred cc---ccccccCCCCccccCceeecC-CCC-CcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 32 334566789999999999976 464 899999999999999999999999999999998888776543 348
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
|+++++||++||++||.+|||+.|+|+||||...
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999999999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=425.51 Aligned_cols=262 Identities=37% Similarity=0.644 Sum_probs=230.4
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh----------hHHHHHHHHHHHHHhCCCCCccc
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ----------GLMEQIKREISVMRLVKHPNIVE 80 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv~ 80 (414)
+..+.++|++++.||+|+||+||+|.+..+++.||+|++.+...... ...+.+.+|+.+++.++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 44577899999999999999999999999999999999987553321 23567899999999999999999
Q ss_pred eEEEEEeCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC---CeEE
Q 015005 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG---NLKV 156 (414)
Q Consensus 81 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~---~~kl 156 (414)
+++++.+...+|+|||||+||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999999998876 8899999999999999999999999999999999999999776 6999
Q ss_pred eecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC
Q 015005 157 SDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE 236 (414)
Q Consensus 157 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 236 (414)
+|||++..... .......+||+.|+|||++.+ .|+ .++|||||||++|+|++|..||.+.+..+....+..+.+.
T Consensus 191 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 191 VDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KYN-EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp CCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986543 334566789999999999875 464 8999999999999999999999999999999999888876
Q ss_pred CC----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 237 FP----PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 237 ~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
++ ..+|+++++||++||++||.+|||+.|+|+||||.+...
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 65 458999999999999999999999999999999976543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=402.11 Aligned_cols=262 Identities=34% Similarity=0.567 Sum_probs=239.0
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 44678999999999999999999999999999999998776555555678899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+||||++|++|.+++.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DG 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS--TT
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc--Cc
Confidence 99999999999998887 7899999999999999999999999999999999999999999999999999986542 22
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 251 (414)
......+||+.|+|||++.+..+. .++||||||+++|+|++|..||......+.+..+......+|..+++++.+||++
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 234556799999999999887775 8999999999999999999999998888888888888888999999999999999
Q ss_pred hcccCcCCCCChHHHhcCCccccCCC
Q 015005 252 ILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
||+.||.+|||+.|+++||||.....
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HccCChhHCcCHHHHhcCccccCCCc
Confidence 99999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=396.92 Aligned_cols=255 Identities=31% Similarity=0.504 Sum_probs=214.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++.+.||+|+||+||+|.+ .+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 46899999999999999999998 68899999999765432 22346778999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||+++ +|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--ccc
Confidence 999985 88888875 6799999999999999999999999999999999999999999999999999975432 122
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--cc---------------
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EY--------------- 235 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~--------------- 235 (414)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 3345679999999999977554458999999999999999999999988776665555331 00
Q ss_pred ------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 236 ------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 236 ------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.++..+++++.+||++||+.||++|||+.|+++||||.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012347889999999999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=398.27 Aligned_cols=263 Identities=29% Similarity=0.434 Sum_probs=214.9
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch--hhHHHHHHHHHHHHHhCC---CCCccceEE
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK--QGLMEQIKREISVMRLVK---HPNIVELKE 83 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~ 83 (414)
.+|..+.++|++.+.||+|+||+||+|++..+++.||+|++....... ......+.+|+.+++.++ ||||+++++
T Consensus 2 p~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp --------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred CCCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 357788999999999999999999999999999999999997544221 112245667888877764 999999999
Q ss_pred EEEeCC-----EEEEEEEccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeE
Q 015005 84 VMATKT-----KVFFVIEYVKGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLK 155 (414)
Q Consensus 84 ~~~~~~-----~~~lv~E~~~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~k 155 (414)
++.... .++++|||+. |+|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEE
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEE
Confidence 998765 6899999997 5999988863 399999999999999999999999999999999999999999999
Q ss_pred EeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc
Q 015005 156 VSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY 235 (414)
Q Consensus 156 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 235 (414)
|+|||++..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.....
T Consensus 161 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 161 LADFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp ECSCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EeeCccccccCC---CcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999986542 3344567899999999999888875 899999999999999999999999888777766643210
Q ss_pred C---------------------------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 236 E---------------------------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 236 ~---------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
. ..+.++.++.+||.+||+.||.+|||+.|+|+||||.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 0 1134788999999999999999999999999999998653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=390.96 Aligned_cols=258 Identities=36% Similarity=0.647 Sum_probs=232.2
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..+.++|++.+.||+|+||+||+|.+..++..||+|.+.+..... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 356788999999999999999999999999999999997755433 46788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE---cCCCCeEEeecCCCccccc
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 167 (414)
|+||||++|++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999999998876 789999999999999999999999999999999999999 7889999999999975432
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC----CCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP----WISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~ 243 (414)
.......+||+.|+|||++.+. + +.++||||||+++|+|++|..||...+..+....+..+....|. .+++
T Consensus 162 ---~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 162 ---GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ---TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred ---ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 3344566799999999998764 5 58999999999999999999999999988888888888877765 5899
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
++.+||.+||+.||.+|||+.++++||||.+...
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 9999999999999999999999999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=402.77 Aligned_cols=257 Identities=31% Similarity=0.491 Sum_probs=206.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||+|+||+||+|.+..+|+.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 46899999999999999999999999999999999765422 2245678999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 95 IEYVKGGELFAKVLK-------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
|||++ |+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99998 588888764 2589999999999999999999999999999999999999999999999999986542
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc-------------
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE------------- 234 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------- 234 (414)
........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 161 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 --PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp --CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred --CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 22234456799999999999875444589999999999999999999999988777666654310
Q ss_pred ---------------------cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 235 ---------------------YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 235 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
...+..++.++.+||++||+.||.+|||+.|+++||||.+-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 011224788999999999999999999999999999998644
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=411.42 Aligned_cols=260 Identities=23% Similarity=0.384 Sum_probs=218.2
Q ss_pred ccCCEEEeeeeeec--CCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 14 LFGKYEMGRMLGQG--TFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 14 ~~~~y~~~~~LG~G--~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..++|++.+.||+| +||+||+|++..+|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 46789999999999 99999999999999999999998765433 3467888999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 92 FFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999999875 57999999999999999999999999999999999999999999999999998643211
Q ss_pred c-----CCCccccccCCCcccCchhhcc--cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc-------
Q 015005 169 W-----NDGLLHTQCGTPAYVAPEVLRK--KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE------- 234 (414)
Q Consensus 169 ~-----~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------- 234 (414)
. ........+||+.|+|||++.+ ..|+ .++|||||||++|+|++|..||.+.+.......+..+.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBC-THHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 1 1122334579999999999987 4564 89999999999999999999998754433332222111
Q ss_pred ---------------------------------------cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 235 ---------------------------------------YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 235 ---------------------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+.+..+++++.+||++||+.||.+|||+.|+++||||...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 12345578999999999999999999999999999999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=395.97 Aligned_cols=259 Identities=29% Similarity=0.457 Sum_probs=215.2
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
++++|++.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 468999999999999999999999999999999998765432 3345678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 94 VIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
||||+++++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 157 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSD 157 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--ccc
Confidence 9999999999988876 6799999999999999999999999999999999999999999999999999986443 222
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-------------------
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA------------------- 233 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------- 233 (414)
.....+||+.|+|||++.+....+.++||||||+++|+|++|..||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 3456679999999999987544458999999999999999999999987766554433221
Q ss_pred --ccCCC----------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 --EYEFP----------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 --~~~~~----------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..+.+ +.++.++.+||++||+.||.+|||++|+++||||.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 00111 3478889999999999999999999999999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=399.78 Aligned_cols=260 Identities=33% Similarity=0.589 Sum_probs=232.1
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh---hHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ---GLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
++.+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 45567889999999999999999999999999999999987543321 125678999999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC----CeEEeecCCC
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG----NLKVSDFGLS 162 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~----~~kl~DFGla 162 (414)
.+.+|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999987 6799999999999999999999999999999999999999888 7999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP---- 238 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 238 (414)
..... .......+||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.+..+....+......++
T Consensus 167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp EECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eecCc---cccccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 85443 2234556799999999999887775 899999999999999999999999988888888877766655
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..++..+.+||++||+.||.+|||+.|+++||||..
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 468999999999999999999999999999999964
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=403.43 Aligned_cols=254 Identities=37% Similarity=0.705 Sum_probs=203.9
Q ss_pred cccCCEEEe---eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeC
Q 015005 13 ILFGKYEMG---RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATK 88 (414)
Q Consensus 13 ~~~~~y~~~---~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 88 (414)
.+.++|++. +.||+|+||+||+|.+..+++.||+|++.+.. ...+.+|+.+++.+. ||||+++++++.+.
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 345678886 88999999999999999999999999996542 356778999999996 99999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC---CeEEeecCCCcc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG---NLKVSDFGLSAL 164 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~---~~kl~DFGla~~ 164 (414)
...|+||||++||+|.+++.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 999999999999999999987 6799999999999999999999999999999999999998766 799999999985
Q ss_pred cccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH-------HHHHHHHHhcccCC
Q 015005 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI-------MKMYRKIFKAEYEF 237 (414)
Q Consensus 165 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~~ 237 (414)
... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||...+. .+....+..+.+.+
T Consensus 159 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 159 KPP--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp CCC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred cCC--CCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 433 23345567899999999999888875 899999999999999999999987543 46677777777766
Q ss_pred CC----CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 238 PP----WISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 238 ~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+. .+++++.+||++||+.||.+|||+.|+++||||...
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 53 489999999999999999999999999999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=390.13 Aligned_cols=263 Identities=33% Similarity=0.633 Sum_probs=227.1
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 4678899999999999999999999999999999999765432 23577899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999999886 67999999999999999999999999999999999999999999999999999865432222
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHHHhcccCCC--CCCCHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKIFKAEYEFP--PWISCDARRL 248 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~l 248 (414)
......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.. ..+..+.......+ ..+++++.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 33456789999999999988777567899999999999999999999876543 23333433333222 3589999999
Q ss_pred HHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 249 ISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
|.+||+.||.+|||+.|+++||||.+...
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 99999999999999999999999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=423.86 Aligned_cols=261 Identities=37% Similarity=0.671 Sum_probs=229.8
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
...+.++|++.+.||+|+||+||+|.+..+++.||+|++.+...... ....+.+|+.++++++||||+++++++.+...
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 34578899999999999999999999999999999999976543322 25678899999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc---CCCCeEEeecCCCcccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD---ENGNLKVSDFGLSALPE 166 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~---~~~~~kl~DFGla~~~~ 166 (414)
+|+|||||+||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999999998876 8899999999999999999999999999999999999995 45679999999998654
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCCC
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWIS 242 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s 242 (414)
. .......+||+.|+|||++.+. | +.++|||||||++|+|++|..||.+.+..+....+..+.+.++ ..+|
T Consensus 176 ~---~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 176 Q---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp C---C----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred C---CCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 3 3344567899999999999764 6 4899999999999999999999999999888888888776543 3489
Q ss_pred HHHHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 243 CDARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
+++++||++||+.||.+|||+.|+|+||||.+...
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 99999999999999999999999999999986543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=401.85 Aligned_cols=263 Identities=31% Similarity=0.484 Sum_probs=212.0
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
.......++|++.+.||+|+||+||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 33567788999999999999999999999999999999999765432 22345678999999999999999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc-----CCCCeEEeecCCC
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD-----ENGNLKVSDFGLS 162 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~-----~~~~~kl~DFGla 162 (414)
..+|+||||++| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999999999985 99898887 6899999999999999999999999999999999999995 4445999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc--C----
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY--E---- 236 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~---- 236 (414)
..... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+..... .
T Consensus 185 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 75432 223345567899999999998765446899999999999999999999999887766666543210 0
Q ss_pred -----CC-------------------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 237 -----FP-------------------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 237 -----~~-------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+ ..+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 00 1167899999999999999999999999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=389.92 Aligned_cols=256 Identities=33% Similarity=0.595 Sum_probs=220.6
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
-.+.++|++.+.||+|+||+||+|.+..++..||+|++....... ..+.+.+|+++++.++||||+++++++.+....
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 356789999999999999999999999999999999998765332 257788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE---cCCCCeEEeecCCCc
Q 015005 92 FFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSA 163 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl---~~~~~~kl~DFGla~ 163 (414)
|+||||++||+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999988753 579999999999999999999999999999999999999 456789999999998
Q ss_pred ccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC---CC
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP---PW 240 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~ 240 (414)
.... .......+||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.+.......+.......+ ..
T Consensus 176 ~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (285)
T 3is5_A 176 LFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP 250 (285)
T ss_dssp C-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CC
T ss_pred ecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCc
Confidence 6443 233456679999999999864 45 4799999999999999999999999888877777665554443 23
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+++++.+||++||+.||.+|||+.|+++||||++
T Consensus 251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 7899999999999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=421.52 Aligned_cols=257 Identities=39% Similarity=0.679 Sum_probs=224.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..+.++|++.+.||+|+||+||+|++..++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 3456689999999999999999999999999999999987654322 246788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC---CCeEEeecCCCccccc
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN---GNLKVSDFGLSALPEQ 167 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~---~~~kl~DFGla~~~~~ 167 (414)
|+|||||+||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999999998876 789999999999999999999999999999999999999764 4599999999986543
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC----CCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP----WISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~ 243 (414)
.......+||+.|+|||++.+ .|+ .++|||||||++|+|++|..||.+.+..+....+..+.+.++. .+|+
T Consensus 192 ---~~~~~~~~gt~~y~aPE~l~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 192 ---QKKMKERLGTAYYIAPEVLRK-KYD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp ---TBCBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred ---CccccccCCCcCeeCHHHHcc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 234456789999999999874 464 8999999999999999999999999999999998888776542 4899
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
++.+||++||+.||.+|||+.|+|+||||.+
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 9999999999999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=418.50 Aligned_cols=257 Identities=28% Similarity=0.486 Sum_probs=213.0
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK---- 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 88 (414)
.+.++|++++.||+|+||+||+|.+..+++.||||++.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccC-hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 4578999999999999999999999999999999999865332 33457788999999999999999999999654
Q ss_pred --CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 --TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 --~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
..+|+||||++++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 138 ~~~~~~lv~E~~~~~-l~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 138 EFQDVYLVMELMDAN-LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp TCCEEEEEEECCSEE-HHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred cCCeEEEEEeCCCCC-HHHHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 4689999999865 555554 469999999999999999999999999999999999999999999999999998643
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-----------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY----------- 235 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 235 (414)
. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+..+...-.
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 3345667899999999999998886 899999999999999999999999887776666543110
Q ss_pred ----------------C----CCCC-----------CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 236 ----------------E----FPPW-----------ISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 236 ----------------~----~~~~-----------~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
. +|.. .++++.+||++||+.||.+|||++|+|+||||....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 0 0110 156799999999999999999999999999997543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=391.49 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=223.7
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
+|+.+.++|++.+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 57888999999999999999999999999999999999997766555556788999999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.+|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999999999987 78999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-----CCCCCCH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-----FPPWISC 243 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~ 243 (414)
........+||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.+......+......+ .++.+++
T Consensus 165 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 165 -SLTQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred -cccccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 11223456799999999999887775 8899999999999999999999998877665555544332 3456899
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
.+.++|.+||++||.+||+..+.+.+.|.
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 99999999999999999976666666664
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=401.62 Aligned_cols=255 Identities=39% Similarity=0.710 Sum_probs=209.7
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
+.+.++|++.+.||+|+||+||+|.+..+++.||+|++..... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 4567789999999999999999999999999999999976432 35678999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC---CCCeEEeecCCCccccc
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---NGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 167 (414)
|+||||++||+|.+.+.. +.+++.++..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999999887 67999999999999999999999999999999999999975 88999999999986432
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHHHhcccCCC----CCCC
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKIFKAEYEFP----PWIS 242 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~s 242 (414)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...... ..+..+.......+ +.++
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 204 ---QVLMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ---ccccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 2334567899999999999887775 8999999999999999999999776544 46667776655443 3589
Q ss_pred HHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 243 CDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.++.+||++||+.||++|||+.|+++||||...
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=393.93 Aligned_cols=260 Identities=34% Similarity=0.637 Sum_probs=217.9
Q ss_pred ccccCCEEEe-eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 015005 12 NILFGKYEMG-RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT 89 (414)
Q Consensus 12 ~~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 89 (414)
..+.++|++. +.||+|+||+||+|.+..+++.||||++.+.... ..+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3467789995 7899999999999999999999999999765422 246788999999985 7999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC---eEEeecCCCccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN---LKVSDFGLSALP 165 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~---~kl~DFGla~~~ 165 (414)
.+|+||||++||+|.+++.. +.+++.+++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999999987 78999999999999999999999999999999999999998776 999999998754
Q ss_pred cccc-----CCCccccccCCCcccCchhhcc-----cCCCCCccchhhhhhhhhhhhcCCCCCCCch-------------
Q 015005 166 EQLW-----NDGLLHTQCGTPAYVAPEVLRK-----KGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN------------- 222 (414)
Q Consensus 166 ~~~~-----~~~~~~~~~gt~~y~APE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~------------- 222 (414)
.... ........+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 3211 1122345679999999999875 335 478999999999999999999997753
Q ss_pred --HHHHHHHHHhcccCCC----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 223 --IMKMYRKIFKAEYEFP----PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 223 --~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
....+..+..+.+.+| ..+++++.+||++||+.||.+|||+.|+++||||...
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 3445667777777766 3589999999999999999999999999999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=400.62 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=218.9
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-----CCCccceEE
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-----HPNIVELKE 83 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~ 83 (414)
..+..+.++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+|+.+++.+. ||||+++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 346788899999999999999999999999999999999997532 22456778999999986 999999999
Q ss_pred EEEeCCEEEEEEEccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC----------
Q 015005 84 VMATKTKVFFVIEYVKGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---------- 150 (414)
Q Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---------- 150 (414)
++...+..|+||||+ |++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 89999999863 4999999999999999999999999999999999999975
Q ss_pred ---------------CCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCC
Q 015005 151 ---------------NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGF 215 (414)
Q Consensus 151 ---------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~ 215 (414)
++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSS
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCC
Confidence 78999999999985332 23456799999999999988875 8999999999999999999
Q ss_pred CCCCCchHHHHHHHHHhcccCCCC----------------------------------------------CCCHHHHHHH
Q 015005 216 LPFQNENIMKMYRKIFKAEYEFPP----------------------------------------------WISCDARRLI 249 (414)
Q Consensus 216 ~Pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~s~~~~~li 249 (414)
.||...+..+....+.....+.|. ..++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 999988776665554432222221 1236788999
Q ss_pred HhhcccCcCCCCChHHHhcCCccc
Q 015005 250 SRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
++||+.||.+|||+.|+|+||||+
T Consensus 337 ~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999994
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=399.51 Aligned_cols=260 Identities=35% Similarity=0.662 Sum_probs=229.2
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc-----hhhHHHHHHHHHHHHHhC-CCCCccceEEE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-----KQGLMEQIKREISVMRLV-KHPNIVELKEV 84 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 84 (414)
...+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 345668899999999999999999999999999999999765421 122356788999999999 79999999999
Q ss_pred EEeCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 85 MATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
+...+..|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 9999999999999999999999987 789999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCCCccccccCCCcccCchhhccc------CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCC
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKK------GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF 237 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (414)
.... .......+||+.|+|||++.+. .+ +.++|||||||++|+|++|..||...+.......+..+.+.+
T Consensus 249 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 249 HLEP---GEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp ECCT---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ccCC---CcccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 5442 2334567899999999998643 34 478999999999999999999999988888888887776655
Q ss_pred C----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 238 P----PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 238 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+ ..++.++.+||.+||+.||.+|||+.|+++||||.+
T Consensus 325 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 325 SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 4 358899999999999999999999999999999963
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=399.79 Aligned_cols=257 Identities=28% Similarity=0.491 Sum_probs=211.0
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++.+.||+|+||+||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 478999999999999999999999999999999997544221 112345799999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||++ |+|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~ 155 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 155 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence 99998 588888775 4599999999999999999999999999999999999999999999999999975432 223
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-----------------
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY----------------- 235 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------------- 235 (414)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 344567899999999998754445899999999999999999999999887776665543110
Q ss_pred -------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 236 -------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 236 -------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
..++.+++++.+||++||+.||.+|||++|+++||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 01124688999999999999999999999999999997643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=403.22 Aligned_cols=255 Identities=30% Similarity=0.513 Sum_probs=223.9
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh-----hHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ-----GLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3467899999999999999999999999999999999987653221 12345678999999999999999999999
Q ss_pred eCCEEEEEEEccCCC-chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 87 TKTKVFFVIEYVKGG-ELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg-~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
+.+.+|+||||+.+| +|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999999776 99999987 6899999999999999999999999999999999999999999999999999985
Q ss_pred cccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHH
Q 015005 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCD 244 (414)
Q Consensus 165 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 244 (414)
... .......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .........|..++++
T Consensus 180 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 180 LER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKE 250 (335)
T ss_dssp CCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHH
T ss_pred CCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHH
Confidence 432 3344567899999999999988886688999999999999999999997633 2233445566778999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 245 ARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+.+||.+||++||.+|||+.++++||||.+.
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=404.18 Aligned_cols=254 Identities=32% Similarity=0.574 Sum_probs=220.0
Q ss_pred ccCCEEE--eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 14 LFGKYEM--GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 14 ~~~~y~~--~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..+.|.+ .+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 3445666 67899999999999999999999999999875432 246788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE--cCCCCeEEeecCCCccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL--DENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl--~~~~~~kl~DFGla~~~~~ 167 (414)
|+||||++||+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999999999998875 469999999999999999999999999999999999999 5677899999999986543
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 243 (414)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+......++ +.+++
T Consensus 242 ---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 242 ---REKLKVNFGTPEFLAPEVVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp ---TCBCCCCCSSCTTCCHHHHTTCBCC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred ---ccccccccCCCcEeChhhccCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 2334456799999999999877664 799999999999999999999999988888888887766554 35899
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
++.+||.+||+.||.+|||+.|+++||||..
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 9999999999999999999999999999965
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=400.67 Aligned_cols=261 Identities=34% Similarity=0.564 Sum_probs=222.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc--hhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK--KQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3567899999999999999999999999999999999865432 23346789999999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 015005 91 VFFVIEYVKGGELFAKVLK-----------------------------------------GKLKEESARKYFQQLISAVD 129 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-----------------------------------------~~~~e~~~~~~~~ql~~al~ 129 (414)
.|+||||++||+|.+.+.. ..+++..++.++.|++.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999998851 12467889999999999999
Q ss_pred HHHhCCcEEecCCCCcEEEcCCC--CeEEeecCCCcccccccCC--CccccccCCCcccCchhhcc--cCCCCCccchhh
Q 015005 130 FCHSRGVYHRDLKPENLLLDENG--NLKVSDFGLSALPEQLWND--GLLHTQCGTPAYVAPEVLRK--KGYDGAKSDIWS 203 (414)
Q Consensus 130 ~lH~~gi~HrDlkp~NILl~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~--~~~~~~~~DiwS 203 (414)
|||++||+||||||+|||++.++ .+||+|||++......... ......+||+.|+|||++.+ ..+ +.++||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~Diws 261 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWS 261 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC-CTHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC-CcHHHHHH
Confidence 99999999999999999998776 8999999999864332111 13456679999999999975 344 58999999
Q ss_pred hhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC----CCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 204 CGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP----WISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 204 lGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
|||++|+|++|..||.+.+..+....+......++. .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 999999999999999998888888888777655442 37999999999999999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=407.52 Aligned_cols=252 Identities=34% Similarity=0.631 Sum_probs=210.5
Q ss_pred cccCCEEEe-eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHH-hCCCCCccceEEEEEe---
Q 015005 13 ILFGKYEMG-RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVKHPNIVELKEVMAT--- 87 (414)
Q Consensus 13 ~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~--- 87 (414)
.+.++|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|+.++. ..+||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 456778887 7999999999999999999999999999642 34668888874 4589999999999976
Q ss_pred -CCEEEEEEEccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC---CCCeEEeecC
Q 015005 88 -KTKVFFVIEYVKGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---NGNLKVSDFG 160 (414)
Q Consensus 88 -~~~~~lv~E~~~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---~~~~kl~DFG 160 (414)
...+|+||||++||+|.+++... .+++.+++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 66899999999999999999862 5999999999999999999999999999999999999997 7899999999
Q ss_pred CCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH----HHHHHHHhcccC
Q 015005 161 LSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM----KMYRKIFKAEYE 236 (414)
Q Consensus 161 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~ 236 (414)
++..... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+.. .....+..+.+.
T Consensus 210 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 210 FAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred cccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 9985432 2344577899999999999888885 8999999999999999999999875432 244556666665
Q ss_pred CC----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 237 FP----PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 237 ~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
+| ..++.++.+||++||+.||.+|||+.|+++||||....
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 54 35899999999999999999999999999999997643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=402.02 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=215.5
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK---- 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 88 (414)
.+.++|++.+.||+|+||+||+|.+..+|+.||||.+..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 356789999999999999999999999999999999966432 233457789999999999999999999999765
Q ss_pred --CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 --TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 --~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
..+|+||||+ |++|.+++..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3569999999 8899999988999999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-----------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY----------- 235 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 235 (414)
. .....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.....
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 234567999999999998743335899999999999999999999999887766655543110
Q ss_pred --------------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 236 --------------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 236 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..++.+++++.+||.+||+.||.+|||+.|+++||||..-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 1224578999999999999999999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=399.01 Aligned_cols=264 Identities=27% Similarity=0.447 Sum_probs=223.7
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT- 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 89 (414)
...+.++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 4678899999999999999999999999999999999998766555556678999999999999999999999987654
Q ss_pred ---EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 90 ---KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 90 ---~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
..|+||||++|++|.+++.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 45999999999999999986 78999999999999999999999999999999999999999999999999999865
Q ss_pred ccccC-CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CC
Q 015005 166 EQLWN-DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PW 240 (414)
Q Consensus 166 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~ 240 (414)
..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...............+ ..
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 43211 1223445799999999999888775 799999999999999999999999888777666665544332 45
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++.++.+||.+||+.||.+||++.+++.|+|+...
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 89999999999999999999999999999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=392.57 Aligned_cols=263 Identities=33% Similarity=0.612 Sum_probs=228.3
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch-hhHHHHHHHHHHHHHhCCCCCccceEEEE--EeCCE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK-QGLMEQIKREISVMRLVKHPNIVELKEVM--ATKTK 90 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~~ 90 (414)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.+..... ....+.+.+|+.+++.++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 5789999999999999999999999999999999998754332 23457789999999999999999999998 44568
Q ss_pred EEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
.|+||||++++ |.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999999977 5555553 5799999999999999999999999999999999999999999999999999986544
Q ss_pred ccCCCccccccCCCcccCchhhcccC-CCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKG-YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDAR 246 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 246 (414)
...........||+.|+|||++.+.. +.+.++||||||+++|+|++|..||.+.+.......+..+.+.+|..+++++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 33344455667999999999997643 23468999999999999999999999999888888888888889999999999
Q ss_pred HHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 247 RLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
+||.+||+.||.+|||+.|+++||||.+...
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 9999999999999999999999999987544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=384.03 Aligned_cols=258 Identities=34% Similarity=0.624 Sum_probs=226.1
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh---hHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ---GLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 345789999999999999999999999999999999987544321 12567899999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC----CeEEeecCCCcc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG----NLKVSDFGLSAL 164 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~----~~kl~DFGla~~ 164 (414)
..|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999999976 7899999999999999999999999999999999999998877 899999999975
Q ss_pred cccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CC
Q 015005 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PW 240 (414)
Q Consensus 165 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~ 240 (414)
... ........||+.|+|||++.+..+. .++||||||+++|+|++|..||...+..+....+.......+ +.
T Consensus 162 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 162 IEA---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp CC-----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ccC---CCcccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 432 2233456799999999999887775 899999999999999999999999888888887777665554 46
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
++..+.+||.+||+.||.+|||+.++++||||..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 8899999999999999999999999999999965
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=397.60 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=219.3
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe------
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT------ 87 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 87 (414)
..++|++.+.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 4689999999999999999999999999999999997654332 223567799999999999999999999987
Q ss_pred --CCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 88 --KTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 88 --~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
.+.+|+||||++| +|.+.+.. ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4579999999985 66666665 679999999999999999999999999999999999999999999999999997
Q ss_pred cccccc--CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCC-
Q 015005 164 LPEQLW--NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW- 240 (414)
Q Consensus 164 ~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~- 240 (414)
...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......++.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 644221 22334566799999999999875544689999999999999999999999988877766654422222111
Q ss_pred -------------------------------CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 241 -------------------------------ISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 241 -------------------------------~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.++++.+||.+||+.||.+|||++|+++||||....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 267799999999999999999999999999997643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=390.03 Aligned_cols=256 Identities=38% Similarity=0.708 Sum_probs=226.6
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence 456788999999999999999999999999999999998654322 35688999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE---cCCCCeEEeecCCCccccc
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 167 (414)
|+||||++|++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999999998876 789999999999999999999999999999999999999 7788999999999975332
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 243 (414)
......+||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+..+.+.++ ..+++
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 162 ----GIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp ----BTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred ----CccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 234456799999999999887775 899999999999999999999999888888888877765443 45899
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++.+||.+||+.||.+|||+.|+++||||...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=392.12 Aligned_cols=256 Identities=22% Similarity=0.362 Sum_probs=210.1
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHh-CCCCCccceEEEEEe
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL-VKHPNIVELKEVMAT 87 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 87 (414)
..++.+.++|++.+.||+|+||+||+|.+..+|+.||||++......... ......|+..+.. .+||||+++++++.+
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 34566678999999999999999999999999999999998765443332 2344455555544 499999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
.+.+|+||||+ +++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999999999 6688887775 56999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc--CCCCCCCH
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY--EFPPWISC 243 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~ 243 (414)
.. .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..|+..... +..+..+.. .++..+++
T Consensus 208 ~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 279 (311)
T 3p1a_A 208 GT---AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSS 279 (311)
T ss_dssp C---------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCH
T ss_pred cc---CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCH
Confidence 32 233455679999999999886 56 4899999999999999999766655433 222332222 23456899
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
++.+||.+||++||.+|||+.|+++||||++
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=394.60 Aligned_cols=260 Identities=28% Similarity=0.420 Sum_probs=218.3
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
-...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 34578999999999999999999999999999999999765433 23356678999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+||||+++++|.++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--P 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC--C
Confidence 999999999999888765 7899999999999999999999999999999999999999999999999999975443 2
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc----------------
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE---------------- 234 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---------------- 234 (414)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 2334566799999999999876444689999999999999999999999887665554443210
Q ss_pred ---cCC------------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 235 ---YEF------------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 235 ---~~~------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
... .+.+++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 011 1247889999999999999999999999999999965
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=382.44 Aligned_cols=261 Identities=36% Similarity=0.628 Sum_probs=228.4
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeecccc------chhhHHHHHHHHHHHHHhCC-CCCccceEE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV------KKQGLMEQIKREISVMRLVK-HPNIVELKE 83 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~ 83 (414)
...+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+.+|+.+++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 45678999999999999999999999999999999999976531 11223567889999999995 999999999
Q ss_pred EEEeCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 84 VMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
++......|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999999987 78999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhc------ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLR------KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE 236 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 236 (414)
..... .......+||+.|+|||++. ...+ +.++||||||+++|+|++|..||...+.......+..+...
T Consensus 172 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 172 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred hhcCC---CcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence 75432 23345667999999999986 2334 47999999999999999999999998888888888777665
Q ss_pred CC----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 237 FP----PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 237 ~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++ ..++.++.+||.+||+.||.+|||+.|+++||||.+.
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 54 2478999999999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=394.11 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=222.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||+|+||+||+|.+..+++.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999999999999999999876554444567889999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||+. |+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 99998 577777653 6899999999999999999999999999999999999999999999999999985432
Q ss_pred ccccccCCCcccCchhhc---ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC--CCCCCCHHHHH
Q 015005 173 LLHTQCGTPAYVAPEVLR---KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE--FPPWISCDARR 247 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~ 247 (414)
....+||+.|+|||++. ...+ +.++|||||||++|+|++|..||...+.......+.....+ .+..++..+.+
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 284 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 284 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred -CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 23567999999999985 3445 47999999999999999999999988776666666555433 23468999999
Q ss_pred HHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 248 LISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
||.+||+.||++|||++++++||||.+..
T Consensus 285 li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 285 FVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 99999999999999999999999997654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=397.51 Aligned_cols=260 Identities=26% Similarity=0.451 Sum_probs=220.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----C
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK-----T 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 89 (414)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 4799999999999999999999999999999999975432 23457788999999999999999999999765 4
Q ss_pred EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
..|+||||+. |+|.+.+..+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred eEEEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 7999999997 599999988999999999999999999999999999999999999999999999999999998654322
Q ss_pred C-CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--------------
Q 015005 170 N-DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE-------------- 234 (414)
Q Consensus 170 ~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------- 234 (414)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 2234556899999999997665544589999999999999999999998876655544443210
Q ss_pred --------c---------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 235 --------Y---------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 235 --------~---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
. ..++.+++++.+||.+||+.||.+|||+.|+++||||.+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 0 012457899999999999999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=411.37 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=198.1
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe-----C
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT-----K 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~ 88 (414)
+.++|++.+.||+|+||+||+|.+..+++.||||++.+... .....+.+.+|+.+|+.++||||+++++++.. .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 45789999999999999999999999999999999965432 23345778999999999999999999999943 3
Q ss_pred CEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
..+|+||||+ +|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 5799999998 5789888887 6799999999999999999999999999999999999999999999999999986542
Q ss_pred ccCC-------------------------CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc---------
Q 015005 168 LWND-------------------------GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS--------- 213 (414)
Q Consensus 168 ~~~~-------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~--------- 213 (414)
.... ......+||+.|+|||++......+.++|||||||++|+|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 2111 134556899999999987544433589999999999999998
Q ss_pred --CCCCCCCchH--------------------HHHHHHHHh--cc-----------------------------cCCCCC
Q 015005 214 --GFLPFQNENI--------------------MKMYRKIFK--AE-----------------------------YEFPPW 240 (414)
Q Consensus 214 --g~~Pf~~~~~--------------------~~~~~~i~~--~~-----------------------------~~~~~~ 240 (414)
|..||.+.+. ......+.. +. ....+.
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 6777766431 111111111 00 001234
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+++++.+||++||..||.+|||++|+|+||||..-
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 68999999999999999999999999999999764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=380.30 Aligned_cols=254 Identities=19% Similarity=0.285 Sum_probs=215.8
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 90 (414)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++........ ....+.+|+..+..+ +||||+++++++.+.+.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 3456789999999999999999999999999999999986543322 346788999999999 99999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC--------------
Q 015005 91 VFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN-------------- 151 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~-------------- 151 (414)
.|+||||++|++|.+++.. +.+++.+++.++.|++.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999999875 569999999999999999999999999999999999999844
Q ss_pred -----CCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHH
Q 015005 152 -----GNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKM 226 (414)
Q Consensus 152 -----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~ 226 (414)
..+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++|..|+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred ccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 4799999999985432 22346999999999998764445789999999999999999988766543
Q ss_pred HHHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 227 YRKIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 227 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
...+..+. ...|..+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 23333333 35677899999999999999999999999999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=404.23 Aligned_cols=261 Identities=27% Similarity=0.402 Sum_probs=209.1
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK---- 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 88 (414)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 457899999999999999999999999999999999975432 233457889999999999999999999999776
Q ss_pred -CEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 -TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 -~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
..+|+||||+. |+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 57999999996 599999987 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCC--------------------CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCC----------
Q 015005 167 QLWND--------------------GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFL---------- 216 (414)
Q Consensus 167 ~~~~~--------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~---------- 216 (414)
..... ......+||+.|+|||++......+.++|||||||++|+|++|..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 32111 234677899999999997544434589999999999999998544
Q ss_pred -CCCCch-----------------HHHHHHHHHh------------------------cccCC-------CCCCCHHHHH
Q 015005 217 -PFQNEN-----------------IMKMYRKIFK------------------------AEYEF-------PPWISCDARR 247 (414)
Q Consensus 217 -Pf~~~~-----------------~~~~~~~i~~------------------------~~~~~-------~~~~s~~~~~ 247 (414)
+|.+.+ .......+.. ..... .+.+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 443322 1111111110 00111 1358999999
Q ss_pred HHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 248 LISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
||++||+.||.+|||++|+|+||||..-
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=383.43 Aligned_cols=259 Identities=27% Similarity=0.471 Sum_probs=230.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
......|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 345567999999999999999999999999999999997665432 357889999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 92 FFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
|+||||++|++|.+++..+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 96 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 173 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--Q 173 (303)
T ss_dssp EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--B
T ss_pred EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--c
Confidence 99999999999999998899999999999999999999999999999999999999999999999999999754431 2
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLIS 250 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 250 (414)
.......||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+..... ..+..++..+.+||.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 252 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 252 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHH
T ss_pred cccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHH
Confidence 233456799999999999887775 799999999999999999999998877766666554443 456678999999999
Q ss_pred hhcccCcCCCCChHHHhcCCccccC
Q 015005 251 RILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+||+.||.+|||+.++++||||.+.
T Consensus 253 ~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 253 ACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred HHcCCChhhCcCHHHHhhChhhhcC
Confidence 9999999999999999999999764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=396.09 Aligned_cols=261 Identities=28% Similarity=0.434 Sum_probs=214.8
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch--hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK--QGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
...++|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 45688999999999999999999999999999999997643322 1123467899999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.|+||||+++ +|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~- 164 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS- 164 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS-
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC-
Confidence 9999999986 78887776 4699999999999999999999999999999999999999999999999999986543
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-----CC------
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-----EF------ 237 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-----~~------ 237 (414)
........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+..... .+
T Consensus 165 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 165 -PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp -CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred -CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 223345678999999999997655445889999999999999999999999888777766654210 00
Q ss_pred -----------------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 238 -----------------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 238 -----------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
...++.++.+||++||+.||.+|||+.|+++||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 134578999999999999999999999999999997653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=392.06 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=210.1
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT---- 89 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 89 (414)
+.++|++.+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 56789999999999999999999999999999999976542 234578899999999999999999999986543
Q ss_pred -----------------------------------------------------EEEEEEEccCCCchHHHHhcC----CC
Q 015005 90 -----------------------------------------------------KVFFVIEYVKGGELFAKVLKG----KL 112 (414)
Q Consensus 90 -----------------------------------------------------~~~lv~E~~~gg~L~~~i~~~----~~ 112 (414)
.+|+|||||+||+|.+++... ..
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 389999999999999999862 35
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC----------CCccccccCCCc
Q 015005 113 KEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN----------DGLLHTQCGTPA 182 (414)
Q Consensus 113 ~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~----------~~~~~~~~gt~~ 182 (414)
++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ .......+||+.
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 6677999999999999999999999999999999999999999999999986543211 122345679999
Q ss_pred ccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-CCCCCCHHHHHHHHhhcccCcCCCC
Q 015005 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE-FPPWISCDARRLISRILVADPQKRI 261 (414)
Q Consensus 183 y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~ 261 (414)
|+|||++.+..++ .++|||||||++|+|++|..|+.. .......+.....+ .+...++++.+||.+||+.||.+||
T Consensus 242 y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 242 YMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp GSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred ccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence 9999999988775 899999999999999999777532 22223333333222 1133578899999999999999999
Q ss_pred ChHHHhcCCcccc
Q 015005 262 SVSEIMINPWFIK 274 (414)
Q Consensus 262 s~~eil~hp~f~~ 274 (414)
|+.|+++||||.+
T Consensus 319 s~~~~l~~~~f~~ 331 (332)
T 3qd2_B 319 EATDIIENAIFEN 331 (332)
T ss_dssp CHHHHHHSTTCCC
T ss_pred CHHHHhhchhhhc
Confidence 9999999999964
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=390.44 Aligned_cols=260 Identities=28% Similarity=0.511 Sum_probs=225.2
Q ss_pred hccccCCEEEe-eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 015005 11 RNILFGKYEMG-RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATK 88 (414)
Q Consensus 11 ~~~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 88 (414)
.+.+.++|.+. +.||+|+||+||+|.+..+++.||+|++.+..... .....+.+|+.+++.+ .||||+++++++.+.
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 45677889998 89999999999999999999999999998654332 2356788999999999 579999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC---CCCeEEeecCCC
Q 015005 89 TKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---NGNLKVSDFGLS 162 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---~~~~kl~DFGla 162 (414)
..+|+||||++||+|.+++.. +.+++.+++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 999999999999999999864 67999999999999999999999999999999999999997 789999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP---- 238 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 238 (414)
..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.......+
T Consensus 182 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 257 (327)
T 3lm5_A 182 RKIGH---ACELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF 257 (327)
T ss_dssp EEC------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred cccCC---ccccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh
Confidence 86542 2234556799999999999888775 899999999999999999999999888888777766554433
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..+++.+.+||.+||+.||.+|||++++++||||...
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 3588999999999999999999999999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=398.09 Aligned_cols=251 Identities=29% Similarity=0.422 Sum_probs=211.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe-----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT----- 87 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 87 (414)
...++|++.+.||+|+||+||+|.+..+|+.||+|++...... ..+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4567899999999999999999999999999999999755322 2379999999999999999999843
Q ss_pred ---------------------------------CCEEEEEEEccCCCchHHHHh----c-CCCCHHHHHHHHHHHHHHHH
Q 015005 88 ---------------------------------KTKVFFVIEYVKGGELFAKVL----K-GKLKEESARKYFQQLISAVD 129 (414)
Q Consensus 88 ---------------------------------~~~~~lv~E~~~gg~L~~~i~----~-~~~~e~~~~~~~~ql~~al~ 129 (414)
...+++||||++| +|.+.+. . +.+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 6665554 2 67999999999999999999
Q ss_pred HHHhCCcEEecCCCCcEEEc-CCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhh
Q 015005 130 FCHSRGVYHRDLKPENLLLD-ENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVL 208 (414)
Q Consensus 130 ~lH~~gi~HrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil 208 (414)
|||++||+||||||+|||++ .++.+||+|||++..... .......+||+.|+|||++.+....+.++||||+||++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999999998 688999999999985432 23345667899999999998765445899999999999
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHhc-----------------cc------------CCCCCCCHHHHHHHHhhcccCcCC
Q 015005 209 FVLLSGFLPFQNENIMKMYRKIFKA-----------------EY------------EFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 209 ~~ll~g~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
|+|++|..||.+.+..+....+... .. .+|..+++++.+||++||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999998877666655431 00 134568899999999999999999
Q ss_pred CCChHHHhcCCcccc
Q 015005 260 RISVSEIMINPWFIK 274 (414)
Q Consensus 260 R~s~~eil~hp~f~~ 274 (414)
|||+.|+++||||..
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999965
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=392.24 Aligned_cols=260 Identities=26% Similarity=0.449 Sum_probs=214.3
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--CCccceEEEEEeCC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH--PNIVELKEVMATKT 89 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~ 89 (414)
.+..++|++.+.||+|+||+||+|.+ .+++.||+|++....... ...+.+.+|+.+++.++| |||+++++++.+..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccch-HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 34567899999999999999999987 568899999998665432 345778999999999976 99999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.+|+||| +.+++|.+++.. +.+++.++..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999999 567899999987 7899999999999999999999999999999999999996 688999999999866543
Q ss_pred cCCCccccccCCCcccCchhhcc-----------cCCCCCccchhhhhhhhhhhhcCCCCCCCch-HHHHHHHHHh--cc
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRK-----------KGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-IMKMYRKIFK--AE 234 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~--~~ 234 (414)
.........+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.... .......+.. ..
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 23333456789999999999865 334 478999999999999999999998743 2333444443 33
Q ss_pred cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 235 YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
..+|...+.++.+||.+||+.||.+|||+.|+++||||....
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 456777889999999999999999999999999999997643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=403.87 Aligned_cols=258 Identities=24% Similarity=0.409 Sum_probs=216.0
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC------CCCCccceEEE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV------KHPNIVELKEV 84 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~ 84 (414)
++.+.++|++.+.||+|+||+||+|.+..+++.||||++..... ....+.+|+.+++.+ +||||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR----FHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc----hHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 45677899999999999999999999999999999999976432 245677888888876 57899999999
Q ss_pred EEeCCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC--eEEeec
Q 015005 85 MATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN--LKVSDF 159 (414)
Q Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~--~kl~DF 159 (414)
+.....+|+||||+. ++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999999996 588888876 34999999999999999999999999999999999999999887 999999
Q ss_pred CCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc----
Q 015005 160 GLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY---- 235 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---- 235 (414)
|++.... ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 247 G~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 247 GSSCYEH-----QRVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp TTCEETT-----CCCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccceecC-----CcccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9997432 234467899999999999988885 899999999999999999999999877666554432100
Q ss_pred ----------------C---------------------------------------CCCCCCHHHHHHHHhhcccCcCCC
Q 015005 236 ----------------E---------------------------------------FPPWISCDARRLISRILVADPQKR 260 (414)
Q Consensus 236 ----------------~---------------------------------------~~~~~s~~~~~li~~~L~~dp~~R 260 (414)
. ++...++++.+||++||+.||.+|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 0 011237789999999999999999
Q ss_pred CChHHHhcCCccccCCCCC
Q 015005 261 ISVSEIMINPWFIKGFSKP 279 (414)
Q Consensus 261 ~s~~eil~hp~f~~~~~~~ 279 (414)
||+.|+|+||||++..+.+
T Consensus 401 pta~e~L~Hpw~~~~~~~~ 419 (429)
T 3kvw_A 401 MTPGQALRHPWLRRRLPKP 419 (429)
T ss_dssp CCHHHHHTSTTTC------
T ss_pred CCHHHHhCChhhccCCCCC
Confidence 9999999999998865543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=392.39 Aligned_cols=266 Identities=28% Similarity=0.424 Sum_probs=221.5
Q ss_pred hHhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 7 DERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 7 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
+......+.++|++.+.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.
T Consensus 2 p~~~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 79 (353)
T 2b9h_A 2 PKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHENIITIFNIQR 79 (353)
T ss_dssp CTTCCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CcccccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc--chHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence 344567788999999999999999999999999999999999964332 233567889999999999999999999986
Q ss_pred eC-----CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCC
Q 015005 87 TK-----TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL 161 (414)
Q Consensus 87 ~~-----~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGl 161 (414)
.. ...|+||||+. |+|.+.+..+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CSCSTTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccCccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 54 67999999997 6899999888999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCC--------CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc
Q 015005 162 SALPEQLWND--------GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA 233 (414)
Q Consensus 162 a~~~~~~~~~--------~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 233 (414)
+......... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 9865422111 11234579999999999876444458999999999999999999999988766554433210
Q ss_pred ------------------------ccC--------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 ------------------------EYE--------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 ------------------------~~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
... .++.+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000 123578999999999999999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=385.45 Aligned_cols=264 Identities=28% Similarity=0.441 Sum_probs=216.3
Q ss_pred hhHhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEE
Q 015005 6 MDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVM 85 (414)
Q Consensus 6 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 85 (414)
+.....++..++|++.+.||+|+||+||+|.+ +|+.||+|++....... ...+.+.+|+.++++++||||+++++++
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34444567788999999999999999999985 68899999997665432 3356788999999999999999999999
Q ss_pred EeCCEEEEEEEccCCCchHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCC--cEEecCCCCcEEEcCCCCeEEeec
Q 015005 86 ATKTKVFFVIEYVKGGELFAKVLKGK----LKEESARKYFQQLISAVDFCHSRG--VYHRDLKPENLLLDENGNLKVSDF 159 (414)
Q Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~~~~----~~e~~~~~~~~ql~~al~~lH~~g--i~HrDlkp~NILl~~~~~~kl~DF 159 (414)
.+...+|+||||++||+|.+++.... +++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999999998733 999999999999999999999999 999999999999999999999999
Q ss_pred CCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHH--hcccCC
Q 015005 160 GLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF--KAEYEF 237 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~--~~~~~~ 237 (414)
|++..... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+. ......
T Consensus 184 g~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T 3p86_A 184 GLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260 (309)
T ss_dssp C-------------------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred CCCccccc--cccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 99975432 22234556799999999999988775 89999999999999999999999988777766653 344567
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhc--CCccccC
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMI--NPWFIKG 275 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~f~~~ 275 (414)
|..+++++.+||.+||+.||.+|||+.++++ ++++...
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 7889999999999999999999999999987 4555443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=395.64 Aligned_cols=262 Identities=24% Similarity=0.424 Sum_probs=223.7
Q ss_pred hHhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 7 DERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 7 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
...+++...++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 101 (360)
T 3eqc_A 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFY 101 (360)
T ss_dssp HHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred hhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--HHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence 345567888999999999999999999999999999999999976532 234577899999999999999999999999
Q ss_pred eCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
+.+..|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred ECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999999999987 7899999999999999999999996 999999999999999999999999999975
Q ss_pred cccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHH----------------
Q 015005 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYR---------------- 228 (414)
Q Consensus 165 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~---------------- 228 (414)
... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+......
T Consensus 182 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 182 LID----SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp HHH----HC----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred ccc----ccccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 432 123456799999999999888775 89999999999999999999998765443221
Q ss_pred --------------------------HHHhccc-CCC-CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 229 --------------------------KIFKAEY-EFP-PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 229 --------------------------~i~~~~~-~~~-~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+..... ..+ ..++.++.+||++||+.||.+|||+.|+++||||...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 1222221 122 2378899999999999999999999999999999763
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=376.70 Aligned_cols=253 Identities=23% Similarity=0.463 Sum_probs=218.0
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe----CCE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT----KTK 90 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 90 (414)
...|++.+.||+|+||+||+|.+..++..||+|++....... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 345899999999999999999999999999999998665443 335778999999999999999999999876 467
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEEecCCCCcEEEc-CCCCeEEeecCCCcccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRG--VYHRDLKPENLLLD-ENGNLKVSDFGLSALPE 166 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~g--i~HrDlkp~NILl~-~~~~~kl~DFGla~~~~ 166 (414)
+|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999999987 88999999999999999999999999 99999999999998 78999999999997433
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch-HHHHHHHHHhccc--CCCCCCCH
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-IMKMYRKIFKAEY--EFPPWISC 243 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~--~~~~~~s~ 243 (414)
.......+||+.|+|||++.+. + +.++||||||+++|+|++|..||.... ....+..+..+.. .++...++
T Consensus 184 ----~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 184 ----ASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ----ccccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 2334566799999999998753 5 489999999999999999999998744 4444444444322 34456789
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
++.+||.+||+.||.+|||+.|+++||||..
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=394.83 Aligned_cols=261 Identities=32% Similarity=0.573 Sum_probs=224.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccc-hhhHHHHHHHHHHHHHhC-CCCCccceEEEEEe
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVK-KQGLMEQIKREISVMRLV-KHPNIVELKEVMAT 87 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 87 (414)
.-.++|++.+.||+|+||+||+|++. .+++.||||++.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 44579999999999999999999984 58999999999765431 112234567899999999 79999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
.+.+|+||||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999999987 789999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccCchhhccc-CCCCCccchhhhhhhhhhhhcCCCCCCCc----hHHHHHHHHHhcccCCCCCC
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKK-GYDGAKSDIWSCGVVLFVLLSGFLPFQNE----NIMKMYRKIFKAEYEFPPWI 241 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~ 241 (414)
.. ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ......+.+......+|..+
T Consensus 211 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 211 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 21 12233456899999999999853 22347899999999999999999999753 34556667777788888899
Q ss_pred CHHHHHHHHhhcccCcCCCC-----ChHHHhcCCcccc
Q 015005 242 SCDARRLISRILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
+..+.+||.+||+.||.+|| |+.|+++||||.+
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 99999999999999999999 9999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=405.01 Aligned_cols=258 Identities=36% Similarity=0.677 Sum_probs=210.7
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch-----hhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK-----QGLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++.+..... ......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456789999999999999999999999999999999998764321 112235789999999999999999999986
Q ss_pred eCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC---CeEEeecCCC
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG---NLKVSDFGLS 162 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~---~~kl~DFGla 162 (414)
. ...|+||||++||+|.+.+.. +.+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4 568999999999999998876 7899999999999999999999999999999999999997554 5999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcc---cCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHHHhcccCCC
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRK---KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKIFKAEYEFP 238 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~ 238 (414)
..... .......+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||...... .....+..+...++
T Consensus 290 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 290 KILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp TSCC--------------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred eecCC---CccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence 86542 334456789999999999864 344 47899999999999999999999865432 34445555555443
Q ss_pred ----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 239 ----PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 239 ----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..+++++.+||.+||+.||.+|||++|+++||||..
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 358999999999999999999999999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=397.15 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=214.7
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC--CCCccceEEEEEeCCEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK--HPNIVELKEVMATKTKVF 92 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~ 92 (414)
..+|++.+.||+|+||+||+|.+.. ++.||||++...... ....+.+.+|+.+++.++ ||||+++++++...+.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 4569999999999999999999764 899999999876543 234578899999999996 599999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+||| +.+++|.+++.. +.+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.........
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9999 568899999887 7899999999999999999999999999999999999995 689999999999865433222
Q ss_pred CccccccCCCcccCchhhccc----------CCCCCccchhhhhhhhhhhhcCCCCCCCch-HHHHHHHHHhcc--cCCC
Q 015005 172 GLLHTQCGTPAYVAPEVLRKK----------GYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-IMKMYRKIFKAE--YEFP 238 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~----------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~--~~~~ 238 (414)
......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+.... ..+|
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence 334567899999999998752 123478999999999999999999998743 334445555433 4567
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+.+.++.+||.+||+.||.+|||+.|+++||||...
T Consensus 291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 7789999999999999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=395.57 Aligned_cols=256 Identities=28% Similarity=0.482 Sum_probs=209.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC---
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT--- 89 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 89 (414)
.+.++|++.+.||+|+||+||+|.+..+++.||||++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 4578999999999999999999999999999999999765432 234567889999999999999999999997665
Q ss_pred ---EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 90 ---KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 90 ---~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
.+|+||||++| +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 89999999975 6777765 579999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-----------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY----------- 235 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 235 (414)
. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 2234556899999999999988775 899999999999999999999999887776666543211
Q ss_pred -----------CC--------------CC------CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 236 -----------EF--------------PP------WISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 236 -----------~~--------------~~------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+ |. ..+.++.+||++||+.||.+|||++|+++||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 00 00 015678999999999999999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=399.14 Aligned_cols=256 Identities=32% Similarity=0.464 Sum_probs=212.3
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
..++...++|++.+.||+|+||+||+|.+..+++ +|+|.+...... ..+|+++++.++||||+++++++...
T Consensus 33 ~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp SSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEec
Confidence 3456777899999999999999999999877766 888887654322 23799999999999999999999654
Q ss_pred C------EEEEEEEccCCCchHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc-CCCCeEEe
Q 015005 89 T------KVFFVIEYVKGGELFAKVL----KGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD-ENGNLKVS 157 (414)
Q Consensus 89 ~------~~~lv~E~~~gg~L~~~i~----~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~-~~~~~kl~ 157 (414)
. .+|+||||++++.+..... .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~ 184 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI 184 (394)
T ss_dssp SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEe
Confidence 3 4899999998765443322 36899999999999999999999999999999999999999 78999999
Q ss_pred ecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc----
Q 015005 158 DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA---- 233 (414)
Q Consensus 158 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---- 233 (414)
|||+++.... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 185 DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 185 DFGSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp CCTTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eCCCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999985432 233446678999999999977654458999999999999999999999998877666555431
Q ss_pred -------------cc------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 -------------EY------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 -------------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.. .+++.+++++.+||.+||+.||.+|||+.|+++||||..-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 00 1234588999999999999999999999999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=396.07 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=202.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK---- 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 88 (414)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 3458999999999999999999999999999999999764322 23456788999999999999999999999754
Q ss_pred --CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 --TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 --~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
..+|++||++ +++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 7899999888899999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc------------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE------------ 234 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 234 (414)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 23456799999999999874444589999999999999999999999988766665543310
Q ss_pred -----------cCC--------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 235 -----------YEF--------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 235 -----------~~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
... .+..++++.+||++||+.||.+|||+.|+|+||||...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 001 12468899999999999999999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=379.68 Aligned_cols=261 Identities=36% Similarity=0.665 Sum_probs=229.4
Q ss_pred HhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 8 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
...+..+.++|++.+.||+|+||+||+|.+..+++.||+|++....... ...+.+.+|+.++++++||||+++++++.+
T Consensus 14 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (287)
T 2wei_A 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILED 92 (287)
T ss_dssp HHHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeC
Confidence 3446678899999999999999999999999999999999997654432 235678899999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC---CCeEEeecCCCc
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN---GNLKVSDFGLSA 163 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~---~~~kl~DFGla~ 163 (414)
.+..|+||||+++++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999999988876 789999999999999999999999999999999999999764 469999999998
Q ss_pred ccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----C
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----P 239 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~ 239 (414)
.... ........||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+...++ .
T Consensus 173 ~~~~---~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (287)
T 2wei_A 173 CFQQ---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247 (287)
T ss_dssp TBCC---CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGT
T ss_pred eecC---CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhh
Confidence 6443 2233445689999999998764 5 4899999999999999999999999888888888877765543 3
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.+++++.+||++||+.||.+|||+.|+++||||.+
T Consensus 248 ~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred hcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 58999999999999999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=394.14 Aligned_cols=258 Identities=24% Similarity=0.511 Sum_probs=227.2
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhh--------------HHHHHHHHHHHHHhCCCC
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQG--------------LMEQIKREISVMRLVKHP 76 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~--------------~~~~~~~Ei~il~~l~hp 76 (414)
++...++|++.+.||+|+||.||+|.+ +++.||+|++......... ..+.+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 456789999999999999999999998 9999999999765433211 126789999999999999
Q ss_pred CccceEEEEEeCCEEEEEEEccCCCchHHH------Hhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcE
Q 015005 77 NIVELKEVMATKTKVFFVIEYVKGGELFAK------VLK---GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENL 146 (414)
Q Consensus 77 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~------i~~---~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NI 146 (414)
||+++++++.+.+..|+||||++||+|.++ +.. +.+++..++.++.|++.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999988 553 579999999999999999999999 9999999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhccc-CCCCCccchhhhhhhhhhhhcCCCCCCCchH-H
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK-GYDGAKSDIWSCGVVLFVLLSGFLPFQNENI-M 224 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~ 224 (414)
+++.++.+||+|||++..... .......||+.|+|||++.+. .+.+.++||||||+++|+|++|..||...+. .
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 999999999999999985432 244566799999999999877 4543389999999999999999999998766 6
Q ss_pred HHHHHHHhcccCCC-------------------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 225 KMYRKIFKAEYEFP-------------------PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 225 ~~~~~i~~~~~~~~-------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+....+..+...+| ..+++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 77777777777766 568999999999999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=377.36 Aligned_cols=258 Identities=31% Similarity=0.524 Sum_probs=225.3
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT--KTKV 91 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 91 (414)
..++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 4678999999999999999999999999999999998765432 235678999999999999999999998854 6789
Q ss_pred EEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cEEecCCCCcEEEcCCCCeEEeecCC
Q 015005 92 FFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRG-----VYHRDLKPENLLLDENGNLKVSDFGL 161 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~g-----i~HrDlkp~NILl~~~~~~kl~DFGl 161 (414)
|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999999875 23999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCC
Q 015005 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPW 240 (414)
Q Consensus 162 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 240 (414)
+..... .........||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+..+.. ..|..
T Consensus 163 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 163 ARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHC-----CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred heeecc--ccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 875432 11223455799999999999887775 889999999999999999999999888887777777665 56677
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++.++.+||.+||+.||.+|||+.|+++|+|+...
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 99999999999999999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=382.78 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=215.6
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE----
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA---- 86 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~---- 86 (414)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 6678899999999999999999999999999999999997553 233577889999999999999999999873
Q ss_pred ----------eCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc-CCCCeE
Q 015005 87 ----------TKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD-ENGNLK 155 (414)
Q Consensus 87 ----------~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~-~~~~~k 155 (414)
.....|+||||++ |+|.+.+..+.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+|
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 4478999999998 6999999889999999999999999999999999999999999999997 567999
Q ss_pred EeecCCCccccccc-CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc
Q 015005 156 VSDFGLSALPEQLW-NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE 234 (414)
Q Consensus 156 l~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 234 (414)
|+|||++....... .........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998654321 12234456789999999998764444589999999999999999999999887766665554321
Q ss_pred c------------------------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 235 Y------------------------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 235 ~------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
. ..++.++.++.+||++||+.||.+|||+.|+++||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 1 1124589999999999999999999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=384.14 Aligned_cols=251 Identities=26% Similarity=0.475 Sum_probs=210.8
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEe--CCE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMAT--KTK 90 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 90 (414)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 4578999999999999999999999999999999996432 356889999999997 9999999999998 678
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-CeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-NLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 169 (414)
.++||||+++++|.+.+. .+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~-- 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-- 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT--
T ss_pred eEEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC--
Confidence 999999999999988875 499999999999999999999999999999999999999777 899999999985442
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc-hHHHHHHH-------------HHhccc
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE-NIMKMYRK-------------IFKAEY 235 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~-------------i~~~~~ 235 (414)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +....... +.....
T Consensus 184 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 -GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp -TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred -CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 233456689999999999987444458999999999999999999999542 22111111 111111
Q ss_pred CC------------------------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 236 EF------------------------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 236 ~~------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.. +..+++++.+||++||++||.+|||++|+++||||..-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 11 12278999999999999999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=386.16 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=213.7
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT- 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 89 (414)
+..+.++|++.+.||+|+||+||+|.+..+++.||+|++....... ..+.+.+|+++++.++||||+++++++...+
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 4567889999999999999999999999999999999997654332 2567789999999999999999999998765
Q ss_pred -EEEEEEEccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE----cCCCCeEEeecC
Q 015005 90 -KVFFVIEYVKGGELFAKVLKG----KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL----DENGNLKVSDFG 160 (414)
Q Consensus 90 -~~~lv~E~~~gg~L~~~i~~~----~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl----~~~~~~kl~DFG 160 (414)
..|+||||++|++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 889999999999999999862 29999999999999999999999999999999999999 778889999999
Q ss_pred CCcccccccCCCccccccCCCcccCchhhc--------ccCCCCCccchhhhhhhhhhhhcCCCCCCCc----hHHHHHH
Q 015005 161 LSALPEQLWNDGLLHTQCGTPAYVAPEVLR--------KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE----NIMKMYR 228 (414)
Q Consensus 161 la~~~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~ 228 (414)
++..... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||... ...+...
T Consensus 162 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 162 AARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CceecCC---CCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 9986443 33345567999999999986 3445 48999999999999999999999642 2344455
Q ss_pred HHHhccc-------------------CCC------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCC
Q 015005 229 KIFKAEY-------------------EFP------PWISCDARRLISRILVADPQKRISVSEIMINP 270 (414)
Q Consensus 229 ~i~~~~~-------------------~~~------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 270 (414)
++..+.+ .+| ..++..+.+||++||+.||++|||++|+++||
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 5544332 111 12455788999999999999999999999997
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=405.21 Aligned_cols=248 Identities=18% Similarity=0.230 Sum_probs=205.7
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHH---HHhCCCCCccceE-------EE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISV---MRLVKHPNIVELK-------EV 84 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~i---l~~l~hpnIv~l~-------~~ 84 (414)
.++|++.+.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+.+ ++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4789999999999999999999999999999999987655444556789999954 5555799999998 77
Q ss_pred EEeCCE-----------------EEEEEEccCCCchHHHHhc-CCCCH-------HHHHHHHHHHHHHHHHHHhCCcEEe
Q 015005 85 MATKTK-----------------VFFVIEYVKGGELFAKVLK-GKLKE-------ESARKYFQQLISAVDFCHSRGVYHR 139 (414)
Q Consensus 85 ~~~~~~-----------------~~lv~E~~~gg~L~~~i~~-~~~~e-------~~~~~~~~ql~~al~~lH~~gi~Hr 139 (414)
+++.+. .|+||||+ +|+|.+++.. +.+++ ..+..++.|++.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 776643 89999999 6899999986 55555 7788899999999999999999999
Q ss_pred cCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhccc-----------CCCCCccchhhhhhhh
Q 015005 140 DLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK-----------GYDGAKSDIWSCGVVL 208 (414)
Q Consensus 140 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~~~~~~DiwSlGvil 208 (414)
||||+|||++.++.+||+|||++... .......+| +.|+|||++.+. .|+ .++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHHHHH
Confidence 99999999999999999999999842 224456678 999999999877 664 899999999999
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 209 FVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 209 ~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
|+|++|..||.+.+.......+. ..++.+++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999998765443332222 234568999999999999999999999999999999964
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=385.37 Aligned_cols=258 Identities=36% Similarity=0.688 Sum_probs=214.3
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc-----hhhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-----KQGLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
..+.++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 45667899999999999999999999999999999999765432 1122345789999999999999999999998
Q ss_pred eCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC---eEEeecCCC
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN---LKVSDFGLS 162 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~---~kl~DFGla 162 (414)
... .|+||||++|++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 765 8999999999999998876 78999999999999999999999999999999999999987664 999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhc---ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHHHhcccCCC
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLR---KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKIFKAEYEFP 238 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~ 238 (414)
..... .......+||+.|+|||++. ...+ +.++|||||||++|+|++|..||...... .....+..+....+
T Consensus 165 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 165 KILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp EECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred eeccc---ccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 85432 22334567999999999974 3344 48999999999999999999999765432 33344444544432
Q ss_pred ----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 239 ----PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 239 ----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..++.++.+||.+||+.||.+|||+.++++||||..
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 457999999999999999999999999999999965
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=377.13 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=202.1
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+..++|++.+.||+|+||+||+|.+..+|+.||+|++....... ...+.+.++...++.++||||+++++++.+++..|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 56789999999999999999999999999999999997654322 22344555556688889999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 93 FVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
+||||++| +|.+.+.. +.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999985 77665542 5799999999999999999999998 99999999999999999999999999998643
Q ss_pred cccCCCccccccCCCcccCchhh----cccCCCCCccchhhhhhhhhhhhcCCCCCCC-chHHHHHHHH-HhcccCCC-C
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVL----RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKI-FKAEYEFP-P 239 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i-~~~~~~~~-~ 239 (414)
. .......+||+.|+|||++ .+..+ +.++|||||||++|+|++|..||.. .......... .......+ .
T Consensus 162 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 162 D---DVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred c---cccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 3 2233445799999999997 33444 4789999999999999999999985 2333333333 33333333 3
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 589999999999999999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=381.54 Aligned_cols=257 Identities=31% Similarity=0.453 Sum_probs=218.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
....++|++.+.||+|+||+||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 35678899999999999999999999999999999999765322 256788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999999998875 67999999999999999999999999999999999999999999999999987532211
Q ss_pred CCCccccccCCCcccCchhhc-----ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC---CCCCC
Q 015005 170 NDGLLHTQCGTPAYVAPEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE---FPPWI 241 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~ 241 (414)
.......+||+.|+|||++. +..+ +.++||||||+++|+|++|..||...+.......+.....+ .+..+
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcccc
Confidence 11223457999999999984 3444 48999999999999999999999998877777666655433 34568
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+.++.+||.+||+.||.+|||+.++++||||..
T Consensus 249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 999999999999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=378.78 Aligned_cols=260 Identities=25% Similarity=0.447 Sum_probs=217.3
Q ss_pred HhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 8 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
+.+.....++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .+.+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 21 DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred hhhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 34455677899999999999999999999999999999999976432 3568899999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
.+.+|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999999999999873 68999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc---cCCCCCCC
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE---YEFPPWIS 242 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s 242 (414)
... ........||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+.... ...+..++
T Consensus 176 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
T 3com_A 176 TDT--MAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWS 252 (314)
T ss_dssp BTT--BSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred hhh--ccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCC
Confidence 331 1223456799999999999888775 88999999999999999999999877665554444332 23355679
Q ss_pred HHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 243 CDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.++.+||.+||+.||.+|||+.++++||||...
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 999999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=391.17 Aligned_cols=254 Identities=22% Similarity=0.398 Sum_probs=220.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEEC-------CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNL-------VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEV 84 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 84 (414)
...++|++.+.||+|+||+||+|.+. .++..||+|++..... ....+.+.+|+.+++.+ +||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB--HHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC--HHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 45678999999999999999999864 3556899999976532 23467899999999999 89999999999
Q ss_pred EEeCCEEEEEEEccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEE
Q 015005 85 MATKTKVFFVIEYVKGGELFAKVLKG-----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLL 147 (414)
Q Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NIL 147 (414)
+.+.+.+|+||||++||+|.+++... .+++.++..++.||+.||.|||++||+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 99999999999999999999998762 3789999999999999999999999999999999999
Q ss_pred EcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHH
Q 015005 148 LDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKM 226 (414)
Q Consensus 148 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 226 (414)
++.++.+||+|||++................||+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+..+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999855432222334455678999999999887775 89999999999999999 9999998877777
Q ss_pred HHHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 227 YRKIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 227 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+..+..+. ...|..++.++.+||.+||+.||.+|||+.|++++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77666553 45677899999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=395.22 Aligned_cols=263 Identities=20% Similarity=0.288 Sum_probs=226.1
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEE-----ECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEE
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGK-----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEV 84 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 84 (414)
+.+...++|++.+.||+|+||+||+|. +..+++.||||++...... .....+.+|+.+++.++||||++++++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh--hhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 345667899999999999999999999 5567889999999654322 234578899999999999999999999
Q ss_pred EEeCCEEEEEEEccCCCchHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC---C
Q 015005 85 MATKTKVFFVIEYVKGGELFAKVLK--------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG---N 153 (414)
Q Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~i~~--------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~---~ 153 (414)
+.+....|+||||++||+|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.+| .
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 9999999999999999999999876 2489999999999999999999999999999999999999655 5
Q ss_pred eEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHh
Q 015005 154 LKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFK 232 (414)
Q Consensus 154 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~ 232 (414)
+||+|||+++...............||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999754333333344556789999999999888775 89999999999999998 9999999988888887776
Q ss_pred cc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 233 AE-YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 233 ~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+. ...|..++..+.+||.+||+.||.+|||+.+++++.|+...
T Consensus 302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 54 45567789999999999999999999999999999987543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=379.40 Aligned_cols=256 Identities=28% Similarity=0.450 Sum_probs=214.8
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEe----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMAT---- 87 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~---- 87 (414)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... .+.+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 4578999999999999999999999999999999999765432 35788999999999 89999999999987
Q ss_pred --CCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 88 --KTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 88 --~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
...+|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 5689999999999999999875 47999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhc-----ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE- 236 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~- 236 (414)
...... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.......+.....+
T Consensus 177 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 2x7f_A 177 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253 (326)
T ss_dssp C---------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred eecCcC--ccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence 864431 22334567999999999986 3344 47899999999999999999999887776665555544332
Q ss_pred -CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 237 -FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 237 -~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+..++..+.+||.+||..||.+|||+.++++||||...
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 235589999999999999999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=382.34 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=215.7
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEE-CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC------Cccce
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKN-LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP------NIVEL 81 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l 81 (414)
..++.+.++|++.+.||+|+||+||+|.+ ..+++.||+|++.... ...+.+.+|+.+++.++|+ +++++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 34788999999999999999999999998 5689999999996542 2346788999999988655 49999
Q ss_pred EEEEEeCCEEEEEEEccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC--------
Q 015005 82 KEVMATKTKVFFVIEYVKGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-------- 150 (414)
Q Consensus 82 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-------- 150 (414)
++++.+.+..|+||||+ +++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 88999988763 5899999999999999999999999999999999999987
Q ss_pred -----------CCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCC
Q 015005 151 -----------NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQ 219 (414)
Q Consensus 151 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~ 219 (414)
++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCC
Confidence 67899999999975332 23456799999999999988775 89999999999999999999999
Q ss_pred CchHHHHHHHHHhcccCC--------------------------------------------CCCCCHHHHHHHHhhccc
Q 015005 220 NENIMKMYRKIFKAEYEF--------------------------------------------PPWISCDARRLISRILVA 255 (414)
Q Consensus 220 ~~~~~~~~~~i~~~~~~~--------------------------------------------~~~~s~~~~~li~~~L~~ 255 (414)
..+..+....+.....+. +...++++.+||.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 877665444332211111 111346788999999999
Q ss_pred CcCCCCChHHHhcCCcccc
Q 015005 256 DPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 256 dp~~R~s~~eil~hp~f~~ 274 (414)
||.+|||+.|+++||||..
T Consensus 316 dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDL 334 (339)
T ss_dssp STTTSCCHHHHTTSGGGGG
T ss_pred CcccccCHHHHhcCHHHHH
Confidence 9999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=384.31 Aligned_cols=262 Identities=30% Similarity=0.523 Sum_probs=197.6
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
..+..++|++.+.||+|+||+||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 456678999999999999999999999889999999999765432 235678899999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCC
Q 015005 91 VFFVIEYVKGGELFAKVLK---------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL 161 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~---------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGl 161 (414)
.|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999998862 4599999999999999999999999999999999999999999999999999
Q ss_pred Cccccccc---CCCccccccCCCcccCchhhcc-cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC-
Q 015005 162 SALPEQLW---NDGLLHTQCGTPAYVAPEVLRK-KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE- 236 (414)
Q Consensus 162 a~~~~~~~---~~~~~~~~~gt~~y~APE~~~~-~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~- 236 (414)
+....... .........||+.|+|||++.+ ..+ +.++||||||+++|+|++|..||..................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCC-CTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCC-CchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 87543211 1122345679999999999876 345 48999999999999999999999886655444443333221
Q ss_pred ---------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 237 ---------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 237 ---------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+..++.++.+||.+||+.||.+|||+.++++||||.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 224578899999999999999999999999999999764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=393.81 Aligned_cols=254 Identities=26% Similarity=0.464 Sum_probs=209.7
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC--------CCCccc
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK--------HPNIVE 80 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~ 80 (414)
.+++.+.++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.+++.++ ||||++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 457788899999999999999999999999999999999997542 23467889999999885 788999
Q ss_pred eEEEEE----eCCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCC
Q 015005 81 LKEVMA----TKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENG 152 (414)
Q Consensus 81 l~~~~~----~~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~ 152 (414)
+++++. +...+|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 999997 5568999999995 555555543 4699999999999999999999998 999999999999999775
Q ss_pred -------------------------------------------------CeEEeecCCCcccccccCCCccccccCCCcc
Q 015005 153 -------------------------------------------------NLKVSDFGLSALPEQLWNDGLLHTQCGTPAY 183 (414)
Q Consensus 153 -------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 183 (414)
.+||+|||++..... .....+||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcc
Confidence 899999999985432 23456799999
Q ss_pred cCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch------HHHHHHHHHh--c----------------------
Q 015005 184 VAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN------IMKMYRKIFK--A---------------------- 233 (414)
Q Consensus 184 ~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~------~~~~~~~i~~--~---------------------- 233 (414)
+|||++.+..|+ .++|||||||++|+|++|..||...+ .......+.. +
T Consensus 260 ~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 260 RSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp CCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred cCChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 999999988875 89999999999999999999997643 2222222211 0
Q ss_pred ------------------ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 234 ------------------EYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 234 ------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
.+..+...+.++.+||.+||+.||.+|||++|+++||||.
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0111222356788999999999999999999999999996
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=383.45 Aligned_cols=266 Identities=24% Similarity=0.389 Sum_probs=202.0
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCe---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQE---SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
+..++|++.+.||+|+||+||+|.+..++. .||+|++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 456789999999999999999999877765 89999997654332 23578899999999999999999999998776
Q ss_pred EE------EEEEEccCCCchHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEE
Q 015005 90 KV------FFVIEYVKGGELFAKVLKG-------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV 156 (414)
Q Consensus 90 ~~------~lv~E~~~gg~L~~~i~~~-------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl 156 (414)
.. |+||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 65 9999999999999988642 5999999999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-
Q 015005 157 SDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE- 234 (414)
Q Consensus 157 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~- 234 (414)
+|||++................+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+.
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 999999865432222233345578899999999888775 89999999999999999 999999887777777766554
Q ss_pred cCCCCCCCHHHHHHHHhhcccCcCCCCC-------hHHHhcCCccccCCCCCc
Q 015005 235 YEFPPWISCDARRLISRILVADPQKRIS-------VSEIMINPWFIKGFSKPV 280 (414)
Q Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~s-------~~eil~hp~f~~~~~~~~ 280 (414)
...++.+++++.+||.+||+.||.+||| +++++.|||+......|.
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 4667789999999999999999999999 778899999987655443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=381.83 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=220.0
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCe---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQE---SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
+++..++|++.+.||+|+||+||+|.+..+++ .||||++..... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45667899999999999999999999986555 599999976432 2235678999999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
.+..|+||||++||+|.+++.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999999999975 58999999999999999999999999999999999999999999999999999865
Q ss_pred ccccCC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCC
Q 015005 166 EQLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWIS 242 (414)
Q Consensus 166 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 242 (414)
...... .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 432111 122334567889999999887775 79999999999999999 99999998888887777665 445677899
Q ss_pred HHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 243 CDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+++.+||.+||+.||.+|||+.++++.
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999853
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=387.94 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=213.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE-
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV- 91 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~- 91 (414)
.+.++|++.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 3568999999999999999999999999999999999765432 33457788999999999999999999999877654
Q ss_pred -----EEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 92 -----FFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 92 -----~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
|+||||+. ++|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cceeEEEEEcccc-ccHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 57876663 469999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-----------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY----------- 235 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 235 (414)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 196 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 196 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred c-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 2 234567999999999998743345899999999999999999999999877666655533100
Q ss_pred --------------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 236 --------------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 236 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..++.+++++.+||++||+.||.+|||+.|+++||||..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 112357899999999999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=394.19 Aligned_cols=251 Identities=30% Similarity=0.426 Sum_probs=208.1
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK----- 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 88 (414)
...+|++.+.||+|+||+||+|.+..+|+.||||.+..... ...+|+++++.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34479999999999999999999999999999999975432 223799999999999999999998542
Q ss_pred -CEEEEEEEccCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC-CCeEEeecCC
Q 015005 89 -TKVFFVIEYVKGGELFAKVL-----KGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN-GNLKVSDFGL 161 (414)
Q Consensus 89 -~~~~lv~E~~~gg~L~~~i~-----~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~-~~~kl~DFGl 161 (414)
..+++||||+++ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 247799999986 5544443 2679999999999999999999999999999999999999965 5689999999
Q ss_pred CcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--------
Q 015005 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA-------- 233 (414)
Q Consensus 162 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------- 233 (414)
++.... .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+.++...
T Consensus 204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 985432 223345689999999999977543458999999999999999999999998776665554431
Q ss_pred ---------ccC------------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 ---------EYE------------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 ---------~~~------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.+. +++.+++++.+||++||+.||.+|||+.|+++||||...
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 111 234568999999999999999999999999999999653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=383.19 Aligned_cols=259 Identities=31% Similarity=0.578 Sum_probs=223.1
Q ss_pred HhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh---hHHHHHHHHHHHHHhCC--CCCccceE
Q 015005 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ---GLMEQIKREISVMRLVK--HPNIVELK 82 (414)
Q Consensus 8 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~ 82 (414)
...++.+.++|++.+.||+|+||+||+|.+..+++.||+|++........ ...+.+.+|+.+++.++ ||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 34467889999999999999999999999999999999999987643321 11234668999999996 59999999
Q ss_pred EEEEeCCEEEEEEEccCC-CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc-CCCCeEEeec
Q 015005 83 EVMATKTKVFFVIEYVKG-GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD-ENGNLKVSDF 159 (414)
Q Consensus 83 ~~~~~~~~~~lv~E~~~g-g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~-~~~~~kl~DF 159 (414)
+++...+..++|||++.+ ++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999999999986 899999886 7899999999999999999999999999999999999999 7789999999
Q ss_pred CCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC
Q 015005 160 GLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP 239 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 239 (414)
|++..... .......||+.|+|||++.+..+.+.++||||||+++|+|++|..||.... .+......++.
T Consensus 195 g~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~ 264 (320)
T 3a99_A 195 GSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 264 (320)
T ss_dssp TTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSS
T ss_pred cccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccc
Confidence 99985432 233456799999999999887776678999999999999999999998753 24455667778
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.+++++.+||.+||+.||.+|||+.|+++||||....
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 8999999999999999999999999999999997643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=385.14 Aligned_cols=260 Identities=24% Similarity=0.404 Sum_probs=209.7
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc--------hhhHHHHHHHHHHHHHhCCCCCccceEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK--------KQGLMEQIKREISVMRLVKHPNIVELKE 83 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 83 (414)
..+.++|++.+.||+|+||.||+|.+. +|+.||||++...... .....+.+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 457789999999999999999999975 4899999999654322 2223478899999999999999999999
Q ss_pred EEEe-----CCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEE
Q 015005 84 VMAT-----KTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV 156 (414)
Q Consensus 84 ~~~~-----~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl 156 (414)
++.. ...+|+||||++ |+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9854 347899999998 577777765 47999999999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--
Q 015005 157 SDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE-- 234 (414)
Q Consensus 157 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-- 234 (414)
+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 176 ~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 176 CDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999974332 2334556799999999999874444589999999999999999999999987766655553210
Q ss_pred ----------------------c--------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 235 ----------------------Y--------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 235 ----------------------~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
. ..++..++.+.+||.+||+.||.+|||+.|+++||||...+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 0 11234688999999999999999999999999999997654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=368.93 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=218.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||+|+||+||+|.+. +++.||+|++....... +.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999986 57789999998655432 5688999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 162 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 162 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence 999999999999976 569999999999999999999999999999999999999999999999999997543211 11
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLIS 250 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 250 (414)
......||+.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+..+ ....|..+++++.++|.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence 22344578889999999887775 89999999999999999 99999999888888877766 34556678999999999
Q ss_pred hhcccCcCCCCChHHHhcC
Q 015005 251 RILVADPQKRISVSEIMIN 269 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~h 269 (414)
+||+.||.+|||+.++++|
T Consensus 242 ~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 242 HCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCcccCcCHHHHHHH
Confidence 9999999999999999876
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=372.00 Aligned_cols=254 Identities=28% Similarity=0.509 Sum_probs=208.4
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe------
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT------ 87 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 87 (414)
+.++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 4568999999999999999999999999999999996532 235678899999999999999999998865
Q ss_pred -------CCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEee
Q 015005 88 -------KTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSD 158 (414)
Q Consensus 88 -------~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~D 158 (414)
....|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 4578999999999999999985 3588999999999999999999999999999999999999999999999
Q ss_pred cCCCccccccc------------CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc-hHHH
Q 015005 159 FGLSALPEQLW------------NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE-NIMK 225 (414)
Q Consensus 159 FGla~~~~~~~------------~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~ 225 (414)
||++....... ........+||+.|+|||++.+.+..+.++|||||||++|+|++ ||... +...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99998643211 11233456799999999999876444589999999999999998 66543 3345
Q ss_pred HHHHHHhcccCCCC----CCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 226 MYRKIFKAEYEFPP----WISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 226 ~~~~i~~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
....+......+|+ ..+..+.+||++||+.||.+|||+.++++||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 55555555555443 45677999999999999999999999999999965
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=387.31 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=215.9
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEE-----ECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGK-----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVM 85 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 85 (414)
+...++|++.+.||+|+||.||+|. +..+++.||||++...... ...+.+.+|+.+++++ +||||+++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH--HHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 4567899999999999999999998 5667799999999765432 2356789999999999 799999999999
Q ss_pred EeCC-EEEEEEEccCCCchHHHHhcCC-----------------------------------------------------
Q 015005 86 ATKT-KVFFVIEYVKGGELFAKVLKGK----------------------------------------------------- 111 (414)
Q Consensus 86 ~~~~-~~~lv~E~~~gg~L~~~i~~~~----------------------------------------------------- 111 (414)
.+.+ .+|+||||++||+|.+++....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8755 4999999999999999987622
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccc
Q 015005 112 --------------LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ 177 (414)
Q Consensus 112 --------------~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 177 (414)
+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 899999999999999999999999999999999999999999999999999865432222234456
Q ss_pred cCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHH-HHHHh-cccCCCCCCCHHHHHHHHhhcc
Q 015005 178 CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMY-RKIFK-AEYEFPPWISCDARRLISRILV 254 (414)
Q Consensus 178 ~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~-~~i~~-~~~~~~~~~s~~~~~li~~~L~ 254 (414)
.||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+....... ..+.. .....|..+++++.++|.+||+
T Consensus 256 ~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp EECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 789999999999887775 89999999999999998 99999886544333 33333 3456677899999999999999
Q ss_pred cCcCCCCChHHHhcC
Q 015005 255 ADPQKRISVSEIMIN 269 (414)
Q Consensus 255 ~dp~~R~s~~eil~h 269 (414)
.||.+|||+.|+++|
T Consensus 335 ~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 335 GEPSQRPTFSELVEH 349 (359)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCCCHHHHHHH
Confidence 999999999999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=382.25 Aligned_cols=255 Identities=23% Similarity=0.313 Sum_probs=222.4
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
....++|++.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 556789999999999999999999987 4568999999976543 234577899999999999999999999999
Q ss_pred eCCEEEEEEEccCCCchHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecC
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK-------------------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDL 141 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~-------------------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDl 141 (414)
+.+..|+||||++||+|.+++.. ..+++.+++.++.|++.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999999876 56999999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCC
Q 015005 142 KPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN 220 (414)
Q Consensus 142 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~ 220 (414)
||+|||++.++.+||+|||++................||+.|+|||++.+..++ .++||||||+++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999754432222334456789999999999887775 89999999999999999 9999999
Q ss_pred chHHHHHHHHHhccc-CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 221 ENIMKMYRKIFKAEY-EFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 221 ~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.+..+....+..+.. ..|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 888888777776654 5677899999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=381.53 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=213.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE--
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK-- 90 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 90 (414)
.+.++|++.+.||+|+||+||+|.+..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 3568999999999999999999999999999999999765432 3345678899999999999999999999987654
Q ss_pred ----EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 91 ----VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 91 ----~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
+|+||||+. ++|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMG-LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEecccc-CCHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999997 58877664 469999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc------------
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE------------ 234 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 234 (414)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 178 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 178 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred C-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 2 23456789999999999874334589999999999999999999999887666555443210
Q ss_pred -------------------cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 235 -------------------YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 235 -------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
...++.+++++.+||.+||+.||.+|||++|+++||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0123457899999999999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=385.41 Aligned_cols=255 Identities=21% Similarity=0.401 Sum_probs=223.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECC-------CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLV-------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKE 83 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 83 (414)
++..++|++.+.||+|+||+||+|.+.. .+..||+|++..... ......+.+|+++++.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--HHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 4566899999999999999999999754 336799999976533 23357789999999999 9999999999
Q ss_pred EEEeCCEEEEEEEccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcE
Q 015005 84 VMATKTKVFFVIEYVKGGELFAKVLKG-----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENL 146 (414)
Q Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NI 146 (414)
++.+.+..|+||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 999999999999999999999999863 399999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHH
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMK 225 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 225 (414)
|++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999865543333344556688999999999887775 89999999999999999 999999988888
Q ss_pred HHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 226 MYRKIFKA-EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 226 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
....+..+ ....|..+++++.+||++||+.||.+|||+.|++++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87777665 445677899999999999999999999999999976
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=378.06 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=221.9
Q ss_pred HhhhccccCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceE
Q 015005 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELK 82 (414)
Q Consensus 8 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 82 (414)
...-+...++|++.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 3334566789999999999999999999873 4568999999975432 23457789999999999999999999
Q ss_pred EEEEeCCEEEEEEEccCCCchHHHHhc-C------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcE
Q 015005 83 EVMATKTKVFFVIEYVKGGELFAKVLK-G------------------------KLKEESARKYFQQLISAVDFCHSRGVY 137 (414)
Q Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~i~~-~------------------------~~~e~~~~~~~~ql~~al~~lH~~gi~ 137 (414)
+++.+.+..|+||||++||+|.+++.. . .+++.++..++.|++.||.|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999999876 2 289999999999999999999999999
Q ss_pred EecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCC
Q 015005 138 HRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFL 216 (414)
Q Consensus 138 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~ 216 (414)
||||||+|||++.++.+||+|||++................+|+.|+|||++.+..++ .++|||||||++|+|++ |..
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999754332222223445678899999999887775 89999999999999999 999
Q ss_pred CCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 217 PFQNENIMKMYRKIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 217 Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
||.+.+.......+..+. ...|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999887777766665543 45677799999999999999999999999999865
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=369.64 Aligned_cols=257 Identities=30% Similarity=0.528 Sum_probs=213.5
Q ss_pred cccCCEEEee-----eeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 13 ILFGKYEMGR-----MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 13 ~~~~~y~~~~-----~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
....+|+..+ .||+|+||+||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 90 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSE 90 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEe
Confidence 3344455544 99999999999999999999999999976542 234678899999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC-CCCeEEeecCCC
Q 015005 88 KTKVFFVIEYVKGGELFAKVLKG----KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-NGNLKVSDFGLS 162 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~----~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-~~~~kl~DFGla 162 (414)
.+..++||||++|++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 91 NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccc
Confidence 99999999999999999998763 4679999999999999999999999999999999999987 899999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcccC--CCCCccchhhhhhhhhhhhcCCCCCCCchHH--HHHH-HHHhcccCC
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKG--YDGAKSDIWSCGVVLFVLLSGFLPFQNENIM--KMYR-KIFKAEYEF 237 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~-~i~~~~~~~ 237 (414)
...... ........||+.|+|||++.+.. + +.++||||||+++|+|++|..||...... .... .........
T Consensus 171 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 2clq_A 171 KRLAGI--NPCTETFTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI 247 (295)
T ss_dssp EESCC-------CCCCCCGGGCCHHHHHHGGGGC-SHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCC
T ss_pred cccCCC--CCcccccCCCccccChhhhcCCCCCC-CcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccc
Confidence 754331 22234567999999999997643 4 47899999999999999999999754322 2222 223344567
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
|..+++++.+||.+||+.||++|||+.++++||||...
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 77899999999999999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=392.00 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=197.5
Q ss_pred hccccCCEEE-eeeeeecCCeEEEEEEEC--CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 11 RNILFGKYEM-GRMLGQGTFAKVYYGKNL--VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 11 ~~~~~~~y~~-~~~LG~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
...+.+.|++ ++.||+|+||+||+|.+. .+++.||+|++...... ..+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (405)
T 3rgf_A 15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLS 89 (405)
T ss_dssp CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence 4566778988 568999999999999966 57889999999765432 357799999999999999999999965
Q ss_pred --CCEEEEEEEccCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE----cCC
Q 015005 88 --KTKVFFVIEYVKGGELFAKVLK----------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL----DEN 151 (414)
Q Consensus 88 --~~~~~lv~E~~~gg~L~~~i~~----------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl----~~~ 151 (414)
...+|+||||+.| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 6789999999974 77776652 149999999999999999999999999999999999999 677
Q ss_pred CCeEEeecCCCccccccc-CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH------
Q 015005 152 GNLKVSDFGLSALPEQLW-NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM------ 224 (414)
Q Consensus 152 ~~~kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~------ 224 (414)
+.+||+|||++....... ........+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 899999999998654321 1133456789999999999988664468999999999999999999999765431
Q ss_pred ---HHHHHHHhc--ccCC------------------------------------CCCCCHHHHHHHHhhcccCcCCCCCh
Q 015005 225 ---KMYRKIFKA--EYEF------------------------------------PPWISCDARRLISRILVADPQKRISV 263 (414)
Q Consensus 225 ---~~~~~i~~~--~~~~------------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~ 263 (414)
+....+... .+.. ....++++.+||++||+.||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 222222211 0000 01126789999999999999999999
Q ss_pred HHHhcCCccccCC
Q 015005 264 SEIMINPWFIKGF 276 (414)
Q Consensus 264 ~eil~hp~f~~~~ 276 (414)
+|+|+||||....
T Consensus 329 ~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 329 EQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHTSGGGTSSS
T ss_pred HHHhcChhhccCC
Confidence 9999999998653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=381.16 Aligned_cols=258 Identities=27% Similarity=0.363 Sum_probs=203.2
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE-
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK- 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 90 (414)
....++|++.+.||+|+||+||+|.+..+|+.||||++....... ....+|++.++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 355789999999999999999999999999999999986643322 345577888888999999999999976433
Q ss_pred ------EEEEEEccCCCchHHH---Hhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcEEecCCCCcEEEcC-CCCeEEe
Q 015005 91 ------VFFVIEYVKGGELFAK---VLK-GKLKEESARKYFQQLISAVDFCH--SRGVYHRDLKPENLLLDE-NGNLKVS 157 (414)
Q Consensus 91 ------~~lv~E~~~gg~L~~~---i~~-~~~~e~~~~~~~~ql~~al~~lH--~~gi~HrDlkp~NILl~~-~~~~kl~ 157 (414)
+|+||||++++.+... ... ..+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 8999999987643322 223 67999999999999999999999 999999999999999996 8999999
Q ss_pred ecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc--
Q 015005 158 DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-- 235 (414)
Q Consensus 158 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-- 235 (414)
|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 175 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 175 DFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999986543 23334567999999999997766446899999999999999999999999887766665543100
Q ss_pred ------------------------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 236 ------------------------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 236 ------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
..+...++++.+||.+||+.||.+|||+.|+++||||....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 11122567899999999999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=380.46 Aligned_cols=256 Identities=28% Similarity=0.439 Sum_probs=213.8
Q ss_pred HhhhccccCCEEEeeeeeecCCeEEEEEEECCCC-eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC------ccc
Q 015005 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQ-ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN------IVE 80 (414)
Q Consensus 8 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~ 80 (414)
-.+++.+.++|++.+.||+|+||+||+|.+..++ +.||+|++.... ...+.+.+|+.+++.++|++ ++.
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 3568889999999999999999999999998777 789999997542 23467788999999987655 899
Q ss_pred eEEEEEeCCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE---------
Q 015005 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL--------- 148 (414)
Q Consensus 81 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl--------- 148 (414)
+++++...+..|+||||+ +++|.+.+.. ..+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 999999999999999999 5566666654 369999999999999999999999999999999999999
Q ss_pred ----------cCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCC
Q 015005 149 ----------DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPF 218 (414)
Q Consensus 149 ----------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf 218 (414)
+.++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCC
Confidence 5678999999999975332 23456799999999999888775 8999999999999999999999
Q ss_pred CCchHHHHHHHHHhcccCCC--------------------------------------------CCCCHHHHHHHHhhcc
Q 015005 219 QNENIMKMYRKIFKAEYEFP--------------------------------------------PWISCDARRLISRILV 254 (414)
Q Consensus 219 ~~~~~~~~~~~i~~~~~~~~--------------------------------------------~~~s~~~~~li~~~L~ 254 (414)
...+.......+.......| ...+.++.+||++||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 98776554443322111111 1124578899999999
Q ss_pred cCcCCCCChHHHhcCCcccc
Q 015005 255 ADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 255 ~dp~~R~s~~eil~hp~f~~ 274 (414)
.||.+|||+.|+++||||..
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAG 339 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGG
T ss_pred CChhhCcCHHHHhcChhhcC
Confidence 99999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=374.09 Aligned_cols=256 Identities=30% Similarity=0.451 Sum_probs=215.8
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEEC-CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCccceEEEEE---
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNL-VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV---KHPNIVELKEVMA--- 86 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~--- 86 (414)
..++|++.+.||+|+||+||+|.+. .+++.||+|++........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4578999999999999999999995 6789999999976543221 123456787777766 8999999999987
Q ss_pred --eCCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCC
Q 015005 87 --TKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL 161 (414)
Q Consensus 87 --~~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGl 161 (414)
.....++||||++ |+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5678999999998 599888876 3499999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc-------
Q 015005 162 SALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE------- 234 (414)
Q Consensus 162 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------- 234 (414)
+..... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+....
T Consensus 167 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 167 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccC---CCCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 986543 2234456799999999999887775 89999999999999999999999988776666654310
Q ss_pred --------------------cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 235 --------------------YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 235 --------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..+++.++..+.+||.+||+.||.+|||+.|+++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 01234578899999999999999999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=384.53 Aligned_cols=255 Identities=29% Similarity=0.429 Sum_probs=214.5
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CC-----CccceEE
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HP-----NIVELKE 83 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~ 83 (414)
.++.+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ |+ +|+++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 35677899999999999999999999999999999999997543 23466778999988884 55 4999999
Q ss_pred EEEeCCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcEEecCCCCcEEEc--CCCCeEE
Q 015005 84 VMATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCH--SRGVYHRDLKPENLLLD--ENGNLKV 156 (414)
Q Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH--~~gi~HrDlkp~NILl~--~~~~~kl 156 (414)
++...+.+|+||||++ |+|.+.+.. +.+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 9999999999999996 499898876 45999999999999999999999 57999999999999995 4778999
Q ss_pred eecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC
Q 015005 157 SDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE 236 (414)
Q Consensus 157 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 236 (414)
+|||++..... .....+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+....+......
T Consensus 203 ~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 203 VDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EeccCceeccc-----ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999985432 23456899999999999988875 8999999999999999999999998877766655432110
Q ss_pred CC------------------------------------C-C---------------------------CCHHHHHHHHhh
Q 015005 237 FP------------------------------------P-W---------------------------ISCDARRLISRI 252 (414)
Q Consensus 237 ~~------------------------------------~-~---------------------------~s~~~~~li~~~ 252 (414)
.| + . .++++.+||++|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 356 (382)
T 2vx3_A 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM 356 (382)
T ss_dssp CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence 00 0 0 013689999999
Q ss_pred cccCcCCCCChHHHhcCCccccC
Q 015005 253 LVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 253 L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
|+.||++|||+.|+|+||||.+.
T Consensus 357 L~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 357 LDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999763
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=392.67 Aligned_cols=251 Identities=18% Similarity=0.224 Sum_probs=195.4
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC--CCCCccceE-------EEEEe
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV--KHPNIVELK-------EVMAT 87 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~~~ 87 (414)
+|++.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 499999999999999999999999999999999887654445567788886555555 699988755 56654
Q ss_pred C-----------------CEEEEEEEccCCCchHHHHhc--CCCCHHHH------HHHHHHHHHHHHHHHhCCcEEecCC
Q 015005 88 K-----------------TKVFFVIEYVKGGELFAKVLK--GKLKEESA------RKYFQQLISAVDFCHSRGVYHRDLK 142 (414)
Q Consensus 88 ~-----------------~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~------~~~~~ql~~al~~lH~~gi~HrDlk 142 (414)
. ..+|+||||++ |+|.+++.. ..+++... ..++.||+.||+|||++||+|||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 4 34899999999 899999986 34444444 5667999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcc--cCCCCCccchhhhhhhhhhhhcCCCCCCC
Q 015005 143 PENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRK--KGYDGAKSDIWSCGVVLFVLLSGFLPFQN 220 (414)
Q Consensus 143 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~ 220 (414)
|+|||++.+|.+||+|||++..... ......||+.|+|||++.+ ..| +.++|||||||++|+|++|..||..
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999985432 2225567799999999976 556 4899999999999999999999987
Q ss_pred chHHH--HHHH-----HHhcccCCC--CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 221 ENIMK--MYRK-----IFKAEYEFP--PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 221 ~~~~~--~~~~-----i~~~~~~~~--~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..... .+.. .......++ +.+++++.+||.+||+.||++|||+.++++||||.+
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 63321 1110 001122233 468999999999999999999999999999999965
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=363.88 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=218.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
+...++|++.+.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 345678999999999999999999875 6778999999765443 25688999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD- 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT-
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh-
Confidence 999999999999999886 45999999999999999999999999999999999999999999999999999754321
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc-CCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~ 247 (414)
.........||+.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+..+.. ..|...++++.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 11122334567789999999887775 89999999999999999 9999999888877777766544 456668999999
Q ss_pred HHHhhcccCcCCCCChHHHhcC
Q 015005 248 LISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~h 269 (414)
+|.+||+.||.+|||+.+++++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=373.40 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=211.7
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
...++|++.+.||+|+||+||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 34678999999999999999999999999999999985532 234578899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+||||++||+|.+++.. +.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999986 6799999999999999999999999999999999999999999999999999976433211
Q ss_pred C------------CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH-----HHHHHHhc
Q 015005 171 D------------GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK-----MYRKIFKA 233 (414)
Q Consensus 171 ~------------~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~-----~~~~i~~~ 233 (414)
. ......+||+.|+|||++.+..++ .++||||||+++|+|++|..||....... ..... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~--~ 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF--L 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH--H
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc--c
Confidence 1 111256799999999999988775 89999999999999999999986532110 00111 1
Q ss_pred ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 234 EYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
....|+.+++++.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12346778899999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=369.26 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=210.0
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.....++|++.+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 34567899999999999999999999999999999999987655555556789999999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
.|+||||++|++|.+++.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 187 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE- 187 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc-
Confidence 9999999999999999987 78999999999999999999999999999999999999999999999999999754431
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc---CCCCCCCHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY---EFPPWISCDAR 246 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~ 246 (414)
.........||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..... ..++.+++++.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence 11223456799999999999887775 899999999999999999999998877654444433222 34567899999
Q ss_pred HHHHhhcccCcCCCC-ChHHHhc
Q 015005 247 RLISRILVADPQKRI-SVSEIMI 268 (414)
Q Consensus 247 ~li~~~L~~dp~~R~-s~~eil~ 268 (414)
+||.+||+.||.+|| |++++++
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999 7777764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=364.55 Aligned_cols=251 Identities=27% Similarity=0.483 Sum_probs=207.6
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch-hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK-QGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
++-.++|++.+.||+|+||+||+|.+ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 34568999999999999999999996 48899999997654332 2235678899999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cEEecCCCCcEEEcC--------CCCeEEeec
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRG---VYHRDLKPENLLLDE--------NGNLKVSDF 159 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~g---i~HrDlkp~NILl~~--------~~~~kl~DF 159 (414)
.|+||||++|++|.+++..+.+++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred eEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999999998889999999999999999999999999 999999999999986 778999999
Q ss_pred CCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc--cCC
Q 015005 160 GLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--YEF 237 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~ 237 (414)
|++..... .......||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.+.......+.... .+.
T Consensus 161 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 161 GLAREWHR----TTKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred Cccccccc----ccccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence 99975432 222356799999999999887775 89999999999999999999999987776666665544 345
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
|..+++++.+||.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 67789999999999999999999999999865
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=378.00 Aligned_cols=257 Identities=33% Similarity=0.625 Sum_probs=212.6
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh---hHHHHHHHHHHHHHhC----CCCCccce
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ---GLMEQIKREISVMRLV----KHPNIVEL 81 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~Ei~il~~l----~hpnIv~l 81 (414)
..++.+.++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++.+ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 3457788999999999999999999999999999999999976543221 1123456799999988 89999999
Q ss_pred EEEEEeCCEEEEEEEc-cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc-CCCCeEEee
Q 015005 82 KEVMATKTKVFFVIEY-VKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD-ENGNLKVSD 158 (414)
Q Consensus 82 ~~~~~~~~~~~lv~E~-~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~-~~~~~kl~D 158 (414)
++++...+..++|||+ +.+++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999999 789999999986 7899999999999999999999999999999999999999 789999999
Q ss_pred cCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC
Q 015005 159 FGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP 238 (414)
Q Consensus 159 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 238 (414)
||++..... .......||+.|+|||++.+..+.+.++||||||+++|+|++|..||.... .+......++
T Consensus 184 fg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~ 253 (312)
T 2iwi_A 184 FGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP 253 (312)
T ss_dssp CSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC
T ss_pred cchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc
Confidence 999985432 234456799999999999887776568999999999999999999998643 3445667788
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..++.++.+||.+||+.||++|||+.|+++||||...
T Consensus 254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 8899999999999999999999999999999999764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=370.23 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=212.9
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCC-------eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQ-------ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEV 84 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 84 (414)
++..++|++.+.||+|+||+||+|.+..++ ..||+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456789999999999999999999988877 4799999966442 235778999999999999999999999
Q ss_pred EEeCCEEEEEEEccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC--------e
Q 015005 85 MATKTKVFFVIEYVKGGELFAKVLKG--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN--------L 154 (414)
Q Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~--------~ 154 (414)
+.+.+..|+||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999999873 3999999999999999999999999999999999999998887 9
Q ss_pred EEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcC-CCCCCCchHHHHHHHHHhc
Q 015005 155 KVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG-FLPFQNENIMKMYRKIFKA 233 (414)
Q Consensus 155 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~ 233 (414)
||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++| ..||...+... .......
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYED 233 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhc
Confidence 9999999874322 23456899999999998744345899999999999999995 55555544433 3344555
Q ss_pred ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 234 EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
....|...++++.+||.+||+.||.+|||+.++++|
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 667777789999999999999999999999999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=365.74 Aligned_cols=252 Identities=19% Similarity=0.273 Sum_probs=215.0
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 89 (414)
++.+.++|++.+.||+|+||+||+|.+..+++.||+|++...... +.+.+|+.+++.+ +|||++++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 678889999999999999999999999999999999998754432 3577899999999 7999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC-----eEEeecCCC
Q 015005 90 KVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN-----LKVSDFGLS 162 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~-----~kl~DFGla 162 (414)
..|+||||+ |++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 9999999986 46999999999999999999999999999999999999987776 999999999
Q ss_pred cccccccCC-----CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc---hHHHHHHHHHhcc
Q 015005 163 ALPEQLWND-----GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE---NIMKMYRKIFKAE 234 (414)
Q Consensus 163 ~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~ 234 (414)
......... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+. .....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 865432211 124566799999999999887775 8999999999999999999999873 3344444443332
Q ss_pred cC-----CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 235 YE-----FPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 235 ~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.. .++.+++++.+||.+||+.||.+|||+.+|++.
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 22 234689999999999999999999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=386.51 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=216.6
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
-.++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+++|+.++||||+++++++.+.+.+|+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC--HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 35689999999999999999999999999999999975432 2234568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 94 VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
||||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999999999999876 46999999999999999999999999999999999999999999999999999753221111
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRLI 249 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 249 (414)
.......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++++.+||
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 111222356789999999877775 89999999999999998 99999998777766666544 4566778999999999
Q ss_pred HhhcccCcCCCCChHHHhc
Q 015005 250 SRILVADPQKRISVSEIMI 268 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~ 268 (414)
.+||+.||.+|||+.++++
T Consensus 349 ~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 349 EQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=366.61 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=217.4
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
++-.++|++.+.||+|+||+||+|.+. ++..||+|++....... +.+.+|+.+++.++||||+++++++.+....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 345679999999999999999999875 67789999997654432 5688999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999986 689999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 247 (414)
........||+.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+..+. ...|...++.+.+
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (283)
T 3gen_A 175 -YTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 252 (283)
T ss_dssp -HHSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -cccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHH
Confidence 1122344578889999999887775 89999999999999998 999999988888777777654 4456678999999
Q ss_pred HHHhhcccCcCCCCChHHHhcCC
Q 015005 248 LISRILVADPQKRISVSEIMINP 270 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp 270 (414)
||.+||+.||.+|||+.++++|-
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 253 IMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHHHH
Confidence 99999999999999999999763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=379.89 Aligned_cols=253 Identities=22% Similarity=0.338 Sum_probs=214.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeE----EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQES----VAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
...++|++.+.||+|+||+||+|.+..+++. ||+|.+...... .....+.+|+.+++.++||||+++++++. .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 4467899999999999999999999888876 666666433221 11345678999999999999999999986 4
Q ss_pred CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
+..++||||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 568999999999999999886 579999999999999999999999999999999999999999999999999998765
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHH
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCD 244 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 244 (414)
............||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.........+..+ ....|..++.+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred cccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence 43333344556788899999999887775 89999999999999999 99999988777776666655 44567778999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcC
Q 015005 245 ARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+.+||.+||+.||.+|||+.+++++
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999887
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=373.42 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=221.8
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
++..++|++.+.||+|+||+||+|.+. .+++.||+|.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 456789999999999999999999876 46788999999755432 23457889999999999999999999999
Q ss_pred eCCEEEEEEEccCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeE
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK-----------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLK 155 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~-----------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~k 155 (414)
+.+..|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 99999999999999999998875 3579999999999999999999999999999999999999999999
Q ss_pred EeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc
Q 015005 156 VSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE 234 (414)
Q Consensus 156 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 234 (414)
|+|||++................||+.|+|||++.+..++ .++||||||+++|+|++ |..||.+.+.......+..+.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 9999999865432222233445678999999999887775 89999999999999999 899999988888777776655
Q ss_pred c-CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 235 Y-EFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 235 ~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
. ..+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3 5667799999999999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=378.24 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=216.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEE-----CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKN-----LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVM 85 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 85 (414)
+.-.++|++.+.||+|+||+||+|.+ ..++..||+|++...... ...+.+.+|+.+++++ +||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34567899999999999999999997 346778999999754322 2346788999999999 899999999999
Q ss_pred EeCCEEEEEEEccCCCchHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecC
Q 015005 86 ATKTKVFFVIEYVKGGELFAKVLKG------------------------KLKEESARKYFQQLISAVDFCHSRGVYHRDL 141 (414)
Q Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~~~------------------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDl 141 (414)
...+..|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 9999999999999999999999762 2799999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCC
Q 015005 142 KPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQN 220 (414)
Q Consensus 142 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~ 220 (414)
||+|||++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999865443222233455688999999999887775 89999999999999998 9999988
Q ss_pred chHHHHHHHHHhc--ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCc
Q 015005 221 ENIMKMYRKIFKA--EYEFPPWISCDARRLISRILVADPQKRISVSEIMINPW 271 (414)
Q Consensus 221 ~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 271 (414)
......+...... ....|..+++++.+||.+||+.||.+|||+.++++|..
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 7654444444433 34556778999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=376.76 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=208.8
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEE----EEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESV----AIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
...++|++.+.||+|+||+||+|.+..+++.+ |+|.+..... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 44678999999999999999999998887765 6666643322 22356789999999999999999999999876
Q ss_pred CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
. .++++||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999886 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHH
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCD 244 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 244 (414)
............||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+ ..+.|+.++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43233333445678899999999988775 89999999999999999 99999987776666655544 34567779999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcC
Q 015005 245 ARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+.+|+.+||+.||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=379.48 Aligned_cols=254 Identities=32% Similarity=0.593 Sum_probs=186.7
Q ss_pred hccccCCEEEee-eeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe--
Q 015005 11 RNILFGKYEMGR-MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT-- 87 (414)
Q Consensus 11 ~~~~~~~y~~~~-~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 87 (414)
+..+.++|++.+ .||+|+||+||+|.+..+++.||+|++..... ........++.++||||+++++++..
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 456788999965 69999999999999999999999999965421 11222334567799999999999976
Q ss_pred --CCEEEEEEEccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC---CCeEEeec
Q 015005 88 --KTKVFFVIEYVKGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN---GNLKVSDF 159 (414)
Q Consensus 88 --~~~~~lv~E~~~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~---~~~kl~DF 159 (414)
...+|+||||++||+|.+++... .+++.+++.++.|++.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 55689999999999999999863 69999999999999999999999999999999999999864 45999999
Q ss_pred CCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHH----HHHHHhccc
Q 015005 160 GLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKM----YRKIFKAEY 235 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~ 235 (414)
|++.... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||........ ...+.....
T Consensus 176 g~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 176 GFAKETT----QNALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp TTCEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccceecc----ccccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 9997543 2234566799999999999777775 789999999999999999999987654433 222333333
Q ss_pred CCC----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 236 EFP----PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 236 ~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.+| ..+++++.+||++||+.||.+|||+.|+++||||....
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 333 35899999999999999999999999999999997643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=375.44 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=212.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKV 91 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 91 (414)
.+.++|++.+.||+|+||+||+|.+..+++.||||++...... +.+.+|+.+++.+ +||||+++++++......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 4567899999999999999999999999999999999765332 3577999999999 999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC-----eEEeecCCCcc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN-----LKVSDFGLSAL 164 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~-----~kl~DFGla~~ 164 (414)
|+||||+ |++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 9999999885 68999999999999999999999999999999999999998887 99999999986
Q ss_pred cccccCCC-----ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC---chHHHHHHHHHhcccC
Q 015005 165 PEQLWNDG-----LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN---ENIMKMYRKIFKAEYE 236 (414)
Q Consensus 165 ~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~ 236 (414)
........ .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+ .+..+.+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 43321111 23467899999999999988775 899999999999999999999987 4445556665544444
Q ss_pred CCC-----CCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 237 FPP-----WISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 237 ~~~-----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.|. .++ ++.+||.+||+.||.+||++.+|++
T Consensus 239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 332 244 9999999999999999999998865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=367.00 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=207.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCC---CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVT---QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
++..++|++.+.||+|+||+||+|.+..+ +..||+|.+..... ....+.+.+|+.+++.++||||+++++++. .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 46678999999999999999999998654 45799999865432 234567899999999999999999999984 5
Q ss_pred CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
+..|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 678999999999999999986 369999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHH
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCD 244 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 244 (414)
.. .........+|+.|+|||++.+..++ .++||||||+++|+|++ |..||.+.+..+....+..+. .+.|+.++++
T Consensus 168 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 168 DS-TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 245 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred cc-cccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 32 11123344578899999999887775 79999999999999996 999999877777666666543 4577789999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcC
Q 015005 245 ARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+.++|.+||+.||.+|||+.+++++
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=372.34 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=217.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEE-----CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKN-----LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVM 85 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 85 (414)
+...++|++.+.||+|+||+||+|.+ ..+++.||+|++...... ...+.+.+|+.+++++ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH--HHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 45567999999999999999999984 457889999999765432 2357789999999999 999999999999
Q ss_pred EeCCEEEEEEEccCCCchHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcE
Q 015005 86 ATKTKVFFVIEYVKGGELFAKVLKG-------------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENL 146 (414)
Q Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~~~-------------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NI 146 (414)
.+.+..|+||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 9999999999999999999998763 389999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHH
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMK 225 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 225 (414)
|++.++.+||+|||++................||+.|+|||++.+..++ .++||||||+++|+|++ |..||.+.....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999865443222233445678899999999887775 89999999999999999 999998865544
Q ss_pred HHHHHHhc--ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 226 MYRKIFKA--EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 226 ~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
........ ....+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 44433332 234466789999999999999999999999999865
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=376.19 Aligned_cols=264 Identities=19% Similarity=0.278 Sum_probs=220.8
Q ss_pred HhhhccccCCEEEeeeeeecCCeEEEEEE-----ECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceE
Q 015005 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGK-----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELK 82 (414)
Q Consensus 8 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 82 (414)
..+.++..++|++.+.||+|+||.||+|. +..+++.||+|++..... ......+.+|+.+++.++||||++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 22 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp GGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc--hhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 34567788999999999999999999998 556788999999965432 22356788999999999999999999
Q ss_pred EEEEeCCEEEEEEEccCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC---
Q 015005 83 EVMATKTKVFFVIEYVKGGELFAKVLKG--------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN--- 151 (414)
Q Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~--------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~--- 151 (414)
+++.+....|+||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 9999999999999999999999999863 38999999999999999999999999999999999999944
Q ss_pred CCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHH
Q 015005 152 GNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKI 230 (414)
Q Consensus 152 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i 230 (414)
..+||+|||++................||+.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 46999999998754332222233455689999999999887775 89999999999999998 99999998887777777
Q ss_pred Hhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 231 FKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 231 ~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..+. ...+..++..+.+||.+||+.||.+|||+.+++++.|+..
T Consensus 259 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 259 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 6553 4556778999999999999999999999999999999754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=381.53 Aligned_cols=254 Identities=27% Similarity=0.483 Sum_probs=209.1
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-----------CCCccce
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-----------HPNIVEL 81 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l 81 (414)
...++|++.+.||+|+||+||+|.+..+++.||+|++..... ..+.+.+|+.+++.++ ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 346799999999999999999999999999999999975432 2456788999998876 8999999
Q ss_pred EEEEEeCC----EEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcC---
Q 015005 82 KEVMATKT----KVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDE--- 150 (414)
Q Consensus 82 ~~~~~~~~----~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~--- 150 (414)
++++...+ .++++|||+ |++|.+++.. +.+++..+..++.||+.||.|||++ ||+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99998654 899999999 8999998875 4699999999999999999999998 9999999999999953
Q ss_pred ---CCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH----
Q 015005 151 ---NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI---- 223 (414)
Q Consensus 151 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---- 223 (414)
.+.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 34799999999975432 23445799999999999988775 899999999999999999999986542
Q ss_pred --HHHHHHHH------------------------------------------hcccCCCCCCCHHHHHHHHhhcccCcCC
Q 015005 224 --MKMYRKIF------------------------------------------KAEYEFPPWISCDARRLISRILVADPQK 259 (414)
Q Consensus 224 --~~~~~~i~------------------------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (414)
......+. .....++..++.++.+||++||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11111111 1122334445678999999999999999
Q ss_pred CCChHHHhcCCccccCCC
Q 015005 260 RISVSEIMINPWFIKGFS 277 (414)
Q Consensus 260 R~s~~eil~hp~f~~~~~ 277 (414)
|||++|+++||||.+...
T Consensus 325 Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp CBCHHHHHTCGGGTTCTT
T ss_pred cCCHHHHhhChhhhcccC
Confidence 999999999999987543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=373.01 Aligned_cols=255 Identities=22% Similarity=0.399 Sum_probs=219.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEEC-------CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNL-------VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKE 83 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 83 (414)
+...++|++.+.||+|+||+||+|.+. .++..||+|++..... ....+.+.+|+.+++.+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc--HHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 455689999999999999999999975 4677899999976543 22357789999999999 8999999999
Q ss_pred EEEeCCEEEEEEEccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcE
Q 015005 84 VMATKTKVFFVIEYVKGGELFAKVLKG-----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENL 146 (414)
Q Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NI 146 (414)
++.+.+.+|+||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 999999999999999999999998763 389999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHH
Q 015005 147 LLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMK 225 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 225 (414)
|++.++.+||+|||++................+|+.|+|||++.+..++ .++||||||+++|+|++ |..||.+.+..+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999999999999854432111223344578899999999887775 89999999999999999 999999988887
Q ss_pred HHHHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 226 MYRKIFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 226 ~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
....+..+. ...|..++.++.+||.+||+.||.+|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777776554 45667799999999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=367.27 Aligned_cols=255 Identities=21% Similarity=0.341 Sum_probs=209.7
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEE----ECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEE
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVM 85 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 85 (414)
.++...++|++.+.||+|+||+||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 356778899999999999999999998 56789999999997543 22356789999999999999999999998
Q ss_pred Ee--CCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCC
Q 015005 86 AT--KTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGL 161 (414)
Q Consensus 86 ~~--~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGl 161 (414)
.. ...+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 54 3568999999999999999986 4599999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH----------------
Q 015005 162 SALPEQLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM---------------- 224 (414)
Q Consensus 162 a~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------------- 224 (414)
+......... .......||+.|+|||++.+..++ .++||||||+++|+|++|..||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9865432111 223344577889999999988875 8999999999999999999998765332
Q ss_pred HHHHHHH-hcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 225 KMYRKIF-KAEYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 225 ~~~~~i~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.....+. ....+.|..+++++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1122222 2344567789999999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=364.69 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=214.9
Q ss_pred CcccchhHhhhccccCCEEEee-eeeecCCeEEEEEE--ECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC
Q 015005 1 MKFETMDERVRNILFGKYEMGR-MLGQGTFAKVYYGK--NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77 (414)
Q Consensus 1 ~~~~~~~~~~~~~~~~~y~~~~-~LG~G~~g~Vy~a~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn 77 (414)
|+.+.+....-..-.++|++.+ .||+|+||+||+|. +..+++.||+|++..... .....+.+.+|+.+++.++|||
T Consensus 1 m~~~~i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~ 79 (291)
T 1xbb_A 1 MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPY 79 (291)
T ss_dssp ----------CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTT
T ss_pred CcccccCcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCC
Confidence 5555554444445567899998 99999999999994 456789999999976543 2334578999999999999999
Q ss_pred ccceEEEEEeCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEE
Q 015005 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV 156 (414)
Q Consensus 78 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl 156 (414)
|+++++++ ..+..|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||
T Consensus 80 i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl 158 (291)
T 1xbb_A 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 158 (291)
T ss_dssp BCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred EEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEE
Confidence 99999999 56778999999999999999987 67999999999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc
Q 015005 157 SDFGLSALPEQLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE 234 (414)
Q Consensus 157 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 234 (414)
+|||++......... .......||+.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+..+.
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 237 (291)
T 1xbb_A 159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 237 (291)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred ccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999754332111 112234567899999999887775 79999999999999999 999999988877777766554
Q ss_pred -cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 235 -YEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 235 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
...|..+++++.++|.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4567789999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=367.85 Aligned_cols=260 Identities=26% Similarity=0.447 Sum_probs=211.9
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC--CCCccceEEEEEeCC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK--HPNIVELKEVMATKT 89 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~ 89 (414)
....++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 345668999999999999999999975 5889999999765443 234577899999999997 599999999999999
Q ss_pred EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
..|+||| +.+++|.+++.. +.+++.++..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 9999999 568899999987 7899999999999999999999999999999999999996 589999999999865443
Q ss_pred cCCCccccccCCCcccCchhhcc-----------cCCCCCccchhhhhhhhhhhhcCCCCCCCch-HHHHHHHHHhc--c
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRK-----------KGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN-IMKMYRKIFKA--E 234 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~--~ 234 (414)
.........+||+.|+|||++.+ ..+ +.++||||||+++|+|++|..||.... .......+... .
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 258 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CC-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccC-CchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence 22223445679999999999875 234 478999999999999999999998743 23333444433 3
Q ss_pred cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 235 YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
..+|...+.++.+||.+||+.||.+|||+.|+++||||....
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 356677889999999999999999999999999999997653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=372.51 Aligned_cols=253 Identities=24% Similarity=0.369 Sum_probs=209.0
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEE----EEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESV----AIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
...++|++.+.||+|+||+||+|.+..+++.+ |+|.+..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 44688999999999999999999998888766 5555543221 22357788999999999999999999999876
Q ss_pred CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
. .++++||+.+|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 7899999999999999876 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHH
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCD 244 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 244 (414)
............||+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+.......+..+. .+.|+.++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333334455678899999999988775 89999999999999999 999999887776666665543 5667779999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcC
Q 015005 245 ARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+.+||++||+.||.+|||+.|+++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=358.39 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=217.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 468999999999999999999986 6788999999865543 25788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 999999999999986 569999999999999999999999999999999999999999999999999997543211 11
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLIS 250 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 250 (414)
......||+.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+..+. ...|..++..+.+||.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 239 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence 22344578899999999887775 89999999999999999 999999988888877776653 3456678999999999
Q ss_pred hhcccCcCCCCChHHHhcC
Q 015005 251 RILVADPQKRISVSEIMIN 269 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~h 269 (414)
+||+.||.+|||+.+++++
T Consensus 240 ~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 240 HCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=362.80 Aligned_cols=259 Identities=27% Similarity=0.500 Sum_probs=209.0
Q ss_pred HhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 8 ERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 8 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
...+....++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 103 (310)
T 2wqm_A 24 PDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103 (310)
T ss_dssp GGGTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CCcccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 34466778899999999999999999999999999999999986554444456788999999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
.+..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 9999999999999999988863 56999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch--HHHHHHHHHhcccCC--C
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN--IMKMYRKIFKAEYEF--P 238 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~~--~ 238 (414)
..... .........||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.. .......+.....+. +
T Consensus 184 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (310)
T 2wqm_A 184 RFFSS--KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS 260 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCT
T ss_pred eeecC--CCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcc
Confidence 76443 12233456799999999999887775 89999999999999999999997643 334444554444332 2
Q ss_pred CCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 239 PWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
..++.++.+||.+||+.||.+|||+.+++++
T Consensus 261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 4589999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=371.49 Aligned_cols=249 Identities=21% Similarity=0.249 Sum_probs=202.7
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----E
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT----K 90 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 90 (414)
.++|++.+.||+|+||+||+|.+. ++.||||++...... .....+|+.+++.++||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchH----HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 468999999999999999999864 899999999654322 345567999999999999999999998744 4
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEEecCCCCcEEEcCCCCeEEeecC
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSR----------GVYHRDLKPENLLLDENGNLKVSDFG 160 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~----------gi~HrDlkp~NILl~~~~~~kl~DFG 160 (414)
+|+||||+++|+|.+++..+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 79999999999999999988999999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccccCCCccccccCCCcccCchhhcccCCC----CCccchhhhhhhhhhhhcCCCCCCCch--------------
Q 015005 161 LSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD----GAKSDIWSCGVVLFVLLSGFLPFQNEN-------------- 222 (414)
Q Consensus 161 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~----~~~~DiwSlGvil~~ll~g~~Pf~~~~-------------- 222 (414)
++...............+||+.|+|||++.+.... +.++|||||||++|+|++|..||.+..
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99765443333344556899999999999863221 357899999999999999999997532
Q ss_pred --HHHHHHHHHhccc--CCCCC-----CCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 223 --IMKMYRKIFKAEY--EFPPW-----ISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 223 --~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.......+..... ..+.. .+.++.+||.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222222222221 11111 23459999999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=370.38 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=216.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEE--EEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESV--AIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT 89 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 89 (414)
.-.++|++.+.||+|+||.||+|.+..++..+ |+|.+..... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45679999999999999999999999898865 9999875332 22346788999999999 8999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC
Q 015005 90 KVFFVIEYVKGGELFAKVLKG-----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~-----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~ 152 (414)
..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999999999998763 599999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHH
Q 015005 153 NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIF 231 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 231 (414)
.+||+|||++...... .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999998743321 122344578899999999887775 89999999999999998 999999988888777766
Q ss_pred hc-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCC
Q 015005 232 KA-EYEFPPWISCDARRLISRILVADPQKRISVSEIMINP 270 (414)
Q Consensus 232 ~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 270 (414)
.+ ....|..+++++.+||.+||+.||.+|||+.+++++-
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 55 3456677899999999999999999999999999763
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=358.23 Aligned_cols=248 Identities=21% Similarity=0.348 Sum_probs=216.2
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK-- 88 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 88 (414)
..+..++|++.+.||+|+||+||+|.+ .++.||+|++....... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 456678999999999999999999997 48899999998764332 2356789999999999999999999999887
Q ss_pred CEEEEEEEccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 89 TKVFFVIEYVKGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRG--VYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~g--i~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
...++||||++||+|.+++... .+++..+..++.|++.||.|||++| ++||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 7899999999999999999873 4899999999999999999999999 9999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCcccCchhhcccCCCCC--ccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc--ccCCCC
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGA--KSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--EYEFPP 239 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~--~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~ 239 (414)
... .....||+.|+|||++.+..+... ++||||||+++|+|++|..||...+.......+... ....|.
T Consensus 162 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3kmu_A 162 SFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234 (271)
T ss_dssp TTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred eec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC
Confidence 322 234578999999999987655422 799999999999999999999988877776666544 345677
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+++++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 89999999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=365.00 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=199.7
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
...++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+..+..+++.++||||+++++++.+.+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 45678999999999999999999999999999999997654332 22334455556788889999999999999999999
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+||||+ ++.+...... +.+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-- 177 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC--
Confidence 999999 5566555543 6899999999999999999999996 999999999999999999999999999975432
Q ss_pred CCCccccccCCCcccCchhhc-----ccCCCCCccchhhhhhhhhhhhcCCCCCCC-chHHHHHHHHHhcccC-CC--CC
Q 015005 170 NDGLLHTQCGTPAYVAPEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQN-ENIMKMYRKIFKAEYE-FP--PW 240 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~-~~--~~ 240 (414)
........||+.|+|||++. ...+ +.++|||||||++|+|++|..||.. .........+.....+ .| ..
T Consensus 178 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 178 -DKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp ----------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred -CccccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 22334567999999999995 3344 4789999999999999999999987 3444555555555433 33 34
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+++++.+||.+||+.||.+|||+.++++||||.+
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 7999999999999999999999999999999964
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=360.21 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=212.9
Q ss_pred hHhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhH----HHHHHHHHHHHHhCCCCCccceE
Q 015005 7 DERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGL----MEQIKREISVMRLVKHPNIVELK 82 (414)
Q Consensus 7 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l~ 82 (414)
...++....++|++.+.||+|+||+||+|.+..+++.||+|++.......... .+.+.+|+.+++.++||||++++
T Consensus 10 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp --CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred chhhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 44556677899999999999999999999999999999999997654332211 26788999999999999999999
Q ss_pred EEEEeCCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cEEecCCCCcEEEcCCCC-----
Q 015005 83 EVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRG--VYHRDLKPENLLLDENGN----- 153 (414)
Q Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~g--i~HrDlkp~NILl~~~~~----- 153 (414)
+++.+.. ++||||++||+|.+.+.. ..+++..+..++.|++.||.|||++| |+||||||+|||++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence 9997666 699999999999988865 57999999999999999999999999 999999999999988876
Q ss_pred eEEeecCCCcccccccCCCccccccCCCcccCchhhcc--cCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH--HHHH
Q 015005 154 LKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRK--KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK--MYRK 229 (414)
Q Consensus 154 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~--~~~~ 229 (414)
+||+|||++.... .......||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||...+... ....
T Consensus 168 ~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 168 AKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp EEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred EEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 9999999997432 23455679999999999843 334 478999999999999999999998654322 2333
Q ss_pred HHhc--ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 230 IFKA--EYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 230 i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+... ....|..+++++.+||.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3332 34567779999999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=364.10 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=221.2
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.++..++|++.+.||+|+||+||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34667889999999999999999999999999999999975432 24678899999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
.|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999999975 4599999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDA 245 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 245 (414)
. .........||+.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+... ....|..+++++
T Consensus 164 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (288)
T 3kfa_A 164 D-TYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241 (288)
T ss_dssp S-SSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred C-ccccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHH
Confidence 2 11223344578899999999888775 89999999999999999 99999987776666665544 445677799999
Q ss_pred HHHHHhhcccCcCCCCChHHHhc
Q 015005 246 RRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+||++||+.||.+|||+.++++
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=369.62 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=215.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEE-----CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKN-----LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVM 85 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 85 (414)
+...++|++.+.||+|+||+||+|.+ ..+++.||+|++...... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc--HHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 45568999999999999999999984 457789999999765432 2356788999999999 799999999998
Q ss_pred EeCC-EEEEEEEccCCCchHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEE
Q 015005 86 ATKT-KVFFVIEYVKGGELFAKVLKGK-----------------LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLL 147 (414)
Q Consensus 86 ~~~~-~~~lv~E~~~gg~L~~~i~~~~-----------------~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NIL 147 (414)
...+ .+|+||||++||+|.+++.... +++..+..++.|++.||.|||++||+||||||+||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7754 5999999999999999998632 899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHH-
Q 015005 148 LDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMK- 225 (414)
Q Consensus 148 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~- 225 (414)
++.++.+||+|||++................||+.|+|||++.+..++ .++||||||+++|+|++ |..||.+.....
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 999999999999999865432222233455689999999999887775 89999999999999998 999998765433
Q ss_pred HHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 226 MYRKIFKA-EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 226 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
....+..+ ....|..+++++.++|.+||+.||.+|||+.|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33333333 345677799999999999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=378.61 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=207.5
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
.+...++|++.+.||+|+||+||+|.+. .++..||||++..... ....+.+.+|+.++++++||||+++++++.+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3455678999999999999999999876 4677899999976432 2235678999999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
....|+||||++||+|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999999999986 47999999999999999999999999999999999999999999999999999865
Q ss_pred ccccCC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCC
Q 015005 166 EQLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWIS 242 (414)
Q Consensus 166 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 242 (414)
...... .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..+ ..+.+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence 432111 112233467889999999888775 79999999999999998 99999988887777776654 334566789
Q ss_pred HHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 243 CDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.++.+||.+||+.||.+|||+.++++
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=371.71 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=216.7
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCe-----EEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQE-----SVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVM 85 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 85 (414)
+...++|++.+.||+|+||+||+|.+..+++ .||+|++...... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA--DEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh--HHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4556789999999999999999999877664 7999999765432 2356789999999999 899999999999
Q ss_pred EeCCEEEEEEEccCCCchHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC
Q 015005 86 ATKTKVFFVIEYVKGGELFAKVLK---------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE 150 (414)
Q Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~~---------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~ 150 (414)
.+.+.+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 999999999999999999998864 35799999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHH
Q 015005 151 NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRK 229 (414)
Q Consensus 151 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~ 229 (414)
++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 999999999999865432222223445678899999999887775 89999999999999998 9999988655444444
Q ss_pred HHhc--ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 230 IFKA--EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 230 i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+... ....|...+.++.+||.+||+.||.+|||+.|++++
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 4433 334567789999999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=361.30 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=217.1
Q ss_pred ccCCEEEee-eeeecCCeEEEEEEEC--CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 14 LFGKYEMGR-MLGQGTFAKVYYGKNL--VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 14 ~~~~y~~~~-~LG~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
..++|.+.+ .||+|+||.||+|.+. .++..||+|++..... ....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc--hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 356788887 9999999999999854 4788899999976532 23467889999999999999999999999 4566
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
.|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999999864 56999999999999999999999999999999999999999999999999999865321
Q ss_pred cC-CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHH
Q 015005 169 WN-DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDA 245 (414)
Q Consensus 169 ~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 245 (414)
.. ........||+.|+|||++.+..++ .++||||||+++|+|++ |..||...+..+....+..+. ...|+.+++++
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHH
Confidence 11 1122344578999999999877775 79999999999999998 999999887777777766554 46677899999
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCc
Q 015005 246 RRLISRILVADPQKRISVSEIMINPW 271 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~ 271 (414)
.+||.+||+.||.+|||+.+++++.+
T Consensus 243 ~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 243 YALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999998865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=370.87 Aligned_cols=257 Identities=23% Similarity=0.378 Sum_probs=192.6
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHH-HHHhCCCCCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREIS-VMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~ 90 (414)
+...++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+. +++.++||||+++++++.+.+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH--HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch--HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 456789999999999999999999999999999999997654322 2345556666 6777899999999999999999
Q ss_pred EEEEEEccCCCchHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 91 VFFVIEYVKGGELFAKVL------KGKLKEESARKYFQQLISAVDFCHSR-GVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~------~~~~~e~~~~~~~~ql~~al~~lH~~-gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
.|+||||++| +|.+.+. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999986 7766665 36799999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccCCCccccccCCCcccCchhh----cccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHHHhcccC-C
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVL----RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKIFKAEYE-F 237 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~-~ 237 (414)
.... ........||+.|+|||++ .+..+ +.++|||||||++|+|++|..||...+.. +....+..+..+ +
T Consensus 175 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 175 QLVD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp C---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred eccc---ccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 5432 2223345799999999998 34445 48999999999999999999999875432 222222222221 2
Q ss_pred C----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 238 P----PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 238 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
+ ..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 2 3478999999999999999999999999999999653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=359.98 Aligned_cols=250 Identities=25% Similarity=0.411 Sum_probs=215.4
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe---
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT--- 87 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 87 (414)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 4567788999999999999999999999999999999997653 245689999999999999999999865
Q ss_pred -------------CCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC
Q 015005 88 -------------KTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN 151 (414)
Q Consensus 88 -------------~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~ 151 (414)
...+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 4568999999999999999864 579999999999999999999999999999999999999999
Q ss_pred CCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHH
Q 015005 152 GNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF 231 (414)
Q Consensus 152 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~ 231 (414)
+.+||+|||++..... ........||+.|+|||++.+..+. .++||||||+++|+|++|..||... ......+.
T Consensus 159 ~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~ 232 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET--SKFFTDLR 232 (284)
T ss_dssp TEEEECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred CCEEECcchhheeccc---cccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence 9999999999975443 2233456799999999999887775 8999999999999999999987532 22333333
Q ss_pred hcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 232 KAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 232 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.. ..+..++.++.+||.+||+.||.+|||+.|+++|+|..+.
T Consensus 233 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 233 DG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp TT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred cc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 32 3566789999999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=362.00 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=199.9
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
..+++..++|++.+.||+|+||+||+|.+. ..||+|++...... ....+.+.+|+.+++.++||||++++++. ..
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 446788999999999999999999999853 35999999765433 23457789999999999999999999965 55
Q ss_pred CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
...++||||++|++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 678999999999999999864 679999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccCchhhc---ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH-HHHHHHhcccC-----C
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLR---KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK-MYRKIFKAEYE-----F 237 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~-----~ 237 (414)
............||+.|+|||++. +..+ +.++||||||+++|+|++|..||....... ....+..+... .
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred cccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence 333333445667999999999986 3444 468999999999999999999998754443 33333333322 2
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+..+++++.+||.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3457899999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=364.61 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=205.9
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECC---CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC--
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLV---TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT-- 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 89 (414)
.++|++.+.||+|+||+||+|.+.. ++..||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4689999999999999999998765 56689999997654332 23567889999999999999999999998765
Q ss_pred ---EEEEEEEccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeec
Q 015005 90 ---KVFFVIEYVKGGELFAKVLK-------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDF 159 (414)
Q Consensus 90 ---~~~lv~E~~~gg~L~~~i~~-------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DF 159 (414)
..|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 35999999999999998842 46999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCC
Q 015005 160 GLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEF 237 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~ 237 (414)
|++................+++.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+..+ ....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 270 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC
Confidence 999865432222233445678899999999887775 89999999999999999 99999988777777766655 3456
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 271 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 67799999999999999999999999999865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=361.04 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=210.6
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEE----ECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
+.....+|++.+.||+|+||.||+|. +..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 34556679999999999999999998 5778999999999765422 23577899999999999999999999998
Q ss_pred eC--CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 87 TK--TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 87 ~~--~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
.. ..+|+||||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 76 679999999999999999854 67999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch---------------HHHH
Q 015005 163 ALPEQLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN---------------IMKM 226 (414)
Q Consensus 163 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---------------~~~~ 226 (414)
......... .......||+.|+|||++.+..++ .++||||||+++|+|++|..|+.... ....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 865432111 123455688899999999887775 78999999999999999998865432 1122
Q ss_pred HHHHHh-cccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 227 YRKIFK-AEYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 227 ~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
...+.. ...+.|+.+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 222222 234567789999999999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=365.95 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=212.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCC----eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQ----ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
++...+|++.+.||+|+||+||+|.+..++ ..||+|++..... ......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 455678999999999999999999876553 4699999975432 2235678899999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
.+..|+||||++||+|.+++.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999999999875 57999999999999999999999999999999999999999999999999999865
Q ss_pred ccccC-CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCC
Q 015005 166 EQLWN-DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWIS 242 (414)
Q Consensus 166 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 242 (414)
..... ........+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..+ ..+.+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 276 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred ccccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence 43211 1122234568899999999887775 79999999999999998 99999988887777777655 445667789
Q ss_pred HHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 243 CDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.++.+||.+||+.||.+||++.+++++
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=359.14 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=212.2
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECC---CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLV---TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
....++|++.+.||+|+||+||+|.+.. ++..||+|++...... ...+.+.+|+.+++.++||||+++++++.++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL--DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH--HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc--hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 4557889999999999999999998654 3456999999765322 2357789999999999999999999998754
Q ss_pred CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
..|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 56899999999999999976 469999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHH
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCD 244 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 244 (414)
.. .........+|+.|+|||++.+..++ .++||||||+++|+|++ |..||...........+..+ ..+.|..+++.
T Consensus 165 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 165 DE-DYYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV 242 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred cc-cccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence 32 11123345578899999999887775 89999999999999998 99999876665555555444 44567779999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcC
Q 015005 245 ARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+.+||.+||+.||.+|||+.|++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=356.90 Aligned_cols=250 Identities=21% Similarity=0.282 Sum_probs=208.7
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEE-EEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEV-MATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~ 90 (414)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++...... +.+.+|+.+++.++|++++..+.. ......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence 35678999999999999999999999999999999998765432 357899999999998876655554 477889
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE---cCCCCeEEeecCCCccc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALP 165 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl---~~~~~~kl~DFGla~~~ 165 (414)
.|+||||+ +++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999999 8999999983 679999999999999999999999999999999999999 48889999999999865
Q ss_pred ccccCC-----CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch---HHHHHHHHHhcccCC
Q 015005 166 EQLWND-----GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN---IMKMYRKIFKAEYEF 237 (414)
Q Consensus 166 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~ 237 (414)
...... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+ ....+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cccccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 432211 123456799999999999987775 89999999999999999999998632 223333333333333
Q ss_pred C-----CCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 238 P-----PWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 238 ~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
| ..+|+++.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 3 668999999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=380.40 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=210.5
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT- 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 89 (414)
+..+.++|++.+.||+|+||+||+|.+..+|+.||+|++....... ..+.+.+|+++++.++||||+++++++...+
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 4567889999999999999999999999999999999997654332 2567789999999999999999999998765
Q ss_pred -EEEEEEEccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE----cCCCCeEEeecC
Q 015005 90 -KVFFVIEYVKGGELFAKVLKG----KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL----DENGNLKVSDFG 160 (414)
Q Consensus 90 -~~~lv~E~~~gg~L~~~i~~~----~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl----~~~~~~kl~DFG 160 (414)
..|+||||++||+|.+++... .+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 789999999999999998762 39999999999999999999999999999999999999 777889999999
Q ss_pred CCcccccccCCCccccccCCCcccCchhhcc--------cCCCCCccchhhhhhhhhhhhcCCCCCCCc----hHHHHHH
Q 015005 161 LSALPEQLWNDGLLHTQCGTPAYVAPEVLRK--------KGYDGAKSDIWSCGVVLFVLLSGFLPFQNE----NIMKMYR 228 (414)
Q Consensus 161 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~ 228 (414)
++..... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||... ...+...
T Consensus 162 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 162 AARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GCEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CceEccC---CCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 9985433 223345679999999999865 334 37899999999999999999999642 2334455
Q ss_pred HHHhcccC-------------------CC------CCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 229 KIFKAEYE-------------------FP------PWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 229 ~i~~~~~~-------------------~~------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
++..+.+. .| ..++..+.++|++||+.||++|||+.+++++
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 55544321 11 1234578899999999999999999998654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=378.25 Aligned_cols=243 Identities=26% Similarity=0.436 Sum_probs=211.4
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-EE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT-KV 91 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~ 91 (414)
+..++|++.+.||+|+||+||+|.+ .++.||||++.... ..+.+.+|+.+|++++||||+++++++.... .+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 4567899999999999999999986 47899999997653 2357889999999999999999999987665 79
Q ss_pred EEEEEccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 92 FFVIEYVKGGELFAKVLK-G--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
|+||||+++|+|.+++.. + .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~- 341 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 341 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-
Confidence 999999999999999986 3 379999999999999999999999999999999999999999999999999974322
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDAR 246 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 246 (414)
......+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..+ ....|..+++++.
T Consensus 342 ----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 342 ----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 416 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ----cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 12334678999999999888775 89999999999999998 99999987776666666554 4567788999999
Q ss_pred HHHHhhcccCcCCCCChHHHhc
Q 015005 247 RLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~ 268 (414)
+||.+||+.||.+|||+.++++
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=368.27 Aligned_cols=257 Identities=16% Similarity=0.212 Sum_probs=203.6
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECC---CCeEEEEEEeeccccchhh--------HHHHHHHHHHHHHhCCCCCcc
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLV---TQESVAIKVINKDQVKKQG--------LMEQIKREISVMRLVKHPNIV 79 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv 79 (414)
.+...++|++.+.||+|+||+||+|.+.. ++..+|+|++......... ....+.+|+..++.++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 44556799999999999999999999987 7889999999765422110 013366888999999999999
Q ss_pred ceEEEEEe----CCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC--
Q 015005 80 ELKEVMAT----KTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-- 152 (414)
Q Consensus 80 ~l~~~~~~----~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-- 152 (414)
++++++.. ....|+||||+ |++|.+++.. +.+++.++..++.|++.||+|||++||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 99999988 78999999999 9999999986 6899999999999999999999999999999999999999887
Q ss_pred CeEEeecCCCcccccccC-----CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc--hHHH
Q 015005 153 NLKVSDFGLSALPEQLWN-----DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE--NIMK 225 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--~~~~ 225 (414)
.+||+|||+++....... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||... +...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999976543211 1223556799999999999987775 8999999999999999999999652 2222
Q ss_pred HHHHHHhcccCCC---------CCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 226 MYRKIFKAEYEFP---------PWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 226 ~~~~i~~~~~~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
............| ..++.++.+||.+||+.||.+|||+.++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 2211111111222 2688999999999999999999999999763
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=372.14 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=209.8
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
..++|++.+.||+|+||+||+|.+ .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 567899999999999999999996 4789999999876533 235678999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 94 VIEYVKGGELFAKVLKG-----KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~~-----~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999988653 4899999999999999999999999999999999999999999999999999754433
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHH-------HHHHHhccc------
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKM-------YRKIFKAEY------ 235 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~-------~~~i~~~~~------ 235 (414)
.........+||+.|+|||++.+..++ .++|||||||++|+|++|..||........ ......+..
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 233334455699999999999887775 899999999999999999999976432211 111111111
Q ss_pred C----CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCc
Q 015005 236 E----FPPWISCDARRLISRILVADPQKRISVSEIMINPW 271 (414)
Q Consensus 236 ~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 271 (414)
. .++..+..+.+++.+||+.||++|||+.|++++..
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 12224567899999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=356.68 Aligned_cols=250 Identities=21% Similarity=0.287 Sum_probs=203.2
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEE-EeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVM-ATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~ 90 (414)
-.+.++|++.+.||+|+||+||+|.+..+++.||+|++...... +.+.+|+.+++.++|++++..+..+ ...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 35668999999999999999999999999999999997655432 3477899999999887766665554 77889
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE---cCCCCeEEeecCCCccc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALP 165 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl---~~~~~~kl~DFGla~~~ 165 (414)
.++||||+ +++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999999 9999999884 689999999999999999999999999999999999999 78899999999999865
Q ss_pred ccccCC-----CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH---HHHHHHHHhcccCC
Q 015005 166 EQLWND-----GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI---MKMYRKIFKAEYEF 237 (414)
Q Consensus 166 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~ 237 (414)
...... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+. ...+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 432211 123456799999999999988775 899999999999999999999976432 12333333333333
Q ss_pred C-----CCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 238 P-----PWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 238 ~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
| ..+++++.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 3 567999999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=358.20 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=209.7
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCC---CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEE-EeCC
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVT---QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVM-ATKT 89 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~ 89 (414)
...+|++.+.||+|+||+||+|.+..+ +..+|+|.+..... ....+.+.+|+.++++++||||+++++++ ..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC--HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 345799999999999999999986543 34689999875432 23457789999999999999999999985 4567
Q ss_pred EEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
..|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 88999999999999999976 5689999999999999999999999999999999999999999999999999986533
Q ss_pred cc--CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc-CCCCCCCH
Q 015005 168 LW--NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISC 243 (414)
Q Consensus 168 ~~--~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~ 243 (414)
.. .........||+.|+|||++.+..++ .++||||||+++|+|++ |.+||...+.......+..+.. ..|..++.
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence 21 11223445688899999999888775 89999999999999999 6778877766666666655544 44667899
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhc
Q 015005 244 DARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+.++|.+||+.||.+|||+.|+++
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=352.56 Aligned_cols=249 Identities=21% Similarity=0.363 Sum_probs=214.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
++..++|++.+.||+|+||+||+|.+. ++..||+|.+...... .+.+.+|+++++.++||||+++++++.. +..
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 345678999999999999999999964 6778999999765432 3578899999999999999999999864 568
Q ss_pred EEEEEccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 92 FFVIEYVKGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
|+||||++|++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999999998762 7999999999999999999999999999999999999999999999999999864321
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDAR 246 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 246 (414)
.........+|+.|+|||++.+..++ .++||||||+++|+|++ |..||.+.+..+....+..+ ....|..++.++.
T Consensus 163 -~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (279)
T 1qpc_A 163 -EYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240 (279)
T ss_dssp -CEECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred -ccccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHH
Confidence 11122344578899999999877665 79999999999999999 99999998887777776655 3455677899999
Q ss_pred HHHHhhcccCcCCCCChHHHhc
Q 015005 247 RLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~ 268 (414)
+||.+||+.||++|||+.++++
T Consensus 241 ~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 241 QLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=359.10 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=200.7
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHh--CCCCCccceEEEEEe
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL--VKHPNIVELKEVMAT 87 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~ 87 (414)
++..+.++|++.+.||+|+||+||+|.+ +++.||+|++.... ...+.+|.+++.. ++||||+++++++..
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence 4567889999999999999999999986 78999999986542 2345567777666 799999999998754
Q ss_pred ----CCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEEecCCCCcEEEcCCCCeE
Q 015005 88 ----KTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH--------SRGVYHRDLKPENLLLDENGNLK 155 (414)
Q Consensus 88 ----~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH--------~~gi~HrDlkp~NILl~~~~~~k 155 (414)
...+|+||||+++|+|.+++..+.+++..+..++.|++.||+||| ++||+||||||+|||++.++.+|
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred ccCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 356899999999999999998899999999999999999999999 99999999999999999999999
Q ss_pred EeecCCCcccccccCC--CccccccCCCcccCchhhcccCCC-----CCccchhhhhhhhhhhhcC----------CCCC
Q 015005 156 VSDFGLSALPEQLWND--GLLHTQCGTPAYVAPEVLRKKGYD-----GAKSDIWSCGVVLFVLLSG----------FLPF 218 (414)
Q Consensus 156 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~-----~~~~DiwSlGvil~~ll~g----------~~Pf 218 (414)
|+|||++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999999754321111 112345799999999999876322 2589999999999999999 8888
Q ss_pred CCch----HHHHHHHHHhcc---cCCCC-----CCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 219 QNEN----IMKMYRKIFKAE---YEFPP-----WISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 219 ~~~~----~~~~~~~i~~~~---~~~~~-----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.... ............ ...|. ..++++.+||.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 6531 122223322221 22222 14567999999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=362.49 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=211.0
Q ss_pred ccccCCE-EEeeeeeecCCeEEEEEE----ECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 12 NILFGKY-EMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 12 ~~~~~~y-~~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
.++.++| ++++.||+|+||+||++. +..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--hHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 3567777 999999999999998875 345889999999976532 233567899999999999999999999998
Q ss_pred e--CCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 87 T--KTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 87 ~--~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
+ ...+|+||||+++|+|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 8 46899999999999999999988899999999999999999999999999999999999999999999999999986
Q ss_pred cccccCC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH---------------HHHH
Q 015005 165 PEQLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM---------------KMYR 228 (414)
Q Consensus 165 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------------~~~~ 228 (414)
....... .......||+.|+|||++.+..++ .++||||||+++|+|++|..||...... ....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 5432111 123445688899999999887775 7899999999999999999999765332 1111
Q ss_pred HHHh-cccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 229 KIFK-AEYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 229 ~i~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+.. ...+.|..++.++.+||++||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2222 234566779999999999999999999999999984
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=355.88 Aligned_cols=250 Identities=23% Similarity=0.350 Sum_probs=210.0
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCe---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE-E
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQE---SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV-F 92 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-~ 92 (414)
.|++.+.||+|+||+||+|.+..++. .||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE--MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 56777999999999999998765544 799999965432 23457888999999999999999999999876655 9
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc-
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW- 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 169 (414)
++|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999986 579999999999999999999999999999999999999999999999999997543221
Q ss_pred -CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHH
Q 015005 170 -NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDAR 246 (414)
Q Consensus 170 -~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 246 (414)
.........||+.|+|||.+.+..++ .++||||||+++|+|++ |.+||...+.......+.... ...|..+++++.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 22233455688999999999887775 89999999999999999 556666666555555555443 456677899999
Q ss_pred HHHHhhcccCcCCCCChHHHhcC
Q 015005 247 RLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~h 269 (414)
+||.+||+.||.+|||+.++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=385.92 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=217.3
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
-..+|++.+.||+|+||.||+|.+..++..||||++...... .+.+.+|+.+|++++||||+++++++.+...+|+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 456799999999999999999999999999999999765432 4678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 94 VIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 372 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-T 372 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-C
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC-c
Confidence 9999999999999975 45999999999999999999999999999999999999999999999999999865321 1
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRL 248 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 248 (414)
........+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++++.+|
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1112234567889999999887775 89999999999999999 99999987776666665544 345677899999999
Q ss_pred HHhhcccCcCCCCChHHHhc
Q 015005 249 ISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~ 268 (414)
|.+||+.||.+|||+.++++
T Consensus 452 i~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHH
Confidence 99999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=370.66 Aligned_cols=255 Identities=14% Similarity=0.178 Sum_probs=202.3
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCC-----CeEEEEEEeeccccchhhH--------HHHHHHHHHHHHhCCCCCc
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVT-----QESVAIKVINKDQVKKQGL--------MEQIKREISVMRLVKHPNI 78 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~--------~~~~~~Ei~il~~l~hpnI 78 (414)
+...++|++.+.||+|+||+||+|.+..+ ++.||+|++.......... ......|+..++.++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 34456999999999999999999998764 5889999987654211100 1223456667788899999
Q ss_pred cceEEEEEeC----CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc--C
Q 015005 79 VELKEVMATK----TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD--E 150 (414)
Q Consensus 79 v~l~~~~~~~----~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~--~ 150 (414)
+++++++... ...|+||||+ |++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9999998764 5689999999 9999999876 5799999999999999999999999999999999999999 8
Q ss_pred CCCeEEeecCCCcccccccCC-----CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH
Q 015005 151 NGNLKVSDFGLSALPEQLWND-----GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK 225 (414)
Q Consensus 151 ~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~ 225 (414)
++.+||+|||+++........ ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 899999999999765432211 122445699999999999988775 89999999999999999999998642221
Q ss_pred HHHHHHh----cc-------cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 226 MYRKIFK----AE-------YEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 226 ~~~~i~~----~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+..... .. .-.+..++.++.+||.+||..||.+||++.+|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111110 00 0112457899999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=378.44 Aligned_cols=248 Identities=22% Similarity=0.375 Sum_probs=214.5
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+..++|++.+.||+|+||+||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. ...+|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 44678999999999999999999975 577899999976442 2467899999999999999999999986 56789
Q ss_pred EEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999999999999985 379999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 247 (414)
........+|+.|+|||++....++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++++.+
T Consensus 339 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 339 -YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp -HHTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred -eeccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 0112234467889999999887775 89999999999999999 99999998887777776654 34567789999999
Q ss_pred HHHhhcccCcCCCCChHHHhc
Q 015005 248 LISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~ 268 (414)
||.+||+.||.+|||+.+|++
T Consensus 417 li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=362.14 Aligned_cols=259 Identities=23% Similarity=0.323 Sum_probs=214.2
Q ss_pred hHhhhccc-cCCEEEeeeeeecCCeEEEEEE----ECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccce
Q 015005 7 DERVRNIL-FGKYEMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVEL 81 (414)
Q Consensus 7 ~~~~~~~~-~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l 81 (414)
...+.+.+ .++|++.+.||+|+||.||+|. +..+++.||+|++..... ...+.+.+|+++++.++||||+++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~ 89 (327)
T 3lxl_A 13 ACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP---DQQRDFQREIQILKALHSDFIVKY 89 (327)
T ss_dssp ----CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH---HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hcChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH---HHHHHHHHHHHHHHhcCCCceeEE
Confidence 34455555 4689999999999999999998 567899999999976532 235678999999999999999999
Q ss_pred EEEEE--eCCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEe
Q 015005 82 KEVMA--TKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVS 157 (414)
Q Consensus 82 ~~~~~--~~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~ 157 (414)
++++. +....|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~ 169 (327)
T 3lxl_A 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIA 169 (327)
T ss_dssp EEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred EEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEc
Confidence 99986 55779999999999999999876 569999999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH------------
Q 015005 158 DFGLSALPEQLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM------------ 224 (414)
Q Consensus 158 DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~------------ 224 (414)
|||++......... .......||+.|+|||++.+..+. .++||||||+++|+|++|..||......
T Consensus 170 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3lxl_A 170 DFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248 (327)
T ss_dssp CGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC
T ss_pred ccccceecccCCccceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc
Confidence 99999865332111 122345688899999999887774 8999999999999999999999765432
Q ss_pred ---HHHHHHHh-cccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 225 ---KMYRKIFK-AEYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 225 ---~~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.....+.. ...+.|..+++++.+||.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12222222 2345677799999999999999999999999999654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=358.21 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=207.8
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECC-CCe--EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLV-TQE--SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
.+..++|++.+.||+|+||+||+|.+.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4456789999999999999999998643 333 6999999876554445567899999999999999999999999876
Q ss_pred CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
. .++||||+++++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 8999999999999999876 579999999999999999999999999999999999999999999999999997653
Q ss_pred cccCC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc--cCCCCCCC
Q 015005 167 QLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE--YEFPPWIS 242 (414)
Q Consensus 167 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s 242 (414)
..... .......+|+.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+.... .+.+..++
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 32111 122345678899999999887775 79999999999999999 999999988888877776654 34556789
Q ss_pred HHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 243 CDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 243 ~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.++.++|.+||+.||.+|||+.+++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=353.65 Aligned_cols=243 Identities=26% Similarity=0.424 Sum_probs=205.4
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-CEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK-TKV 91 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~ 91 (414)
...++|++.+.||+|+||+||+|.+ +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++... +..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 4568999999999999999999986 58899999997543 246788999999999999999999997544 578
Q ss_pred EEEEEccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 92 FFVIEYVKGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
|+||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~- 169 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 169 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc-
Confidence 9999999999999998862 389999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDAR 246 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 246 (414)
......+++.|+|||++.+..++ .++||||||+++|+|++ |..||...+..+....+..+ ....+..+++.+.
T Consensus 170 ----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 170 ----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred ----cccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence 12344688999999999887775 89999999999999998 99999987776666666554 3456777999999
Q ss_pred HHHHhhcccCcCCCCChHHHhc
Q 015005 247 RLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~ 268 (414)
++|.+||+.||.+|||+.++++
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCChhhCCCHHHHHH
Confidence 9999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=360.76 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=205.7
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe----CC
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT----KT 89 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~ 89 (414)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH---HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 35689999999999999999999999999999999865432 235678899999999999999999999863 35
Q ss_pred EEEEEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 90 KVFFVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
..|+||||+++|+|.+.+.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999999999988874 5699999999999999999999999999999999999999999999999999875
Q ss_pred cccccCCC-------ccccccCCCcccCchhhcccCC--CCCccchhhhhhhhhhhhcCCCCCCCchHH--HHHHHHHh-
Q 015005 165 PEQLWNDG-------LLHTQCGTPAYVAPEVLRKKGY--DGAKSDIWSCGVVLFVLLSGFLPFQNENIM--KMYRKIFK- 232 (414)
Q Consensus 165 ~~~~~~~~-------~~~~~~gt~~y~APE~~~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~~i~~- 232 (414)
........ ......||+.|+|||++.+..+ .+.++||||||+++|+|++|..||...... .....+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 43211110 1123468999999999875442 247999999999999999999999642211 11111111
Q ss_pred cccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCC
Q 015005 233 AEYEFPPWISCDARRLISRILVADPQKRISVSEIMINP 270 (414)
Q Consensus 233 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 270 (414)
...+.++.++.++.+||.+||+.||.+|||+.+++++-
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 12334456899999999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=374.02 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=198.5
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 89 (414)
...+.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.+..
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 45667788899999999999998764 4689999999986542 24567899999876 8999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhcCCC--------CHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC----------
Q 015005 90 KVFFVIEYVKGGELFAKVLKGKL--------KEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN---------- 151 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~--------~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~---------- 151 (414)
.+|+|||||. |+|.+++..... ++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 9999999996 699999987432 233457799999999999999999999999999999754
Q ss_pred ---CCeEEeecCCCcccccccCC--CccccccCCCcccCchhhcc-------cCCCCCccchhhhhhhhhhhhc-CCCCC
Q 015005 152 ---GNLKVSDFGLSALPEQLWND--GLLHTQCGTPAYVAPEVLRK-------KGYDGAKSDIWSCGVVLFVLLS-GFLPF 218 (414)
Q Consensus 152 ---~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~-------~~~~~~~~DiwSlGvil~~ll~-g~~Pf 218 (414)
+.+||+|||++......... ......+||+.|+|||++.+ ..+ +.++|||||||++|+|++ |..||
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCC-CTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCc-chhhhhHhHHHHHHHHHhCCCCCC
Confidence 47999999999865432111 12345689999999999975 334 589999999999999999 99999
Q ss_pred CCchHHHHHHHHHhcccCCCC-------CCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 219 QNENIMKMYRKIFKAEYEFPP-------WISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 219 ~~~~~~~~~~~i~~~~~~~~~-------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
....... ..+..+....+. .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 241 ~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 241 GDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp CSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 8754332 234444333322 24578999999999999999999999999999964
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=375.27 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=210.2
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+..++|++.+.||+|+||+||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.+ ...|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 445789999999999999999999864 467999999765432 3578899999999999999999999876 6789
Q ss_pred EEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+||||+++|+|.+++.. ..+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 333 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN- 333 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC-
Confidence 99999999999999974 46999999999999999999999999999999999999999999999999999865421
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 247 (414)
.........+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|+.+++.+.+
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred ceecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11122344578899999999887775 89999999999999999 99999998887777776655 34667789999999
Q ss_pred HHHhhcccCcCCCCChHHHhc
Q 015005 248 LISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~ 268 (414)
||.+||+.||.+|||++++++
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=358.32 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=203.2
Q ss_pred hHhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC--CCCCccceEEE
Q 015005 7 DERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV--KHPNIVELKEV 84 (414)
Q Consensus 7 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~~~ 84 (414)
....+..+.++|++.+.||+|+||.||+|.+. ++.||+|++.... .....+|.+++..+ +||||++++++
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 33456778889999999999999999999864 8999999986442 23344566666554 89999999999
Q ss_pred EEeC----CEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEEecCCCCcEEEcCCC
Q 015005 85 MATK----TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSR--------GVYHRDLKPENLLLDENG 152 (414)
Q Consensus 85 ~~~~----~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~--------gi~HrDlkp~NILl~~~~ 152 (414)
+... ..+|+||||++||+|.+++....+++..+..++.|++.||.|||++ ||+||||||+|||++.++
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 9887 7899999999999999999889999999999999999999999999 999999999999999999
Q ss_pred CeEEeecCCCcccccccCC--CccccccCCCcccCchhhcccCCCCC-----ccchhhhhhhhhhhhcC----------C
Q 015005 153 NLKVSDFGLSALPEQLWND--GLLHTQCGTPAYVAPEVLRKKGYDGA-----KSDIWSCGVVLFVLLSG----------F 215 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~-----~~DiwSlGvil~~ll~g----------~ 215 (414)
.+||+|||++......... ......+||+.|+|||++.+..+... ++|||||||++|+|++| .
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 9999999999754322111 11235679999999999987766522 38999999999999999 7
Q ss_pred CCCCCch-----HHHHHHHHHhc--ccCCCC-----CCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 216 LPFQNEN-----IMKMYRKIFKA--EYEFPP-----WISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 216 ~Pf~~~~-----~~~~~~~i~~~--~~~~~~-----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.||.... .......+... ...+|. .++.++.+||.+||+.||.+|||+.++++|
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 7775421 12222222211 222332 345679999999999999999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=373.41 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=196.7
Q ss_pred cccC--CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 015005 13 ILFG--KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKT 89 (414)
Q Consensus 13 ~~~~--~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 89 (414)
...+ +|.+.+.||+|+||+|+.. ...+++.||||++...... .+.+|+.+++.+ +||||+++++++.+..
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 4444 4999999999999997643 3468999999999765432 245899999999 7999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC---C--CCeEEeecCCC
Q 015005 90 KVFFVIEYVKGGELFAKVLKG--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---N--GNLKVSDFGLS 162 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---~--~~~kl~DFGla 162 (414)
..|+|||||. |+|.+++... ..++..+..++.|++.||.|||++||+||||||+|||++. + ..+||+|||+|
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999996 5999998863 4666778899999999999999999999999999999953 2 35889999999
Q ss_pred ccccccc-CCCccccccCCCcccCchhhcc---cCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcccCC
Q 015005 163 ALPEQLW-NDGLLHTQCGTPAYVAPEVLRK---KGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEYEF 237 (414)
Q Consensus 163 ~~~~~~~-~~~~~~~~~gt~~y~APE~~~~---~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (414)
....... ........+||+.|+|||++.+ ..+ +.++|||||||++|+|++ |..||...................
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 8654321 1123445679999999999974 333 468999999999999999 999997654443322221111111
Q ss_pred ---CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 238 ---PPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 238 ---~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+...+..+.+||.+||+.||.+|||+.|+++||||..
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 1224556899999999999999999999999999964
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=367.50 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=201.6
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCC---eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE-eCCEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQ---ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA-TKTKVF 92 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~ 92 (414)
.|++.+.||+|+||+||+|.+..++ ..||+|.+..... ....+.+.+|+.++++++||||+++++++. ..+..|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC--SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 5899999999999999999875432 4689999865332 234678899999999999999999999874 456889
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999999999986 4689999999999999999999999999999999999999999999999999985432111
Q ss_pred --CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHH
Q 015005 171 --DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDAR 246 (414)
Q Consensus 171 --~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 246 (414)
........||+.|+|||++.+..++ .++|||||||++|+|++ |.+||...+..+....+..+. ...|..++..+.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1122344578899999999888775 89999999999999999 788898766555555555544 345677899999
Q ss_pred HHHHhhcccCcCCCCChHHHhcC
Q 015005 247 RLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil~h 269 (414)
++|.+||+.||.+|||+.|++++
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999865
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=361.85 Aligned_cols=245 Identities=16% Similarity=0.236 Sum_probs=203.0
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCC--------CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccc------
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVT--------QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVE------ 80 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~------ 80 (414)
.++|++.+.||+|+||+||+|.+..+ ++.||+|++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 57999999999999999999999874 889999999754 24678999999999999887
Q ss_pred ---------eEEEEEe-CCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEE
Q 015005 81 ---------LKEVMAT-KTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLL 147 (414)
Q Consensus 81 ---------l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NIL 147 (414)
+++++.. ....|+||||+ |++|.+++.. +.+++.++..++.|++.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777776 78999999999 9999999986 57999999999999999999999999999999999999
Q ss_pred EcCCC--CeEEeecCCCcccccccC-----CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCC
Q 015005 148 LDENG--NLKVSDFGLSALPEQLWN-----DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQN 220 (414)
Q Consensus 148 l~~~~--~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~ 220 (414)
++.++ .+||+|||++........ ........||+.|+|||++.+..++ .++|||||||++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCccc
Confidence 99998 999999999986543221 1122445799999999999887775 899999999999999999999987
Q ss_pred ch--HHHHHHH---HHhcccCCC------CCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 221 EN--IMKMYRK---IFKAEYEFP------PWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 221 ~~--~~~~~~~---i~~~~~~~~------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.. ....... +......++ ..++.++.+||.+||+.||.+|||+.++++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 53 2222222 222222222 2468999999999999999999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=365.83 Aligned_cols=245 Identities=16% Similarity=0.210 Sum_probs=202.0
Q ss_pred ccCCEEEeeeeeecCCeEEEEE-----EECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC---CCCccceEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYG-----KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK---HPNIVELKEVM 85 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~ 85 (414)
..++|++.+.||+|+||+||+| .+..+++.||+|++.... ...+.+|+++++.++ |+||+++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 3567999999999999999999 467789999999997543 345778888888886 99999999999
Q ss_pred EeCCEEEEEEEccCCCchHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC---------
Q 015005 86 ATKTKVFFVIEYVKGGELFAKVL------KGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--------- 150 (414)
Q Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~------~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~--------- 150 (414)
...+..|+||||++||+|.+++. .+.+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 99999999999999999999996 256999999999999999999999999999999999999998
Q ss_pred --CCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHH
Q 015005 151 --NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYR 228 (414)
Q Consensus 151 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~ 228 (414)
++.+||+|||+|...............+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 899999999999755433334455677899999999999988875 89999999999999999999996543210
Q ss_pred HHHhcccCC-CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCC
Q 015005 229 KIFKAEYEF-PPWISCDARRLISRILVADPQKRISVSEIMINP 270 (414)
Q Consensus 229 ~i~~~~~~~-~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 270 (414)
......+ ..+.+..+.+++.+||+.+|.+|++..+.+.+.
T Consensus 293 --~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 293 --CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp --EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred --eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 0000111 123567899999999999999997665555443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=351.60 Aligned_cols=232 Identities=31% Similarity=0.616 Sum_probs=193.4
Q ss_pred ccccCCEEEe-eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHH-HhCCCCCccceEEEEEe--
Q 015005 12 NILFGKYEMG-RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKHPNIVELKEVMAT-- 87 (414)
Q Consensus 12 ~~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~-- 87 (414)
..+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 4567788887 8899999999999999999999999999642 3456888887 56699999999999987
Q ss_pred --CCEEEEEEEccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC---CCCeEEeec
Q 015005 88 --KTKVFFVIEYVKGGELFAKVLKG---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---NGNLKVSDF 159 (414)
Q Consensus 88 --~~~~~lv~E~~~gg~L~~~i~~~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---~~~~kl~DF 159 (414)
...+|+||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 67899999999999999999862 5999999999999999999999999999999999999998 789999999
Q ss_pred CCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHH----HHHhccc
Q 015005 160 GLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYR----KIFKAEY 235 (414)
Q Consensus 160 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~----~i~~~~~ 235 (414)
|++.... +..+ +.++|||||||++|+|++|..||...+...... .+.....
T Consensus 165 g~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 165 GFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219 (299)
T ss_dssp TTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred ccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence 9986322 1224 378999999999999999999998765543321 1122233
Q ss_pred CCC----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 236 EFP----PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 236 ~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.+| ..+++++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 333 45899999999999999999999999999999997653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=351.58 Aligned_cols=242 Identities=29% Similarity=0.475 Sum_probs=199.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+-.++|++.+.||+|+||+||+|.+ .++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 3467899999999999999999986 47899999986432 24678899999999999999999998863 478
Q ss_pred EEEEccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcEEecCCCCcEEEcCCCC-eEEeecCCCcc
Q 015005 93 FVIEYVKGGELFAKVLKG----KLKEESARKYFQQLISAVDFCHS---RGVYHRDLKPENLLLDENGN-LKVSDFGLSAL 164 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~~----~~~e~~~~~~~~ql~~al~~lH~---~gi~HrDlkp~NILl~~~~~-~kl~DFGla~~ 164 (414)
+||||++||+|.+++... .+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 999999999999999863 37899999999999999999999 89999999999999998887 79999999975
Q ss_pred cccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch--HHHHHHHHHh-cccCCCCCC
Q 015005 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN--IMKMYRKIFK-AEYEFPPWI 241 (414)
Q Consensus 165 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~-~~~~~~~~~ 241 (414)
... ......||+.|+|||++.+..++ .++||||||+++|+|++|..||.... .......+.. .....+..+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQT-----HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred ccc-----ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 432 22345699999999999887775 89999999999999999999997532 2223333332 334556678
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+..+.+||.+||+.||.+|||+.+++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=362.03 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=207.7
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.....++|++.+.||+|+||+||+|.+ .+++.||+|++........ ...+.+|+.+++.++||||+++++++.+.+.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 345678999999999999999999984 4789999999976543322 2368899999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 91 VFFVIEYVKGGELFAKVLKG-----KLKEESARKYFQQLISAVDFCHSR---GVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~-----~~~e~~~~~~~~ql~~al~~lH~~---gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
.++||||++||+|.+.+... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 99999999999999999762 399999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH----HHHHHHHhccc---
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM----KMYRKIFKAEY--- 235 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~--- 235 (414)
...... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...... .....+.....
T Consensus 182 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 182 KLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp EECCSS-SSCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccCcc-cccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 865432 22334455699999999999887774 8999999999999999999999632211 01111111100
Q ss_pred ------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCc
Q 015005 236 ------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPW 271 (414)
Q Consensus 236 ------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 271 (414)
..+...+..+.+|+.+||+.||.+|||+.|+++|.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 111123467999999999999999999999998864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=357.56 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=189.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEE-----
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMA----- 86 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~----- 86 (414)
....+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE---EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch---HHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 344589999999999999999999999999999999865432 23567889999999995 999999999994
Q ss_pred ---eCCEEEEEEEccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cEEecCCCCcEEEcCCCCeEEe
Q 015005 87 ---TKTKVFFVIEYVKGGELFAKVLK----GKLKEESARKYFQQLISAVDFCHSRG--VYHRDLKPENLLLDENGNLKVS 157 (414)
Q Consensus 87 ---~~~~~~lv~E~~~gg~L~~~i~~----~~~~e~~~~~~~~ql~~al~~lH~~g--i~HrDlkp~NILl~~~~~~kl~ 157 (414)
....++++|||+. |+|.+++.. +.+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 3456899999996 688887753 57999999999999999999999999 9999999999999999999999
Q ss_pred ecCCCcccccccCC----------CccccccCCCcccCchhh---cccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH
Q 015005 158 DFGLSALPEQLWND----------GLLHTQCGTPAYVAPEVL---RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM 224 (414)
Q Consensus 158 DFGla~~~~~~~~~----------~~~~~~~gt~~y~APE~~---~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~ 224 (414)
|||++......... ......+||+.|+|||++ .+..+ +.++|||||||++|+|++|..||......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 99999865432111 111255699999999998 34444 47999999999999999999999875544
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 225 KMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 225 ~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
...... ...+.+...+..+.+||++||+.||.+|||+.|+++|.+-
T Consensus 260 ~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 260 RIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 332221 1223345578889999999999999999999999998653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.59 Aligned_cols=254 Identities=21% Similarity=0.342 Sum_probs=210.0
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEE----ECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGK----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA 86 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 86 (414)
.....++|++.+.||+|+||.||+|. +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 45667789999999999999999998 46789999999997643 223567899999999999999999999986
Q ss_pred eCC--EEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 87 TKT--KVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 87 ~~~--~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
..+ .+++||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 544 78999999999999999986 45999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH----------------H
Q 015005 163 ALPEQLWND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM----------------K 225 (414)
Q Consensus 163 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----------------~ 225 (414)
......... .......+++.|+|||++.+..++ .++||||||+++|+|++|..||...... .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 865432111 112334578889999999887775 7999999999999999999998754211 1
Q ss_pred HHHHHHh-cccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 226 MYRKIFK-AEYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 226 ~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
....+.. ...+.|..++.++.+||++||+.||.+|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1112222 234567779999999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=382.91 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=208.7
Q ss_pred cCCEEEee-eeeecCCeEEEEEEEC--CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 15 FGKYEMGR-MLGQGTFAKVYYGKNL--VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 15 ~~~y~~~~-~LG~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
.+++.+.+ .||+|+||+||+|.+. .++..||||++..... ....+.+.+|+++|+.++||||+++++++.+ +.+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 34566666 8999999999999775 3566799999976532 2235788999999999999999999999986 569
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+||||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999999875 569999999999999999999999999999999999999999999999999998654321
Q ss_pred CC-CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHH
Q 015005 170 ND-GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDAR 246 (414)
Q Consensus 170 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 246 (414)
.. .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+. ...|..+++++.
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 569 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 11 112233467899999999888775 89999999999999998 999999988777777776654 467788999999
Q ss_pred HHHHhhcccCcCCCCChHHHh
Q 015005 247 RLISRILVADPQKRISVSEIM 267 (414)
Q Consensus 247 ~li~~~L~~dp~~R~s~~eil 267 (414)
+||.+||+.||.+|||+.+++
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHH
Confidence 999999999999999999984
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=355.81 Aligned_cols=248 Identities=29% Similarity=0.383 Sum_probs=203.7
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeecccc-chhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV-KKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
|..++.||+|+||+||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 55669999999999999985 688999999975432 233446789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 97 YVKGGELFAKVLK----GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 97 ~~~gg~L~~~i~~----~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999998873 469999999999999999999999999999999999999999999999999998654322222
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH----HHHHHHhccc-----------CC
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK----MYRKIFKAEY-----------EF 237 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~-----------~~ 237 (414)
.....+||+.|+|||++.+. + +.++||||||+++|+|++|..||....... ....+..... ..
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 33456799999999998764 4 479999999999999999999998754321 1122211111 11
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22345678999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=356.58 Aligned_cols=259 Identities=20% Similarity=0.326 Sum_probs=196.5
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHH--HHhCCCCCccceEEEEEe-
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISV--MRLVKHPNIVELKEVMAT- 87 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~i--l~~l~hpnIv~l~~~~~~- 87 (414)
.....++|++.+.||+|+||+||+|.+ +++.||+|++..... ..+..|.++ +..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 456788999999999999999999975 789999999975432 223334444 456899999999986643
Q ss_pred ----CCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEEecCCCCcEEEcCCCCe
Q 015005 88 ----KTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSR---------GVYHRDLKPENLLLDENGNL 154 (414)
Q Consensus 88 ----~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~---------gi~HrDlkp~NILl~~~~~~ 154 (414)
...+|+||||++||+|.+++.....++..+..++.|++.||.|||++ ||+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 33689999999999999999988889999999999999999999999 99999999999999999999
Q ss_pred EEeecCCCccccccc------CCCccccccCCCcccCchhhccc-------CCCCCccchhhhhhhhhhhhcCCCCCCCc
Q 015005 155 KVSDFGLSALPEQLW------NDGLLHTQCGTPAYVAPEVLRKK-------GYDGAKSDIWSCGVVLFVLLSGFLPFQNE 221 (414)
Q Consensus 155 kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~APE~~~~~-------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 221 (414)
||+|||++....... ........+||+.|+|||++.+. .+ +.++|||||||++|+|++|..||...
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA-LKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH-HHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccc-ccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999997543211 12223455799999999999762 23 36799999999999999997765321
Q ss_pred hH-----------------HHHHHHHHhc---ccCCCCC------CCHHHHHHHHhhcccCcCCCCChHHH------hcC
Q 015005 222 NI-----------------MKMYRKIFKA---EYEFPPW------ISCDARRLISRILVADPQKRISVSEI------MIN 269 (414)
Q Consensus 222 ~~-----------------~~~~~~i~~~---~~~~~~~------~s~~~~~li~~~L~~dp~~R~s~~ei------l~h 269 (414)
.. .......... ...+|.. +++++.+||.+||+.||++|||+.|+ +.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 10 1111122111 2233332 34479999999999999999999999 557
Q ss_pred CccccCCCC
Q 015005 270 PWFIKGFSK 278 (414)
Q Consensus 270 p~f~~~~~~ 278 (414)
+|-++....
T Consensus 319 ~~~~~~~~~ 327 (336)
T 3g2f_A 319 IWERNKSVS 327 (336)
T ss_dssp CCCC-----
T ss_pred HHHhcccCC
Confidence 777665443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=383.23 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=208.8
Q ss_pred EEE-eeeeeecCCeEEEEEEE--CCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 18 YEM-GRMLGQGTFAKVYYGKN--LVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 18 y~~-~~~LG~G~~g~Vy~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+.+ .+.||+|+||+||+|.+ ..+++.||||++...... ....+.+.+|+++|+.++||||+++++++..+ ..++|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEE
Confidence 444 34899999999999954 457789999999765432 33457899999999999999999999999754 58899
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC-CC
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN-DG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 172 (414)
|||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999999999987 6799999999999999999999999999999999999999999999999999986533211 11
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLIS 250 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 250 (414)
......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+. ...|..++.++.+||.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 22334578899999999888775 89999999999999998 999999988888877776654 4567789999999999
Q ss_pred hhcccCcCCCCChHHHhc
Q 015005 251 RILVADPQKRISVSEIMI 268 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~ 268 (414)
+||+.||++|||+.++++
T Consensus 607 ~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHTCSSTTTSCCHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHH
Confidence 999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=354.00 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=209.0
Q ss_pred hHhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHh--CCCCCccceEEE
Q 015005 7 DERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL--VKHPNIVELKEV 84 (414)
Q Consensus 7 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~ 84 (414)
+..++..+.++|++.+.||+|+||+||+|.+ +++.||+|++.... ...+.+|+++++. ++||||++++++
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 3445667788999999999999999999986 58999999996432 3457789999887 789999999999
Q ss_pred EEeCC----EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEEecCCCCcEEEcCCC
Q 015005 85 MATKT----KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCH--------SRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 85 ~~~~~----~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH--------~~gi~HrDlkp~NILl~~~~ 152 (414)
+.... .+|+||||+++|+|.+++....+++..+..++.|++.||.||| ++||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 98876 8999999999999999999889999999999999999999999 89999999999999999999
Q ss_pred CeEEeecCCCcccccccCC--CccccccCCCcccCchhhcccCCCC-----CccchhhhhhhhhhhhcC----------C
Q 015005 153 NLKVSDFGLSALPEQLWND--GLLHTQCGTPAYVAPEVLRKKGYDG-----AKSDIWSCGVVLFVLLSG----------F 215 (414)
Q Consensus 153 ~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~-----~~~DiwSlGvil~~ll~g----------~ 215 (414)
.+||+|||++......... ......+||+.|+|||++.+..... .++|||||||++|+|++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999754432110 0234557999999999997653221 579999999999999999 8
Q ss_pred CCCCCc-----hHHHHHHHHHhccc--CCCC-----CCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 216 LPFQNE-----NIMKMYRKIFKAEY--EFPP-----WISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 216 ~Pf~~~-----~~~~~~~~i~~~~~--~~~~-----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
.||... ........+..... ..|. ..+..+.+||.+||+.||.+|||+.++++|
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 899764 23344444433322 2232 123578899999999999999999999876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=376.88 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=214.6
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+..++|++.+.||+|+||+||+|.+.. +..||||++...... .+.+.+|+++|+.++||||+++++++.+ ..+|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 456789999999999999999999864 467999999765432 3578899999999999999999999876 6789
Q ss_pred EEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+||||+++|+|.+++.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999999974 469999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 247 (414)
........+++.|+|||++.+..++ .++|||||||+||+|++ |..||.+....+....+..+ ..+.|..++.++.+
T Consensus 418 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 418 -YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp -HHTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -eecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 0112234577899999999887775 89999999999999999 99999998887777776655 34567789999999
Q ss_pred HHHhhcccCcCCCCChHHHhcC
Q 015005 248 LISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~h 269 (414)
||.+||+.||++|||+.+|++.
T Consensus 496 li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=365.69 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=209.2
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-CCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH-PNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~ 90 (414)
..+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|..+..++.....
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 35678999999999999999999999999999999998765432 247789999999976 666677777788899
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE---cCCCCeEEeecCCCccc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL---DENGNLKVSDFGLSALP 165 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl---~~~~~~kl~DFGla~~~ 165 (414)
.|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99999999 9999999984 689999999999999999999999999999999999999 68899999999999865
Q ss_pred ccccCC-----CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch---HHHHHHHHHhccc--
Q 015005 166 EQLWND-----GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN---IMKMYRKIFKAEY-- 235 (414)
Q Consensus 166 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~-- 235 (414)
...... ......+||+.|+|||++.+..+. .++|||||||+||+|++|..||.+.. ....+..+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 432211 122366899999999999988775 89999999999999999999998732 3344444333222
Q ss_pred ---CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 236 ---EFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 236 ---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
..+..++.++.+||.+||+.||.+||++.+|++
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223567899999999999999999999988753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=366.38 Aligned_cols=245 Identities=20% Similarity=0.275 Sum_probs=199.4
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc-----hhhHHHHHHHHHHHHHhCC---------CCCc
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-----KQGLMEQIKREISVMRLVK---------HPNI 78 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnI 78 (414)
...++|++.+.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4467899999999999999999997 7899999999876432 2223467889999998885 7888
Q ss_pred cceEEEEE------------------------------eCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHH
Q 015005 79 VELKEVMA------------------------------TKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAV 128 (414)
Q Consensus 79 v~l~~~~~------------------------------~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al 128 (414)
+++.+++. +.+.+|+|||||++|++.+.+.++.+++.+++.++.||+.||
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 77777643 268899999999999887888778899999999999999999
Q ss_pred HHHH-hCCcEEecCCCCcEEEcCCC--------------------CeEEeecCCCcccccccCCCccccccCCCcccCch
Q 015005 129 DFCH-SRGVYHRDLKPENLLLDENG--------------------NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187 (414)
Q Consensus 129 ~~lH-~~gi~HrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 187 (414)
+||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9999 99999999999999999887 899999999986432 2458999999999
Q ss_pred hhcccCCCCCccchhhhhhh-hhhhhcCCCCCCCchH-HHHHHHHHhc-cc--CC----CCCCCHHHHHHHHhhcccCcC
Q 015005 188 VLRKKGYDGAKSDIWSCGVV-LFVLLSGFLPFQNENI-MKMYRKIFKA-EY--EF----PPWISCDARRLISRILVADPQ 258 (414)
Q Consensus 188 ~~~~~~~~~~~~DiwSlGvi-l~~ll~g~~Pf~~~~~-~~~~~~i~~~-~~--~~----~~~~s~~~~~li~~~L~~dp~ 258 (414)
++.+.. +.++||||+|++ .+++++|..||..... ......+... .. .. ++.+++++.+||++||+.|
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 998765 479999998776 7889999999965322 1222333321 11 11 1236889999999999987
Q ss_pred CCCChHHHh-cCCccc
Q 015005 259 KRISVSEIM-INPWFI 273 (414)
Q Consensus 259 ~R~s~~eil-~hp~f~ 273 (414)
|++|+| +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999994
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=379.75 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=214.3
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCC---CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVT---QESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
....++|++.+.||+|+||+||+|.+..+ +..||+|.+..... ....+.+.+|+.+++.++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 45567899999999999999999998653 46799999865432 234577899999999999999999999985 4
Q ss_pred CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
+..|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 668999999999999999986 369999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHH
Q 015005 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCD 244 (414)
Q Consensus 167 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 244 (414)
.. .........||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+. .+.|+.+++.
T Consensus 543 ~~-~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 543 DS-TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHH
T ss_pred CC-cceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 32 11222345578899999999887775 89999999999999997 999999988888777776654 5678889999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcC
Q 015005 245 ARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+.+||.+||+.||.+|||+.++++.
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=387.46 Aligned_cols=258 Identities=29% Similarity=0.430 Sum_probs=207.1
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe---
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT--- 87 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 87 (414)
.....++|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS--PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC--HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 34456999999999999999999999999999999999876432 2335778999999999999999999998765
Q ss_pred ---CCEEEEEEEccCCCchHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC---eEEe
Q 015005 88 ---KTKVFFVIEYVKGGELFAKVLK-G---KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN---LKVS 157 (414)
Q Consensus 88 ---~~~~~lv~E~~~gg~L~~~i~~-~---~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~---~kl~ 157 (414)
.+..|+||||++||+|.+++.. + .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 6788999999999999999986 2 5999999999999999999999999999999999999997775 9999
Q ss_pred ecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHH--------
Q 015005 158 DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRK-------- 229 (414)
Q Consensus 158 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~-------- 229 (414)
|||++..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||........+..
T Consensus 167 DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 167 DLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp SCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred cccccccccc---ccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 9999986543 2334556899999999999888775 899999999999999999999976533221100
Q ss_pred -H-----HhcccCC------C----CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 230 -I-----FKAEYEF------P----PWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 230 -i-----~~~~~~~------~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
+ ..+...+ | ..+++.+.+||.+||.+||.+|||+.|+++||||..
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 0111111 1 225678999999999999999999999999999853
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=368.57 Aligned_cols=246 Identities=19% Similarity=0.232 Sum_probs=194.7
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-CCc---------cc------
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH-PNI---------VE------ 80 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnI---------v~------ 80 (414)
.|+..+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.++| +|. +.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 48899999999999999999999999999999975444333345778999999999977 321 11
Q ss_pred ------eEEEEEe-----CCEEEEEEEccCCCchHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecC
Q 015005 81 ------LKEVMAT-----KTKVFFVIEYVKGGELFAKVL--------KGKLKEESARKYFQQLISAVDFCHSRGVYHRDL 141 (414)
Q Consensus 81 ------l~~~~~~-----~~~~~lv~E~~~gg~L~~~i~--------~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDl 141 (414)
+..++.. ...++++|+++ +++|.+++. .+.+++..+..++.|++.||+|||++||+||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 1111111 22467788876 589988885 235788889999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhh----------cccCCCCCccchhhhhhhhhhh
Q 015005 142 KPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL----------RKKGYDGAKSDIWSCGVVLFVL 211 (414)
Q Consensus 142 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~~~~~~DiwSlGvil~~l 211 (414)
||+|||++.++.+||+|||+++.... .....+| +.|+|||++ .+..| +.++|||||||++|+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHH
Confidence 99999999999999999999875433 2456678 999999999 33345 3799999999999999
Q ss_pred hcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 212 LSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 212 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
++|+.||...+.......+.. ....+|+++.+||.+||+.||.+|||+.++++||||..
T Consensus 311 ltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 999999988765443333322 22457899999999999999999999999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=352.95 Aligned_cols=254 Identities=23% Similarity=0.407 Sum_probs=209.5
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTK 90 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 90 (414)
.++..++|++.+.||+|+||.||+|.+.. .+|+|++....... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 34567899999999999999999998753 49999997654322 123456789999999999999999999999999
Q ss_pred EEEEEEccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccc
Q 015005 91 VFFVIEYVKGGELFAKVLKG--KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~--~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 168 (414)
+|+||||++|++|.+++... .+++..+..++.|++.||.|||++|++||||||+|||++ ++.+||+|||++......
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999999999873 699999999999999999999999999999999999998 789999999998754321
Q ss_pred ---cCCCccccccCCCcccCchhhccc--------CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCC
Q 015005 169 ---WNDGLLHTQCGTPAYVAPEVLRKK--------GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF 237 (414)
Q Consensus 169 ---~~~~~~~~~~gt~~y~APE~~~~~--------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (414)
..........||+.|+|||++.+. ...+.++||||||+++|+|++|..||...+.......+..+..+.
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 122334455699999999998752 122478999999999999999999999988887777766554432
Q ss_pred --CCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 238 --PPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 238 --~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+..++.++.+||.+||+.||.+|||+.++++.
T Consensus 263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 23578899999999999999999999999863
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=340.58 Aligned_cols=229 Identities=17% Similarity=0.213 Sum_probs=194.1
Q ss_pred hhhc-cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 9 RVRN-ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 9 ~~~~-~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
..|+ ++.++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+
T Consensus 23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 3456 778899999999999999999999999999999999987765545556788999999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 88 KTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
.+..|+||||++|++|.+++..+. .+.++..++.|++.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTSP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTCC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred CCcEEEEEEecCCCCHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999999999987654 666789999999999999999999999999999999999999998543
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHH---HHHhcccC----CCCC
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYR---KIFKAEYE----FPPW 240 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~---~i~~~~~~----~~~~ 240 (414)
|++| + +.++|||||||++|+|++|..||.+.+...... +....... .++.
T Consensus 175 ---------------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 175 ---------------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231 (286)
T ss_dssp ---------------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred ---------------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence 3332 3 478999999999999999999998765322110 11112111 2356
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+++++.+||.+||+.||.+| |+.|+++.
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 89999999999999999999 99999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=381.30 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=203.9
Q ss_pred hhccccCCEEEeeeeeecCCeEEEEEEECC-CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 10 VRNILFGKYEMGRMLGQGTFAKVYYGKNLV-TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 10 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
.++.+.++|++.+.||+|+||+||+|.+.. +++.||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 456778999999999999999999999976 799999999865432 23356788999999999999999999999876
Q ss_pred CE-----EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 89 TK-----VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 89 ~~-----~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
+. .|+||||++|++|.+.+.. .+++.++..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 55 7999999999999887665 89999999999999999999999999999999999999875 99999999998
Q ss_pred ccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCH
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISC 243 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 243 (414)
.... ....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+....... ........++
T Consensus 230 ~~~~------~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~~~~ 295 (681)
T 2pzi_A 230 RINS------FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------EDDPVLKTYD 295 (681)
T ss_dssp ETTC------CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------TTCHHHHHCH
T ss_pred hccc------CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCccccccccc------ccccccccCH
Confidence 5432 1456799999999998764 4 47999999999999999999998763211000 0000011467
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
.+.+||.+||++||.+||+..+.+.|+|+.
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 899999999999999999999999999873
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=317.96 Aligned_cols=230 Identities=14% Similarity=0.119 Sum_probs=162.2
Q ss_pred eeeecCCeEEEEEEECCCCeEEEEEEeeccccc-------hhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEE
Q 015005 23 MLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK-------KQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 23 ~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv 94 (414)
..+.|+.|.+..++....|+.||+|++.+.... .+...+.+.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467788888888888889999999999875321 222356799999999999 799999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|||++|++|.+.+.. +++++. .++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCcc
Confidence 999999999999998 677764 4889999999999999999999999999999999999999999986543 2334
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRIL 253 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 253 (414)
..+.+||+.|||||++.+.. ..++|+||+|++++.+.++..|+. ..+. ..|.. ...+..+...+.
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~----~~~~~-~~~~~~l~~~l~ 460 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVW----QEPVE-RWNFVLLLALFE 460 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHH----TSCGG-GCSHHHHHHHHH
T ss_pred ccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhh----cCCCC-CCcHHHHHHHHh
Confidence 56788999999999998753 357999999999999988754431 1111 11111 113456777778
Q ss_pred ccCcCCCCChHHHhcCCcc
Q 015005 254 VADPQKRISVSEIMINPWF 272 (414)
Q Consensus 254 ~~dp~~R~s~~eil~hp~f 272 (414)
..+|..|+.......++|.
T Consensus 461 ~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 461 KKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp TGGGSCCGGGSSCCHHHHH
T ss_pred CCCCCCCCChhhhccchhH
Confidence 8888888877777667765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-31 Score=269.67 Aligned_cols=188 Identities=19% Similarity=0.197 Sum_probs=145.6
Q ss_pred EEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch-----hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK-----QGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 19 ~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
...+.||+|+||+||+|. ..+..+++|......... ....+++.+|++++++++||||+++..++...+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 345789999999999994 567889999875543321 1224568999999999999999966666667778899
Q ss_pred EEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC-
Q 015005 94 VIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG- 172 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 172 (414)
||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. ++||+|||+++.........
T Consensus 417 VmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999999876 6789999999999999999999999999999998 99999999998654321111
Q ss_pred ----ccccccCCCcccCchhhcc--cCCCCCccchhhhhhhhhhhhcCCCCC
Q 015005 173 ----LLHTQCGTPAYVAPEVLRK--KGYDGAKSDIWSCGVVLFVLLSGFLPF 218 (414)
Q Consensus 173 ----~~~~~~gt~~y~APE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf 218 (414)
.....+||+.|||||++.. .+|. ..+|+||..+-..+-..++-+|
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhcccc
Confidence 1246689999999999986 5675 6789999888877776666555
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=205.97 Aligned_cols=124 Identities=32% Similarity=0.606 Sum_probs=112.1
Q ss_pred CCcccccccCCCCCCCchhhhhhh---ccCccccccCChhHHHHHHHHHHHHcCCeEEEeceEEEEEeeecCCCcceEEE
Q 015005 287 GDNRDFISSMSSGFDLSSLFESER---KSGSMFTSKCSSSAIMGKLESLAKKLNLGVCVKEFKVKMQGKDEGRKGKLAVT 363 (414)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~ 363 (414)
.|+|++|+ +|+|+|||.+|+... ++.+||+|..+++.++++++++++.+|+.++++++++++++..+|++|.|++.
T Consensus 7 lNAFdiIs-~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l~v~ 85 (143)
T 2ehb_D 7 MNAFEMIT-LSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQLAVV 85 (143)
T ss_dssp CCHHHHHT-TCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCCEEE
T ss_pred cCHHHHHH-HCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceEEEE
Confidence 57999998 999999999998653 67899999999999999999999999999998888999999999999999999
Q ss_pred EEEEEecCceEEEEEEecCCChHhHHHHhhhhhhhhcccceeeccCCCC
Q 015005 364 AEVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVWSWQGENN 412 (414)
Q Consensus 364 ~ei~~~~~~~~~v~~~k~~Gd~le~~~~~~~~l~~~l~~~v~~~~~~~~ 412 (414)
+|||+++|+++||||+|++||++||++||+ +|+++|+||||+|+++.+
T Consensus 86 ~EVfevapsl~vVEvrks~GD~lEy~k~~~-~Lr~~L~diV~~~~~~~~ 133 (143)
T 2ehb_D 86 IEIYEVAPSLFMVDVRKAAGETLEYHKFYK-KLCSKLENIIWRATEGIP 133 (143)
T ss_dssp EEEEEEETTEEEEEEEEEESCHHHHHHHHH-HHHHHSTTTBCC------
T ss_pred EEEEEecCCEEEEEEEecCCChHHHHHHHH-HHHHHhhcceecCCCCCc
Confidence 999999999999999999999999999997 899999999999998654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=225.06 Aligned_cols=147 Identities=18% Similarity=0.272 Sum_probs=118.3
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh---------------hHHHHHHHHHHHHHhCCCCCccceE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ---------------GLMEQIKREISVMRLVKHPNIVELK 82 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l~ 82 (414)
|.+++.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+++.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 34449999999999999999 8899999999965332110 12456889999999998 4 5565
Q ss_pred EEEEeCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 83 EVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
+++.. +..|+||||++||+|.+ +. ...+..++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR-----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc-----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 55544 45699999999999987 42 234567999999999999999999999999999999 999999999998
Q ss_pred cccccccCCCccccccCCCcccCchhhcc
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRK 191 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 191 (414)
. .+..|+|||.+.+
T Consensus 240 ~---------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 240 V---------------EVGEEGWREILER 253 (282)
T ss_dssp E---------------ETTSTTHHHHHHH
T ss_pred e---------------ECCCCCHHHHHHH
Confidence 7 3456899998853
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-27 Score=189.08 Aligned_cols=116 Identities=28% Similarity=0.414 Sum_probs=102.8
Q ss_pred CCcccccccCCCCCCCchhhhhhh--ccCccccccCChhHHHHHHHHHHHHcCCeEEEeceEEEEEeeecCCCcceEEEE
Q 015005 287 GDNRDFISSMSSGFDLSSLFESER--KSGSMFTSKCSSSAIMGKLESLAKKLNLGVCVKEFKVKMQGKDEGRKGKLAVTA 364 (414)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~~ 364 (414)
.|+|++|+ +|+++|||.+|+... ++.+||+|..+++.++++++++++.+|+.+++++++ ++..+|++|.|++.+
T Consensus 6 lNAFdiIs-~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l~v~~ 81 (123)
T 2zfd_B 6 MNAFDIIS-GSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNFAMVV 81 (123)
T ss_dssp CCHHHHHH-TSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTEEEEE
T ss_pred ccHHHHHH-HCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccEEEEE
Confidence 58999998 999999999997632 567999999999999999999999999999987654 566789999999999
Q ss_pred EEEEecCceEEEEEEecCCChHhHHHHhhhhhhhhcccceee
Q 015005 365 EVYEVAPEVAVVEFSKSAGDTLEYKKFCEEDVRPALKDIVWS 406 (414)
Q Consensus 365 ei~~~~~~~~~v~~~k~~Gd~le~~~~~~~~l~~~l~~~v~~ 406 (414)
|||+++|+++||||+|++||++||++||.++|+++|+||||.
T Consensus 82 EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 82 EINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 999999999999999999999999998877899999999984
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=191.53 Aligned_cols=139 Identities=18% Similarity=0.296 Sum_probs=110.0
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeE--EEEEEeeccccc---------------------hhhHHHHHHHHHHHHHhCC
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQES--VAIKVINKDQVK---------------------KQGLMEQIKREISVMRLVK 74 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~--vaiK~~~~~~~~---------------------~~~~~~~~~~Ei~il~~l~ 74 (414)
|++.+.||+|+||.||+|.+..+|+. ||||++...... .......+.+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778999 999997543211 0011246889999999998
Q ss_pred CCCc--cceEEEEEeCCEEEEEEEccCC-C----chHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEEecCCCCcE
Q 015005 75 HPNI--VELKEVMATKTKVFFVIEYVKG-G----ELFAKVLKGKLKEESARKYFQQLISAVDFCH-SRGVYHRDLKPENL 146 (414)
Q Consensus 75 hpnI--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH-~~gi~HrDlkp~NI 146 (414)
|+++ +.+++. ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| ++||+||||||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 8764 444432 356899999942 3 66655432 345678899999999999999 99999999999999
Q ss_pred EEcCCCCeEEeecCCCcc
Q 015005 147 LLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 147 Ll~~~~~~kl~DFGla~~ 164 (414)
|++. .++|+|||+|..
T Consensus 203 Ll~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EESS--SEEECCCTTCEE
T ss_pred EEcC--cEEEEECccccc
Confidence 9988 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=8.2e-20 Score=177.24 Aligned_cols=138 Identities=13% Similarity=0.193 Sum_probs=102.8
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc---------------hhhH----HHHHHHHHHHHHhCCCCCc
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK---------------KQGL----MEQIKREISVMRLVKHPNI 78 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~---------------~~~~----~~~~~~Ei~il~~l~hpnI 78 (414)
|++++.||.|++|.||+|.+ .+|+.||||+++..... .... .-...+|...|.++.++++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999997 47999999997543211 0000 1123467888888865554
Q ss_pred cceEEEEEeCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC-----
Q 015005 79 VELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN----- 153 (414)
Q Consensus 79 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~----- 153 (414)
.-..-+.... .+|||||++|++|..... ...+..++.|++.+|.+||++||+||||||.|||++.+|.
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence 3222222222 379999999998865432 2345678999999999999999999999999999988773
Q ss_pred -----eEEeecCCCc
Q 015005 154 -----LKVSDFGLSA 163 (414)
Q Consensus 154 -----~kl~DFGla~ 163 (414)
+.|+||+-+.
T Consensus 249 ~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 249 SITLTPIIIXFPQMV 263 (397)
T ss_dssp SEEEEEEECCCTTCE
T ss_pred ccccceEEEEeCCcc
Confidence 8999999875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=5.9e-14 Score=129.83 Aligned_cols=145 Identities=17% Similarity=0.178 Sum_probs=116.0
Q ss_pred hhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEe
Q 015005 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMAT 87 (414)
Q Consensus 9 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 87 (414)
.+++ .++.|++...++.|+.+.||++.. .+..+++|+........ ...+.+|+.+++.+. +..+.++++++.+
T Consensus 8 ~l~~-~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 81 (263)
T 3tm0_A 8 ELKK-LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HHHH-HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred HHHH-HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence 3444 346799999999999999999974 36889999987532111 235789999999984 6778899999999
Q ss_pred CCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------
Q 015005 88 KTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS---------------------------------- 133 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~---------------------------------- 133 (414)
.+..|+||||++|.+|.+... +......++.++..+|..||+
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred CCceEEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 999999999999999876531 223345788899999999998
Q ss_pred -------------------------CCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 134 -------------------------RGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 134 -------------------------~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799999876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.37 E-value=1.5e-12 Score=119.67 Aligned_cols=135 Identities=13% Similarity=0.159 Sum_probs=102.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--ccceEEEEEeCCEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN--IVELKEVMATKTKVF 92 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~ 92 (414)
...|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+....+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 45677766555677799999964 567789999976541 134678999999885444 556889888888899
Q ss_pred EEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 015005 93 FVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRG------------------------------------- 135 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~g------------------------------------- 135 (414)
+||||++|.+|. . .... ...+..++...|..||+..
T Consensus 92 ~v~e~i~G~~l~--~--~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 92 LLLGEVPGQDLL--S--SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEEECCSSEETT--T--SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEEecCCcccC--c--CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 999999999883 1 1122 2356677778888888643
Q ss_pred ---------------------cEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 136 ---------------------VYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 136 ---------------------i~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
++|+|++|.||+++.++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.29 E-value=7.5e-12 Score=121.18 Aligned_cols=142 Identities=16% Similarity=0.289 Sum_probs=108.3
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEee--ccccchhhHHHHHHHHHHHHHhCC--CCCccceEEEEEeC---CE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVIN--KDQVKKQGLMEQIKREISVMRLVK--HPNIVELKEVMATK---TK 90 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~ 90 (414)
..-.+.|+.|.++.||++.. .+..+++|+.. ...... ....+.+|+.+++.+. +..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~--~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLP--SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCC--cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 34567899999999999874 34678899876 322111 1346789999999996 45578899888776 45
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS------------------------------------- 133 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~------------------------------------- 133 (414)
.|+||||++|..+.+.. ...+++.+...++.+++.+|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CEEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred eEEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 89999999998775421 1357888889999999999999997
Q ss_pred ---------------------CCcEEecCCCCcEEEcCCCC--eEEeecCCCcc
Q 015005 134 ---------------------RGVYHRDLKPENLLLDENGN--LKVSDFGLSAL 164 (414)
Q Consensus 134 ---------------------~gi~HrDlkp~NILl~~~~~--~kl~DFGla~~ 164 (414)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 46999999999999997763 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.19 E-value=1.6e-11 Score=116.16 Aligned_cols=183 Identities=18% Similarity=0.228 Sum_probs=124.7
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCC--ccceEEEEEeCC---EEEEE
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPN--IVELKEVMATKT---KVFFV 94 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpn--Iv~l~~~~~~~~---~~~lv 94 (414)
.+.++.|....||++. ..+++|+.... .....+.+|..+++.+ .+.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4669999999999863 45899986533 2246788999999888 4433 345554443333 45899
Q ss_pred EEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 015005 95 IEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS----------------------------------------- 133 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~----------------------------------------- 133 (414)
||+++|..|..... ..++..+...++.|+...+..||+
T Consensus 95 m~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred EcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99999988865332 467888888899999999999986
Q ss_pred -----------------CCcEEecCCCCcEEEcC--CCCeEEeecCCCcccccccCCCccccccCCCcc---cCchhhcc
Q 015005 134 -----------------RGVYHRDLKPENLLLDE--NGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAY---VAPEVLRK 191 (414)
Q Consensus 134 -----------------~gi~HrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y---~APE~~~~ 191 (414)
..++|+|++|.||+++. .+.+.|+||+.+....... .......+ ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHHHHH
Confidence 24799999999999998 4568899999987432210 00011111 22332110
Q ss_pred --cCCCC-----------CccchhhhhhhhhhhhcCCCCCCC
Q 015005 192 --KGYDG-----------AKSDIWSCGVVLFVLLSGFLPFQN 220 (414)
Q Consensus 192 --~~~~~-----------~~~DiwSlGvil~~ll~g~~Pf~~ 220 (414)
..|.. ...+.|++|.++|.+.+|..||..
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 01111 125899999999999999877644
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.01 E-value=2.7e-09 Score=85.71 Aligned_cols=86 Identities=19% Similarity=0.249 Sum_probs=74.3
Q ss_pred cccccCChhHHHHHHHHHHHHcCCeEEEec-eEEEEEeeecCCCcceEEEEEEEEec-CceEEEEEEecCCChHhHHHHh
Q 015005 315 MFTSKCSSSAIMGKLESLAKKLNLGVCVKE-FKVKMQGKDEGRKGKLAVTAEVYEVA-PEVAVVEFSKSAGDTLEYKKFC 392 (414)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~~~~~~~~~l~~~~ei~~~~-~~~~~v~~~k~~Gd~le~~~~~ 392 (414)
..+|..++.+++..+.+++..+|+.+..++ +.+.........++.+.|++||+++. +++++|+|+|.+||.+.|+++|
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc 111 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 111 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHH
Confidence 357788999999999999999999999765 78888654434567899999999995 8999999999999999999999
Q ss_pred hhhhhhhcc
Q 015005 393 EEDVRPALK 401 (414)
Q Consensus 393 ~~~l~~~l~ 401 (414)
. +|.+.|+
T Consensus 112 ~-~il~~L~ 119 (120)
T 3ose_A 112 S-KIANELK 119 (120)
T ss_dssp H-HHHHHCC
T ss_pred H-HHHHHhc
Confidence 8 7887764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=7.8e-08 Score=88.74 Aligned_cols=133 Identities=16% Similarity=0.202 Sum_probs=97.6
Q ss_pred eeeecCCe-EEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEEEccCC
Q 015005 23 MLGQGTFA-KVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKVFFVIEYVKG 100 (414)
Q Consensus 23 ~LG~G~~g-~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~g 100 (414)
.+..|..+ .||+......+..+.+|+-... ....+.+|...|+.+. +--+.+++.++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34455554 7999887777788999987543 2356788999999884 33367889999999999999999999
Q ss_pred CchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 015005 101 GELFAKVLKGKLKEESARKYFQQLISAVDFCHS----------------------------------------------- 133 (414)
Q Consensus 101 g~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~----------------------------------------------- 133 (414)
.++.+..... ......+..++...|..||+
T Consensus 105 ~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 105 KTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 8876654431 12233455566666666663
Q ss_pred -----------CCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 134 -----------RGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 134 -----------~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999877777999998863
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=1.5e-07 Score=88.82 Aligned_cols=133 Identities=19% Similarity=0.216 Sum_probs=96.4
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC---CccceEEEEE-eCCEEEEEEE
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP---NIVELKEVMA-TKTKVFFVIE 96 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lv~E 96 (414)
.+.++.|....||+. +..+++|+.... .....+.+|..+|+.+.+. .+.+++.+.. ..+..|++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 466899999999988 567899985321 2346788999999999642 2556676664 3456789999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 015005 97 YVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSR------------------------------------------ 134 (414)
Q Consensus 97 ~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~------------------------------------------ 134 (414)
+++|..+.... -..++..+...+..|+...|..||+.
T Consensus 94 ~i~G~~l~~~~-~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 94 KVQGQILGEDG-MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCCSEECHHHH-HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ccCCeECchhh-hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99998886532 13445555566666666666666642
Q ss_pred ------------------CcEEecCCCCcEEEcC---CCCe-EEeecCCCcc
Q 015005 135 ------------------GVYHRDLKPENLLLDE---NGNL-KVSDFGLSAL 164 (414)
Q Consensus 135 ------------------gi~HrDlkp~NILl~~---~~~~-kl~DFGla~~ 164 (414)
.++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 4554 8999998874
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.51 E-value=2e-07 Score=74.72 Aligned_cols=85 Identities=18% Similarity=0.209 Sum_probs=71.6
Q ss_pred ccccCChhHHHHHHHHHHHHcCCeEEE-eceEEEEEeeecCCCcceEEEEEEEEe-cCceEEEEEEecCCChHhHHHHhh
Q 015005 316 FTSKCSSSAIMGKLESLAKKLNLGVCV-KEFKVKMQGKDEGRKGKLAVTAEVYEV-APEVAVVEFSKSAGDTLEYKKFCE 393 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~l~~~~ei~~~-~~~~~~v~~~k~~Gd~le~~~~~~ 393 (414)
.+|+.++..++..+.++++.+|+.++. +.+.+.........+..+.|++||+++ ..+++.|+|+|.+||.+.|+++|.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~ 112 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHH
Confidence 567778999999999999999999996 457777754333335679999999999 478999999999999999999998
Q ss_pred hhhhhhcc
Q 015005 394 EDVRPALK 401 (414)
Q Consensus 394 ~~l~~~l~ 401 (414)
+|-..|+
T Consensus 113 -~IL~eLk 119 (126)
T 1v5s_A 113 -KIANELK 119 (126)
T ss_dssp -HHHHHTT
T ss_pred -HHHHHHh
Confidence 7888777
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=4.2e-07 Score=88.82 Aligned_cols=81 Identities=12% Similarity=0.069 Sum_probs=51.6
Q ss_pred EeeeeeecCCeEEEEEEECCCCeEEEEEEeecccc-ch---hhHHHHHHHHHHHHHhCCC--CC-ccceEEEEEeCCEEE
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV-KK---QGLMEQIKREISVMRLVKH--PN-IVELKEVMATKTKVF 92 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~---~~~~~~~~~Ei~il~~l~h--pn-Iv~l~~~~~~~~~~~ 92 (414)
-.+.||.|..+.||++....+++.+++|....... .. ....+++..|.++++.+.. |. +.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997656678899998653211 00 0113456789999888732 33 4455543 455568
Q ss_pred EEEEccCCCc
Q 015005 93 FVIEYVKGGE 102 (414)
Q Consensus 93 lv~E~~~gg~ 102 (414)
+|||+++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999998743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=3.2e-07 Score=88.27 Aligned_cols=84 Identities=17% Similarity=0.208 Sum_probs=57.8
Q ss_pred EEEeeee-eecCCeEEEEEEEC--C----CCeEEEEEEeeccc---cchhhHHHHHHHHHHHHHhCC-C--CCccceEEE
Q 015005 18 YEMGRML-GQGTFAKVYYGKNL--V----TQESVAIKVINKDQ---VKKQGLMEQIKREISVMRLVK-H--PNIVELKEV 84 (414)
Q Consensus 18 y~~~~~L-G~G~~g~Vy~a~~~--~----~~~~vaiK~~~~~~---~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~ 84 (414)
....+.| +.|....+|+.... . ++..+++|+..... ... ...+.+|+.+++.+. + -.+.+++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 4456778 88999999988643 1 26789999875433 101 134678999888884 3 346778887
Q ss_pred EEeC---CEEEEEEEccCCCchH
Q 015005 85 MATK---TKVFFVIEYVKGGELF 104 (414)
Q Consensus 85 ~~~~---~~~~lv~E~~~gg~L~ 104 (414)
..+. +..|+||||++|..+.
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCCC
T ss_pred ccCCCccCCceEEEEecCCCChh
Confidence 7655 3578999999986543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.34 E-value=4.1e-06 Score=79.57 Aligned_cols=134 Identities=18% Similarity=0.198 Sum_probs=78.8
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-----CCCccceE-E--EEEeCCEEE
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-----HPNIVELK-E--VMATKTKVF 92 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 92 (414)
.+.|+.|..+.||++.. .+..+++|+..... ..+..|..+++.+. .|.++... + +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 35566678899999874 33459999987521 23334555555542 34444310 0 224577899
Q ss_pred EEEEccCCCchH--------------HHHhc--CCC--C-----------HH--------H-------------------
Q 015005 93 FVIEYVKGGELF--------------AKVLK--GKL--K-----------EE--------S------------------- 116 (414)
Q Consensus 93 lv~E~~~gg~L~--------------~~i~~--~~~--~-----------e~--------~------------------- 116 (414)
++|||++|..+. ..+.. ..+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986431 11111 111 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHH-------------hCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 117 ----ARKYFQQLISAVDFCH-------------SRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 117 ----~~~~~~ql~~al~~lH-------------~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
...+..++..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223334566665 3589999999999999888899999999875
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=4e-05 Score=59.22 Aligned_cols=84 Identities=17% Similarity=0.316 Sum_probs=68.1
Q ss_pred ccccCChhHHHHHHHHHHHHcCCeEEEe-ceEEEEEeeecCCCcceEEEEEEEEecCceEEEEEEecCCC--------hH
Q 015005 316 FTSKCSSSAIMGKLESLAKKLNLGVCVK-EFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGD--------TL 386 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~l~~~~ei~~~~~~~~~v~~~k~~Gd--------~l 386 (414)
..|...+.+++..+-++++.+|+.|+.. .+.|++..........+.+.+++|++.++.+++||++..|| .+
T Consensus 12 IrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~~~~~ 91 (106)
T 4eai_A 12 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHTI 91 (106)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSSCHHH
T ss_pred ceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCCcCcE
Confidence 4566678899999999999999999975 58888864322223458899999999989999999999995 89
Q ss_pred hHHHHhhhhhhhhc
Q 015005 387 EYKKFCEEDVRPAL 400 (414)
Q Consensus 387 e~~~~~~~~l~~~l 400 (414)
+|-++|. .+-..|
T Consensus 92 ~F~d~ca-~li~~l 104 (106)
T 4eai_A 92 EFFEMCA-NLIKIL 104 (106)
T ss_dssp HHHHHHH-HHHHHC
T ss_pred eHHHHHH-HHHHHH
Confidence 9999998 565544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.00 E-value=5.8e-05 Score=71.13 Aligned_cols=77 Identities=12% Similarity=0.213 Sum_probs=61.4
Q ss_pred EEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC---CCCccceEEEEEeCCEEEEEE
Q 015005 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK---HPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 19 ~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.-.+.|+.|....+|+... ++..+++|+..... ...+.+|...|+.|. ...+++++.+....+..|+||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3457799999999999974 56789999976431 356788999998883 356788999888888999999
Q ss_pred EccCCCch
Q 015005 96 EYVKGGEL 103 (414)
Q Consensus 96 E~~~gg~L 103 (414)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.97 E-value=3.2e-05 Score=76.06 Aligned_cols=32 Identities=19% Similarity=0.353 Sum_probs=28.4
Q ss_pred HhCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 132 H~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
+...++|+|++|.|||++.++ +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456899999999999998776 99999999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.93 E-value=2.1e-05 Score=73.69 Aligned_cols=131 Identities=14% Similarity=0.157 Sum_probs=75.7
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEEEEEcc-
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI-VELKEVMATKTKVFFVIEYV- 98 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~- 98 (414)
.+.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++ .+++.. +.+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 788999999999998 45899988643211 1123468888877743233 455544 344457899999
Q ss_pred CCCchHHH------------------HhcCC--CC-----HHHHHHHHHH--------------HHHHHHHHH-------
Q 015005 99 KGGELFAK------------------VLKGK--LK-----EESARKYFQQ--------------LISAVDFCH------- 132 (414)
Q Consensus 99 ~gg~L~~~------------------i~~~~--~~-----e~~~~~~~~q--------------l~~al~~lH------- 132 (414)
+|.++... +.... ++ ......+..+ +...+..+.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66544210 11100 10 1111111111 111111111
Q ss_pred -hCCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 133 -SRGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 133 -~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
...++|+|+.|.||+ ..++.+.++||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 124899999999999 5677899999998863
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.92 E-value=4.8e-05 Score=71.67 Aligned_cols=140 Identities=11% Similarity=0.133 Sum_probs=79.8
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--ccceEE------EEEeC
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN--IVELKE------VMATK 88 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~ 88 (414)
...-.+.|+.|....+|++... +| .+++|+...... .+.+..|+.+++.+...+ +.+++. +....
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 3444567888999999998743 33 689999875311 124556777777763212 223321 12345
Q ss_pred CEEEEEEEccCCCchHH--------------HHhc--CCC--------CHHHHHHHH---------------HHHHHHHH
Q 015005 89 TKVFFVIEYVKGGELFA--------------KVLK--GKL--------KEESARKYF---------------QQLISAVD 129 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~--------------~i~~--~~~--------~e~~~~~~~---------------~ql~~al~ 129 (414)
+..+++|+|++|..+.. .+.. ..+ ........+ ..+...++
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 67899999999864310 1111 011 111101100 11333445
Q ss_pred HHHh-------CCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 130 FCHS-------RGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 130 ~lH~-------~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
.+++ .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 5542 479999999999999877666899999876
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.90 E-value=0.00017 Score=66.98 Aligned_cols=90 Identities=10% Similarity=0.056 Sum_probs=63.8
Q ss_pred chhHhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CC--Cccce
Q 015005 5 TMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HP--NIVEL 81 (414)
Q Consensus 5 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hp--nIv~l 81 (414)
.+...+.+....+..-++.+|.|..+.||+... .+|+.|.+|+........ ...+.+|+..|+.|. .. -+.++
T Consensus 4 ~v~a~~~~l~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v 79 (288)
T 3f7w_A 4 SVAARVTELTGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQV 79 (288)
T ss_dssp HHHHHHHHHHCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCE
T ss_pred HHHHHHHHhcCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceE
Confidence 345556666667788899999999999999974 578899999876443222 235678999999884 21 24455
Q ss_pred EEEEEeCCEEEEEEEccCCCc
Q 015005 82 KEVMATKTKVFFVIEYVKGGE 102 (414)
Q Consensus 82 ~~~~~~~~~~~lv~E~~~gg~ 102 (414)
+.+ +. -++||||++++.
T Consensus 80 ~~~--~~--~~lv~e~l~~~~ 96 (288)
T 3f7w_A 80 AGW--DD--RTLAMEWVDERP 96 (288)
T ss_dssp EEE--ET--TEEEEECCCCCC
T ss_pred Eec--cC--ceEEEEeecccC
Confidence 544 23 378999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00011 Score=64.82 Aligned_cols=121 Identities=17% Similarity=0.091 Sum_probs=81.3
Q ss_pred CchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccccc
Q 015005 101 GELFAKVLK--GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQ 177 (414)
Q Consensus 101 g~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 177 (414)
-+|.+.+.. ++++|++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+|++.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 378888875 799999999999999999877621 2222444567999999999988763 2111
Q ss_pred cCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 015005 178 CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255 (414)
Q Consensus 178 ~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 255 (414)
.....+.|||.... ..+.+.=|||||+++|.-+--.+| ..-+..+|+++..||..|..-
T Consensus 98 ~~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhc
Confidence 12335678887642 223678999999999988764333 122345899999999999866
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.74 E-value=7e-05 Score=71.03 Aligned_cols=135 Identities=13% Similarity=0.131 Sum_probs=71.8
Q ss_pred eeeeeecCCeE-EEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--CCccceEEEEEeCCEEEEEEEc
Q 015005 21 GRMLGQGTFAK-VYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH--PNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 21 ~~~LG~G~~g~-Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~ 97 (414)
.+.|+.|+... +|+... .++..+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 45566665555 666652 2366788887543321 234467777777632 23456666543333 789999
Q ss_pred cCCCchHHHHhcC------------------------C---CCHHHHH-------HHH-------------HHHHHHHHH
Q 015005 98 VKGGELFAKVLKG------------------------K---LKEESAR-------KYF-------------QQLISAVDF 130 (414)
Q Consensus 98 ~~gg~L~~~i~~~------------------------~---~~e~~~~-------~~~-------------~ql~~al~~ 130 (414)
+.|..+.+.+... . +...... .++ ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776654332211 1 1121110 000 011112222
Q ss_pred H------HhCCcEEecCCCCcEEEcCC----CCeEEeecCCCcc
Q 015005 131 C------HSRGVYHRDLKPENLLLDEN----GNLKVSDFGLSAL 164 (414)
Q Consensus 131 l------H~~gi~HrDlkp~NILl~~~----~~~kl~DFGla~~ 164 (414)
+ +..+++|||+.|.||+++.+ +.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 2 23579999999999999874 6799999998863
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00026 Score=58.00 Aligned_cols=72 Identities=15% Similarity=0.260 Sum_probs=56.5
Q ss_pred ccccCChhHHHHHHHHHHHHcCCeEEEec-eEEEEEeeecCCCcceEEEEEEEEecCceEEEEEEecCCChHh
Q 015005 316 FTSKCSSSAIMGKLESLAKKLNLGVCVKE-FKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLE 387 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~~~~~~~~~l~~~~ei~~~~~~~~~v~~~k~~Gd~le 387 (414)
..|...+.+|+..+-++++.||+.|+..+ +.|++..........+.+.+++|++.++.++|||++..||..|
T Consensus 9 IrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 9 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 34566788999999999999999999854 8888865332222357899999999999999999999999876
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00036 Score=57.99 Aligned_cols=72 Identities=15% Similarity=0.260 Sum_probs=56.9
Q ss_pred ccccCChhHHHHHHHHHHHHcCCeEEEec-eEEEEEeeecCCCcceEEEEEEEEecCceEEEEEEecCCChHh
Q 015005 316 FTSKCSSSAIMGKLESLAKKLNLGVCVKE-FKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLE 387 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~~~~~~~~~l~~~~ei~~~~~~~~~v~~~k~~Gd~le 387 (414)
..|+..+.+|+..+-++++.||+.|+..+ +.|++..........+.|.+++|++.++.++|||++..||..|
T Consensus 23 IrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 23 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 45667789999999999999999999854 8888865322222357899999999999999999999999876
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00018 Score=69.72 Aligned_cols=135 Identities=15% Similarity=0.134 Sum_probs=82.7
Q ss_pred eeeeeecCCeEEEEEEECC-------CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEE
Q 015005 21 GRMLGQGTFAKVYYGKNLV-------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKVF 92 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 92 (414)
.+.|..|-...+|++.... +++.+.+|+.... .. ....+.+|..+++.+. +.-..++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 4567888899999987542 3578999986331 11 1345668999998884 3323566666543 2
Q ss_pred EEEEccCCCchHH--------------H---HhcCC------C--CHHHHHHHHHHHHH-------------------HH
Q 015005 93 FVIEYVKGGELFA--------------K---VLKGK------L--KEESARKYFQQLIS-------------------AV 128 (414)
Q Consensus 93 lv~E~~~gg~L~~--------------~---i~~~~------~--~e~~~~~~~~ql~~-------------------al 128 (414)
+||||++|..|.. . +.... . -..++..|..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999999865421 1 11111 1 13455666655422 23
Q ss_pred HHHH----h----CCcEEecCCCCcEEEcCC----CCeEEeecCCCc
Q 015005 129 DFCH----S----RGVYHRDLKPENLLLDEN----GNLKVSDFGLSA 163 (414)
Q Consensus 129 ~~lH----~----~gi~HrDlkp~NILl~~~----~~~kl~DFGla~ 163 (414)
..|. . ..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3332 2 259999999999999876 789999999886
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00017 Score=58.49 Aligned_cols=85 Identities=11% Similarity=0.172 Sum_probs=66.6
Q ss_pred ccccCChhHHHHHHHHHHHHcCCeEEEe---------c-eEEEEEeeecCC-----CcceEEEEEEEEecCceEEEEEEe
Q 015005 316 FTSKCSSSAIMGKLESLAKKLNLGVCVK---------E-FKVKMQGKDEGR-----KGKLAVTAEVYEVAPEVAVVEFSK 380 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~-~~i~~~~~~~~~-----~~~l~~~~ei~~~~~~~~~v~~~k 380 (414)
..|...+.+|+..+-++++.||+.|+.. + +.|++....+.. ...+.+.+++|++.++.+||||++
T Consensus 17 IRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YLlDFk~ 96 (137)
T 2qrd_A 17 VRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVKS 96 (137)
T ss_dssp EEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEEE
T ss_pred cccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEEEEEEe
Confidence 4566778899999999999999999965 5 778875432211 134788999999999999999999
Q ss_pred cCCC---------------h----HhHHHHhhhhhhhhcc
Q 015005 381 SAGD---------------T----LEYKKFCEEDVRPALK 401 (414)
Q Consensus 381 ~~Gd---------------~----le~~~~~~~~l~~~l~ 401 (414)
..|+ . .+|-.+|. .|-..|.
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca-~Li~eLa 135 (137)
T 2qrd_A 97 NGYKDIYSHPERTADHGMDDLKSSFPFLDLCA-MLVCKLF 135 (137)
T ss_dssp EEEEESCC-------------CCCTTHHHHHH-HHHHHHH
T ss_pred cCCccccccCccccccCCccccccccHHHHHH-HHHHHHh
Confidence 9999 5 88999987 5655553
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00024 Score=69.99 Aligned_cols=75 Identities=12% Similarity=0.143 Sum_probs=50.8
Q ss_pred EeeeeeecCCeEEEEEEECC-------CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEE
Q 015005 20 MGRMLGQGTFAKVYYGKNLV-------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI-VELKEVMATKTKV 91 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~ 91 (414)
-.+.|+.|....+|++.... .+..+++|+...... ...+.+|..+++.+...++ .++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence 45678899999999998643 257899999843211 1344579999988853333 56766553 2
Q ss_pred EEEEEccCCCch
Q 015005 92 FFVIEYVKGGEL 103 (414)
Q Consensus 92 ~lv~E~~~gg~L 103 (414)
.+|+||++|-.|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00066 Score=63.93 Aligned_cols=134 Identities=16% Similarity=0.133 Sum_probs=78.6
Q ss_pred eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--ccceEEE-----EEeCCEEEEE
Q 015005 22 RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN--IVELKEV-----MATKTKVFFV 94 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~-----~~~~~~~~lv 94 (414)
..|+ |....||++.. .+|+.+++|+....... ...+..|..+++.+...+ +++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998753 35667999998643221 245667888887773212 3333332 2345677899
Q ss_pred EEccCCCchH-----H---------HHhc----CC------CCHHHH----------------------HHHHHHHHHHH
Q 015005 95 IEYVKGGELF-----A---------KVLK----GK------LKEESA----------------------RKYFQQLISAV 128 (414)
Q Consensus 95 ~E~~~gg~L~-----~---------~i~~----~~------~~e~~~----------------------~~~~~ql~~al 128 (414)
||+++|..+. . .+.. .. .+.... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885431 0 0110 00 111110 11112222222
Q ss_pred HHH----HhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 129 DFC----HSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 129 ~~l----H~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
.-+ +..+++|+|++|.|||++ + .+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 222 234689999999999998 4 89999998875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00099 Score=63.38 Aligned_cols=31 Identities=19% Similarity=0.370 Sum_probs=27.8
Q ss_pred CCcEEecCCCCcEEEcCCCCeEEeecCCCcc
Q 015005 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSAL 164 (414)
Q Consensus 134 ~gi~HrDlkp~NILl~~~~~~kl~DFGla~~ 164 (414)
.+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888999999988763
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0016 Score=51.67 Aligned_cols=73 Identities=15% Similarity=0.245 Sum_probs=54.1
Q ss_pred ccccCChhHHHHHHHHHHHHcCCeEEEe-ceEEEEEeeecCCCcceEEEEEEEEecCceEEEEEEecCCChHhH
Q 015005 316 FTSKCSSSAIMGKLESLAKKLNLGVCVK-EFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLEY 388 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~l~~~~ei~~~~~~~~~v~~~k~~Gd~le~ 388 (414)
..|...+.+++..+-++++.+|+.|+.. .+.|++............+.+++|++.++.+++||++..||..|.
T Consensus 12 IrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~ 85 (130)
T 4eag_A 12 IRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQ 85 (130)
T ss_dssp BCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC------
T ss_pred eecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhc
Confidence 3455668899999999999999999975 488888643333334577899999999999999999999996554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00048 Score=66.26 Aligned_cols=76 Identities=12% Similarity=0.100 Sum_probs=45.9
Q ss_pred EeeeeeecCCeEEEEEEECC--------CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC-ccceEEEEEeCCE
Q 015005 20 MGRMLGQGTFAKVYYGKNLV--------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN-IVELKEVMATKTK 90 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~ 90 (414)
-.+.|+.|....+|++.... .+..+++|+....... ......|..+++.+...+ ..+++... .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 35678889899999997543 1367899987543211 112357888888874333 44666544 33
Q ss_pred EEEEEEccCCCch
Q 015005 91 VFFVIEYVKGGEL 103 (414)
Q Consensus 91 ~~lv~E~~~gg~L 103 (414)
++||||++|..+
T Consensus 110 -~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 -GRIEEWLYGDPL 121 (369)
T ss_dssp -EEEEECCCSEEC
T ss_pred -cEEEEEecCCcC
Confidence 689999998543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0035 Score=62.16 Aligned_cols=76 Identities=14% Similarity=0.187 Sum_probs=49.6
Q ss_pred EeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEEEEEcc
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI-VELKEVMATKTKVFFVIEYV 98 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~ 98 (414)
-.+.|+.|-...+|++.....+..+++|+....... .. ...+|..+++.|...++ .++++.+. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 356788899999999986544588999987542111 11 12589999999865554 56776662 2 2599999
Q ss_pred CCCch
Q 015005 99 KGGEL 103 (414)
Q Consensus 99 ~gg~L 103 (414)
+|-.|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0099 Score=49.86 Aligned_cols=84 Identities=13% Similarity=0.234 Sum_probs=64.4
Q ss_pred ccccCChhHHHHHHHHHHHHcCCeEEE-e---ceEEEEEeeec---------CCCcceEEEEEEEEecCceEEEEEEecC
Q 015005 316 FTSKCSSSAIMGKLESLAKKLNLGVCV-K---EFKVKMQGKDE---------GRKGKLAVTAEVYEVAPEVAVVEFSKSA 382 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~i~~~~~~~---------~~~~~l~~~~ei~~~~~~~~~v~~~k~~ 382 (414)
..|...+.+++..+-++++.+|+.|++ + .|.|++..... +....+.|.+++|++.++.+|+||+ ..
T Consensus 55 IrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLDfk-~~ 133 (179)
T 3t4n_A 55 IRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFK-FD 133 (179)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEEEE-EE
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEEEE-ec
Confidence 456677889999999999999999997 3 47788753211 1113488999999999999999999 77
Q ss_pred C----------------------ChHhHHHHhhhhhhhhcc
Q 015005 383 G----------------------DTLEYKKFCEEDVRPALK 401 (414)
Q Consensus 383 G----------------------d~le~~~~~~~~l~~~l~ 401 (414)
| ....|-.+|. +|--.|.
T Consensus 134 G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca-~LI~eLa 173 (179)
T 3t4n_A 134 GWESSYGDDTTVSNISEDEMSTFSAYPFLHLTT-KLIMELA 173 (179)
T ss_dssp EEECC----------------CCCCHHHHHHHH-HHHHHHH
T ss_pred cccccccccccccccccccccccCCccHHHHHH-HHHHHHH
Confidence 8 6788988887 5655553
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0057 Score=59.96 Aligned_cols=76 Identities=13% Similarity=0.138 Sum_probs=49.4
Q ss_pred EeeeeeecCCeEEEEEEECCC-------CeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEE
Q 015005 20 MGRMLGQGTFAKVYYGKNLVT-------QESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKV 91 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 91 (414)
-++.|..|....+|++..... +..+++++....... .-...+|..+++.+. +.-..++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 356678888999999986421 578999997442211 112357888888884 32245566533 33
Q ss_pred EEEEEccCCCch
Q 015005 92 FFVIEYVKGGEL 103 (414)
Q Consensus 92 ~lv~E~~~gg~L 103 (414)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.68 E-value=0.14 Score=49.46 Aligned_cols=30 Identities=33% Similarity=0.469 Sum_probs=25.7
Q ss_pred CcEEecCCCCcEEE------cCCCCeEEeecCCCcc
Q 015005 135 GVYHRDLKPENLLL------DENGNLKVSDFGLSAL 164 (414)
Q Consensus 135 gi~HrDlkp~NILl------~~~~~~kl~DFGla~~ 164 (414)
.++|+|+.+.|||+ ++++.+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 37899999999999 4567899999999874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.52 E-value=1.5 Score=38.42 Aligned_cols=83 Identities=20% Similarity=0.171 Sum_probs=63.0
Q ss_pred CCCCccceEEEEEeCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCcEEecCCCCcEEEcCCC
Q 015005 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVD-FCHSRGVYHRDLKPENLLLDENG 152 (414)
Q Consensus 74 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~-~lH~~gi~HrDlkp~NILl~~~~ 152 (414)
.||++ -..+-.+++.+.+..+.-+++.=+..+ ..++..+.++++.+|+.... ++ ..-+|-=|.|+||++|.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCC
Confidence 68888 555567888888888776555444544 46788888888888877655 33 4568888999999999999
Q ss_pred CeEEeecCCC
Q 015005 153 NLKVSDFGLS 162 (414)
Q Consensus 153 ~~kl~DFGla 162 (414)
.+++.-.|+-
T Consensus 122 ~p~i~hRGi~ 131 (219)
T 4ano_A 122 EPFFLHVGVK 131 (219)
T ss_dssp CEEESCCEET
T ss_pred cEEEEEcCCc
Confidence 9999877764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.13 E-value=2.3 Score=37.05 Aligned_cols=114 Identities=12% Similarity=0.241 Sum_probs=77.6
Q ss_pred CCCCccceEEEEEeCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC
Q 015005 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN 153 (414)
Q Consensus 74 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~ 153 (414)
.||+.++. .+-++.+.+.+.++.-+.+.=+..+ ..++..+.++++.+|+....++ ..-+|-=|.|+||+++.++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i--k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~~ 117 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI--KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDGL 117 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG--GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTSC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH--HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCCC
Confidence 68999877 6777777776666654433222333 4578888889999998877444 44588889999999999999
Q ss_pred eEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchh-hhhhhhhhhhcCCCCC
Q 015005 154 LKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIW-SCGVVLFVLLSGFLPF 218 (414)
Q Consensus 154 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~Diw-SlGvil~~ll~g~~Pf 218 (414)
+++.--|+-..+ +|. .....|.| ..=+++..+++++..|
T Consensus 118 p~i~~RGik~~l-------------------~P~-------~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 118 PIAKTRGLQNVV-------------------DPL-------PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EEESCCEETTTB-------------------SCC-------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEEEEccCccCC-------------------CCC-------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999877764321 111 11233444 3567788888887775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 414 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-91 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-88 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-85 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-85 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-83 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-83 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-82 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-81 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-79 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-78 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-78 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-77 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-77 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-76 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-76 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-76 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-76 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-74 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-73 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-73 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-72 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-72 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-70 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-70 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-69 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-67 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-67 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-65 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-64 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-63 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-63 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-62 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-62 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-62 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-62 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-60 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-56 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-56 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-54 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-51 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-45 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 9e-13 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 273 bits (698), Expect = 8e-91
Identities = 92/262 (35%), Positives = 152/262 (58%), Gaps = 6/262 (2%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+E+GR LG+G F VY + ++ +A+KV+ K Q++K G+ Q++RE+ + ++HP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRG 135
NI+ L T+V+ ++EY G ++ ++ K K E+ Y +L +A+ +CHS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
V HRD+KPENLLL G LK++DFG S T CGT Y+ PE++ + +D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255
K D+WS GV+ + L G PF+ + Y++I + E+ FP +++ AR LISR+L
Sbjct: 183 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 256 DPQKRISVSEIMINPWFIKGFS 277
+P +R + E++ +PW S
Sbjct: 242 NPSQRPMLREVLEHPWITANSS 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 267 bits (683), Expect = 3e-88
Identities = 86/263 (32%), Positives = 148/263 (56%), Gaps = 8/263 (3%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
++ G++LG+G+F+ V + L T AIK++ K + K+ + + RE VM + HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRG 135
V+L K++F + Y K GEL + K G E R Y +++SA+++ H +G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
+ HRDLKPEN+LL+E+ +++++DFG + + ++ GT YV+PE+L +K
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255
SD+W+ G +++ L++G PF+ N +++KI K EY+FP AR L+ ++LV
Sbjct: 189 -KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 256 DPQKRISVSE------IMINPWF 272
D KR+ E + +P+F
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFF 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (665), Expect = 1e-85
Identities = 92/267 (34%), Positives = 153/267 (57%), Gaps = 6/267 (2%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+++ + LG+G + +V N VT+E+VA+K+++ + E IK+EI + +++ H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNH 62
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSR 134
N+V+ + +EY GGELF ++ + E A+++F QL++ V + H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
G+ HRD+KPENLLLDE NLK+SDFGL+ + + LL+ CGT YVAPE+L+++ +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 195 DGAKSDIWSCGVVLFVLLSGFLPF-QNENIMKMYRKIFKAEYEFPPW--ISCDARRLISR 251
D+WSCG+VL +L+G LP+ Q + + Y + + PW I L+ +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 252 ILVADPQKRISVSEIMINPWFIKGFSK 278
ILV +P RI++ +I + W+ K K
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (661), Expect = 8e-85
Identities = 89/277 (32%), Positives = 144/277 (51%), Gaps = 14/277 (5%)
Query: 4 ETMDERVRNIL-----FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQG 58
E + E++R+I+ KY +GQG VY ++ T + VAI+ +N Q K+
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK- 61
Query: 59 LMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESAR 118
E I EI VMR K+PNIV + +++ V+EY+ GG L V + + E
Sbjct: 62 --ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA 119
Query: 119 KYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQC 178
++ + A++F HS V HRD+K +N+LL +G++K++DFG A + T
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMV 177
Query: 179 GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA---EY 235
GTP ++APEV+ +K Y K DIWS G++ ++ G P+ NEN ++ I E
Sbjct: 178 GTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
Query: 236 EFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272
+ P +S R ++R L D +KR S E++ + +
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (652), Expect = 1e-83
Identities = 77/272 (28%), Positives = 135/272 (49%), Gaps = 14/272 (5%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+E+ LG G F KVY +N T A KVI+ ++ +E EI ++ HPN
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPN 70
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRG 135
IV+L + + ++ +IE+ GG + A +L+ L E + +Q + A+++ H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR----K 191
+ HRDLK N+L +G++K++DFG+SA + + GTP ++APEV+ K
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 192 KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY---EFPPWISCDARRL 248
K+D+WS G+ L + P N M++ KI K+E P S + +
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 249 ISRILVADPQKRISVSEIMINPWFIKGFSKPV 280
+ + L + R + S+++ +P+ +KP+
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 256 bits (655), Expect = 4e-83
Identities = 85/313 (27%), Positives = 143/313 (45%), Gaps = 15/313 (4%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
+ Y++ LG G F V+ T + A K + + E +++EI M ++
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVL 80
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFC 131
+HP +V L + ++ + E++ GGELF KV K+ E+ A +Y +Q+ +
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 132 HSRGVYHRDLKPENLLL--DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
H H DLKPEN++ + LK+ DFGL+A L + GT + APEV
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVA 197
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISCDA 245
K G +D+WS GV+ ++LLSG PF EN + R + ++ IS D
Sbjct: 198 EGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 246 RRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRDFISSMSSGFDLSSL 305
+ I ++L+ADP R+++ + + +PW G + I S+ + +D
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPE 316
Query: 306 FESERKSGSMFTS 318
S ++S
Sbjct: 317 PLPPLGRISNYSS 329
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 253 bits (646), Expect = 8e-82
Identities = 71/267 (26%), Positives = 136/267 (50%), Gaps = 15/267 (5%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
++ Y++ LG G F V+ T K IN + +K EIS+M +
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQL 83
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFC 131
HP ++ L + K ++ ++E++ GGELF ++ K+ E Y +Q +
Sbjct: 84 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 132 HSRGVYHRDLKPENLLLD--ENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
H + H D+KPEN++ + + ++K+ DFGL+ +L D ++ T + APE++
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIV 200
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISCDA 245
++ +D+W+ GV+ +VLLSG PF E+ ++ + + + ++EF +S +A
Sbjct: 201 DREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 246 RRLISRILVADPQKRISVSEIMINPWF 272
+ I +L +P+KR++V + + +PW
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWL 286
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 249 bits (636), Expect = 8e-81
Identities = 65/263 (24%), Positives = 118/263 (44%), Gaps = 11/263 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+ R +G G+F VY+ +++ E VAIK ++ + + I +E+ ++ ++HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELF-AKVLKGKLKEESARKYFQQLISAVDFCHSRG 135
N ++ + + + V+EY G +V K L+E + + + HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR--KKG 193
+ HRD+K N+LL E G +K+ DFG +++ ++ GTP ++APEV+ +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW--ISCDARRLISR 251
K D+WS G+ L P N N M I + E S R +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 252 ILVADPQKRISVSEIMINPWFIK 274
L PQ R + ++ + + ++
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLR 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (629), Expect = 1e-79
Identities = 79/309 (25%), Positives = 145/309 (46%), Gaps = 17/309 (5%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
L+ KY + LG+G F V+ ++++ K + + +K+EIS++ +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIA 58
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFC 131
+H NI+ L E + ++ + E++ G ++F ++ +L E Y Q+ A+ F
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 132 HSRGVYHRDLKPENLLLD--ENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
HS + H D++PEN++ + +K+ +FG + QL P Y APEV
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISCDA 245
+ +D+WS G +++VLLSG PF E ++ I AEY F IS +A
Sbjct: 176 QHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 246 RRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRDFISSMSSGFDLSSL 305
+ R+LV + + R++ SE + +PW + + I +R + ++ DL+ +
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK-DLNMV 293
Query: 306 FESERKSGS 314
+ R S
Sbjct: 294 VSAARISCG 302
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 241 bits (615), Expect = 4e-78
Identities = 97/275 (35%), Positives = 145/275 (52%), Gaps = 20/275 (7%)
Query: 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK------QGLMEQIKREIS 68
+ YE +LG+G + V + T + A+K+I+ Q L E +E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 69 VMRLVK-HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLIS 126
++R V HPNI++LK+ T T F V + +K GELF + K L E+ RK + L+
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
+ H + HRDLKPEN+LLD++ N+K++DFG S QL L CGTP+Y+AP
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAP 178
Query: 187 EVLRKKGYD-----GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP--- 238
E++ D G + D+WS GV+++ LL+G PF + M M R I Y+F
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238
Query: 239 -PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
S + L+SR LV PQKR + E + +P+F
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 6e-78
Identities = 78/268 (29%), Positives = 132/268 (49%), Gaps = 17/268 (6%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
YE+ +G G++ + + + + K ++ + + + + E++++R +KHP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHP 63
Query: 77 NIVELKEVM--ATKTKVFFVIEYVKGGELF-----AKVLKGKLKEESARKYFQQLISAVD 129
NIV + + T T ++ V+EY +GG+L + L EE + QL A+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 130 FCHSRG-----VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYV 184
CH R V HRDLKP N+ LD N+K+ DFGL+ + + GTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYM 181
Query: 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISC 243
+PE + + Y+ KSDIWS G +L+ L + PF + ++ KI + ++ P S
Sbjct: 182 SPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240
Query: 244 DARRLISRILVADPQKRISVSEIMINPW 271
+ +I+R+L R SV EI+ NP
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 240 bits (613), Expect = 2e-77
Identities = 86/261 (32%), Positives = 154/261 (59%), Gaps = 12/261 (4%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+++ R LG G+F +V+ ++ A+KV+ K+ V + +E E ++ +V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEES-ARKYFQQLISAVDFCHSRGV 136
I+ + ++F +++Y++GGELF+ + K + A+ Y ++ A+++ HS+ +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 137 YHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDG 196
+RDLKPEN+LLD+NG++K++DFG + + +T CGTP Y+APEV+ K Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYN- 179
Query: 197 AKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVAD 256
D WS G++++ +L+G+ PF + N MK Y KI AE FPP+ + D + L+SR++ D
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 257 PQKRI-----SVSEIMINPWF 272
+R+ ++ +PWF
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWF 260
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 239 bits (612), Expect = 3e-77
Identities = 102/264 (38%), Positives = 155/264 (58%), Gaps = 14/264 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
Y+ +LG G F++V ++ TQ+ VAIK I K ++ + ++ EI+V+ +KHP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHP 67
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVL-KGKLKEESARKYFQQLISAVDFCHSRG 135
NIV L ++ + ++ +++ V GGELF +++ KG E A + Q++ AV + H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 136 VYHRDLKPENLLL---DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
+ HRDLKPENLL DE+ + +SDFGLS + +L T CGTP YVAPEVL +K
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISCDARRL 248
Y D WS GV+ ++LL G+ PF +EN K++ +I KAEYEF IS A+
Sbjct: 185 PYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 249 ISRILVADPQKRISVSEIMINPWF 272
I ++ DP+KR + + + +PW
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWI 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 2e-76
Identities = 87/258 (33%), Positives = 147/258 (56%), Gaps = 6/258 (2%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHP 76
+ + +MLG+G+F KV+ + T + AIK + KD V +E E V+ L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRG 135
+ + TK +FFV+EY+ GG+L + K A Y ++I + F HS+G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
+ +RDLK +N+LLD++G++K++DFG+ E + D +T CGTP Y+APE+L + Y+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255
D WS GV+L+ +L G PF ++ +++ I +P W+ +A+ L+ ++ V
Sbjct: 182 -HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 256 DPQKRISV-SEIMINPWF 272
+P+KR+ V +I +P F
Sbjct: 241 EPEKRLGVRGDIRQHPLF 258
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 5e-76
Identities = 89/266 (33%), Positives = 152/266 (57%), Gaps = 9/266 (3%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
+ ++ ++LG+GTF KV + T A+K++ K+ + + + E V++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKG-KLKEESARKYFQQLISAVDFC 131
+HP + LK T ++ FV+EY GGELF + + EE AR Y +++SA+++
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRK 191
HSR V +RD+K ENL+LD++G++K++DFGL E + + + T CGTP Y+APEVL
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 192 KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251
Y D W GVV++ ++ G LPF N++ +++ I E FP +S +A+ L++
Sbjct: 180 NDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
Query: 252 ILVADPQKRIS-----VSEIMINPWF 272
+L DP++R+ E+M + +F
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 5e-76
Identities = 68/265 (25%), Positives = 125/265 (47%), Gaps = 15/265 (5%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
I G+ +G+ +G G+F VY GK VA+K++N Q L + K E+ V+R
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQL-QAFKNEVGVLRK 60
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFA--KVLKGKLKEESARKYFQQLISAVDF 130
+H NI+ T ++ V ++ +G L+ +++ K + +Q +D+
Sbjct: 61 TRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
H++ + HRDLK N+ L E+ +K+ DFGL+ + + G+ ++APEV+R
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 191 --KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY------EFPPWIS 242
K +SD+++ G+VL+ L++G LP+ N N + Y +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 243 CDARRLISRILVADPQKRISVSEIM 267
+RL++ L +R +I+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQIL 264
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 9e-76
Identities = 79/265 (29%), Positives = 132/265 (49%), Gaps = 18/265 (6%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLME---QIKREISVMRL 72
+Y++G +LG G F VY G + VAIK + KD++ G + ++ E+ +++
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 73 VK--HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAV 128
V ++ L + ++E + + + G L+EE AR +F Q++ AV
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 129 DFCHSRGVYHRDLKPENLLLDEN-GNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187
CH+ GV HRD+K EN+L+D N G LK+ DFG AL D + GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPE 179
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARR 247
+R Y G + +WS G++L+ ++ G +PF+++ +I + + F +S + +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233
Query: 248 LISRILVADPQKRISVSEIMINPWF 272
LI L P R + EI +PW
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 1e-74
Identities = 64/310 (20%), Positives = 129/310 (41%), Gaps = 53/310 (17%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+E LG G V+ + + +A K+I+ + K + QI RE+ V+ P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSR- 134
IV + ++ +E++ GG L + K G++ E+ K +I + + +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
+ HRD+KP N+L++ G +K+ DFG+S D + ++ GT +Y++PE L+ Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 195 DGAKSDIWSCGVVLFVLLSGFLPFQ---NENIMKMYRKIFKAEYEFPPW----------- 240
+SDIWS G+ L + G P + + M+ + + P
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 241 ------------------------------ISCDARRLISRILVADPQKRISVSEIMINP 270
S + + +++ L+ +P +R + ++M++
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 271 WFIKGFSKPV 280
+ + ++ V
Sbjct: 300 FIKRSDAEEV 309
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 4e-73
Identities = 88/268 (32%), Positives = 144/268 (53%), Gaps = 16/268 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV---KKQGLMEQIKREISVMRLV 73
Y+ G LG G FA V + T A K I K + ++ E I+RE+S+++ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 74 KHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCH 132
+HPN++ L EV KT V ++E V GGELF + + L EE A ++ +Q+++ V + H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 133 SRGVYHRDLKPENLLLDENG----NLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
S + H DLKPEN++L + +K+ DFGL+ ++ GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISCD 244
+ + ++D+WS GV+ ++LLSG PF + + + YEF S
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 245 ARRLISRILVADPQKRISVSEIMINPWF 272
A+ I R+LV DP+KR+++ + + +PW
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 228 bits (581), Expect = 5e-73
Identities = 70/268 (26%), Positives = 127/268 (47%), Gaps = 11/268 (4%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
L +YE+G +LG G ++V+ ++L VA+KV+ D + + +RE +
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 74 KHPNIVELKEVMATKTK----VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAV 128
HP IV + + +T + V+EYV G L V G + + A + A+
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCGTPAYVAPE 187
+F H G+ HRD+KP N+++ +KV DFG++ + + + GT Y++PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISC 243
R D A+SD++S G VL+ +L+G PF ++ + + + + + P +S
Sbjct: 185 QARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243
Query: 244 DARRLISRILVADPQKRISVSEIMINPW 271
D ++ + L +P+ R + M
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 2e-72
Identities = 61/269 (22%), Positives = 128/269 (47%), Gaps = 19/269 (7%)
Query: 16 GKY-EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
G++ + +G+G+F VY G + T VA + ++ K ++ K E +++ ++
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEMLKGLQ 66
Query: 75 HPNIVELKEVMATKTK----VFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVD 129
HPNIV + + K + V E + G L + + +K + R + +Q++ +
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 130 FCHSRG--VYHRDLKPENLLL-DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
F H+R + HRDLK +N+ + G++K+ D GL+ L GTP ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPEFMAP 182
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE-NIMKMYRKIFKAEY--EFPPWISC 243
E+ +K YD D+++ G+ + + + P+ N ++YR++ F
Sbjct: 183 EMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 244 DARRLISRILVADPQKRISVSEIMINPWF 272
+ + +I + + +R S+ +++ + +F
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 228 bits (582), Expect = 4e-72
Identities = 78/267 (29%), Positives = 135/267 (50%), Gaps = 16/267 (5%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK--- 74
+ + R++G+G F +VY + T + A+K ++K ++K + E ++ LV
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHS 133
P IV + T K+ F+++ + GG+L + + G E R Y ++I ++ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKG 193
R V +RDLKP N+LLDE+G++++SD GL+ ++ H GT Y+APEVL+K
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGV 181
Query: 194 YDGAKSDIWSCGVVLFVLLSGFLPFQNEN---IMKMYRKIFKAEYEFPPWISCDARRLIS 250
+ +D +S G +LF LL G PF+ ++ R E P S + R L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 251 RILVADPQKRISV-----SEIMINPWF 272
+L D +R+ E+ +P+F
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 223 bits (568), Expect = 3e-70
Identities = 82/262 (31%), Positives = 146/262 (55%), Gaps = 12/262 (4%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+++ + LG G+F +V K+ + A+K+++K +V K +E E +++ V P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRG 135
+V+L+ + ++ V+EYV GGE+F+ + + G+ E AR Y Q++ ++ HS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
+ +RDLKPENLL+D+ G ++V+DFG + + T CGTP +APE++ KGY+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYN 216
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRILVA 255
D W+ GV+++ + +G+ PF + +++Y KI + FP S D + L+ +L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 256 DPQKRI-----SVSEIMINPWF 272
D KR V++I + WF
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 4e-70
Identities = 89/289 (30%), Positives = 150/289 (51%), Gaps = 32/289 (11%)
Query: 11 RNILFGKYE-MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISV 69
+N + Y+ ++LG G KV N TQE A+K++ + +RE+ +
Sbjct: 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVEL 57
Query: 70 M-RLVKHPNIVELKEV----MATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYF 121
R + P+IV + +V A + + V+E + GGELF+++ E A +
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 122 QQLISAVDFCHSRGVYHRDLKPENLLLD---ENGNLKVSDFGLSALPEQLWNDGLLHTQC 178
+ + A+ + HS + HRD+KPENLL N LK++DFG + ++ + L T C
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPC 174
Query: 179 GTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM----KMYRKIFKAE 234
TP YVAPEVL + YD D+WS GV++++LL G+ PF + + + M +I +
Sbjct: 175 YTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233
Query: 235 YEFP----PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
YEFP +S + + LI +L +P +R++++E M +PW ++ P
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 2e-69
Identities = 69/297 (23%), Positives = 123/297 (41%), Gaps = 38/297 (12%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+Y +G+G + V + V + VAIK I+ + Q ++ REI ++ +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRH 65
Query: 76 PNIVELKEVMATKT----KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFC 131
NI+ + +++ T K +++ ++ G +L+ + L + + Q++ + +
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
HS V HRDLKP NLLL+ +LK+ DFGL+ + G L T Y APE++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP------------ 238
DIWS G +L +LS F ++ + I
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 239 -------------------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276
P A L+ ++L +P KRI V + + +P+ + +
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 3e-67
Identities = 74/296 (25%), Positives = 117/296 (39%), Gaps = 34/296 (11%)
Query: 19 EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQV--KKQGLMEQIKREISVMRLVKHP 76
E LG+G FA VY ++ T + VAIK I K G+ REI +++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVDFCHSRG 135
NI+ L + K+ + V ++++ L + Y + +++ H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
+ HRDLKP NLLLDENG LK++DFGL+ Q T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMY 178
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----------------- 238
G D+W+ G +L LL ++ + +IF+
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 239 -----------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPVAVC 283
D LI + + +P RI+ ++ + +F P C
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPGPTPGC 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 3e-67
Identities = 84/295 (28%), Positives = 139/295 (47%), Gaps = 35/295 (11%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
++ +G+GT+ VY +N +T E VA+K I D + +G+ REIS+++ + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 61
Query: 77 NIVELKEVMATKTKVFFVIEYVKGG--ELFAKVLKGKLKEESARKYFQQLISAVDFCHSR 134
NIV+L +V+ T+ K++ V E++ + + + Y QL+ + FCHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 135 GVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGY 194
V HRDLKP+NLL++ G +K++DFGL+ + T Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 195 DGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP---------------- 238
DIWS G + +++ F ++ + +IF+
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 239 -------------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKPV 280
P + D R L+S++L DP KRIS + +P+F + +KPV
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPV 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 4e-66
Identities = 67/300 (22%), Positives = 122/300 (40%), Gaps = 44/300 (14%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
KYE +GQGTF +V+ ++ T + VA+K + + +K+G REI +++L+KH
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKH 68
Query: 76 PNIVELKEVMATKT--------KVFFVIEYVKGGEL-FAKVLKGKLKEESARKYFQQLIS 126
N+V L E+ TK ++ V ++ + + K ++ Q L++
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL--PEQLWNDGLLHTQCGTPAYV 184
+ + H + HRD+K N+L+ +G LK++DFGL+ + + T Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWI--- 241
PE+L + G D+W G ++ + + Q I + P +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 242 -----------------------------SCDARRLISRILVADPQKRISVSEIMINPWF 272
A LI ++LV DP +RI + + + +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 6e-65
Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 17/277 (6%)
Query: 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQES--VAIKVINKDQVKKQGLMEQIKREISV 69
N+L E LG G F V G + ++ VAIKV+ + ++ E++ RE +
Sbjct: 9 NLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQI 62
Query: 70 MRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVL--KGKLKEESARKYFQQLISA 127
M + +P IV L V + V+E GG L ++ + ++ + + Q+
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGTPAYVAP 186
+ + + HRDL N+LL K+SDFGLS AL + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCD 244
E + + + ++SD+WS GV ++ LS G P++ ++ I + + E PP +
Sbjct: 182 ECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 240
Query: 245 ARRLISRILVADPQKRISVSEI--MINPWFIKGFSKP 279
L+S + + R + + + SK
Sbjct: 241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-64
Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 36/288 (12%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQES-----VAIKVINKDQVKKQGLMEQIKREI 67
E G++LG G F KV ++ VA+K++ + E + E+
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSEL 91
Query: 68 SVM-RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK----------------- 109
+M +L H NIV L ++ + EY G+L +
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 110 -------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162
L E + Q+ ++F + HRDL N+L+ +K+ DFGL+
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNE 221
N + ++APE L + Y KSD+WS G++L+ + S G P+
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 222 NIMKMYRKIFKAEY--EFPPWISCDARRLISRILVADPQKRISVSEIM 267
+ + K+ + + + P + + + ++ D +KR S +
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-64
Identities = 66/259 (25%), Positives = 111/259 (42%), Gaps = 11/259 (4%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVT---QESVAIKVINKDQVKKQGLMEQIKREISVMRLVK 74
+ LG G+F V G+ SVA+K + D + + M+ RE++ M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 75 HPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCH 132
H N++ L V+ T + V E G L ++ K G + +Y Q+ + +
Sbjct: 70 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 133 SRGVYHRDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGTPAYVAPEVLRK 191
S+ HRDL NLLL +K+ DFGL ALP+ + + + A+ APE L+
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 192 KGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY--EFPPWISCDARRL 248
+ + SD W GV L+ + + G P+ N ++ KI K P D +
Sbjct: 189 RTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 249 ISRILVADPQKRISVSEIM 267
+ + P+ R + +
Sbjct: 248 MVQCWAHKPEDRPTFVALR 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 5e-64
Identities = 64/261 (24%), Positives = 112/261 (42%), Gaps = 19/261 (7%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
+ + ++ + +G+G F V G VA+K I D + E SVM
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA-----QAFLAEASVMTQ 56
Query: 73 VKHPNIVELKEVMA-TKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAV 128
++H N+V+L V+ K ++ V EY+ G L + L + K+ + A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 129 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEV 188
++ HRDL N+L+ E+ KVSDFGL+ + T + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEA 171
Query: 189 LRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDAR 246
LR+K + KSD+WS G++L+ + S G +P+ + + ++ K + P
Sbjct: 172 LREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230
Query: 247 RLISRILVADPQKRISVSEIM 267
++ D R S ++
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLR 251
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-63
Identities = 78/295 (26%), Positives = 125/295 (42%), Gaps = 50/295 (16%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
Y +++G G+F VY K + E VAIK + +D+ RE+ +MR + H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCN 74
Query: 78 IVELKEVMAT------KTKVFFVIEYVKGGEL----FAKVLKGKLKEESARKYFQQLISA 127
IV L+ + + + V++YV K L + Y QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNL-KVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
+ + HS G+ HRD+KP+NLLLD + + K+ DFG + +QL + + Y AP
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRAP 191
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK-------------- 232
E++ + D+WS G VL LL G F ++ + +I K
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 233 ---AEYEFP------------PWISCDARRLISRILVADPQKRISVSEIMINPWF 272
E++FP P +A L SR+L P R++ E + +F
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-63
Identities = 57/261 (21%), Positives = 111/261 (42%), Gaps = 11/261 (4%)
Query: 22 RMLGQGTFAKVYYG--KNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIV 79
+ LG G F V G + ++VA+K++ + L +++ E +VM+ + +P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNPYIV 71
Query: 80 ELKEVMATKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYH 138
+ + + V+E + G L + + +K+++ + Q+ + + H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 139 RDLKPENLLLDENGNLKVSDFGLS-ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGA 197
RDL N+LL K+SDFGLS AL + APE + + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189
Query: 198 KSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISRILVA 255
KSD+WS GV+++ S G P++ ++ + K E P + L++
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 256 DPQKRISVSEI--MINPWFIK 274
D + R + + + ++
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 3e-63
Identities = 68/297 (22%), Positives = 128/297 (43%), Gaps = 46/297 (15%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
+ Y + +G G + V + T VAIK + + + ++ RE+ +++ +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHM 74
Query: 74 KHPNIVELKEVMATK------TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLIS 126
+H N++ L +V T + V+ ++ G K++K KL E+ + Q++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLK 132
Query: 127 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAP 186
+ + H+ G+ HRDLKP NL ++E+ LK+ DFGL+ D + T Y AP
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAP 187
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW------ 240
EV+ DIWS G ++ +++G F+ + + ++I K P
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 241 -------------------------ISCDARRLISRILVADPQKRISVSEIMINPWF 272
S A L+ ++LV D ++R++ E + +P+F
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 6e-63
Identities = 62/292 (21%), Positives = 122/292 (41%), Gaps = 42/292 (14%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
+Y+ +G G + V + T VA+K +++ ++ RE+ +++ +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHE 77
Query: 77 NIVELKEVMATKTKV-----FFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFC 131
N++ L +V + +++ ++ G +L V KL ++ + Q++ + +
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 132 HSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRK 191
HS + HRDLKP NL ++E+ LK+ DFGL+ + T Y APE++
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLN 192
Query: 192 KGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW----------- 240
+ DIWS G ++ LL+G F + + + I +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 241 --------------------ISCDARRLISRILVADPQKRISVSEIMINPWF 272
+ A L+ ++LV D KRI+ ++ + + +F
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-62
Identities = 61/254 (24%), Positives = 111/254 (43%), Gaps = 11/254 (4%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+ LG G F V YGK Q VAIK+I + + + ++ E VM + H
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFA--KVLKGKLKEESARKYFQQLISAVDFCHSRG 135
+V+L V + +F + EY+ G L + ++ + + + + + + A+++ S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
HRDL N L+++ G +KVSDFGLS + PEVL +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 196 GAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISRIL 253
+KSDIW+ GV+++ + S G +P++ + I + P S ++
Sbjct: 180 -SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 254 VADPQKRISVSEIM 267
+R + ++
Sbjct: 239 HEKADERPTFKILL 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 201 bits (512), Expect = 1e-62
Identities = 78/286 (27%), Positives = 134/286 (46%), Gaps = 34/286 (11%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KY +G+GT+ VY +N E+ A+K I ++ + +G+ REIS+++ +KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGELFA-KVLKGKLKEESARKYFQQLISAVDFCHSRG 135
NIV+L +V+ TK ++ V E++ V +G L+ +A+ + QL++ + +CH R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
V HRDLKP+NLL++ G LK++DFGL+ + T Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 196 GAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-------------------- 235
DIWS G + +++G F + +IF+
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 236 ---------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272
F + L+S++L DP +RI+ + + + +F
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (510), Expect = 3e-62
Identities = 62/267 (23%), Positives = 113/267 (42%), Gaps = 13/267 (4%)
Query: 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQES---VAIKVINKDQVKKQGLMEQIKREI 67
+ I ++ +++G G F +V G + + VAIK + +KQ E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEA 78
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESARKYFQQLI 125
S+M HPN++ L+ V+ T V + E+++ G L F + G+ + +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT---QCGTPA 182
+ + + HRDL N+L++ N KVSDFGLS E +D +
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 183 YVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPW 240
+ APE ++ + + SD+WS G+V++ ++S G P+ + + I + P
Sbjct: 199 WTAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD 257
Query: 241 ISCDARRLISRILVADPQKRISVSEIM 267
+L+ D R +I+
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 5e-62
Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 35/294 (11%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76
KYE +G+GT+ V+ KN T E VA+K + D +G+ REI +++ +KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 61
Query: 77 NIVELKEVMATKTKVFFVIEYVKGGEL-FAKVLKGKLKEESARKYFQQLISAVDFCHSRG 135
NIV L +V+ + K+ V E+ + G L E + + QL+ + FCHSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
V HRDLKP+NLL++ NG LK+++FGL+ + T Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 196 GAKSDIWSCGVVLFVLLSGFLP-FQNENIMKMYRKIFKAEYEFP---------------- 238
D+WS G + L + P F ++ ++IF+
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 239 -------------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKGFSKP 279
P ++ R L+ +L +P +RIS E + +P+F F P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFCPP 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 7e-62
Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 43/294 (14%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVT-QESVAIKVINKDQVKKQGLMEQIKREISVMRL--- 72
+YE +G+G + KV+ ++L VA+K + ++G+ RE++V+R
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLET 66
Query: 73 VKHPNIVELKEVMAT-----KTKVFFVIEYVKGG--ELFAKVLKGKLKEESARKYFQQLI 125
+HPN+V L +V +TK+ V E+V KV + + E+ + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVA 185
+DF HS V HRDLKP+N+L+ +G +K++DFGL+ + + T Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRA 183
Query: 186 PEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY---------- 235
PEVL + Y D+WS G + + F+ + + KI
Sbjct: 184 PEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 236 -----------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWF 272
+F I + L+ + L +P KRIS + +P+F
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-62
Identities = 76/271 (28%), Positives = 136/271 (50%), Gaps = 15/271 (5%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLV---TQESVAIKVINKDQV-KKQGLMEQIKREISVMRL 72
+E+ ++LG G + KV+ + + T + A+KV+ K + +K E + E V+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 73 VKH-PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKG-KLKEESARKYFQQLISAVDF 130
++ P +V L T+TK+ +++Y+ GGELF + + + E + Y +++ A++
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
H G+ +RD+K EN+LLD NG++ ++DFGLS + V
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 191 KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN----IMKMYRKIFKAEYEFPPWISCDAR 246
D WS GV+++ LL+G PF + ++ R+I K+E +P +S A+
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264
Query: 247 RLISRILVADPQKRIS-----VSEIMINPWF 272
LI R+L+ DP+KR+ EI + +F
Sbjct: 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-61
Identities = 71/262 (27%), Positives = 117/262 (44%), Gaps = 12/262 (4%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQES---VAIKVINKDQVKKQGLMEQIKREISV 69
I + E+GR +G+G F V+ G + + VAIK + E+ +E
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALT 61
Query: 70 MRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISA 127
MR HP+IV+L V+ T+ V+ ++E GEL + + L S Y QL +A
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187
+ + S+ HRD+ N+L+ N +K+ DFGLS E ++APE
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 179
Query: 188 VLRKKGYDGAKSDIWSCGVVLF-VLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWISCDA 245
+ + + SD+W GV ++ +L+ G PFQ + +I E PP
Sbjct: 180 SINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238
Query: 246 RRLISRILVADPQKRISVSEIM 267
L+++ DP +R +E+
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELK 260
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (506), Expect = 1e-61
Identities = 68/263 (25%), Positives = 119/263 (45%), Gaps = 17/263 (6%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
+ M LG G + +VY G +VA+K + +D ++ E+ +E +VM+
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKE 69
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELF---AKVLKGKLKEESARKYFQQLISAVD 129
+KHPN+V+L V + + + E++ G L + + ++ Q+ SA++
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGT---PAYVAP 186
+ + HRDL N L+ EN +KV+DFGLS +L G + AP
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAP 185
Query: 187 EVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFK-AEYEFPPWISCD 244
E L + KSD+W+ GV+L+ + + G P+ ++ ++Y + K E P
Sbjct: 186 ESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244
Query: 245 ARRLISRILVADPQKRISVSEIM 267
L+ +P R S +EI
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIH 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-61
Identities = 64/267 (23%), Positives = 112/267 (41%), Gaps = 15/267 (5%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
I + LGQG F +V+ G T VAIK + + E +E VM+
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKK 68
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLK---EESARKYFQQLISAVD 129
++H +V+L V+ ++ ++ V EY+ G L + K Q+ S +
Sbjct: 69 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
+ HRDL+ N+L+ EN KV+DFGL+ L E + APE
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAA 186
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARR 247
+ KSD+WS G++L L + G +P+ ++ ++ + PP
Sbjct: 187 LYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
Query: 248 LISRILVADPQKRISVSEI--MINPWF 272
L+ + +P++R + + + +F
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-61
Identities = 68/298 (22%), Positives = 126/298 (42%), Gaps = 10/298 (3%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINK--DQVKKQGLMEQIKREISVMRLVKH 75
++ ++LG G F VY G + E V I V K + ++I E VM V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLK--EESARKYFQQLISAVDFCHS 133
P++ L + T T V + + + G L V + K + + Q+ +++
Sbjct: 71 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 134 RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKG 193
R + HRDL N+L+ ++K++DFGL+ L + ++A E + +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 194 YDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISR 251
Y +SD+WS GV ++ L++ G P+ ++ + K E PP + D ++ +
Sbjct: 190 YT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 252 ILVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRDFISSMSSGFDLSSLFESE 309
+ D R E++I + P + GD R + S + +L + E
Sbjct: 249 CWMIDADSRPKFRELIIEFSKMA--RDPQRYLVIQGDERMHLPSPTDSNFYRALMDEE 304
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 5e-61
Identities = 61/254 (24%), Positives = 108/254 (42%), Gaps = 11/254 (4%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN 77
+ +G G F V+ G L + VAIK I + + + E E VM + HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 78 IVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLK--EESARKYFQQLISAVDFCHSRG 135
+V+L V + + V E+++ G L + + E+ + + +
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 136 VYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYD 195
V HRDL N L+ EN +KVSDFG++ + +PEV Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 196 GAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY-EFPPWISCDARRLISRIL 253
+KSD+WS GV+++ + S G +P++N + ++ I P S ++++
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 254 VADPQKRISVSEIM 267
P+ R + S ++
Sbjct: 240 KERPEDRPAFSRLL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-60
Identities = 57/279 (20%), Positives = 105/279 (37%), Gaps = 24/279 (8%)
Query: 9 RVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREIS 68
+ + + ++G+G F +V + + + + + E+
Sbjct: 3 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 69 VM-RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELF-----------------AKVLKG 110
V+ +L HPNI+ L + ++ IEY G L A
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 111 KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170
L + + + +D+ + HRDL N+L+ EN K++DFGLS
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EV 179
Query: 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRK 229
++A E L Y SD+WS GV+L+ ++S G P+ ++Y K
Sbjct: 180 YVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238
Query: 230 IFKAEY-EFPPWISCDARRLISRILVADPQKRISVSEIM 267
+ + E P + L+ + P +R S ++I+
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-60
Identities = 56/267 (20%), Positives = 114/267 (42%), Gaps = 15/267 (5%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL 72
+ ++ LG G F +V+ G VA+K + + + + E ++M+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQ 64
Query: 73 VKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVD 129
++H +V L V+ T+ ++ + EY++ G L + KL Q+ +
Sbjct: 65 LQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 130 FCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVL 189
F R HRDL+ N+L+ + + K++DFGL+ L E + APE +
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAI 182
Query: 190 RKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARR 247
G KSD+WS G++L +++ G +P+ ++ + + + P + +
Sbjct: 183 N-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241
Query: 248 LISRILVADPQKRISVSEI--MINPWF 272
L+ P+ R + + ++ +F
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 192 bits (488), Expect = 1e-58
Identities = 75/298 (25%), Positives = 131/298 (43%), Gaps = 53/298 (17%)
Query: 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVM-RLVKH 75
Y++ R LG+G +++V+ N+ E V +K++ + K +IKREI ++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK------KIKREIKILENLRGG 89
Query: 76 PNIVELKEVMATKTK--VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS 133
PNI+ L +++ V E+V + L L + R Y +++ A+D+CHS
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQ--LYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 134 RGVYHRDLKPENLLLD-ENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKK 192
G+ HRD+KP N+++D E+ L++ D+GL+ E + + + + PE+L
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 193 GYDGAKSDIWSCGVVLFVLLSGFLPF--------QNENIMK------MYRKIFKAEYEFP 238
D+WS G +L ++ PF Q I K +Y I K E
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 239 PW------------------------ISCDARRLISRILVADPQKRISVSEIMINPWF 272
P +S +A + ++L D Q R++ E M +P+F
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (482), Expect = 5e-58
Identities = 59/283 (20%), Positives = 103/283 (36%), Gaps = 35/283 (12%)
Query: 17 KYEMGRMLGQGTFAKVYYGK-----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
E R +G+G F +V+ + VA+K++ ++ + +RE ++M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMA 71
Query: 72 LVKHPNIVELKEVMATKTKVFFVIEYVKGGELF-------------------------AK 106
+PNIV+L V A + + EY+ G+L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 107 VLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166
L +Q+ + + + R HRDL N L+ EN +K++DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 167 QLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFL-PFQNENIMK 225
++ PE + Y +SD+W+ GVVL+ + S L P+ +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 226 MYRKIFKAEY-EFPPWISCDARRLISRILVADPQKRISVSEIM 267
+ + P + L+ P R S I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-57
Identities = 63/279 (22%), Positives = 103/279 (36%), Gaps = 31/279 (11%)
Query: 17 KYEMGRMLGQGTFAKVYYGK-----NLVTQESVAIKVINKDQVKKQGLMEQIKREISVM- 70
+ G+ LG G F KV +VA+K++ E + E+ V+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLS 81
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELF-------------------AKVLKGK 111
L H NIV L + EY G+L + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 112 LKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171
L E + Q+ + F S+ HRDL N+LL K+ DFGL+ + N
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKI 230
+ ++APE + +SD+WS G+ L+ L S G P+ + + K+
Sbjct: 202 VVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 231 FKAEY--EFPPWISCDARRLISRILVADPQKRISVSEIM 267
K + P + ++ ADP KR + +I+
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-57
Identities = 55/282 (19%), Positives = 122/282 (43%), Gaps = 30/282 (10%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQES-------VAIKVINKDQVKKQGLMEQIKR 65
+ + +G+ LG+G F +V + + + VA+K++ D +K + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLIS 67
Query: 66 EISVM-RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELF-----------------AKV 107
E+ +M + KH NI+ L ++ ++EY G L +
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 108 LKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167
+ +L + Q+ +++ S+ HRDL N+L+ E+ +K++DFGL+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKM 226
+ ++APE L + Y +SD+WS GV+L+ + + G P+ + ++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 227 YRKIFKAEY-EFPPWISCDARRLISRILVADPQKRISVSEIM 267
++ + + + P + + ++ A P +R + +++
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 2e-56
Identities = 57/265 (21%), Positives = 110/265 (41%), Gaps = 12/265 (4%)
Query: 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQES----VAIKVINKDQVKKQGLMEQIKREI 67
I +++G G F +VY G + VAIK + +KQ E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEA 60
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLI 125
+M H NI+ L+ V++ + + EY++ G L + + G+ + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 126 SAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA-LPEQLWNDGLLHTQCGTPAYV 184
+ + + + HRDL N+L++ N KVSDFGLS L + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 185 APEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWIS 242
APE + + + SD+WS G+V++ +++ G P+ + ++ + I P
Sbjct: 181 APEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239
Query: 243 CDARRLISRILVADPQKRISVSEIM 267
+L+ + + +R ++I+
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIV 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-56
Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 17/274 (6%)
Query: 8 ERVRNILFGKYEM----GRMLGQGTFAKVYYGK---NLVTQESVAIKVINKDQVKKQGLM 60
+ V++++ G + ++G+G F VY+G N + A+K +N+ + G +
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEV 72
Query: 61 EQIKREISVMRLVKHPNIVELKEV-MATKTKVFFVIEYVKGGEL--FAKVLKGKLKEESA 117
Q E +M+ HPN++ L + + ++ V+ Y+K G+L F + +
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 118 RKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSAL--PEQLWNDGLLH 175
+ Q+ + F S+ HRDL N +LDE +KV+DFGL+ ++ +
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE 234
++A E L+ + + KSD+WS GV+L+ L++ G P+ + N + + +
Sbjct: 193 GAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 251
Query: 235 Y-EFPPWISCDARRLISRILVADPQKRISVSEIM 267
P + ++ + + R S SE++
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 285
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 8e-56
Identities = 60/293 (20%), Positives = 105/293 (35%), Gaps = 31/293 (10%)
Query: 6 MDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR 65
M+ RV N +Y +GR +G G+F +Y G ++ E VAIK+ Q+
Sbjct: 1 MELRVGN----RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHI 51
Query: 66 EISVMRLVKHPN-IVELKEVMATKTKVFFVIEYVKGGELF-AKVLKGKLKEESARKYFQQ 123
E + ++++ I ++ A V+E + K ++ Q
Sbjct: 52 ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQ 111
Query: 124 LISAVDFCHSRGVYHRDLKPENLL---LDENGNLKVSDFGLS-----ALPEQLWNDGLLH 175
+IS +++ HS+ HRD+KP+N L + + + DFGL+ A Q
Sbjct: 112 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 176 TQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY 235
GT Y + + D+ S G VL G LP+Q +K +
Sbjct: 172 NLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 236 --------EFPPWISCDARRLISRILVADPQKRISVSEI---MINPWFIKGFS 277
+ ++ + S + N + +GFS
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-55
Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 55/307 (17%)
Query: 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV 73
+ +Y+ + +G G V + V +VAIK +++ + Q ++ RE+ +M+ V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 73
Query: 74 KHPNIVELKEVMATK------TKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISA 127
H NI+ L V + V+ V+E + +V++ +L E Q++
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSYLLYQMLCG 131
Query: 128 VDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPE 187
+ HS G+ HRDLKP N+++ + LK+ DFGL+ ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPE 188
Query: 188 VLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPW------- 240
V+ GY DIWS G ++ ++ + F + + + K+ + P
Sbjct: 189 VILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 241 -----------------------------------ISCDARRLISRILVADPQKRISVSE 265
+ AR L+S++LV DP KRISV +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 266 IMINPWF 272
+ +P+
Sbjct: 308 ALQHPYI 314
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-54
Identities = 59/284 (20%), Positives = 113/284 (39%), Gaps = 27/284 (9%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGKN-----LVTQESVAIKVINKDQVKKQGLMEQIKREI 67
+ K M R LGQG+F VY G + VAIK +N+ ++ + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEA 74
Query: 68 SVMRLVKHPNIVELKEVMATKTKVFFVIEYVKGGELF-----------AKVLKGKLKEES 116
SVM+ ++V L V++ ++E + G+L +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 117 ARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT 176
+ ++ + + ++ HRDL N ++ E+ +K+ DFG++ +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGF-LPFQNENIMKMYRKIFKAEY 235
+++PE L+ + SD+WS GVVL+ + + P+Q + ++ R + +
Sbjct: 195 GLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253
Query: 236 -EFPPWISCDARRLISRILVADPQKRISVSEIM------INPWF 272
+ P L+ +P+ R S EI+ + P F
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 178 bits (452), Expect = 9e-54
Identities = 49/275 (17%), Positives = 97/275 (35%), Gaps = 26/275 (9%)
Query: 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR 71
N++ Y++GR +G+G+F ++ G NL+ + VAIK + Q++ E +
Sbjct: 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYK 55
Query: 72 LVKH-PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGK-LKEESARKYFQQLISAVD 129
L+ I + VI+ + L G+ ++ +Q+++ V
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 130 FCHSRGVYHRDLKPENLLLDE-----NGNLKVSDFGLSAL-----PEQLWNDGLLHTQCG 179
H + + +RD+KP+N L+ + V DFG+ +Q G
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 180 TPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY---- 235
T Y++ + + D+ + G V L G LP+Q +K +
Sbjct: 176 TARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 236 ----EFPPWISCDARRLISRILVADPQKRISVSEI 266
E + + + +
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 7e-52
Identities = 59/281 (20%), Positives = 113/281 (40%), Gaps = 28/281 (9%)
Query: 13 ILFGKYEMGRMLGQGTFAKVYYGK-----NLVTQESVAIKVINKDQVKKQGLMEQIKREI 67
+ ++G+ LG+G F +V T +VA+K++ + + +
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELK 68
Query: 68 SVMRLVKHPNIVELKEVMA-TKTKVFFVIEYVKGGELF-----------------AKVLK 109
++ + H N+V L + ++E+ K G L + K
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 110 GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169
L E Y Q+ ++F SR HRDL N+LL E +K+ DFGL+ +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGF-LPFQNENIMKMYR 228
+ ++APE + + Y +SD+WS GV+L+ + S P+ I + +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 229 KIFKAEY--EFPPWISCDARRLISRILVADPQKRISVSEIM 267
+ K P + + + + + +P +R + SE++
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-51
Identities = 62/293 (21%), Positives = 117/293 (39%), Gaps = 47/293 (16%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75
+ +G+G F +V+ GK E VA+K+ + + + + EI +++H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRH 56
Query: 76 PNIVELKEVM----ATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFC 131
NI+ T T+++ V +Y + G LF + + + E K S +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 132 HS--------RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN--DGLLHTQCGTP 181
H + HRDLK +N+L+ +NG ++D GL+ + + D + + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 182 AYVAPEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMY--------- 227
Y+APEVL K ++DI++ G+V + + ++
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 228 -----RKIFKAEYEFPP----WISCDA----RRLISRILVADPQKRISVSEIM 267
RK+ + P W SC+A +++ A+ R++ I
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (397), Expect = 5e-45
Identities = 67/358 (18%), Positives = 124/358 (34%), Gaps = 71/358 (19%)
Query: 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIK-------REIS 68
+Y + R LG G F+ V+ K++V VA+K++ D+V + ++IK + +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 69 VMRLVKHPNIVELKEVMATKTKVFFVIEYVKGG------ELFAKVLKGKLKEESARKYFQ 122
+ +I++L + K + V L K + ++ +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 123 QLISAVDFCH-SRGVYHRDLKPENLLLDENG-NLKVSDFGLSALPEQLWNDGLLHTQCGT 180
QL+ +D+ H G+ H D+KPEN+L++ + ++ L W D T
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 181 PAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMY------------- 227
Y +PEVL + +DIWS ++F L++G F+ +
Sbjct: 193 REYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 228 -----------------------------------RKIFKAEYEFPPWISCDARRLISRI 252
+ +Y+F + + +S +
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 253 LVADPQKRISVSEIMINPWFIKGFSKPVAVCIDDGDNRDFISSMSSGFDLSSLFESER 310
L DP+KR ++ +PW SG D+ FE R
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTLGMEEI-------RVPDRELYGSGSDIPGWFEEVR 362
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 1e-20
Identities = 29/201 (14%), Positives = 65/201 (32%), Gaps = 19/201 (9%)
Query: 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLM-------EQIKREISVM 70
+G+++G+G + V+ + E +K + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 71 RLVKHPNIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDF 130
+ + +L+ + K + EL +++ E+ + ++ V
Sbjct: 61 ARNEFRALQKLQGLAVPKV--YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 131 CHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLR 190
+ RG+ H DL N+L+ E G + + DF S + +L
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV----RNIITYFS 173
Query: 191 KKGYDGAKSDIWSCGVVLFVL 211
+ + DI S + +L
Sbjct: 174 RTY--RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 62.1 bits (151), Expect = 9e-13
Identities = 14/80 (17%), Positives = 31/80 (38%), Gaps = 2/80 (2%)
Query: 317 TSKCSSSAIMGKLESLAKKLNLGVCVKE-FKVKMQGKDEGRKGKLAVTAEVYEVA-PEVA 374
TS S +M ++ + N +E F + D + + EV ++ +
Sbjct: 16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLN 75
Query: 375 VVEFSKSAGDTLEYKKFCEE 394
V F + +G ++ +K +
Sbjct: 76 GVRFKRISGTSIAFKNIASK 95
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.26 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.76 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.23 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 97.69 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.4 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.33 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.27 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 96.57 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 95.95 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-67 Score=486.83 Aligned_cols=257 Identities=35% Similarity=0.703 Sum_probs=240.0
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.-+++|++++.||+|+||+||+|+++.+++.||+|++.+....+....+.+.+|+++++.++|||||++++++.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 34678999999999999999999999999999999998776665556778999999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND 171 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 171 (414)
+|||||+||+|.+.+.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.... .
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~ 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 158 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----C
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----C
Confidence 99999999999999987 889999999999999999999999999999999999999999999999999997543 2
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISR 251 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 251 (414)
......+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+.++....+.+|+.+|+++++||.+
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred CcccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 334567899999999999998885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCCChHHHhcCCcccc
Q 015005 252 ILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
||++||++|||++|+|+||||..
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-67 Score=487.31 Aligned_cols=262 Identities=34% Similarity=0.639 Sum_probs=226.7
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
+.++|++++.||+|+||+||+|+++.+|+.||||++++....+ ..+.+.+|+++|++++|||||++++++.+++.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 5788999999999999999999999999999999998765332 24578899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 94 VIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||||+||+|++++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999999986 689999999999999999999999999999999999999999999999999998765433344
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHHHhcccCCC--CCCCHHHHHHH
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKIFKAEYEFP--PWISCDARRLI 249 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~li 249 (414)
...+.+||+.|||||++.+..|++.++|||||||++|+|++|+.||...+.. ..+..+.......+ ..+|+++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 5567789999999999998888767899999999999999999999876543 33333333333322 35899999999
Q ss_pred HhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 250 SRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
++||+.||++|||++|+++||||++...
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 9999999999999999999999986543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-66 Score=485.60 Aligned_cols=259 Identities=33% Similarity=0.642 Sum_probs=234.7
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
-++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++++||||+++++++.+++.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 36799999999999999999999999999999999877665555567899999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||||+||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+..........
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 999999999998886 8999999999999999999999999999999999999999999999999999987654434445
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRIL 253 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 253 (414)
..+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.++....+.+|..+|+++++||++||
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 245 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 245 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTS
T ss_pred cccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 5677899999999999998885 899999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCChHH------HhcCCcccc
Q 015005 254 VADPQKRISVSE------IMINPWFIK 274 (414)
Q Consensus 254 ~~dp~~R~s~~e------il~hp~f~~ 274 (414)
++||++|||++| +++||||..
T Consensus 246 ~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 246 VLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred cCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 999999999988 588999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-65 Score=482.91 Aligned_cols=267 Identities=33% Similarity=0.503 Sum_probs=234.5
Q ss_pred cccchhHhhhccc-----cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC
Q 015005 2 KFETMDERVRNIL-----FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHP 76 (414)
Q Consensus 2 ~~~~~~~~~~~~~-----~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hp 76 (414)
|++++-+.+++.. .++|++.+.||+|+||+||+|++..+|+.||||++.+..... .+.+.+|+.+|+.++||
T Consensus 1 sd~~~~~~l~~~~~~~dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~Hp 77 (293)
T d1yhwa1 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNP 77 (293)
T ss_dssp CHHHHHHHHHHHSBSSCTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCT
T ss_pred ChHHHHHHHhccCCCCCcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCC
Confidence 3444444444433 347999999999999999999999999999999998654332 46789999999999999
Q ss_pred CccceEEEEEeCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEE
Q 015005 77 NIVELKEVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV 156 (414)
Q Consensus 77 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl 156 (414)
|||++++++.+.+.+|+|||||+||+|.+++.++.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||
T Consensus 78 nIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl 157 (293)
T d1yhwa1 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKL 157 (293)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred CEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEee
Confidence 99999999999999999999999999999988899999999999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc---
Q 015005 157 SDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA--- 233 (414)
Q Consensus 157 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--- 233 (414)
+|||+|+.... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+.......+...
T Consensus 158 ~DFG~a~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~ 234 (293)
T d1yhwa1 158 TDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234 (293)
T ss_dssp CCCTTCEECCS--TTCCBCCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC
T ss_pred ccchhheeecc--ccccccccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999986543 23345677899999999999998885 8999999999999999999999988777666655543
Q ss_pred ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 234 EYEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
....|+.+|+++++||.+||++||.+|||+.|+|+||||+.
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 23456679999999999999999999999999999999964
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-64 Score=485.38 Aligned_cols=258 Identities=34% Similarity=0.643 Sum_probs=240.9
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
-+++|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|+.+|+.++||||+++++++++.+.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 46789999999999999999999999999999999988766555557788999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 94 VIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||||+||+|++++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ...
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~~ 160 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTC
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CCc
Confidence 9999999999999987 8899999999999999999999999999999999999999999999999999985432 234
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRI 252 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 252 (414)
.....+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+..++++.+..+.+.+|..+|+++++||++|
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhh
Confidence 55678999999999999999995 89999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCCC-----hHHHhcCCcccc
Q 015005 253 LVADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 253 L~~dp~~R~s-----~~eil~hp~f~~ 274 (414)
|++||.+|++ ++|+++||||..
T Consensus 240 L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ccCCchhhcccccccHHHHHcCccccc
Confidence 9999999994 899999999965
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-63 Score=474.41 Aligned_cols=254 Identities=34% Similarity=0.701 Sum_probs=237.3
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46799999999999999999999999999999999877665555578899999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||||+||+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----c
Confidence 999999999998887 7899999999999999999999999999999999999999999999999999986432 3
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRIL 253 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 253 (414)
..+.+||+.|||||++.+.+|+ .++|||||||++|+|++|+.||.+.+..+.+.++..+...+|+.+|+++.++|.+||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 4567899999999999998886 799999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCC-----ChHHHhcCCcccc
Q 015005 254 VADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 254 ~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
++||.+|+ |++++++||||+.
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhCHHhccccchhhHHHHHcCccccc
Confidence 99999996 8999999999965
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-64 Score=472.02 Aligned_cols=255 Identities=29% Similarity=0.471 Sum_probs=226.1
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
+.|++++.||+|+||+||+|++..+|+.||+|++.+.... ..+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 5699999999999999999999999999999999765432 2467889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|||+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..... ...
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence 99999999998765 57999999999999999999999999999999999999999999999999999754321 123
Q ss_pred cccccCCCcccCchhhc-----ccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccC---CCCCCCHHH
Q 015005 174 LHTQCGTPAYVAPEVLR-----KKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYE---FPPWISCDA 245 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~ 245 (414)
..+.+||+.|+|||++. +..| +.++|||||||++|+|++|..||.+.+..+.+.++..+..+ .|..+|+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 44678999999999984 3345 48999999999999999999999998888888888776543 356789999
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 246 RRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
.+||++||++||++|||++|+++||||+...
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999997543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-63 Score=474.06 Aligned_cols=258 Identities=39% Similarity=0.728 Sum_probs=216.1
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
+.+.++|++.+.||+|+||+||+|+++.+|+.||||++.+...... .+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3456789999999999999999999999999999999987655432 45688999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc---CCCCeEEeecCCCccccc
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD---ENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~---~~~~~kl~DFGla~~~~~ 167 (414)
|+|||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+....
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999999999986 7899999999999999999999999999999999999995 578999999999986432
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 243 (414)
.....+.+||+.|||||++.+..|+ .++|||||||++|+|++|..||.+.+..+....+..+.+.++ +.+|+
T Consensus 163 ---~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 163 ---GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238 (307)
T ss_dssp -------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred ---CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence 3345677899999999999998885 899999999999999999999999999999999988776554 45899
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++.+||.+||++||.+|||++|+++||||...
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-63 Score=463.14 Aligned_cols=254 Identities=31% Similarity=0.529 Sum_probs=217.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT--KTKVF 92 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 92 (414)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+..... ...+.+.+|+++|++++|||||++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 467999999999999999999999999999999998765543 345778999999999999999999999864 46689
Q ss_pred EEEEccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 93 FVIEYVKGGELFAKVLK-----GKLKEESARKYFQQLISAVDFCHSRG-----VYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-----~~~~e~~~~~~~~ql~~al~~lH~~g-----i~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998853 57999999999999999999999976 999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-CCCCCC
Q 015005 163 ALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY-EFPPWI 241 (414)
Q Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~ 241 (414)
+.... ........+||+.|||||++.+..|+ .++|||||||++|+|++|..||.+.+..+...++..+.. ..|..+
T Consensus 162 ~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 162 RILNH--DTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeccc--CCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 86543 23344567899999999999988885 899999999999999999999999999999888888776 466779
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhcCCcc
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMINPWF 272 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~hp~f 272 (414)
|+++.+||++||++||.+|||++|+++|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-62 Score=468.26 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=227.4
Q ss_pred CEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEE
Q 015005 17 KYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIE 96 (414)
Q Consensus 17 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 96 (414)
.|++.+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999988766655566789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCccc
Q 015005 97 YVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLH 175 (414)
Q Consensus 97 ~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 175 (414)
||+||+|...+.. +++++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 9999999776665 7899999999999999999999999999999999999999999999999999985432 34
Q ss_pred cccCCCcccCchhhccc---CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCC--CCCCCHHHHHHHH
Q 015005 176 TQCGTPAYVAPEVLRKK---GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF--PPWISCDARRLIS 250 (414)
Q Consensus 176 ~~~gt~~y~APE~~~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~s~~~~~li~ 250 (414)
..+||+.|||||++.+. .|+ .++|||||||++|+|++|..||.+.+..+...++..+..+. +..+|+++.+||.
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~-~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcC-chhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 56899999999998643 354 79999999999999999999999988888777777665543 3458999999999
Q ss_pred hhcccCcCCCCChHHHhcCCccccCC
Q 015005 251 RILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 251 ~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
+||++||.+|||++|+|+||||.+..
T Consensus 249 ~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 99999999999999999999997643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-62 Score=463.02 Aligned_cols=259 Identities=34% Similarity=0.602 Sum_probs=234.4
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchh---hHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQ---GLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
+.+.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++++|||||+++++++++
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3466789999999999999999999999999999999987654322 2357899999999999999999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC----CeEEeecCCCc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG----NLKVSDFGLSA 163 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~----~~kl~DFGla~ 163 (414)
+.+|+|||||+||+|.+++.. +.+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999999977 7899999999999999999999999999999999999998776 59999999998
Q ss_pred ccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----C
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----P 239 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~ 239 (414)
.... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+....+.++ +
T Consensus 166 ~~~~---~~~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 166 KIDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp ECTT---SCBCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hcCC---CccccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 6432 3345567899999999999988775 899999999999999999999999999999999988877665 5
Q ss_pred CCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 240 WISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 240 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.+|+++++||++||++||.+|||++|+++||||+.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 68999999999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-62 Score=473.90 Aligned_cols=258 Identities=30% Similarity=0.577 Sum_probs=233.9
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..++++|++++.||+|+||+||+|++..+|+.||||++.+.... ..+.+.+|+.+|++++|||||++++++.+++.+
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh---hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45678999999999999999999999999999999999765432 246788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC--CCCeEEeecCCCccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--NGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~--~~~~kl~DFGla~~~~~ 167 (414)
|+|||||+||+|.+.+.. +.+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~- 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD- 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC-
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc-
Confidence 999999999999999854 67999999999999999999999999999999999999964 6789999999998654
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCCCH
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISC 243 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 243 (414)
......+.+||+.|||||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+....+.++ +.+|+
T Consensus 178 --~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 178 --PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp --TTSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred --cccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 23445678899999999999998885 899999999999999999999999999999999988877655 35899
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 244 DARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
++++||++||++||++|||++|+|+||||....
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999998654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-62 Score=474.52 Aligned_cols=255 Identities=32% Similarity=0.641 Sum_probs=238.1
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
-+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.++|||||++++++.+...+|+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 36899999999999999999999999999999999987766555556789999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 94 VIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
||||+.||+|...+.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~----- 193 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----- 193 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-----
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-----
Confidence 9999999999999887 8999999999999999999999999999999999999999999999999999986432
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRI 252 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 252 (414)
...+.+||+.|||||++.+.+|+ .++|||||||++|+|++|..||.+.+....+.++..+.+.+|..+|+++.+||++|
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 34467899999999999998886 89999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCC-----ChHHHhcCCcccc
Q 015005 253 LVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 253 L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
|++||.+|+ |++++++||||..
T Consensus 273 L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred hhhCHHhccccccccHHHHHcCccccC
Confidence 999999995 8999999999965
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-62 Score=472.92 Aligned_cols=257 Identities=27% Similarity=0.558 Sum_probs=233.6
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
.+.++|++.+.||+|+||+||+|++..+|+.||||++++..... .+.+.+|+.+|++++|||||++++++++++.+|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35678999999999999999999999999999999998765332 457889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc--CCCCeEEeecCCCcccccc
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD--ENGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~--~~~~~kl~DFGla~~~~~~ 168 (414)
+|||||+||+|++.+.. .++++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~-- 180 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-- 180 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC--
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC--
Confidence 99999999999998775 4699999999999999999999999999999999999998 57899999999998654
Q ss_pred cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCC----CCCCHH
Q 015005 169 WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFP----PWISCD 244 (414)
Q Consensus 169 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 244 (414)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+..+.+.+| +.+|++
T Consensus 181 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 181 -PDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp -TTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred -CCCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 34456678899999999999998885 899999999999999999999999999999999988877655 458999
Q ss_pred HHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 245 ARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 245 ~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
+.+||++||++||.+|||+.|+|+||||+...
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99999999999999999999999999998654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-62 Score=467.63 Aligned_cols=257 Identities=33% Similarity=0.618 Sum_probs=234.9
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHH-hCCCCCccceEEEEEeCCEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMR-LVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l 93 (414)
+++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|..++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 468999999999999999999999999999999998766544444566677777765 6899999999999999999999
Q ss_pred EEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 94 VIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence 9999999999999987 8899999999999999999999999999999999999999999999999999985443 233
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDARRLISRI 252 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 252 (414)
.....+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+..+++.++..+.+.+|..+|+++.+||++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 45567899999999999998886 89999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCCChH-HHhcCCcccc
Q 015005 253 LVADPQKRISVS-EIMINPWFIK 274 (414)
Q Consensus 253 L~~dp~~R~s~~-eil~hp~f~~ 274 (414)
|++||.+|||+. ++++||||.+
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999995 8999999965
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-62 Score=454.27 Aligned_cols=257 Identities=24% Similarity=0.478 Sum_probs=223.3
Q ss_pred hhccccCCE-EEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe-
Q 015005 10 VRNILFGKY-EMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT- 87 (414)
Q Consensus 10 ~~~~~~~~y-~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 87 (414)
+|....|+| ++.+.||+|+||+||+|.+..+++.||+|.+....... ...+.+.+|+++|++++|||||++++++++
T Consensus 2 ~g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWEST 80 (270)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred CCcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence 455667787 78889999999999999999999999999998765443 235678999999999999999999999975
Q ss_pred ---CCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEEecCCCCcEEEc-CCCCeEEeecC
Q 015005 88 ---KTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRG--VYHRDLKPENLLLD-ENGNLKVSDFG 160 (414)
Q Consensus 88 ---~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~g--i~HrDlkp~NILl~-~~~~~kl~DFG 160 (414)
...+|+|||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred cccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence 4578999999999999999987 78999999999999999999999999 99999999999996 57899999999
Q ss_pred CCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc-hHHHHHHHHHhccc--CC
Q 015005 161 LSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE-NIMKMYRKIFKAEY--EF 237 (414)
Q Consensus 161 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~--~~ 237 (414)
+|+... .....+.+||+.|||||++.+ +|+ .++|||||||++|+|++|+.||.+. +....++.+..+.. .+
T Consensus 161 la~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~ 234 (270)
T d1t4ha_ 161 LATLKR----ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 234 (270)
T ss_dssp GGGGCC----TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred cceecc----CCccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCccc
Confidence 998533 234567789999999999876 464 8999999999999999999999764 45556666665543 34
Q ss_pred CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 238 PPWISCDARRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
+...++++.+||.+||++||++|||++|+|+||||+
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 456899999999999999999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-61 Score=451.64 Aligned_cols=258 Identities=36% Similarity=0.613 Sum_probs=230.6
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch------hhHHHHHHHHHHHHHhCC-CCCccceEEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK------QGLMEQIKREISVMRLVK-HPNIVELKEVMA 86 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 86 (414)
|.++|++.+.||+|+||+||+|++..+|+.||||++++..... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 4689999999999999999999999999999999998765332 223457889999999996 999999999999
Q ss_pred eCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
+++.+|+|||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999976 89999999999999999999999999999999999999999999999999999865
Q ss_pred ccccCCCccccccCCCcccCchhhccc-----CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC-
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKK-----GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP- 239 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~- 239 (414)
.. .......+||+.|+|||++.+. ...+.++||||+||++|+|++|+.||.+.+.....+.+..+.+..+.
T Consensus 161 ~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 161 DP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp CT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 43 3344567899999999998642 22257899999999999999999999999999988888888765443
Q ss_pred ---CCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 240 ---WISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 240 ---~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.+|+++++||.+||++||++|||++|+++||||++
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999964
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-62 Score=468.76 Aligned_cols=256 Identities=24% Similarity=0.430 Sum_probs=218.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+..++|++.+.||+|+||+||+|++..+|+.||+|++++... ....+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456789999999999999999999999999999999976532 334578899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+|||||+||+|.+++.+ +.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|++||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence 99999999999999986 889999999999999999999997 5999999999999999999999999999985432
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHH------------------------
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKM------------------------ 226 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~------------------------ 226 (414)
....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+....
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred -CccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 223467899999999999998886 899999999999999999999976532211
Q ss_pred ------------------HHHHHhcc-cCCCC-CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 227 ------------------YRKIFKAE-YEFPP-WISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 227 ------------------~~~i~~~~-~~~~~-~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
...+.... +..|. .+|.++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00111111 11221 268899999999999999999999999999999753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-61 Score=462.32 Aligned_cols=254 Identities=28% Similarity=0.548 Sum_probs=232.0
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
+.++|++++.||+|+||+||+|.+..+|+.||+|++++.... ...+.+|+++|+.++|||||++++++++.+.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 678999999999999999999999999999999999876432 3467899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC--CCeEEeecCCCccccccc
Q 015005 94 VIEYVKGGELFAKVLK-G-KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN--GNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~-~-~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 169 (414)
|||||+||+|++++.. + .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence 9999999999999986 3 79999999999999999999999999999999999999854 489999999998543
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC----CCCHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP----WISCDA 245 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~ 245 (414)
........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.++..+.+.+|. .+|+++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred cCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 23445677899999999999888775 8999999999999999999999999999999999998887764 589999
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 246 RRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++||++||++||.+|||++|+++||||.+.
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.2e-61 Score=466.72 Aligned_cols=256 Identities=30% Similarity=0.491 Sum_probs=223.0
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHH---HHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKR---EISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~---Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
+++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+ |+++++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 578999999999999999999999999999999998765543333333444 46777788899999999999999999
Q ss_pred EEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 92 FFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|+|||||+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--- 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--- 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS---
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC---
Confidence 999999999999999987 7899999999999999999999999999999999999999999999999999985432
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch---HHHHHHHHHhcccCCCCCCCHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN---IMKMYRKIFKAEYEFPPWISCDARR 247 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~~~~~ 247 (414)
......+||+.|+|||++.+....+.++|||||||+||+|++|..||.+.+ .....+.+......+|..+|+++++
T Consensus 160 -~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 160 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp -SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred -CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 334567899999999999754433589999999999999999999998754 3344455556667788889999999
Q ss_pred HHHhhcccCcCCCCC-----hHHHhcCCcccc
Q 015005 248 LISRILVADPQKRIS-----VSEIMINPWFIK 274 (414)
Q Consensus 248 li~~~L~~dp~~R~s-----~~eil~hp~f~~ 274 (414)
||.+||++||.+||| ++|+++||||+.
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 999999999999999 799999999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-61 Score=448.60 Aligned_cols=252 Identities=33% Similarity=0.606 Sum_probs=222.8
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhh---HHHHHHHHHHHHHhCC--CCCccceEEEEEeC
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQG---LMEQIKREISVMRLVK--HPNIVELKEVMATK 88 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~ 88 (414)
+.++|++.+.||+|+||+||+|++..+|+.||||++.+....... ...++.+|+.+|++++ |||||++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 568999999999999999999999999999999999876543211 1234668999999986 89999999999999
Q ss_pred CEEEEEEEccCC-CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCC-CCeEEeecCCCccc
Q 015005 89 TKVFFVIEYVKG-GELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDEN-GNLKVSDFGLSALP 165 (414)
Q Consensus 89 ~~~~lv~E~~~g-g~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~-~~~kl~DFGla~~~ 165 (414)
+.+|+||||+.+ +++.+.+.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999986 577787776 789999999999999999999999999999999999999854 79999999999854
Q ss_pred ccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCCCCCHHH
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPPWISCDA 245 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 245 (414)
. .....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...+ .+..+...+++.+|+++
T Consensus 162 ~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~ 231 (273)
T d1xwsa_ 162 K----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231 (273)
T ss_dssp C----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHH
T ss_pred c----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHH
Confidence 3 2344567899999999999988887678999999999999999999998743 45677888899999999
Q ss_pred HHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 246 RRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
++||++||++||++|||++|+++||||++.
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-59 Score=442.99 Aligned_cols=258 Identities=32% Similarity=0.514 Sum_probs=218.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++++.||+|+||+||+|.+..+|+.||||++...... ....+.+.+|+++|++++|||||++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 47899999999999999999999999999999999765432 22346788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCC
Q 015005 95 IEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDG 172 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 172 (414)
|||+.|+.+...... +.+++.+++.++.|++.||+|||++||+||||||+|||++.++++||+|||+|+.... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Ccc
Confidence 999987655444333 5799999999999999999999999999999999999999999999999999975433 233
Q ss_pred ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc-----------------
Q 015005 173 LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY----------------- 235 (414)
Q Consensus 173 ~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------------- 235 (414)
.....+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+..+...++.....
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 455668999999999998888877899999999999999999999999887766665543110
Q ss_pred -CC-----------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 236 -EF-----------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 236 -~~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
.. .+.+|.++.+||++||++||++|||+.|+++||||++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 01 12467899999999999999999999999999999753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=445.98 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=215.3
Q ss_pred EeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccch--hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEc
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKK--QGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEY 97 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 97 (414)
.++.||+|+||+||+|++..+|+.||||++++..... ....+.+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 5689999999999999999999999999997654322 12235688999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCcccc
Q 015005 98 VKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGLLHT 176 (414)
Q Consensus 98 ~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 176 (414)
+.|+++...... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... .......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Ccccccc
Confidence 999888777765 6799999999999999999999999999999999999999999999999999986543 2334456
Q ss_pred ccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhccc--------------------C
Q 015005 177 QCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEY--------------------E 236 (414)
Q Consensus 177 ~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--------------------~ 236 (414)
.+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+..+...++..... .
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 78999999999987665556899999999999999999999999888877776653210 0
Q ss_pred --------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 237 --------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 237 --------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..+.+++++.+||++||+.||++|||++|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 012468899999999999999999999999999999754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=452.06 Aligned_cols=255 Identities=34% Similarity=0.630 Sum_probs=217.5
Q ss_pred hccccCCEEEe-eeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHh-CCCCCccceEEEEEe-
Q 015005 11 RNILFGKYEMG-RMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRL-VKHPNIVELKEVMAT- 87 (414)
Q Consensus 11 ~~~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~- 87 (414)
+..+.++|++. ++||+|+||+||+|++..+++.||||++++. ..+.+|+.++.+ ++|||||++++++++
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 45677899987 5699999999999999999999999999643 356789998765 489999999999976
Q ss_pred ---CCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC---CCCeEEee
Q 015005 88 ---KTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---NGNLKVSD 158 (414)
Q Consensus 88 ---~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---~~~~kl~D 158 (414)
...+|+|||||+||+|++++.+ ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 4679999999999999999976 26999999999999999999999999999999999999985 56799999
Q ss_pred cCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHH----HHHHHHhcc
Q 015005 159 FGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMK----MYRKIFKAE 234 (414)
Q Consensus 159 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~ 234 (414)
||+|+.... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+... +...+..+.
T Consensus 158 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 158 FGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp CTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred cceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence 999985443 3445677899999999999988886 89999999999999999999998765433 333444455
Q ss_pred cCCCC----CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCCC
Q 015005 235 YEFPP----WISCDARRLISRILVADPQKRISVSEIMINPWFIKGFS 277 (414)
Q Consensus 235 ~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~~ 277 (414)
+.+|. .+|+++.+||++||++||++|||+.|+++||||.+...
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 55553 38999999999999999999999999999999976543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.5e-59 Score=436.18 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=221.3
Q ss_pred hccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-
Q 015005 11 RNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT- 89 (414)
Q Consensus 11 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 89 (414)
+..+.++|++.+.||+|+||+||+|++..+|+.||||++.+....+....+.+.+|+++++.++||||+++++++...+
T Consensus 2 p~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred CcCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 4567889999999999999999999999999999999998877666666778999999999999999999999997654
Q ss_pred ---EEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 90 ---KVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 90 ---~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
.+|+|||||+||+|.+.+.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++..+|+|||.+...
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 48999999999999998876 78999999999999999999999999999999999999999999999999998754
Q ss_pred cccc-CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCC----CCC
Q 015005 166 EQLW-NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF----PPW 240 (414)
Q Consensus 166 ~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~ 240 (414)
.... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+...++....... ++.
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp C----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred ccccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 3321 22345567899999999999988885 89999999999999999999999998888887777766543 346
Q ss_pred CCHHHHHHHHhhcccCcCCCCChHHHhcCCccc
Q 015005 241 ISCDARRLISRILVADPQKRISVSEIMINPWFI 273 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~ 273 (414)
+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 899999999999999999999555555566653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-58 Score=433.91 Aligned_cols=256 Identities=30% Similarity=0.483 Sum_probs=218.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++.+.||+|+||+||+|++. +|+.||||++...... ....+.+.+|+.+|++++|||||++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 479999999999999999999985 8899999999776543 23357889999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|||+.++.+...... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc--Cccc
Confidence 999998888777775 7899999999999999999999999999999999999999999999999999976443 2233
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc-------------------
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE------------------- 234 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------- 234 (414)
.....|++.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+..+...++....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 4556799999999999887776799999999999999999999999887776666554210
Q ss_pred ----------cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 235 ----------YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 235 ----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
...++.+++++.+||++||++||++|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0123347889999999999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-58 Score=431.13 Aligned_cols=262 Identities=25% Similarity=0.358 Sum_probs=222.2
Q ss_pred CcccchhHhhhccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccc
Q 015005 1 MKFETMDERVRNILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVE 80 (414)
Q Consensus 1 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 80 (414)
|.++++.-.--++-.++|++.+.||+|+||+||+|.+..+++.||||+++.+... .+++.+|+++|++++|||||+
T Consensus 2 ~~p~~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~ 77 (287)
T d1opja_ 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQ 77 (287)
T ss_dssp CCTTSTTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCCCCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEec
Confidence 4444443322234567899999999999999999999999999999999765432 457889999999999999999
Q ss_pred eEEEEEeCCEEEEEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEe
Q 015005 81 LKEVMATKTKVFFVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVS 157 (414)
Q Consensus 81 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~ 157 (414)
+++++.+++.+|+|||||++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++++||+
T Consensus 78 ~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred CCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEc
Confidence 99999999999999999999999999875 478999999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCC-CCCchHHHHHHHHHhc-cc
Q 015005 158 DFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLP-FQNENIMKMYRKIFKA-EY 235 (414)
Q Consensus 158 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~~~~~~~i~~~-~~ 235 (414)
|||+|+..... .........||+.|+|||++.+..|+ .++|||||||++|+|++|..| |.+.+....++.+..+ .+
T Consensus 158 DFG~a~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~ 235 (287)
T d1opja_ 158 DFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235 (287)
T ss_dssp CCCCTTTCCSS-SSEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred cccceeecCCC-CceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC
Confidence 99999865431 11223344589999999999988885 899999999999999996554 5566666666655544 45
Q ss_pred CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 236 EFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+.|..+|+++.+||.+||+.||++|||++||++
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 677789999999999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=432.42 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=215.3
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCC-CeEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCccceEEEEEe---
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVT-QESVAIKVINKDQVKKQGLMEQIKREISVMRLV---KHPNIVELKEVMAT--- 87 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~--- 87 (414)
.++|++++.||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999765 67899999976543321 223456788877766 79999999999853
Q ss_pred --CCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 88 --KTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 88 --~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
...+|++|||+.++.+...... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3578999999999877555443 679999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc---------
Q 015005 164 LPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--------- 234 (414)
Q Consensus 164 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------- 234 (414)
.... .......+||+.|+|||++.+.+|+ .++||||+||++|+|++|..||.+.+..+...++....
T Consensus 165 ~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 165 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 6433 3345677899999999999998886 89999999999999999999999988877776654310
Q ss_pred ------------------cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 235 ------------------YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 235 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
..++..+++++.+||++||++||++|||+.|+|+||||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0123457889999999999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-58 Score=437.77 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=215.7
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCe-----EEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQE-----SVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATK 88 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 88 (414)
.++|++++.||+|+||+||+|++..+++ .||+|.+...... .....+.+|+.+|+++ +|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3689999999999999999999876543 6999998654332 2346788999999998 899999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCC
Q 015005 89 TKVFFVIEYVKGGELFAKVLKG------------------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPE 144 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~------------------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~ 144 (414)
+.+|+|||||+||+|.+++... .+++..++.++.|++.||+|||++||+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 9999999999999999998652 4899999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchH
Q 015005 145 NLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENI 223 (414)
Q Consensus 145 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~ 223 (414)
|||++.++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||++|+|+| |..||.+.+.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999875543333334566789999999999988885 89999999999999998 8999988766
Q ss_pred HHHHHHHHhcc--cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 224 MKMYRKIFKAE--YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 224 ~~~~~~i~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
...+.++.... ++.|..+|+++.+||.+||+.||++|||++||++|
T Consensus 273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55555555543 45677899999999999999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-57 Score=428.26 Aligned_cols=264 Identities=24% Similarity=0.362 Sum_probs=213.9
Q ss_pred ccchhHhhh----ccccCCEEEeeeeeecCCeEEEEEEECCCCe---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCC
Q 015005 3 FETMDERVR----NILFGKYEMGRMLGQGTFAKVYYGKNLVTQE---SVAIKVINKDQVKKQGLMEQIKREISVMRLVKH 75 (414)
Q Consensus 3 ~~~~~~~~~----~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h 75 (414)
++.+.+.+. ++-.+.|++.+.||+|+||+||+|.+..+++ .||||.+...... ...+.+.+|+++|++++|
T Consensus 9 ~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp SSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCC
Confidence 344444443 3446789999999999999999999887665 5889988654432 235678999999999999
Q ss_pred CCccceEEEEEeCCEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC
Q 015005 76 PNIVELKEVMATKTKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN 153 (414)
Q Consensus 76 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~ 153 (414)
||||++++++.+++.+|+|||||+||+|.+++.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~ 166 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV 166 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc
Confidence 9999999999999999999999999999998876 57999999999999999999999999999999999999999999
Q ss_pred eEEeecCCCcccccccCCC---ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHH
Q 015005 154 LKVSDFGLSALPEQLWNDG---LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRK 229 (414)
Q Consensus 154 ~kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~ 229 (414)
+||+|||+|+......... ......||+.|||||++.+..|+ .++|||||||++|+|+| |..||.+.+..+....
T Consensus 167 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~ 245 (299)
T d1jpaa_ 167 CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245 (299)
T ss_dssp EEECCC-----------------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred EEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999998654322111 12234589999999999988775 79999999999999998 8999999888888887
Q ss_pred HHhcc-cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 230 IFKAE-YEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 230 i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+..+. .+.|..++.++.+||.+||+.||++|||+.||+++
T Consensus 246 i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 246 IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 76653 56677799999999999999999999999998764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-57 Score=437.39 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=215.8
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT---- 89 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 89 (414)
+-++|++++.||+|+||+||+|.+..+|+.||||++.+.... ....+.+.+|+++|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 678999999999999999999999999999999999765433 344678899999999999999999999997654
Q ss_pred --EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 90 --KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 90 --~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
.+|+||||| |++|...+..+++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|.....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred cceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 67888888789999999999999999999999999999999999999999999999999999985432
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc-------------
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE------------- 234 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------- 234 (414)
.....+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 174 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 174 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 34567899999999999877666789999999999999999999999877665544332211
Q ss_pred ------------------cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 235 ------------------YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 235 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
...++.+++++.+||++||+.||.+|||+.|+|+||||..-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 01234578999999999999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=426.48 Aligned_cols=252 Identities=25% Similarity=0.441 Sum_probs=206.5
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+-.++|++.+.||+|+||+||+|+.. ..||||+++...... ...+.+.+|+.+|++++|||||++++++. .+.+|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 34578999999999999999999743 359999997654433 34678999999999999999999999875 45689
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+|||||+||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++++||+|||+|+.......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999999865 5799999999999999999999999999999999999999999999999999987654334
Q ss_pred CCccccccCCCcccCchhhccc---CCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHH-hccc-----CCCCCC
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKK---GYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIF-KAEY-----EFPPWI 241 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~-~~~~-----~~~~~~ 241 (414)
.....+.+||+.|||||++.+. .| +.++|||||||+||+|+||+.||.+.+......... .+.. ..+..+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~-~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred cccccccccCcccCCHHHHhcccCCCC-CchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 4455667899999999999653 24 478999999999999999999998865544433333 3221 235568
Q ss_pred CHHHHHHHHhhcccCcCCCCChHHHhcCC
Q 015005 242 SCDARRLISRILVADPQKRISVSEIMINP 270 (414)
Q Consensus 242 s~~~~~li~~~L~~dp~~R~s~~eil~hp 270 (414)
|+++.+||.+||+.||.+|||+.||+++-
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 99999999999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-57 Score=429.79 Aligned_cols=260 Identities=26% Similarity=0.382 Sum_probs=214.8
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe-------
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT------- 87 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------- 87 (414)
+++|++++.||+|+||+||+|++..+|+.||||++.++.... ....++.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 689999999999999999999999999999999997765432 335678899999999999999999999855
Q ss_pred -CCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 88 -KTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 88 -~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
++.+|++|||+.++.+...... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3568999999988877655554 68999999999999999999999999999999999999999999999999999754
Q ss_pred ccc--cCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCCCC----
Q 015005 166 EQL--WNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEFPP---- 239 (414)
Q Consensus 166 ~~~--~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~---- 239 (414)
... .......+.+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+.......++
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 422 12234455689999999999987654468999999999999999999999988777666555432211110
Q ss_pred ----------------------------CCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 240 ----------------------------WISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 240 ----------------------------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..++++.+||.+||++||++|||+.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 136778999999999999999999999999999853
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-57 Score=419.93 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=208.8
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
.+|++.+.||+|+||+||+|.+. +++.||||++++.... .+.+.+|++++++++|||||++++++..++.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 47999999999999999999975 6778999999765433 357889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
|||++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++++||+|||+|+..... ....
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~-~~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC-Ccee
Confidence 99999999998875 56899999999999999999999999999999999999999999999999999865432 1223
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHHHh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLISR 251 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 251 (414)
.....||+.|+|||++.+..|+ .++||||+||++|+|+| |.+||...+..+....+..+. ...|..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3456799999999999988886 89999999999999999 678888888888888776654 45677789999999999
Q ss_pred hcccCcCCCCChHHHhcC
Q 015005 252 ILVADPQKRISVSEIMIN 269 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~h 269 (414)
||+.||++|||++||++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-57 Score=423.99 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=218.4
Q ss_pred CCEEEeee-eeecCCeEEEEEEECC--CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 16 GKYEMGRM-LGQGTFAKVYYGKNLV--TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 16 ~~y~~~~~-LG~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.... ....+.+.+|+++|++++|||||++++++.++ .+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--HHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence 46888885 9999999999998754 455799999976532 23467899999999999999999999999764 589
Q ss_pred EEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 93 FVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
+|||||+||+|.+++.. +.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999999998764 5799999999999999999999999999999999999999999999999999986543211
Q ss_pred -CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHH
Q 015005 171 -DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARR 247 (414)
Q Consensus 171 -~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 247 (414)
.......+||+.|+|||++.+..|+ .++|||||||++|+|+| |..||.+.+..+....+..+. ++.|+.+|+++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1223355789999999999888775 89999999999999998 999999888777777777654 5678889999999
Q ss_pred HHHhhcccCcCCCCChHHH---hcCCccc
Q 015005 248 LISRILVADPQKRISVSEI---MINPWFI 273 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~ei---l~hp~f~ 273 (414)
||.+||+.||++|||+.+| |+|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999888 6778763
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-57 Score=420.23 Aligned_cols=252 Identities=21% Similarity=0.363 Sum_probs=218.0
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFF 93 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 93 (414)
-.++|++.+.||+|+||+||+|.+. ++..||||+++..... .+.+.+|+++|++++|||||++++++.+ +.+|+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 4568999999999999999999975 6788999999765432 3578999999999999999999998854 56799
Q ss_pred EEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC
Q 015005 94 VIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN 170 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 170 (414)
|||||++|+|.+.+.. .++++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~ 163 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-E 163 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-C
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC-c
Confidence 9999999999987764 36999999999999999999999999999999999999999999999999999865431 1
Q ss_pred CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHHH
Q 015005 171 DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARRL 248 (414)
Q Consensus 171 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 248 (414)
........||+.|+|||++.+..|+ .++|||||||++|+|+| |.+||...+..+..+.+..+ ....|..+++++.+|
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence 1233456799999999999887775 89999999999999999 56667777777777777665 455678899999999
Q ss_pred HHhhcccCcCCCCChHHHhc--CCccc
Q 015005 249 ISRILVADPQKRISVSEIMI--NPWFI 273 (414)
Q Consensus 249 i~~~L~~dp~~R~s~~eil~--hp~f~ 273 (414)
|.+||+.||++|||++||++ |+||.
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999999988 78875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=431.72 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=215.2
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----E
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT----K 90 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 90 (414)
..+|++++.||+|+||+||+|.+..+|+.||||++.+... ....+.+.+|+.+|++++||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC--hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 3789999999999999999999999999999999976543 334677889999999999999999999997653 2
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc-
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW- 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 169 (414)
.+++++++.||+|++++..+++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 3444556679999999988999999999999999999999999999999999999999999999999999997643322
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcc---------------
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAE--------------- 234 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------------- 234 (414)
........+||+.|+|||++....+++.++||||+||++|+|++|..||.+.+............
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 22345667899999999998666655689999999999999999999999876654443322100
Q ss_pred -------c---------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccCC
Q 015005 235 -------Y---------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKGF 276 (414)
Q Consensus 235 -------~---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~~ 276 (414)
. ...+.+|+++.+||.+||+.||.+|||+.|+|+||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0 01235788999999999999999999999999999997543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-56 Score=417.24 Aligned_cols=257 Identities=31% Similarity=0.515 Sum_probs=222.1
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFV 94 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 94 (414)
+++|++++.||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4689999999999999999999999999999999976653 334567899999999999999999999999999999999
Q ss_pred EEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 95 IEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
+|++.|++|...+.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|..... ....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~--~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--CCSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC--CCcc
Confidence 999999999888876 7899999999999999999999999999999999999999999999999999986543 2233
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCC-CCchHHHHHHHHHhcc------------------
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPF-QNENIMKMYRKIFKAE------------------ 234 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf-~~~~~~~~~~~i~~~~------------------ 234 (414)
.....+++.|+|||++.+..+.+.++||||+||++|+|++|..|| .+.+..+...++....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 445568899999999988776668999999999999999999885 5555555555543210
Q ss_pred -----------cCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 235 -----------YEFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 235 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
...++.+++++.+||++||++||.+|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0122346889999999999999999999999999999964
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-57 Score=422.09 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=210.2
Q ss_pred eeeeecCCeEEEEEEEC--CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEEccC
Q 015005 22 RMLGQGTFAKVYYGKNL--VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 22 ~~LG~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 99 (414)
+.||+|+||+||+|.+. .+++.||||++..... +....+.+.+|+++|++++|||||+++++++++ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999754 4567899999975543 334467899999999999999999999999765 5789999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCC-Cccccc
Q 015005 100 GGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWND-GLLHTQ 177 (414)
Q Consensus 100 gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~ 177 (414)
||+|.+++.. ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999887 77999999999999999999999999999999999999999999999999999864432111 122345
Q ss_pred cCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHHHhhccc
Q 015005 178 CGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLISRILVA 255 (414)
Q Consensus 178 ~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 255 (414)
.||+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+..+....+..+. ++.|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 699999999999888775 89999999999999998 899999988888887777654 567888999999999999999
Q ss_pred CcCCCCChHHH---hcCCcc
Q 015005 256 DPQKRISVSEI---MINPWF 272 (414)
Q Consensus 256 dp~~R~s~~ei---l~hp~f 272 (414)
||.+|||+++| |+|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 99999999998 456654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=414.07 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=221.2
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVFFVI 95 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 95 (414)
++|++++.||+|+||+||+|+++ +++.||||++++..... +.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 46899999999999999999974 78899999998765433 57889999999999999999999999999999999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccCCCc
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWNDGL 173 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 173 (414)
||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence 99999999988765 67999999999999999999999999999999999999999999999999999865432 2223
Q ss_pred cccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHHHHHh
Q 015005 174 LHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARRLISR 251 (414)
Q Consensus 174 ~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 251 (414)
.....||+.|+|||++.+..|+ .++|||||||++|+|+| |+.||.+.+..+...++..+. ...|..+++++.+||++
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3456799999999999988886 79999999999999998 899999999888888887764 45677789999999999
Q ss_pred hcccCcCCCCChHHHhcC
Q 015005 252 ILVADPQKRISVSEIMIN 269 (414)
Q Consensus 252 ~L~~dp~~R~s~~eil~h 269 (414)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=427.76 Aligned_cols=250 Identities=30% Similarity=0.412 Sum_probs=210.4
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe------CC
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT------KT 89 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 89 (414)
-+|+.+++||+|+||+||+|++..+|+.||||++.+.... ..+|+++|++++||||+++++++.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 3799999999999999999999999999999999765432 2379999999999999999999854 34
Q ss_pred EEEEEEEccCCCchHHHH---hc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-CeEEeecCCCcc
Q 015005 90 KVFFVIEYVKGGELFAKV---LK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-NLKVSDFGLSAL 164 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i---~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-~~kl~DFGla~~ 164 (414)
++|+|||||+++.+.... .. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 689999999877543332 22 5799999999999999999999999999999999999999775 899999999985
Q ss_pred cccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhc-----------
Q 015005 165 PEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKA----------- 233 (414)
Q Consensus 165 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------- 233 (414)
... .....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||...+..+.+..+...
T Consensus 173 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 432 334556789999999999877655568999999999999999999999988776666555321
Q ss_pred ------ccC------------CCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 234 ------EYE------------FPPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 234 ------~~~------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
... ..+.+++++.+||++||+.||++|||+.|+|+||||..-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 011 123478999999999999999999999999999999753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=426.10 Aligned_cols=262 Identities=32% Similarity=0.573 Sum_probs=225.4
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEEC---CCCeEEEEEEeeccccc-hhhHHHHHHHHHHHHHhCCC-CCccceEEEEE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNL---VTQESVAIKVINKDQVK-KQGLMEQIKREISVMRLVKH-PNIVELKEVMA 86 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~ 86 (414)
.+-+++|++++.||+|+||+||+|.+. .+|+.||||++++.... +....+.+.+|+++|++++| |||++++++++
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 345688999999999999999999874 47899999999765432 22234568899999999966 89999999999
Q ss_pred eCCEEEEEEEccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccc
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLK-GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALP 165 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~-~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~ 165 (414)
+...+|++|||+.||+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999987 78999999999999999999999999999999999999999999999999999755
Q ss_pred ccccCCCccccccCCCcccCchhhcccC-CCCCccchhhhhhhhhhhhcCCCCCCCchH----HHHHHHHHhcccCCCCC
Q 015005 166 EQLWNDGLLHTQCGTPAYVAPEVLRKKG-YDGAKSDIWSCGVVLFVLLSGFLPFQNENI----MKMYRKIFKAEYEFPPW 240 (414)
Q Consensus 166 ~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~ 240 (414)
... ......+.+||+.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+. ....+......+++|..
T Consensus 180 ~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 180 VAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred ccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 332 233455678999999999997654 345789999999999999999999977543 34445555667788888
Q ss_pred CCHHHHHHHHhhcccCcCCCC-----ChHHHhcCCcccc
Q 015005 241 ISCDARRLISRILVADPQKRI-----SVSEIMINPWFIK 274 (414)
Q Consensus 241 ~s~~~~~li~~~L~~dp~~R~-----s~~eil~hp~f~~ 274 (414)
+|+++.+||++||++||.+|| |++|+++||||+.
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 999999999999999999999 4899999999965
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=414.94 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=207.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCC---eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQ---ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
.++|++++.||+|+||+||+|.+..++ ..||||.+..... ....+.+.+|+.+|++++|||||++++++. .+.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 468999999999999999999986543 5688998854432 334577899999999999999999999995 5678
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+.....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~- 161 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS- 161 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-
Confidence 999999999999988765 57999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 247 (414)
........+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+..+.+..+..+. .+.|+.+|+++.+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 22234456789999999999988885 79999999999999998 899999988888888877665 5678889999999
Q ss_pred HHHhhcccCcCCCCChHHHhcC
Q 015005 248 LISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~h 269 (414)
||.+||+.||++|||+.||++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-56 Score=429.54 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=217.0
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----C
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK-----T 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 89 (414)
-++|++++.||+|+||+||+|++..+|+.||||++.+..... ...+++.+|+++|++++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 468999999999999999999999999999999998664332 3356788999999999999999999999643 3
Q ss_pred EEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 90 KVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
..+++|+|+.||+|.+++..+++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--- 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--- 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT---
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC---
Confidence 34666777889999999988999999999999999999999999999999999999999999999999999997543
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHhcccCC------------
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFKAEYEF------------ 237 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 237 (414)
....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 234567799999999998887777789999999999999999999999987776666554321111
Q ss_pred -------------------CCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 238 -------------------PPWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 238 -------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
...+++++++||++||+.||.+|||+.|+|+||||++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 12478899999999999999999999999999999763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.2e-55 Score=417.61 Aligned_cols=250 Identities=26% Similarity=0.472 Sum_probs=208.9
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeC--CE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATK--TK 90 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~ 90 (414)
..++|++++.||+|+||+||+|++..+|+.||||++++.. .+++.+|+++|+.++ ||||+++++++... ..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3568999999999999999999999999999999996543 356889999999995 99999999999854 56
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCC-CeEEeecCCCccccccc
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENG-NLKVSDFGLSALPEQLW 169 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 169 (414)
+|+|||||.+++|.... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 107 ~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~-- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT--
T ss_pred eeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC--
Confidence 99999999999997653 5799999999999999999999999999999999999998765 599999999985442
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHH-HHHHHHHh-------------ccc
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIM-KMYRKIFK-------------AEY 235 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~-------------~~~ 235 (414)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||...... .....+.. ...
T Consensus 183 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 -GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp -TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred -CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 334566789999999999887665568999999999999999999999764321 11111100 000
Q ss_pred ------------------------CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcCCcccc
Q 015005 236 ------------------------EFPPWISCDARRLISRILVADPQKRISVSEIMINPWFIK 274 (414)
Q Consensus 236 ------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~ 274 (414)
.....+++++.+||++||++||++|||++|+|+||||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011237889999999999999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=418.66 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=211.0
Q ss_pred CCEEEeeeeeecCCeEEEEEEECCCCe----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 16 GKYEMGRMLGQGTFAKVYYGKNLVTQE----SVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 16 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
..|++++.||+|+||+||+|.+..+|+ .||+|.+..... ....+.+.+|+.++++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 569999999999999999999988876 477777754322 23357899999999999999999999999875 56
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+++|||+.+|+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 788899999999888775 579999999999999999999999999999999999999999999999999998655433
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhcc-cCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAE-YEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 247 (414)
.........||+.|+|||++.+..|+ .++|||||||++|+|+| |..||.+.+..+....+..+. ++.|+.+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 33334455789999999999988885 89999999999999998 899999887777777776654 5677889999999
Q ss_pred HHHhhcccCcCCCCChHHHhcCCc
Q 015005 248 LISRILVADPQKRISVSEIMINPW 271 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~hp~ 271 (414)
||.+||+.||.+|||+.||++|..
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHHH
Confidence 999999999999999999998843
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=408.37 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=208.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCC----eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQ----ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATK 88 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 88 (414)
+--..|++.++||+|+||+||+|.+..++ ..||||.+....... ....+.+|++++++++|||||++++++.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH--HHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 34457999999999999999999877654 479999997554332 356788999999999999999999999999
Q ss_pred CEEEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccc
Q 015005 89 TKVFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPE 166 (414)
Q Consensus 89 ~~~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~ 166 (414)
+..++|||||.+|++.+.+.. +.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999999988775 679999999999999999999999999999999999999999999999999998654
Q ss_pred cccC-CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcC-CCCCCCchHHHHHHHHHhc-ccCCCCCCCH
Q 015005 167 QLWN-DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG-FLPFQNENIMKMYRKIFKA-EYEFPPWISC 243 (414)
Q Consensus 167 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 243 (414)
.... ........||+.|+|||++.+..|+ .++|||||||++|+|++| .+||...+..+.++.+..+ .++.|..++.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence 3211 1233445689999999999988886 799999999999999995 5666666777777776655 3466777999
Q ss_pred HHHHHHHhhcccCcCCCCChHHHhc
Q 015005 244 DARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 244 ~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
++.+||.+||+.||++|||+.||++
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-55 Score=409.56 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=213.9
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKVF 92 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 92 (414)
+-.++|++.+.||+|+||+||+|.+..+ +.||||++...... .+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 3457899999999999999999998655 56999999765433 3578899999999999999999999854 5679
Q ss_pred EEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+||||+++|+|...+.. +.+++.++..++.|++.||+|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~- 166 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN- 166 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC-
Confidence 99999999999888764 57999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcC-CCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG-FLPFQNENIMKMYRKIFKA-EYEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 247 (414)
.........||+.|+|||++....++ .++||||+||++|+|++| .+|+......+....+..+ ..+.|+.++.++.+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 245 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred CceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence 22233456799999999999988885 899999999999999995 6666777777777777655 45678889999999
Q ss_pred HHHhhcccCcCCCCChHHHhc--CCccccC
Q 015005 248 LISRILVADPQKRISVSEIMI--NPWFIKG 275 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~--hp~f~~~ 275 (414)
||.+||+.||++|||+++|++ ++||...
T Consensus 246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999987 8888653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-55 Score=422.17 Aligned_cols=255 Identities=28% Similarity=0.476 Sum_probs=205.7
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe------
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT------ 87 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 87 (414)
+.++|++++.||+|+||+||+|++..+|+.||||++.+.... .....++.+|+.++++++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 458999999999999999999999999999999999876543 3345678999999999999999999999963
Q ss_pred CCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccc
Q 015005 88 KTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQ 167 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 167 (414)
.+.+|+|||||.|+.+. .+ ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||+++....
T Consensus 94 ~~~~~iv~Ey~~~~l~~-~~-~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQ-VI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCEEEEEEECCSEEHHH-HH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CceeEEEEeccchHHHH-hh-hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 47899999999876554 33 36799999999999999999999999999999999999999999999999999885443
Q ss_pred ccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHHHHh---------------
Q 015005 168 LWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRKIFK--------------- 232 (414)
Q Consensus 168 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------- 232 (414)
.......+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+......++..
T Consensus 172 ---~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 ---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ---ccccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 3344566899999999999988775 899999999999999999999998776655444321
Q ss_pred -------cccCC--------------C------CCCCHHHHHHHHhhcccCcCCCCChHHHhcCCccccC
Q 015005 233 -------AEYEF--------------P------PWISCDARRLISRILVADPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 233 -------~~~~~--------------~------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~f~~~ 275 (414)
..... + ..+++++.+||++||+.||++|||++|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 11000 0 1136678999999999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-54 Score=409.45 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=219.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT 89 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 89 (414)
.++|++.+.||+|+||+||+|+.. .+++.||||+++..... ...+++.+|+++|++++||||+++++++.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--HHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 457999999999999999999865 35678999999765432 34577999999999999999999999999999
Q ss_pred EEEEEEEccCCCchHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCC
Q 015005 90 KVFFVIEYVKGGELFAKVLKG-------------------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPE 144 (414)
Q Consensus 90 ~~~lv~E~~~gg~L~~~i~~~-------------------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~ 144 (414)
..+++|||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 999999999999999988641 3789999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCC-CCCCCchH
Q 015005 145 NLLLDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGF-LPFQNENI 223 (414)
Q Consensus 145 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~-~Pf~~~~~ 223 (414)
|||++.++++||+|||+|+............+.+||+.|+|||.+.+..|+ .++|||||||++|+|++|. .||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999865544444455567899999999999998886 8999999999999999985 78999988
Q ss_pred HHHHHHHHhccc-CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 224 MKMYRKIFKAEY-EFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 224 ~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+....+..+.. +.|..+++++.+||.+||+.||++|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888877764 467789999999999999999999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-55 Score=406.71 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=206.5
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECC-CC--eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLV-TQ--ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKTKV 91 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 91 (414)
.++|++.+.||+|+||+||+|+... ++ ..||||++.+.........+.+.+|+.+|++++||||+++++++.++ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence 3579999999999999999998643 33 46899999877666666678899999999999999999999999764 67
Q ss_pred EEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 92 FFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
++|||||++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999987765 679999999999999999999999999999999999999999999999999998654322
Q ss_pred CCC-ccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhccc--CCCCCCCHHH
Q 015005 170 NDG-LLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKAEY--EFPPWISCDA 245 (414)
Q Consensus 170 ~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~ 245 (414)
... ......||+.|+|||++.+..++ .++|||||||++|+|+| |..||.+.+..+...++..... +.|+.+|+++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 221 22344678899999999987775 88999999999999998 8999999999998888876654 4566789999
Q ss_pred HHHHHhhcccCcCCCCChHHHhc
Q 015005 246 RRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 246 ~~li~~~L~~dp~~R~s~~eil~ 268 (414)
.+||.+||+.||++|||++||++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=408.42 Aligned_cols=252 Identities=22% Similarity=0.405 Sum_probs=218.2
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCC-------eEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQ-------ESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVM 85 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 85 (414)
-.++|++++.||+|+||.||+|++..++ ..||||+++++.... ....+.+|...+.++ +|||||++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH--HHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3579999999999999999999876554 479999997655432 356788899999888 899999999999
Q ss_pred EeCCEEEEEEEccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEE
Q 015005 86 ATKTKVFFVIEYVKGGELFAKVLKG-----------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLL 148 (414)
Q Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl 148 (414)
.+++.+|+|||||++|+|.+++... .+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 9999999999999999999999742 48999999999999999999999999999999999999
Q ss_pred cCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHH
Q 015005 149 DENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMY 227 (414)
Q Consensus 149 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~ 227 (414)
+.++.+||+|||+++..............+||+.|+|||.+.+..|+ .++|||||||++|+|++ |.+||.+.+....+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 99999999999999977665555556667899999999999988886 89999999999999998 79999998888888
Q ss_pred HHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 228 RKIFKA-EYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 228 ~~i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
..+..+ .+..|.++++++.+||.+||+.||++|||+.||++
T Consensus 248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 777655 45678889999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=409.19 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=203.9
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECC-----CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEe
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLV-----TQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMAT 87 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 87 (414)
-.++|++++.||+|+||+||+|.+.. +++.||||++....... ..+.+.+|..++.++ +||||+.+++++..
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH--HHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 34789999999999999999998654 45789999997544332 245677888887776 78999999999865
Q ss_pred C-CEEEEEEEccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEc
Q 015005 88 K-TKVFFVIEYVKGGELFAKVLK-----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLD 149 (414)
Q Consensus 88 ~-~~~~lv~E~~~gg~L~~~i~~-----------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~ 149 (414)
. ..+|+|||||+||+|.+++.. ..+++.++..++.|++.||+|||++||+||||||+|||++
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 168 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence 4 578999999999999999864 2489999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcC-CCCCCCchHHHHHH
Q 015005 150 ENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG-FLPFQNENIMKMYR 228 (414)
Q Consensus 150 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~ 228 (414)
.++++||+|||+|+..............+||+.|+|||++.+..|+ .++|||||||++|+|++| ..||.+.+....+.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999865543333445567899999999999988775 899999999999999986 57887765444443
Q ss_pred H-HHhc-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 229 K-IFKA-EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 229 ~-i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
. +..+ .+..|..+++++.+||.+||+.||++|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 3333 456677899999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=406.51 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=215.0
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeE--EEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQES--VAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMATKTK 90 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 90 (414)
-.++|++.+.||+|+||+||+|.+..+|.. ||||.+..... ....+.+.+|+++|+++ +|||||++++++.+++.
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 356899999999999999999999888875 66777654332 22356789999999999 79999999999999999
Q ss_pred EEEEEEccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCC
Q 015005 91 VFFVIEYVKGGELFAKVLK-----------------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGN 153 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~-----------------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~ 153 (414)
+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 9999999999999999853 46899999999999999999999999999999999999999999
Q ss_pred eEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcC-CCCCCCchHHHHHHHHHh
Q 015005 154 LKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG-FLPFQNENIMKMYRKIFK 232 (414)
Q Consensus 154 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~ 232 (414)
+||+|||+|+..... ......+||+.|+|||.+.+..|+ .++|||||||++|+|++| .+||.+.+..+.+..+..
T Consensus 166 ~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 166 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred eEEcccccccccccc---ccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 999999999864432 223456799999999999988885 889999999999999996 568999888888888776
Q ss_pred c-ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 233 A-EYEFPPWISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 233 ~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+ .++.|..+++++.+||.+||+.||++|||+.||+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5 456677899999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-54 Score=397.11 Aligned_cols=243 Identities=26% Similarity=0.426 Sum_probs=207.2
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEE-eCCEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMA-TKTKVF 92 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~ 92 (414)
-.++|++++.||+|+||.||+|++ .|..||||+++++. ..+.+.+|++++++++||||+++++++. +.+.+|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 456899999999999999999986 57889999997543 2467889999999999999999999985 456789
Q ss_pred EEEEccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCccccccc
Q 015005 93 FVIEYVKGGELFAKVLK---GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLW 169 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~---~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 169 (414)
+||||+++|+|.+++.+ ..+++..++.++.|++.||.|||+++|+||||||+|||++.+|++||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--
Confidence 99999999999999875 2599999999999999999999999999999999999999999999999999985432
Q ss_pred CCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 015005 170 NDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKMYRKIFKA-EYEFPPWISCDARR 247 (414)
Q Consensus 170 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 247 (414)
......+|+.|+|||++.+..++ .++|||||||++|+|+| |..||...+..+....+..+ .+++|+.+++++.+
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred ---CCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 23455789999999999888875 89999999999999998 79999998888888777654 45778889999999
Q ss_pred HHHhhcccCcCCCCChHHHhcC
Q 015005 248 LISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 248 li~~~L~~dp~~R~s~~eil~h 269 (414)
||++||+.||.+|||+.+++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=402.99 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=221.3
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEECC-----CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNLV-----TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT 87 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 87 (414)
+-.++|++++.||+|+||+||+|.+.. ++..||||++++.... .....+.+|++++++++||||+++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh--HHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 345899999999999999999998752 4578999999765432 235678999999999999999999999999
Q ss_pred CCEEEEEEEccCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEE
Q 015005 88 KTKVFFVIEYVKGGELFAKVLK-----------GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKV 156 (414)
Q Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-----------~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl 156 (414)
++..++||||+++|+|.+++.. ..++...+..++.|++.||.|||+++|+||||||+|||++.++++||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 9999999999999999988753 13688999999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcC-CCCCCCchHHHHHHHHHhccc
Q 015005 157 SDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSG-FLPFQNENIMKMYRKIFKAEY 235 (414)
Q Consensus 157 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~ 235 (414)
+|||+|+..............+||+.|+|||.+.+..++ .++|||||||++|+|+|| .+||.+.+..+.+..+..+..
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 999999876544333344555799999999999988875 789999999999999997 689999988888888877554
Q ss_pred -CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 236 -EFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 236 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
..|+.+++.+.+||.+||+.||++|||+.+|++
T Consensus 254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 567789999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=401.67 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=216.6
Q ss_pred cccCCEEEeeeeeecCCeEEEEEEEC-----CCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCccceEEEEE
Q 015005 13 ILFGKYEMGRMLGQGTFAKVYYGKNL-----VTQESVAIKVINKDQVKKQGLMEQIKREISVMRLV-KHPNIVELKEVMA 86 (414)
Q Consensus 13 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 86 (414)
+-.++|++++.||+|+||+||+|.+. .+++.||||+++..... .....+.+|+.+++.+ +|||||++++++.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 33579999999999999999999753 46789999999765432 2356788999999999 6999999999999
Q ss_pred eCCEEEEEEEccCCCchHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEE
Q 015005 87 TKTKVFFVIEYVKGGELFAKVLKG-------------------KLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLL 147 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~-------------------~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NIL 147 (414)
++..+|+|||||+||+|.+++... .+++..+..++.||+.||+|||++|++||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 999999999999999999998652 4899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhc-CCCCCCCchHHHH
Q 015005 148 LDENGNLKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLS-GFLPFQNENIMKM 226 (414)
Q Consensus 148 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 226 (414)
++.++.+|++|||+++..............+||+.|+|||++.+..++ .++|||||||++|+|+| |.+||...+..+.
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876543333344556899999999999887775 89999999999999998 6777777666555
Q ss_pred HHHHHhc--ccCCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 227 YRKIFKA--EYEFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 227 ~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
+.++... .+..|..+|+++.+||.+||++||++|||++||++
T Consensus 257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5555443 33456678999999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=387.41 Aligned_cols=247 Identities=24% Similarity=0.321 Sum_probs=204.7
Q ss_pred EeeeeeecCCeEEEEEEECCCC---eEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEe-CCEEEEEE
Q 015005 20 MGRMLGQGTFAKVYYGKNLVTQ---ESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMAT-KTKVFFVI 95 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv~ 95 (414)
..++||+|+||+||+|.+..++ ..||||.+++.. .....+++.+|+++|++++|||||++++++.. +...++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3678999999999999986643 369999996533 23346789999999999999999999999875 56899999
Q ss_pred EccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCCcccccccC--C
Q 015005 96 EYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALPEQLWN--D 171 (414)
Q Consensus 96 E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--~ 171 (414)
|||++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||+++....... .
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999999998886 4688899999999999999999999999999999999999999999999999986543211 1
Q ss_pred CccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCc-hHHHHHHHHHhc-ccCCCCCCCHHHHHHH
Q 015005 172 GLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNE-NIMKMYRKIFKA-EYEFPPWISCDARRLI 249 (414)
Q Consensus 172 ~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~-~~~~~~~~s~~~~~li 249 (414)
.......||+.|+|||.+.+..++ .++||||||+++|+|++|..||... +..+....+..+ .+..|+.+++++.+||
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li 267 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM 267 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHH
Confidence 223345689999999999888775 8999999999999999977776553 344445555554 4456778999999999
Q ss_pred HhhcccCcCCCCChHHHhcC
Q 015005 250 SRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 250 ~~~L~~dp~~R~s~~eil~h 269 (414)
.+||+.||++|||+.||++|
T Consensus 268 ~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 268 LKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-50 Score=383.87 Aligned_cols=255 Identities=22% Similarity=0.278 Sum_probs=203.3
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC-ccceEEEEEeCCEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPN-IVELKEVMATKTKVFF 93 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~l 93 (414)
.++|++++.||+|+||+||+|++..+|+.||||++..+... +.+.+|+++++.++|+| |+.+.+++.+.+..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 35899999999999999999999999999999998765432 34778999999997766 5556667788899999
Q ss_pred EEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC---CCCeEEeecCCCcccccc
Q 015005 94 VIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---NGNLKVSDFGLSALPEQL 168 (414)
Q Consensus 94 v~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~---~~~~kl~DFGla~~~~~~ 168 (414)
||||+.+ +|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+.....
T Consensus 81 vme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 81 VMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999955 55555443 68999999999999999999999999999999999999863 457999999999865432
Q ss_pred cC-----CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchHHHHHHH---HHhcc-----c
Q 015005 169 WN-----DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENIMKMYRK---IFKAE-----Y 235 (414)
Q Consensus 169 ~~-----~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~---i~~~~-----~ 235 (414)
.. .......+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||........... ..... .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 21 1233456799999999999998885 899999999999999999999987554432222 21111 1
Q ss_pred CCCCCCCHHHHHHHHhhcccCcCCCCChHH---HhcCCccccCC
Q 015005 236 EFPPWISCDARRLISRILVADPQKRISVSE---IMINPWFIKGF 276 (414)
Q Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e---il~hp~f~~~~ 276 (414)
..++.+|+++.+||.+||+.||++||++++ +|+|+|...+.
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 234568999999999999999999999874 57888765543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.5e-50 Score=378.09 Aligned_cols=250 Identities=20% Similarity=0.277 Sum_probs=208.5
Q ss_pred ccccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-CCccceEEEEEeCCE
Q 015005 12 NILFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH-PNIVELKEVMATKTK 90 (414)
Q Consensus 12 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~ 90 (414)
+++.++|++++.||+|+||+||+|++..+|+.||||+++..... ..+.+|+++++.++| +|++.+++++.....
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 75 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 75 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence 35678999999999999999999999999999999998765322 346789999999965 899999999999999
Q ss_pred EEEEEEccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcC-----CCCeEEeecCCCc
Q 015005 91 VFFVIEYVKGGELFAKVLK--GKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-----NGNLKVSDFGLSA 163 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~-----~~~~kl~DFGla~ 163 (414)
.|+||||+ |++|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99999999 6888888875 57999999999999999999999999999999999999974 5789999999998
Q ss_pred ccccccC-----CCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCch---HHHHHHHHHhccc
Q 015005 164 LPEQLWN-----DGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNEN---IMKMYRKIFKAEY 235 (414)
Q Consensus 164 ~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~ 235 (414)
....... .......+||+.|||||++.+..++ .++|||||||++|+|++|..||.+.. ....+.++.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 6543211 1234456899999999999988875 89999999999999999999997542 3333333332221
Q ss_pred -----CCCCCCCHHHHHHHHhhcccCcCCCCChHHHhc
Q 015005 236 -----EFPPWISCDARRLISRILVADPQKRISVSEIMI 268 (414)
Q Consensus 236 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 268 (414)
..++.+|+++.+++..|+..+|++||+.+.+.+
T Consensus 234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 223568899999999999999999999877643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=377.84 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=194.4
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----E
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNIVELKEVMATKT----K 90 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 90 (414)
...|.+.+.||+|+||+||+|+. +|+.||||+++.+... ......|+..+..++|||||++++++.+.+ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 45799999999999999999985 7899999999654321 122234555566789999999999997654 6
Q ss_pred EEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 91 VFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS--------RGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~--------~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
+|+|||||++|+|.+++.+..+++.....++.|++.||+|+|+ +||+||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 8999999999999999999899999999999999999999996 69999999999999999999999999999
Q ss_pred cccccccC--CCccccccCCCcccCchhhcccCC-----CCCccchhhhhhhhhhhhcCCCCCCCc--------------
Q 015005 163 ALPEQLWN--DGLLHTQCGTPAYVAPEVLRKKGY-----DGAKSDIWSCGVVLFVLLSGFLPFQNE-------------- 221 (414)
Q Consensus 163 ~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~-------------- 221 (414)
+....... .......+||+.|+|||++.+... .+.++|||||||+||+|+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 86543211 123445789999999999876431 135799999999999999998876431
Q ss_pred -hHHHHHHHHHhccc--CCCCC-----CCHHHHHHHHhhcccCcCCCCChHHHhcC
Q 015005 222 -NIMKMYRKIFKAEY--EFPPW-----ISCDARRLISRILVADPQKRISVSEIMIN 269 (414)
Q Consensus 222 -~~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dp~~R~s~~eil~h 269 (414)
+............. .+|.. .+..+.+|+.+||+.||++|||+.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22233333332222 22222 22358899999999999999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-48 Score=377.00 Aligned_cols=257 Identities=25% Similarity=0.442 Sum_probs=201.6
Q ss_pred hhhcccc-CCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-----------CC
Q 015005 9 RVRNILF-GKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-----------HP 76 (414)
Q Consensus 9 ~~~~~~~-~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-----------hp 76 (414)
.+|+.+. +||++++.||+|+||+||+|++..+|+.||||+++++... .+.+.+|+.+++.++ ||
T Consensus 5 ~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 5 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp CTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 3577765 6799999999999999999999999999999999865432 356778898888775 57
Q ss_pred CccceEEEEEe--CCEEEEEEEccCCCchHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEecCCCCcEEEc
Q 015005 77 NIVELKEVMAT--KTKVFFVIEYVKGGELFAKVL----KGKLKEESARKYFQQLISAVDFCHS-RGVYHRDLKPENLLLD 149 (414)
Q Consensus 77 nIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~----~~~~~e~~~~~~~~ql~~al~~lH~-~gi~HrDlkp~NILl~ 149 (414)
||+++++++.. ....+++|+++..+....... ...+++..++.++.|++.||+|||+ +||+||||||+|||++
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence 89999988754 467778888776654333222 2579999999999999999999998 8999999999999998
Q ss_pred CCCC------eEEeecCCCcccccccCCCccccccCCCcccCchhhcccCCCCCccchhhhhhhhhhhhcCCCCCCCchH
Q 015005 150 ENGN------LKVSDFGLSALPEQLWNDGLLHTQCGTPAYVAPEVLRKKGYDGAKSDIWSCGVVLFVLLSGFLPFQNENI 223 (414)
Q Consensus 150 ~~~~------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~ 223 (414)
.++. ++++|||.|..... .....+||+.|+|||++.+..|+ .++||||+||++++|++|+.||...+.
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCcc
Confidence 7654 99999999975432 33567899999999999988886 899999999999999999999975432
Q ss_pred H------HHHHH---HHh---------------------------------------cccCCCCCCCHHHHHHHHhhccc
Q 015005 224 M------KMYRK---IFK---------------------------------------AEYEFPPWISCDARRLISRILVA 255 (414)
Q Consensus 224 ~------~~~~~---i~~---------------------------------------~~~~~~~~~s~~~~~li~~~L~~ 255 (414)
. ..... +.. .....+...++++.+||.+||++
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 1 11110 000 00111122466799999999999
Q ss_pred CcCCCCChHHHhcCCccccC
Q 015005 256 DPQKRISVSEIMINPWFIKG 275 (414)
Q Consensus 256 dp~~R~s~~eil~hp~f~~~ 275 (414)
||.+|||++|+|+||||++.
T Consensus 315 dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 315 DPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp STTTCBCHHHHHTCGGGTTC
T ss_pred ChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=5.7e-27 Score=205.78 Aligned_cols=136 Identities=17% Similarity=0.289 Sum_probs=108.7
Q ss_pred EEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccc---------------hhhHHHHHHHHHHHHHhCCCCCccceE
Q 015005 18 YEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVK---------------KQGLMEQIKREISVMRLVKHPNIVELK 82 (414)
Q Consensus 18 y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~ 82 (414)
|.+++.||+|+||+||+|.+. +|+.||||+++..... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468999999999999999974 7899999987532111 011123456789999999999999988
Q ss_pred EEEEeCCEEEEEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEecCCCCcEEEcCCCCeEEeecCCC
Q 015005 83 EVMATKTKVFFVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLS 162 (414)
Q Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~~gi~HrDlkp~NILl~~~~~~kl~DFGla 162 (414)
++. . .+++|||++++.+. .+++..+..++.|++.+|.|||++||+||||||+|||+++++ ++|+|||+|
T Consensus 81 ~~~--~--~~lvme~~~~~~~~------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a 149 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELY------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 149 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGG------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTC
T ss_pred Eec--C--CEEEEEeecccccc------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCc
Confidence 663 2 26999999987653 355666788999999999999999999999999999998654 999999999
Q ss_pred ccc
Q 015005 163 ALP 165 (414)
Q Consensus 163 ~~~ 165 (414)
...
T Consensus 150 ~~~ 152 (191)
T d1zara2 150 VEV 152 (191)
T ss_dssp EET
T ss_pred ccC
Confidence 754
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.26 E-value=1.3e-11 Score=94.16 Aligned_cols=86 Identities=17% Similarity=0.224 Sum_probs=77.0
Q ss_pred cccccCChhHHHHHHHHHHHHcCCeEEEe-ceEEEEEeeecCCCcceEEEEEEEEec-CceEEEEEEecCCChHhHHHHh
Q 015005 315 MFTSKCSSSAIMGKLESLAKKLNLGVCVK-EFKVKMQGKDEGRKGKLAVTAEVYEVA-PEVAVVEFSKSAGDTLEYKKFC 392 (414)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~l~~~~ei~~~~-~~~~~v~~~k~~Gd~le~~~~~ 392 (414)
..||..++++|+.++.++++.+|+.+..+ .+.+......++.++.+.|++||+++. +++++|+|+|.+||+++|+++|
T Consensus 14 ~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~ 93 (102)
T d1ul7a_ 14 KTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 93 (102)
T ss_dssp CCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHH
T ss_pred ecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHH
Confidence 45888999999999999999999999865 488999887778889999999999994 7999999999999999999999
Q ss_pred hhhhhhhcc
Q 015005 393 EEDVRPALK 401 (414)
Q Consensus 393 ~~~l~~~l~ 401 (414)
. +|...|+
T Consensus 94 ~-~il~~l~ 101 (102)
T d1ul7a_ 94 S-KIANELK 101 (102)
T ss_dssp H-HHHHHCC
T ss_pred H-HHHHhcc
Confidence 8 6776664
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.76 E-value=2e-08 Score=90.00 Aligned_cols=141 Identities=16% Similarity=0.140 Sum_probs=97.6
Q ss_pred ccCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEE
Q 015005 14 LFGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKVF 92 (414)
Q Consensus 14 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 92 (414)
+...|+..+..+.++.+.||+.. ..+..+.+|+........ ...+.+|...++.+. +--+.+++.+..+++..|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 34578888876666678999886 566678889876543322 234678888888774 433678888889999999
Q ss_pred EEEEccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 015005 93 FVIEYVKGGELFAKVLKGKLKEESARKYFQQLISAVDFCHS--------------------------------------- 133 (414)
Q Consensus 93 lv~E~~~gg~L~~~i~~~~~~e~~~~~~~~ql~~al~~lH~--------------------------------------- 133 (414)
+||++++|..+........- ...+..++...+..||+
T Consensus 87 lv~~~l~G~~~~~~~~~~~~----~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQS----PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEEECCSSEEHHHHTTTCSC----HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEEeccccccccccccccc----HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999999887554322111 12223333333444442
Q ss_pred --------------------CCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 134 --------------------RGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 134 --------------------~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
..++|+|+.|.|||+++++..-|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 137999999999999877666799999886
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.24 E-value=2.2e-06 Score=75.82 Aligned_cols=74 Identities=12% Similarity=0.156 Sum_probs=53.0
Q ss_pred eeeecC-CeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--CCccceEEEEEeCCEEEEEEEccC
Q 015005 23 MLGQGT-FAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH--PNIVELKEVMATKTKVFFVIEYVK 99 (414)
Q Consensus 23 ~LG~G~-~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~~~ 99 (414)
.+..|. -+.||+... ..+..+.+|....... ..+..|...++.+.. -.+.+++.+..+++..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 344454 478998874 4667789998654432 246678888887743 336678888888899999999999
Q ss_pred CCch
Q 015005 100 GGEL 103 (414)
Q Consensus 100 gg~L 103 (414)
|-++
T Consensus 90 G~~~ 93 (255)
T d1nd4a_ 90 GQDL 93 (255)
T ss_dssp SEET
T ss_pred cccc
Confidence 8665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.23 E-value=2.1e-06 Score=81.56 Aligned_cols=81 Identities=15% Similarity=0.119 Sum_probs=51.2
Q ss_pred eeeeeecCCeEEEEEEECCCCeEEEEEEeeccc-cch---hhHHHHHHHHHHHHHhC-CC-C-CccceEEEEEeCCEEEE
Q 015005 21 GRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQ-VKK---QGLMEQIKREISVMRLV-KH-P-NIVELKEVMATKTKVFF 93 (414)
Q Consensus 21 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~-~~~---~~~~~~~~~Ei~il~~l-~h-p-nIv~l~~~~~~~~~~~l 93 (414)
.+.||.|....||++.+..+++.+++|...... ... .....+...|...|+.+ .+ | .+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567899999999999987788899999754211 000 01134566788888876 23 3 35556544 4556678
Q ss_pred EEEccCCCch
Q 015005 94 VIEYVKGGEL 103 (414)
Q Consensus 94 v~E~~~gg~L 103 (414)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987544
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.69 E-value=0.00013 Score=57.32 Aligned_cols=71 Identities=15% Similarity=0.252 Sum_probs=57.8
Q ss_pred cccCChhHHHHHHHHHHHHcCCeEEEe-ceEEEEEeeecCCCcceEEEEEEEEecCceEEEEEEecCCChHh
Q 015005 317 TSKCSSSAIMGKLESLAKKLNLGVCVK-EFKVKMQGKDEGRKGKLAVTAEVYEVAPEVAVVEFSKSAGDTLE 387 (414)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~l~~~~ei~~~~~~~~~v~~~k~~Gd~le 387 (414)
.|+..+.+|+..+-++++.||+.|++. .+.|++..........+.+..++|++.++.|||||+...|+-.|
T Consensus 6 rS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 6 RSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp EECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 456778899999999999999999975 48898876444444567899999999999999999999998765
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.40 E-value=0.00035 Score=63.80 Aligned_cols=128 Identities=17% Similarity=0.186 Sum_probs=75.9
Q ss_pred CeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCc-----cce--EEEEEeCCEEEEEEEccCCC
Q 015005 29 FAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKHPNI-----VEL--KEVMATKTKVFFVIEYVKGG 101 (414)
Q Consensus 29 ~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~l--~~~~~~~~~~~lv~E~~~gg 101 (414)
--.||++.. .+|..|++|+.+..... .+++..|...+..|...++ +.. -......+..+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 358999974 57888999998654332 3567788888887742222 111 12335577899999999875
Q ss_pred chH--------------HHHhc-----------------------------CCCCHHH---HHHHHHHHHHHHHHHH---
Q 015005 102 ELF--------------AKVLK-----------------------------GKLKEES---ARKYFQQLISAVDFCH--- 132 (414)
Q Consensus 102 ~L~--------------~~i~~-----------------------------~~~~e~~---~~~~~~ql~~al~~lH--- 132 (414)
.+. ..+.. ..++... ....+.++...+.-+-
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 331 00000 0011111 1222233333332221
Q ss_pred -hCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 133 -SRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 133 -~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
..+++|+|+.|.|||+++ + ..++||+-+.
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 247999999999999964 3 4689999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.33 E-value=0.00045 Score=64.85 Aligned_cols=75 Identities=12% Similarity=0.088 Sum_probs=51.0
Q ss_pred EeeeeeecCCeEEEEEEECC-------CCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEE
Q 015005 20 MGRMLGQGTFAKVYYGKNLV-------TQESVAIKVINKDQVKKQGLMEQIKREISVMRLVK-HPNIVELKEVMATKTKV 91 (414)
Q Consensus 20 ~~~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 91 (414)
-++.|+.|-.-.+|++.... ..+.|.+++.-... . .....+|..+++.+. +.-..++++++.+
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 34678999999999997643 24567777764221 1 234568999999884 4334577777643
Q ss_pred EEEEEccCCCch
Q 015005 92 FFVIEYVKGGEL 103 (414)
Q Consensus 92 ~lv~E~~~gg~L 103 (414)
.+|+||++|..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 589999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.27 E-value=0.00052 Score=62.10 Aligned_cols=142 Identities=13% Similarity=0.147 Sum_probs=77.6
Q ss_pred cCCEEEeeeeeecCCeEEEEEEECCCCeEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-----CCccce---EEEEE
Q 015005 15 FGKYEMGRMLGQGTFAKVYYGKNLVTQESVAIKVINKDQVKKQGLMEQIKREISVMRLVKH-----PNIVEL---KEVMA 86 (414)
Q Consensus 15 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~Ei~il~~l~h-----pnIv~l---~~~~~ 86 (414)
.|...-.+.|..|---+.|+.... . ..+++|++..... .+.+..|+.++..|.. |..+.. ..+..
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~-~-g~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTT-K-DPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEES-S-CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCceEeecCCCCcccCeEEEEEC-C-CcEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCCCccee
Confidence 344444555667777889998743 3 4599999865321 1345567777777632 222211 11223
Q ss_pred eCCEEEEEEEccCCCchHH--------------HHh---c-------------------------CCCCHHHHHHHHHHH
Q 015005 87 TKTKVFFVIEYVKGGELFA--------------KVL---K-------------------------GKLKEESARKYFQQL 124 (414)
Q Consensus 87 ~~~~~~lv~E~~~gg~L~~--------------~i~---~-------------------------~~~~e~~~~~~~~ql 124 (414)
.......++.+..|..... .+. . ...........+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence 3566777777777643210 000 0 000111122223333
Q ss_pred HHHHHHHH----hCCcEEecCCCCcEEEcCCCCeEEeecCCCc
Q 015005 125 ISAVDFCH----SRGVYHRDLKPENLLLDENGNLKVSDFGLSA 163 (414)
Q Consensus 125 ~~al~~lH----~~gi~HrDlkp~NILl~~~~~~kl~DFGla~ 163 (414)
...+...+ ..|++|+|+.+.|++++.+...-|+||+.+.
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 33333333 2589999999999999988877899999886
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=96.57 E-value=0.004 Score=47.59 Aligned_cols=64 Identities=13% Similarity=0.232 Sum_probs=49.2
Q ss_pred ccccCChhHHHHHHHHHHHHcCCeEEEec----------eEEEEEeeec-----CCCcceEEEEEEEEecCceEEEEEE
Q 015005 316 FTSKCSSSAIMGKLESLAKKLNLGVCVKE----------FKVKMQGKDE-----GRKGKLAVTAEVYEVAPEVAVVEFS 379 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~i~~~~~~~-----~~~~~l~~~~ei~~~~~~~~~v~~~ 379 (414)
+.|+..+.+++..+-++++.||+.++..+ +.|++.-..+ +....+.+.+++|++.++.+||||+
T Consensus 7 IRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlDFK 85 (127)
T d2qrda1 7 VRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVK 85 (127)
T ss_dssp EEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEE
T ss_pred cccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEEEc
Confidence 35667888999999999999999998522 6787753211 1223467899999999999999997
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=95.95 E-value=0.012 Score=47.31 Aligned_cols=65 Identities=14% Similarity=0.258 Sum_probs=46.2
Q ss_pred ccccCChhHHHHHHHHHHHHcCCeEEEe---c-eEEEEEeeec---------CCCcceEEEEEEEEecCceEEEEEEe
Q 015005 316 FTSKCSSSAIMGKLESLAKKLNLGVCVK---E-FKVKMQGKDE---------GRKGKLAVTAEVYEVAPEVAVVEFSK 380 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~i~~~~~~~---------~~~~~l~~~~ei~~~~~~~~~v~~~k 380 (414)
+.|...+-+++..+-++++.||+.|+.. + +.|++....+ .....+.+.+++|++.++.+||||+-
T Consensus 50 IRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlDFK~ 127 (171)
T d2qlva1 50 IRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFKF 127 (171)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEEEEE
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEEEec
Confidence 5677889999999999999999999863 2 7777753211 11123678999999999999999974
|